"Age","Gender","AMITRIPTYLINE","BUPROPION","CITALOPRAM","DESVENLAFAXINE","DOXEPIN","DULOXETINE","ESCITALOPRAM","FLUOXETINE","MIRTAZAPINE","NORTRIPTYLINE","PAROXETINE","ROPINIROLE","SERTRALINE","TRAZODONE","VENLAFAXINE","OTHER","Description1","Description2","Description3","Description4","Description5","Description6","Description7"
"13-19","Female",0.01200800534,0.06676386305,0.2838842322,0.2824716267,0.1089552239,0.2120123203,0.1374918843,0.2625168077,0.1077731881,0.04090909091,0.2529902138,0.1328125,0.298520142,0.04183639767,0.2990056818,0.1876975494,NA,NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.3619047619,NA,NA,NA,NA,0.3838862559,NA,NA,NA,"ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,0.03571428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4198895028,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1255230126,NA,NA,NA,NA,NA,0.3865336658,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.2983870968,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3703703704,NA,NA,NA,"ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.3287197232,NA,NA,NA,NA,NA,NA,NA,NA,"ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.3888888889,NA,NA,NA,NA,NA,NA,NA,NA,"ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659)","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1333333333,NA,NA,NA,"ADJUSTMENT DISORDER WITH ANXIETY (dxo:ICD9:30924)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.06944444444,0.1388888889,NA,NA,NA,NA,0.1893491124,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"13-19","Female",NA,0.02416918429,NA,NA,NA,NA,0.1317829457,NA,NA,NA,NA,NA,0.3620689655,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09322033898,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.07643312102,0.1764705882,NA,NA,NA,NA,0.1834862385,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"13-19","Female",NA,NA,0.1617161716,NA,NA,NA,0.08505747126,0.1279863481,NA,NA,NA,NA,0.1392961877,NA,NA,0.1226415094,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.119047619,NA,NA,NA,NA,0.1391304348,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1960784314,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.07446808511,0.1590106007,NA,NA,NA,NA,0.1637168142,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1590909091,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA
"13-19","Female",NA,0.02479338843,NA,NA,NA,NA,NA,0.1282051282,NA,NA,NA,NA,0.186746988,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.0589569161,0.201754386,NA,NA,NA,NA,0.1658536585,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.3858267717,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALBUTEROL",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1530054645,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALBUTEROL SULFATE",NA,NA,NA,NA,NA,NA
"13-19","Female",0.01582591494,0.06422018349,0.2702702703,NA,NA,0.1677419355,0.1086956522,0.234939759,NA,NA,NA,NA,0.2765957447,NA,0.4403669725,0.2056410256,"AMITRIPTYLINE HCL",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1383928571,"AMITRIPTYLINE HCL","BUPROPION HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.3816793893,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.223880597,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.2105263158,NA,NA,NA,NA,NA,NA,NA,NA,0.1478873239,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"13-19","Female",0.01388888889,NA,NA,NA,NA,NA,NA,0.3700440529,NA,NA,NA,NA,NA,NA,NA,0.2008196721,"AMITRIPTYLINE HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"13-19","Female",0.01315789474,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"13-19","Female",0.006802721088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss",NA,NA,NA,NA
"13-19","Female",0.007407407407,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.09433962264,0.3461538462,NA,NA,NA,NA,0.3881578947,NA,NA,0.27734375,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"13-19","Female",0.00542888165,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"13-19","Female",0.02112676056,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3639240506,NA,NA,0.2051282051,"AMITRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.170984456,"AMITRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,0.04724409449,NA,NA,NA,NA,0.1193016489,0.3107344633,NA,NA,0.2756756757,NA,0.5092592593,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1454545455,0.3168316832,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.24375,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1055276382,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.05882352941,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.08762886598,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.0701754386,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1176470588,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.1981981982,NA,NA,0.08666666667,0.05586592179,0.1635220126,NA,NA,NA,NA,0.1224489796,NA,0.1513157895,NA,"ARIPIPRAZOLE",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09174311927,"ARIPIPRAZOLE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.2045454545,NA,NA,NA,NA,NA,NA,NA,0.1120689655,"ARIPIPRAZOLE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1153846154,NA,NA,NA,"ARIPIPRAZOLE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1724137931,NA,NA,0.09589041096,"ARIPIPRAZOLE","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,0.03846153846,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,0.03846153846,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)",NA,NA,NA,NA,NA
"13-19","Female",NA,0.04195804196,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","BUPROPION HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,0.01657458564,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"13-19","Female",NA,0.04790419162,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"13-19","Female",NA,0.04365904366,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1968085106,NA,NA,NA,NA,NA,0.3937823834,NA,NA,NA,"AZITHROMYCIN",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,0.04494581631,0.2174688057,NA,NA,0.1415929204,0.121927237,0.2466555184,NA,NA,0.2234042553,NA,0.2630434783,0.03351955307,0.25,0.2142857143,"BUPROPION HCL",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,0.05445544554,0.327510917,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.234375,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.16,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1455696203,"BUPROPION HCL","DULOXETINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,0.02341137124,NA,NA,NA,NA,0.1930232558,0.248,NA,NA,NA,NA,0.2676056338,NA,NA,0.1844660194,"BUPROPION HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1652173913,"BUPROPION HCL","ESCITALOPRAM OXALATE","FLUOXETINE HCL",NA,NA,NA,NA
"13-19","Female",NA,0.0206185567,NA,NA,NA,NA,0.2878787879,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1443850267,"BUPROPION HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,0.06363636364,NA,NA,NA,NA,0.1139240506,0.2506224066,NA,NA,NA,NA,0.2117647059,NA,NA,0.2163225172,"BUPROPION HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,0.04519774011,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1441441441,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1962616822,"BUPROPION HCL","FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2242990654,"BUPROPION HCL","FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.2746478873,NA,NA,NA,NA,0.3361344538,NA,NA,0.1743119266,"BUPROPION HCL","FLUOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,0.04605263158,NA,NA,NA,NA,NA,0.1804511278,NA,NA,NA,NA,NA,NA,NA,0.158490566,"BUPROPION HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1666666667,NA,NA,NA,NA,NA,NA,NA,0.09243697479,"BUPROPION HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09558823529,"BUPROPION HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1554054054,NA,NA,NA,NA,NA,0.4272727273,0.04545454545,NA,0.2283464567,"BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"13-19","Female",NA,0.02312138728,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,0.02898550725,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,0.02482269504,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"13-19","Female",NA,0.01485148515,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"13-19","Female",NA,0.01694915254,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5378787879,"BUPROPION HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5267857143,"BUPROPION HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5403726708,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"13-19","Female",NA,0.3450134771,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4070660522,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3076923077,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3341968912,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1927083333,"BUPROPION HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5339805825,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1857923497,"BUPROPION HCL","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1704781705,"BUPROPION HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,0.05128205128,NA,NA,NA,NA,NA,NA,NA,NA,0.2722513089,NA,NA,NA,NA,0.2407407407,"BUPROPION HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,0.07604562738,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1525423729,0.05208333333,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1653543307,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07627118644,"BUPROPION HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1393442623,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,NA,NA,NA,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06779661017,"BUPROPION HCL","RISPERIDONE",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08771929825,"BUPROPION HCL","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,0.03237410072,0.1982758621,NA,NA,NA,0.1229050279,0.2298387097,NA,NA,NA,NA,0.3023474178,NA,NA,0.2297297297,"BUPROPION HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,0.06086956522,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1417624521,"BUPROPION HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,0.04943502825,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0157480315,NA,0.1760738374,"BUPROPION HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,0.06481481481,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3072916667,0.1700288184,"BUPROPION HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1641791045,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CEFDINIR",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.3725490196,NA,NA,NA,0.08256880734,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CETIRIZINE HCL",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.09090909091,NA,NA,NA,NA,NA,0.3511450382,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",NA,NA,NA,NA,NA,NA
"13-19","Female",0.02586206897,0.04754601227,0.3401572467,NA,NA,0.198757764,0.1392857143,0.2339075249,NA,NA,0.2025723473,NA,0.2726574501,0.005208333333,0.4397590361,0.1703406814,"CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.25,NA,NA,NA,NA,NA,NA,NA,NA,0.1601941748,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"13-19","Female",NA,0.06956521739,0.2990936556,NA,NA,NA,NA,0.3112244898,NA,NA,NA,NA,0.2516556291,NA,NA,0.1546052632,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1570247934,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,0.2941176471,NA,NA,NA,0.06741573034,0.22,NA,NA,NA,NA,0.256097561,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.05504587156,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA,NA
"13-19","Female",NA,NA,0.2679425837,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"13-19","Female",NA,NA,0.2313432836,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"13-19","Female",NA,NA,0.2843137255,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"13-19","Female",NA,NA,0.2672413793,NA,NA,NA,NA,0.1923076923,NA,NA,NA,NA,0.2713178295,NA,NA,0.06611570248,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"13-19","Female",NA,NA,0.1227436823,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LAMOTRIGINE",NA,NA,NA,NA,NA
"13-19","Female",NA,0.02830188679,NA,NA,NA,NA,0.1567567568,0.3413173653,NA,NA,NA,NA,0.3577586207,0,NA,0.2009345794,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.247706422,NA,NA,NA,NA,NA,NA,NA,NA,0.369047619,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.2548108825,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.2209302326,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"13-19","Female",NA,NA,0.2647058824,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Female",NA,NA,0.5742092457,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.575,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.472,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.2926829268,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1203703704,NA,NA,0.1036585366,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.2242990654,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06703910615,"CITALOPRAM HYDROBROMIDE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.4344827586,NA,NA,NA,NA,0.1557377049,NA,NA,NA,NA,0.1455696203,NA,NA,0.09142857143,"CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.5815602837,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA
"13-19","Female",NA,0.03921568627,0.312039312,NA,NA,NA,0.2115384615,0.2173913043,NA,NA,NA,NA,0.3164179104,NA,NA,0.1397379913,"CITALOPRAM HYDROBROMIDE","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.2385057471,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.016,NA,0.1883333333,"CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.2890625,NA,NA,NA,NA,0.3023255814,NA,NA,NA,NA,0.2962962963,NA,NA,NA,"CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.214953271,NA,NA,NA,NA,0.2246376812,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",NA,NA,NA,NA,NA,NA
"13-19","Female",0.02312138728,0.02717391304,0.3349056604,NA,NA,NA,0.1330589849,0.31678487,NA,NA,0.304,NA,0.4180138568,0.04568527919,0.4194630872,0.1604278075,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.513986014,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.3315789474,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.504587156,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"13-19","Female",0.005128205128,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.06086956522,0.1604938272,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"13-19","Female",NA,0.07284768212,NA,NA,NA,NA,NA,0.09803921569,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.3190954774,NA,NA,NA,NA,0.4013157895,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5271317829,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4444444444,NA,NA,NA,"DESOGESTREL-ETHINYL ESTRADIOL",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,0.2973760933,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1700680272,"DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.09036144578,0.2869565217,NA,NA,NA,NA,0.4303482587,NA,NA,NA,"DEXTROAMPHETAMINE/AMPHETAMINE",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4722222222,NA,NA,NA,"DEXTROAMPHETAMINE/AMPHETAMINE","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5169491525,NA,NA,NA,"DEXTROAMPHETAMINE/AMPHETAMINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.2816901408,NA,NA,NA,NA,NA,NA,NA,NA,"DIZZINESS AND GIDDINESS (dxo:ICD9:7804)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,0.1555555556,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1883116883,"DOXEPIN HCL",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,0.2396053559,0.1639344262,NA,NA,NA,NA,NA,NA,NA,NA,0.1465076661,"DULOXETINE HCL",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1428571429,"DULOXETINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.149122807,"DULOXETINE HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,0.06481481481,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,0.1237458194,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,0.3865546218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,0.2151394422,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1448598131,"DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Female",0.01162790698,0.03526448363,0.4004237288,NA,NA,0.3245614035,0.1820750908,0.2246056782,0.07185628743,NA,0.2397959184,NA,0.2517613903,0.03892215569,0.4423076923,0.139314845,"ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,0.04347826087,NA,NA,NA,NA,0.1585160202,0.2937293729,NA,NA,NA,NA,0.2114695341,NA,NA,0.1348511384,"ESCITALOPRAM OXALATE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1538461538,0.2566371681,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1240310078,NA,NA,NA,NA,NA,NA,NA,NA,0.1466666667,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05769230769,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"13-19","Female",NA,NA,0.2293577982,NA,NA,NA,0.1347708895,0.1384615385,NA,NA,NA,NA,0.203125,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05454545455,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1214285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.09401709402,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.09865470852,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1111111111,NA,NA,NA,NA,NA,0.1944444444,NA,NA,0.06474820144,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1139240506,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06626506024,"ESCITALOPRAM OXALATE","LAMOTRIGINE",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05940594059,"ESCITALOPRAM OXALATE","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,0.03001876173,0.4761904762,NA,NA,NA,NA,0.3344947735,NA,NA,NA,NA,0.3737113402,0.04975124378,0.4695121951,0.1133603239,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.2857142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.2016806723,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08296943231,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Female",NA,0.03333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.2397660819,NA,NA,NA,NA,NA,NA,0.007462686567,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4936708861,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1015089163,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1283783784,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.06796116505,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.09302325581,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1446540881,NA,NA,NA,NA,NA,0.2173913043,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.4697336562,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.5034482759,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.3817330211,NA,NA,NA,NA,NA,NA,NA,NA,0.4105263158,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1709401709,"ESCITALOPRAM OXALATE","MIRTAZAPINE",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1184210526,"ESCITALOPRAM OXALATE","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1587301587,NA,NA,NA,NA,0.1428571429,NA,NA,0.05381165919,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02290076336,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.165,NA,NA,NA,NA,0.1772151899,NA,NA,NA,"ESCITALOPRAM OXALATE","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08465608466,"ESCITALOPRAM OXALATE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08612440191,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1984126984,0.1877022654,NA,NA,NA,NA,0.1623188406,NA,NA,0.1228070175,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1009174312,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1111111111,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,0.02816901408,NA,NA,NA,NA,0.1390728477,0.2112211221,NA,NA,NA,NA,0.3081861958,NA,NA,0.1330561331,"ESCITALOPRAM OXALATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1310344828,NA,NA,NA,NA,NA,0.2321428571,NA,NA,0.0981595092,"ESCITALOPRAM OXALATE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.170212766,NA,NA,NA,NA,NA,NA,0.01435406699,NA,0.1423401689,"ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1607142857,"ESCITALOPRAM OXALATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.3428571429,NA,NA,NA,0.1344537815,NA,NA,NA,NA,NA,0.4372469636,NA,NA,NA,"ETHINYL ESTRADIOL/DROSPIRENONE",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1338582677,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ETHINYL ESTRADIOL/DROSPIRENONE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1982758621,NA,NA,NA,"FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"13-19","Female",NA,NA,0.1369047619,NA,NA,NA,NA,0.1869158879,NA,NA,NA,NA,0.1333333333,NA,NA,NA,"FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.125,NA,NA,NA,"FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1791044776,NA,NA,NA,"FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Female",0.02730375427,0.05855599773,0.2367549669,NA,NA,0.1914414414,0.1150372988,0.3042067234,0.09872611465,0.03738317757,0.2270363951,NA,0.2490504612,0.02272727273,0.3684210526,0.1542443064,"FLUOXETINE HCL",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.2169491525,NA,NA,NA,NA,0.15,NA,NA,0.05511811024,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1804511278,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1474654378,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.15,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"13-19","Female",NA,NA,0.2101910828,NA,NA,NA,0.07508532423,0.3181818182,NA,NA,NA,NA,0.2022058824,NA,0.2016806723,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.07389162562,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.0737704918,NA,NA,NA,NA,NA,0.1964285714,NA,NA,0.09302325581,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.2059620596,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1578947368,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1278195489,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.2085308057,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.171314741,NA,NA,NA,NA,0.09836065574,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1769230769,NA,NA,NA,NA,0.07843137255,NA,NA,0.06504065041,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"13-19","Female",NA,NA,0.188034188,NA,NA,NA,NA,0.25,NA,NA,NA,NA,0.1961722488,NA,NA,0.1066666667,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.252173913,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.21,NA,NA,NA,NA,NA,NA,NA,0.13,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1860465116,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1082024433,NA,NA,NA,NA,0.15625,NA,NA,0.04639175258,"FLUOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.07407407407,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LAMOTRIGINE","Last AD: Same & No Remiss",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.09243697479,NA,NA,NA,NA,NA,NA,NA,0.112,"FLUOXETINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,0.03488372093,0.3360655738,NA,NA,NA,0.1154791155,NA,NA,NA,NA,NA,0.3537234043,0.01860465116,NA,0.1956521739,"FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.4671532847,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1327433628,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.06299212598,NA,NA,NA,NA,NA,NA,NA,NA,0.09266409266,"FLUOXETINE HCL","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Female",NA,0.04132231405,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02105263158,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,0.2290076336,NA,NA,NA,NA,0.3,NA,NA,NA,NA,NA,0.4964539007,NA,NA,0.3344709898,"FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.2333582648,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.3090909091,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.3636363636,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1485849057,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1493506494,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.2244897959,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1597222222,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.245243129,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.3155893536,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.192513369,NA,NA,NA,NA,0.2671755725,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.2321428571,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.5131233596,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.5632183908,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.6019900498,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"13-19","Female",NA,0.357615894,NA,NA,NA,NA,0.3442622951,0.4236760125,NA,NA,NA,NA,0.3953488372,NA,NA,0.4037940379,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.4375,NA,NA,NA,NA,NA,NA,NA,0.2869565217,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.17,NA,NA,NA,NA,NA,NA,NA,0.1533742331,"FLUOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.4637681159,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1482649842,"FLUOXETINE HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.3381294964,NA,NA,0.3169014085,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.07826086957,NA,NA,NA,NA,0.226744186,NA,NA,NA,NA,0.1078431373,NA,NA,0.07142857143,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04651162791,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1927083333,NA,NA,NA,NA,NA,NA,NA,0.05555555556,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.2790697674,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.328,NA,NA,NA,NA,0.1523809524,NA,NA,NA,"FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09385113269,"FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.3403141361,NA,NA,NA,NA,NA,NA,NA,0.09170305677,"FLUOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07547169811,"FLUOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Female",NA,NA,0.1811594203,NA,NA,NA,0.05759162304,0.3488773748,NA,NA,NA,NA,0.1716981132,NA,0.1893491124,0.124260355,"FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1057692308,NA,NA,NA,"FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1102362205,"FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.25,NA,NA,NA,NA,NA,NA,NA,0.168,"FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1287128713,"FLUOXETINE HCL","RISPERIDONE",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.4847250509,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA
"13-19","Female",NA,0.05555555556,0.2723004695,NA,NA,NA,0.08656716418,0.272007913,NA,NA,NA,NA,0.285313377,NA,NA,0.1355932203,"FLUOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.219895288,NA,NA,NA,NA,0.2430555556,NA,NA,0.1403508772,"FLUOXETINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,0.04395604396,NA,NA,NA,NA,0.09649122807,0.2597799511,NA,NA,NA,NA,0.243902439,0.03076923077,NA,0.1598207618,"FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.3153153153,NA,NA,NA,NA,NA,NA,NA,0.1564885496,"FLUOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,0.03529411765,NA,NA,NA,NA,0.132183908,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.04807692308,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Female",NA,NA,0.4314720812,NA,NA,NA,0.1178451178,0.3407407407,NA,NA,0.3035714286,NA,0.4143426295,NA,0.6015625,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA,NA
"13-19","Female",0.004850746269,0.03738317757,NA,NA,NA,NA,NA,0.3189655172,NA,0.02450408401,NA,NA,0.4102564103,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA,NA
"13-19","Female",0.001739130435,NA,NA,NA,NA,NA,NA,NA,NA,0.04310344828,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA,NA
"13-19","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA
"13-19","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Female",0.006060606061,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1464788732,0.3475609756,NA,NA,NA,NA,0.3786407767,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.42,NA,NA,NA,"IBUPROFEN",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,0.01408450704,0.1502145923,NA,NA,NA,0.05521472393,0.1134020619,NA,NA,NA,NA,0.1438679245,0.01315789474,0.1590909091,0.09803921569,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.08653846154,NA,NA,NA,0.05769230769,0.09615384615,NA,NA,NA,NA,0.1361702128,NA,0.185840708,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1196581197,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","SERTRALINE HCL",NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.04444444444,0.08088235294,NA,NA,NA,NA,0.1288659794,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1610738255,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1790393013,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.06422018349,NA,NA,NA,NA,NA,0.1441441441,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.088,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.206779661,NA,NA,0.09302325581,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2075471698,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"13-19","Female",NA,NA,0.1756272401,NA,NA,0.1218274112,0.07672796449,0.1446679526,NA,NA,0.1521961185,NA,0.1597287184,0.04419889503,0.1866501854,0.06779661017,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.07246376812,0.1074380165,NA,NA,NA,NA,0.06722689076,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06862745098,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0396039604,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.05586592179,0.170212766,NA,NA,NA,NA,NA,NA,NA,0.09803921569,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.0572519084,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2393162393,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.152173913,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1361256545,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2603174603,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2717842324,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09756097561,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.632,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1538461538,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1043478261,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29623)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.05714285714,NA,NA,NA,0.3212121212,NA,0.1875,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,0.1547619048,NA,NA,NA,NA,0.1232394366,NA,NA,NA,NA,0.08602150538,0.05309734513,0.1266375546,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"13-19","Female",NA,NA,0.1428571429,NA,NA,NA,0.08602150538,0.1135371179,NA,NA,NA,NA,0.075,NA,0.1226415094,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1811594203,NA,NA,0.04026845638,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1153846154,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL",NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1078431373,NA,NA,NA,NA,0.2116788321,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1612903226,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1711711712,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","POSTTRAUMATIC STRESS DISORDER (dxo:ICD9:30981)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"13-19","Female",NA,NA,0.1577484364,NA,NA,0.09836065574,0.07190710138,0.1324599709,NA,NA,0.1390449438,NA,0.1469489415,0.02912621359,0.1381733021,0.1149897331,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"13-19","Female",NA,NA,0.1506849315,NA,NA,NA,NA,0.1161103048,NA,NA,0.1208791209,NA,0.1428571429,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA
"13-19","Female",NA,NA,0.2416666667,NA,NA,NA,NA,0.1904761905,NA,NA,NA,NA,0.3085714286,NA,NA,0.1203007519,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1225806452,NA,NA,NA,NA,0.1419354839,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1460674157,NA,NA,NA,NA,0.179245283,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA
"13-19","Female",NA,NA,0.2705882353,NA,NA,NA,0.06112469438,0.2213740458,NA,NA,NA,NA,0.3150470219,NA,0.2014925373,0.1067961165,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2605042017,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3564356436,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","VENLAFAXINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,0.1388888889,NA,NA,NA,0.07718120805,0.1279069767,NA,NA,NA,NA,0.1089918256,NA,0.08870967742,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1142857143,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2679738562,NA,NA,0.08870967742,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.3615384615,NA,NA,NA,NA,0.43359375,0.003875968992,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.09547738693,NA,NA,0.07112970711,0.06761565836,0.1119631902,NA,NA,NA,NA,0.1229050279,NA,0.1287128713,0.0648312611,"LAMOTRIGINE",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06451612903,NA,NA,NA,"LAMOTRIGINE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3162393162,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.0962962963,NA,NA,NA,NA,0.1037181996,NA,NA,0.08196721311,"LAMOTRIGINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07272727273,NA,NA,NA,"LAMOTRIGINE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09549795362,"LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09502262443,0.0737704918,"LAMOTRIGINE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Diff & No Remiss",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5350318471,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"13-19","Female",NA,0.0487804878,NA,NA,NA,NA,0.1157024793,NA,NA,NA,NA,NA,0.3965517241,NA,NA,NA,"Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.05454545455,0.104,NA,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.05970149254,NA,NA,NA,NA,NA,NA,NA,NA,0.1003584229,"Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,0.02962962963,0.2371134021,NA,NA,NA,0.108892922,0.3342465753,NA,NA,NA,NA,NA,0.02242152466,0.373015873,0.1920903955,"Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009803921569,NA,NA,"Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2290502793,"Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1941176471,NA,NA,"Last AD: Diff & Remiss",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,0.1267605634,NA,NA,NA,NA,0.2745098039,0.4375,NA,NA,NA,NA,NA,NA,NA,0.3805555556,"Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1486486486,NA,NA,"Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08860759494,"Last AD: Same & No Remiss",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1056910569,NA,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009803921569,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.38,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2166666667,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1761904762,NA,NA,NA,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2523364486,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3148148148,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)","SERTRALINE HCL",NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2319749216,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3705583756,NA,NA,NA,"Last AD: Same & No Remiss","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2669502127,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2358490566,NA,NA,0.1652173913,"Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009259259259,NA,NA,"Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2774674115,NA,"Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4403669725,"Last AD: Same & Remiss",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5620437956,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.524691358,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5826771654,NA,NA,NA,"Last AD: Same & Remiss","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5707317073,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5151515152,"Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.35,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.44397463,NA,NA,NA,"LEVONORGESTREL-ETHIN ESTRADIOL",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4234234234,NA,NA,NA,"LEVONORGESTREL-ETHIN ESTRADIOL","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3445378151,NA,NA,NA,"LISDEXAMFETAMINE DIMESYLATE",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.32,NA,NA,NA,NA,0.3669724771,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5330188679,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,0.4651162791,NA,NA,NA,NA,0.5378787879,0.6216216216,NA,NA,NA,NA,0.5777777778,NA,NA,0.5538461538,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.593495935,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5348837209,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1844660194,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1441441441,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Female",NA,0.3702531646,0.6213592233,NA,NA,0.4031620553,0.4161979753,0.442155309,NA,NA,NA,NA,0.5070754717,0.2723004695,0.4263959391,0.4295857988,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.35,0.4316939891,NA,NA,NA,NA,0.5055350554,NA,NA,0.4611398964,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5046728972,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.253968254,NA,0.3881334981,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4708333333,0.4160583942,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,0.06470588235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1727272727,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Female",NA,0.08823529412,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.380952381,NA,NA,NA,"METHYLPHENIDATE HCL",NA,NA,NA,NA,NA,NA
"13-19","Female",0.007407407407,NA,NA,NA,NA,NA,0.09345794393,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.157323689,NA,NA,NA,NA,NA,NA,0.1614035088,"MIRTAZAPINE",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2745098039,NA,NA,0.2051282051,"MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1343873518,"MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.3714285714,NA,NA,NA,NA,NA,NA,NA,NA,"MONTELUKAST SODIUM",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,0.05681818182,0.3560209424,NA,NA,NA,0.1560693642,0.4044117647,NA,NA,NA,NA,0.4032786885,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.3643410853,NA,NA,NA,NA,0.4375,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA
"13-19","Female",NA,0.05418719212,NA,NA,NA,NA,0.1643835616,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1602209945,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NORETHINDRONE-E.ESTRADIOL-IRON",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.3495934959,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4439834025,NA,NA,NA,"NORGESTIMATE-ETHINYL ESTRADIOL",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05462184874,NA,NA,NA,NA,NA,0.1953125,"NORTRIPTYLINE HCL",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5367231638,NA,NA,NA,"Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1666666667,"Num Previous Antidep: 4+",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1556886228,"Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1075757576,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1325301205,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1769911504,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.2153846154,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OMEPRAZOLE",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.3626373626,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER ACNE (dxo:ICD9:7061)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.2877697842,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER GENERAL COUNSELING AND ADVICE FOR CONTRACEPTIVE MANAGEMENT (dxo:ICD9:V2509)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,0.05213270142,NA,NA,NA,NA,0.1355932203,0.3873873874,NA,NA,NA,NA,0.525862069,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.09166666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1463414634,0.3366336634,NA,NA,NA,NA,NA,NA,NA,NA,"PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3986928105,NA,NA,NA,"PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,0.04318181818,0.2475247525,NA,NA,NA,0.09977827051,0.2563559322,NA,NA,0.3100436681,NA,0.2961832061,0.03947368421,NA,0.1364452424,"PAROXETINE HCL",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2487046632,NA,NA,NA,NA,0.06666666667,"PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1262135922,"PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2873563218,NA,0.3240223464,NA,NA,0.2254901961,"PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2752293578,NA,NA,0.0652173913,NA,0.2164179104,"PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,0.04743833017,0.1804008909,NA,NA,0.1428571429,0.141509434,0.1215753425,NA,NA,0.1062801932,NA,0.1119648738,0.02465753425,0.1531393568,0.07614213198,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.07746478873,0.0701754386,NA,NA,NA,NA,0.1244019139,NA,NA,NA,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05418719212,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,0.1,NA,NA,NA,NA,0.1428571429,NA,NA,NA,NA,0.276504298,NA,NA,0.06970509383,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1629955947,NA,NA,0.1286549708,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2097902098,NA,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2238095238,0.145631068,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.247706422,"PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2243589744,NA,NA,NA,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3267973856,NA,NA,NA,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.09444444444,0.2744360902,NA,NA,NA,NA,NA,NA,NA,NA,"PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.1962616822,NA,NA,NA,0.1038647343,0.1758499414,NA,NA,NA,NA,0.1981382979,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.0325203252,0.1105769231,NA,NA,NA,NA,0.1379310345,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Female",NA,NA,0.1282051282,NA,NA,NA,0.08205689278,0.1406326034,NA,NA,NA,NA,0.1497560976,NA,NA,0.1203007519,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.07386363636,0.1413043478,NA,NA,NA,NA,0.1367924528,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1151515152,NA,NA,NA,NA,0.1511111111,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1183673469,NA,NA,NA,NA,0.3076923077,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.05,0.1596244131,NA,NA,NA,NA,0.1231527094,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1794871795,NA,NA,NA,NA,NA,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.09433962264,0.2355555556,NA,NA,NA,NA,0.3333333333,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792)",NA,NA,NA,NA,NA,NA
"13-19","Female",0.007142857143,0.05091649695,0.1581699346,NA,NA,NA,0.07915567282,0.1598746082,NA,NA,0.1111111111,NA,0.1752321981,NA,0.2134831461,0.1216389245,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1590909091,NA,NA,NA,NA,0.1975308642,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3357142857,NA,NA,0.1157024793,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1391304348,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,0.1260504202,NA,NA,0.06629834254,0.1304347826,NA,NA,NA,NA,0.1683168317,NA,NA,NA,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.09900990099,NA,NA,NA,NA,NA,NA,NA,NA,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09243697479,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3846153846,NA,NA,0.09266409266,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.1347150259,0.1361256545,NA,0.1195652174,0.08073770492,0.1472031403,NA,NA,0.1488095238,NA,0.1478982875,0.02424242424,0.1574344023,0.09523809524,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.1216216216,NA,NA,NA,0.08115183246,0.1538461538,NA,NA,NA,NA,0.1302170284,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2211538462,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.1212121212,NA,NA,NA,NA,NA,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.1104294479,NA,NA,NA,0.08333333333,0.1631701632,NA,NA,NA,NA,0.2931034483,NA,0.1711711712,0.1365187713,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2572815534,NA,NA,0.1755725191,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3025210084,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.075,0.1214285714,NA,NA,NA,NA,0.0625,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.0652173913,0.152,NA,NA,NA,NA,0.1656441718,NA,NA,NA,"PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.09166666667,NA,NA,NA,0.0380952381,0.1013513514,NA,NA,NA,NA,0.09595959596,NA,0.1366459627,0.1053484603,"RISPERIDONE",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1369294606,NA,NA,0.09401709402,"RISPERIDONE","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08502024291,"RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.1052631579,NA,NA,NA,NA,NA,0.4299065421,NA,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA,NA
"13-19","Female",0.0162601626,NA,NA,NA,NA,NA,0.1502145923,0.3895348837,NA,NA,0.2872340426,NA,NA,NA,NA,0.1176470588,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA,NA
"13-19","Female",0.004777070064,NA,0.3292383292,NA,NA,NA,NA,0.3146034533,NA,NA,0.2777777778,NA,0.3811063218,0.02491103203,0.4184100418,NA,"ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.552238806,NA,NA,NA,"ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3762376238,NA,NA,NA,"ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)","UNSPECIFIED VIRAL INFECTION, IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE (dxo:ICD9:07999)",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.3106508876,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4086378738,NA,NA,NA,"SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA,NA,NA
"13-19","Female",0.01823708207,0.03808864266,0.2402968037,NA,NA,0.2538071066,0.1276302173,0.2431023912,0.08429118774,NA,0.2412398922,NA,0.3413204037,0.02868852459,0.4219512195,0.1723209478,"SERTRALINE HCL",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,0.07042253521,NA,NA,NA,NA,0.1194029851,0.152866242,NA,NA,NA,NA,0.294653706,0.01213592233,NA,0.2052052052,"SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.347826087,NA,NA,0.1700680272,"SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.2869565217,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2191780822,NA,NA,NA,"SUICIDAL IDEATION (dxo:ICD9:V6284)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4473684211,NA,NA,NA,"SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.247706422,NA,NA,NA,NA,0.3172413793,NA,NA,NA,"SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3839285714,NA,NA,NA,"TOPIRAMATE",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,0.05752212389,0.2412060302,NA,NA,0.1842105263,0.05454545455,0.1577777778,NA,NA,NA,NA,0.2326388889,0.02583798883,0.2005347594,0.1909752295,"TRAZODONE HCL",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02564102564,0.2696629213,0.1934156379,"TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3859649123,NA,NA,NA,"UNSPECIFIED CONSTIPATION (dxo:ICD9:56400)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,0.2432432432,0.0979020979,0.3819444444,NA,NA,NA,NA,0.3782991202,NA,NA,NA,"UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.453038674,NA,NA,NA,"UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,0.3426966292,NA,NA,NA,0.1006289308,0.296819788,NA,NA,NA,NA,0.3676767677,NA,NA,NA,"UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4162436548,NA,NA,NA,"UNSPECIFIED VIRAL INFECTION, IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE (dxo:ICD9:07999)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,0.131147541,0.3691588785,NA,NA,NA,NA,0.3597359736,NA,NA,NA,"URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,0.04205607477,0.2392638037,NA,NA,NA,0.1489361702,0.2447916667,NA,NA,NA,NA,0.2664907652,NA,0.3212335368,0.1628686327,"VENLAFAXINE HCL",NA,NA,NA,NA,NA,NA
"13-19","Female",NA,NA,NA,NA,NA,NA,NA,0.2857142857,NA,NA,NA,NA,NA,NA,NA,NA,"VOMITING ALONE (dxo:ICD9:78703)",NA,NA,NA,NA,NA,NA
"13-19","Male",0.01156642432,0.05294588438,0.250501002,0.2644628099,0.1213720317,0.198920586,0.1392090166,0.2472190333,0.101762365,0.06037735849,0.2470845481,NA,0.2687846204,0.02617018095,0.2629217516,0.1625669279,NA,NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3551401869,NA,NA,NA,"ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2162162162,NA,NA,NA,"ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.3486842105,NA,NA,NA,NA,NA,NA,NA,NA,"ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,0.02928870293,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1875,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"13-19","Male",NA,NA,0.1370967742,NA,NA,NA,0.09793814433,0.09545454545,NA,NA,NA,NA,0.1424731183,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.0701754386,0.1339285714,NA,NA,NA,NA,0.1515151515,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1132075472,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.05769230769,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.213740458,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALBUTEROL SULFATE",NA,NA,NA,NA,NA,NA
"13-19","Male",0.00726744186,NA,NA,NA,NA,NA,NA,0.2403846154,NA,NA,NA,NA,0.2222222222,NA,NA,0.1674641148,"AMITRIPTYLINE HCL",NA,NA,NA,NA,NA,NA
"13-19","Male",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss",NA,NA,NA,NA
"13-19","Male",0.006644518272,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3047619048,NA,NA,NA,"AMITRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1588785047,"AMITRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,0.06470588235,NA,NA,NA,NA,0.1068376068,NA,NA,NA,0.3116883117,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,0.1031746032,NA,NA,NA,0.1025641026,0.09770114943,NA,NA,NA,NA,0.1115702479,NA,0.1538461538,NA,"ARIPIPRAZOLE",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.09,NA,NA,NA,NA,NA,NA,NA,NA,"ARIPIPRAZOLE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1133333333,NA,NA,0.1619047619,"ARIPIPRAZOLE","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,0.03564223268,NA,NA,NA,NA,NA,NA,0.04987531172,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,0.04081632653,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)",NA,NA,NA,NA,NA
"13-19","Male",NA,0.04098360656,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","METHYLPHENIDATE HCL",NA,NA,NA,NA
"13-19","Male",NA,0.02459016393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"13-19","Male",NA,0.02310231023,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","BUPROPION HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,0.02005730659,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"13-19","Male",NA,0.007092198582,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"13-19","Male",NA,0.02051282051,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"13-19","Male",NA,0.008474576271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.03669724771,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"13-19","Male",NA,0.03829787234,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","METHYLPHENIDATE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1355932203,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","MIRTAZAPINE",NA,NA,NA,NA,NA
"13-19","Male",NA,0.02784810127,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"13-19","Male",NA,0.02564102564,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Male",NA,0.01668984701,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,0.01515151515,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","BUPROPION HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,0.01379310345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"13-19","Male",NA,0.007352941176,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","METHYLPHENIDATE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.1493506494,NA,NA,NA,NA,NA,0.2784810127,NA,NA,NA,"AZITHROMYCIN",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,0.03338795576,0.2184210526,NA,NA,0.1776649746,0.1218045113,0.2190860215,0.06730769231,NA,0.2340425532,NA,0.2002902758,0.01724137931,0.228021978,0.1881413911,"BUPROPION HCL",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,0.04666666667,0.2684563758,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1868131868,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"13-19","Male",NA,0.01069518717,NA,NA,NA,NA,0.2051835853,NA,NA,NA,NA,NA,NA,NA,NA,0.1666666667,"BUPROPION HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"13-19","Male",NA,0.01503759398,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"13-19","Male",NA,0.05542168675,NA,NA,NA,NA,NA,0.2518628912,NA,NA,NA,NA,0.1782945736,NA,NA,0.1896869245,"BUPROPION HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,0.04761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1440677966,"BUPROPION HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0956937799,"BUPROPION HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.09345794393,NA,NA,NA,NA,NA,NA,0,NA,0.2071005917,"BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"13-19","Male",NA,0.04225352113,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Male",NA,0.02183406114,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Male",NA,0.01453287197,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"13-19","Male",NA,0.0126984127,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4964539007,"BUPROPION HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"13-19","Male",NA,0.2741312741,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4413793103,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3577235772,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1885964912,"BUPROPION HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1527093596,"BUPROPION HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Male",NA,0.03623188406,NA,NA,NA,NA,NA,NA,NA,NA,0.2397660819,NA,NA,NA,NA,0.1727272727,"BUPROPION HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,0.03166226913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09356725146,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.16,"BUPROPION HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08936170213,"BUPROPION HCL","RISPERIDONE",NA,NA,NA,NA,NA
"13-19","Male",NA,0.05378973105,NA,NA,NA,NA,NA,0.2192982456,NA,NA,NA,NA,0.2603174603,NA,NA,0.188365651,"BUPROPION HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2293577982,"BUPROPION HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Male",NA,0.0408997955,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007352941176,NA,0.1571218796,"BUPROPION HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2612612613,0.1415929204,"BUPROPION HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,0.03361344538,0.2952860955,NA,NA,NA,0.1237113402,0.1867321867,NA,NA,0.264516129,NA,0.2371541502,0.008771929825,NA,0.1457627119,"CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,0.1983471074,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1366906475,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,0.380952381,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"13-19","Male",NA,NA,0.2058823529,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"13-19","Male",NA,NA,0.06930693069,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LAMOTRIGINE",NA,NA,NA,NA,NA
"13-19","Male",NA,0.03351955307,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.21,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,0.2303370787,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,0.573964497,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,0.2356020942,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,0.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","RISPERIDONE",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,0.3006535948,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2405063291,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,0.2176470588,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1290322581,"CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,0.03418803419,0.3767123288,NA,NA,NA,0.1617977528,0.3098591549,NA,NA,NA,NA,0.4375,0.01910828025,0.4069767442,0.128,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.46,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.08653846154,0.06363636364,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"13-19","Male",NA,0.02906976744,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.2404371585,NA,NA,NA,NA,0.4649122807,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,0.29375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.15,0.335443038,NA,NA,NA,NA,0.3630136986,NA,NA,NA,"DEXTROAMPHETAMINE/AMPHETAMINE",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4032258065,NA,NA,NA,"DEXTROAMPHETAMINE/AMPHETAMINE","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4965034965,NA,NA,NA,"DEXTROAMPHETAMINE/AMPHETAMINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,0.2403225806,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1441048035,"DULOXETINE HCL",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,0.1337579618,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,0.2735849057,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,0.02972399151,0.452173913,NA,NA,NA,0.1921406412,0.205834684,0.07382550336,NA,0.219895288,NA,0.2233796296,0.02717391304,0.4247787611,0.1301694915,"ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.1464435146,NA,NA,NA,NA,NA,NA,NA,NA,0.125,"ESCITALOPRAM OXALATE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.1611111111,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.1341991342,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.1570247934,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"13-19","Male",NA,0.02,NA,NA,NA,NA,NA,0.3063063063,NA,NA,NA,NA,0.4028776978,0.03149606299,NA,0.1596244131,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09009009009,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.1110320285,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.104,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.4885844749,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.3756345178,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1261261261,"ESCITALOPRAM OXALATE","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07518796992,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06796116505,"ESCITALOPRAM OXALATE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1533333333,NA,NA,0.09239130435,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06034482759,"ESCITALOPRAM OXALATE","RISPERIDONE",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.1497797357,NA,NA,NA,NA,NA,0.29296875,NA,NA,0.1333333333,"ESCITALOPRAM OXALATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.1487603306,NA,NA,NA,NA,NA,NA,0.01973684211,NA,0.1229946524,"ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,0.1584158416,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1030534351,NA,NA,NA,"FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09259259259,NA,NA,NA,"FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Male",NA,0.04710920771,0.2165137615,NA,NA,0.1313868613,0.125120308,0.3002985075,0.0811965812,NA,0.1890909091,NA,0.2125506073,0.01408450704,0.357615894,0.1412300683,"FLUOXETINE HCL",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.25,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.1794871795,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.1047619048,0.3358208955,NA,NA,NA,NA,0.1981132075,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.2138728324,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.2363636364,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.2253521127,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.3358778626,NA,NA,NA,NA,NA,NA,NA,0.1467889908,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.1162790698,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.09090909091,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"13-19","Male",NA,0.003039513678,NA,NA,NA,NA,0.09868421053,NA,NA,NA,NA,NA,0.3134328358,0,NA,0.135,"FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04807692308,"FLUOXETINE HCL","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.2298507463,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.1685393258,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.2258064516,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.2510822511,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.2739726027,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.5640394089,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.6796116505,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.5245901639,NA,NA,NA,NA,NA,NA,NA,0.427480916,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.2631578947,NA,NA,NA,NA,NA,NA,NA,0.125,"FLUOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1059907834,"FLUOXETINE HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.2341920375,NA,NA,NA,NA,0.1025641026,NA,NA,0.1020408163,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.296,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1363636364,"FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.1726618705,NA,NA,NA,NA,NA,NA,NA,0.1166666667,"FLUOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.1136363636,0.3252595156,NA,NA,NA,NA,0.1920903955,NA,NA,0.1170731707,"FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.1165644172,NA,NA,NA,NA,NA,NA,NA,0.08108108108,"FLUOXETINE HCL","RISPERIDONE",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.4705882353,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.06617647059,0.2574257426,NA,NA,NA,NA,0.2638888889,NA,NA,0.1310679612,"FLUOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.253814147,NA,NA,NA,NA,NA,0.0243902439,NA,0.169527897,"FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,0.03333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA,NA
"13-19","Male",0.01321003963,NA,NA,NA,NA,NA,NA,NA,NA,0.03813559322,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA,NA
"13-19","Male",0.01183431953,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA,NA
"13-19","Male",0.005649717514,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.1230769231,0.3015873016,NA,NA,NA,NA,0.3541666667,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3537414966,NA,NA,NA,"IBUPROFEN",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03571428571,"IMIPRAMINE HCL",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,0.04237288136,0.149068323,NA,NA,NA,0.07831325301,0.111627907,NA,NA,NA,NA,0.1224489796,0.01212121212,0.1052631579,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.08125,NA,NA,NA,NA,NA,0.08,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.08208955224,NA,NA,NA,NA,NA,0.06611570248,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1769911504,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1446540881,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.06666666667,NA,NA,NA,NA,NA,0.1634615385,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2410071942,NA,NA,0.07547169811,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Male",NA,NA,0.1588486141,NA,NA,0.1587301587,0.0880952381,0.1422643746,NA,NA,0.1260229133,NA,0.1481012658,0.02962962963,0.1939252336,0.09160305344,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.04716981132,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.04838709677,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1504424779,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.24,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.419047619,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL",NA,NA,NA,NA
"13-19","Male",NA,NA,0.05511811024,NA,NA,NA,NA,0.1176470588,NA,NA,NA,NA,0.1162079511,NA,0.08661417323,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.0487804878,0.1153846154,NA,NA,NA,NA,0.1029411765,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1683168317,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1789473684,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"13-19","Male",NA,NA,0.1492957746,NA,NA,NA,0.08488964346,0.1375494071,NA,NA,0.1415929204,NA,0.1323692992,NA,0.1434599156,0.08921933086,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.1311953353,NA,NA,0.1487603306,NA,0.1145833333,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2721893491,NA,NA,0.1261261261,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.1739130435,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.0752688172,0.1946902655,NA,NA,NA,NA,0.3045977011,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Male",NA,NA,0.07382550336,NA,NA,NA,0.06756756757,0.07575757576,NA,NA,NA,NA,0.08150470219,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2158273381,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3404255319,0.01276595745,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,0.06134969325,NA,NA,NA,0.05109489051,0.0977443609,NA,NA,NA,NA,0.1048034934,NA,0.119266055,0.04380952381,"LAMOTRIGINE",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07462686567,NA,NA,NA,"LAMOTRIGINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0796812749,"LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Diff & No Remiss",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09090909091,"Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Male",NA,0.01794871795,NA,NA,NA,NA,0.1255411255,0.3172413793,NA,NA,NA,NA,NA,0.04487179487,NA,0.1666666667,"Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01538461538,NA,NA,"Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.34375,NA,NA,NA,NA,NA,NA,NA,NA,0.3827160494,"Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05172413793,"Last AD: Same & No Remiss",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.06418918919,NA,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2936507937,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2350230415,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1848184818,NA,NA,NA,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2677824268,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.078125,NA,NA,NA,"Last AD: Same & No Remiss","RISPERIDONE","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3490566038,NA,NA,NA,"Last AD: Same & No Remiss","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.251984127,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01052631579,NA,NA,"Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1921824104,NA,"Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5656565657,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.504,"Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3739837398,NA,NA,NA,"LISDEXAMFETAMINE DIMESYLATE",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,0.4955752212,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5451977401,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,0.3230769231,NA,NA,NA,NA,0.4285714286,0.464028777,NA,NA,NA,NA,0.5288461538,0.2376237624,0.5384615385,0.4255319149,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5403225806,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3595505618,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,0.05833333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,0.05504587156,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,0.009090909091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3487179487,NA,NA,NA,"METHYLPHENIDATE HCL",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.347107438,NA,NA,NA,"METHYLPHENIDATE HCL","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1302998966,NA,NA,NA,NA,NA,NA,0.1421965318,"MIRTAZAPINE",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1226415094,NA,NA,NA,0.2922077922,NA,NA,0.1896551724,"MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1687763713,"MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,0.009708737864,NA,NA,NA,NA,NA,0.3428571429,NA,NA,NA,NA,0.4347826087,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,0.02659574468,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07784431138,NA,NA,NA,NA,NA,0.1666666667,"NORTRIPTYLINE HCL",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1549295775,"Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08863198459,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08333333333,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,0.3435114504,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER ACNE (dxo:ICD9:7061)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,0.06,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,0.06153846154,0.2443181818,NA,NA,NA,0.136,0.265917603,NA,NA,0.2993630573,NA,0.2585227273,0.04587155963,NA,0.1401617251,"PAROXETINE HCL",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2571428571,NA,NA,NA,NA,NA,"PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3333333333,NA,NA,NA,"PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.231884058,NA,NA,NA,NA,NA,"PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,0.03452855246,0.1120218579,NA,NA,NA,NA,0.1165644172,NA,NA,0.07567567568,NA,0.1373555841,0.01098901099,0.108033241,0.06334841629,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.08333333333,0.08108108108,NA,NA,NA,NA,0.1538461538,NA,NA,NA,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08737864078,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.1833333333,NA,NA,NA,NA,0.25,NA,NA,0.0725388601,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09174311927,NA,NA,NA,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2196969697,NA,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,0.2051282051,NA,NA,NA,0.07346938776,0.2062084257,NA,NA,NA,NA,0.2121896163,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.1495327103,NA,NA,NA,NA,NA,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"13-19","Male",NA,NA,0.1257142857,NA,NA,NA,0.05726872247,0.144766147,NA,NA,NA,NA,0.1375,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.1298701299,NA,NA,NA,NA,0.07643312102,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.1325966851,NA,NA,NA,NA,0.1217391304,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.1126760563,0.2179487179,NA,NA,NA,NA,0.2896551724,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,0.04752475248,0.1354166667,NA,NA,NA,0.07620320856,0.1332560834,0.04424778761,NA,0.1060606061,NA,0.1402671756,NA,0.1474358974,0.08502024291,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.1388888889,NA,NA,NA,NA,0.09900990099,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1111111111,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.05217391304,0.1172413793,NA,NA,NA,NA,NA,NA,NA,NA,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07258064516,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,0.1364829396,NA,NA,NA,0.07502287283,0.1504491018,NA,NA,NA,NA,0.1326034063,0.007575757576,0.1769230769,0.1050228311,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.1006289308,NA,NA,NA,NA,NA,0.08374384236,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.05303030303,0.1807228916,NA,NA,NA,NA,0.2865497076,NA,NA,0.1283185841,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,0.07619047619,NA,NA,NA,NA,NA,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,0.0796460177,NA,NA,NA,NA,NA,0.1793103448,NA,NA,NA,"PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,0.075,NA,NA,NA,0.05882352941,0.07782101167,NA,NA,NA,NA,0.1160714286,NA,0.1377245509,0.06099110546,"RISPERIDONE",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1170212766,NA,NA,0.09166666667,"RISPERIDONE","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09795918367,"RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,0.09900990099,NA,NA,NA,NA,0.1755725191,NA,NA,NA,NA,NA,0.41,NA,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA,NA
"13-19","Male",0.007547169811,NA,0.3111111111,NA,NA,NA,NA,0.291087963,NA,NA,0.3129032258,NA,0.3647944412,0.01276595745,0.3253968254,NA,"ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5544871795,NA,NA,NA,"ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)","SERTRALINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,0.04907306434,0.2116182573,NA,NA,0.1734104046,0.1191626409,0.2192439863,0.1239316239,NA,0.226044226,NA,0.3194815882,0.02702702703,0.3828571429,0.1669525443,"SERTRALINE HCL",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2689486553,0.02127659574,NA,0.1928721174,"SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2844036697,NA,NA,NA,"SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.204379562,NA,NA,NA,"SUICIDAL IDEATION (dxo:ICD9:V6284)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,0.0572519084,0.1709401709,NA,NA,0.1531531532,0.09595959596,0.1855670103,NA,NA,NA,NA,0.1705882353,0.01706970128,0.1721854305,0.164851671,"TRAZODONE HCL",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2537313433,0.1490384615,"TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3619047619,NA,NA,NA,"UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3392857143,NA,NA,NA,"UNSPECIFIED VIRAL INFECTION, IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE (dxo:ICD9:07999)",NA,NA,NA,NA,NA,NA
"13-19","Male",NA,0.03703703704,NA,NA,NA,NA,0.1449275362,NA,NA,NA,NA,NA,0.3111111111,NA,0.294197031,0.1462333826,"VENLAFAXINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",0.01870076493,0.05587382085,0.4293897751,0.4398037138,0.1445163187,0.340869398,0.1809321283,0.4060326444,0.1508036691,0.06954302079,0.3769337051,0.2183381089,0.4550471654,0.03394144345,0.4530869967,0.2731660462,NA,NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.01315789474,0.3963414634,NA,NA,NA,0.125,0.4390243902,NA,0.02777777778,NA,NA,0.4588045234,NA,0.4826789838,NA,"ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5290322581,NA,"ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5963855422,NA,NA,NA,"ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4234234234,NA,NA,NA,"ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900)","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4511278195,NA,NA,NA,"ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900)","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1134289439,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1914893617,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.298013245,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.0873015873,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1230769231,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.125748503,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02995008319,NA,NA,NA,NA,0.1438356164,NA,NA,NA,0.387755102,NA,0.4847074468,NA,0.5161290323,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.03731343284,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01628664495,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.009708737864,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",NA,0.04899135447,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","BUPROPION HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02027027027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA
"20-40","Female",NA,0.01948842875,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.02985074627,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02380952381,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.05,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"20-40","Female",NA,0.01485148515,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01612903226,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.03684210526,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.009433962264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.01680672269,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3625,NA,0.5982905983,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4608695652,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3803921569,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.599137931,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.03873239437,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02673796791,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03571428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5977653631,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","POLYCYSTIC OVARIES (dxo:ICD9:2564)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.05940594059,NA,NA,NA,NA,0.1730769231,NA,NA,NA,0.3441558442,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02252252252,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6424242424,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4406779661,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04587155963,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4394904459,NA,NA,NA,0.123683005,NA,NA,NA,NA,NA,0.436211115,NA,NA,0.1181818182,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1229773463,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.09375,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.488,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5459183673,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.547008547,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4893617021,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","ENCOUNTER FOR OTHER SPECIFIED ANTENATAL SCREENING (dxo:ICD9:V288)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5634920635,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","ENCOUNTER FOR OTHER SPECIFIED ANTENATAL SCREENING (dxo:ICD9:V288)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4710743802,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5033783784,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.252688172,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1422413793,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2363636364,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.125748503,NA,NA,NA,NA,NA,0.5745856354,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1386861314,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4336283186,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","IBUPROFEN","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1744966443,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4452554745,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5740740741,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","Last AD: Same & No Remiss","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3638888889,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4842767296,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","Last AD: Same & No Remiss","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5339805825,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.09900990099,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4666666667,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","NORETHINDRONE","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5865921788,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","NORETHINDRONE","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4310160428,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4178082192,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6755319149,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.646875,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4644236073,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4403292181,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1293859649,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3706896552,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4785714286,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5431472081,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6057803468,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6837416481,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5017196905,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4292682927,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4045801527,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3890784983,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4285714286,NA,0.45,NA,"ACETAMINOPHEN WITH CODEINE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3833333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ACUTE GASTRITIS WITHOUT MENTION OF HEMORRHAGE (dxo:ICD9:53500)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4693877551,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5181818182,NA,NA,NA,"ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4453125,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5617283951,NA,NA,NA,"ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619)","AZITHROMYCIN",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.6393442623,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5495495495,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5912408759,NA,NA,NA,"ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1363636364,"ACUTE TONSILLITIS (dxo:ICD9:463)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4933333333,NA,NA,NA,NA,0.4377289377,NA,NA,NA,NA,NA,NA,NA,NA,"ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6174496644,NA,NA,NA,NA,NA,NA,NA,NA,"ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4070351759,NA,NA,NA,NA,NA,NA,NA,NA,"ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1401869159,NA,NA,NA,NA,NA,0.4503311258,NA,NA,NA,"ADJUSTMENT DISORDER WITH ANXIETY (dxo:ICD9:30924)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.19,NA,NA,NA,"ADJUSTMENT DISORDER WITH ANXIETY (dxo:ICD9:30924)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.07518796992,NA,NA,NA,NA,NA,0.265,NA,NA,NA,"ADJUSTMENT DISORDER WITH ANXIETY (dxo:ICD9:30924)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,0.02272727273,0.4270833333,NA,NA,NA,0.1126005362,0.4578947368,NA,NA,NA,NA,0.484939759,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.07432432432,0.2429906542,NA,NA,NA,NA,0.3181818182,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.2278481013,NA,NA,NA,0.06859205776,0.1604278075,NA,NA,NA,NA,0.1965065502,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.06086956522,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA
"20-40","Female",NA,0.02362204724,NA,NA,NA,NA,0.09615384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1168831169,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6451612903,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02713347921,0.4306220096,NA,NA,NA,0.1413043478,0.3928571429,NA,NA,NA,NA,0.4345047923,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.009433962264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.05982905983,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.07666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.08547008547,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"20-40","Female",NA,0.009433962264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,0.0275862069,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","BUPROPION HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03773584906,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA
"20-40","Female",NA,0.01520912548,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.01910828025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","BUPROPION HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,0.03370786517,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","BUPROPION HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.384,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"20-40","Female",NA,NA,0.28125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"20-40","Female",NA,NA,0.2716049383,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,0.008474576271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.01851851852,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,0.01769911504,NA,NA,NA,NA,0.1893939394,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1157894737,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1061946903,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"20-40","Female",NA,NA,0.2718446602,NA,NA,NA,0.1271676301,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,0.01183431953,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.09022556391,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1518987342,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1647058824,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2105263158,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3714285714,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2732919255,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2415458937,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3601532567,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,0.06024096386,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.06666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"20-40","Female",NA,NA,0.1917808219,NA,NA,NA,0.06115107914,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,0.2438095238,NA,NA,NA,0.08183079057,0.2051282051,NA,NA,0.23,NA,0.2277777778,NA,0.2677165354,0.06086956522,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2972027972,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2780487805,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.05769230769,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,0.04545454545,0.2080223881,NA,NA,0.2096774194,0.06293222683,0.1946607341,NA,NA,0.2,NA,0.1985915493,NA,0.2188841202,0.1198347107,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.05367231638,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3089171975,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2457627119,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.08823529412,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3745318352,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,0.006756756757,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.03141361257,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1092436975,NA,NA,NA,NA,NA,0.2413793103,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.1621621622,NA,NA,NA,0.071875,0.2045454545,NA,NA,NA,NA,0.1995841996,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.09615384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.08609271523,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4272727273,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,0.02606635071,0.2326283988,NA,NA,NA,0.06575963719,0.2508710801,NA,NA,NA,NA,0.2798264642,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.05,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.2063492063,NA,NA,NA,0.07592407592,0.2949640288,NA,NA,NA,NA,0.1933333333,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.06329113924,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.06603773585,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,0.05309734513,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.593495935,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01954397394,0.4543889845,NA,NA,NA,NA,NA,NA,NA,0.380952381,NA,NA,NA,0.5413533835,NA,"ALBUTEROL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.575,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALBUTEROL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4879518072,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALBUTEROL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1648351648,NA,NA,NA,NA,NA,NA,NA,0.4637681159,NA,"ALBUTEROL SULFATE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1443298969,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALBUTEROL SULFATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6833333333,NA,"ALBUTEROL SULFATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.347826087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALLERGY, UNSPECIFIED NOT ELSEWHERE CLASSIFIED (dxo:ICD9:9953)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.03333333333,0.4304635762,NA,NA,NA,0.1652360515,0.4529411765,NA,NA,NA,NA,0.4571230982,NA,0.5015673981,NA,"ALPRAZOLAM",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1659919028,0.3308823529,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.157480315,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1380952381,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,0.05797101449,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","BUPROPION HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01769911504,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.602739726,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4051724138,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.5490196078,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5438596491,NA,"ALPRAZOLAM","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2727272727,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.141509434,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5792349727,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5515463918,NA,NA,NA,"ALPRAZOLAM","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1607142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4031746032,NA,NA,NA,"ALPRAZOLAM","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5714285714,NA,NA,NA,"ALPRAZOLAM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.375,NA,NA,NA,"ALPRAZOLAM","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.0396039604,NA,NA,NA,NA,0.1135734072,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5899705015,NA,NA,NA,"ALPRAZOLAM","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3928571429,NA,NA,NA,"ALPRAZOLAM","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4455445545,NA,NA,NA,"ALPRAZOLAM","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",0.03101862676,0.03464947623,0.3827893175,0.4050632911,NA,0.3149405772,0.1343390805,0.3822393822,0.1900826446,0.0487804878,0.2763915547,NA,0.409733124,0.01395348837,0.4077134986,0.2982039986,"AMITRIPTYLINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",0.04570383912,0.05882352941,NA,NA,NA,0.2857142857,0.1416666667,0.4761904762,NA,NA,NA,NA,NA,NA,0.3666666667,0.2576656775,"AMITRIPTYLINE HCL","BUPROPION HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.419047619,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2826086957,"AMITRIPTYLINE HCL","BUPROPION HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2918660287,"AMITRIPTYLINE HCL","BUPROPION HCL","DULOXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2413793103,NA,NA,NA,NA,NA,NA,NA,NA,0.2108843537,"AMITRIPTYLINE HCL","BUPROPION HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"20-40","Female",NA,0.03787878788,NA,NA,NA,NA,NA,0.4689655172,NA,NA,NA,NA,NA,NA,NA,0.3185595568,"AMITRIPTYLINE HCL","BUPROPION HCL","FLUOXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4375,"AMITRIPTYLINE HCL","BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",0.03305785124,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","BUPROPION HCL","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1030042918,"AMITRIPTYLINE HCL","BUPROPION HCL","LAMOTRIGINE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1138211382,"AMITRIPTYLINE HCL","BUPROPION HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA
"20-40","Female",0.03333333333,0.05354330709,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1532846715,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.03862660944,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1509433962,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,0.03378378378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1931818182,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3902439024,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5065789474,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5253164557,"AMITRIPTYLINE HCL","BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4566473988,"AMITRIPTYLINE HCL","BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2737430168,"AMITRIPTYLINE HCL","BUPROPION HCL","Num Previous Antidep: 4+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2228070175,"AMITRIPTYLINE HCL","BUPROPION HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2666666667,"AMITRIPTYLINE HCL","BUPROPION HCL","Num Previous Antidep: 4+","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2105263158,"AMITRIPTYLINE HCL","BUPROPION HCL","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.0487804878,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4383561644,NA,NA,0.3352769679,"AMITRIPTYLINE HCL","BUPROPION HCL","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.07006369427,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.18230563,"AMITRIPTYLINE HCL","BUPROPION HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5047619048,0.2941176471,"AMITRIPTYLINE HCL","BUPROPION HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",0.01419878296,0.04545454545,0.5274803712,NA,NA,NA,0.1509433962,0.3421052632,NA,NA,NA,NA,0.3333333333,NA,NA,0.3142857143,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"20-40","Female",0.009523809524,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA
"20-40","Female",0.01851851852,NA,0.5977653631,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3688212928,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6028368794,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,NA,0.5744680851,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"20-40","Female",NA,NA,0.5729166667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2797202797,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,NA,0.6956521739,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.320754717,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.3416666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3166666667,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4903225806,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.5807860262,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,0.5533333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2478632479,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2571428571,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",0.03783783784,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"20-40","Female",0.01333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",0.01709401709,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2133333333,"AMITRIPTYLINE HCL","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.237804878,"AMITRIPTYLINE HCL","DOXEPIN HCL",NA,NA,NA,NA,NA
"20-40","Female",0.05167173252,NA,NA,NA,NA,0.4878640777,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3248587571,"AMITRIPTYLINE HCL","DULOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2571428571,"AMITRIPTYLINE HCL","DULOXETINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.5860465116,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4387096774,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.375,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5357142857,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3333333333,"AMITRIPTYLINE HCL","DULOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.4013605442,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2767857143,"AMITRIPTYLINE HCL","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",0.03554868624,0.008064516129,0.5247524752,NA,NA,NA,0.2949956102,NA,NA,NA,NA,NA,0.4112149533,NA,NA,0.2400722022,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Female",0.01652892562,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA
"20-40","Female",0.01935483871,NA,NA,NA,NA,NA,0.3019230769,NA,NA,NA,NA,NA,NA,NA,NA,0.2958801498,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3215130024,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2872340426,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2976190476,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1642857143,NA,NA,NA,NA,NA,NA,NA,NA,0.1902173913,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.248,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2789115646,NA,NA,NA,NA,NA,NA,NA,NA,0.1734693878,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2037037037,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",0.03364879075,0.04827586207,NA,NA,NA,NA,0.1619047619,0.5214408233,NA,NA,NA,NA,NA,NA,NA,0.3045936396,"AMITRIPTYLINE HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",0.01481481481,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA
"20-40","Female",0.0243902439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3533123028,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5984095427,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5448028674,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3017751479,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.7074829932,NA,NA,NA,NA,NA,NA,NA,0.4074074074,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6956521739,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2857142857,NA,NA,NA,NA,NA,NA,NA,0.3160621762,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5816993464,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5984095427,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.474137931,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4836601307,NA,NA,NA,NA,NA,NA,NA,0.2838427948,"AMITRIPTYLINE HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2456140351,"AMITRIPTYLINE HCL","FLUOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2913385827,"AMITRIPTYLINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2635658915,"AMITRIPTYLINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",0.01278772379,NA,NA,NA,NA,NA,NA,NA,NA,0.05670103093,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05882352941,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA
"20-40","Female",0.007610350076,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",0.002739726027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA
"20-40","Female",0.01242236025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",0.004716981132,NA,NA,NA,NA,NA,NA,NA,NA,0.07926829268,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA
"20-40","Female",0.02255639098,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.05982905983,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1300813008,"AMITRIPTYLINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3571428571,NA,NA,NA,"AMITRIPTYLINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4059405941,NA,"AMITRIPTYLINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"AMITRIPTYLINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1056218058,"AMITRIPTYLINE HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06956521739,"AMITRIPTYLINE HCL","LAMOTRIGINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0730994152,"AMITRIPTYLINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.032,0.3699421965,NA,NA,0.329305136,0.1140350877,0.3882352941,NA,0.02127659574,0.222972973,NA,0.4450757576,0,0.4377358491,0.2580645161,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5612244898,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6543624161,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2661290323,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3756097561,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6206896552,0.3137254902,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3116883117,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",0.01948051948,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4296875,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0.1928571429,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.3333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,0.4083769634,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6754385965,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"20-40","Female",0.03472222222,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6694915254,NA,NA,0.4033613445,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7165354331,NA,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",0.01157024793,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"20-40","Female",0.006006006006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA
"20-40","Female",0.008968609865,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3125,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",0.01308900524,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",0.01449275362,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4223602484,NA,NA,0.410041841,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3818181818,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5409139214,"AMITRIPTYLINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7166666667,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.593220339,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4752475248,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.522875817,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5966386555,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"20-40","Female",0.2690909091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5028653295,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3366336634,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.398255814,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",0.01886792453,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2604166667,"AMITRIPTYLINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2710280374,"AMITRIPTYLINE HCL","MIRTAZAPINE","Num Previous Antidep: 4+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2101449275,"AMITRIPTYLINE HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2372881356,"AMITRIPTYLINE HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",0.01923076923,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2989690722,"AMITRIPTYLINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6635514019,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6489028213,NA,NA,NA,"AMITRIPTYLINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2444987775,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2481315396,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2824427481,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",0.02184466019,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4873501997,NA,NA,NA,NA,0.3135048232,"AMITRIPTYLINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2912621359,NA,"AMITRIPTYLINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4326923077,"AMITRIPTYLINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1408450704,"AMITRIPTYLINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09482758621,"AMITRIPTYLINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3006756757,"AMITRIPTYLINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"20-40","Female",0.01307189542,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",0.03083700441,0.02083333333,0.4153846154,NA,NA,0.3055555556,0.1144578313,0.376,NA,NA,NA,NA,0.5477117819,NA,0.5660377358,0.3670143416,"AMITRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.512195122,NA,NA,0.2883895131,"AMITRIPTYLINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4830508475,NA,NA,NA,"AMITRIPTYLINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",0.08906882591,NA,NA,NA,NA,0.1696428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2361070273,"AMITRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5294117647,0.2647058824,"AMITRIPTYLINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",0.04867256637,NA,NA,NA,NA,NA,0.1584158416,NA,NA,NA,NA,NA,NA,NA,0.6186594203,0.3080324245,"AMITRIPTYLINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",0.0243902439,0.02400662252,0.4280442804,NA,NA,NA,0.143972343,0.435105068,NA,0.06086956522,0.3505908835,NA,0.4912280702,0.01941747573,0.5102880658,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.03225806452,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03228476821,NA,NA,NA,NA,0.1772151899,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04395604396,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA
"20-40","Female",NA,0.04046242775,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"20-40","Female",NA,0.04620462046,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA
"20-40","Female",NA,0.02692307692,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3138686131,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"20-40","Female",NA,0.03488372093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA
"20-40","Female",NA,0.03896103896,NA,NA,NA,NA,0.4615384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3383084577,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA
"20-40","Female",NA,0.02083333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA
"20-40","Female",NA,0.02307692308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"20-40","Female",NA,0.009259259259,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1391941392,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.03636363636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA
"20-40","Female",NA,0.04166666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"20-40","Female",NA,0.03225806452,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,0.04117647059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.01739130435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.02127659574,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"20-40","Female",NA,0.02068965517,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1442307692,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUSPIRONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1777777778,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CETIRIZINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04526748971,NA,NA,NA,NA,0.3047945205,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01083032491,NA,NA,NA,NA,0.2184300341,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.06201550388,NA,NA,NA,NA,0.2928571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.02366863905,NA,NA,NA,NA,0.1639344262,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CLONAZEPAM",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CLONAZEPAM","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1181818182,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CLONAZEPAM","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1935483871,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CLONAZEPAM","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,0.02411347518,0.4097222222,NA,NA,NA,0.1379800853,0.442159383,NA,NA,0.3716814159,NA,0.4832535885,NA,0.5294117647,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"20-40","Female",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.08421052632,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1366906475,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.577092511,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4193548387,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5818181818,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA
"20-40","Female",NA,0.01801801802,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"20-40","Female",NA,0.04301075269,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1789709172,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.547008547,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.02517985612,NA,NA,NA,NA,0.3025276461,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1981981982,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.106557377,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1139240506,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2237762238,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,0.01531728665,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3220338983,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3225806452,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1305578011,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.156424581,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1105398458,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1067961165,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.108974359,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1251819505,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.5642458101,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.6258064516,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3161290323,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1779661017,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.33243607,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1450777202,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ETHINYL ESTRADIOL/DROSPIRENONE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,0.03529411765,NA,NA,NA,NA,0.2326732673,0.5835616438,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01169590643,NA,NA,NA,NA,0.1333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3523809524,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3956043956,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.615819209,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1689189189,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","GABAPENTIN",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01127819549,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1848739496,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","GUAIFENESIN/P-EPHED HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1349325337,NA,NA,NA,0.4146341463,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.04761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5313653137,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1803278689,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.08045977011,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.06793478261,NA,NA,NA,0.1920529801,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.03553299492,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA
"20-40","Female",NA,0.01639344262,NA,NA,NA,NA,0.1789473684,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1678321678,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Diff & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,0.02452316076,NA,NA,NA,NA,0.1670146138,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1057692308,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.03149606299,NA,NA,NA,NA,0.1388888889,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.04663212435,NA,NA,NA,NA,0.2754237288,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3010471204,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & No Remiss","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6101694915,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.02575107296,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","LORAZEPAM",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1674641148,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","MORBID OBESITY (dxo:ICD9:27801)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03603603604,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02376910017,NA,NA,NA,NA,0.1389728097,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,0.01156069364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.09836065574,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","OMEPRAZOLE",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02158273381,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1226415094,NA,NA,NA,0.343373494,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1135531136,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PALPITATIONS (dxo:ICD9:7851)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,0.03418803419,NA,NA,NA,NA,NA,NA,NA,NA,0.3618421053,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03184713376,NA,NA,NA,NA,0.2448979592,NA,NA,NA,0.5240641711,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5021645022,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1243781095,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.0932642487,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.07643312102,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,0.03614457831,NA,NA,NA,NA,0.09653465347,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.09,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.09722222222,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.007142857143,NA,NA,NA,NA,0.1466666667,NA,NA,NA,0.2868020305,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2357142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1052631579,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",NA,0.02102102102,NA,NA,NA,NA,0.2555331992,NA,NA,NA,NA,NA,0.7170731707,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.006060606061,NA,NA,NA,NA,NA,NA,NA,NA,0.3398058252,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.09900990099,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","UNSPECIFIED ACUTE REACTION TO STRESS (dxo:ICD9:3089)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1409395973,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1768707483,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02608695652,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","VALACYCLOVIR HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02836879433,NA,NA,NA,NA,0.2569832402,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.1436170213,0.1417910448,NA,0.1565656566,0.1,0.1328671329,NA,NA,NA,NA,0.1421319797,NA,0.2142857143,0.1383928571,"ARIPIPRAZOLE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.1126760563,NA,NA,NA,NA,NA,NA,NA,NA,0.1862745098,0.09293680297,"ARIPIPRAZOLE","BUPROPION HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1363636364,"ARIPIPRAZOLE","BUPROPION HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1470588235,"ARIPIPRAZOLE","BUPROPION HCL","FLUOXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06542056075,"ARIPIPRAZOLE","BUPROPION HCL","LAMOTRIGINE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1764705882,NA,NA,0.1708860759,"ARIPIPRAZOLE","BUPROPION HCL","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06306306306,"ARIPIPRAZOLE","BUPROPION HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2702702703,NA,"ARIPIPRAZOLE","BUPROPION HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.1843971631,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.135483871,"ARIPIPRAZOLE","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.1160714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ARIPIPRAZOLE","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.1973684211,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1262135922,"ARIPIPRAZOLE","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.1843971631,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1513513514,"ARIPIPRAZOLE","DULOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.1096774194,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ARIPIPRAZOLE","DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.2013422819,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1637931034,"ARIPIPRAZOLE","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1544715447,NA,NA,NA,NA,NA,NA,NA,NA,0.1360294118,"ARIPIPRAZOLE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.07425742574,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ARIPIPRAZOLE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1047619048,NA,NA,NA,NA,NA,NA,NA,NA,0.1386861314,"ARIPIPRAZOLE","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2151394422,NA,NA,NA,NA,NA,NA,NA,0.1265822785,"ARIPIPRAZOLE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.101910828,NA,NA,NA,NA,NA,NA,NA,NA,"ARIPIPRAZOLE","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.1869158879,NA,NA,NA,NA,NA,NA,NA,0.1415929204,"ARIPIPRAZOLE","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.1160714286,NA,0.09448818898,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ARIPIPRAZOLE","LAMOTRIGINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1337209302,NA,NA,NA,"ARIPIPRAZOLE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2045454545,NA,NA,0.2,"ARIPIPRAZOLE","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2076923077,NA,NA,0.1160714286,"ARIPIPRAZOLE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1450381679,"ARIPIPRAZOLE","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1523178808,0.1296296296,"ARIPIPRAZOLE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1898734177,0.1563981043,"ARIPIPRAZOLE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5178571429,NA,NA,NA,NA,0.5327380952,NA,NA,NA,"ATORVASTATIN CALCIUM",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6197916667,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6535433071,NA,NA,NA,"ATORVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.0342405619,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05921052632,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.03951367781,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03846153846,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","BUPROPION HCL",NA,NA,NA,NA
"20-40","Female",NA,0.04854368932,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",NA,0.05072463768,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","BUPROPION HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.0378250591,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.01428571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04895104895,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03758290346,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.06138613861,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","BUPROPION HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.0248447205,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.03816793893,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","METHYLPHENIDATE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.008849557522,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.0546875,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4696969697,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AZELASTINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4340527578,NA,NA,NA,0.1304347826,NA,NA,NA,NA,NA,0.4920634921,NA,0.4651162791,0.2342342342,"AZITHROMYCIN",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1363636364,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AZITHROMYCIN","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6172839506,NA,NA,NA,"AZITHROMYCIN","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4368932039,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN NEOPLASM OF COLON (dxo:ICD9:2113)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1461538462,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN NEOPLASM OF SKIN OF TRUNK, EXCEPT SCROTUM (dxo:ICD9:2165)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1181102362,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN NEOPLASM OF SKIN OF TRUNK, EXCEPT SCROTUM (dxo:ICD9:2165)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3771929825,NA,NA,NA,NA,0.2679738562,NA,NA,NA,NA,0.4473684211,NA,NA,NA,"BIPOLAR DISORDER, UNSPECIFIED (dxo:ICD9:29680)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3347826087,NA,NA,NA,0.1677852349,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BODY MASS INDEX BETWEEN 19-24, ADULT (dxo:ICD9:V851)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1165644172,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BODY MASS INDEX BETWEEN 19-24, ADULT (dxo:ICD9:V851)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",0.02487562189,0.04659252767,0.3897275724,0.5585696671,0.08755760369,0.3216833096,0.1429707921,0.360377108,0.08095238095,0.06649616368,0.3284278536,NA,0.4061499039,0.01616458486,0.4416761042,0.2929067019,"BUPROPION HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.05313496281,0.4618625599,NA,NA,0.3140495868,0.1958405546,0.3919129082,NA,NA,0.356557377,NA,0.4366197183,0.01408450704,0.5876923077,0.3246349798,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5213675214,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4649122807,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2876106195,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","DULOXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.05519480519,0.5257731959,NA,NA,NA,0.2829457364,NA,NA,NA,NA,NA,NA,NA,NA,0.2317979198,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"20-40","Female",NA,0.04918032787,NA,NA,NA,NA,0.3644067797,NA,NA,NA,NA,NA,NA,NA,NA,0.297029703,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3695652174,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2314049587,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1913043478,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.06607929515,0.4736842105,NA,NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA,0.2605790646,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.05555555556,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,0.5892857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.2375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1707317073,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1121495327,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"20-40","Female",NA,NA,0.3774193548,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2366412214,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"20-40","Female",NA,NA,0.2307692308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"20-40","Female",NA,NA,0.3468208092,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1897810219,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,0.1959459459,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1130952381,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA
"20-40","Female",NA,NA,0.1650485437,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07829181495,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","LAMOTRIGINE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05555555556,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.04229017567,0.6515679443,NA,NA,NA,0.2180451128,NA,NA,NA,NA,NA,NA,0.01652892562,0.5287356322,0.4285714286,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.04491725768,0.6682926829,NA,NA,NA,0.2727272727,0.5042016807,NA,NA,NA,NA,0.4786324786,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,0.02976190476,0.5652173913,NA,NA,NA,NA,0.54,NA,NA,NA,NA,0.4716981132,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"20-40","Female",NA,NA,0.564,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4660194175,0.4320137694,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,0.03652968037,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Female",NA,0.03409090909,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,0.01321585903,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01234567901,NA,0.2920353982,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.075,0.6054852321,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5122807018,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.05365853659,0.6209386282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,NA,0.5948275862,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.52,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,0.0252764613,0.3289817232,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3427719821,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.02307692308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,NA,0.3962264151,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"20-40","Female",NA,NA,0.4186046512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3991596639,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4794520548,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09848484848,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1551724138,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4040697674,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.5912408759,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.55859375,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6899224806,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6129032258,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4789473684,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.6929133858,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.625,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"20-40","Female",NA,0.452173913,0.5990990991,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5688487585,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4774774775,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5042016807,NA,NA,NA,NA,0.4789915966,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Antidep: 2,3",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2274881517,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2016129032,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"20-40","Female",NA,NA,0.5764499121,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6355140187,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Remissions: 2+",NA,NA,NA,NA
"20-40","Female",NA,0.05357142857,0.3916666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2278481013,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.07407407407,0.2766497462,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.136915078,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1044776119,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1304347826,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2380952381,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1631205674,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.2598039216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1839464883,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,0.05198776758,0.411311054,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.414893617,NA,NA,0.2857142857,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.03201970443,0.36875,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01117318436,NA,0.2597212032,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.05590062112,0.3918367347,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2666666667,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.06976744186,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2331288344,"BUPROPION HCL","CLONAZEPAM",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1885714286,"BUPROPION HCL","CLONAZEPAM","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.01379310345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CLONAZEPAM","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.048,NA,NA,NA,NA,NA,0.5762711864,NA,NA,NA,NA,NA,NA,0.595959596,0.303030303,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.384057971,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.375,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3235294118,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5766423358,NA,NA,NA,NA,NA,NA,NA,0.4833333333,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.7207207207,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5491803279,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4970760234,NA,NA,NA,NA,NA,NA,0.5335820896,0.2625215889,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.404109589,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3036649215,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7445255474,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,0.01411764706,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"20-40","Female",NA,0.03125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,0.01694915254,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA
"20-40","Female",NA,0.01593625498,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA
"20-40","Female",NA,0.005714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",NA,0.05504587156,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"20-40","Female",NA,0.06349206349,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA
"20-40","Female",NA,0.05535055351,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"20-40","Female",NA,0.05789473684,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3037974684,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6097560976,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.674796748,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.02521008403,NA,0.6297577855,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2742616034,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2592592593,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06666666667,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","LAMOTRIGINE",NA,NA,NA,NA
"20-40","Female",NA,0.02013422819,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5089285714,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.125,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1807909605,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2727272727,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.07831325301,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2549019608,"BUPROPION HCL","DOXEPIN HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.07575757576,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DOXEPIN HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1875,"BUPROPION HCL","DOXEPIN HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.168,"BUPROPION HCL","DOXEPIN HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.04268292683,0.3216783217,NA,NA,0.397260274,0.1214574899,0.3295454545,NA,NA,NA,NA,0.4022346369,NA,NA,0.2566402208,"BUPROPION HCL","DULOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01408450704,NA,NA,NA,NA,0.2727272727,NA,NA,NA,NA,NA,NA,NA,NA,0.2280701754,"BUPROPION HCL","DULOXETINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"20-40","Female",NA,0.01960784314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA
"20-40","Female",NA,0.04504504505,NA,NA,NA,0.4347826087,NA,0.358778626,NA,NA,NA,NA,NA,NA,NA,0.1965811966,"BUPROPION HCL","DULOXETINE HCL","FLUOXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1666666667,"BUPROPION HCL","DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.07070707071,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07396449704,"BUPROPION HCL","DULOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05844155844,"BUPROPION HCL","DULOXETINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.03902439024,NA,NA,NA,0.498245614,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.345276873,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.04081632653,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3742331288,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,0.0380952381,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Female",NA,0.08461538462,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.08275862069,NA,NA,NA,0.6513761468,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.03260869565,NA,NA,NA,0.2651162791,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.251572327,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3189655172,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4978165939,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.5747126437,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4527559055,"BUPROPION HCL","DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,"BUPROPION HCL","DULOXETINE HCL","Num Previous Antidep: 4+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2272727273,"BUPROPION HCL","DULOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.256097561,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1218274112,"BUPROPION HCL","DULOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1165048544,"BUPROPION HCL","DULOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"20-40","Female",NA,0.03571428571,NA,NA,NA,0.3981481481,NA,NA,NA,NA,NA,NA,0.4935897436,NA,NA,0.3195488722,"BUPROPION HCL","DULOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.07831325301,NA,NA,NA,0.2871287129,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1859605911,"BUPROPION HCL","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2558139535,"BUPROPION HCL","DULOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",0.01785714286,0.04067630483,0.5135869565,NA,NA,0.4535714286,0.2618151893,0.3550624133,NA,NA,0.3915857605,NA,0.4083250743,0.02136752137,0.5821782178,0.2428426653,"BUPROPION HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Female",NA,0.05050505051,NA,NA,NA,NA,0.2101265823,0.3888888889,NA,NA,NA,NA,NA,NA,NA,0.211038961,"BUPROPION HCL","ESCITALOPRAM OXALATE","FLUOXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.03846153846,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1637931034,"BUPROPION HCL","ESCITALOPRAM OXALATE","FLUOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06796116505,"BUPROPION HCL","ESCITALOPRAM OXALATE","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.02487562189,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Diff & No Remiss",NA,NA,NA
"20-40","Female",NA,0.01680672269,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2549019608,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1051212938,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1454545455,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss"
"20-40","Female",NA,0.01398601399,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Diff & No Remiss",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09649122807,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08695652174,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08849557522,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1529235382,NA,NA,NA,NA,NA,NA,NA,NA,0.2034883721,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.152917505,NA,NA,NA,NA,NA,NA,NA,NA,0.201754386,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1417910448,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)"
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1255230126,NA,NA,NA,NA,NA,NA,NA,NA,0.1376811594,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1554404145,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1169590643,NA,NA,NA,NA,NA,NA,NA,NA,0.1174377224,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.07555555556,NA,NA,NA,NA,NA,NA,NA,NA,0.08924485126,"BUPROPION HCL","ESCITALOPRAM OXALATE","LAMOTRIGINE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05921052632,"BUPROPION HCL","ESCITALOPRAM OXALATE","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.03688212928,NA,NA,NA,0.4383561644,0.3103609939,NA,NA,NA,NA,NA,NA,0.02272727273,0.5971731449,0.2986928105,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.04504504505,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"20-40","Female",NA,0.03504043127,NA,NA,NA,NA,0.3230769231,0.4527027027,NA,NA,NA,NA,0.49375,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,0.02702702703,NA,NA,NA,NA,0.2783375315,0.5,NA,NA,NA,NA,0.4825174825,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.253164557,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3223140496,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5555555556,0.2797029703,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,0.06624605678,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2169811321,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2486187845,NA,NA,NA,NA,NA,NA,NA,NA,0.1403508772,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"20-40","Female",NA,0.01824817518,NA,NA,NA,NA,0.2868217054,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,0.03880597015,NA,NA,NA,NA,0.3418803419,NA,NA,NA,NA,NA,NA,0.005208333333,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.06077348066,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,0.1002132196,NA,NA,NA,NA,0.5760456274,NA,NA,NA,NA,NA,NA,NA,NA,0.5194174757,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.5661764706,NA,NA,NA,NA,0.7196261682,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"20-40","Female",NA,0.08965517241,NA,NA,NA,NA,0.6075581395,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,0.03017832647,NA,NA,NA,NA,0.1677943166,NA,NA,NA,NA,NA,NA,NA,NA,0.23246878,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.04605263158,NA,NA,NA,NA,0.2093023256,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,0.04587155963,NA,NA,NA,NA,0.2139303483,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2528089888,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3430232558,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1218274112,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.112,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.15,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.198757764,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1886792453,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3170731707,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3007712082,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.5190839695,NA,NA,NA,NA,NA,NA,NA,NA,0.5515463918,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7058823529,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5595238095,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.625698324,NA,NA,NA,NA,NA,NA,NA,NA,0.679245283,"BUPROPION HCL","ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"20-40","Female",NA,0.308988764,NA,NA,NA,NA,0.4973637961,NA,NA,NA,NA,NA,NA,NA,NA,0.4755381605,"BUPROPION HCL","ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2700729927,"BUPROPION HCL","ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1538461538,"BUPROPION HCL","ESCITALOPRAM OXALATE","MIRTAZAPINE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4527027027,NA,NA,NA,NA,0.493902439,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Num Previous Antidep: 2,3",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7227722772,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2169811321,NA,NA,NA,NA,NA,NA,NA,NA,0.149068323,"BUPROPION HCL","ESCITALOPRAM OXALATE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1596638655,"BUPROPION HCL","ESCITALOPRAM OXALATE","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"20-40","Female",NA,NA,0.5090909091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1504854369,"BUPROPION HCL","ESCITALOPRAM OXALATE","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.268907563,NA,NA,NA,0.3706293706,NA,NA,NA,NA,0.2099447514,"BUPROPION HCL","ESCITALOPRAM OXALATE","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.08391608392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1396332863,"BUPROPION HCL","ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1483870968,"BUPROPION HCL","ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1201716738,"BUPROPION HCL","ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1684210526,"BUPROPION HCL","ESCITALOPRAM OXALATE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1492537313,NA,NA,NA,NA,NA,NA,NA,NA,0.1384083045,"BUPROPION HCL","ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07142857143,"BUPROPION HCL","ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.202166065,NA,NA,NA,NA,NA,NA,NA,NA,0.1984126984,"BUPROPION HCL","ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1847133758,"BUPROPION HCL","ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.368852459,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,0.02865329513,NA,NA,NA,NA,0.2254901961,0.3495145631,NA,NA,NA,NA,0.4729411765,NA,NA,0.2233009709,"BUPROPION HCL","ESCITALOPRAM OXALATE","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.03892944039,NA,NA,NA,NA,0.2380952381,NA,NA,NA,NA,NA,NA,0.0078125,NA,0.191661481,"BUPROPION HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.0593220339,NA,NA,NA,NA,0.2596153846,NA,NA,NA,NA,NA,NA,NA,0.610619469,0.2206148282,"BUPROPION HCL","ESCITALOPRAM OXALATE","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.02727272727,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ETONOGESTREL/ETHINYL ESTRADIOL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02553191489,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ETONOGESTREL/ETHINYL ESTRADIOL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.04135338346,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUCONAZOLE",NA,NA,NA,NA,NA
"20-40","Female",NA,0.0253164557,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUCONAZOLE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.01818181818,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUCONAZOLE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",0.0625,0.05314312588,0.4061962134,NA,NA,0.3032258065,0.1545988258,0.4130170316,NA,NA,0.3190184049,NA,0.3512241055,0.01807228916,0.5338842975,0.30878116,"BUPROPION HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.234741784,NA,NA,NA,NA,NA,NA,NA,0.1805157593,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA
"20-40","Female",NA,0.05714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Diff & No Remiss",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1803278689,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1121495327,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1621621622,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3597733711,NA,NA,NA,NA,NA,NA,NA,0.21875,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4059405941,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)"
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4059405941,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Num Previous Antidep: 2,3","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2011494253,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1650485437,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3879781421,NA,NA,NA,NA,NA,NA,NA,0.2435897436,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2168674699,NA,NA,NA,NA,NA,NA,NA,0.1314741036,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.1241830065,NA,NA,NA,NA,NA,NA,NA,0.07824427481,"BUPROPION HCL","FLUOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.07407407407,NA,NA,NA,NA,NA,NA,NA,0.07174887892,"BUPROPION HCL","FLUOXETINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.04138321995,NA,NA,NA,NA,0.1468253968,0.6159695817,NA,NA,NA,NA,NA,0.0162601626,0.5628140704,0.4162561576,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.03683241252,NA,NA,NA,NA,0.16,0.5928045789,NA,NA,NA,NA,0.4411764706,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,0.03846153846,NA,NA,NA,NA,NA,0.5135951662,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5454545455,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3935810811,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,0.04081632653,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2201834862,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"20-40","Female",NA,0.03636363636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,0.03643724696,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01530612245,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.05063291139,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,0.09375,NA,NA,NA,NA,NA,0.5917602996,NA,NA,NA,NA,NA,NA,NA,0.4349112426,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.5655737705,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"20-40","Female",NA,0.09128630705,NA,NA,NA,NA,NA,0.594,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4693877551,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3980582524,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,0.03851640514,NA,NA,NA,NA,NA,0.2905109489,NA,NA,NA,NA,NA,NA,NA,0.3446475196,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.03731343284,NA,NA,NA,NA,NA,0.34375,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3425414365,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.37109375,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4172661871,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1202531646,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1652173913,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3896103896,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5914634146,NA,NA,NA,NA,NA,NA,NA,0.5575980392,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.72,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5044247788,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.4,NA,NA,NA,NA,NA,0.6544715447,NA,NA,NA,NA,NA,NA,NA,0.619047619,"BUPROPION HCL","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"20-40","Female",NA,0.3612334802,NA,NA,NA,NA,NA,0.5682593857,NA,NA,NA,NA,NA,NA,NA,0.5120967742,"BUPROPION HCL","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4621848739,NA,NA,NA,NA,NA,NA,NA,0.2977099237,"BUPROPION HCL","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2013888889,"BUPROPION HCL","FLUOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2794117647,"BUPROPION HCL","FLUOXETINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5915378356,NA,NA,NA,NA,0.4380952381,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5454545455,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3333333333,NA,NA,NA,NA,NA,NA,NA,0.15,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 4+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3793103448,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 4+","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.301369863,NA,NA,NA,NA,NA,NA,NA,0.178041543,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2328767123,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1415929204,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 4+","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6078431373,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Remissions: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2264150943,"BUPROPION HCL","FLUOXETINE HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA
"20-40","Female",NA,0.07567567568,NA,NA,NA,NA,NA,0.3829787234,NA,NA,0.4676258993,NA,NA,NA,NA,0.3121019108,"BUPROPION HCL","FLUOXETINE HCL","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.07575757576,NA,NA,NA,NA,NA,0.28,NA,NA,NA,NA,NA,NA,NA,0.1669106881,"BUPROPION HCL","FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.186440678,"BUPROPION HCL","FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1304347826,"BUPROPION HCL","FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5117845118,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2730923695,"BUPROPION HCL","FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2671755725,NA,NA,NA,NA,NA,NA,NA,0.1515151515,"BUPROPION HCL","FLUOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08490566038,"BUPROPION HCL","FLUOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2723004695,NA,NA,NA,NA,NA,NA,NA,0.2077562327,"BUPROPION HCL","FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1981132075,"BUPROPION HCL","FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1304347826,"BUPROPION HCL","FLUOXETINE HCL","RISPERIDONE",NA,NA,NA,NA
"20-40","Female",NA,0.05511811024,NA,NA,NA,NA,0.112,0.4082733813,NA,NA,NA,NA,0.4272030651,NA,NA,0.3093812375,"BUPROPION HCL","FLUOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.04738562092,NA,NA,NA,NA,NA,0.3208333333,NA,NA,NA,NA,NA,0.015625,NA,0.2258454106,"BUPROPION HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2037037037,"BUPROPION HCL","FLUOXETINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,0.04182509506,NA,NA,NA,NA,NA,0.3628318584,NA,NA,NA,NA,NA,NA,0.58125,0.2333901193,"BUPROPION HCL","FLUOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.04615384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04458598726,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,0.05882352941,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.0195035461,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.0394265233,NA,NA,NA,0.3983739837,NA,NA,NA,NA,0.3212121212,NA,NA,NA,NA,0.2754237288,"BUPROPION HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1133333333,NA,NA,NA,NA,NA,NA,NA,0.6339285714,0.2465116279,"BUPROPION HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.009132420091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6230769231,NA,NA,NA,NA,NA,"BUPROPION HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",0.009756097561,0.0625,NA,NA,NA,NA,NA,NA,NA,0.06153846154,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"20-40","Female",0.01550387597,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.02298850575,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.07082152975,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1776649746,0.08768656716,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06211180124,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"20-40","Female",NA,0.0462962963,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA
"20-40","Female",NA,0.04201680672,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA
"20-40","Female",NA,0.05300353357,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1025641026,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09482758621,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PAROXETINE HCL",NA,NA,NA
"20-40","Female",NA,0.05825242718,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04545454545,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2242990654,NA,NA,0.15625,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2079207921,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06884057971,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1650485437,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2798165138,NA,NA,0.150997151,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.180952381,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03896103896,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2731707317,0.1871345029,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.2705882353,NA,NA,0.2680412371,0.08571428571,0.2448979592,NA,NA,0.1846153846,NA,0.2645502646,NA,0.3052434457,0.1418439716,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.07788161994,NA,NA,NA,NA,NA,NA,NA,NA,0.145,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08839779006,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.05365853659,0.2547169811,NA,NA,NA,NA,NA,NA,NA,0.09840425532,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2090909091,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3533333333,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Num Previous Antidep: 2,3","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3303571429,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4513888889,NA,NA,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1552795031,0.07874015748,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06597222222,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2212389381,NA,NA,0.1121495327,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2404371585,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2133333333,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA
"20-40","Female",NA,NA,0.2171428571,NA,NA,NA,0.1,0.2228915663,NA,NA,NA,NA,0.244,NA,0.216080402,0.1119402985,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3849206349,NA,NA,0.26875,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3664122137,0.1709401709,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1176470588,NA,NA,NA,NA,NA,0.3543123543,NA,NA,0.2168674699,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3448275862,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1351351351,0.08641975309,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08527131783,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2590673575,NA,NA,0.1106719368,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2254901961,0.1615384615,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"BUPROPION HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.00826446281,NA,NA,"BUPROPION HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01117318436,NA,NA,"BUPROPION HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.1634980989,NA,NA,0.1127272727,0.07913669065,0.1398305085,NA,NA,NA,NA,0.1351351351,NA,0.1160714286,0.08446932814,"BUPROPION HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4270462633,"BUPROPION HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3272727273,"BUPROPION HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.380952381,"BUPROPION HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1097560976,"BUPROPION HCL","LAMOTRIGINE","MIRTAZAPINE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06481481481,"BUPROPION HCL","LAMOTRIGINE","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09042553191,"BUPROPION HCL","LAMOTRIGINE","Num Previous Antidep: 4+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08333333333,"BUPROPION HCL","LAMOTRIGINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05185185185,"BUPROPION HCL","LAMOTRIGINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0297029703,"BUPROPION HCL","LAMOTRIGINE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08,"BUPROPION HCL","LAMOTRIGINE","RISPERIDONE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02803738318,"BUPROPION HCL","LAMOTRIGINE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1600831601,NA,NA,0.09385113269,"BUPROPION HCL","LAMOTRIGINE","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09032258065,"BUPROPION HCL","LAMOTRIGINE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07526408451,"BUPROPION HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06278026906,"BUPROPION HCL","LAMOTRIGINE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1014492754,0.07956989247,"BUPROPION HCL","LAMOTRIGINE","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",0.007874015748,0.03317535545,0.4160263447,NA,NA,0.4007858546,0.1344717182,0.4422018349,NA,NA,0.3129032258,NA,0.4681335357,0.01397712834,0.4926884139,0.2408482706,"BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2246376812,"BUPROPION HCL","Last AD: Diff & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA
"20-40","Female",NA,0.05882352941,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"20-40","Female",NA,0.04672897196,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,0.03225806452,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.04761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5028248588,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA
"20-40","Female",NA,0.04128440367,NA,NA,NA,NA,0.1398601399,0.4907407407,NA,NA,NA,NA,0.561465721,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"20-40","Female",NA,0.05138339921,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"20-40","Female",NA,0.06329113924,NA,NA,NA,NA,NA,NA,NA,NA,0.6889952153,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"20-40","Female",NA,0.05418719212,NA,NA,NA,NA,0.1488095238,0.512,NA,NA,NA,NA,0.6265533028,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5044247788,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"20-40","Female",NA,0.05652759085,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009708737864,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.04830917874,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6930693069,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2300884956,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.46875,0.4036458333,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1135135135,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6196078431,0.4449339207,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,0.05128205128,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.05799648506,NA,NA,NA,NA,0.1392405063,NA,NA,NA,NA,NA,NA,NA,0.610619469,0.3349875931,"BUPROPION HCL","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03333333333,"BUPROPION HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,0.04195804196,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2475247525,"BUPROPION HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,0.03973509934,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007874015748,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.05223880597,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2314814815,"BUPROPION HCL","Last AD: Diff & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1296296296,NA,NA,NA,NA,NA,NA,NA,NA,0.103626943,"BUPROPION HCL","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.08,NA,NA,NA,NA,NA,NA,NA,NA,0.1209677419,"BUPROPION HCL","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2,"BUPROPION HCL","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1245421245,NA,NA,NA,0.31,NA,NA,NA,NA,0.2775119617,"BUPROPION HCL","Last AD: Diff & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,0.04360325827,NA,NA,NA,0.3720930233,0.1622911695,NA,NA,NA,NA,NA,0.6046511628,0.02255639098,0.5381818182,0.4525547445,"BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.39,"BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,0.04024767802,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.004784688995,NA,0.2945736434,"BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.03623188406,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5333333333,NA,NA,0.2200956938,"BUPROPION HCL","Last AD: Diff & No Remiss","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,0.05098039216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01075268817,NA,0.1074918567,"BUPROPION HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.04678362573,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02777777778,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,0.05119047619,NA,NA,NA,NA,0.1633986928,NA,NA,NA,NA,NA,NA,NA,0.6729651163,0.3992015968,"BUPROPION HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.1103633917,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6239316239,"BUPROPION HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,0.5862068966,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7024390244,"BUPROPION HCL","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,0.5328467153,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,0.6581196581,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6611570248,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","Num Previous Remissions: 2+","SERTRALINE HCL",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5625,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6535433071,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7254901961,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"20-40","Female",NA,0.06270627063,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6285714286,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4508196721,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6390977444,NA,NA,0.679245283,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,0.0972972973,NA,NA,NA,NA,NA,NA,NA,NA,0.7052023121,NA,NA,NA,NA,0.3953488372,"BUPROPION HCL","Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.07803790412,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6315789474,NA,NA,0.4785894207,"BUPROPION HCL","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.4339622642,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.1016949153,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6753731343,0.3216080402,"BUPROPION HCL","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.02272962618,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2433862434,"BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,0.1501706485,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,0.05031446541,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",NA,NA,NA,NA
"20-40","Female",NA,0.02403846154,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",NA,NA,NA,NA
"20-40","Female",NA,0.01906779661,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA
"20-40","Female",NA,0.01378446115,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"20-40","Female",NA,0.01680672269,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4535519126,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"20-40","Female",NA,0.01764705882,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.441025641,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,0.02417582418,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3545816733,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4387755102,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2011173184,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.01290322581,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA
"20-40","Female",NA,0.02164502165,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689)",NA,NA,NA,NA
"20-40","Female",NA,0.02234636872,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"20-40","Female",NA,0.03529411765,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,0.03296703297,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA
"20-40","Female",NA,0.028125,NA,NA,NA,NA,NA,NA,NA,NA,0.3026315789,NA,NA,NA,NA,0.3093220339,"BUPROPION HCL","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2946428571,"BUPROPION HCL","Last AD: Same & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.04866180049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1832460733,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1333333333,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1565217391,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1296296296,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,0.04081632653,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","POLYCYSTIC OVARIES (dxo:ICD9:2564)",NA,NA,NA,NA
"20-40","Female",NA,0.005524861878,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"20-40","Female",NA,0.02639296188,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2429906542,"BUPROPION HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2079207921,"BUPROPION HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,0.01290322581,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA
"20-40","Female",NA,0.01904761905,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",NA,0.01714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,0.02394526796,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3751891074,NA,NA,0.3506988564,"BUPROPION HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.412195122,"BUPROPION HCL","Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.03282828283,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,0.04265402844,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03181818182,NA,0.1700819672,"BUPROPION HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4117647059,"BUPROPION HCL","Last AD: Same & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,0.006756756757,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","VALACYCLOVIR HCL",NA,NA,NA,NA
"20-40","Female",NA,0.03235294118,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3287197232,0.3416370107,"BUPROPION HCL","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.4357298475,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5464184731,"BUPROPION HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7299270073,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA
"20-40","Female",NA,0.4901960784,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7475083056,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7606382979,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.4696132597,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7418677859,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7068965517,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7089552239,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7408759124,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.811827957,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5777777778,NA,NA,NA,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5766423358,NA,NA,NA,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4772727273,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6595744681,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.510989011,"BUPROPION HCL","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5436893204,"BUPROPION HCL","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5711086226,"BUPROPION HCL","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5183673469,"BUPROPION HCL","Last AD: Same & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5128,"BUPROPION HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4857142857,"BUPROPION HCL","Last AD: Same & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5114822547,"BUPROPION HCL","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04672897196,"BUPROPION HCL","LITHIUM CARBONATE",NA,NA,NA,NA,NA
"20-40","Female",NA,0.0790960452,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","LORAZEPAM",NA,NA,NA,NA,NA
"20-40","Female",NA,0.005714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","LORAZEPAM","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.4490861619,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6527590848,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.6762589928,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7727272727,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6972477064,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.631372549,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.4622844828,NA,NA,NA,NA,NA,0.6055045872,NA,NA,NA,NA,NA,NA,NA,0.641025641,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.4954954955,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.65,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6560509554,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6142857143,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.4615384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7286821705,NA,NA,0.6260869565,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.4056603774,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.616745283,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6014492754,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3495934959,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.367576244,0.5480769231,NA,NA,0.597826087,0.4452214452,0.5018181818,NA,NA,NA,NA,0.5693430657,NA,0.6050420168,0.5400098184,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5257731959,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5205992509,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4616895874,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.3705882353,NA,NA,NA,NA,NA,NA,NA,NA,0.7024793388,NA,NA,NA,NA,NA,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.53125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7172413793,NA,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,0.3634204276,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6323907455,NA,NA,0.5612745098,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3793103448,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.4030172414,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4777190332,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4068965517,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,0.3714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6526610644,0.5251509054,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.04402515723,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.05,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.1287128713,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","METHYLPHENIDATE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.07446808511,NA,NA,NA,NA,NA,NA,0.1542857143,NA,NA,NA,NA,NA,NA,0.193072955,"BUPROPION HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2283464567,"BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1677559913,"BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1153846154,"BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3088235294,"BUPROPION HCL","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.189258312,"BUPROPION HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1485148515,"BUPROPION HCL","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.05543237251,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03610108303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.06609195402,NA,NA,NA,NA,NA,NA,NA,0.1011904762,NA,NA,NA,NA,NA,0.2472906404,"BUPROPION HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2349726776,"BUPROPION HCL","NORTRIPTYLINE HCL","Num Previous Antidep: 4+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2571428571,"BUPROPION HCL","NORTRIPTYLINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3238095238,"BUPROPION HCL","NORTRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2323943662,"BUPROPION HCL","NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5138888889,NA,NA,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.695473251,NA,NA,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.297029703,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5158730159,NA,NA,NA,NA,0.6213191991,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5892857143,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5042735043,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1779661017,NA,0.2596153846,NA,NA,0.2180397727,"BUPROPION HCL","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3258426966,NA,NA,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 4+","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2888888889,"BUPROPION HCL","Num Previous Antidep: 4+","ROPINIROLE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2835820896,"BUPROPION HCL","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3691460055,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 4+","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2098939929,"BUPROPION HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1973875181,"BUPROPION HCL","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1646191646,"BUPROPION HCL","Num Previous Antidep: 4+","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5131578947,NA,NA,NA,NA,NA,"BUPROPION HCL","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6257309942,NA,NA,0.6433566434,"BUPROPION HCL","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.0406779661,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01709401709,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1669565217,"BUPROPION HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1902654867,"BUPROPION HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1942446043,"BUPROPION HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.0462633452,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03669724771,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,0.07255520505,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04716981132,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,0.07894736842,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.0395256917,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,0.05405405405,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04971475143,0.4,NA,NA,0.3389830508,0.1368421053,0.3843648208,NA,NA,0.4766073046,NA,0.4486803519,NA,0.6510067114,0.2827476038,"BUPROPION HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2635983264,NA,NA,NA,NA,0.1335504886,"BUPROPION HCL","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2718446602,"BUPROPION HCL","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,0.02702702703,NA,NA,NA,NA,NA,NA,NA,NA,0.4347826087,NA,0.4309392265,NA,NA,0.3333333333,"BUPROPION HCL","PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.05140186916,NA,NA,NA,NA,NA,NA,NA,NA,0.3367875648,NA,NA,NA,NA,0.2258883249,"BUPROPION HCL","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2551724138,"BUPROPION HCL","PAROXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.06685768863,0.2057142857,NA,NA,0.1787439614,NA,0.1301369863,NA,NA,NA,NA,0.1656050955,NA,0.2038664323,0.0831842576,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.07272727273,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06060606061,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1489361702,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.132231405,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,0.05426356589,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2665562914,NA,NA,0.1831869511,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1286173633,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06432748538,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2244897959,0.1513761468,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2681281619,0.1719745223,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.045,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","POLYCYSTIC OVARIES (dxo:ICD9:2564)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02919708029,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3788487282,"BUPROPION HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3333333333,"BUPROPION HCL","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.280334728,"BUPROPION HCL","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6991150442,NA,NA,NA,"BUPROPION HCL","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4968553459,NA,NA,NA,"BUPROPION HCL","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,0.03105590062,NA,NA,NA,NA,NA,0.3550295858,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.34,NA,NA,NA,"BUPROPION HCL","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,0.02639296188,NA,0.21,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.118611379,"BUPROPION HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4086956522,NA,NA,0.25390625,"BUPROPION HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1698113208,"BUPROPION HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1657458564,"BUPROPION HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1130434783,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0756302521,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1538461538,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1452991453,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0979020979,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.1960784314,0.08040201005,0.2333333333,NA,NA,NA,NA,0.1802325581,NA,0.2580645161,0.1446469248,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2882352941,NA,NA,0.2301790281,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2807017544,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.065,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2978723404,0.25,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.106918239,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.103875969,"BUPROPION HCL","RISPERIDONE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08026755853,"BUPROPION HCL","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1555555556,"BUPROPION HCL","RISPERIDONE","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.05882352941,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2935871743,"BUPROPION HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2243767313,"BUPROPION HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.05699481865,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04109589041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,0.04419191919,NA,0.6331877729,NA,NA,0.1349693252,NA,NA,NA,NA,NA,NA,NA,NA,0.3054393305,"BUPROPION HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",0.02068965517,0.04806177119,0.3864678899,NA,NA,0.2965641953,0.1621187801,0.3953917051,NA,NA,0.3418079096,NA,0.4632159986,0.02525252525,0.5533230294,0.3542816702,"BUPROPION HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5792811839,NA,NA,0.384180791,"BUPROPION HCL","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,0.05692307692,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3445255474,0.003571428571,NA,0.2626325639,"BUPROPION HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.05813953488,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4927113703,NA,0.6492537313,0.2619589977,"BUPROPION HCL","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.246031746,"BUPROPION HCL","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03992740472,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4861111111,NA,NA,0.234828496,"BUPROPION HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2288135593,"BUPROPION HCL","TOPIRAMATE",NA,NA,NA,NA,NA
"20-40","Female",NA,0.05852282743,0.2560386473,NA,NA,0.2575250836,0.1428571429,0.2441471572,NA,NA,NA,NA,0.2905027933,0.01693719125,0.3042505593,0.2369779243,"BUPROPION HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.06360424028,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01875,0.3577817531,0.2328767123,"BUPROPION HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.07547169811,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04438642298,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","VALACYCLOVIR HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.06390243902,0.3976261128,NA,NA,0.4491525424,0.1378600823,0.3469387755,NA,NA,0.3538461538,NA,0.4366972477,0.03571428571,0.4937978358,0.2599126955,"BUPROPION HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4210526316,NA,NA,NA,0.1594684385,NA,NA,NA,NA,NA,0.4776119403,NA,NA,0.1363636364,"BUSPIRONE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3969849246,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUSPIRONE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2272727273,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUSPIRONE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6814814815,NA,NA,NA,"BUSPIRONE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4347826087,NA,NA,NA,NA,NA,NA,NA,NA,"CANDIDIASIS OF VULVA AND VAGINA (dxo:ICD9:1121)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.407079646,NA,NA,NA,NA,NA,NA,NA,NA,"CANDIDIASIS OF VULVA AND VAGINA (dxo:ICD9:1121)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",0.01224489796,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.56,0.0157480315,NA,NA,"CARISOPRODOL",NA,NA,NA,NA,NA,NA
"20-40","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CARISOPRODOL","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2049689441,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CEFDINIR",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1367521368,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CEFDINIR","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4294478528,NA,NA,NA,NA,0.4890510949,NA,NA,NA,NA,NA,NA,NA,NA,"CELECOXIB",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4444444444,NA,NA,NA,NA,NA,NA,NA,NA,"CERVICALGIA (dxo:ICD9:7231)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.511589404,NA,0.1359223301,NA,0.1344667697,NA,NA,NA,NA,NA,0.5564516129,NA,0.5869565217,NA,"CETIRIZINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5800711744,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CETIRIZINE HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5688073394,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CETIRIZINE HCL","CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.3565217391,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CETIRIZINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2608695652,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CETIRIZINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1470588235,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CETIRIZINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.5547945205,NA,NA,NA,0.1005586592,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CETIRIZINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1174089069,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CETIRIZINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4363636364,NA,"CHEST PAIN, OTHER (dxo:ICD9:78659)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4230769231,NA,NA,NA,"CHEST PAIN, OTHER (dxo:ICD9:78659)","CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4196428571,NA,NA,NA,0.1153846154,0.381294964,NA,NA,NA,NA,0.4527972028,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.448,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.09465020576,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5918367347,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03361344538,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4166666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3949579832,NA,NA,NA,"CHRONIC FATIGUE SYNDROME (dxo:ICD9:78071)",NA,NA,NA,NA,NA,NA
"20-40","Female",0.01210898083,0.03191828918,0.4700887503,0.5667655786,0.07731958763,0.3453757225,0.2158582423,0.4122751323,0.09736842105,0.05479452055,0.3520804755,NA,0.4266544678,0.01962533452,0.5527522936,0.2576716664,"CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.514619883,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3333333333,"CITALOPRAM HYDROBROMIDE","CLONAZEPAM",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2389380531,"CITALOPRAM HYDROBROMIDE","CLONAZEPAM","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.2631578947,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","CLONAZEPAM","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6075268817,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.2892561983,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6015625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03301886792,0.5794117647,NA,NA,NA,NA,0.6046511628,NA,NA,NA,NA,NA,NA,0.6193548387,0.352688172,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02380952381,NA,NA,NA,NA,NA,0.375,NA,NA,NA,NA,NA,NA,0.4681818182,0.2753036437,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5782312925,0.4236453202,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.3817663818,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6200607903,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3225806452,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.52,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2406015038,"CITALOPRAM HYDROBROMIDE","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5941176471,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEXTROAMPHETAMINE/AMPHETAMINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5670103093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2074468085,"CITALOPRAM HYDROBROMIDE","DOXEPIN HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02542372881,0.5145985401,NA,NA,0.4548022599,NA,NA,NA,NA,NA,NA,0.4253731343,NA,NA,0.2337434095,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.214953271,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.01657458564,0.6116811365,NA,NA,NA,0.3101851852,0.4082191781,NA,NA,0.3917050691,NA,0.4370860927,0.01834862385,0.6386554622,0.2132545932,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4852941176,NA,NA,NA,0.2307692308,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2375,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA
"20-40","Female",NA,0.01838235294,0.6777777778,NA,NA,NA,0.3399693721,NA,NA,NA,NA,NA,NA,NA,0.6461538462,0.2703488372,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.7102803738,NA,NA,NA,0.3571428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,NA,0.5828877005,NA,NA,NA,0.316,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"20-40","Female",NA,NA,0.5816326531,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2236842105,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.4600938967,NA,NA,NA,NA,NA,NA,NA,NA,0.3450980392,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.3673965937,NA,NA,NA,0.1703406814,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1483870968,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,NA,0.375,NA,NA,NA,0.1597222222,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"20-40","Female",NA,NA,0.3727272727,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,NA,0.6144578313,NA,NA,NA,0.5535714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.5555555556,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.49,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Num Previous Antidep: 2,3",NA,NA,NA,NA
"20-40","Female",NA,NA,0.5821596244,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08108108108,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4833333333,NA,NA,0.2100840336,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.4035087719,NA,NA,NA,0.2663316583,NA,NA,NA,NA,NA,NA,0.03571428571,NA,0.2431077694,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6447368421,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESOMEPRAZOLE MAGNESIUM",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.6228070175,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.6768292683,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ETHINYL ESTRADIOL/DROSPIRENONE",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02955665025,0.4432717678,NA,NA,0.2910447761,0.2006920415,0.5025380711,NA,NA,0.3017751479,NA,0.4180327869,NA,0.5828571429,0.213592233,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01030927835,NA,NA,NA,NA,0.1759259259,NA,NA,NA,NA,NA,NA,NA,NA,0.2615384615,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6540540541,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3741935484,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.3601694915,NA,NA,NA,NA,0.296819788,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5673076923,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6540540541,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"20-40","Female",NA,NA,0.3712121212,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.252173913,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.3434343434,NA,NA,NA,NA,0.3623188406,NA,NA,NA,NA,NA,NA,NA,0.1959064327,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.188034188,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.01,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02222222222,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.5925925926,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GUAIFENESIN/PHENYLEPHRINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5954716981,NA,NA,NA,0.2166666667,NA,NA,NA,0.5147928994,NA,NA,NA,0.6701570681,0.3076923077,"CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1782178218,NA,NA,NA,NA,NA,NA,NA,NA,0.3524590164,"CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.12,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.4086294416,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.3189655172,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,NA,0.5670886076,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.5398230088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",0.008510638298,NA,NA,NA,NA,NA,NA,NA,NA,0.02173913043,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"20-40","Female",0.01492537313,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.4901960784,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","IBUPROFEN",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.2449494949,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1096774194,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.1129032258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA
"20-40","Female",NA,NA,0.1910569106,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,0.234375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09708737864,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07058823529,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,0.1818181818,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1209677419,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.379525593,NA,NA,0.2317073171,0.1097744361,0.2629969419,NA,NA,0.2613636364,NA,0.2656587473,NA,0.296875,0.1558441558,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.07492795389,NA,NA,NA,NA,NA,NA,NA,NA,0.1461538462,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08620689655,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.07177033493,0.1946902655,NA,NA,NA,NA,0.1904761905,NA,0.2300884956,0.1378205128,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,0.2858575727,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,0.2180851064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"20-40","Female",NA,NA,0.224,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"20-40","Female",NA,NA,0.2859744991,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,0.456,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,0.1979166667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Female",NA,NA,0.2025316456,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1116751269,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,0.2307692308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,0.3620283019,NA,NA,NA,0.1625,0.2373737374,NA,NA,0.2252252252,NA,0.2614379085,NA,0.2462121212,0.1448763251,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,0.261627907,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,0.2909090909,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.2100840336,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03797468354,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.1461988304,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,0.2376237624,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.6074766355,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02521008403,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01342281879,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.3636363636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.5043478261,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.65,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","IRREGULAR MENSTRUAL CYCLE (dxo:ICD9:6264)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.1287188828,NA,NA,NA,0.07692307692,0.1134751773,NA,NA,NA,NA,0.1728395062,NA,NA,0.07676348548,"CITALOPRAM HYDROBROMIDE","LAMOTRIGINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.08965517241,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LAMOTRIGINE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.1335616438,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07883817427,"CITALOPRAM HYDROBROMIDE","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",0.009009009009,0.02171903882,NA,NA,NA,0.2930513595,0.1848505907,0.3796909492,NA,NA,0.323782235,NA,0.4227467811,0.01870503597,0.4573829532,0.2761953204,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02732240437,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6296296296,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5441176471,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,0.5675,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6244725738,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.6028169014,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007575757576,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2722513089,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6272727273,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2348484848,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.564792176,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3746130031,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.01886792453,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2478632479,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01941747573,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1240875912,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1520737327,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2095808383,NA,NA,NA,0.2857142857,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,0.01910828025,0.6050420168,NA,NA,NA,0.1387283237,NA,NA,NA,NA,NA,NA,NA,0.51875,0.25,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02941176471,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4086956522,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,0.01986754967,0.601965602,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01512859304,NA,0.3731617647,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.03409090909,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,0.26875,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",0.0462962963,0.05839416058,NA,0.5688073394,NA,0.4713375796,0.2806804374,0.5636743215,NA,NA,0.4791666667,NA,0.5407801418,0.09356725146,0.5523809524,0.3629712999,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6390532544,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6086956522,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2808219178,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,0.0796460177,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2777777778,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.5481481481,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04090909091,NA,0.3596491228,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4125874126,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.3366705279,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4285714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.4121212121,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","NORGESTIMATE-ETHINYL ESTRADIOL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4019607843,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.3665031535,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4647887324,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.2589928058,NA,NA,NA,NA,NA,NA,NA,0.3333333333,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.2338709677,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.4764705882,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.3186813187,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.3173076923,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"20-40","Female",NA,NA,0.2914285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.152,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.2336769759,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.4351851852,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","ROUTINE POSTPARTUM FOLLOW-UP (dxo:ICD9:V242)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.3313609467,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.3265306122,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.367816092,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.3897058824,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.305019305,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02298850575,NA,0.3451536643,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.2736842105,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.2946428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.5969005166,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.6228070175,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6569767442,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","NORGESTIMATE-ETHINYL ESTRADIOL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.4609053498,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,0.7454545455,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA,NA,NA
"20-40","Female",NA,NA,0.7413793103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Remissions: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6330275229,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6074074074,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.4862385321,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6293436293,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5408970976,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6097560976,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6475409836,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LEVONORGESTREL-ETHIN ESTRADIOL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3233082707,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LEVONORGESTREL-ETHIN ESTRADIOL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6030534351,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LEVONORGESTREL-ETHIN ESTRADIOL","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.7025316456,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.6387096774,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LORATADINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5495495495,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LORAZEPAM",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.6791171477,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5706214689,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.6554621849,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.4309623431,0.6143437077,NA,NA,0.5784313725,0.5574712644,0.5438596491,NA,NA,NA,NA,0.5251798561,NA,NA,0.5522827688,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.676056338,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6376146789,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5511111111,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.4117647059,NA,NA,NA,NA,NA,0.1363636364,NA,NA,NA,NA,NA,NA,0.1966759003,"CITALOPRAM HYDROBROMIDE","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2142857143,"CITALOPRAM HYDROBROMIDE","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.4953271028,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","MONTELUKAST SODIUM",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.6344537815,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03488372093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.6252983294,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","NORGESTIMATE-ETHINYL ESTRADIOL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5501355014,NA,NA,NA,NA,NA,NA,0.1555555556,NA,NA,NA,NA,NA,0.345646438,"CITALOPRAM HYDROBROMIDE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5728476821,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6461538462,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.5783664459,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.7413793103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Remissions: 2+",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1607843137,"CITALOPRAM HYDROBROMIDE","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.6374269006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"20-40","Female",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5859375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02822580645,0.464333782,NA,NA,NA,0.2222222222,0.4098360656,NA,NA,0.4573002755,NA,0.4891774892,NA,NA,0.1891304348,"CITALOPRAM HYDROBROMIDE","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4263565891,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2307692308,"CITALOPRAM HYDROBROMIDE","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.05769230769,0.280148423,NA,NA,0.1100917431,NA,0.1778846154,NA,NA,NA,NA,0.1791044776,NA,NA,0.1065693431,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.2835820896,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09748427673,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1188118812,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.2317708333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1886792453,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1048387097,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6470588235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4362416107,"CITALOPRAM HYDROBROMIDE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.6422222222,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.6625,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4675324675,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.5769230769,NA,NA,NA,NA,0.4140127389,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3591160221,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.4214285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2441860465,NA,0.2741935484,0.1468860165,"CITALOPRAM HYDROBROMIDE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2421875,"CITALOPRAM HYDROBROMIDE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.2441860465,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09677419355,"CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3531073446,NA,NA,0.18,0.1542288557,0.26,NA,NA,NA,NA,0.1744680851,NA,0.213740458,0.1902173913,"CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.2662721893,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1962025316,"CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.1531100478,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07947019868,"CITALOPRAM HYDROBROMIDE","RISPERIDONE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5418326693,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4382022472,"CITALOPRAM HYDROBROMIDE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.6057142857,NA,NA,0.3093220339,NA,NA,NA,NA,NA,NA,NA,NA,0.3316582915,"CITALOPRAM HYDROBROMIDE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.6330935252,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ROUTINE POSTPARTUM FOLLOW-UP (dxo:ICD9:V242)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5485362096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5267175573,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6493506494,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03878583474,0.4536328872,NA,NA,0.4277456647,0.1759259259,0.3727272727,NA,NA,0.3163636364,NA,0.4712411705,0.01960784314,0.5110294118,0.2203672788,"CITALOPRAM HYDROBROMIDE","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.572815534,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.4184100418,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4126394052,0.02631578947,NA,0.2613636364,"CITALOPRAM HYDROBROMIDE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2212389381,"CITALOPRAM HYDROBROMIDE","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5128205128,"CITALOPRAM HYDROBROMIDE","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.6085526316,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4721780604,NA,NA,0.2616033755,"CITALOPRAM HYDROBROMIDE","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.623655914,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","TOPIRAMATE",NA,NA,NA,NA,NA
"20-40","Female",NA,0.05405405405,0.429031516,NA,NA,0.2047244094,0.2208333333,0.2651515152,NA,NA,0.2692307692,NA,0.321969697,0.02289281998,0.4684684685,0.2921137339,"CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3987341772,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2650273224,"CITALOPRAM HYDROBROMIDE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6363636364,NA,NA,0.4803921569,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5586353945,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5968992248,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","VALACYCLOVIR HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04347826087,0.4689597315,NA,NA,NA,0.2510822511,0.3820224719,NA,NA,0.3388429752,NA,0.4108280255,NA,0.6120481928,0.2326565144,"CITALOPRAM HYDROBROMIDE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4339622642,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CLINDAMYCIN HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",0.006944444444,0.01983002833,0.390070922,NA,NA,NA,0.1781609195,0.3480662983,0.07339449541,NA,NA,NA,0.4712643678,0.0102739726,0.4610778443,0.170212766,"CLONAZEPAM",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3085106383,NA,NA,NA,NA,NA,NA,NA,NA,0.286407767,"CLONAZEPAM","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1732673267,"CLONAZEPAM","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1625,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CLONAZEPAM","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6074766355,NA,NA,NA,NA,NA,NA,NA,0.3453608247,"CLONAZEPAM","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3358208955,"CLONAZEPAM","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3357664234,"CLONAZEPAM","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4330708661,NA,NA,NA,"CLONAZEPAM","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6054421769,NA,NA,NA,"CLONAZEPAM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2056074766,"CLONAZEPAM","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1851851852,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CLONAZEPAM","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6162162162,NA,NA,0.3313432836,"CLONAZEPAM","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3854166667,"CLONAZEPAM","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3857142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CLOTRIMAZOLE/BETAMETHASONE DIP",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3921568627,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01127819549,0.4423076923,NA,"CODEINE PHOSPHATE/GUAIFENESIN",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,0.0701754386,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CONTACT DERMATITIS AND OTHER ECZEMA, DUE TO UNSPECIFIED CAUSE (dxo:ICD9:6929)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.0511627907,0.3564463705,NA,NA,NA,NA,0.3581514763,NA,NA,NA,NA,0.3927747886,NA,0.359223301,NA,"CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5209302326,NA,NA,NA,NA,NA,NA,NA,NA,"CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3333333333,NA,NA,NA,NA,NA,NA,NA,NA,"CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016)","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3495575221,NA,NA,NA,"CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,NA,NA,NA,"CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4621212121,NA,NA,NA,"CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.309178744,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4356435644,NA,NA,NA,"CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016)","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5364431487,NA,NA,NA,"CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4590163934,NA,NA,NA,"CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3439490446,NA,NA,NA,NA,0.3801169591,NA,NA,NA,NA,0.3394833948,NA,NA,NA,"CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1129032258,0.4625,NA,NA,NA,NA,NA,0.009009009009,NA,NA,"CYCLOBENZAPRINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3716814159,NA,NA,NA,0.1779661017,0.3614457831,NA,NA,0.4330708661,NA,0.3457943925,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6148648649,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6084656085,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6826923077,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5785714286,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",0.01243523316,0.02541189612,0.4684431978,0.591943958,0.1370967742,0.4069767442,0.1319514661,0.4684002633,NA,0.02870813397,0.4081632653,NA,0.514455152,0.009118541033,0.5313199105,0.2629716981,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.6050955414,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.6538461538,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DESVENLAFAXINE SUCCINATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.5671641791,NA,NA,NA,NA,NA,NA,NA,NA,0.7122302158,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DULOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02577319588,0.6517857143,NA,NA,NA,0.265917603,0.5649350649,NA,NA,NA,NA,NA,NA,0.618902439,0.3202099738,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Female",0.01,0.007575757576,0.6598639456,NA,NA,NA,NA,0.5497835498,NA,NA,NA,NA,NA,NA,0.5433070866,0.1796246649,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2233009709,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.637254902,0.4380952381,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1090146751,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1277258567,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.5321100917,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3350923483,NA,NA,NA,NA,NA,NA,NA,NA,0.2336448598,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5445544554,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1162790698,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ETHINYL ESTRADIOL/DROSPIRENONE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,0.08737864078,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ETONOGESTREL/ETHINYL ESTRADIOL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02797202797,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUCONAZOLE",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03535353535,NA,NA,NA,NA,NA,0.59030837,NA,NA,NA,NA,NA,NA,0.6369636964,0.3740831296,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4672897196,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6385542169,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5333333333,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA
"20-40","Female",NA,0.05405405405,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5480225989,0.2876106195,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.64,0.3630952381,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3864278982,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4184100418,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.35,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & No Remiss","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5746192893,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5892857143,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5145631068,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6385542169,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6114649682,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5583333333,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6033519553,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",NA,0.03821656051,NA,NA,NA,NA,NA,0.4912280702,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01127819549,0.5773809524,NA,NA,NA,0.1076320939,0.4752747253,NA,NA,0.4569892473,NA,0.6538461538,NA,0.5863267671,0.2564102564,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1844660194,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5071428571,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6170212766,NA,0.6347826087,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.615658363,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",0.008169934641,0.01098901099,NA,NA,NA,NA,NA,NA,NA,0.03086419753,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"20-40","Female",0.01570680628,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HEADACHE (dxo:ICD9:7840)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1416309013,NA,NA,NA,NA,NA,0.4224137931,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1515151515,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HYDROCODONE/ACETAMINOPHEN","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03428571429,0.335483871,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.1890547264,NA,NA,NA,NA,NA,NA,0.2369942197,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,0.01754385965,NA,NA,NA,NA,NA,0.358974359,NA,NA,NA,NA,NA,0.02147239264,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009009009009,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3603603604,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.01401869159,NA,NA,NA,NA,NA,0.4161490683,NA,NA,NA,NA,NA,NA,0.5074074074,0.3189368771,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3148148148,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6237623762,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1747572816,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.04651162791,NA,NA,NA,NA,NA,0.5961538462,NA,NA,NA,NA,NA,NA,0.6117021277,0.4121863799,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3716814159,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.373015873,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.303030303,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4026666667,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01129943503,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4255319149,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5898734177,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5863377609,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",0.03225806452,NA,NA,NA,NA,NA,NA,0.4607843137,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03311258278,NA,NA,NA,NA,NA,0.5507246377,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01385681293,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4454545455,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","NORGESTIMATE-ETHINYL ESTRADIOL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02461538462,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02214452214,NA,NA,NA,0.4066666667,0.08187134503,0.449197861,NA,NA,NA,NA,0.5663716814,NA,0.6168831169,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.006993006993,NA,0.6666666667,NA,0.4718309859,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,0.03731343284,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02285714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4621848739,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01754385965,NA,NA,NA,NA,NA,NA,NA,NA,0.5974025974,NA,NA,NA,0.6720430108,0.2783505155,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4298245614,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03485254692,NA,NA,NA,NA,NA,0.2213114754,NA,NA,NA,NA,NA,NA,0.2677595628,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01941747573,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03921568627,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"20-40","Female",0,0.03009259259,NA,0.6365159129,NA,0.4425675676,0.1423699915,0.4970414201,NA,NA,0.4351851852,NA,NA,NA,NA,0.2244897959,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3961038961,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1166666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4411764706,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5523809524,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5870967742,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02491103203,NA,NA,NA,NA,0.2264150943,0.5550458716,NA,NA,NA,NA,0.645026178,NA,0.651416122,0.3668261563,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4711538462,NA,NA,NA,NA,NA,NA,0.5391705069,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4848484848,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2118644068,0.4257028112,NA,NA,NA,NA,NA,NA,0.5338345865,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5339805825,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03086419753,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","VALACYCLOVIR HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03797468354,NA,NA,NA,NA,NA,0.5042735043,NA,NA,NA,NA,NA,NA,0.6222076216,0.3663101604,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4172661871,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF FOOT (dxo:ICD9:1104)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4406779661,NA,NA,NA,0.1023622047,0.4208754209,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5476190476,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1013513514,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1382978723,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESLORATADINE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1397058824,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESLORATADINE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.515729266,NA,NA,NA,"DESOGESTREL-ETHINYL ESTRADIOL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6239316239,NA,NA,NA,"DESOGESTREL-ETHINYL ESTRADIOL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4689655172,NA,NA,NA,"DESOGESTREL-ETHINYL ESTRADIOL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6904761905,NA,NA,NA,"DESOGESTREL-ETHINYL ESTRADIOL","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6622807018,NA,NA,NA,"DESOGESTREL-ETHINYL ESTRADIOL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04012345679,0.4378698225,0.4571773221,NA,0.4436090226,0.1926977688,0.3402061856,NA,NA,NA,NA,0.5143603133,NA,0.6346153846,0.2437174016,"DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2326732673,"DESVENLAFAXINE SUCCINATE","DULOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.297188755,NA,NA,NA,NA,NA,NA,NA,NA,0.2252252252,"DESVENLAFAXINE SUCCINATE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4857142857,NA,NA,NA,NA,NA,NA,NA,0.2046511628,"DESVENLAFAXINE SUCCINATE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.1045576408,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09322033898,"DESVENLAFAXINE SUCCINATE","LAMOTRIGINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06976744186,"DESVENLAFAXINE SUCCINATE","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.04761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3921568627,"DESVENLAFAXINE SUCCINATE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3230769231,"DESVENLAFAXINE SUCCINATE","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.4214559387,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.4615384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.6992481203,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.5635738832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4444444444,"DESVENLAFAXINE SUCCINATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.2679738562,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.5043478261,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.1929133858,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.1551724138,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.2724252492,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.6666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5222222222,NA,NA,0.2426035503,"DESVENLAFAXINE SUCCINATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.5475409836,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2183333333,"DESVENLAFAXINE SUCCINATE","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2,"DESVENLAFAXINE SUCCINATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.442455243,NA,NA,NA,0.18767507,0.4449760766,NA,NA,NA,NA,0.4289156627,0.01176470588,0.3529411765,NA,"DEXTROAMPHETAMINE/AMPHETAMINE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6028037383,NA,NA,NA,NA,NA,NA,NA,NA,"DEXTROAMPHETAMINE/AMPHETAMINE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3583815029,NA,NA,NA,"DEXTROAMPHETAMINE/AMPHETAMINE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,"DEXTROAMPHETAMINE/AMPHETAMINE","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1717171717,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEXTROAMPHETAMINE/AMPHETAMINE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6115107914,NA,NA,NA,"DEXTROAMPHETAMINE/AMPHETAMINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.009852216749,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3663366337,NA,NA,NA,NA,0.449704142,NA,NA,NA,NA,0.4903846154,NA,0.4585987261,NA,"DIAZEPAM",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4690265487,NA,NA,NA,NA,NA,NA,NA,NA,"DIAZEPAM","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3947368421,NA,NA,NA,NA,NA,NA,NA,NA,"DIFFUSE CYSTIC MASTOPATHY (dxo:ICD9:6101)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05263157895,NA,NA,NA,NA,NA,NA,"DISTURBANCE OF SKIN SENSATION (dxo:ICD9:7820)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01801801802,NA,NA,NA,NA,NA,NA,"DISTURBANCE OF SKIN SENSATION (dxo:ICD9:7820)","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4083333333,NA,NA,NA,0.1472081218,0.398,NA,NA,NA,NA,0.4846153846,NA,0.3913043478,0.1496062992,"DIZZINESS AND GIDDINESS (dxo:ICD9:7804)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5377358491,NA,NA,NA,NA,NA,NA,NA,NA,"DIZZINESS AND GIDDINESS (dxo:ICD9:7804)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0495049505,NA,NA,NA,NA,NA,NA,"DIZZINESS AND GIDDINESS (dxo:ICD9:7804)","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3846153846,NA,0.2503144654,NA,0.1052631579,0.3039215686,NA,NA,NA,NA,0.4081632653,NA,NA,0.2416422287,"DOXEPIN HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.5096153846,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2165605096,"DOXEPIN HCL","DULOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2311111111,NA,NA,NA,NA,NA,NA,NA,NA,0.2035928144,"DOXEPIN HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.25,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,0.262295082,NA,NA,0.4907407407,NA,NA,NA,NA,NA,NA,NA,0.2763819095,"DOXEPIN HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08125,"DOXEPIN HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.198019802,"DOXEPIN HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,0.146039604,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4905660377,"DOXEPIN HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.35,"DOXEPIN HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1532846715,"DOXEPIN HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5794392523,NA,NA,NA,NA,NA,"DOXEPIN HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,0.2156862745,NA,NA,NA,NA,NA,NA,NA,0.5882352941,NA,NA,0.3,"DOXEPIN HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2344689379,"DOXEPIN HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6736111111,0.2698412698,"DOXEPIN HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4338235294,NA,NA,NA,NA,NA,NA,NA,NA,"DOXYCYCLINE HYCLATE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4196428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXYCYCLINE MONOHYDRATE",NA,NA,NA,NA,NA,NA
"20-40","Female",0.01073345259,0.03210649961,0.4388185654,NA,0.09565217391,0.3731695332,0.1796733212,0.407804878,0.07843137255,0.0495049505,0.3457446809,NA,0.4460916442,0.04405286344,0.6011235955,0.2325929963,"DULOXETINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.0253164557,NA,NA,NA,0.4761904762,0.3129161119,0.3548387097,NA,NA,NA,NA,0.38,NA,NA,0.2110091743,"DULOXETINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Female",NA,0.0234375,NA,NA,NA,0.5048543689,0.3580786026,NA,NA,NA,NA,NA,NA,NA,NA,0.25,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.38,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3823529412,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1901408451,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3550724638,NA,NA,NA,NA,NA,NA,NA,NA,0.2252559727,"DULOXETINE HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1923076923,"DULOXETINE HCL","ESCITALOPRAM OXALATE","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.007874015748,0.4356435644,NA,NA,0.4136253041,0.1493506494,0.5276752768,NA,NA,NA,NA,0.4275362319,NA,NA,0.2153465347,"DULOXETINE HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.009803921569,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.7580645161,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3482142857,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.752,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.3148148148,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,"DULOXETINE HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",0.006535947712,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.1862068966,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09032258065,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.1379310345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.2746478873,0.1390728477,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.2178988327,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.223880597,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.1764705882,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.2803030303,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1506849315,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.2773109244,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.1074380165,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08154506438,"DULOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.06930693069,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","LAMOTRIGINE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.4203821656,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.1277777778,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08045977011,"DULOXETINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",0,0.03120124805,0.4259259259,NA,NA,NA,0.1560846561,0.4734513274,NA,NA,NA,NA,0.5,0.003355704698,0.5083056478,0.2429022082,"DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6036585366,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3986928105,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.447761194,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3071428571,"DULOXETINE HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.5194444444,NA,NA,NA,NA,NA,NA,NA,0.01405152225,NA,0.4041811847,"DULOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.4661016949,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.5769230769,NA,NA,NA,NA,NA,NA,NA,NA,0.7394957983,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.07960199005,NA,NA,NA,NA,0.2302631579,0.5964912281,NA,NA,NA,NA,0.6280991736,NA,0.6030534351,0.3406193078,"DULOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4402985075,"DULOXETINE HCL","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.5277777778,NA,NA,NA,NA,NA,NA,NA,0.02941176471,NA,NA,"DULOXETINE HCL","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.2483081728,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.2608695652,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.2827586207,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.1785714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.1857142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.1952662722,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.2774193548,NA,NA,NA,NA,NA,NA,0.3839285714,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.2580645161,NA,NA,NA,NA,NA,NA,NA,0.01,NA,0.3,"DULOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.3270440252,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.540166205,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5826086957,"DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.54,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5875,"DULOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.532967033,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.6052631579,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5811965812,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.5245901639,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5038910506,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.5304347826,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4669811321,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.2857142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1879432624,"DULOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.5461538462,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.306122449,"DULOXETINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5783783784,NA,NA,NA,"DULOXETINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.185483871,"DULOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1450381679,"DULOXETINE HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.487804878,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.4,NA,NA,NA,NA,0.4587628866,NA,NA,NA,NA,0.2391304348,"DULOXETINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.2514619883,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1167883212,"DULOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.1818181818,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1138211382,"DULOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.4596774194,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3474576271,"DULOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1404958678,"DULOXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07894736842,"DULOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1619047619,"DULOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.2558922559,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1466666667,"DULOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.255033557,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1407407407,"DULOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0826446281,"DULOXETINE HCL","RISPERIDONE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.3818770227,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3122171946,"DULOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.5135951662,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02189781022,0.4086956522,NA,NA,0.4196428571,0.2256637168,0.3181818182,NA,NA,NA,NA,0.5167714885,NA,NA,0.2680151707,"DULOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.3103448276,NA,NA,NA,NA,NA,NA,0.3846153846,NA,NA,0.2683982684,"DULOXETINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.5851851852,NA,NA,NA,NA,NA,NA,0.4897959184,NA,NA,NA,"DULOXETINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.3432048682,0.1531531532,NA,NA,NA,NA,NA,NA,0.03825136612,NA,0.2595359811,"DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2164948454,"DULOXETINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.5307017544,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03921568627,NA,NA,NA,0.5714285714,0.1678832117,0.4351851852,NA,NA,NA,NA,0.4112903226,NA,0.6833333333,0.2297297297,"DULOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04046242775,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DYSMETABOLIC SYNDROME X (dxo:ICD9:2777)",NA,NA,NA,NA,NA,NA
"20-40","Female",0,NA,0.4901960784,NA,NA,NA,NA,0.4086538462,NA,NA,NA,NA,0.5130890052,0.00826446281,0.5881006865,0.2476190476,"DYSTHYMIC DISORDER (dxo:ICD9:3004)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6046511628,NA,NA,NA,NA,NA,NA,NA,NA,"DYSTHYMIC DISORDER (dxo:ICD9:3004)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6260869565,NA,"DYSTHYMIC DISORDER (dxo:ICD9:3004)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6071428571,NA,NA,NA,"DYSTHYMIC DISORDER (dxo:ICD9:3004)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6322580645,NA,"DYSTHYMIC DISORDER (dxo:ICD9:3004)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5481171548,NA,NA,NA,"ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5140186916,NA,NA,NA,"ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963)","ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5551724138,NA,NA,NA,"ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5136842105,NA,NA,NA,"ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.525862069,NA,NA,NA,"ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963)","SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7124183007,NA,NA,NA,"ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963)","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5526315789,NA,NA,NA,"ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4318181818,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ELETRIPTAN HYDROBROMIDE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1739130435,0.4588235294,NA,NA,NA,NA,NA,NA,NA,NA,"ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2074074074,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3758389262,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ENCOUNTER FOR OTHER SPECIFIED AFTERCARE (dxo:ICD9:V5889)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6335403727,NA,NA,NA,"ENCOUNTER FOR OTHER SPECIFIED ANTENATAL SCREENING (dxo:ICD9:V288)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5970149254,NA,NA,NA,"ENCOUNTER FOR OTHER SPECIFIED ANTENATAL SCREENING (dxo:ICD9:V288)","ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5418719212,NA,NA,NA,"ENCOUNTER FOR OTHER SPECIFIED ANTENATAL SCREENING (dxo:ICD9:V288)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5714285714,NA,NA,NA,"ENCOUNTER FOR OTHER SPECIFIED ANTENATAL SCREENING (dxo:ICD9:V288)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5046439628,NA,NA,NA,"ENCOUNTER FOR OTHER SPECIFIED ANTENATAL SCREENING (dxo:ICD9:V288)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.572327044,NA,NA,NA,"ENCOUNTER FOR OTHER SPECIFIED ANTENATAL SCREENING (dxo:ICD9:V288)","SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5807228916,NA,NA,NA,"ENCOUNTER FOR OTHER SPECIFIED ANTENATAL SCREENING (dxo:ICD9:V288)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.527027027,NA,NA,NA,"ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.496350365,NA,NA,NA,"ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283)","IBUPROFEN","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6204379562,NA,NA,NA,"ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283)","NORETHINDRONE","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4635193133,NA,NA,NA,"ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5260115607,NA,NA,NA,"ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5036900369,NA,NA,NA,"ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4285714286,NA,NA,NA,"ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283)","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5648148148,NA,NA,NA,"ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283)","SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5494880546,NA,NA,NA,"ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283)","SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.595890411,NA,NA,NA,"ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283)","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5234541578,NA,NA,NA,"ENCOUNTER FOR ROUTINE SCREENING FOR MALFORMATION USING ULTRASONICS (dxo:ICD9:V283)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",0.02072141213,0.020657277,0.57859375,NA,0.08778625954,0.451843044,0.2496772806,0.3946012776,0.111627907,0.03873239437,0.3569979716,NA,0.4310285121,0.01480263158,0.5428488709,0.2015220889,"ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3086419753,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ETHINYL ESTRADIOL/DROSPIRENONE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.214953271,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ETHINYL ESTRADIOL/DROSPIRENONE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1173184358,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ETHINYL ESTRADIOL/DROSPIRENONE","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2269230769,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ETHINYL ESTRADIOL/DROSPIRENONE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,0.01591511936,0.5520361991,NA,NA,NA,0.2297226583,0.4937106918,NA,NA,0.3368421053,NA,0.4266211604,0.01680672269,0.5194805195,0.1737193764,"ESCITALOPRAM OXALATE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01071428571,NA,NA,NA,NA,0.2958199357,0.6036036036,NA,NA,NA,NA,NA,NA,0.4583333333,0.1974248927,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3157894737,0.6511627907,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3185840708,0.5815602837,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2181818182,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2371794872,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1679012346,0.3174157303,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3944954128,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4038461538,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5663716814,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.4051724138,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6511627907,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.46,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2709677419,NA,NA,NA,NA,NA,0.4603174603,NA,NA,0.1351351351,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1882352941,0.343220339,NA,NA,NA,NA,NA,0.03875968992,NA,0.2144578313,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1578947368,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.4551282051,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GABAPENTIN",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.184,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GABAPENTIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,0.04285714286,NA,NA,NA,NA,0.3591836735,NA,NA,NA,NA,NA,NA,NA,NA,0.2980769231,"ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02164502165,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1504424779,"ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.137254902,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1787709497,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3189189189,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2613636364,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GUAIFENESIN/P-EPHED HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1486486486,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GUAIFENESIN/P-EPHED HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2789115646,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GUAIFENESIN/PHENYLEPHRINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.0962962963,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GUAIFENESIN/PHENYLEPHRINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6603773585,NA,NA,NA,0.1915966387,NA,NA,NA,0.4957264957,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.544,0.1172413793,"ESCITALOPRAM OXALATE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.0821529745,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",0.003558718861,NA,NA,NA,NA,NA,NA,NA,NA,0.01342281879,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"20-40","Female",0.005681818182,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3167701863,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.07643312102,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","HYDROCODONE/ACETAMINOPHEN","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1551724138,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","HYDROCODONE/ACETAMINOPHEN","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2627737226,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","HYDROCODONE/ACETAMINOPHEN","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.2670454545,NA,NA,NA,0.2028571429,NA,NA,NA,NA,NA,0.2205882353,NA,NA,0.06443914081,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1256544503,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.08962264151,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.06081081081,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)"
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05517241379,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.09202453988,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.08411214953,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05691056911,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08148148148,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.364902507,NA,NA,0.2713178295,0.1807407407,0.2200557103,NA,NA,0.2372881356,NA,0.2618595825,NA,0.2829076621,0.1385041551,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1132075472,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1438848921,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1194029851,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.212962963,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL"
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02259887006,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"20-40","Female",NA,NA,0.3357142857,NA,NA,0.2580645161,NA,0.2213740458,NA,NA,NA,NA,0.1851851852,NA,0.2409638554,0.07304785894,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1737288136,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1827160494,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1054407423,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.07,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1369047619,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1093474427,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.4042553191,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"20-40","Female",NA,NA,0.1780821918,NA,NA,NA,0.1397058824,NA,NA,NA,NA,NA,0.1440677966,NA,0.0737704918,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Female",NA,NA,0.128440367,NA,NA,NA,0.1296296296,NA,NA,NA,NA,NA,NA,NA,0.06862745098,0.04296875,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,0.3333333333,NA,NA,0.2511848341,0.1751207729,0.1866028708,NA,NA,0.225,NA,0.248603352,NA,0.2836676218,0.09523809524,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1962616822,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1417322835,NA,NA,NA,NA,NA,0.3534482759,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1806722689,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1369863014,NA,NA,NA,NA,NA,0.1100917431,NA,NA,0.09915014164,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1185983827,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09448818898,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4676258993,0.01351351351,NA,NA,"ESCITALOPRAM OXALATE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"ESCITALOPRAM OXALATE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.06871609403,0.1675977654,NA,NA,NA,NA,0.1046511628,NA,NA,0.06069802731,"ESCITALOPRAM OXALATE","LAMOTRIGINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.05633802817,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LAMOTRIGINE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.06910569106,NA,NA,NA,NA,NA,NA,NA,NA,0.05405405405,"ESCITALOPRAM OXALATE","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",0.00790513834,0.01605442177,0.5733041575,NA,NA,0.394437421,NA,0.4625706215,0.06557377049,NA,0.3812785388,NA,0.4843902439,0.01226993865,0.4982130093,0.168784029,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2066115702,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3274336283,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"20-40","Female",NA,0.01673640167,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2774566474,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2734375,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2606060606,NA,NA,NA,NA,NA,0.6086956522,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3367139959,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1581632653,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3125,NA,NA,NA,NA,NA,0.6676923077,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3229873909,NA,NA,NA,NA,NA,NA,0.004854368932,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3673469388,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.502617801,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,NA,NA,0.1991525424,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5887096774,0.2033898305,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2303206997,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2788461538,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,0.02857142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"20-40","Female",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA
"20-40","Female",NA,0.03076923077,NA,NA,NA,NA,0.3483870968,NA,NA,NA,NA,NA,NA,NA,NA,0.28125,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.005025125628,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007246376812,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1386138614,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07894736842,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"20-40","Female",NA,0.01960784314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07236842105,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.213592233,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08196721311,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1735159817,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4013605442,NA,NA,NA,NA,0.1974522293,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.5700934579,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA
"20-40","Female",NA,0.02597402597,NA,NA,NA,NA,0.2886178862,NA,NA,NA,NA,NA,0.674796748,0,0.5229357798,0.2203791469,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5666666667,NA,NA,0.1354166667,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,0.01324503311,NA,NA,NA,NA,0.2982583454,NA,NA,NA,NA,NA,NA,0.007972665148,NA,0.2685025818,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.3839285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.5137614679,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4455445545,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",NA,0.02928870293,NA,NA,NA,NA,0.3333333333,NA,NA,NA,NA,NA,NA,NA,0.6868686869,0.2636363636,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.09090909091,0.7078085642,NA,NA,0.5231481481,NA,0.5543071161,NA,NA,NA,NA,0.6,0.1544117647,0.6455331412,0.4170812604,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.675,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.5755813953,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.26,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.4409937888,NA,NA,NA,NA,NA,NA,NA,NA,0.4098360656,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.61,NA,NA,NA,NA,NA,NA,0.07647058824,NA,0.4122137405,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3565217391,NA,NA,NA,NA,NA,NA,NA,NA,0.3625730994,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1300087813,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2296819788,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1418439716,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","MORBID OBESITY (dxo:ICD9:27801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1351351351,NA,NA,NA,NA,NA,0.416,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1361256545,NA,NA,NA,NA,NA,0.4029850746,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1524050633,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1416837782,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2873563218,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1885245902,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1203703704,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","OMEPRAZOLE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.09844559585,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1696428571,NA,NA,NA,0.243697479,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.197761194,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1221374046,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.06878306878,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1196581197,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1293103448,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1257995736,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1153846154,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1308724832,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1357142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1238938053,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.03846153846,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1213266163,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.07207207207,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.08609271523,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1571856287,NA,NA,NA,NA,NA,0.3497854077,NA,NA,0.17,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.08,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TOPIRAMATE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1658163265,NA,NA,NA,NA,NA,NA,0.004291845494,NA,0.2271880819,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1693548387,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1851851852,NA,NA,NA,NA,NA,NA,NA,0.476635514,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.5457875458,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.5815602837,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.5392156863,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.4657534247,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.6466552316,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.4622641509,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5490196078,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.5981794538,NA,NA,NA,NA,NA,NA,NA,NA,0.593220339,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3909090909,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.3,NA,NA,NA,NA,0.4285714286,0.5952380952,NA,NA,NA,NA,0.582010582,NA,NA,0.4868913858,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.4036697248,NA,NA,NA,NA,NA,NA,NA,NA,0.4732142857,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.435530086,NA,NA,NA,NA,NA,NA,NA,NA,0.4017467249,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4503816794,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2732240437,NA,0.1955555556,NA,NA,NA,NA,NA,NA,0.1932773109,"ESCITALOPRAM OXALATE","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2164179104,"ESCITALOPRAM OXALATE","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3349753695,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","MORBID OBESITY (dxo:ICD9:27801)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02631578947,NA,NA,NA,NA,0.3227665706,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2946428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","NORETHINDRONE-E.ESTRADIOL-IRON","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3060686016,NA,NA,0.1128205128,NA,NA,NA,NA,NA,0.2338709677,"ESCITALOPRAM OXALATE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6343825666,NA,NA,NA,"ESCITALOPRAM OXALATE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.4778325123,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Num Previous Episodes: 2+",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4615384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1222222222,"ESCITALOPRAM OXALATE","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1025641026,"ESCITALOPRAM OXALATE","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.426035503,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.313253012,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","OMEPRAZOLE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2387387387,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02127659574,0.5955882353,NA,NA,NA,0.2150537634,0.3895348837,NA,NA,0.4588796186,NA,0.4131944444,NA,0.5185185185,0.1881390593,"ESCITALOPRAM OXALATE","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2,NA,NA,NA,NA,NA,NA,NA,NA,0.2314049587,"ESCITALOPRAM OXALATE","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.06766917293,0.228125,NA,NA,NA,0.2742857143,0.1782178218,NA,NA,NA,NA,0.1925675676,NA,0.2252252252,0.06674473068,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1782178218,NA,NA,NA,NA,NA,NA,NA,NA,0.04491725768,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05982905983,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0996978852,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1230769231,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3409090909,NA,NA,NA,NA,NA,NA,NA,NA,0.3816793893,"ESCITALOPRAM OXALATE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,NA,NA,NA,"ESCITALOPRAM OXALATE","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.504587156,NA,NA,NA,"ESCITALOPRAM OXALATE","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6573426573,NA,NA,NA,0.2382445141,0.4038461538,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2018348624,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2176165803,0.1959459459,NA,NA,NA,NA,0.1784037559,NA,NA,0.15,"ESCITALOPRAM OXALATE","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.3505154639,NA,NA,NA,0.2154195011,0.1964285714,NA,NA,NA,NA,0.1773049645,NA,0.3071895425,0.09528907923,"ESCITALOPRAM OXALATE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.141509434,"ESCITALOPRAM OXALATE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.152,"ESCITALOPRAM OXALATE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2062937063,NA,NA,NA,NA,NA,NA,NA,NA,0.09307359307,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0625,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1102941176,NA,NA,NA,NA,NA,NA,NA,NA,0.1288888889,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.2155172414,NA,NA,0.1282051282,0.2073578595,0.2172284644,NA,NA,NA,NA,0.1877729258,NA,0.2339449541,0.1237113402,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1764705882,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1388888889,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1766917293,NA,NA,NA,NA,NA,NA,NA,NA,0.147766323,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1063829787,NA,NA,NA,NA,NA,NA,NA,NA,0.05185185185,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09036144578,"ESCITALOPRAM OXALATE","RISPERIDONE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3403361345,NA,NA,NA,NA,NA,NA,NA,NA,0.3661202186,"ESCITALOPRAM OXALATE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3235294118,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.5461538462,0.2956760049,NA,NA,NA,0.4596774194,NA,NA,NA,NA,0.2474226804,"ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.275862069,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3106796117,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",0,0.03300330033,0.5578947368,NA,NA,0.3846153846,0.2277265745,0.3526119403,NA,NA,0.3161094225,NA,0.4774074074,0.006172839506,0.5236907731,0.223628692,"ESCITALOPRAM OXALATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5888888889,NA,NA,NA,"ESCITALOPRAM OXALATE","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2471590909,NA,NA,NA,NA,NA,0.3767605634,0.02,NA,0.1956521739,"ESCITALOPRAM OXALATE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4609929078,NA,NA,0.22,"ESCITALOPRAM OXALATE","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.26,"ESCITALOPRAM OXALATE","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5019556714,NA,NA,0.2055555556,"ESCITALOPRAM OXALATE","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.3120567376,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","TOPIRAMATE",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02109704641,0.4812030075,NA,NA,NA,0.2541956611,0.2401746725,NA,NA,NA,NA,0.3523489933,0.01484828922,0.4224137931,0.2083555082,"ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2692307692,NA,NA,NA,NA,NA,NA,0.01481481481,NA,0.206235012,"ESCITALOPRAM OXALATE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.5955882353,0.237037037,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2133333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02555910543,0.4795321637,NA,NA,NA,0.2836004932,0.3666666667,NA,NA,0.3624161074,NA,0.375,NA,0.6181102362,0.223880597,"ESCITALOPRAM OXALATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4250764526,NA,NA,NA,0.1340206186,0.3916449086,NA,NA,NA,NA,NA,NA,NA,NA,"ESOMEPRAZOLE MAGNESIUM",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5436893204,NA,NA,NA,NA,NA,NA,NA,NA,"ESOMEPRAZOLE MAGNESIUM","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4617117117,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5352697095,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3726415094,NA,NA,NA,NA,NA,NA,NA,NA,"ESTRADIOL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5724637681,NA,NA,NA,NA,NA,NA,NA,NA,"ESTRADIOL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03883495146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESTROGEN,ESTER/ME-TESTOSTERONE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4033149171,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESZOPICLONE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4636363636,NA,NA,NA,0.141337386,NA,0.1262135922,NA,0.3069767442,NA,0.5078630897,NA,NA,NA,"ETHINYL ESTRADIOL/DROSPIRENONE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1111111111,NA,NA,NA,0.3591549296,NA,0.6341463415,NA,NA,NA,"ETHINYL ESTRADIOL/DROSPIRENONE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.407079646,NA,NA,NA,"ETHINYL ESTRADIOL/DROSPIRENONE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6025641026,NA,NA,NA,"ETHINYL ESTRADIOL/DROSPIRENONE","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5324675325,NA,NA,NA,NA,NA,"ETHINYL ESTRADIOL/DROSPIRENONE","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.6181818182,NA,NA,0.1274601687,NA,NA,NA,0.2985915493,NA,NA,NA,NA,NA,"ETHINYL ESTRADIOL/DROSPIRENONE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1142857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ETHINYL ESTRADIOL/DROSPIRENONE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4563106796,NA,NA,NA,"ETHINYL ESTRADIOL/DROSPIRENONE","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6818181818,NA,NA,NA,"ETHINYL ESTRADIOL/DROSPIRENONE","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04152249135,NA,NA,NA,NA,NA,0.4094827586,NA,NA,0.3274336283,NA,NA,NA,NA,NA,"ETONOGESTREL/ETHINYL ESTRADIOL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5362903226,NA,NA,NA,NA,NA,NA,NA,NA,"ETONOGESTREL/ETHINYL ESTRADIOL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3783783784,NA,NA,NA,NA,NA,NA,NA,NA,"ETONOGESTREL/ETHINYL ESTRADIOL","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5544554455,NA,NA,NA,NA,NA,NA,NA,NA,"ETONOGESTREL/ETHINYL ESTRADIOL","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5272727273,NA,NA,NA,NA,NA,"ETONOGESTREL/ETHINYL ESTRADIOL","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04444444444,NA,NA,NA,NA,NA,NA,NA,NA,0.359375,NA,NA,NA,NA,NA,"ETONOGESTREL/ETHINYL ESTRADIOL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5111111111,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"EXAMINATION OF EYES AND VISION (dxo:ICD9:V720)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.1804511278,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2615384615,NA,NA,NA,"FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,0.4382978723,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FEVER AND OTHER PHYSIOLOGIC DISTURBANCES OF TEMPERATURE REGULATION (dxo:ICD9:7806)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4305555556,NA,"FEVER, UNSPECIFIED (dxo:ICD9:78060)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006060606061,NA,NA,"FEXOFENADINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FEXOFENADINE/PSEUDOEPHEDRINE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1067961165,NA,NA,NA,NA,NA,0.3955555556,NA,NA,NA,"FLATULENCE, ERUCTATION, AND GAS PAIN (dxo:ICD9:7873)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.03461538462,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4887218045,NA,NA,NA,"FLUCONAZOLE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.03738317757,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FLUCONAZOLE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.05188679245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FLUCONAZOLE","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.0380952381,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FLUCONAZOLE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",0.02055702918,0.03838261919,0.4163522013,0.5011990408,0.09966777409,0.3473451327,0.158988764,0.4415876131,0.123119015,0.07086614173,0.36508994,NA,0.4246386054,0.01814183617,0.5270582201,0.2364811246,"FLUOXETINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5909090909,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GABAPENTIN",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.640776699,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GABAPENTIN","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6023622047,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3106796117,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5666666667,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.5166666667,NA,NA,NA,0.1866666667,0.5557074504,NA,NA,0.5034246575,NA,0.7096774194,NA,0.6945606695,0.3219178082,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.09900990099,NA,NA,NA,NA,NA,NA,NA,0.6285714286,0.2325581395,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2483660131,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2764705882,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.25,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2222222222,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5808383234,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4854368932,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.414084507,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5480769231,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",0.01310043668,NA,NA,NA,NA,NA,NA,0.5031055901,NA,0.06707317073,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"20-40","Female",0.01818181818,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3962264151,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5845070423,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3113069016,NA,NA,NA,NA,0.1981132075,NA,0.1531531532,0.0942408377,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2009569378,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.1551724138,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.1872146119,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.1465517241,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2912087912,NA,NA,NA,NA,NA,NA,NA,0.1029411765,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06629834254,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2467532468,NA,NA,NA,NA,NA,NA,NA,0.1470588235,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.2908587258,NA,NA,0.2847222222,0.1060329068,0.3815484469,NA,NA,0.2487804878,NA,0.2762148338,NA,0.3023255814,0.1858974359,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.09523809524,NA,NA,NA,NA,NA,NA,NA,NA,0.1960784314,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2192982456,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL"
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08653846154,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.08045977011,NA,NA,NA,NA,NA,NA,NA,NA,0.1201413428,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2492378049,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.1507352941,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.1610738255,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.1733333333,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2435158501,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3828125,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3958333333,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5882352941,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.224137931,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Num Previous Antidep: 2,3","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2192982456,NA,NA,NA,NA,0.1862745098,NA,0.1793103448,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2036199095,NA,NA,NA,NA,NA,NA,NA,0.09045226131,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2125984252,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2192513369,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3537414966,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA
"20-40","Female",NA,NA,0.2941176471,NA,NA,NA,0.0875,0.3706563707,NA,NA,0.2196969697,NA,0.2307692308,NA,0.2699115044,0.1692307692,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2532467532,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3571428571,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2891986063,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.06,0.2431818182,NA,NA,NA,NA,NA,NA,NA,0.07301587302,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.1722222222,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05769230769,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.1603053435,NA,NA,NA,NA,NA,NA,NA,0.09482758621,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5464566929,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5869565217,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6641221374,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02307692308,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3470588235,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5159010601,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,0.1736111111,NA,NA,NA,0.1047619048,0.1348028826,NA,NA,NA,NA,0.1897810219,NA,NA,0.07202881152,"FLUOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.07991803279,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LAMOTRIGINE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3697916667,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.1333333333,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LAMOTRIGINE","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.09357798165,NA,NA,NA,NA,NA,NA,NA,0.05642023346,"FLUOXETINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09523809524,"FLUOXETINE HCL","LAMOTRIGINE","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",0.009950248756,0.02396931927,0.4009360374,NA,NA,0.3558718861,0.1201413428,NA,NA,NA,0.3362831858,NA,0.4363791631,0.01313868613,0.5081967213,0.2512868507,"FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01481481481,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6034482759,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5952380952,NA,NA,NA,NA,0.6578947368,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5270833333,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6352941176,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.629969419,NA,NA,NA,NA,0.6698564593,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5916069601,NA,NA,NA,NA,NA,0.006993006993,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6244131455,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.119266055,NA,NA,NA,NA,NA,NA,NA,NA,0.2469135802,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.287037037,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3558282209,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.04166666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.02127659574,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01801801802,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.137254902,NA,NA,NA,NA,NA,NA,NA,NA,0.167539267,"FLUOXETINE HCL","Last AD: Diff & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1203007519,"FLUOXETINE HCL","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.06153846154,NA,NA,NA,NA,NA,NA,NA,NA,0.07392996109,"FLUOXETINE HCL","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1538461538,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,0.03146853147,NA,NA,NA,NA,0.1461988304,NA,NA,NA,NA,NA,NA,NA,0.4626865672,0.256,"FLUOXETINE HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4782608696,NA,NA,0.2296296296,"FLUOXETINE HCL","Last AD: Diff & No Remiss","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,0.05333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01342281879,NA,0.3928571429,"FLUOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.01657458564,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5916230366,0.3282051282,"FLUOXETINE HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",0.05555555556,0.064,0.5375,NA,NA,0.4141791045,0.2316890882,NA,NA,NA,0.5142857143,NA,0.5714285714,0.08267716535,0.5863539446,0.3215903372,"FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6756756757,"FLUOXETINE HCL","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6083916084,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2547169811,"FLUOXETINE HCL","Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3039215686,"FLUOXETINE HCL","Last AD: Diff & Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3053435115,"FLUOXETINE HCL","Last AD: Diff & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,0.1100917431,NA,NA,NA,NA,NA,0.6974789916,NA,NA,NA,NA,NA,NA,NA,0.3838862559,"FLUOXETINE HCL","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3689320388,"FLUOXETINE HCL","Last AD: Diff & Remiss","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6012861736,NA,NA,NA,NA,NA,0.06840390879,NA,0.3876651982,"FLUOXETINE HCL","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3728813559,"FLUOXETINE HCL","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3006253722,NA,NA,NA,NA,NA,NA,NA,0.2735042735,"FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4057377049,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3389830508,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","MASTODYNIA (dxo:ICD9:61171)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3448275862,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3725490196,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3216350124,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2165450122,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2804232804,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4166666667,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3305785124,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3777777778,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3290322581,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3051643192,NA,NA,0.3032786885,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.210467706,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2252252252,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1683168317,"FLUOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2207953604,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.1774193548,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3162393162,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2837370242,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2489270386,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2274368231,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2476038339,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.170212766,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3172268908,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3428571429,NA,NA,NA,NA,0.3333333333,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.460251046,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","TOPIRAMATE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2819905213,NA,NA,NA,NA,NA,0.004329004329,NA,0.3090128755,"FLUOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2864864865,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3481953291,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2583333333,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3235294118,NA,NA,NA,NA,NA,NA,0.4537815126,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3301886792,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","ZOLPIDEM TARTRATE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5853137517,NA,NA,NA,NA,NA,NA,NA,0.4710743802,"FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6115107914,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6887417219,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4987212276,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.696,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.696969697,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Remissions: 2+",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.619047619,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5350756534,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4722222222,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5878594249,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6283185841,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6217765043,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6940298507,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","TOPIRAMATE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5679012346,"FLUOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6038961039,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5719063545,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5119047619,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2956521739,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6813880126,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3863636364,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LEVOTHYROXINE SODIUM","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.1468926554,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LITHIUM CARBONATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.07476635514,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LITHIUM CARBONATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5095541401,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LORAZEPAM",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5545454545,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4814814815,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.654676259,NA,NA,NA,NA,0.6725663717,NA,NA,0.5514018692,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6826923077,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5847457627,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6255924171,NA,NA,NA,NA,NA,NA,NA,0.3303571429,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2307692308,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,0.4457831325,0.5950413223,NA,NA,0.519379845,0.3821428571,0.5702592087,NA,NA,NA,NA,0.5962732919,NA,NA,0.5367647059,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6218905473,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4731182796,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5351812367,NA,NA,NA,NA,NA,0.16,NA,0.450617284,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4748201439,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5585585586,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MASTODYNIA (dxo:ICD9:61171)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5434782609,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3651315789,0.1576923077,NA,NA,NA,NA,NA,NA,0.2361445783,"FLUOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1470588235,"FLUOXETINE HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5925925926,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MONTELUKAST SODIUM",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6470588235,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MULTIPLE SCLEROSIS (dxo:ICD9:340)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6302521008,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.007751937984,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5254988914,NA,0.1144781145,NA,NA,NA,NA,NA,0.2998027613,"FLUOXETINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6034482759,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","NORTRIPTYLINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6352941176,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6291793313,NA,NA,NA,NA,0.6299212598,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5916496945,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6214953271,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2848484848,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 4+","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2965517241,NA,NA,NA,NA,NA,NA,NA,0.1449275362,"FLUOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1754385965,"FLUOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.690647482,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Remissions: 2+",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1449275362,"FLUOXETINE HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1,"FLUOXETINE HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1461988304,"FLUOXETINE HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5652173913,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","OTHER GENERAL COUNSELING AND ADVICE FOR CONTRACEPTIVE MANAGEMENT (dxo:ICD9:V2509)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.05660377358,NA,NA,NA,NA,NA,0.633744856,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6006825939,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.05089820359,0.3684210526,NA,NA,NA,0.1832460733,0.4817767654,NA,NA,0.4210526316,NA,0.4124513619,NA,NA,0.1804670913,"FLUOXETINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3333333333,NA,NA,NA,NA,NA,NA,NA,0.2598425197,"FLUOXETINE HCL","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.06944444444,0.2083333333,NA,NA,0.168,NA,0.3079406068,NA,NA,0.2413793103,NA,0.2196078431,NA,0.2349206349,0.1077283372,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.295,NA,NA,NA,NA,NA,NA,NA,0.09418282548,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.126984127,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2208333333,NA,NA,NA,NA,NA,NA,NA,0.1675531915,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2767857143,NA,NA,NA,NA,NA,NA,0.214953271,0.1161290323,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4534161491,NA,NA,NA,NA,NA,NA,NA,0.3493975904,"FLUOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5539568345,NA,NA,NA,"FLUOXETINE HCL","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5675675676,NA,NA,NA,"FLUOXETINE HCL","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.524691358,NA,NA,NA,0.157480315,0.4471236652,NA,NA,NA,NA,NA,NA,NA,0.3317073171,"FLUOXETINE HCL","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3821138211,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.42,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3962264151,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3333333333,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4433497537,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3333333333,NA,NA,NA,NA,0.2403846154,NA,NA,NA,"FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2672413793,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.3113207547,NA,NA,NA,NA,0.40625,NA,NA,NA,NA,0.26,NA,0.2444444444,0.1584385763,"FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1759259259,"FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3619302949,NA,NA,NA,NA,NA,NA,NA,0.1452784504,"FLUOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2704918033,NA,NA,NA,NA,NA,NA,NA,0.09448818898,"FLUOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2727272727,NA,NA,NA,NA,NA,NA,NA,0.09230769231,"FLUOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.1550387597,NA,NA,0.2166666667,0.09777777778,0.3337378641,NA,NA,NA,NA,0.233463035,NA,0.2461538462,0.1531914894,"FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.313304721,NA,NA,NA,NA,NA,NA,NA,0.2112676056,"FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3222222222,NA,NA,NA,NA,NA,NA,NA,0.09708737864,"FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.1705426357,NA,NA,NA,NA,NA,NA,NA,0.1106382979,"FLUOXETINE HCL","RISPERIDONE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1180555556,"FLUOXETINE HCL","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6379310345,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","RIZATRIPTAN BENZOATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4492753623,NA,NA,NA,NA,NA,NA,NA,0.3291925466,"FLUOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.4885496183,NA,NA,0.2068965517,0.5673758865,NA,NA,NA,NA,NA,NA,NA,0.2975609756,"FLUOXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04270986745,0.3747412008,NA,NA,0.2931937173,0.1561996779,0.4344507136,NA,NA,0.3015873016,NA,0.439864657,0.006849315068,0.5178571429,0.2214342002,"FLUOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5117647059,NA,NA,NA,"FLUOXETINE HCL","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3121546961,NA,NA,NA,NA,0.4448818898,0.02380952381,NA,0.2156334232,"FLUOXETINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5409836066,NA,NA,0.2912621359,"FLUOXETINE HCL","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.619047619,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6182795699,NA,NA,NA,NA,0.5125148987,NA,NA,0.2307692308,"FLUOXETINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.6134453782,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","TERCONAZOLE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.615625,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","TOPIRAMATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5242718447,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","TRAMADOL HCL/ACETAMINOPHEN",NA,NA,NA,NA,NA
"20-40","Female",NA,0.05960264901,0.2730769231,NA,NA,0.2585034014,0.1,0.3893960674,NA,NA,NA,NA,0.3664122137,0.01831896552,0.329787234,0.2598134895,"FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3368421053,NA,NA,NA,NA,NA,0.03816793893,0.5267857143,0.2093023256,"FLUOXETINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.475,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","UNSPECIFIED ALOPECIA (dxo:ICD9:70400)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5888223553,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5663716814,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5323275862,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5545851528,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03243243243,0.406779661,NA,NA,NA,0.2173913043,0.4716342083,NA,NA,0.3863636364,NA,0.4538258575,0.02255639098,0.5662650602,0.249017038,"FLUOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5138888889,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02857142857,0.4674329502,NA,NA,0.3195020747,0.1689373297,0.4708520179,NA,0.04109589041,NA,NA,0.467961165,NA,NA,0.2060606061,"GABAPENTIN",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2169811321,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6363636364,NA,NA,NA,"GABAPENTIN","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.3510971787,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Female",0.01388888889,0.03189703414,NA,NA,NA,NA,0.1511035654,0.3788300836,NA,NA,NA,NA,0.4926686217,NA,NA,0.1957671958,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.07627118644,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA
"20-40","Female",NA,0.01463414634,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4074074074,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5607476636,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.01675977654,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.0350877193,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01769911504,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.09649122807,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,0.04453441296,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1703703704,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.06097560976,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6789667897,NA,NA,0.3310344828,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4491803279,NA,NA,0.3720930233,0.1346423562,NA,NA,NA,NA,NA,NA,NA,0.5401459854,NA,"GUAIFENESIN/P-EPHED HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1165048544,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GUAIFENESIN/P-EPHED HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4579124579,NA,NA,NA,0.1635514019,NA,NA,NA,NA,NA,NA,NA,0.6043165468,NA,"GUAIFENESIN/PHENYLEPHRINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1228070175,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GUAIFENESIN/PHENYLEPHRINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1597222222,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GUAIFENESIN/PHENYLEPHRINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.395480226,NA,NA,NA,0.5739130435,NA,"GUAIFENESIN/PSEUDOEPHEDRNE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3881748072,NA,NA,NA,0.5575221239,NA,"GUAIFENESIN/PSEUDOEPHEDRNE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5671641791,NA,NA,NA,NA,NA,"GUAIFENESIN/PSEUDOEPHEDRNE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4930555556,NA,NA,NA,NA,NA,"GUAIFENESIN/PSEUDOEPHEDRNE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",0.003968253968,0.01355932203,0.5394984326,NA,NA,0.3560864619,0.1152388173,0.4379643388,NA,NA,0.4014848658,NA,0.568321392,NA,0.5681285571,0.1998231653,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.09523809524,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5943396226,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","IBUPROFEN",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.263803681,NA,NA,NA,0.078125,NA,NA,NA,0.237388724,NA,NA,NA,0.365,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3421052632,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3783783784,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,0.170212766,NA,NA,NA,0.06305309735,NA,NA,NA,0.1572815534,NA,0.2580645161,NA,0.227027027,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5875706215,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5083333333,NA,NA,NA,NA,NA,NA,NA,0.3595505618,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","LABORATORY EXAMINATION (dxo:ICD9:V726)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1550387597,NA,NA,NA,NA,NA,NA,NA,0.5221238938,0.2159090909,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1418439716,NA,NA,NA,0.4299065421,NA,NA,NA,0.5826771654,0.3021978022,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2865853659,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2912621359,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7064220183,0.3870967742,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3083333333,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.390070922,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3425797503,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3619047619,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4175257732,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5785123967,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5511482255,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.601010101,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.6363636364,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5680751174,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","LEVONORGESTREL-ETHIN ESTRADIOL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6993006993,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","LEVONORGESTREL-ETHIN ESTRADIOL","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5436893204,NA,NA,NA,NA,0.625,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.6184971098,NA,NA,NA,NA,NA,NA,NA,0.4810126582,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","LORATADINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5514018692,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","LORATADINE","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5163043478,NA,NA,NA,NA,0.4834437086,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA
"20-40","Female",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5253164557,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","NORETHINDRONE-ETHIN. ESTRADIOL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5588235294,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5084745763,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","NORGESTIMATE-ETHINYL ESTRADIOL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01621621622,NA,NA,NA,NA,NA,0.4478527607,NA,NA,NA,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1478599222,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.119047619,NA,NA,NA,0.392,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4822335025,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.55,NA,NA,NA,0.1945701357,NA,NA,NA,0.5400410678,NA,NA,NA,0.7022222222,0.2626865672,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5955882353,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.4821428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5371428571,NA,NA,NA,0.09929078014,0.3710144928,NA,NA,0.3333333333,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.2242424242,NA,NA,NA,0.06787330317,NA,NA,NA,0.1897810219,NA,NA,NA,0.1975308642,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1328125,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","ROFECOXIB",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02702702703,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4571428571,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3689320388,NA,0.5573770492,NA,0.573964497,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.6339285714,NA,NA,NA,0.2006802721,NA,NA,NA,0.4713804714,NA,0.6175226586,NA,0.6415770609,0.3142144638,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.584,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SERTRALINE HCL","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SERTRALINE HCL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.5191256831,NA,NA,0.4488636364,NA,0.5412844037,NA,0.4392523364,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6878980892,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4322033898,NA,NA,NA,NA,0.506993007,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4703389831,NA,NA,NA,0.06763285024,0.4410646388,NA,NA,0.4245283019,NA,0.5326315789,NA,0.4869565217,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4125874126,NA,NA,NA,NA,0.5850340136,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2213114754,NA,NA,NA,0.4770642202,NA,NA,NA,0.6051454139,0.3672566372,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",0.006966329408,0.0255839822,0.5034965035,NA,NA,NA,0.1293103448,0.3772070626,NA,0.04239326518,NA,NA,0.4778761062,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA,NA
"20-40","Female",0.0125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",0.0223880597,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05696202532,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","NORTRIPTYLINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04587155963,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0306122449,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","MIGRAINE WITHOUT AURA, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04861111111,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","MIGRAINE WITHOUT AURA, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34610)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA
"20-40","Female",0.004216444132,NA,NA,NA,NA,NA,NA,NA,NA,0.05580558056,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1475409836,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","NORTRIPTYLINE HCL",NA,NA,NA,NA
"20-40","Female",0.00495049505,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",0.006369426752,NA,NA,NA,NA,NA,NA,NA,NA,0.0325203252,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA
"20-40","Female",NA,0.02857142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,0.1455108359,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02346041056,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"20-40","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270)",NA,NA,NA,NA,NA
"20-40","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",0.007692307692,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","OXYCODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",0.02142857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",0.005736137667,0.01648351648,NA,NA,NA,NA,NA,0.3504273504,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",0.01215805471,NA,NA,NA,NA,NA,NA,NA,NA,0.04411764706,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0303030303,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",0.03015075377,NA,NA,NA,NA,NA,NA,NA,NA,0.07272727273,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA
"20-40","Female",0.01550387597,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4782608696,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEMATURIA (dxo:ICD9:5997)",NA,NA,NA,NA,NA,NA
"20-40","Female",0.002487562189,0.03982300885,NA,NA,NA,0.3393939394,0.1355653128,0.4432624113,NA,0,0.3247863248,NA,0.4926605505,0.01126126126,NA,0.1591448931,"HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4854014599,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","IBUPROFEN",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1307692308,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","OXYCODONE HCL/ACETAMINOPHEN",NA,NA,NA,NA,NA
"20-40","Female",0.01047120419,0.03174603175,NA,NA,NA,0.3271889401,0.1423728814,0.4454976303,NA,NA,NA,NA,NA,NA,NA,0.2301587302,"HYDROCODONE/ACETAMINOPHEN","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.05714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6056338028,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1089108911,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","TRAMADOL HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1121495327,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1293103448,NA,NA,NA,NA,NA,0.4166666667,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4231738035,NA,NA,NA,0.1290322581,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROCODONE/HOMATROPINE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.07751937984,NA,NA,NA,NA,NA,0.5329341317,NA,NA,NA,"HYDROXYCHLOROQUINE SULFATE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6759259259,NA,NA,NA,"HYDROXYCHLOROQUINE SULFATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.05405405405,NA,NA,0.1028368794,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROXYZINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,0.2014925373,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROXYZINE HCL","UNSPECIFIED URTICARIA (dxo:ICD9:7089)",NA,NA,NA,NA,NA
"20-40","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYOSCYAMINE SULFATE",NA,NA,NA,NA,NA,NA
"20-40","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYOSCYAMINE SULFATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3982300885,NA,NA,NA,NA,NA,NA,NA,0.3081761006,NA,0.4337623013,0.006389776358,0.4255319149,NA,"IBUPROFEN",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3907284768,NA,NA,NA,"IBUPROFEN","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.536,NA,NA,NA,"IBUPROFEN","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.43,NA,NA,NA,"IBUPROFEN","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5222929936,NA,NA,NA,"IBUPROFEN","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4649122807,NA,NA,NA,"IBUPROFEN","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5878787879,NA,NA,NA,"IBUPROFEN","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4496124031,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4892601432,NA,NA,NA,"IBUPROFEN","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.406779661,NA,NA,NA,"IBUPROFEN","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1846153846,"IMIPRAMINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1083743842,"IMIPRAMINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"20-40","Female",0.03846153846,0.05186721992,0.1938610662,0.1666666667,NA,0.10626703,0.07120253165,0.159453303,NA,NA,0.1341463415,NA,0.1561051005,0.01572327044,0.1776470588,0.1086350975,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.1403508772,NA,NA,0.1056338028,0.03579952267,0.1139240506,NA,NA,NA,NA,0.0989010989,NA,0.09966777409,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1489361702,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","SERTRALINE HCL",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1926605505,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"20-40","Female",NA,NA,0.1450381679,NA,NA,NA,0.02279202279,0.119266055,NA,NA,NA,NA,0.09734513274,NA,0.06766917293,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2049180328,NA,NA,0.07792207792,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2122641509,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1282051282,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL","TRAZODONE HCL",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.21,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL","VENLAFAXINE HCL",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2317880795,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","VENLAFAXINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.149122807,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2095238095,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1881188119,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1790123457,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7064220183,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2904761905,NA,NA,NA,NA,0.08080808081,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05660377358,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,0.01818181818,0.1493506494,NA,NA,0.04424778761,NA,NA,NA,NA,NA,NA,0.168,0.04255319149,0.1992882562,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2402234637,NA,NA,0.09604519774,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2216981132,0.07575757576,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,0.07086614173,0.1428571429,0.1282051282,NA,NA,0.0537084399,0.141509434,NA,NA,NA,NA,0.1693989071,NA,0.161971831,0.09714285714,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3162393162,NA,NA,0.08463949843,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0875,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.1826086957,NA,NA,0.1403508772,NA,0.1764705882,NA,NA,NA,NA,0.3065693431,NA,NA,0.1021194605,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1992337165,NA,NA,0.1542553191,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07692307692,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2818181818,0.119047619,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2631578947,0.1072555205,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.09,0.215496368,0.304526749,0.03521126761,0.2143671608,0.07061480037,0.2023322422,NA,NA,0.1795570698,NA,0.2110197791,0.03149606299,0.269481933,0.1187384045,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.05633802817,0.06422018349,NA,NA,NA,NA,0.0843373494,NA,0.126984127,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.04395604396,NA,NA,NA,NA,NA,0.08130081301,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009708737864,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.06140350877,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","LAMOTRIGINE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2897196262,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL"
"20-40","Female",NA,NA,NA,NA,NA,NA,0.07305936073,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.08450704225,NA,NA,NA,NA,NA,NA,NA,NA,0.1059602649,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04545454545,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.081232493,0.1688311688,NA,NA,NA,NA,NA,NA,0.2692307692,0.114713217,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1402439024,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1287878788,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.08,NA,NA,NA,NA,NA,NA,NA,NA,0.1567567568,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.04651162791,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.0612244898,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2408906883,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2272727273,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2028985507,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1884984026,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1870503597,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.272073922,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4038461538,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3688888889,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2646223737,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3823529412,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01360544218,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.320083682,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3333333333,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4457831325,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2571428571,NA,NA,NA,NA,0.2384615385,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.1932773109,NA,NA,NA,NA,0.1923076923,NA,NA,NA,NA,0.1519756839,NA,NA,0.09701492537,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4150943396,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.1650485437,NA,NA,NA,NA,0.09923664122,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,0.6470588235,NA,NA,NA,0.5701219512,0.6260162602,NA,NA,NA,NA,0.652173913,NA,0.6355140187,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.637254902,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.6036866359,NA,NA,NA,NA,NA,0.6524822695,NA,0.6442307692,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7063492063,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1901840491,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1844660194,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29623)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1843971631,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Num Previous Antidep: 2,3","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL"
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.313253012,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Num Previous Antidep: 2,3","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3981481481,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.0396039604,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.06837606838,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1403508772,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,0.2789855072,NA,NA,NA,0.1032258065,0.236453202,NA,NA,0.345124283,NA,0.2906666667,NA,NA,0.09743589744,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1948717949,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2100840336,NA,NA,NA,NA,0.05309734513,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Female",NA,NA,0.2670157068,NA,NA,NA,0.1578947368,0.2113821138,NA,NA,0.3835051546,NA,0.2530120482,NA,0.3571428571,0.1572700297,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3684210526,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.1337047354,NA,NA,0.1134020619,NA,0.1639344262,NA,NA,0.1363636364,NA,0.1115537849,0.0414507772,0.1231593039,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.1313868613,0.1014492754,NA,0.1176470588,0.06682577566,0.1317073171,NA,NA,0.1533742331,NA,0.1060606061,NA,0.1228571429,0.04545454545,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2338709677,NA,0.1652173913,0.07534246575,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1979695431,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1639344262,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL","VENLAFAXINE HCL",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2717391304,0.09473684211,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.1165048544,NA,NA,NA,NA,0.2425531915,NA,0.1623376623,0.1487603306,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.206405694,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1935483871,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2549019608,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1842105263,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","POSTTRAUMATIC STRESS DISORDER (dxo:ICD9:30981)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.1703703704,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1628959276,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","POSTTRAUMATIC STRESS DISORDER (dxo:ICD9:30981)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.277027027,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2661290323,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2193548387,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2777777778,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2084507042,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.07432432432,0.2254901961,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Female",NA,0.05084745763,0.1986265188,0.2550607287,NA,0.1973415133,0.06544460524,0.1875796178,NA,NA,0.164495114,NA,0.2000388802,0.03233830846,0.2393665158,0.1056268509,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.2670454545,NA,NA,0.07089552239,NA,NA,NA,0.1379310345,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",NA,NA,0.1951219512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA
"20-40","Female",NA,NA,0.228125,NA,NA,0.2253521127,0.09954751131,0.1895910781,NA,NA,0.2146596859,NA,0.3452647278,NA,0.3056300268,0.1272727273,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3777777778,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3288288288,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2646657572,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1623931624,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3806451613,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.2578125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.1869158879,NA,NA,NA,NA,0.1964285714,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA
"20-40","Female",NA,NA,0.3304347826,NA,NA,NA,0.11,NA,NA,NA,NA,NA,0.2824427481,NA,0.4174107143,0.1540540541,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.1118881119,NA,NA,NA,0.05479452055,0.1167883212,NA,NA,NA,NA,0.2,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1042345277,NA,NA,NA,0.1235294118,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.2453222453,NA,NA,0.2277992278,0.08847736626,0.2449438202,NA,NA,0.2190812721,NA,0.3598499062,NA,0.3076923077,0.18,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4249084249,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3648293963,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2927818329,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.04320987654,NA,NA,NA,NA,NA,0.25,0,0.3116883117,0.1636363636,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3387096774,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2403846154,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.3273809524,NA,NA,0.2777777778,0.1027190332,0.3176470588,NA,NA,0.23,NA,0.2955665025,NA,0.4042179262,0.1772151899,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.1096408318,0.1531531532,NA,0.1067961165,0.06150341686,0.1279826464,NA,NA,0.1111111111,NA,0.1360448808,0.007299270073,0.1609848485,0.08487084871,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1581632653,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1881188119,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2695035461,NA,NA,NA,NA,0.06896551724,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1538461538,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,0.0297029703,0.1165048544,NA,NA,NA,0.04424778761,0.08910891089,NA,NA,NA,NA,0.1089108911,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05223880597,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.07857142857,NA,NA,NA,NA,NA,0.2589928058,NA,NA,0.07196029777,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2285714286,NA,NA,0.1503759398,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2830188679,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2643678161,0.07920792079,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",0.005263157895,0.02996254682,0.4331797235,NA,NA,NA,NA,0.3965517241,0.1386138614,NA,NA,NA,0.4483801296,0.01098498718,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6271186441,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5966850829,0.01,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006993006993,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005376344086,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.392,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3924050633,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006003430532,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5316804408,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.01234567901,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3230769231,NA,NA,NA,NA,NA,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009900990099,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5743589744,0,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6285714286,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01117318436,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4587155963,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3541666667,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4125,NA,NA,NA,NA,0.4722222222,0.007075471698,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3943661972,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4819277108,NA,NA,NA,"IRREGULAR MENSTRUAL CYCLE (dxo:ICD9:6264)",NA,NA,NA,NA,NA,NA
"20-40","Female",0.01734104046,0.04968944099,NA,NA,NA,NA,NA,NA,NA,0.0152284264,NA,NA,NA,NA,NA,NA,"IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641)",NA,NA,NA,NA,NA,NA
"20-40","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4872727273,NA,NA,NA,"ISOMETHEPT/DICHLPHN/ACETAMINOP",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5785123967,NA,NA,NA,"ISOMETHEPT/DICHLPHN/ACETAMINOP","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4583333333,NA,NA,NA,"KETOCONAZOLE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4613003096,NA,NA,NA,0.145631068,NA,NA,NA,0.3314285714,NA,NA,NA,NA,0.1296296296,"LABORATORY EXAMINATION (dxo:ICD9:V726)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LABORATORY EXAMINATION (dxo:ICD9:V726)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4491525424,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4899328859,NA,NA,NA,"LABORATORY EXAMINATION, UNSPECIFIED (dxo:ICD9:V7260)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.140709561,0.1141045959,NA,0.109375,0.05525460455,0.1293604651,0.04255319149,NA,0.1100917431,NA,0.1415929204,0.02762430939,0.1613316261,0.07380298872,"LAMOTRIGINE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09821428571,NA,NA,NA,"LAMOTRIGINE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.144,NA,"LAMOTRIGINE","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4868421053,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4705882353,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.3677419355,NA,0.3644859813,NA,NA,NA,NA,NA,NA,0.4304635762,0.4226950355,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3655913978,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.375,0.424,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08407079646,"LAMOTRIGINE","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09389671362,"LAMOTRIGINE","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08938547486,"LAMOTRIGINE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09811320755,"LAMOTRIGINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03669724771,"LAMOTRIGINE","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.168,NA,NA,NA,NA,0.04098360656,"LAMOTRIGINE","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.04672897196,0.09090909091,NA,0.03773584906,NA,0.02857142857,NA,NA,NA,NA,NA,NA,0.07558139535,NA,"LAMOTRIGINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06542056075,NA,NA,NA,"LAMOTRIGINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1126760563,NA,"LAMOTRIGINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1388888889,"LAMOTRIGINE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04807692308,"LAMOTRIGINE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05357142857,NA,"LAMOTRIGINE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1553398058,0.06071428571,"LAMOTRIGINE","RISPERIDONE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05579399142,"LAMOTRIGINE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1226415094,NA,"LAMOTRIGINE","RISPERIDONE","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08510638298,"LAMOTRIGINE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06422018349,"LAMOTRIGINE","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.1764705882,NA,NA,NA,0.1073825503,0.1582278481,NA,NA,NA,NA,0.1423712342,NA,NA,0.08443708609,"LAMOTRIGINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1465517241,NA,NA,0.07714285714,"LAMOTRIGINE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.1208791209,NA,0.137254902,NA,NA,NA,NA,NA,NA,0.1158536585,0.08116723884,"LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1252747253,0.08469055375,"LAMOTRIGINE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.1739130435,NA,NA,NA,NA,0.1293103448,NA,NA,NA,NA,0.1823529412,NA,0.1543443065,0.06776379477,"LAMOTRIGINE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04188481675,NA,NA,NA,NA,0.213740458,NA,NA,NA,NA,NA,0.4615384615,0.005259203606,NA,NA,"Last AD: Diff & No Remiss",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.0350877193,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01639344262,NA,0.1791907514,"Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Female",NA,0.005376344086,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.02112676056,0.2931034483,NA,NA,0.2949640288,0.1151832461,0.4098360656,NA,NA,NA,NA,0.4739884393,0.009433962264,0.4508196721,0.2410501193,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6793478261,NA,NA,NA,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4761904762,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4491525424,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5953846154,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6610169492,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.661971831,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6038961039,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6159143076,0.01136363636,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.72265625,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6285714286,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3677419355,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.4757281553,NA,NA,NA,0.1589403974,NA,NA,NA,NA,NA,NA,NA,NA,0.2685950413,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4088541667,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3796296296,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2158273381,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6305970149,0.3352601156,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,0.03883495146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270)","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",0.009174311927,0.02809573361,0.3974025974,NA,NA,0.3333333333,0.1389548694,0.4090019569,NA,NA,NA,NA,0.4475138122,0.01823708207,0.4609053498,0.1958115183,"Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04098360656,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2595419847,"Last AD: Diff & No Remiss","PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02255639098,NA,0.4176245211,"Last AD: Diff & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2596153846,"Last AD: Diff & No Remiss","PAROXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09734513274,"Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,0.03205128205,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01960784314,NA,NA,"Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007936507937,NA,NA,"Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,0.3365384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2673267327,"Last AD: Diff & No Remiss","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3706896552,NA,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1130434783,NA,NA,NA,NA,NA,NA,NA,NA,0.1929824561,"Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.08641975309,NA,NA,NA,NA,NA,NA,NA,NA,0.1533742331,"Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1487603306,"Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.08580858086,NA,NA,NA,NA,NA,NA,NA,NA,0.1555023923,"Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.16,"Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1205673759,"Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1507352941,NA,NA,NA,0.2777777778,NA,NA,NA,NA,0.2635135135,"Last AD: Diff & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",0.01498127341,0.02190974493,0.3714953271,NA,NA,0.3092369478,0.1484407484,0.3958009331,0.1228070175,NA,0.3272357724,NA,NA,0.01261829653,0.4595086442,0.26179941,"Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01960784314,NA,NA,NA,NA,NA,0.4375,NA,NA,NA,NA,NA,NA,0.3728813559,0.2556818182,"Last AD: Diff & No Remiss","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,0.01020408163,NA,NA,NA,NA,0.1157024793,NA,NA,NA,NA,NA,NA,0.009977827051,NA,0.4206896552,"Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.05347593583,NA,NA,NA,NA,0.2027027027,NA,NA,NA,NA,NA,NA,NA,0.7183098592,0.348,"Last AD: Diff & No Remiss","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",0.008583690987,0.03549382716,0.3130699088,NA,NA,0.2628571429,0.145631068,0.3432835821,0.07339449541,NA,0.2882882883,NA,0.3773987207,0.01307847082,0.48,0.2686104218,"Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01785714286,0.6360655738,0.3780487805,"Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",0.02884615385,0.02889576883,0.3677419355,NA,NA,0.3348214286,0.1520979021,0.452173913,NA,NA,0.4117647059,NA,0.4608695652,0.01095890411,NA,0.2370540852,"Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.0901734104,NA,0.5540983607,NA,0.499047619,NA,NA,0.2814371257,NA,NA,NA,NA,0.1085201794,0.623255814,NA,"Last AD: Diff & Remiss",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5048543689,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.6220472441,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.489539749,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.5,NA,NA,NA,NA,0.56,NA,NA,NA,NA,NA,NA,NA,NA,0.6875,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.450617284,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7222222222,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.4509803922,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5833333333,NA,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.634085213,0.05084745763,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3953488372,"Last AD: Diff & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,0.05288461538,0.7066115702,NA,NA,0.4594594595,0.235,0.5714285714,NA,NA,NA,NA,0.63125,0.1507936508,0.649122807,0.2679012346,"Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3243243243,"Last AD: Diff & Remiss","PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5438596491,NA,NA,0.104,NA,0.4150943396,"Last AD: Diff & Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2641509434,"Last AD: Diff & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2,"Last AD: Diff & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2941176471,"Last AD: Diff & Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1925465839,NA,NA,NA,NA,NA,NA,NA,NA,0.3125,"Last AD: Diff & Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",0.03012048193,0.05246523388,0.5962643678,0.6092715232,NA,0.4621359223,0.225,0.5204513399,NA,NA,0.4829721362,NA,NA,0.09278350515,0.606271777,0.3675970048,"Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5963302752,0.364,"Last AD: Diff & Remiss","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6368038741,0.04455445545,NA,0.4092307692,"Last AD: Diff & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.1442307692,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7247706422,NA,0.79,0.35546875,"Last AD: Diff & Remiss","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06609947644,NA,NA,"Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09722222222,0.68,0.4181818182,"Last AD: Diff & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.0625,0.6470588235,NA,NA,0.4862385321,0.1949860724,0.5219298246,NA,NA,NA,NA,0.5795918367,0.125984252,NA,0.3291814947,"Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1364190012,"Last AD: Same & No Remiss",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3918367347,NA,NA,NA,"Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4444444444,NA,"Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3671875,NA,NA,NA,"Last AD: Same & No Remiss","MASTODYNIA (dxo:ICD9:61171)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04385964912,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","NORTRIPTYLINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1265822785,NA,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.125,NA,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","MIRTAZAPINE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3271028037,NA,NA,NA,"Last AD: Same & No Remiss","MYOPIA (dxo:ICD9:3671)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4910714286,NA,NA,NA,"Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4319526627,NA,NA,NA,"Last AD: Same & No Remiss","NORETHINDRONE","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04699093157,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3663366337,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3090128755,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2252747253,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3685478321,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4375,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.381443299,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3032258065,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.003861003861,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3074141049,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2977099237,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3953488372,NA,NA,NA,"Last AD: Same & No Remiss","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2856117689,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1883561644,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2347826087,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2155172414,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2741935484,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2988505747,NA,0.4117647059,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2857142857,NA,NA,NA,NA,0.2857142857,"Last AD: Same & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1711229947,NA,NA,NA,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2081316554,NA,NA,NA,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1408450704,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008086253369,NA,NA,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2278761062,NA,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4334140436,NA,NA,NA,"Last AD: Same & No Remiss","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4678571429,NA,NA,NA,"Last AD: Same & No Remiss","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3027027027,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.36,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3235294118,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1634615385,"Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3660714286,NA,"Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2275132275,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01834862385,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2222222222,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.257889991,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3554216867,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1559633028,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007462686567,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2311557789,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1418918919,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1568627451,NA,NA,NA,"Last AD: Same & No Remiss","RISPERIDONE","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1791044776,NA,NA,NA,NA,"Last AD: Same & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3904761905,NA,NA,NA,"Last AD: Same & No Remiss","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3563010393,NA,NA,0.2461538462,"Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4347252747,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4337349398,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","TOPIRAMATE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3039443155,0.008333333333,NA,0.3203252033,"Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3901515152,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3869346734,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3462282398,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4482758621,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3990147783,NA,0.4436090226,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4954954955,NA,"Last AD: Same & No Remiss","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009691629956,NA,0.2479338843,"Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008620689655,NA,NA,"Last AD: Same & No Remiss","TRAZODONE HCL","UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007142857143,0.28515625,0.3438596491,"Last AD: Same & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3443404556,NA,"Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4907407407,"Last AD: Same & Remiss",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7066666667,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.593495935,NA,NA,NA,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7324414716,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6214285714,NA,NA,NA,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7363636364,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7170068027,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.743315508,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6756756757,NA,NA,NA,"Last AD: Same & Remiss","MASTODYNIA (dxo:ICD9:61171)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.4809160305,NA,NA,NA,NA,NA,NA,0.5,"Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6721311475,NA,NA,NA,"Last AD: Same & Remiss","MYOPIA (dxo:ICD9:3671)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6022099448,NA,NA,NA,"Last AD: Same & Remiss","NORETHINDRONE","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6310679612,NA,NA,NA,"Last AD: Same & Remiss","NORGESTIMATE-ETHINYL ESTRADIOL","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.468401487,"Last AD: Same & Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7954545455,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4885654886,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7946428571,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5765765766,NA,NA,NA,"Last AD: Same & Remiss","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5639374425,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5434173669,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5797101449,"Last AD: Same & Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4882154882,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5684647303,NA,NA,NA,"Last AD: Same & Remiss","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6170212766,NA,NA,NA,"Last AD: Same & Remiss","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4387096774,NA,NA,NA,"Last AD: Same & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5507246377,"Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.625,NA,NA,NA,"Last AD: Same & Remiss","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.62,NA,NA,NA,"Last AD: Same & Remiss","SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6066216084,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6601941748,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6472114137,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6467391304,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","TOPIRAMATE",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5454545455,"Last AD: Same & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6348547718,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5757575758,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5904977376,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4827586207,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5501156515,"Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5330661323,"Last AD: Same & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6001959824,0.4977578475,"Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3950617284,NA,NA,NA,NA,0.4943181818,NA,0.4645669291,0.1165048544,"LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3137254902,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LEUKORRHEA, NOT SPECIFIED AS INFECTIVE (dxo:ICD9:6235)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1186440678,0.4060150376,NA,NA,NA,NA,NA,NA,NA,NA,"LEVOFLOXACIN",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LEVOFLOXACIN","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.476984127,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5381561535,NA,NA,NA,"LEVONORGESTREL-ETHIN ESTRADIOL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.408,NA,NA,NA,"LEVONORGESTREL-ETHIN ESTRADIOL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6418918919,NA,NA,NA,"LEVONORGESTREL-ETHIN ESTRADIOL","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.4295774648,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5481927711,NA,NA,NA,"LEVONORGESTREL-ETHIN ESTRADIOL","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6727272727,NA,NA,NA,"LEVONORGESTREL-ETHIN ESTRADIOL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4807692308,NA,NA,NA,"LEVONORGESTREL-ETHIN ESTRADIOL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5098039216,NA,NA,NA,0.156462585,0.4384384384,NA,NA,NA,NA,0.5343839542,NA,NA,0.1813471503,"LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4730290456,NA,NA,NA,"LEVOTHYROXINE SODIUM","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.677852349,NA,NA,NA,"LEVOTHYROXINE SODIUM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.08235294118,0.4173913043,NA,NA,NA,NA,NA,NA,NA,NA,"LEVOTHYROXINE SODIUM","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6697986577,NA,NA,NA,"LEVOTHYROXINE SODIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5691056911,NA,NA,NA,"LEVOTHYROXINE SODIUM","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4237288136,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4453781513,NA,NA,NA,"LISDEXAMFETAMINE DIMESYLATE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4570446735,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LISINOPRIL/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.06666666667,0.09316770186,NA,NA,NA,NA,NA,0.06363636364,0.1777777778,NA,"LITHIUM CARBONATE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1543209877,NA,"LITHIUM CARBONATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5464480874,NA,NA,NA,0.1179245283,NA,NA,NA,0.4946921444,NA,NA,NA,NA,NA,"LORATADINE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5762711864,NA,NA,NA,NA,NA,"LORATADINE","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",0,0.0253164557,0.4132492114,NA,NA,NA,NA,0.4224422442,NA,NA,NA,NA,0.4833333333,NA,NA,NA,"LORAZEPAM",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5904761905,NA,NA,NA,"LORAZEPAM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6086956522,NA,NA,NA,"LORAZEPAM","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.0223880597,0.4065934066,NA,NA,NA,NA,0.3602484472,0.09556313993,NA,0.2695652174,NA,0.4639498433,NA,0.58,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"LUMBAGO (dxo:ICD9:7242)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.4606741573,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6303571429,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.6748768473,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7226107226,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7049808429,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6323296355,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6194690265,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.5052816901,0.6598837209,0.6339869281,NA,0.5890410959,0.5751391466,0.6370808679,NA,NA,NA,NA,0.631840796,0.4050632911,0.6796116505,0.626399776,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.524691358,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6678571429,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5862068966,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.668207024,NA,NA,0.645631068,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6428571429,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3571428571,NA,0.5964233929,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6862745098,0.6603773585,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6505139501,0.582781457,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1171171171,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MILD (dxo:ICD9:29631)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4186046512,NA,NA,NA,NA,0.422907489,NA,NA,NA,NA,0.4701986755,NA,0.5346534653,0.2710280374,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.179245283,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.1965811966,NA,NA,NA,NA,0.1904761905,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.1781609195,NA,NA,NA,NA,0.1440677966,NA,NA,NA,NA,0.2131782946,NA,NA,0.1984126984,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1278195489,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.602739726,NA,NA,0.3669064748,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3818181818,NA,NA,0.2483221477,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1089108911,NA,NA,NA,NA,NA,0.1804511278,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",0.2186046512,0.3898048707,0.593824228,0.5959933222,0.298245614,0.5479532164,0.4779915227,0.5629531971,0.399103139,0.3361702128,0.5837438424,NA,0.6042402827,0.3039399625,0.601843318,0.5102158606,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.375,NA,NA,NA,NA,NA,NA,0.4432071269,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4868421053,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5072463768,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.422310757,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.4444444444,NA,NA,NA,NA,0.5636363636,NA,NA,NA,0.624567474,NA,NA,NA,NA,0.6192893401,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.616,NA,NA,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.6129032258,0.6388888889,NA,NA,0.6310679612,NA,NA,NA,NA,NA,NA,0.6568627451,NA,0.6582278481,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6909871245,NA,NA,0.5779816514,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5850340136,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6481481481,0.5145631068,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.6976744186,NA,NA,NA,NA,0.6436781609,NA,NA,NA,NA,NA,0.7586206897,NA,NA,0.7008547009,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2719298246,NA,NA,NA,NA,NA,NA,NA,0.3275862069,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3620689655,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","RISPERIDONE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4850746269,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.3721590909,0.5838926174,NA,NA,0.6474820144,0.5160493827,0.4864864865,NA,NA,0.6339285714,NA,0.6420807453,NA,NA,0.5531400966,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6115485564,0.2058823529,NA,0.4760273973,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5894039735,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.323699422,NA,NA,NA,0.4968944099,0.4953271028,NA,NA,NA,NA,NA,NA,0.2695346795,0.5505050505,0.4833295532,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5853174603,0.418972332,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.4127906977,NA,NA,NA,NA,0.5259259259,0.525862069,NA,NA,NA,NA,NA,NA,0.6023185484,0.5293132328,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04647160069,NA,NA,NA,NA,NA,0.5043478261,NA,NA,NA,NA,0.5167286245,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.04761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1700680272,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6165413534,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.05300859599,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5743243243,NA,0.6100628931,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.06481481481,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3939393939,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5774647887,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.09473684211,0.3678343949,NA,NA,NA,NA,0.4282828283,NA,0.4635416667,0.1610169492,"MASTODYNIA (dxo:ICD9:61171)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1231527094,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MASTODYNIA (dxo:ICD9:61171)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6301369863,NA,NA,NA,"MASTODYNIA (dxo:ICD9:61171)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2520325203,NA,NA,NA,"MASTODYNIA (dxo:ICD9:61171)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1619433198,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MEDROXYPROGESTERONE ACETATE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1343283582,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MEDROXYPROGESTERONE ACETATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.347826087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MELOXICAM",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4220779221,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"METAXALONE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.485,NA,NA,NA,"METFORMIN HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.02580645161,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"METHYLPHENIDATE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4331797235,NA,NA,NA,NA,NA,NA,NA,NA,"METOCLOPRAMIDE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3825503356,NA,NA,NA,NA,NA,NA,NA,NA,"METOCLOPRAMIDE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4967741935,NA,NA,NA,NA,0.3253588517,NA,NA,NA,NA,0.4714285714,NA,0.5405405405,NA,"METRONIDAZOLE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3137254902,NA,NA,NA,"METRONIDAZOLE","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.3488372093,NA,NA,NA,NA,0.3243243243,NA,NA,NA,NA,0.4,NA,NA,NA,"METRONIDAZOLE","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4696969697,NA,NA,NA,"MIGRAINE WITHOUT AURA, WITH INTRACTABLE MIGRAINE, SO STATED, WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34611)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3983739837,NA,NA,NA,NA,NA,NA,0.02614379085,NA,NA,0.48125,NA,NA,NA,"MIGRAINE WITHOUT AURA, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34610)",NA,NA,NA,NA,NA,NA
"20-40","Female",0.007575757576,0.02597402597,0.4335664336,NA,NA,NA,0.1786542923,0.3942857143,NA,0.04041916168,NA,NA,0.4724137931,NA,NA,NA,"MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1517857143,NA,NA,NA,NA,NA,NA,"MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"20-40","Female",0.008356545961,NA,NA,NA,NA,NA,0.1635802469,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6378378378,NA,NA,NA,"MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4965034965,NA,NA,NA,"MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03977272727,0.2694300518,NA,NA,0.2023346304,0.1361702128,0.2789115646,0.2091836735,NA,0.2342342342,NA,0.2653846154,NA,0.4181818182,0.2179236043,"MIRTAZAPINE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2314049587,"MIRTAZAPINE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2371794872,"MIRTAZAPINE","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1986607143,"MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1755725191,"MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4285714286,NA,NA,NA,NA,0.2380952381,"MIRTAZAPINE","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1274509804,"MIRTAZAPINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07407407407,"MIRTAZAPINE","RISPERIDONE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1860465116,NA,NA,NA,0.4192229039,NA,NA,0.2242268041,"MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.232,"MIRTAZAPINE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.2,NA,NA,NA,NA,NA,NA,0.2102839601,"MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1964285714,"MIRTAZAPINE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5189189189,0.1884984026,"MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4672897196,NA,NA,NA,NA,0.4613003096,NA,NA,NA,NA,0.4833333333,NA,NA,0.2085561497,"MONTELUKAST SODIUM",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.02721088435,NA,NA,NA,NA,0.1738122827,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MORBID OBESITY (dxo:ICD9:27801)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.04,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MORBID OBESITY (dxo:ICD9:27801)","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1466666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MORBID OBESITY (dxo:ICD9:27801)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1265822785,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MOXIFLOXACIN HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1215686275,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MOXIFLOXACIN HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1295336788,0.4189944134,NA,NA,NA,NA,0.4846153846,NA,NA,NA,"MULTIPLE SCLEROSIS (dxo:ICD9:340)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.04015799868,0.5166666667,NA,NA,NA,0.1577464789,0.4931506849,NA,NA,0.3904761905,NA,0.5374077977,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.02617801047,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04587155963,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3410404624,NA,NA,NA,NA,NA,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04716981132,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1919191919,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.675,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01941747573,NA,NA,NA,NA,NA,0.4803921569,NA,NA,NA,NA,NA,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",0.006993006993,NA,NA,NA,NA,NA,0.162601626,NA,NA,NA,NA,NA,0.4845938375,NA,NA,NA,"NAPROXEN",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5555555556,NA,NA,NA,"NAPROXEN","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03151862464,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.04790419162,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,NA,NA,NA,"NONALLOPATHIC LESION OF CERVICAL REGION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:7391)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3582089552,NA,NA,NA,NA,NA,"NONALLOPATHIC LESION OF THORACIC REGION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:7392)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3605442177,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT ALCOHOL ABUSE, UNSPECIFIED DRUNKENNESS (dxo:ICD9:30500)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.02003704327,NA,NA,NA,NA,0.1419784726,0.4373626374,NA,NA,NA,NA,0.4457323498,0.01287553648,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.01327433628,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01324503311,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01829268293,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.09565217391,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02564102564,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01869158879,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02962962963,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.008928571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02822580645,NA,NA,NA,NA,0.1491053678,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03015075377,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5948275862,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.006134969325,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","VALACYCLOVIR HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02678571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","VARENICLINE TARTRATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5486590038,NA,NA,NA,"NORETHINDRONE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.582781457,NA,NA,NA,"NORETHINDRONE","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5273159145,NA,NA,NA,"NORETHINDRONE","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5985915493,NA,NA,NA,"NORETHINDRONE","SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6298850575,NA,NA,NA,"NORETHINDRONE","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7021276596,NA,NA,NA,"NORETHINDRONE","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5777331996,NA,NA,NA,"NORETHINDRONE","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1411483254,NA,NA,NA,0.404494382,NA,NA,NA,NA,NA,"NORETHINDRONE-E.ESTRADIOL-IRON",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1518796992,NA,NA,NA,0.391509434,NA,NA,NA,NA,NA,"NORETHINDRONE-E.ESTRADIOL-IRON","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4816955684,NA,NA,NA,"NORETHINDRONE-ETHIN. ESTRADIOL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6864864865,NA,NA,NA,"NORETHINDRONE-ETHIN. ESTRADIOL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4780876494,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5614430665,NA,NA,NA,"NORGESTIMATE-ETHINYL ESTRADIOL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.395480226,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NORGESTIMATE-ETHINYL ESTRADIOL","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.6030534351,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5392156863,NA,NA,NA,"NORGESTIMATE-ETHINYL ESTRADIOL","SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6979865772,NA,NA,NA,"NORGESTIMATE-ETHINYL ESTRADIOL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3719008264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NORGESTIMATE-ETHINYL ESTRADIOL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",0,0.0329218107,0.3385093168,NA,NA,0.3068965517,0.1173469388,0.3493150685,NA,0.1267423851,0.3053892216,NA,0.391509434,NA,0.4680851064,0.3004333173,"NORTRIPTYLINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6601941748,NA,NA,NA,"NORTRIPTYLINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2073170732,"NORTRIPTYLINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4838709677,NA,NA,NA,NA,0.3571428571,"NORTRIPTYLINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1059322034,NA,NA,0.5933333333,NA,NA,0.3470319635,"NORTRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2,NA,NA,NA,NA,NA,0.2640949555,"NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1553398058,NA,NA,NA,NA,0.7083333333,0.2884160757,"NORTRIPTYLINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4436090226,NA,NA,NA,NA,NA,"Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6379310345,NA,NA,NA,"Num Previous Antidep: 2,3","PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6136363636,NA,NA,NA,NA,NA,"Num Previous Antidep: 2,3","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3275862069,NA,NA,NA,"Num Previous Antidep: 2,3","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6112676056,NA,NA,NA,"Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7006802721,NA,NA,NA,"Num Previous Antidep: 2,3","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1805555556,NA,NA,NA,NA,0.1992753623,"Num Previous Antidep: 4+",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3212435233,NA,NA,NA,NA,NA,"Num Previous Antidep: 4+","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.243902439,"Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3694915254,NA,NA,NA,"Num Previous Antidep: 4+","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1990202082,"Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1895604396,"Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1458333333,"Num Previous Antidep: 4+","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4184397163,NA,NA,NA,NA,NA,"Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,0.4824561404,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7695473251,NA,NA,NA,"Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6349206349,NA,NA,NA,"Num Previous Remissions: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.75,NA,"Num Previous Remissions: 2+","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03555878084,NA,NA,NA,NA,NA,0.5192307692,NA,NA,NA,NA,NA,NA,NA,NA,"OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.009523809524,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OBESITY, UNSPECIFIED (dxo:ICD9:27800)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.04032258065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OBESITY, UNSPECIFIED (dxo:ICD9:27800)","POLYCYSTIC OVARIES (dxo:ICD9:2564)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03418803419,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OBESITY, UNSPECIFIED (dxo:ICD9:27800)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02884615385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OBESITY, UNSPECIFIED (dxo:ICD9:27800)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03669724771,NA,NA,NA,NA,0.1612903226,NA,NA,NA,NA,NA,NA,NA,NA,0.1367574257,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1222222222,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1088435374,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06140350877,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1712328767,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1973684211,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1731343284,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1538461538,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4505494505,NA,NA,NA,0.1974358974,0.4811320755,NA,NA,NA,NA,0.512195122,NA,NA,NA,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.698630137,NA,NA,NA,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1466208477,0.485,NA,NA,NA,NA,NA,NA,NA,0.1673640167,"OMEPRAZOLE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1468926554,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OMEPRAZOLE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02762430939,NA,NA,"OPIOID TYPE DEPENDENCE, UNSPECIFIED (dxo:ICD9:30400)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3645833333,NA,NA,NA,0.1333333333,NA,NA,NA,0.3643410853,NA,NA,NA,NA,NA,"OSELTAMIVIR PHOSPHATE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4769975787,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER ACNE (dxo:ICD9:7061)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.0331010453,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.03141361257,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.29,"OTHER ANXIETY STATES (dxo:ICD9:30009)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.05617977528,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER CONVULSIONS (dxo:ICD9:78039)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.421875,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER DYSCHROMIA (dxo:ICD9:70909)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2752293578,NA,NA,NA,NA,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3856502242,NA,NA,NA,NA,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4308300395,NA,NA,NA,NA,0.4353182752,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER GENERAL COUNSELING AND ADVICE FOR CONTRACEPTIVE MANAGEMENT (dxo:ICD9:V2509)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3941605839,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER GENERAL COUNSELING AND ADVICE FOR CONTRACEPTIVE MANAGEMENT (dxo:ICD9:V2509)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.401459854,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER GENERAL SYMPTOMS (dxo:ICD9:78099)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.02783235102,0.4487179487,0.5357142857,NA,0.3646511628,0.1333333333,0.4282722513,NA,NA,0.3888888889,NA,0.4989059081,0.007380073801,0.5246376812,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0,NA,NA,NA,NA,NA,0.3503649635,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03816793893,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.05524861878,NA,NA,NA,NA,0.1650485437,NA,NA,NA,NA,NA,NA,0.009433962264,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.006289308176,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,0.01833333333,NA,0.6091370558,NA,0.3853754941,0.1732283465,0.4633431085,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.06611570248,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.648,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02857142857,NA,NA,NA,0.3611111111,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.0243902439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","VALACYCLOVIR HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4375,NA,NA,NA,0.1266666667,NA,NA,NA,NA,NA,NA,NA,0.5636363636,NA,"OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.04296875,0.375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA,NA,NA
"20-40","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4974874372,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA,NA
"20-40","Female",0.006535947712,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3973509934,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER SPECIFIED DISEASE OF SEBACEOUS GLANDS (dxo:ICD9:7068)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3573883162,NA,NA,0.2396694215,NA,NA,NA,NA,NA,NA,NA,NA,0.3443708609,NA,"OTHER SPECIFIED NONINFLAMMATORY DISORDER OF VAGINA (dxo:ICD9:6238)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4797979798,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER SPECIFIED PRE-OPERATIVE EXAMINATION (dxo:ICD9:V7283)",NA,NA,NA,NA,NA,NA
"20-40","Female",0.005555555556,0.02309468822,NA,NA,0.05,NA,NA,NA,0.08227848101,NA,NA,NA,NA,0.01164483261,NA,NA,"OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.01374570447,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02173913043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009523809524,NA,NA,"OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,0.01960784314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",0.001828153565,0.03077930583,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01336898396,NA,NA,"OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03738317757,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OUTCOME OF DELIVERY, SINGLE LIVEBORN (dxi:ICD9:V270)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)","VALACYCLOVIR HCL",NA,NA,NA,NA
"20-40","Female",NA,0.0251572327,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4573170732,NA,NA,NA,"OVERWEIGHT (dxo:ICD9:27802)",NA,NA,NA,NA,NA,NA
"20-40","Female",0.007874015748,NA,NA,NA,NA,NA,0.1449704142,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OXYCODONE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.05042016807,NA,NA,NA,NA,0.113253012,NA,NA,NA,NA,NA,NA,0.006060606061,NA,NA,"OXYCODONE HCL/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1235955056,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OXYCODONE HCL/ACETAMINOPHEN","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.277992278,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.3275862069,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.3333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PAIN IN JOINT, SITE UNSPECIFIED (dxo:ICD9:71940)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5,NA,NA,NA,0.1238095238,0.4108527132,NA,NA,NA,NA,0.4814814815,NA,0.4385964912,NA,"PAIN IN SOFT TISSUES OF LIMB (dxo:ICD9:7295)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4103967168,NA,NA,0.356097561,0.1147426982,0.3987049029,NA,NA,0.3741007194,NA,0.4782608696,NA,NA,0.1798780488,"PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.305785124,NA,NA,NA,NA,NA,NA,NA,NA,"PALPITATIONS (dxo:ICD9:7851)","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.104283054,NA,NA,NA,0.2898550725,NA,NA,NA,NA,NA,"PALPITATIONS (dxo:ICD9:7851)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.431372549,"PALPITATIONS (dxo:ICD9:7851)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4160583942,NA,NA,NA,NA,NA,NA,NA,NA,"PALPITATIONS (dxo:ICD9:7851)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2547169811,NA,NA,NA,NA,NA,NA,NA,NA,"PALPITATIONS (dxo:ICD9:7851)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02711323764,0.4620689655,NA,NA,NA,NA,0.375,NA,NA,0.3306709265,NA,0.4692913386,NA,NA,NA,"PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5153846154,NA,NA,NA,NA,NA,"PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2785714286,NA,NA,NA,NA,NA,"PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6376146789,NA,NA,NA,"PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4471544715,NA,NA,NA,NA,NA,NA,NA,NA,"PANTOPRAZOLE SODIUM",NA,NA,NA,NA,NA,NA
"20-40","Female",0.01984126984,0.03503480278,0.4510891089,0.578680203,NA,0.3414414414,0.176487748,0.4010500808,0.1185770751,0.04779411765,0.4434667698,NA,0.4600951374,0.03783783784,0.5775862069,0.2075923393,"PAROXETINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.1615384615,NA,NA,NA,NA,0.1588785047,NA,NA,0.28125,NA,0.2663043478,NA,NA,0.08349514563,"PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06912442396,"PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2468619247,NA,NA,NA,NA,0.1238938053,"PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.52,NA,NA,NA,"PAROXETINE HCL","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4468085106,NA,NA,NA,NA,NA,NA,NA,NA,"PAROXETINE HCL","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3483146067,NA,0.2564102564,NA,NA,0.1447368421,"PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2781065089,NA,NA,NA,NA,0.1463414634,"PAROXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.2,NA,NA,NA,0.5201716738,NA,NA,NA,NA,NA,"PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.05031446541,0.4208333333,NA,NA,NA,0.1433691756,0.3473282443,NA,NA,0.4496253122,NA,0.5186360032,NA,0.4905660377,0.1990291262,"PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3931623932,NA,0.4586466165,NA,NA,0.2397260274,"PAROXETINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5322580645,NA,0.5,NA,NA,0.25,"PAROXETINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02232142857,0.2543859649,NA,NA,NA,0.1214285714,0.2260869565,NA,NA,0.3989873418,NA,0.3174603175,0.02697674419,NA,0.2929984779,"PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2272727273,"PAROXETINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.04326923077,0.5,NA,NA,NA,0.1822660099,0.3923076923,NA,NA,0.4925093633,NA,0.4257425743,NA,0.59375,0.2330677291,"PAROXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4740740741,0,NA,NA,"PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742)",NA,NA,NA,NA,NA,NA
"20-40","Female",0.02631578947,0.04444444444,0.1930983847,0.1596045198,NA,0.1404421326,0.1315789474,0.1993127148,NA,NA,0.1337792642,NA,0.1809045226,0.03200883002,0.1943434343,0.1228070175,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.04739336493,0.1302325581,0.156626506,NA,0.1171875,0.0675990676,0.1656050955,NA,NA,0.103030303,NA,0.1588541667,NA,0.1353135314,0.07669616519,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2994923858,NA,NA,0.08646616541,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2608695652,NA,NA,0.09285714286,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06040268456,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2920353982,0.1015873016,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.06043956044,0.1687242798,NA,NA,0.1810344828,NA,0.1794871795,NA,NA,0.1557377049,NA,0.3197071385,NA,0.2960893855,0.1129170231,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3664122137,NA,NA,NA,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.26,NA,NA,0.131826742,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05072463768,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2173913043,NA,NA,NA,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07207207207,0.1801470588,0.08831908832,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.249660787,0.1409574468,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,0.04098360656,0.1923076923,NA,NA,NA,NA,0.1056338028,NA,NA,NA,NA,0.2457142857,NA,0.2924120913,0.1268844221,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03015075377,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"POLYCYSTIC OVARIES (dxo:ICD9:2564)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4197530864,NA,NA,NA,NA,NA,NA,NA,NA,"POLYETHYLENE GLYCOL 3350",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3720930233,NA,NA,NA,"POSTTRAUMATIC STRESS DISORDER (dxo:ICD9:30981)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2363636364,NA,NA,NA,"POSTTRAUMATIC STRESS DISORDER (dxo:ICD9:30981)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,0.08490566038,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3690226265,"PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3773987207,"PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3394495413,"PRAMIPEXOLE DI-HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5257731959,NA,NA,0.4621848739,"PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3341288783,"PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5170068027,0.3125,"PRAMIPEXOLE DI-HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02777777778,0.373015873,NA,NA,0.375,NA,0.3773584906,NA,NA,NA,NA,0.5167785235,NA,NA,NA,"PREGABALIN",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.4089068826,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PREGABALIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.006622516556,0.418892186,NA,NA,0.3243243243,NA,NA,NA,NA,NA,NA,0.4855415352,NA,NA,0.1769911504,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2363636364,NA,NA,NA,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2413793103,NA,NA,NA,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2789473684,NA,NA,NA,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2690763052,NA,NA,NA,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.4360902256,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","ROUTINE POSTPARTUM FOLLOW-UP (dxo:ICD9:V242)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4329896907,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","ROUTINE POSTPARTUM FOLLOW-UP (dxo:ICD9:V242)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.3608247423,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4819277108,NA,NA,NA,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.55,NA,NA,NA,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5324675325,NA,NA,NA,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4305555556,NA,NA,NA,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SECOND-DEGREE PERINEAL LACERATION, WITH DELIVERY (dxi:ICD9:66411)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6363636364,NA,NA,NA,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.641350211,NA,NA,0.2884615385,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,0.006289308176,0.4335664336,NA,NA,0.3063583815,NA,NA,NA,NA,NA,NA,0.4772658838,NA,NA,0.140625,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4033613445,NA,NA,NA,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4021447721,NA,NA,NA,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.3412698413,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4423076923,NA,NA,NA,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",0,0.008403361345,0.472166998,NA,NA,NA,0.1074335323,0.3170892328,NA,NA,0.339673913,NA,NA,0.005235602094,NA,0.1718061674,"PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.009174311927,NA,NA,NA,NA,0.1,0.2713178295,NA,NA,0.3046875,NA,NA,NA,NA,NA,"PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5140186916,NA,NA,NA,NA,0.4132947977,NA,NA,NA,NA,NA,NA,NA,0.2888888889,"PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4418604651,NA,NA,NA,NA,NA,NA,NA,NA,"PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3025210084,NA,NA,NA,NA,NA,NA,NA,NA,"PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.2785145889,NA,NA,NA,NA,NA,NA,NA,NA,"PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA,NA,"PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4213483146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PROGESTERONE, MICRONIZED",NA,NA,NA,NA,NA,NA
"20-40","Female",0.005524861878,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PROMETHAZINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",0.01149425287,NA,NA,NA,NA,NA,0.1288343558,NA,NA,NA,0.3,NA,NA,NA,NA,0.1964285714,"PROPOXYPHENE NAP/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4854368932,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PROPRANOLOL HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.248046875,NA,NA,NA,0.1044776119,0.236,NA,NA,0.1733333333,NA,0.2401960784,NA,0.2763819095,0.1202185792,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.06034482759,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.1854460094,NA,NA,0.1212121212,0.07650273224,0.1826215022,NA,NA,0.2238095238,NA,0.1975497703,NA,0.1768292683,0.1142857143,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.2012987013,NA,NA,NA,0.07480314961,0.1696428571,NA,NA,NA,NA,0.1787878788,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.297029703,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)","SERTRALINE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.09375,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.1856287425,NA,NA,NA,NA,0.36,NA,NA,0.1782178218,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3375796178,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1991701245,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.2719298246,NA,NA,NA,0.09803921569,0.1721311475,NA,NA,NA,NA,0.2103174603,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1260504202,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4589041096,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2481751825,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.1943127962,NA,NA,NA,0.1160092807,0.2596491228,NA,NA,NA,NA,0.318452381,NA,NA,0.2196969697,"PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.08928571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Female",0.008720930233,0.03938185444,0.2069126576,0.2427807487,NA,0.1724137931,0.08121246783,0.2011615628,0.1104294479,0.02521008403,0.1803571429,NA,0.2215693052,0.01824817518,0.2289473684,0.1073684211,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA,NA
"20-40","Female",0.008928571429,NA,NA,NA,NA,NA,0.06837606838,NA,NA,NA,0.1614906832,NA,NA,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.2164948454,NA,NA,NA,0.119205298,0.1653543307,NA,NA,NA,NA,0.4254062038,NA,0.2941176471,0.1456628478,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2058823529,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2946635731,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1462264151,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2038834951,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4466403162,0.1483979764,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.1043956044,0.146627566,NA,0.1680672269,0.06571428571,0.2341772152,NA,NA,NA,NA,0.2044444444,0.02839116719,0.2155172414,0.1384976526,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,0.12,NA,NA,NA,NA,NA,NA,NA,NA,0.1037735849,NA,0.1417910448,0.1057692308,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2788461538,NA,NA,0.1459854015,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3212851406,NA,NA,0.137295082,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3203883495,NA,NA,0.1459227468,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0942408377,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1272727273,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3714285714,0.1029411765,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.1831802803,0.209375,0.03100775194,0.1521984216,0.07721073471,0.1931769723,NA,0.01515151515,0.1700819672,NA,0.2008776207,0.01610305958,0.2173006774,0.1238645747,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.2059925094,NA,NA,NA,0.06462585034,0.1967213115,NA,NA,NA,NA,0.1744186047,NA,0.1764705882,0.09489051095,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2702702703,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.06748466258,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.252173913,NA,NA,0.1666666667,0.1062124248,0.2101694915,NA,NA,NA,NA,0.3464309103,NA,0.3151750973,0.1800180018,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3666666667,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3215859031,NA,NA,0.173374613,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2337349398,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1278195489,0.1580645161,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2862318841,0.1666666667,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.2212389381,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3316498316,0.216802168,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.05737704918,0.03829787234,0.0987654321,NA,NA,NA,NA,0.1245283019,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2553191489,NA,NA,0.08064516129,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.2831050228,NA,NA,NA,0.09443099274,0.2592592593,NA,NA,NA,NA,0.2546296296,NA,NA,0.1818181818,"PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4276315789,NA,NA,NA,"PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.134502924,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RANITIDINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1834319527,NA,NA,NA,0.3081395349,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3510971787,NA,NA,NA,0.4416666667,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.1290322581,NA,NA,0.2027972028,0.1168831169,0.1755725191,NA,NA,NA,NA,0.170212766,NA,0.1641791045,0.1007259528,"RISPERIDONE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2036474164,NA,NA,0.125,"RISPERIDONE","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2248062016,NA,NA,NA,"RISPERIDONE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1090604027,"RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1886792453,0.1666666667,"RISPERIDONE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1949367089,0.122324159,"RISPERIDONE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.423580786,NA,NA,NA,NA,0.5201149425,NA,NA,NA,"RIZATRIPTAN BENZOATE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,NA,NA,NA,"RIZATRIPTAN BENZOATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1441441441,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROFECOXIB",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.05263157895,0.2881355932,NA,NA,0.2666666667,0.1441441441,0.3923076923,NA,NA,NA,0.3003144654,0.3571428571,NA,0.2368421053,0.318356608,"ROPINIROLE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5619047619,NA,NA,0.4464285714,"ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0347826087,NA,0.2365930599,"ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5447154472,0.4155251142,"ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.03229813665,NA,NA,NA,NA,0.1336717428,NA,NA,NA,0.3297491039,NA,0.4751381215,0.01201602136,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.02688172043,NA,NA,NA,NA,0.1492537313,NA,NA,NA,0.421875,NA,NA,NA,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5701754386,NA,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)",NA,NA,NA,NA,NA
"20-40","Female",0.003262051468,0.03389830508,NA,0.6104928458,0.09049773756,0.3659985152,0.1354859752,0.4234711912,0.1088435374,NA,0.3451598774,NA,NA,NA,NA,0.1920623671,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.3051948052,0.1024498886,NA,NA,NA,0.3370786517,NA,NA,NA,NA,0.1916167665,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.303030303,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01785714286,NA,0.6267281106,NA,0.5371900826,0.1918465228,NA,NA,NA,0.4827586207,NA,NA,NA,NA,0.4131054131,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3407407407,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SPECIAL SCREENING EXAMINATION, HUMAN PAPILLOMAVIRUS [HPV] (dxo:ICD9:V7381)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.179245283,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4416243655,NA,NA,0.3833333333,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","TOPIRAMATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1596958175,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","TRAMADOL HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.09701492537,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED CONSTIPATION (dxo:ICD9:56400)",NA,NA,NA,NA,NA
"20-40","Female",0,NA,NA,NA,NA,0.3644067797,0.1461412151,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Female",0.003846153846,NA,NA,NA,NA,NA,NA,0.4351851852,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.2960526316,0.1030756442,0.3821138211,NA,NA,0.2878787879,NA,NA,NA,NA,0.1455696203,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1530944625,0.4367346939,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.01351351351,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","VALACYCLOVIR HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1967213115,NA,NA,NA,NA,NA,NA,NA,NA,0.2715231788,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4132231405,NA,NA,NA,NA,0.4243323442,NA,NA,0.3741007194,NA,0.5048543689,NA,NA,NA,"ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4846153846,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4882780922,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE POSTPARTUM FOLLOW-UP (dxo:ICD9:V242)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4705882353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE POSTPARTUM FOLLOW-UP (dxo:ICD9:V242)","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4798464491,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE POSTPARTUM FOLLOW-UP (dxo:ICD9:V242)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.370140477,NA,NA,0.2820512821,0.1511111111,NA,NA,NA,0.3161764706,NA,0.4456029012,NA,0.3858784893,NA,"SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.44,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)","SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.614,NA,NA,NA,"SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5897435897,NA,NA,NA,"SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)","SERTRALINE HCL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"20-40","Female",NA,NA,0.4175257732,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4216524217,NA,NA,NA,"SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5048543689,NA,NA,NA,"SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)","SURVEILLANCE OF PREVIOUSLY PRESCRIBED CONTRACEPTIVE PILL (dxo:ICD9:V2541)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3941605839,NA,NA,NA,"SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3381642512,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3695299838,NA,NA,NA,"SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4297520661,NA,NA,NA,"SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6134453782,NA,"SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.462915601,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.531824611,NA,0.5551257253,NA,"SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6837606838,NA,NA,NA,"SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6268656716,NA,"SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4861111111,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"SCREENING FOR UNSPECIFIED CONDITION (dxo:ICD9:V829)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5417558887,NA,NA,NA,"SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6355932203,NA,NA,NA,"SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286)","SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5354767184,NA,NA,NA,"SCREENING OF STREPTOCOCCUS B (dxo:ICD9:V286)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5777777778,NA,NA,NA,"SECOND-DEGREE PERINEAL LACERATION, WITH DELIVERY (dxi:ICD9:66411)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5650793651,NA,NA,NA,"SECOND-DEGREE PERINEAL LACERATION, WITH DELIVERY (dxi:ICD9:66411)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",0.01329923274,0.03444203897,0.4133946159,0.5982008996,0.1142061281,0.3661355826,0.1673819742,0.3867149758,0.1136624569,0.04347826087,0.3555555556,0.1388888889,0.4931548497,0.01638554217,0.5483061481,0.2711166495,"SERTRALINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7074468085,NA,NA,NA,"SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6393442623,NA,NA,0.4171779141,"SERTRALINE HCL","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02678571429,NA,NA,NA,0.3333333333,NA,0.5739130435,NA,NA,NA,NA,0.6059903382,NA,0.6095238095,0.2821576763,"SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4734693878,NA,NA,NA,"SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5564516129,NA,NA,NA,"SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.65,NA,NA,NA,"SERTRALINE HCL","SURVEILLANCE OF PREVIOUSLY PRESCRIBED CONTRACEPTIVE PILL (dxo:ICD9:V2541)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6258351893,NA,NA,0.4180327869,"SERTRALINE HCL","TOPIRAMATE",NA,NA,NA,NA,NA
"20-40","Female",0.01652892562,0.03754940711,0.2524271845,NA,NA,0.2771084337,0.1323210412,0.2853717026,NA,NA,0.2553191489,NA,0.4481792717,0.01336760925,0.367816092,0.2988794878,"SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3665158371,0.007462686567,0.6115702479,0.2164179104,"SERTRALINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.4583333333,NA,NA,NA,NA,NA,NA,0.5982404692,NA,NA,NA,"SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5915178571,NA,NA,NA,"SERTRALINE HCL","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5963699222,NA,NA,NA,"SERTRALINE HCL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.640776699,NA,NA,NA,"SERTRALINE HCL","UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6317280453,NA,NA,NA,"SERTRALINE HCL","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.06807511737,0.3986710963,NA,NA,NA,0.1918465228,0.3782894737,NA,NA,0.3987730061,NA,0.4983213429,0.02752293578,0.6599423631,0.2655538695,"SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6697247706,NA,NA,NA,"SERTRALINE HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4015748031,NA,NA,NA,NA,NA,NA,NA,NA,"SILVER SULFADIAZINE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.5251396648,NA,NA,NA,NA,0.5548780488,NA,NA,NA,NA,0.5433962264,NA,NA,NA,"SIMVASTATIN",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.427672956,NA,"SPECIAL SCREENING EXAMINATION, HUMAN PAPILLOMAVIRUS [HPV] (dxo:ICD9:V7381)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4186046512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"SPECIAL SCREENING FOR OTHER SPECIFIED CONDITIONS (dxo:ICD9:V8289)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.2213114754,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"SUICIDAL IDEATION (dxo:ICD9:V6284)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4641148325,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"SULFAMETHOXAZOLE/TRIMETHOPRIM",NA,NA,NA,NA,NA,NA
"20-40","Female",0,NA,0.4149659864,NA,NA,NA,0.1585365854,0.4336734694,NA,NA,0.3402777778,NA,0.5158227848,NA,NA,0.1666666667,"SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3305084746,"SUMATRIPTAN SUCCINATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",0.002614379085,0.0274952919,0.456681351,NA,NA,0.3287671233,NA,0.4366298608,NA,0.03761755486,0.3700954401,NA,0.4669550589,0.01398601399,0.4761549925,0.1745689655,"SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4036697248,NA,NA,NA,NA,NA,NA,NA,NA,"SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)","TERCONAZOLE",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4095238095,NA,NA,NA,NA,0.4463276836,NA,NA,NA,"SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.39,NA,NA,NA,NA,0.5255474453,NA,NA,NA,"SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3577981651,NA,NA,NA,NA,0.3913043478,NA,NA,NA,NA,0.4857685009,NA,NA,NA,"SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA,NA,"SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02941176471,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)","VALACYCLOVIR HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5830618893,NA,0.6791907514,0.2410714286,"SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5289672544,NA,NA,NA,"SURVEILLANCE OF PREVIOUSLY PRESCRIBED CONTRACEPTIVE PILL (dxo:ICD9:V2541)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4757575758,NA,"SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.01470588235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TERBINAFINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3956834532,NA,NA,NA,NA,0.4581939799,NA,NA,NA,NA,NA,NA,0.4532374101,NA,"TERCONAZOLE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3149171271,NA,NA,NA,NA,NA,NA,NA,NA,"TERCONAZOLE","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3115942029,NA,NA,NA,NA,NA,"TIETZE'S DISEASE (dxo:ICD9:7336)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4329268293,NA,NA,NA,NA,0.4112149533,NA,NA,NA,NA,NA,NA,NA,NA,"TIZANIDINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4439655172,NA,NA,NA,0.1689587426,0.4956521739,NA,NA,0.3225806452,NA,0.516801854,NA,NA,0.176744186,"TOPIRAMATE",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3366336634,"TOPIRAMATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,0.02803738318,NA,NA,NA,0.3333333333,0.1622276029,0.4524590164,NA,NA,NA,NA,0.4232804233,0.007843137255,0.4876033058,NA,"TRAMADOL HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.3878787879,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TRAMADOL HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4017094017,NA,NA,0.396039604,NA,0.3917050691,NA,NA,NA,NA,NA,NA,NA,NA,"TRAMADOL HCL/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"20-40","Female",0.02653631285,0.04388349515,0.3050139276,0.3979591837,NA,0.2419724771,0.132518797,0.2714285714,0.06440677966,0.05703422053,0.2402044293,NA,0.3263795424,0.01929442921,0.3189655172,0.2601175024,"TRAZODONE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.03846153846,0.2748091603,NA,NA,NA,0.135678392,0.3185840708,NA,NA,NA,NA,0.3333333333,0.01873935264,0.4233399515,0.252856846,"TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,0.1316872428,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED ACUTE REACTION TO STRESS (dxo:ICD9:3089)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5323741007,NA,NA,NA,"UNSPECIFIED ADJUSTMENT REACTION (dxo:ICD9:3099)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.02857142857,NA,NA,NA,NA,NA,0.3605442177,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED ALOPECIA (dxo:ICD9:70400)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4017094017,NA,NA,NA,0.15,0.37109375,NA,NA,NA,NA,0.4108527132,NA,NA,NA,"UNSPECIFIED CONSTIPATION (dxo:ICD9:56400)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.01005025126,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED ENDOCRINE DISORDER (dxo:ICD9:2599)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.01388888889,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED EPISODIC MOOD DISORDER (dxo:ICD9:29690)",NA,NA,NA,NA,NA,NA
"20-40","Female",0.01016949153,0.0350877193,0.3926470588,NA,NA,0.3541076487,0.1513944223,0.4493783304,NA,0.02777777778,0.3483146067,NA,0.4890899415,0.01608579088,0.4825870647,NA,"UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3716814159,NA,NA,NA,NA,0.4293193717,NA,NA,NA,"UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,0.5882352941,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5480769231,NA,NA,NA,"UNSPECIFIED OTALGIA (dxo:ICD9:38870)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4188034188,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED SEBORRHEIC DERMATITIS (dxo:ICD9:69010)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01438848921,NA,NA,"UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050)",NA,NA,NA,NA,NA,NA
"20-40","Female",0,NA,0.3991935484,NA,NA,NA,NA,0.3790322581,NA,NA,0.3008849558,NA,0.4505978603,NA,NA,NA,"UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.362745098,NA,NA,NA,"UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3944444444,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED TEAR FILM INSUFFICIENCY (dxo:ICD9:37515)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,0.1637279597,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED URTICARIA (dxo:ICD9:7089)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3667502089,NA,NA,0.3201970443,0.1415841584,0.38791423,NA,NA,0.3511111111,NA,0.4322828963,NA,0.45,0.1884057971,"UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.3490566038,NA,NA,NA,NA,0.4285714286,NA,NA,NA,"UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4371428571,NA,NA,NA,"UNSPECIFIED VIRAL INFECTION, IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE (dxo:ICD9:07999)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.447761194,NA,0.408839779,NA,"UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.4213836478,NA,NA,NA,0.1513157895,0.3920386007,NA,NA,NA,NA,0.4582664526,NA,NA,0.2079207921,"URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.02361489555,0.4632516704,NA,NA,NA,NA,NA,NA,NA,0.3636363636,NA,0.4817518248,NA,NA,NA,"VALACYCLOVIR HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,0.02912621359,0.4191919192,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"VARENICLINE TARTRATE",NA,NA,NA,NA,NA,NA
"20-40","Female",0.02390438247,0.03891708968,0.4332472007,NA,0.1218274112,0.4874213836,0.1785940469,0.3965201465,0.06719367589,0.072,0.3762376238,NA,0.4527059971,0.02537593985,0.4725055786,0.2473902654,"VENLAFAXINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6476868327,"VILAZODONE HCL",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,0.3542857143,NA,NA,NA,NA,0.3510638298,NA,NA,NA,NA,NA,NA,NA,NA,"VOMITING ALONE (dxo:ICD9:78703)",NA,NA,NA,NA,NA,NA
"20-40","Female",NA,NA,NA,NA,NA,NA,NA,0.4481327801,NA,NA,NA,NA,0.5176470588,0.008650519031,NA,NA,"ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA,NA
"20-40","Male",0.02423620431,0.05839434423,0.4138391584,0.413699505,0.1427209154,0.3203483255,0.1880092738,0.391023648,0.1539758608,0.08697601435,0.3821123391,0.242979243,0.4220917708,0.03033107136,0.4261613127,0.2474260229,NA,NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.05882352941,0.3649635036,NA,NA,NA,0.1355932203,0.358490566,NA,NA,NA,NA,0.4391304348,NA,0.4644808743,NA,"ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.02676399027,NA,NA,NA,NA,NA,NA,NA,NA,0.512,NA,0.5076923077,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4301675978,NA,NA,NA,"ACETAMINOPHEN WITH CODEINE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.4676724138,NA,NA,NA,NA,NA,0.1386138614,NA,NA,NA,0.5013550136,NA,NA,NA,"ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5811965812,NA,NA,NA,"ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619)","AZITHROMYCIN",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.3956834532,NA,NA,NA,NA,0.4262820513,NA,NA,0.3577981651,NA,NA,NA,NA,NA,"ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.01550387597,NA,NA,NA,NA,0.1776315789,NA,NA,NA,NA,NA,0.4640522876,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.05194805195,NA,NA,NA,NA,NA,0.1935483871,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Male",NA,0.03767123288,0.3928571429,NA,NA,NA,0.1498127341,NA,NA,NA,NA,NA,0.4558823529,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.0396039604,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.06474820144,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Male",NA,0.0350877193,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","BUPROPION HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.01428571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.08823529412,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"20-40","Male",NA,NA,0.1891891892,NA,NA,NA,0.08098591549,0.2727272727,NA,NA,0.246031746,NA,0.2333333333,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"20-40","Male",NA,NA,0.2022727273,NA,NA,NA,0.06258692629,0.1472868217,NA,NA,0.116,NA,0.1704718417,NA,0.2177419355,0.06944444444,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Male",NA,0.04316546763,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.08490566038,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.1538461538,NA,NA,NA,0.07294832827,NA,NA,NA,NA,NA,0.1255411255,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Male",NA,0.03359173127,0.2485875706,NA,NA,NA,0.05263157895,NA,NA,NA,NA,NA,0.224137931,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.06163021869,NA,NA,NA,NA,NA,0.2252252252,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.0275862069,0.4861660079,NA,NA,NA,NA,NA,NA,NA,0.4157303371,NA,NA,NA,NA,NA,"ALBUTEROL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.146875,NA,NA,NA,0.3617021277,NA,NA,NA,0.3775510204,NA,"ALBUTEROL SULFATE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.007874015748,0.4514285714,NA,NA,NA,0.152,NA,NA,NA,NA,NA,0.4724324324,NA,0.4534161491,NA,"ALPRAZOLAM",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1474820144,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.6258992806,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.3181818182,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5196850394,NA,NA,NA,"ALPRAZOLAM","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6482758621,NA,NA,NA,"ALPRAZOLAM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5898305085,NA,NA,NA,"ALPRAZOLAM","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",0.04238329238,0.03869047619,0.3496503497,NA,NA,0.2826086957,0.1598062954,0.3109243697,NA,NA,0.2916666667,NA,0.3304093567,NA,0.3345864662,0.2561764706,"AMITRIPTYLINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",0.05072463768,0.05479452055,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1930635838,"AMITRIPTYLINE HCL","BUPROPION HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.02793296089,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1908396947,"AMITRIPTYLINE HCL","BUPROPION HCL","Num Previous Antidep: 4+",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1825396825,"AMITRIPTYLINE HCL","BUPROPION HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1846153846,"AMITRIPTYLINE HCL","BUPROPION HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",0.05970149254,NA,0.5613496933,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2517241379,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,0.4825174825,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2857142857,"AMITRIPTYLINE HCL","DULOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",0.03246753247,NA,NA,NA,NA,NA,0.3253424658,NA,NA,NA,NA,NA,NA,NA,NA,0.2205323194,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.3571428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.3559322034,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Male",0.08843537415,NA,NA,NA,NA,NA,NA,0.4501845018,NA,NA,NA,NA,NA,NA,NA,0.2933333333,"AMITRIPTYLINE HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",0.006060606061,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"20-40","Male",0.01587301587,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1333333333,"AMITRIPTYLINE HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"20-40","Male",NA,0.05298013245,0.3333333333,NA,NA,0.3303571429,0.1754385965,NA,NA,NA,NA,NA,0.3461538462,0,NA,0.2210526316,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6510067114,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"20-40","Male",0.02092414996,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.487012987,"AMITRIPTYLINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4772727273,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2435897436,"AMITRIPTYLINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2788461538,"AMITRIPTYLINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6516129032,NA,NA,NA,"AMITRIPTYLINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.23,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1711229947,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",0.03846153846,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4931506849,NA,NA,NA,NA,0.2292993631,"AMITRIPTYLINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",0.03947368421,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5160550459,NA,NA,0.3444444444,"AMITRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",0.04854368932,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1850060459,"AMITRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.545045045,0.2520325203,"AMITRIPTYLINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.02753977968,0.4223826715,NA,NA,NA,0.1683399486,0.4898550725,NA,NA,0.3894783378,NA,0.5856777494,0.007194244604,0.611814346,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.02479338843,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.03448275862,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.04545454545,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA
"20-40","Male",NA,0.05504587156,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1176470588,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,0.01995012469,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1597222222,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUSPIRONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1729323308,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.6086956522,NA,NA,NA,0.3253968254,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"20-40","Male",NA,0.024,NA,NA,NA,NA,0.231884058,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1355140187,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CLONAZEPAM",NA,NA,NA,NA,NA
"20-40","Male",NA,0.008771929825,0.5251798561,NA,NA,NA,0.1935953421,0.435,NA,NA,0.4489164087,NA,0.5294117647,NA,0.6019900498,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.2648648649,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1365853659,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5061728395,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.641509434,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.3045112782,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Male",NA,0.005405405405,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1533804238,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1403508772,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.5603448276,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.5668789809,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.04316546763,NA,NA,NA,NA,0.1153846154,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1869158879,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1158536585,NA,NA,NA,0.1981132075,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.05670103093,NA,NA,NA,0.1913875598,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1826923077,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.02919708029,NA,NA,NA,NA,0.1550802139,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3544973545,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5704918033,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.06,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","LORAZEPAM",NA,NA,NA,NA,NA
"20-40","Male",NA,0.03426791277,NA,NA,NA,NA,0.1582733813,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.2366412214,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1376146789,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","OMEPRAZOLE",NA,NA,NA,NA,NA
"20-40","Male",NA,0.01834862385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1301369863,NA,NA,NA,0.3826530612,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4019607843,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.2307692308,NA,NA,NA,0.568868981,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1470588235,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.05,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Male",NA,0.04395604396,NA,NA,NA,NA,0.07818930041,NA,NA,NA,0.1879699248,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.08181818182,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1287128713,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1965317919,NA,NA,NA,NA,NA,0.6836734694,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1531531532,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.08035714286,0.2313432836,NA,0.1516853933,0.08383233533,0.1428571429,NA,NA,NA,NA,0.1012658228,NA,0.1690821256,0.1167883212,"ARIPIPRAZOLE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1204819277,"ARIPIPRAZOLE","BUPROPION HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,0.185840708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ARIPIPRAZOLE","DULOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1111111111,NA,NA,NA,NA,NA,NA,NA,NA,0.1317829457,"ARIPIPRAZOLE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.05737704918,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ARIPIPRAZOLE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1206896552,NA,NA,NA,"ARIPIPRAZOLE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1516853933,NA,NA,0.1205673759,"ARIPIPRAZOLE","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2589928058,NA,"ARIPIPRAZOLE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.5172413793,NA,NA,NA,NA,0.5414634146,NA,NA,NA,NA,0.5540540541,NA,NA,NA,"ATORVASTATIN CALCIUM",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.7175572519,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.70995671,NA,NA,NA,"ATORVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.03328173375,NA,NA,NA,NA,NA,NA,0.08139534884,NA,NA,NA,NA,0,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.03631961259,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.08571428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","BUPROPION HCL",NA,NA,NA,NA
"20-40","Male",NA,0.0380952381,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Male",NA,0.07715133531,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","BUPROPION HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.02191780822,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,0.04458598726,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.03211009174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.04446240905,NA,NA,NA,NA,NA,NA,NA,NA,0.3703703704,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.0505952381,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","BUPROPION HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.02432432432,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,0.06666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","METHYLPHENIDATE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.01538461538,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.03333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.06363636364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.4744318182,NA,NA,NA,0.1666666667,NA,NA,NA,0.4358974359,NA,0.4771863118,NA,0.5035971223,0.1391304348,"AZITHROMYCIN",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1476510067,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN NEOPLASM OF SKIN OF TRUNK, EXCEPT SCROTUM (dxo:ICD9:2165)",NA,NA,NA,NA,NA,NA
"20-40","Male",0.009677419355,0.04797584433,0.3488714426,0.5315789474,NA,0.2741935484,0.1419733993,0.3168067227,0.1048951049,0.08108108108,0.3271028037,NA,0.3510840624,0.01122019635,0.3887841659,0.273733338,"BUPROPION HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.05197827773,0.4465011287,NA,NA,0.2232142857,0.2227488152,0.3463687151,NA,NA,NA,NA,0.3360995851,NA,0.4915254237,0.3473299863,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"20-40","Male",NA,0.03921568627,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2166666667,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2389380531,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.04166666667,0.6686390533,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.481865285,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,0.03623188406,0.7142857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Male",NA,NA,0.5642458101,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"20-40","Male",NA,NA,0.5519125683,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4950980392,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Male",NA,0.09132420091,0.5833333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Male",NA,0.04306220096,0.3333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.358490566,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3064516129,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.560483871,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5114503817,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Male",NA,NA,0.5284974093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Male",NA,NA,0.2617449664,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2115384615,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Male",NA,NA,0.3119266055,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3853211009,NA,NA,0.1908396947,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.06289308176,0.3937823834,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2150537634,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1806451613,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.05333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3153153153,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5826771654,0.2668918919,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,0.01268115942,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2407407407,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.192893401,"BUPROPION HCL","DOXEPIN HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.04597701149,NA,NA,NA,0.3786078098,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2474804031,"BUPROPION HCL","DULOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2129032258,"BUPROPION HCL","DULOXETINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"20-40","Male",NA,0.05777777778,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,0.2277227723,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2047619048,"BUPROPION HCL","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.03886925795,0.4601769912,NA,NA,NA,0.2571524739,0.356097561,NA,NA,0.2803738318,NA,0.3344594595,NA,0.5111111111,0.2222599253,"BUPROPION HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.2156862745,NA,NA,NA,NA,NA,NA,NA,NA,0.1726190476,"BUPROPION HCL","ESCITALOPRAM OXALATE","FLUOXETINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1329479769,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1891891892,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1773049645,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09937888199,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04938271605,"BUPROPION HCL","ESCITALOPRAM OXALATE","LAMOTRIGINE",NA,NA,NA,NA
"20-40","Male",NA,0.03798882682,NA,NA,NA,NA,0.311844078,NA,NA,NA,NA,NA,NA,NA,NA,0.2844827586,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,0.04347826087,NA,NA,NA,NA,0.3550420168,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.2976744186,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2589641434,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Male",NA,0.04026845638,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Male",NA,0.06722689076,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,0.1290322581,NA,NA,NA,NA,0.5778894472,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.6201550388,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Male",NA,0.02953586498,NA,NA,NA,NA,0.1300813008,NA,NA,NA,NA,NA,NA,NA,NA,0.2465373961,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2408759124,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1895424837,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5188284519,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.4690265487,NA,NA,NA,NA,NA,NA,NA,NA,0.4945054945,"BUPROPION HCL","ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1698113208,"BUPROPION HCL","ESCITALOPRAM OXALATE","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1165048544,"BUPROPION HCL","ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1486486486,"BUPROPION HCL","ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.2192982456,NA,NA,NA,NA,NA,NA,NA,NA,0.1709401709,"BUPROPION HCL","ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1931034483,NA,NA,NA,NA,NA,0.3643410853,NA,NA,0.1833333333,"BUPROPION HCL","ESCITALOPRAM OXALATE","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.0487804878,NA,NA,NA,NA,0.2579365079,NA,NA,NA,NA,NA,NA,0.02521008403,NA,0.1786283892,"BUPROPION HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.203125,"BUPROPION HCL","ESCITALOPRAM OXALATE","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.04512195122,0.3496503497,NA,NA,0.2983870968,0.1721311475,0.3905325444,NA,NA,0.3539823009,NA,0.2875399361,NA,0.4677419355,0.3051796547,"BUPROPION HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.08396946565,NA,NA,NA,NA,NA,NA,NA,0.07317073171,"BUPROPION HCL","FLUOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA
"20-40","Male",NA,0.02974828375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5265017668,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,0.008064516129,NA,NA,NA,NA,NA,0.5755395683,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.4459459459,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4785714286,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"20-40","Male",NA,0.08823529412,NA,NA,NA,NA,NA,0.5811965812,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.5765765766,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Male",NA,0.03680981595,NA,NA,NA,NA,NA,0.3777777778,NA,NA,NA,NA,NA,NA,NA,0.3125,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3738317757,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.600896861,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Male",NA,0.3507462687,NA,NA,NA,NA,NA,0.5314685315,NA,NA,NA,NA,NA,NA,NA,0.4756097561,"BUPROPION HCL","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1441441441,"BUPROPION HCL","FLUOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.5729537367,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2095238095,"BUPROPION HCL","FLUOXETINE HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.2335329341,NA,NA,NA,NA,NA,NA,NA,0.1990521327,"BUPROPION HCL","FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1262135922,"BUPROPION HCL","FLUOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.224,"BUPROPION HCL","FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.3448275862,NA,NA,NA,NA,0.3451327434,NA,NA,0.1946902655,"BUPROPION HCL","FLUOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.03883495146,NA,NA,NA,NA,NA,0.2928176796,NA,NA,NA,NA,NA,NA,NA,0.2080924855,"BUPROPION HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2447552448,"BUPROPION HCL","FLUOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.04278074866,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.04285714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,0.0790960452,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04615384615,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"20-40","Male",NA,0.01333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02649006623,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2522522523,NA,NA,0.1557377049,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","SERTRALINE HCL",NA,NA,NA
"20-40","Male",NA,NA,0.2233009709,NA,NA,NA,0.06896551724,NA,NA,NA,NA,NA,0.268907563,NA,0.3352272727,0.1605839416,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.06329113924,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01904761905,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.06603773585,NA,NA,NA,NA,NA,NA,NA,NA,0.1088435374,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04545454545,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1028806584,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3949579832,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04721030043,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1650485437,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","SERTRALINE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.1385542169,NA,NA,NA,NA,0.1101694915,NA,NA,0.06221045665,"BUPROPION HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4659685864,"BUPROPION HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03773584906,"BUPROPION HCL","LAMOTRIGINE","MIRTAZAPINE",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1317365269,"BUPROPION HCL","LAMOTRIGINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1865671642,NA,NA,0.06603773585,"BUPROPION HCL","LAMOTRIGINE","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09615384615,"BUPROPION HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04430379747,"BUPROPION HCL","LAMOTRIGINE","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,0.4,NA,NA,0.3783783784,0.1298527443,0.4548022599,0.09649122807,NA,0.4583333333,NA,0.4844357977,0.01128668172,0.505988024,0.2450687388,"BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,0.04455445545,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5407407407,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5918367347,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7165354331,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"20-40","Male",NA,0.02547770701,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6546275395,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"20-40","Male",NA,0.05905511811,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01851851852,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2115384615,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3962264151,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4611872146,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1398601399,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,0.03260869565,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4021164021,"BUPROPION HCL","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.04320987654,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09051724138,"BUPROPION HCL","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Male",NA,0.03523489933,NA,NA,NA,NA,0.1442307692,NA,NA,NA,NA,NA,NA,NA,NA,0.4705882353,"BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.02380952381,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,0.053420806,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01154734411,NA,0.1260504202,"BUPROPION HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.03846153846,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6632653061,0.4444444444,"BUPROPION HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.1513944223,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.584,"BUPROPION HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6304347826,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5625,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.09727626459,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6335078534,NA,NA,0.4778761062,"BUPROPION HCL","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.1078431373,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.02597402597,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,0.1610738255,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Male",NA,0.01642935378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"20-40","Male",NA,0.02752293578,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Male",NA,0.0297029703,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689)",NA,NA,NA,NA
"20-40","Male",NA,0.01388888889,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"20-40","Male",NA,0.0162601626,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3394495413,"BUPROPION HCL","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.04517453799,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Male",NA,0.02547770701,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Male",NA,0.03149606299,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA
"20-40","Male",NA,0.04761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3333333333,NA,NA,0.3443396226,"BUPROPION HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4045801527,"BUPROPION HCL","Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,0.03883495146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","SILDENAFIL CITRATE",NA,NA,NA,NA
"20-40","Male",NA,0.04232804233,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04,NA,0.1531100478,"BUPROPION HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.02459016393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2980769231,"BUPROPION HCL","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.4218009479,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5708185053,"BUPROPION HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7307692308,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"20-40","Male",NA,0.3964497041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7269624573,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.686746988,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6109090909,"BUPROPION HCL","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5731132075,"BUPROPION HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5705128205,"BUPROPION HCL","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.3903743316,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.616,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.75,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"20-40","Male",NA,0.4768786127,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6613603473,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6334519573,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.3381642512,NA,NA,NA,NA,0.3936170213,0.452991453,NA,NA,NA,NA,NA,NA,0.522875817,0.5298340063,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4836065574,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4716157205,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,0.3253968254,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6050420168,NA,NA,0.5378151261,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.3317073171,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4062165059,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.652173913,0.5168539326,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.04255319149,NA,NA,NA,NA,NA,NA,0.1561181435,NA,NA,NA,NA,NA,NA,0.201843318,"BUPROPION HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1367521368,"BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1887417219,"BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1538461538,"BUPROPION HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1408450704,"BUPROPION HCL","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.028125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.261682243,"BUPROPION HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5592105263,NA,NA,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7094594595,NA,NA,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6519916143,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1469115192,"BUPROPION HCL","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.305785124,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 4+","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1918443003,"BUPROPION HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1834862385,"BUPROPION HCL","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1338582677,"BUPROPION HCL","Num Previous Antidep: 4+","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5555555556,NA,NA,NA,NA,NA,"BUPROPION HCL","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2128279883,"BUPROPION HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.184,"BUPROPION HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.04615384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.06211180124,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.0409252669,0.3465346535,NA,NA,NA,0.1863354037,0.4368932039,NA,NA,0.441588785,NA,0.3969465649,NA,NA,0.2861806311,"BUPROPION HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.320610687,NA,NA,NA,NA,0.1265822785,"BUPROPION HCL","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Male",NA,0.06201550388,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2240437158,"BUPROPION HCL","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.06814580032,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2086956522,0.09239130435,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07251908397,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2723404255,NA,NA,0.180887372,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1133333333,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.243697479,0.1173184358,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3073394495,"BUPROPION HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.05797101449,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09582309582,"BUPROPION HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08865248227,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1230769231,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1,NA,NA,NA,NA,NA,NA,NA,0.2064516129,0.1330561331,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,NA,NA,0.2242424242,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1052631579,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1146788991,"BUPROPION HCL","RISPERIDONE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0612244898,"BUPROPION HCL","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2433234421,"BUPROPION HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.27,"BUPROPION HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.04444444444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.0527201346,0.3183673469,NA,NA,0.2937062937,0.1312849162,0.2965517241,NA,NA,0.3422818792,NA,0.4225007643,NA,0.5405405405,0.3351134846,"BUPROPION HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.02822580645,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3333333333,0.03278688525,NA,0.231372549,"BUPROPION HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2857142857,"BUPROPION HCL","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.06956521739,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","SILDENAFIL CITRATE",NA,NA,NA,NA,NA
"20-40","Male",NA,0.0597979798,NA,NA,NA,0.2142857143,0.07638888889,0.188034188,NA,NA,NA,NA,NA,0.01740506329,0.2142857143,0.2174447174,"BUPROPION HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.04545454545,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3719806763,0.1759036145,"BUPROPION HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.05371900826,0.3728813559,NA,NA,NA,0.1847133758,NA,NA,NA,NA,NA,0.3353293413,NA,0.460639127,0.2400424854,"BUPROPION HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.3783783784,NA,NA,NA,0.1858736059,NA,NA,NA,NA,NA,0.4662921348,NA,NA,NA,"BUSPIRONE HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",0.009433962264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CARISOPRODOL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1603773585,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CEFDINIR",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.4822695035,NA,NA,NA,0.1680672269,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CETIRIZINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4532374101,NA,NA,NA,"CHEST PAIN, OTHER (dxo:ICD9:78659)","CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.3665338645,NA,NA,NA,0.1270491803,0.4090909091,NA,NA,0.400862069,NA,0.4812030075,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.14,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.431372549,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6635514019,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",0.03968253968,0.04210069444,0.4667832168,NA,NA,0.3443804035,0.2223255814,0.3583941606,0.1032258065,0.07438016529,0.3585858586,NA,0.4100887436,0.01025641026,0.5262582057,0.2412208126,"CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.592920354,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","CLONAZEPAM",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.6161825726,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5762711864,0.3229813665,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3923076923,0.2605633803,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4851485149,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,0.3678756477,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,0.5690607735,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,0.5961538462,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEXTROAMPHETAMINE/AMPHETAMINE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.5392156863,NA,NA,0.4905660377,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2397660819,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.02097902098,0.6703056769,NA,NA,NA,0.3421516755,0.3039215686,NA,NA,NA,NA,0.3636363636,NA,NA,0.1827111984,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Male",NA,0.02777777778,NA,NA,NA,NA,0.4280155642,NA,NA,NA,NA,NA,NA,NA,NA,0.2362204724,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.4425287356,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"20-40","Male",NA,NA,0.4566929134,NA,NA,NA,0.1594202899,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2359550562,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.06504065041,0.4088669951,NA,NA,NA,NA,0.4488188976,NA,NA,NA,NA,0.4056603774,NA,NA,0.1782178218,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.3039647577,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09285714286,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"20-40","Male",NA,NA,0.1538461538,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Male",NA,NA,0.388308977,NA,NA,NA,0.09333333333,NA,NA,NA,NA,NA,0.2517482517,NA,NA,0.1923076923,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.05384615385,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07692307692,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Male",NA,NA,0.2711370262,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Male",NA,NA,0.2397959184,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Male",NA,NA,0.2096774194,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Male",NA,NA,0.3595041322,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,NA,NA,0.06965174129,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Male",NA,NA,0.232,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06862745098,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"20-40","Male",NA,NA,0.5725806452,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.1143410853,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07534246575,"CITALOPRAM HYDROBROMIDE","LAMOTRIGINE",NA,NA,NA,NA,NA
"20-40","Male",NA,0.02659574468,NA,NA,NA,0.4051724138,0.2032374101,0.4,0.1043478261,NA,0.3467336683,NA,0.4093686354,0.007712082262,0.4041916168,0.2450549451,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.537037037,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"20-40","Male",NA,NA,0.5414012739,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,NA,0.5325443787,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3925233645,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,0.0198019802,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,0.5478723404,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02341137124,NA,0.4255319149,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.08176100629,NA,NA,NA,0.4854368932,0.3059701493,0.5170068027,NA,NA,NA,NA,0.5238095238,NA,0.6086956522,0.4261006289,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.5565217391,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,0.3415547236,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.3705772812,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Male",NA,NA,0.2294117647,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Male",NA,NA,0.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"20-40","Male",NA,NA,0.2107623318,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3921568627,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,0.3488372093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2594594595,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,0.5927561837,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.5841584158,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5074626866,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,0.6815920398,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.6038961039,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5294117647,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.57,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,0.4488888889,NA,NA,NA,NA,NA,0.145631068,NA,NA,NA,NA,NA,NA,0.2093862816,"CITALOPRAM HYDROBROMIDE","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2868852459,"CITALOPRAM HYDROBROMIDE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.5397727273,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09090909091,"CITALOPRAM HYDROBROMIDE","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.6584158416,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.4557823129,NA,NA,NA,NA,NA,NA,NA,0.428125,NA,NA,NA,NA,0.1818181818,"CITALOPRAM HYDROBROMIDE","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.3108614232,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.121875,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.115942029,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Male",NA,NA,0.2984293194,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.152866242,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,0.3964497041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08841463415,"CITALOPRAM HYDROBROMIDE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.2568807339,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1261261261,"CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.2964169381,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1553784861,"CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.15,"CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,0.1822916667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.132231405,"CITALOPRAM HYDROBROMIDE","RISPERIDONE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.5181818182,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.04022988506,0.3959044369,NA,NA,NA,NA,0.3673469388,NA,NA,NA,NA,0.4375,NA,NA,0.1880108992,"CITALOPRAM HYDROBROMIDE","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.35,NA,NA,0.1729323308,"CITALOPRAM HYDROBROMIDE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.09154929577,0.4074844075,NA,NA,NA,0.2566371681,NA,NA,NA,NA,NA,0.3407407407,0.02455357143,NA,0.2561290323,"CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.06086956522,0.5090909091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.618705036,0.2203389831,"CITALOPRAM HYDROBROMIDE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.02547770701,0.3757961783,NA,NA,NA,0.18359375,NA,0.1005586592,NA,NA,NA,0.4337349398,0.01449275362,0.3781512605,0.1977186312,"CLONAZEPAM",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.359223301,NA,NA,NA,NA,NA,NA,NA,NA,0.2761904762,"CLONAZEPAM","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5505617978,NA,NA,NA,"CLONAZEPAM","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.4433962264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CLOTRIMAZOLE/BETAMETHASONE DIP",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.3623188406,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CODEINE PHOSPHATE/GUAIFENESIN",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.4163265306,NA,NA,NA,NA,0.3333333333,NA,NA,NA,NA,0.3275862069,NA,NA,NA,"CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.119266055,0.3805309735,NA,NA,NA,NA,NA,0.004166666667,NA,NA,"CYCLOBENZAPRINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.4285714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3472222222,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",NA,NA,NA,NA,NA,NA
"20-40","Male",0.01510574018,0.03816793893,0.4761459308,0.6214689266,NA,0.4289156627,0.1497775581,0.4558359621,NA,NA,0.4576023392,NA,0.5285053929,0.01729559748,0.5468594217,0.2310838446,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,0.4563106796,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DULOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.2979683973,NA,NA,NA,NA,NA,NA,NA,0.5873015873,0.3269230769,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Male",NA,0.007299270073,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5238095238,0.1831683168,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.0962962963,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.5879120879,NA,NA,NA,NA,NA,NA,NA,0.3739130435,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2892561983,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.3914285714,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.57771261,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1587301587,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"20-40","Male",0.00826446281,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1434599156,NA,NA,NA,NA,NA,0.4661016949,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.0859375,NA,NA,NA,NA,NA,NA,NA,0.2064777328,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02040816327,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5563909774,0.2679738562,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2920353982,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2666666667,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4117647059,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4549356223,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5692883895,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5959183673,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.01162790698,NA,NA,NA,NA,0.1130434783,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.04854368932,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.04383561644,NA,NA,NA,0.435483871,0.1340782123,NA,NA,NA,NA,NA,0.5675675676,NA,0.5765765766,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6282051282,NA,NA,NA,0.6666666667,0.2276422764,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.04731861199,NA,NA,NA,NA,0.1016949153,0.1869158879,NA,NA,NA,NA,NA,NA,0.2183098592,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.03902439024,NA,NA,NA,NA,0.2183098592,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.612654321,NA,0.6193181818,0.3302325581,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6466380544,0.3333333333,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.375,NA,NA,NA,0.08720930233,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1171171171,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESLORATADINE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.06,NA,0.4285714286,NA,NA,0.1517241379,NA,NA,NA,NA,NA,NA,NA,0.7101449275,0.2278287462,"DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,0.0737704918,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","LAMOTRIGINE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,0.4695121951,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,0.2440944882,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,0.2362204724,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,0.4360902256,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2588832487,"DESVENLAFAXINE SUCCINATE","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2336448598,"DESVENLAFAXINE SUCCINATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.4136904762,NA,NA,NA,0.1659574468,0.414893617,NA,NA,NA,NA,0.4585798817,0.02255639098,0.3846153846,NA,"DEXTROAMPHETAMINE/AMPHETAMINE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.3693693694,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEXTROAMPHETAMINE/AMPHETAMINE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.419047619,NA,NA,NA,"DEXTROAMPHETAMINE/AMPHETAMINE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,NA,NA,NA,"DEXTROAMPHETAMINE/AMPHETAMINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.05844155844,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.4594594595,NA,NA,NA,NA,0.4713375796,NA,NA,NA,"DIAZEPAM",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.147826087,0.4470588235,NA,NA,NA,NA,0.5192307692,NA,NA,NA,"DIZZINESS AND GIDDINESS (dxo:ICD9:7804)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,0.2395128552,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2262996942,"DOXEPIN HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,0.1434599156,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5196078431,NA,NA,NA,"DOXEPIN HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1904761905,"DOXEPIN HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.407079646,NA,NA,NA,NA,NA,NA,NA,NA,"DOXYCYCLINE HYCLATE",NA,NA,NA,NA,NA,NA
"20-40","Male",0.02173913043,0.03432494279,0.4520884521,NA,NA,0.3671406003,0.1923076923,0.3873239437,0.08333333333,NA,0.3313253012,NA,0.4533678756,NA,0.5594059406,0.2157519899,"DULOXETINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.2977777778,NA,NA,NA,NA,NA,NA,NA,NA,0.1714285714,"DULOXETINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.480620155,NA,NA,NA,NA,NA,NA,NA,0.2311557789,"DULOXETINE HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,0.08465608466,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06918238994,"DULOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"20-40","Male",NA,0.0474137931,NA,NA,NA,NA,0.1278195489,NA,NA,NA,NA,NA,NA,0.007142857143,NA,0.2076271186,"DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,0.4455445545,NA,NA,NA,NA,NA,NA,NA,0.02521008403,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3580246914,"DULOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,0.2573705179,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,0.5815217391,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,0.6578947368,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,0.5053191489,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4910179641,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,0.3271028037,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1925465839,"DULOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.56,NA,NA,NA,NA,NA,"DULOXETINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,0.2428571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09756097561,"DULOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5042735043,NA,NA,0.2300469484,"DULOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,0.2981530343,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2010723861,"DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.24,"DULOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.4666666667,NA,NA,NA,NA,0.4615384615,NA,NA,NA,NA,0.5977653631,NA,0.5548387097,NA,"DYSTHYMIC DISORDER (dxo:ICD9:3004)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6336633663,NA,NA,NA,"DYSTHYMIC DISORDER (dxo:ICD9:3004)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.05084745763,NA,NA,NA,NA,0.1698113208,0.4380952381,NA,NA,NA,NA,NA,NA,NA,NA,"ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869)",NA,NA,NA,NA,NA,NA
"20-40","Male",0.02051282051,0.0238758456,0.5809110629,NA,0.1,0.3916666667,0.2565072692,0.3510638298,0.1142355009,0.06164383562,0.328936521,NA,0.3753112771,0.01616915423,0.5353946298,0.1990109396,"ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.22265625,0.4816176471,NA,NA,NA,NA,0.3805970149,NA,NA,0.2022160665,"ESCITALOPRAM OXALATE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1339285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.125,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.3922651934,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.0198019802,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1167883212,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.2983425414,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1495327103,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","HYDROCODONE/ACETAMINOPHEN","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,0.2608695652,NA,NA,NA,0.2176165803,NA,NA,NA,NA,NA,NA,NA,NA,0.06989247312,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1147540984,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1375661376,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06140350877,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Male",NA,NA,0.3033707865,NA,NA,NA,0.159122085,0.31,NA,NA,NA,NA,0.2681564246,NA,0.2311827957,0.2142857143,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1140939597,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1274509804,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1242937853,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1060773481,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.08411214953,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.09598214286,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06194690265,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Male",NA,NA,0.29375,NA,NA,NA,0.1666666667,NA,NA,NA,NA,NA,0.2222222222,NA,0.2063492063,0.123853211,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1401869159,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1957671958,NA,NA,NA,NA,NA,NA,NA,NA,0.04787234043,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1390374332,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.116751269,NA,NA,NA,NA,NA,NA,NA,NA,0.0704845815,"ESCITALOPRAM OXALATE","LAMOTRIGINE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.04761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LAMOTRIGINE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",0,0.01602136182,0.5746835443,NA,NA,0.3372434018,NA,0.4447058824,0.08666666667,NA,0.3534136546,NA,0.4212707182,0.01408450704,0.4898373984,0.1724386724,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,0.024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.3240740741,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.3301886792,NA,NA,NA,NA,NA,0.6886792453,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.320083682,NA,NA,NA,NA,NA,NA,0.01869158879,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2752293578,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,0.0347826087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1386138614,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1036789298,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1730769231,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,0.007692307692,NA,NA,NA,NA,0.3082706767,NA,NA,NA,NA,NA,NA,NA,NA,0.2142857143,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.2973805855,NA,NA,NA,NA,NA,NA,0.0198019802,NA,0.311627907,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.01869158879,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.1225490196,0.7106918239,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6141732283,NA,0.6016949153,0.4386694387,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.6538461538,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1361262758,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.3008130081,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1587301587,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1494920174,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.2051282051,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1428571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.172972973,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1161825726,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1343283582,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1407035176,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1027027027,NA,NA,NA,NA,NA,0.3669724771,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1511627907,NA,NA,NA,NA,NA,NA,NA,NA,0.1791044776,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.5536277603,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.4797687861,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.568627451,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.5743243243,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.4205714286,NA,NA,NA,NA,NA,NA,NA,NA,0.4351585014,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.362962963,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.2622222222,NA,0.1601941748,NA,NA,NA,NA,NA,NA,0.1973244147,"ESCITALOPRAM OXALATE","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.137254902,"ESCITALOPRAM OXALATE","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.3905325444,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6439393939,NA,NA,NA,"ESCITALOPRAM OXALATE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0873015873,"ESCITALOPRAM OXALATE","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.4862385321,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.2791666667,NA,NA,NA,0.4599542334,NA,0.3859649123,NA,NA,0.1635514019,"ESCITALOPRAM OXALATE","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.2768361582,NA,NA,NA,0.2520325203,NA,NA,NA,NA,NA,0.1379310345,NA,NA,0.07109004739,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06930693069,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1466666667,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.2121212121,NA,NA,NA,NA,NA,NA,NA,NA,0.1291208791,"ESCITALOPRAM OXALATE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.2686567164,NA,NA,NA,NA,NA,NA,NA,NA,0.1010830325,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1009174312,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1860465116,0.2086956522,NA,NA,NA,NA,0.2513368984,NA,0.2452830189,0.1608133087,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1652892562,NA,NA,NA,NA,NA,NA,NA,NA,0.1111111111,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02830188679,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09459459459,"ESCITALOPRAM OXALATE","RISPERIDONE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.33,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.03370786517,NA,NA,NA,NA,0.2140127389,0.2695035461,NA,NA,0.3055555556,NA,0.4409030544,NA,0.5514018692,0.1766917293,"ESCITALOPRAM OXALATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1590909091,NA,NA,NA,NA,NA,0.2719298246,NA,NA,0.2,"ESCITALOPRAM OXALATE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.02816901408,NA,NA,NA,NA,0.2483660131,0.2056074766,NA,NA,NA,NA,0.3571428571,0.02322206096,NA,0.1954299459,"ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1951219512,"ESCITALOPRAM OXALATE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.01526717557,NA,NA,NA,NA,0.2364217252,NA,NA,NA,NA,NA,0.3797468354,NA,0.6555555556,0.1398467433,"ESCITALOPRAM OXALATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.3902439024,NA,NA,NA,0.148,0.4758064516,NA,NA,NA,NA,NA,NA,NA,NA,"ESOMEPRAZOLE MAGNESIUM",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.515970516,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5535714286,NA,0.563559322,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.4846153846,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"EXAMINATION OF EYES AND VISION (dxo:ICD9:V720)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA,0.3425925926,NA,NA,NA,NA,NA,"FEVER AND OTHER PHYSIOLOGIC DISTURBANCES OF TEMPERATURE REGULATION (dxo:ICD9:7806)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,NA,NA,NA,"FLATULENCE, ERUCTATION, AND GAS PAIN (dxo:ICD9:7873)",NA,NA,NA,NA,NA,NA
"20-40","Male",0.01538461538,0.04016430853,0.3621123219,NA,NA,0.2932454695,0.1701644923,0.4456626451,0.09879518072,0.06034482759,0.3272910373,NA,0.3510784764,0.02852348993,0.501146789,0.2238413277,"FLUOXETINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.5785123967,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.288,NA,NA,NA,NA,NA,NA,NA,0.1086956522,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.2608695652,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.07207207207,0.3356973995,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.2470119522,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.2695035461,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.2352941176,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.320754717,NA,NA,NA,NA,NA,NA,NA,0.125,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.2179487179,NA,NA,NA,NA,NA,NA,NA,0.06603773585,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.1344537815,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.5853658537,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.1333333333,NA,NA,NA,NA,NA,NA,NA,0.09913793103,"FLUOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.05844155844,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LAMOTRIGINE","Last AD: Same & No Remiss",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.1081081081,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.03095975232,0.3627906977,NA,NA,NA,0.1715976331,NA,NA,NA,0.4108527132,NA,0.4285714286,0.02678571429,0.5058139535,0.2394578313,"FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.4855072464,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.5207667732,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1481481481,"FLUOXETINE HCL","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008658008658,NA,0.397260274,"FLUOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.07894736842,NA,NA,NA,NA,0.2176870748,NA,NA,NA,NA,NA,0.6033057851,NA,0.5403225806,0.3804347826,"FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1467889908,NA,NA,"FLUOXETINE HCL","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.3274209012,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.3752711497,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.1913043478,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.2972972973,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.2621359223,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.2869565217,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.223880597,NA,NA,NA,NA,NA,0,NA,0.2405063291,"FLUOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.6085313175,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.5480769231,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5524475524,"FLUOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.6945337621,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.3798449612,NA,NA,NA,NA,NA,0.5818965517,NA,NA,NA,NA,NA,NA,NA,0.536121673,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.5782312925,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.3714285714,0.1523809524,NA,NA,NA,NA,NA,NA,0.1631944444,"FLUOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.5191082803,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1390374332,"FLUOXETINE HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1386138614,"FLUOXETINE HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.06481481481,NA,NA,NA,NA,NA,0.3964285714,NA,NA,0.4755784062,NA,NA,NA,NA,0.1741935484,"FLUOXETINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.3181818182,NA,NA,NA,NA,NA,NA,NA,0.1278688525,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08450704225,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.2716049383,NA,NA,NA,NA,NA,NA,NA,0.1698113208,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.336,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.4371257485,NA,NA,NA,NA,NA,NA,NA,0.1282051282,"FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.3133333333,NA,NA,NA,NA,NA,NA,NA,0.125748503,"FLUOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.375,NA,NA,NA,NA,NA,NA,NA,0.1659574468,"FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.08928571429,NA,NA,NA,NA,NA,NA,NA,0.1005586592,"FLUOXETINE HCL","RISPERIDONE",NA,NA,NA,NA,NA
"20-40","Male",NA,0.04081632653,0.2920353982,NA,NA,NA,0.1438848921,0.3969594595,NA,NA,NA,NA,0.401062417,NA,NA,0.2129963899,"FLUOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.3389830508,NA,NA,NA,NA,NA,NA,NA,0.1788617886,"FLUOXETINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.05325443787,NA,NA,NA,NA,0.1388888889,0.3611584327,NA,NA,NA,NA,NA,0.01754385965,NA,0.2251420455,"FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2058823529,"FLUOXETINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.07476635514,NA,NA,NA,NA,NA,0.463878327,NA,NA,NA,NA,NA,NA,0.5823529412,0.2309711286,"FLUOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.04316546763,0.3414634146,NA,NA,0.2959183673,0.1436950147,0.3823529412,NA,0.05217391304,NA,NA,0.428057554,NA,NA,0.17,"GABAPENTIN",NA,NA,NA,NA,NA,NA
"20-40","Male",0.008695652174,0.03905325444,NA,NA,NA,NA,0.1683848797,0.4043715847,NA,NA,NA,NA,0.496835443,NA,NA,0.2222222222,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.04237288136,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6981132075,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1078431373,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Male",NA,0.01724137931,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6033519553,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1688311688,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GUAIFENESIN/P-EPHED HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1814345992,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GUAIFENESIN/PHENYLEPHRINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4060606061,NA,NA,NA,NA,NA,"GUAIFENESIN/PSEUDOEPHEDRNE HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",0.009339559706,0.03260869565,0.4347826087,NA,NA,NA,NA,0.45,NA,0.05829015544,NA,NA,0.4734299517,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA,NA
"20-40","Male",0.01255230126,NA,NA,NA,NA,NA,NA,NA,NA,0.09411764706,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA,NA
"20-40","Male",0.005602240896,0.03260869565,NA,NA,NA,0.2848101266,0.1622257053,0.4267990074,0.201754386,NA,0.3674033149,NA,0.4401622718,0.006734006734,NA,0.1720647773,"HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4555555556,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","IBUPROFEN",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1214953271,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6524390244,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.4621212121,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROCODONE/HOMATROPINE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROXYZINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.369193154,NA,NA,NA,NA,NA,NA,NA,0.3303571429,NA,0.4354005168,0.006666666667,NA,NA,"IBUPROFEN",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5705521472,NA,NA,NA,"IBUPROFEN","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1810344828,"IMIPRAMINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1081081081,"IMIPRAMINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"20-40","Male",NA,0.02966101695,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3881278539,NA,NA,NA,"IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.05763688761,0.1914893617,0.1446540881,NA,0.1318681319,0.08020050125,0.1461187215,NA,NA,0.1391752577,NA,0.1184210526,0.01872659176,0.1356321839,0.1210762332,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.03636363636,NA,NA,NA,NA,NA,0.08695652174,NA,0.06451612903,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.02590673575,NA,NA,NA,NA,NA,0.07079646018,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1946564885,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3613861386,NA,NA,NA,NA,0.09016393443,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1067961165,NA,0.1428571429,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Male",NA,0.06086956522,NA,NA,NA,NA,0.05263157895,NA,NA,NA,NA,NA,0.1142857143,NA,NA,0.09433962264,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0564516129,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3178082192,NA,NA,0.1066666667,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.284,0.1181102362,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,0.2080098079,NA,NA,0.2006472492,0.07640344747,0.18359375,NA,NA,0.1730429665,NA,0.2038449802,0.01194539249,0.2315380344,0.1299638989,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.0523255814,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.01851851852,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.09174311927,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1176470588,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1428571429,NA,NA,NA,NA,NA,NA,NA,NA,0.1216216216,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.123655914,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2683823529,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2569444444,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1923076923,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3094462541,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2983725136,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3087248322,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"20-40","Male",NA,NA,0.2090909091,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1298701299,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.65,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"20-40","Male",NA,NA,0.3039215686,NA,NA,NA,0.08878504673,NA,NA,NA,0.3638170974,NA,0.2447552448,NA,NA,0.1584158416,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2276422764,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3505535055,NA,NA,NA,NA,0.125,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Male",NA,NA,0.1139896373,NA,NA,0.125,NA,0.1111111111,NA,NA,0.1172413793,NA,0.09578544061,NA,0.1445086705,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Male",NA,NA,0.09615384615,NA,NA,NA,0.04761904762,0.1111111111,NA,NA,0.12,NA,0.08256880734,NA,0.1122994652,0.0495049505,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1932773109,NA,NA,0.03305785124,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2089552239,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1920529801,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA
"20-40","Male",NA,0.05147058824,0.198019802,0.2681564246,NA,0.1712158809,0.06870229008,0.157016683,NA,NA,0.1595466434,NA,0.1752711497,0.008438818565,0.2063329928,0.1084337349,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Male",NA,NA,0.2075471698,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.369193154,NA,0.2672413793,0.1131221719,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1052631579,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4026845638,0.1409395973,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.03759398496,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Male",NA,NA,0.2356687898,NA,NA,NA,0.1192982456,NA,NA,NA,0.201754386,NA,0.3657635468,NA,0.2747252747,0.2231404959,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.273381295,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1557377049,NA,NA,NA,NA,NA,NA,NA,0.3861111111,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,0.1387096774,0.07,NA,0.1022727273,0.05755395683,0.09865470852,NA,NA,0.108974359,NA,0.1470588235,0.01941747573,0.16796875,0.06282722513,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1542553191,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2068965517,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.05855855856,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2693877551,NA,NA,0.09467455621,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1842105263,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",0.01257861635,0.0243902439,0.4422735346,NA,NA,NA,0.1736526946,0.4198895028,0.1675977654,NA,0.4318181818,NA,0.4641954507,0.01330248699,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3658536585,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007552870091,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5714285714,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.634375,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01851851852,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4716981132,0.007299270073,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"20-40","Male",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4938271605,NA,NA,NA,"KETOCONAZOLE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.4205607477,NA,NA,NA,NA,NA,NA,NA,0.3826086957,NA,NA,NA,NA,NA,"LABORATORY EXAMINATION (dxo:ICD9:V726)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.1137123746,0.1216216216,NA,0.1069042316,0.05656108597,0.1378254211,0.0564516129,NA,0.09836065574,NA,0.1233974359,NA,0.1420560748,0.0768566494,"LAMOTRIGINE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1290322581,NA,NA,NA,"LAMOTRIGINE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3066666667,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1052631579,"LAMOTRIGINE","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05882352941,"LAMOTRIGINE","RISPERIDONE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04716981132,"LAMOTRIGINE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1447562777,NA,NA,0.07182320442,"LAMOTRIGINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1074380165,NA,NA,NA,"LAMOTRIGINE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08096085409,"LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0756302521,0.05072463768,"LAMOTRIGINE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1373626374,0.08223684211,"LAMOTRIGINE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.009523809524,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01179941003,NA,NA,"Last AD: Diff & No Remiss",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02739726027,NA,0.2392638037,"Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2843137255,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6024590164,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5727272727,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6015779093,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2450980392,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3818181818,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,0.01618705036,0.3939393939,NA,NA,NA,0.1278772379,0.4514285714,NA,NA,NA,NA,0.4176829268,0.004608294931,0.4671532847,0.2036363636,"Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03546099291,NA,0.3709677419,"Last AD: Diff & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.128440367,"Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.09615384615,NA,NA,NA,NA,NA,NA,NA,NA,0.1065989848,"Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09090909091,"Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.02274715661,0.35,NA,NA,0.3157894737,0.1614123581,0.3323529412,0.09558823529,NA,0.3686440678,NA,NA,0.01342281879,0.4734042553,0.2459893048,"Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01550387597,NA,0.416,"Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",0.0162601626,0.02427184466,0.3548387097,NA,NA,NA,0.186746988,NA,0.1025641026,NA,NA,NA,0.3136363636,0.01781170483,NA,0.2053675613,"Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01764705882,0.6807511737,0.4464285714,"Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.03203661327,0.4910714286,NA,NA,NA,0.1576763485,0.4117647059,NA,NA,NA,NA,0.4790419162,0.005917159763,NA,0.18,"Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.1291390728,NA,NA,NA,0.5,NA,NA,0.2926829268,NA,NA,NA,NA,0.1218390805,0.6631016043,NA,"Last AD: Diff & Remiss",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4462809917,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3873873874,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6458333333,NA,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,0.1137724551,NA,NA,NA,NA,0.3742331288,NA,NA,NA,NA,NA,0.6462585034,NA,0.640625,0.2798982188,"Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.09571788413,0.5925925926,NA,NA,0.4812030075,0.2144846797,0.5629139073,NA,NA,0.6178861789,NA,NA,0.09523809524,0.5458333333,0.3718104496,"Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6623376623,0.07894736842,NA,NA,"Last AD: Diff & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0888030888,NA,NA,"Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.1081081081,NA,NA,NA,NA,0.3064516129,NA,NA,NA,NA,NA,NA,NA,NA,0.3099730458,"Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1171366594,"Last AD: Same & No Remiss",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.09452054795,NA,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09230769231,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3366336634,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3880597015,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4175824176,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3187560739,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2274881517,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3362831858,"Last AD: Same & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1913439636,NA,NA,NA,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008620689655,NA,NA,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2467532468,NA,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3066666667,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2977099237,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009523809524,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2668329177,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1238938053,NA,NA,NA,"Last AD: Same & No Remiss","RISPERIDONE","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1261261261,NA,NA,NA,NA,"Last AD: Same & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3482493099,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3602484472,0.02419354839,NA,0.2742616034,"Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01092544987,NA,NA,"Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3464720195,NA,"Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"Last AD: Same & Remiss",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6837606838,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6546391753,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.4186046512,NA,NA,NA,NA,NA,NA,0.5853658537,"Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5714285714,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5646711013,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5755395683,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6155793026,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5606060606,"Last AD: Same & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5241460542,"Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.488372093,"Last AD: Same & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6200527704,NA,"Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1726384365,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LEVOFLOXACIN",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5625,NA,NA,NA,"LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.4028776978,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4051724138,NA,NA,NA,"LISDEXAMFETAMINE DIMESYLATE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.416,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LISINOPRIL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.5271966527,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LISINOPRIL/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.096,NA,NA,NA,NA,NA,NA,0.176,NA,"LITHIUM CARBONATE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.5619047619,NA,NA,NA,NA,NA,NA,NA,0.4556213018,NA,NA,NA,NA,NA,"LORATADINE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.05,0.3925233645,NA,NA,NA,NA,0.5333333333,NA,NA,NA,NA,0.4555555556,NA,NA,NA,"LORAZEPAM",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6336633663,NA,NA,NA,"LORAZEPAM","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.05217391304,0.3604060914,NA,NA,NA,NA,0.3785714286,0.1538461538,NA,0.3043478261,NA,0.4672897196,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1981132075,0.4485981308,NA,NA,NA,NA,NA,NA,NA,NA,"LUMBAGO (dxo:ICD9:7242)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.3985765125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6257521059,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.6116504854,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7170868347,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6392156863,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.5172413793,0.6349206349,NA,NA,0.6666666667,0.5955555556,0.5732484076,NA,NA,NA,NA,0.579787234,0.3736842105,0.5921052632,0.6453061224,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6598837209,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6325203252,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6746987952,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.5619834711,NA,NA,NA,NA,0.4571428571,NA,NA,NA,NA,0.4748201439,NA,NA,0.2052980132,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1438848921,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.203539823,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633)",NA,NA,NA,NA,NA,NA
"20-40","Male",0.2481751825,0.3569364162,0.5664160401,0.5441860465,NA,0.5284697509,0.4683641975,0.5062611807,0.345844504,NA,0.5550847458,NA,0.5334728033,0.2718446602,0.5779467681,0.4957002457,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.3592814371,NA,NA,NA,NA,NA,NA,0.4481605351,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4363636364,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5696202532,NA,NA,NA,NA,0.6454545455,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6422018349,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6698113208,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.335483871,NA,NA,NA,NA,0.4615384615,0.52,NA,NA,NA,NA,0.6349557522,NA,NA,0.5201465201,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5677966102,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2327790974,NA,0.4286786787,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5526315789,0.4385964912,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6046176046,0.5324074074,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.05705705706,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4797297297,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.08870967742,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.04155844156,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.480620155,NA,0.5523809524,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.3731343284,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"METAXALONE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.04132231405,0.48,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5149253731,NA,NA,NA,"METHYLPHENIDATE HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4552845528,NA,NA,NA,"METRONIDAZOLE",NA,NA,NA,NA,NA,NA
"20-40","Male",0,NA,NA,NA,NA,NA,0.1693548387,NA,NA,0.05,NA,NA,0.4769230769,NA,NA,NA,"MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.04102564103,0.2365591398,NA,NA,0.2865853659,0.07555555556,0.1860465116,0.2111879321,NA,0.2295081967,NA,0.3903508772,NA,0.376,0.2155172414,"MIRTAZAPINE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1320754717,"MIRTAZAPINE","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1870503597,"MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3966942149,NA,NA,NA,NA,0.25,"MIRTAZAPINE","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05970149254,"MIRTAZAPINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1261261261,"MIRTAZAPINE","RISPERIDONE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.2033898305,NA,NA,NA,0.3434650456,NA,NA,0.2350993377,"MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1824817518,NA,NA,NA,NA,NA,NA,0.1793814433,"MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2113821138,"MIRTAZAPINE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.13,NA,NA,NA,NA,NA,0.5490196078,0.204954955,"MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.5185185185,NA,NA,NA,NA,0.4583333333,NA,NA,NA,NA,0.3725490196,NA,NA,0.28,"MONTELUKAST SODIUM",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.02083333333,NA,NA,NA,NA,0.2020725389,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MORBID OBESITY (dxo:ICD9:27801)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1210526316,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MOXIFLOXACIN HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.04914529915,0.4297297297,NA,NA,NA,0.1552511416,0.4696969697,NA,NA,0.4525547445,NA,0.5298013245,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6446280992,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",0,NA,NA,NA,NA,NA,0.168,NA,NA,NA,NA,NA,0.4705882353,NA,NA,NA,"NAPROXEN",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.02877697842,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5633802817,NA,NA,NA,"NONALLOPATHIC LESION OF CERVICAL REGION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:7391)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3791208791,NA,NA,NA,NA,NA,"NONALLOPATHIC LESION OF THORACIC REGION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:7392)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.3617021277,NA,NA,NA,NA,0.3291139241,NA,NA,NA,NA,NA,0.01369863014,NA,NA,"NONDEPENDENT ALCOHOL ABUSE, UNSPECIFIED DRUNKENNESS (dxo:ICD9:30500)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.02578947368,0.3545454545,NA,NA,NA,0.1311619718,0.3875,0.1478873239,NA,NA,NA,0.4184675835,0.015625,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.0462962963,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.01714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"20-40","Male",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.05357142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.006097560976,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.625,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.02884615385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","VARENICLINE TARTRATE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1539923954,NA,NA,NA,NA,NA,0.2618069815,"NORTRIPTYLINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5846153846,NA,NA,0.3398058252,"NORTRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1849710983,"NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.54,NA,NA,NA,NA,NA,"Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5511811024,NA,NA,NA,NA,NA,"Num Previous Antidep: 2,3","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5879120879,NA,NA,NA,"Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.76,NA,NA,NA,"Num Previous Antidep: 2,3","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1291666667,"Num Previous Antidep: 4+",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3052631579,NA,NA,NA,NA,NA,"Num Previous Antidep: 4+","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1854304636,"Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1775700935,"Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5428571429,NA,NA,NA,NA,NA,"Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,0.03846153846,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.05521472393,NA,NA,NA,NA,0.3039215686,NA,NA,NA,NA,NA,NA,NA,NA,0.141563786,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1776315789,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1160714286,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1387283237,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1142857143,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1736111111,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.4872665535,NA,NA,NA,0.2109038737,0.5185185185,NA,NA,0.3868613139,NA,0.5105932203,NA,NA,0.2259887006,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6359223301,NA,NA,NA,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.05,NA,NA,NA,NA,0.1769041769,0.4772727273,NA,NA,NA,NA,NA,NA,NA,0.1690140845,"OMEPRAZOLE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02153110048,NA,NA,"OPIOID TYPE DEPENDENCE, UNSPECIFIED (dxo:ICD9:30400)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.4718309859,NA,NA,NA,0.1428571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OSELTAMIVIR PHOSPHATE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.3859649123,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER ACNE (dxo:ICD9:7061)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.06930693069,0.3302752294,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3657142857,NA,NA,NA,"OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE, UNSPECIFIED DRUNKENNESS (dxo:ICD9:30390)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.03003003003,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.02542372881,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER CONVULSIONS (dxo:ICD9:78039)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2884615385,NA,NA,NA,NA,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4201680672,NA,NA,NA,NA,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.03059440559,0.4959349593,0.5245901639,NA,0.4071428571,0.1655629139,0.408496732,NA,NA,0.43,NA,0.5122699387,0,0.558685446,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.01098901099,NA,NA,NA,NA,0.1417322835,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1483253589,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.01990049751,0.4086956522,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.480620155,NA,NA,NA,0.1815181518,NA,NA,NA,0.3309859155,NA,0.478,NA,NA,NA,"OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.660130719,NA,NA,NA,"OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",0.01739130435,NA,NA,NA,NA,NA,0.15625,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OXYCODONE HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.05479452055,NA,NA,NA,NA,0.1827411168,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OXYCODONE HCL/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.3411764706,NA,NA,NA,0.1465517241,NA,NA,NA,0.3457943925,NA,0.452991453,NA,NA,NA,"PAIN IN SOFT TISSUES OF LIMB (dxo:ICD9:7295)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.4304812834,NA,NA,NA,0.142599278,0.3963636364,NA,NA,0.3873239437,NA,0.4914675768,NA,NA,0.1782945736,"PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.05136986301,0.4158415842,NA,NA,NA,NA,NA,NA,NA,0.4016393443,NA,0.4523160763,NA,NA,NA,"PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.567839196,NA,NA,NA,NA,NA,"PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)","PAROXETINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.572815534,NA,NA,NA,"PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",0.01818181818,0.03779527559,0.4285714286,NA,NA,0.3223140496,0.1842439644,0.3668831169,0.1505376344,NA,0.4554420152,NA,0.4315436242,0.03801652893,0.5516129032,0.2133634603,"PAROXETINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3072289157,NA,0.2803738318,NA,NA,0.09655172414,"PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07633587786,"PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2972972973,NA,NA,NA,NA,0.1485148515,"PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4516129032,NA,NA,NA,NA,0.1174496644,"PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2568807339,NA,NA,NA,NA,0.1746031746,"PAROXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6861313869,NA,NA,NA,NA,NA,"PAROXETINE HCL","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.03225806452,NA,NA,NA,NA,0.1315789474,NA,NA,NA,0.4383301708,NA,0.4757281553,NA,NA,0.1949458484,"PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.03636363636,NA,NA,NA,NA,NA,NA,NA,NA,0.388638413,NA,NA,0.03353057199,NA,0.2735703246,"PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4961538462,NA,NA,NA,NA,0.1981981982,"PAROXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008474576271,NA,NA,"PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742)",NA,NA,NA,NA,NA,NA
"20-40","Male",0.02752293578,0.03421052632,0.1958384333,0.1635220126,NA,0.1503759398,0.1314553991,0.1530172414,NA,NA,0.1828703704,NA,0.1634146341,0.02777777778,0.1842576029,0.102003643,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.0351758794,0.1315789474,0.1751824818,NA,NA,0.07164179104,0.1130434783,NA,NA,0.1538461538,NA,0.168,NA,0.1559139785,0.06603773585,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2673267327,NA,NA,0.0652173913,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1025641026,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,0.1538461538,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.344783715,NA,NA,0.1026694045,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2520661157,NA,NA,0.1443850267,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03225806452,0.1553398058,0.11,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2314049587,0.1274509804,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2687022901,0.1124260355,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3396689148,"PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3063583815,"PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.237037037,"PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,0.2910447761,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PREGABALIN",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4333333333,NA,NA,NA,NA,NA,"PROPOXYPHENE NAP/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.275659824,NA,NA,NA,0.1003649635,0.2482100239,NA,NA,0.1666666667,NA,0.246130031,NA,0.2192982456,0.1264367816,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.0625,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"20-40","Male",NA,NA,0.1703056769,NA,NA,NA,0.08743169399,0.1626139818,NA,NA,0.1489361702,NA,0.1731481481,NA,0.1485148515,0.08602150538,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.09090909091,0.1714285714,NA,NA,NA,NA,0.1452513966,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3276836158,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1810344828,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5166666667,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.2024539877,NA,NA,NA,0.1243243243,0.2819148936,NA,NA,NA,NA,0.2410714286,NA,NA,0.1678832117,"PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792)",NA,NA,NA,NA,NA,NA
"20-40","Male",0.005780346821,0.04844814534,0.202681388,0.2857142857,NA,0.1683168317,0.07614213198,0.1944444444,0.08653846154,NA,0.1466030989,NA,0.1836141778,0.03431372549,0.2040816327,0.0974025974,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4425087108,NA,NA,0.1204819277,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09090909091,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,0.1416666667,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.1707317073,0.1614583333,NA,NA,0.08424908425,0.1383647799,NA,NA,NA,NA,0.1904761905,0.03401360544,0.2340425532,0.09708737864,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3525641026,NA,NA,0.1093117409,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1485148515,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1103896104,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1666666667,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.1788018433,0.2186234818,NA,0.1397058824,0.08232445521,0.1858490566,0.0490797546,NA,0.1403940887,NA,0.1817288802,0.01670146138,0.1971365639,0.1106442577,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.1337579618,NA,NA,NA,0.06589147287,NA,NA,NA,NA,NA,0.1529411765,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.08974358974,NA,NA,NA,NA,NA,0.3451327434,NA,0.2038834951,0.1627906977,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3105263158,NA,NA,0.1794871795,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1201923077,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3382352941,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3765690377,0.1748251748,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.08737864078,0.1138211382,NA,NA,NA,NA,0.07586206897,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.09090909091,NA,NA,NA,NA,NA,0.1605504587,NA,NA,NA,"PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1465517241,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RABEPRAZOLE SODIUM",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2167832168,NA,NA,NA,NA,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.40625,NA,NA,NA,NA,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.1052631579,NA,NA,0.1627906977,0.06435643564,0.09322033898,NA,NA,NA,NA,0.1161616162,NA,0.1490909091,0.1013171226,"RISPERIDONE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1237785016,NA,NA,0.1103448276,"RISPERIDONE","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07352941176,"RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1859296482,0.1346153846,"RISPERIDONE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1428571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROFECOXIB",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3237924866,NA,NA,NA,0.3087414755,"ROPINIROLE HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.472,NA,NA,NA,"ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2404092072,"ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.0260782347,NA,NA,NA,NA,0.1583236321,NA,NA,NA,0.3936170213,NA,0.4756097561,0.01,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4925373134,NA,NA,NA,"ROUTINE INFANT OR CHILD HEALTH CHECK (dxo:ICD9:V202)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.3290322581,NA,NA,NA,0.1504424779,NA,NA,NA,NA,NA,0.3865814696,NA,NA,NA,"SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4035087719,NA,NA,NA,NA,NA,"SCREENING FOR LIPOID DISORDERS (dxo:ICD9:V7791)",NA,NA,NA,NA,NA,NA
"20-40","Male",0.02012072435,0.03865814696,0.3731609452,0.5950920245,0.1045751634,0.3567567568,0.164019548,0.3392773346,0.1096681097,0.08465608466,0.3398294762,NA,0.4717045649,0.01799775028,0.530726257,0.2406099518,"SERTRALINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5818181818,NA,NA,NA,"SERTRALINE HCL","SILDENAFIL CITRATE",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.688172043,NA,NA,NA,"SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"20-40","Male",NA,0.05405405405,0.2113821138,NA,NA,NA,0.125,0.2907801418,NA,NA,NA,NA,0.4206225681,0.02408111534,NA,0.2694204686,"SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2100840336,"SERTRALINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6369047619,NA,NA,NA,"SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"20-40","Male",NA,0.078125,NA,NA,NA,NA,0.1238095238,NA,NA,NA,NA,NA,0.4798061389,NA,0.5833333333,0.2216748768,"SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,0.03857566766,0.3837837838,NA,NA,NA,NA,NA,NA,NA,0.392,NA,0.4379310345,NA,NA,NA,"SILDENAFIL CITRATE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.5274725275,NA,NA,NA,0.1527777778,0.5740740741,NA,NA,NA,NA,0.5503355705,NA,NA,NA,"SIMVASTATIN",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.2203389831,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2767857143,NA,NA,NA,"SUICIDAL IDEATION (dxo:ICD9:V6284)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.3823529412,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"SULFAMETHOXAZOLE/TRIMETHOPRIM",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4545454545,NA,NA,NA,"SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.03968253968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TADALAFIL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.4711538462,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"THORACIC OR LUMBOSACRAL NEURITIS OR RADICULITIS, UNSPECIFIED (dxo:ICD9:7244)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4260869565,NA,NA,NA,"TOPIRAMATE",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.04504504505,NA,NA,NA,0.3138075314,0.178470255,0.480620155,NA,NA,0.3663366337,NA,0.5149253731,0.01167315175,NA,NA,"TRAMADOL HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",0.01993355482,0.04636785162,0.2843137255,0.3431372549,NA,0.2065868263,0.1583011583,0.2228739003,0.08875739645,NA,0.25,NA,0.2571428571,0.0209761163,0.2737843552,0.2281075028,"TRAZODONE HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01736972705,0.4286644951,0.2395251397,"TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.08396946565,NA,NA,NA,NA,0.03007518797,NA,NA,"UNLISTED PSYCHIATRIC SERVICE OR PROCEDURE (px:CPT4:90899)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,0.1487603306,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED ACUTE REACTION TO STRESS (dxo:ICD9:3089)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.03389830508,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED BACKACHE (dxo:ICD9:7245)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4423076923,NA,NA,NA,"UNSPECIFIED CONSTIPATION (dxo:ICD9:56400)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.02884615385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED EPISODIC MOOD DISORDER (dxo:ICD9:29690)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.01360544218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",NA,NA,NA,NA,NA,NA
"20-40","Male",0.02222222222,0.06417112299,0.4441087613,NA,NA,0.3676767677,0.1552795031,0.4536741214,NA,NA,0.4015151515,NA,0.426323319,0.03305785124,NA,NA,"UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01111111111,NA,NA,"UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4621848739,NA,NA,NA,"UNSPECIFIED VIRAL INFECTION, IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE (dxo:ICD9:07999)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5044247788,NA,NA,NA,"URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,0.04761904762,0.4259259259,NA,NA,NA,NA,NA,NA,NA,0.3495934959,NA,NA,NA,NA,NA,"VALACYCLOVIR HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.3619047619,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"VARENICLINE TARTRATE",NA,NA,NA,NA,NA,NA
"20-40","Male",0.02564102564,0.04204204204,0.4042288557,NA,NA,0.4358974359,0.198011599,0.3520871143,0.1282051282,NA,0.3461538462,NA,0.4126602564,0.01401869159,0.4667421669,0.2132366274,"VENLAFAXINE HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6730769231,"VILAZODONE HCL",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"VOMITING ALONE (dxo:ICD9:78703)",NA,NA,NA,NA,NA,NA
"20-40","Male",NA,NA,NA,NA,NA,NA,NA,0.5058823529,NA,NA,NA,NA,0.4472361809,0.008823529412,NA,NA,"ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA,NA
"41-64","Female",0.03225199719,0.0634887853,0.5212089173,0.5150548355,0.207826087,0.4196903973,0.228410287,0.5023723441,0.1959708232,0.1014889285,0.4637828118,0.3206006065,0.5432607158,0.0345615241,0.5105027377,0.3640137947,NA,NA,NA,NA,NA,NA,NA
"41-64","Female",0.009803921569,0.01886792453,0.4135338346,NA,NA,NA,NA,0.4758064516,NA,0.02702702703,NA,NA,0.4879807692,NA,0.477124183,NA,"ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5323741007,NA,"ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7185929648,NA,NA,NA,"ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.696969697,NA,"ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1298174442,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3410404624,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1206896552,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09708737864,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1273584906,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX (dxo:ICD9:79500)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.0273155416,NA,NA,NA,NA,0.1652892562,NA,0.08490566038,NA,0.4022988506,NA,0.5300621977,NA,0.5153374233,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.04310344828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.009523809524,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.048,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL",NA,NA,NA,NA
"41-64","Female",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.504587156,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","ATORVASTATIN CALCIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8415841584,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","ATORVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.05657093124,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","BUPROPION HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.04385964912,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,0.06818181818,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA
"41-64","Female",NA,0.01818181818,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,0.02,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,0.03448275862,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,0.0593220339,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,0.06666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","BUPROPION HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.02521008403,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.008333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","BUPROPION HCL","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"41-64","Female",NA,0.03428571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,0.009900990099,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.02941176471,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01639344262,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"41-64","Female",NA,0.01408450704,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,0.0197044335,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.03333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.009803921569,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4193548387,NA,0.6842105263,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6842105263,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4787878788,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02884615385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4184397163,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4545454545,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7185185185,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6873239437,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4482758621,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01257861635,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01435406699,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.04702970297,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6636971047,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6451612903,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0,NA,NA,NA,NA,0.1769911504,NA,NA,NA,0.4102564103,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.04102564103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7235294118,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05747126437,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.116,NA,NA,NA,NA,NA,0.4635416667,NA,NA,0.2052980132,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3178294574,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4829931973,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7016574586,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.08988764045,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6526548673,NA,NA,NA,"ABSENCE OF MENSTRUATION (dxo:ICD9:6260)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4814814815,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5028248588,NA,0.3965517241,NA,"ACETAMINOPHEN WITH CODEINE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5401234568,NA,NA,NA,"ACTINIC KERATOSIS (dxo:ICD9:7020)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5454545455,NA,NA,NA,"ACTINIC KERATOSIS (dxo:ICD9:7020)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7636363636,NA,NA,NA,"ACTINIC KERATOSIS (dxo:ICD9:7020)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.3922261484,NA,NA,NA,NA,NA,NA,NA,0.3565891473,NA,NA,NA,NA,NA,"ACUTE GASTRITIS WITHOUT MENTION OF HEMORRHAGE (dxo:ICD9:53500)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4953271028,NA,NA,NA,NA,NA,0.1666666667,NA,NA,NA,0.5875486381,NA,NA,NA,"ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6855670103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5702479339,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6126126126,NA,NA,NA,"ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5161290323,NA,NA,NA,NA,NA,NA,NA,NA,"ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6458333333,NA,NA,NA,NA,NA,NA,NA,NA,"ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4818181818,NA,NA,NA,NA,NA,NA,NA,NA,"ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ACUTE, BUT ILL-DEFINED, CEREBROVASCULAR DISEASE (dxo:ICD9:436)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09,NA,NA,NA,NA,NA,0.4768211921,NA,NA,NA,"ADJUSTMENT DISORDER WITH ANXIETY (dxo:ICD9:30924)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3267326733,NA,NA,NA,"ADJUSTMENT DISORDER WITH ANXIETY (dxo:ICD9:30924)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09523809524,NA,NA,NA,NA,NA,0.2214285714,NA,NA,NA,"ADJUSTMENT DISORDER WITH ANXIETY (dxo:ICD9:30924)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,0.03404255319,0.4211711712,NA,NA,NA,0.12,0.492248062,NA,NA,NA,NA,0.5034642032,NA,NA,0.2547169811,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1746031746,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6202531646,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.08403361345,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7098445596,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1194029851,0.2336448598,NA,NA,NA,NA,0.2820512821,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.2148760331,NA,NA,NA,0.07834101382,0.1570247934,NA,NA,NA,NA,0.2206896552,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09039548023,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6735751295,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02010968921,0.4384384384,NA,NA,NA,0.1283987915,0.4384615385,NA,NA,NA,NA,0.4563591022,NA,0.5,0.2545454545,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.01716738197,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.04,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.05785123967,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.07627118644,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,0.04831460674,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","BUPROPION HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02941176471,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,0.01212121212,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,0.04,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1415929204,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1388888889,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,0.04032258065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,0.05673758865,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","BUPROPION HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.02759526938,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.02197802198,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","BUPROPION HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,0.02941176471,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","BUPROPION HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6242774566,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,NA,0.2689655172,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA
"41-64","Female",NA,NA,0.2941176471,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Female",NA,NA,0.4480874317,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,0.009803921569,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.01666666667,NA,NA,NA,NA,0.3177570093,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2103658537,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1271186441,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1292517007,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Female",NA,NA,0.3858267717,NA,NA,NA,0.1693548387,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,0.01595744681,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1052631579,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2342342342,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.16,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,0.01801801802,NA,NA,NA,NA,NA,0.6032608696,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3892405063,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2689393939,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.277486911,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,0.02816901408,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.05925925926,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.07179487179,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,0.2546689304,NA,NA,NA,0.06257242178,0.2229166667,NA,NA,NA,NA,0.2466124661,NA,0.2302631579,0.1337209302,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2915129151,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3023255814,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA
"41-64","Female",NA,0.05,0.1962095875,NA,NA,0.1714285714,0.05764611689,0.2012779553,NA,NA,0.1755725191,NA,0.2023608769,NA,0.2555555556,0.106557377,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.04511278195,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4430769231,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.05633802817,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3716381418,NA,NA,0.2233009709,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3875968992,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6492537313,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.01704545455,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.008928571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.05789473684,NA,NA,NA,NA,NA,0.2170542636,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.2033898305,NA,NA,NA,0.05627705628,0.2215568862,NA,NA,NA,NA,0.2305389222,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4485981308,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,0.02518518519,0.2613240418,NA,NA,NA,0.09536784741,0.2331606218,NA,NA,NA,NA,0.286908078,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.568,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.1908396947,NA,NA,NA,0.06913580247,0.2244897959,NA,NA,NA,NA,0.1964285714,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.05479452055,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3786407767,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.03883495146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6318181818,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01212121212,0.5055096419,NA,NA,NA,NA,NA,NA,NA,0.4051094891,NA,NA,NA,0.5267857143,NA,"ALBUTEROL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.04597701149,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALBUTEROL","BUPROPION HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02941176471,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALBUTEROL","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6861111111,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALBUTEROL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6981132075,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALBUTEROL","CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.48,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALBUTEROL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6888888889,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALBUTEROL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.572327044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALBUTEROL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6484018265,NA,NA,NA,NA,NA,"ALBUTEROL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1521126761,NA,NA,NA,0.4158415842,NA,NA,NA,0.4216281896,NA,"ALBUTEROL SULFATE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.55,NA,"ALBUTEROL SULFATE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7586206897,NA,"ALBUTEROL SULFATE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4621848739,NA,"ALBUTEROL SULFATE","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7299270073,NA,"ALBUTEROL SULFATE","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6433566434,NA,NA,NA,NA,NA,"ALBUTEROL SULFATE","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1142857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALBUTEROL SULFATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.401459854,NA,"ALBUTEROL SULFATE","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6915708812,NA,"ALBUTEROL SULFATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4725274725,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALLERGY, UNSPECIFIED NOT ELSEWHERE CLASSIFIED (dxo:ICD9:9953)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.55,NA,NA,NA,NA,NA,NA,NA,NA,"ALLOPURINOL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7368421053,NA,NA,NA,NA,NA,NA,NA,NA,"ALLOPURINOL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01837672282,0.4570093458,NA,NA,NA,0.15625,0.4597902098,NA,NA,0.42,NA,0.4889415482,0.01520912548,0.4884210526,0.3660714286,"ALPRAZOLAM",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.03333333333,NA,NA,NA,NA,0.1436314363,0.4420289855,NA,NA,NA,NA,0.4830508475,NA,NA,NA,"ALPRAZOLAM","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1437125749,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1727272727,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4326923077,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1182795699,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5474860335,NA,NA,NA,"ALPRAZOLAM","ATORVASTATIN CALCIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7425149701,NA,NA,NA,"ALPRAZOLAM","ATORVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.072,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","BUPROPION HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01597444089,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.008695652174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","BUPROPION HCL","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,0.05384615385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","BUPROPION HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4537815126,NA,NA,NA,"ALPRAZOLAM","CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6816479401,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6616541353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.4430379747,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6465116279,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.4339622642,NA,NA,NA,0.1590909091,NA,NA,NA,NA,NA,0.5925925926,NA,0.6083333333,NA,"ALPRAZOLAM","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6692913386,NA,NA,NA,"ALPRAZOLAM","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7314814815,NA,"ALPRAZOLAM","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3782051282,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,NA,NA,NA,"ALPRAZOLAM","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1542288557,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1578947368,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3517786561,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5105263158,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.504,NA,NA,NA,"ALPRAZOLAM","ESTRADIOL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6625,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3846153846,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7177419355,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1666666667,NA,NA,NA,NA,NA,0.5039370079,NA,NA,NA,"ALPRAZOLAM","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.546875,NA,NA,NA,"ALPRAZOLAM","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6356589147,NA,NA,NA,"ALPRAZOLAM","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1574074074,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.487394958,NA,NA,NA,"ALPRAZOLAM","IBUPROFEN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4150943396,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4978354978,NA,NA,NA,"ALPRAZOLAM","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7272727273,NA,NA,NA,"ALPRAZOLAM","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3468208092,NA,NA,NA,"ALPRAZOLAM","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3895652174,NA,NA,NA,"ALPRAZOLAM","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7060702875,NA,NA,NA,"ALPRAZOLAM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5142857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4508474576,NA,NA,NA,"ALPRAZOLAM","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7731092437,NA,NA,NA,"ALPRAZOLAM","LEVOTHYROXINE SODIUM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7710843373,NA,NA,NA,"ALPRAZOLAM","LEVOTHYROXINE SODIUM","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4802259887,NA,NA,NA,"ALPRAZOLAM","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01818181818,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5813953488,NA,NA,NA,"ALPRAZOLAM","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3980582524,NA,NA,NA,"ALPRAZOLAM","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5700934579,NA,NA,NA,"ALPRAZOLAM","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01680672269,NA,NA,NA,NA,0.1261682243,0.4571428571,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6922530206,NA,NA,NA,"ALPRAZOLAM","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7768595041,NA,NA,NA,"ALPRAZOLAM","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.509202454,NA,NA,NA,"ALPRAZOLAM","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4117647059,NA,NA,NA,"ALPRAZOLAM","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4519230769,NA,NA,NA,"ALPRAZOLAM","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4513274336,NA,NA,NA,"ALPRAZOLAM","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6782945736,NA,"ALPRAZOLAM","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4285714286,NA,NA,NA,"ALPRAZOLAM","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"41-64","Female",0.04929732587,0.03116011505,0.384057971,0.4807692308,0.2387096774,0.3367768595,0.1441969519,0.3871359223,0.1432664756,0.0808678501,0.327184466,0.2419354839,0.4090168387,0.01967213115,0.428769018,0.3986167693,"AMITRIPTYLINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",0.02,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","AMLODIPINE BESYLATE",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03723404255,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,0.02923976608,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1138211382,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1652892562,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.192,"AMITRIPTYLINE HCL","ARIPIPRAZOLE","DULOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4016393443,"AMITRIPTYLINE HCL","ATORVASTATIN CALCIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6509433962,NA,NA,NA,"AMITRIPTYLINE HCL","ATORVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",0.05866050808,0.05897370437,0.3307086614,NA,NA,0.3015384615,0.1822916667,0.3802816901,NA,NA,NA,NA,0.4,NA,0.4497991968,0.3010957936,"AMITRIPTYLINE HCL","BUPROPION HCL",NA,NA,NA,NA,NA
"41-64","Female",0.07602339181,0.03913043478,0.5093632959,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4071428571,"AMITRIPTYLINE HCL","BUPROPION HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA
"41-64","Female",NA,0.04761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4871794872,"AMITRIPTYLINE HCL","BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4590163934,"AMITRIPTYLINE HCL","BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4343434343,"AMITRIPTYLINE HCL","BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5829787234,"AMITRIPTYLINE HCL","BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2796610169,"AMITRIPTYLINE HCL","BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Antidep: 4+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2307692308,"AMITRIPTYLINE HCL","BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3203883495,"AMITRIPTYLINE HCL","BUPROPION HCL","CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",0.04901960784,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA
"41-64","Female",0.0347826087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3428571429,"AMITRIPTYLINE HCL","BUPROPION HCL","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3523809524,"AMITRIPTYLINE HCL","BUPROPION HCL","DOXEPIN HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2132352941,"AMITRIPTYLINE HCL","BUPROPION HCL","DOXEPIN HCL","Num Previous Antidep: 4+",NA,NA,NA
"41-64","Female",0.04545454545,0.02366863905,NA,NA,NA,0.4402515723,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3111332008,"AMITRIPTYLINE HCL","BUPROPION HCL","DULOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.02919708029,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.358974359,"AMITRIPTYLINE HCL","BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3722627737,"AMITRIPTYLINE HCL","BUPROPION HCL","DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3594771242,"AMITRIPTYLINE HCL","BUPROPION HCL","DULOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4742857143,"AMITRIPTYLINE HCL","BUPROPION HCL","DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2919708029,"AMITRIPTYLINE HCL","BUPROPION HCL","DULOXETINE HCL","Num Previous Antidep: 4+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2533936652,"AMITRIPTYLINE HCL","BUPROPION HCL","DULOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3304347826,"AMITRIPTYLINE HCL","BUPROPION HCL","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",0.06341463415,0.03921568627,NA,NA,NA,NA,0.3493975904,NA,NA,NA,NA,NA,NA,NA,NA,0.2777232581,"AMITRIPTYLINE HCL","BUPROPION HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Female",NA,0.05031446541,NA,NA,NA,NA,0.4260869565,NA,NA,NA,NA,NA,NA,NA,NA,0.2368421053,"AMITRIPTYLINE HCL","BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.44,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.218487395,"AMITRIPTYLINE HCL","BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3298429319,"AMITRIPTYLINE HCL","BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3594470046,"AMITRIPTYLINE HCL","BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5555555556,"AMITRIPTYLINE HCL","BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2289156627,"AMITRIPTYLINE HCL","BUPROPION HCL","ESCITALOPRAM OXALATE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",0.08212560386,0.05338078292,NA,NA,NA,NA,NA,0.4896142433,NA,NA,NA,NA,NA,NA,NA,0.3894736842,"AMITRIPTYLINE HCL","BUPROPION HCL","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.03149606299,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3852459016,"AMITRIPTYLINE HCL","BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6435643564,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5558912387,"AMITRIPTYLINE HCL","BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5503355705,"AMITRIPTYLINE HCL","BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5533980583,"AMITRIPTYLINE HCL","BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6435643564,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2585034014,"AMITRIPTYLINE HCL","BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 4+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2713567839,"AMITRIPTYLINE HCL","BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2248062016,"AMITRIPTYLINE HCL","BUPROPION HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",0.04421768707,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","BUPROPION HCL","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA
"41-64","Female",0.03125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","BUPROPION HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08043875686,"AMITRIPTYLINE HCL","BUPROPION HCL","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4711538462,"AMITRIPTYLINE HCL","BUPROPION HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1228070175,"AMITRIPTYLINE HCL","BUPROPION HCL","LAMOTRIGINE","Num Previous Antidep: 4+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.12,"AMITRIPTYLINE HCL","BUPROPION HCL","LAMOTRIGINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09602649007,"AMITRIPTYLINE HCL","BUPROPION HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",0.03510895884,0.05657492355,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1260162602,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.03910614525,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"41-64","Female",NA,0.06098964327,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,0.04761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5964912281,NA,NA,NA,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA
"41-64","Female",0.03370786517,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1260387812,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4077669903,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,0.03289473684,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4635761589,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,0.07,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02419354839,NA,0.1428571429,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.01851851852,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.4059405941,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",0.01785714286,0.02352941176,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1677943166,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.01818181818,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1876923077,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3458646617,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4715025907,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09433962264,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4018691589,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3761904762,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4730538922,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09782608696,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3943661972,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5435745938,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7434782609,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5409836066,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & Remiss","Num Previous Antidep: 4+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4867256637,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & Remiss","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5799086758,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5324675325,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6623931624,"AMITRIPTYLINE HCL","BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5153846154,"AMITRIPTYLINE HCL","BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.3481012658,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.541705717,"AMITRIPTYLINE HCL","BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5373134328,"AMITRIPTYLINE HCL","BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5215517241,"AMITRIPTYLINE HCL","BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4746136865,"AMITRIPTYLINE HCL","BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2446351931,"AMITRIPTYLINE HCL","BUPROPION HCL","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3159851301,"AMITRIPTYLINE HCL","BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.214953271,"AMITRIPTYLINE HCL","BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2956989247,"AMITRIPTYLINE HCL","BUPROPION HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.303030303,"AMITRIPTYLINE HCL","BUPROPION HCL","NORTRIPTYLINE HCL","Num Previous Antidep: 4+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2666666667,"AMITRIPTYLINE HCL","BUPROPION HCL","NORTRIPTYLINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5897435897,NA,NA,NA,"AMITRIPTYLINE HCL","BUPROPION HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3021947102,"AMITRIPTYLINE HCL","BUPROPION HCL","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.40234375,"AMITRIPTYLINE HCL","BUPROPION HCL","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.261682243,"AMITRIPTYLINE HCL","BUPROPION HCL","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4100719424,"AMITRIPTYLINE HCL","BUPROPION HCL","Num Previous Antidep: 4+","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.296875,"AMITRIPTYLINE HCL","BUPROPION HCL","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3521126761,"AMITRIPTYLINE HCL","BUPROPION HCL","Num Previous Antidep: 4+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.277924828,"AMITRIPTYLINE HCL","BUPROPION HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2680851064,"AMITRIPTYLINE HCL","BUPROPION HCL","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2647058824,"AMITRIPTYLINE HCL","BUPROPION HCL","Num Previous Antidep: 4+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",0.04464285714,0.03546099291,NA,NA,NA,NA,NA,NA,NA,NA,0.5512820513,NA,NA,NA,NA,0.341356674,"AMITRIPTYLINE HCL","BUPROPION HCL","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1333333333,"AMITRIPTYLINE HCL","BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.141509434,"AMITRIPTYLINE HCL","BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3876404494,"AMITRIPTYLINE HCL","BUPROPION HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2406015038,"AMITRIPTYLINE HCL","BUPROPION HCL","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09482758621,"AMITRIPTYLINE HCL","BUPROPION HCL","RISPERIDONE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3821656051,"AMITRIPTYLINE HCL","BUPROPION HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2983425414,"AMITRIPTYLINE HCL","BUPROPION HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",0.04608294931,0.04270462633,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5384615385,NA,NA,0.3569165787,"AMITRIPTYLINE HCL","BUPROPION HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",0.01739130435,0.05486284289,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2376108503,"AMITRIPTYLINE HCL","BUPROPION HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2671755725,"AMITRIPTYLINE HCL","BUPROPION HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",0.05333333333,0.02873563218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5480427046,0.3249427918,"AMITRIPTYLINE HCL","BUPROPION HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.09950248756,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CARISOPRODOL",NA,NA,NA,NA,NA
"41-64","Female",0.01834862385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CARISOPRODOL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",0.05188679245,0.01990049751,0.5835495589,NA,NA,0.3177570093,0.200913242,0.3771428571,NA,NA,NA,NA,0.4,NA,0.5403225806,0.448836684,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",0.05755395683,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA
"41-64","Female",0.03243243243,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",0.02542372881,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss",NA,NA,NA
"41-64","Female",NA,NA,0.5671641791,NA,NA,0.4583333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.41191067,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","DULOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4920634921,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",0.03821656051,NA,0.544,NA,NA,NA,0.3308270677,NA,NA,NA,NA,NA,NA,NA,NA,0.3370165746,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5172413793,NA,NA,NA,NA,NA,NA,NA,0.3358208955,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",0.07053941909,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA
"41-64","Female",0.06206896552,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",0.009433962264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & Remiss",NA,NA,NA
"41-64","Female",NA,NA,0.4417177914,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08771929825,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Female",0.02783300199,NA,0.6813380282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5309661437,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7002398082,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,0.5882352941,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",0,NA,0.5918727915,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4933726068,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3398058252,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3493150685,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",0.03361344538,NA,0.664516129,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5096952909,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6733870968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,0.6239316239,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,0.625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4047619048,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",0.009090909091,NA,0.4188034188,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3668528864,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5238095238,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4166666667,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4642857143,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.46875,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.6637168142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6286149163,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.637254902,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.527607362,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6178861789,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.380952381,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3831775701,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2231404959,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.5899843505,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5675675676,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.7121212121,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Num Previous Remissions: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3958333333,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.2666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.196969697,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2844827586,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4258373206,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3706896552,NA,NA,0.3473684211,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",0.04761904762,NA,0.5071633238,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3672768879,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",0.04587155963,NA,0.61,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4070512821,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.03305785124,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3048780488,"AMITRIPTYLINE HCL","CLONAZEPAM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3586956522,"AMITRIPTYLINE HCL","CLONAZEPAM","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",0.01785714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CLONAZEPAM","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",0.07947805457,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3379310345,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Female",0.06,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",0.02525252525,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",0.04651162791,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",0.05590062112,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",0.08846153846,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA
"41-64","Female",0.0101010101,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3269230769,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8461538462,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5873015873,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA
"41-64","Female",0.02941176471,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA
"41-64","Female",0.02127659574,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8106508876,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",0.05607476636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",0.01550387597,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",0.008474576271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",0.03278688525,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA
"41-64","Female",0.07092198582,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6830985915,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.03816793893,NA,NA,0.6506849315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3961456103,"AMITRIPTYLINE HCL","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2792792793,"AMITRIPTYLINE HCL","DESVENLAFAXINE SUCCINATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",0.1140939597,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED (dxo:ICD9:25001)",NA,NA,NA,NA,NA
"41-64","Female",0.07407407407,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3562005277,"AMITRIPTYLINE HCL","DOXEPIN HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5693430657,"AMITRIPTYLINE HCL","DOXEPIN HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2843137255,"AMITRIPTYLINE HCL","DOXEPIN HCL","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3154362416,"AMITRIPTYLINE HCL","DOXEPIN HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2083333333,"AMITRIPTYLINE HCL","DOXEPIN HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3119266055,"AMITRIPTYLINE HCL","DOXEPIN HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.06201550388,0.04237288136,0.380952381,NA,NA,0.5195389373,0.2228571429,NA,NA,NA,NA,NA,0.384,NA,NA,0.4119857595,"AMITRIPTYLINE HCL","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.05555555556,NA,NA,NA,NA,NA,0.3566878981,NA,NA,NA,NA,NA,NA,NA,NA,0.3404761905,"AMITRIPTYLINE HCL","DULOXETINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.45625,"AMITRIPTYLINE HCL","DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",0.03,NA,NA,NA,NA,0.4895104895,NA,0.6387096774,NA,NA,NA,NA,NA,NA,NA,0.3989637306,"AMITRIPTYLINE HCL","DULOXETINE HCL","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4782608696,"AMITRIPTYLINE HCL","DULOXETINE HCL","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6371681416,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DULOXETINE HCL","GABAPENTIN","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5042735043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DULOXETINE HCL","GABAPENTIN","Last AD: Diff & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA
"41-64","Female",0.06050955414,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DULOXETINE HCL","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA
"41-64","Female",0.04060913706,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DULOXETINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.35,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08,"AMITRIPTYLINE HCL","DULOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1008403361,"AMITRIPTYLINE HCL","DULOXETINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",0.04924242424,NA,NA,NA,NA,0.5674157303,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4703668862,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",0.04273504274,NA,NA,NA,NA,0.5294117647,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4331103679,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.71,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","PREGABALIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.546875,NA,NA,NA,NA,NA,NA,NA,0.016,NA,0.362962963,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5669291339,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",0.075,NA,NA,NA,NA,0.6652078775,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5427509294,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4310344828,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6685714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Diff & Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",0.01746724891,NA,NA,NA,NA,0.3155893536,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3386727689,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3948717949,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.43125,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5961538462,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4228187919,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4476190476,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5827538248,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5348837209,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6289308176,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4622222222,"AMITRIPTYLINE HCL","DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3333333333,"AMITRIPTYLINE HCL","DULOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3703703704,"AMITRIPTYLINE HCL","DULOXETINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.35,"AMITRIPTYLINE HCL","DULOXETINE HCL","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3619047619,"AMITRIPTYLINE HCL","DULOXETINE HCL","Num Previous Antidep: 4+","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2648083624,"AMITRIPTYLINE HCL","DULOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2621359223,"AMITRIPTYLINE HCL","DULOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4645669291,"AMITRIPTYLINE HCL","DULOXETINE HCL","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2479338843,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1565217391,"AMITRIPTYLINE HCL","DULOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4215246637,"AMITRIPTYLINE HCL","DULOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3653846154,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2189781022,"AMITRIPTYLINE HCL","DULOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4460227273,"AMITRIPTYLINE HCL","DULOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",0.04901960784,NA,NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,0.5652173913,NA,NA,0.4057142857,"AMITRIPTYLINE HCL","DULOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",0.06870229008,NA,NA,NA,NA,0.4606741573,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3545210385,"AMITRIPTYLINE HCL","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6061946903,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DULOXETINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",0.08823529412,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.42,"AMITRIPTYLINE HCL","DULOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.05673758865,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DYSTHYMIC DISORDER (dxo:ICD9:3004)",NA,NA,NA,NA,NA
"41-64","Female",0.01360544218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DYSTHYMIC DISORDER (dxo:ICD9:3004)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",0.05094736842,0.02597402597,0.4725274725,NA,NA,0.3966942149,0.3553398058,0.3620689655,NA,NA,NA,NA,0.3757961783,NA,0.4692307692,0.3191374663,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",0.09523809524,NA,NA,NA,NA,NA,NA,0.5588235294,NA,NA,NA,NA,NA,NA,NA,0.3273542601,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",0.05211726384,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA
"41-64","Female",0.03827751196,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1893491124,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1891891892,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Female",0.02512562814,0.04,NA,NA,NA,NA,0.3278008299,NA,NA,NA,NA,NA,NA,NA,NA,0.3060156931,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3283972125,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3001808318,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4237288136,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",0.01851851852,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2788906009,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3866666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",0.1261261261,NA,NA,NA,NA,NA,0.7173144876,NA,NA,NA,NA,NA,NA,NA,NA,0.513368984,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.7448979592,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",0.003623188406,NA,NA,NA,NA,NA,0.2162162162,NA,NA,NA,NA,NA,NA,NA,NA,0.2910798122,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2418300654,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2388059701,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2913385827,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3773584906,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3686868687,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5457142857,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.547826087,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4195804196,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1985294118,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1711711712,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2358490566,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.364640884,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",0.04516129032,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5454545455,NA,NA,0.3098039216,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",0.03361344538,NA,NA,NA,NA,NA,0.358974359,NA,NA,NA,NA,NA,NA,NA,NA,0.2814070352,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",0.06451612903,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3197026022,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.05428226779,0.04938271605,0.4335664336,NA,NA,0.356,0.1739130435,0.5909892262,NA,NA,NA,NA,0.4848484848,NA,0.5238095238,0.448603352,"AMITRIPTYLINE HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5636363636,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","GABAPENTIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6752136752,"AMITRIPTYLINE HCL","FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA
"41-64","Female",0.07333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA
"41-64","Female",0.07284768212,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3789473684,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5576923077,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.1111111111,NA,NA,NA,NA,NA,NA,NA,0.1085271318,"AMITRIPTYLINE HCL","FLUOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Female",0.03515625,0.04504504505,NA,NA,NA,NA,NA,0.63,NA,NA,NA,NA,NA,NA,NA,0.5226950355,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6360026473,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.574002574,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6380952381,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6106870229,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",0.02654867257,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4651773982,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4660194175,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4896551724,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",0.03539823009,NA,NA,NA,NA,NA,NA,0.6847662142,NA,NA,NA,NA,NA,NA,NA,0.4565701559,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6893203883,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6219512195,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5849056604,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Remissions: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3333333333,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4705882353,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5950413223,NA,NA,NA,NA,NA,NA,NA,0.4537815126,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Remissions: 2+",NA,NA,NA
"41-64","Female",0.01650165017,NA,NA,NA,NA,NA,NA,0.4154411765,NA,NA,NA,NA,NA,NA,NA,0.3762711864,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4803149606,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4695652174,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.418699187,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5371900826,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6293706294,NA,NA,NA,NA,NA,NA,NA,0.5906666667,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6732673267,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5813953488,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5838150289,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",0.2571428571,NA,NA,NA,NA,NA,NA,0.6894736842,NA,NA,NA,NA,NA,NA,NA,0.5631578947,"AMITRIPTYLINE HCL","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3700787402,"AMITRIPTYLINE HCL","FLUOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.64,NA,NA,NA,NA,NA,NA,NA,0.3885350318,"AMITRIPTYLINE HCL","FLUOXETINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.635883905,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6015037594,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2307692308,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5868263473,NA,NA,NA,NA,NA,NA,NA,0.4897959184,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Num Previous Remissions: 2+",NA,NA,NA,NA
"41-64","Female",0.08928571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3850574713,"AMITRIPTYLINE HCL","FLUOXETINE HCL","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3576642336,NA,NA,NA,NA,NA,NA,NA,0.1794871795,"AMITRIPTYLINE HCL","FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"AMITRIPTYLINE HCL","FLUOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3194444444,"AMITRIPTYLINE HCL","FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2621359223,"AMITRIPTYLINE HCL","FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5120481928,"AMITRIPTYLINE HCL","FLUOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",0.07453416149,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3645833333,"AMITRIPTYLINE HCL","FLUOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",0.07086614173,NA,NA,NA,NA,NA,NA,0.4534606205,NA,NA,NA,NA,NA,NA,NA,0.3936052922,"AMITRIPTYLINE HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",0.07207207207,NA,NA,NA,NA,NA,NA,0.59375,NA,NA,NA,NA,NA,NA,NA,0.4237288136,"AMITRIPTYLINE HCL","FLUOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3757961783,"AMITRIPTYLINE HCL","GABAPENTIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.225,"AMITRIPTYLINE HCL","GABAPENTIN","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",0.04032258065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"41-64","Female",0.02040816327,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4285714286,NA,NA,NA,NA,0.3618090452,"AMITRIPTYLINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2755905512,"AMITRIPTYLINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",0.05205047319,NA,NA,NA,NA,NA,NA,NA,NA,0.0752688172,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0518134715,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",0.03401360544,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",0.08805031447,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",0.03603603604,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",0.06796116505,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",0.0101999184,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",0.007125890736,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA
"41-64","Female",0.01298701299,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",0.004854368932,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",0.03821656051,NA,NA,NA,NA,NA,NA,NA,NA,0.09375,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA
"41-64","Female",0.01047120419,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",0.05202312139,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",0.004739336493,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",0.04,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",0.09871244635,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",0.0396039604,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.04385964912,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Female",0.01904761905,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HYDROCODONE/ACETAMINOPHEN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",0.009259259259,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HYOSCYAMINE SULFATE",NA,NA,NA,NA,NA
"41-64","Female",0.008403361345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HYOSCYAMINE SULFATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.1923076923,NA,NA,NA,0.1071428571,NA,NA,NA,NA,NA,0.2268907563,NA,0.2295081967,0.1494252874,"AMITRIPTYLINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.173553719,"AMITRIPTYLINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2903225806,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1395348837,"AMITRIPTYLINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3689320388,NA,NA,NA,"AMITRIPTYLINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4243902439,NA,NA,NA,"AMITRIPTYLINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,NA,"AMITRIPTYLINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",0.03759398496,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01948051948,NA,NA,"AMITRIPTYLINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4018691589,0.006389776358,NA,NA,"AMITRIPTYLINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"AMITRIPTYLINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.004545454545,NA,NA,"AMITRIPTYLINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09546377793,"AMITRIPTYLINE HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,"AMITRIPTYLINE HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3474576271,"AMITRIPTYLINE HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1081081081,"AMITRIPTYLINE HCL","LAMOTRIGINE","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06926406926,"AMITRIPTYLINE HCL","LAMOTRIGINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1171171171,"AMITRIPTYLINE HCL","LAMOTRIGINE","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07920792079,"AMITRIPTYLINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1212121212,"AMITRIPTYLINE HCL","LAMOTRIGINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.02243211334,0.4050847458,NA,NA,0.3380782918,0.1235632184,0.4319419238,0.1265822785,0.04702194357,0.3028391167,NA,0.4178240741,0.007174887892,0.4091778203,0.2917025553,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Female",0.03225806452,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1625,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5662650602,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6155747837,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5779816514,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007936507937,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5217391304,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6976744186,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6830065359,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6164383562,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006825938567,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7403846154,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2549019608,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3994845361,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Female",0.008333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4957507082,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",0.05691056911,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1875,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5603271984,0.4667931689,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",0.03761755486,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4736842105,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",0.02550091075,0.01818181818,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6485148515,NA,NA,0.5498923187,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4225352113,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3455882353,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2962962963,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2454545455,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","TOPIRAMATE",NA,NA,NA,NA
"41-64","Female",0.05765407555,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01187335092,NA,0.2006125574,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6078431373,0.4601769912,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3387978142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",0.05821917808,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6607744108,0.5271565495,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5114503817,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6390977444,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","Num Previous Remissions: 2+","SERTRALINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6952380952,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6408450704,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7230046948,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7361702128,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7886178862,NA,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3865546218,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4600938967,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6744186047,0.3819444444,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6462585034,NA,NA,0.5247524752,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.68,0.4705882353,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","Num Previous Remissions: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",0.06730769231,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7026239067,NA,NA,NA,NA,0.4769230769,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",0.06680584551,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7342465753,NA,NA,0.5106837607,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",0.05660377358,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7137096774,0.4447674419,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.01386229609,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.204379562,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"41-64","Female",0.01343570058,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",0.02684563758,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","MORPHINE SULFATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4171779141,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4195402299,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",0.01210428305,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",0.009132420091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA
"41-64","Female",0.009433962264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4125874126,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Female",0.008955223881,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4700460829,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5284552846,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2340425532,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4222222222,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4331210191,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",0.008221993834,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA
"41-64","Female",0.006345177665,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",0.01538461538,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","OXYCODONE HCL",NA,NA,NA,NA
"41-64","Female",0.05095541401,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3867403315,NA,NA,NA,NA,0.3746397695,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3411764706,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",0.04918032787,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",0.02912621359,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","POLYNEUROPATHY IN DIABETES (dxo:ICD9:3572)",NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",0.005331302361,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",0.03076923077,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4419354839,NA,NA,0.4470134875,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5094339623,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",0.01860465116,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01477832512,NA,0.2662721893,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4646840149,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",0.04347826087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",0.01851851852,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3615819209,0.4015151515,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6072368421,"AMITRIPTYLINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7339449541,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7211055276,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7055214724,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5666666667,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5766423358,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7226890756,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7235772358,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5268292683,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7209302326,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.612716763,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6253101737,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5765199161,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.683982684,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5704697987,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5477099237,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5476190476,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5847797063,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6759776536,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6186252772,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6180257511,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",0.2779487179,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5629432624,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.562962963,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4649122807,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4776632302,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5472972973,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4571428571,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",0.2596153846,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7016129032,NA,NA,0.6666666667,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.468627451,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5582524272,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5977653631,NA,"AMITRIPTYLINE HCL","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.0706401766,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA,NA
"41-64","Female",0.04807692308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",0.07514450867,NA,NA,NA,NA,NA,NA,NA,0.2975206612,NA,NA,NA,NA,NA,NA,0.3322411533,"AMITRIPTYLINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2180232558,"AMITRIPTYLINE HCL","MIRTAZAPINE","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2405857741,"AMITRIPTYLINE HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3307086614,"AMITRIPTYLINE HCL","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2336182336,"AMITRIPTYLINE HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2698412698,"AMITRIPTYLINE HCL","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.0974025974,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","MORPHINE SULFATE",NA,NA,NA,NA,NA
"41-64","Female",0.04458598726,NA,NA,NA,NA,NA,NA,NA,NA,0.1391304348,NA,NA,NA,NA,NA,0.3340926348,"AMITRIPTYLINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3333333333,"AMITRIPTYLINE HCL","NORTRIPTYLINE HCL","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2780487805,"AMITRIPTYLINE HCL","NORTRIPTYLINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3571428571,"AMITRIPTYLINE HCL","NORTRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2512077295,"AMITRIPTYLINE HCL","NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3833333333,"AMITRIPTYLINE HCL","NORTRIPTYLINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.563002681,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6957671958,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6870546318,NA,NA,NA,"AMITRIPTYLINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6291390728,NA,NA,NA,"AMITRIPTYLINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2865400495,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.375,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3198380567,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.375,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3631961259,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2819321876,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2644230769,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2948207171,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5593667546,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",0.06306306306,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6387434555,NA,NA,0.5172413793,"AMITRIPTYLINE HCL","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6879432624,0.4603174603,"AMITRIPTYLINE HCL","Num Previous Remissions: 2+","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2568807339,"AMITRIPTYLINE HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4397163121,"AMITRIPTYLINE HCL","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3677419355,"AMITRIPTYLINE HCL","OMEPRAZOLE",NA,NA,NA,NA,NA
"41-64","Female",0.03445229682,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",0.02114803625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",0.03539823009,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",0.08260869565,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","OXYCODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.219047619,"AMITRIPTYLINE HCL","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"41-64","Female",0.04978488015,0.02777777778,0.4571428571,NA,NA,0.3153846154,0.1719745223,0.297029703,NA,NA,0.5725868726,NA,0.4086956522,NA,NA,0.444185142,"AMITRIPTYLINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2123893805,"AMITRIPTYLINE HCL","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",0.07920792079,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3642384106,"AMITRIPTYLINE HCL","PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4691943128,NA,NA,NA,NA,0.3251231527,"AMITRIPTYLINE HCL","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3846153846,"AMITRIPTYLINE HCL","PAROXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.09574468085,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09049773756,"AMITRIPTYLINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.344,NA,NA,0.1595092025,"AMITRIPTYLINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.253164557,0.2176470588,"AMITRIPTYLINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.0594795539,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4673807205,"AMITRIPTYLINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5526315789,"AMITRIPTYLINE HCL","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.412244898,"AMITRIPTYLINE HCL","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4485294118,"AMITRIPTYLINE HCL","PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3525773196,"AMITRIPTYLINE HCL","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4068965517,"AMITRIPTYLINE HCL","PRAMIPEXOLE DI-HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.009090909091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1566820276,"AMITRIPTYLINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3170731707,"AMITRIPTYLINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1153846154,"AMITRIPTYLINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.180952381,"AMITRIPTYLINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3700787402,"AMITRIPTYLINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"AMITRIPTYLINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1323943662,"AMITRIPTYLINE HCL","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1494252874,"AMITRIPTYLINE HCL","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",0.06150341686,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4363636364,NA,NA,NA,0.4478632479,"AMITRIPTYLINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4480874317,"AMITRIPTYLINE HCL","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3520599251,"AMITRIPTYLINE HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4790419162,"AMITRIPTYLINE HCL","ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.02019230769,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",0.04759071981,0.02371541502,0.4109589041,NA,NA,0.3319672131,0.1943319838,0.4113924051,NA,NA,0.3663366337,NA,0.6183724995,NA,0.4561403509,0.494288225,"AMITRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.05673758865,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5296912114,NA,NA,0.3873659118,"AMITRIPTYLINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",0.04347826087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4745762712,NA,NA,0.3888888889,"AMITRIPTYLINE HCL","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3623853211,"AMITRIPTYLINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.390625,"AMITRIPTYLINE HCL","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3150684932,"AMITRIPTYLINE HCL","TOPIRAMATE",NA,NA,NA,NA,NA
"41-64","Female",0.08163265306,0.03636363636,NA,NA,NA,0.2614840989,0.1875,0.3673469388,NA,NA,NA,NA,0.3613445378,0.009615384615,0.3367875648,0.3110101252,"AMITRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.09565217391,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5240793201,0.3581818182,"AMITRIPTYLINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.0310880829,NA,NA,NA,NA,0.4404145078,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",0.06297918949,0.04242424242,0.4579439252,NA,NA,NA,0.2195121951,0.396039604,NA,NA,NA,NA,0.4392523364,NA,0.6299039781,0.4259223858,"AMITRIPTYLINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.003875968992,NA,NA,NA,NA,NA,0.125,NA,NA,NA,NA,NA,NA,0.004926108374,NA,NA,"AMLODIPINE BESYLATE",NA,NA,NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMLODIPINE BESYLATE","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1037735849,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMLODIPINE BESYLATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.08675799087,NA,NA,NA,NA,NA,NA,NA,0.4596774194,NA,"AMLODIPINE BESYLATE/BENAZEPRIL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1333333333,NA,NA,NA,NA,NA,NA,NA,"ANOREXIA (dxo:ICD9:7830)",NA,NA,NA,NA,NA,NA
"41-64","Female",0,0.0242465443,0.5674603175,NA,NA,NA,0.1420926899,0.4719101124,NA,0.03015075377,0.3976646124,0.2571428571,0.6144927536,0.009708737864,0.5714285714,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.0584725537,NA,NA,NA,NA,0.1843137255,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03592814371,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA
"41-64","Female",NA,0.06069364162,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,0.05900621118,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,0.03418803419,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA
"41-64","Female",NA,0.08556149733,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA
"41-64","Female",NA,0.08139534884,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,0.09659090909,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","CLONAZEPAM",NA,NA,NA,NA
"41-64","Female",NA,0.03870967742,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","CLONAZEPAM","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,0.06533575318,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA
"41-64","Female",NA,0.0114416476,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,0.01,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA
"41-64","Female",NA,0.06474820144,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,0.07086614173,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,0.05882352941,NA,NA,NA,NA,0.347826087,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Female",NA,0.03278688525,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,0.03248259861,NA,NA,NA,NA,0.3948497854,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,0.01492537313,NA,NA,NA,NA,0.2883895131,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA
"41-64","Female",NA,0.0796460177,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA
"41-64","Female",NA,0.07476635514,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,0.05617977528,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.05327868852,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,0.04910714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,0.07086614173,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA
"41-64","Female",NA,0.0756302521,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,0.08,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","GABAPENTIN",NA,NA,NA,NA
"41-64","Female",NA,0.06626506024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA
"41-64","Female",NA,0.01324503311,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1272189349,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.06451612903,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,0.06451612903,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA
"41-64","Female",NA,0.05263157895,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA
"41-64","Female",NA,0.04611650485,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.04195804196,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,0.05555555556,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,0.05033557047,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,0.04618937644,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.04402515723,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.09615384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA
"41-64","Female",NA,0.08771929825,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,0.02132998745,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.02144772118,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"41-64","Female",NA,0.05627705628,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,0.02189781022,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Same & No Remiss","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA
"41-64","Female",NA,0.01526717557,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Same & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA
"41-64","Female",NA,0.04329004329,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","LORAZEPAM",NA,NA,NA,NA
"41-64","Female",NA,0.02597402597,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","LORAZEPAM","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,0.06428571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Female",NA,0.08965517241,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA
"41-64","Female",NA,0.05487804878,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"41-64","Female",NA,0.0523255814,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.08771929825,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.03787878788,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","VALACYCLOVIR HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1661538462,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUSPIRONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.5087719298,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUSPIRONE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1408450704,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CETIRIZINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1111111111,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02409638554,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01169590643,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Female",NA,0.0412371134,0.6052631579,NA,NA,NA,0.3444730077,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3301886792,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA
"41-64","Female",NA,0.015625,NA,NA,NA,NA,0.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.03418803419,NA,NA,NA,NA,0.2916666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.03174603175,NA,NA,NA,NA,0.1704834606,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CLONAZEPAM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4068965517,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CLONAZEPAM","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1103448276,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CLONAZEPAM","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2147651007,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CLONAZEPAM","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.02408111534,0.5652173913,NA,NA,NA,0.1436464088,0.5559006211,NA,NA,0.4225352113,NA,0.625,0.008333333333,0.56875,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3492647059,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Female",NA,0.03846153846,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1762114537,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2054794521,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3426966292,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6590163934,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6935483871,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2018348624,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA
"41-64","Female",NA,0.02205882353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Female",NA,0.01923076923,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA
"41-64","Female",NA,0.02843601896,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6847457627,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1639344262,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1369047619,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03389830508,NA,NA,NA,NA,0.2450331126,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1568627451,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.03790087464,NA,NA,NA,NA,0.3655259823,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4734299517,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","GABAPENTIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1842105263,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","GABAPENTIN","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1985294118,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1690140845,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.185483871,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2019230769,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,0.02340425532,NA,NA,NA,NA,NA,NA,NA,NA,0.4159292035,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3049327354,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3722222222,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1376146789,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1512915129,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1956181534,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1494252874,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1142857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","OMEPRAZOLE",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1282051282,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1343490305,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1238095238,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","SIMVASTATIN",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.6767200754,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.6920415225,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3883495146,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","MORBID OBESITY (dxo:ICD9:27801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3855799373,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4010989011,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3756906077,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","OMEPRAZOLE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3577586207,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3325867861,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3928571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.362962963,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1058201058,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESOMEPRAZOLE MAGNESIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.16,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESTROGEN,CON/M-PROGEST ACET",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05555555556,NA,NA,NA,NA,0.2417218543,0.641723356,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01754385965,NA,NA,NA,NA,0.1503267974,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2810810811,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7216981132,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.04310344828,NA,NA,NA,NA,0.1742738589,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","GABAPENTIN",NA,NA,NA,NA,NA
"41-64","Female",NA,0.0243902439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1034482759,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","GUAIFENESIN/P-EPHED HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1426448737,NA,NA,NA,0.4459295261,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3053435115,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6365853659,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.07055214724,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.07352941176,NA,NA,NA,0.216,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.0495049505,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA
"41-64","Female",NA,0.02564102564,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007246376812,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01342281879,NA,NA,NA,NA,0.1475409836,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.01550387597,NA,NA,NA,NA,0.1358974359,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1621621622,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.007299270073,NA,NA,NA,NA,0.1700680272,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.01342281879,NA,NA,NA,NA,0.2405063291,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.375,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2782608696,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3370646766,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3181818182,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & No Remiss","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6959459459,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & Remiss","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7905405405,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.02927927928,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","LORAZEPAM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1619047619,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1516587678,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","MORBID OBESITY (dxo:ICD9:27801)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.0564516129,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02066590126,NA,NA,NA,NA,0.1476709613,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1296296296,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.01498127341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1547169811,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1393939394,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","OMEPRAZOLE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1730769231,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","OMEPRAZOLE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.01597444089,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6363636364,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2242990654,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","OXYCODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1231964484,NA,NA,NA,0.393129771,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.48,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PALPITATIONS (dxo:ICD9:7851)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1152542373,NA,NA,NA,0.2857142857,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PALPITATIONS (dxo:ICD9:7851)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.0297029703,NA,NA,NA,NA,NA,NA,NA,NA,0.393442623,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02551020408,NA,NA,NA,NA,0.2692307692,NA,NA,NA,0.6235955056,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6144414169,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1142857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.07476635514,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.08465608466,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,0.02822580645,NA,NA,NA,NA,0.08306709265,NA,NA,NA,0.1634615385,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.06626506024,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1359223301,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","RISEDRONATE SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3518518519,NA,NA,0,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01515151515,NA,NA,NA,NA,0.1340979268,NA,NA,NA,0.3475285171,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1292517007,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.07299270073,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"41-64","Female",NA,0.02996254682,NA,NA,NA,NA,0.2299107143,NA,NA,NA,0.5135135135,NA,0.797029703,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.149321267,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1209677419,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","UNSPECIFIED ACUTE REACTION TO STRESS (dxo:ICD9:3089)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.182320442,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01360544218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","VALACYCLOVIR HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1071428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","VALSARTAN",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03139013453,NA,NA,NA,NA,0.2546125461,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.2091254753,0.2095435685,NA,0.2058823529,0.1225490196,0.2307692308,NA,NA,NA,NA,0.15625,0.05833333333,0.2390891841,0.1541353383,"ARIPIPRAZOLE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1703296703,NA,NA,NA,NA,NA,NA,NA,NA,0.2151898734,0.1326530612,"ARIPIPRAZOLE","BUPROPION HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1737089202,"ARIPIPRAZOLE","BUPROPION HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1056338028,"ARIPIPRAZOLE","BUPROPION HCL","CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.16,"ARIPIPRAZOLE","BUPROPION HCL","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2261904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1678657074,"ARIPIPRAZOLE","BUPROPION HCL","DULOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2277227723,"ARIPIPRAZOLE","BUPROPION HCL","DULOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1506024096,"ARIPIPRAZOLE","BUPROPION HCL","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1366120219,NA,NA,NA,NA,NA,NA,NA,NA,0.1370558376,"ARIPIPRAZOLE","BUPROPION HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1744186047,"ARIPIPRAZOLE","BUPROPION HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.1971830986,NA,NA,NA,NA,NA,NA,NA,0.1678657074,"ARIPIPRAZOLE","BUPROPION HCL","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08444444444,"ARIPIPRAZOLE","BUPROPION HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05844155844,"ARIPIPRAZOLE","BUPROPION HCL","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05,"ARIPIPRAZOLE","BUPROPION HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2906976744,NA,NA,0.1672727273,"ARIPIPRAZOLE","BUPROPION HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1602564103,"ARIPIPRAZOLE","BUPROPION HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1043956044,"ARIPIPRAZOLE","BUPROPION HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1666666667,"ARIPIPRAZOLE","BUPROPION HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2325581395,0.1894736842,"ARIPIPRAZOLE","BUPROPION HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.3097643098,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1729559748,"ARIPIPRAZOLE","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.1710526316,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ARIPIPRAZOLE","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.255033557,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1832061069,"ARIPIPRAZOLE","CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.1737451737,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2303921569,"ARIPIPRAZOLE","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.08870967742,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ARIPIPRAZOLE","DESVENLAFAXINE SUCCINATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1333333333,"ARIPIPRAZOLE","DESVENLAFAXINE SUCCINATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2090909091,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1751085384,"ARIPIPRAZOLE","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1834862385,"ARIPIPRAZOLE","DULOXETINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.09433962264,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06837606838,"ARIPIPRAZOLE","DULOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1584158416,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07272727273,"ARIPIPRAZOLE","DULOXETINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1584158416,"ARIPIPRAZOLE","DULOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1699716714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ARIPIPRAZOLE","DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5396825397,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ARIPIPRAZOLE","DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1588785047,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.119266055,"ARIPIPRAZOLE","DULOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1751412429,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1742957746,"ARIPIPRAZOLE","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1563342318,NA,NA,NA,NA,NA,NA,NA,NA,0.1289640592,"ARIPIPRAZOLE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1603053435,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ARIPIPRAZOLE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1379310345,NA,NA,NA,NA,NA,NA,NA,NA,0.1271477663,"ARIPIPRAZOLE","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2545454545,NA,0.2666666667,NA,NA,NA,NA,NA,NA,NA,0.1476190476,"ARIPIPRAZOLE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2173913043,NA,NA,NA,NA,NA,NA,NA,NA,"ARIPIPRAZOLE","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2131147541,NA,NA,NA,NA,NA,NA,NA,0.1380208333,"ARIPIPRAZOLE","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.1382113821,NA,0.1151515152,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08,"ARIPIPRAZOLE","LAMOTRIGINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04724409449,"ARIPIPRAZOLE","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1074380165,0.09482758621,"ARIPIPRAZOLE","LAMOTRIGINE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0737704918,NA,"ARIPIPRAZOLE","LAMOTRIGINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1312056738,NA,NA,NA,"ARIPIPRAZOLE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2388888889,NA,"ARIPIPRAZOLE","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4711538462,NA,"ARIPIPRAZOLE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2402597403,NA,NA,NA,NA,0.158974359,"ARIPIPRAZOLE","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1691176471,"ARIPIPRAZOLE","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.1044776119,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ARIPIPRAZOLE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1897810219,NA,"ARIPIPRAZOLE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2114014252,NA,NA,0.1901408451,"ARIPIPRAZOLE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1696428571,NA,NA,0.1651090343,"ARIPIPRAZOLE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.237704918,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1601830664,"ARIPIPRAZOLE","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2016574586,0.1711229947,"ARIPIPRAZOLE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2258064516,0.1726755218,"ARIPIPRAZOLE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATENOLOL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.05555555556,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATENOLOL","BUPROPION HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01851851852,NA,NA,"ATHEROSCLEROSIS OF AORTA (dxo:ICD9:4400)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5406943654,NA,NA,NA,0.1303370787,0.5519455988,NA,NA,0.4861111111,NA,0.5863049661,NA,0.4796747967,0.2580645161,"ATORVASTATIN CALCIUM",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3432835821,"ATORVASTATIN CALCIUM","BUPROPION HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.53,"ATORVASTATIN CALCIUM","BUPROPION HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6377952756,NA,NA,NA,NA,NA,NA,NA,0.6226415094,"ATORVASTATIN CALCIUM","BUPROPION HCL","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.702970297,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6339285714,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2937062937,"ATORVASTATIN CALCIUM","BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6478873239,NA,NA,NA,"ATORVASTATIN CALCIUM","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8344827586,NA,NA,NA,"ATORVASTATIN CALCIUM","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7304347826,NA,NA,NA,"ATORVASTATIN CALCIUM","BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6559139785,NA,NA,0.8037383178,"ATORVASTATIN CALCIUM","BUPROPION HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7420168067,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7058823529,NA,NA,0.4503311258,"ATORVASTATIN CALCIUM","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7757009346,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7126436782,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","CITALOPRAM HYDROBROMIDE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.4644808743,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7959183673,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.63507109,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7506361323,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7534246575,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8230088496,NA,NA,0.4049586777,"ATORVASTATIN CALCIUM","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.465648855,"ATORVASTATIN CALCIUM","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.75,NA,NA,NA,0.3870967742,NA,NA,NA,NA,NA,0.6439393939,NA,NA,0.3468013468,"ATORVASTATIN CALCIUM","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5169491525,NA,NA,0.1833333333,"ATORVASTATIN CALCIUM","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.19,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4135338346,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.456,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","ESOMEPRAZOLE MAGNESIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7424242424,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","ESOMEPRAZOLE MAGNESIUM","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5641025641,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5428571429,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","ESTRADIOL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7586206897,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","ESTRADIOL","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.696,NA,NA,NA,"ATORVASTATIN CALCIUM","ESTROGEN,CON/M-PROGEST ACET",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7398843931,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","ESTROGEN,CON/M-PROGEST ACET","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8344827586,NA,NA,NA,"ATORVASTATIN CALCIUM","ESTROGEN,CON/M-PROGEST ACET","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.8226950355,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","ESTROGENS, CONJUGATED","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7909090909,NA,NA,NA,"ATORVASTATIN CALCIUM","ESTROGENS, CONJUGATED","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7479576399,NA,NA,NA,NA,0.6754385965,NA,NA,0.4468085106,"ATORVASTATIN CALCIUM","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7238095238,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL","GABAPENTIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6953125,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4708276798,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3976833977,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7807435653,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7230769231,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL","LEVOTHYROXINE SODIUM",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6993464052,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7391304348,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5754189944,NA,NA,NA,NA,0.5476190476,NA,NA,NA,"ATORVASTATIN CALCIUM","GABAPENTIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.75,NA,NA,NA,"ATORVASTATIN CALCIUM","GABAPENTIN","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6692607004,NA,NA,NA,"ATORVASTATIN CALCIUM","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7971014493,NA,NA,NA,"ATORVASTATIN CALCIUM","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5163398693,NA,NA,NA,NA,0.4784313725,NA,NA,NA,"ATORVASTATIN CALCIUM","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8212560386,NA,NA,NA,"ATORVASTATIN CALCIUM","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5563909774,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7818181818,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4757281553,"ATORVASTATIN CALCIUM","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4267676768,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4780534351,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.9596774194,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8157068063,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6324324324,NA,NA,NA,"ATORVASTATIN CALCIUM","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8131868132,NA,NA,NA,"ATORVASTATIN CALCIUM","LEVOTHYROXINE SODIUM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7987288136,NA,NA,NA,"ATORVASTATIN CALCIUM","LEVOTHYROXINE SODIUM","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5619047619,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","LISINOPRIL/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.58,NA,NA,NA,"ATORVASTATIN CALCIUM","METFORMIN HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5754716981,NA,NA,NA,"ATORVASTATIN CALCIUM","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5868263473,NA,NA,NA,"ATORVASTATIN CALCIUM","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8039215686,NA,NA,NA,"ATORVASTATIN CALCIUM","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8532110092,NA,NA,NA,"ATORVASTATIN CALCIUM","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4901960784,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6747572816,NA,0.6936936937,NA,NA,0.4014869888,"ATORVASTATIN CALCIUM","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5982905983,NA,NA,NA,"ATORVASTATIN CALCIUM","RAMIPRIL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1462264151,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7870603015,NA,NA,0.4511627907,"ATORVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7409090909,NA,NA,NA,"ATORVASTATIN CALCIUM","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6503496503,NA,NA,NA,"ATORVASTATIN CALCIUM","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8118811881,NA,NA,NA,"ATORVASTATIN CALCIUM","SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7435897436,NA,NA,NA,"ATORVASTATIN CALCIUM","SERTRALINE HCL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6193181818,NA,NA,NA,"ATORVASTATIN CALCIUM","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3666666667,"ATORVASTATIN CALCIUM","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5597826087,NA,NA,NA,"ATORVASTATIN CALCIUM","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.524137931,NA,NA,NA,"ATORVASTATIN CALCIUM","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7226027397,0.43,"ATORVASTATIN CALCIUM","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02898550725,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.04268292683,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.08695652174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","BUPROPION HCL",NA,NA,NA,NA
"41-64","Female",NA,0.08863636364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","BUPROPION HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05769230769,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","BUPROPION HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.03021148036,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.03380588877,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.06761006289,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","BUPROPION HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03811252269,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.1090909091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","BUPROPION HCL","METHYLPHENIDATE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.02479338843,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","METHYLPHENIDATE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.07207207207,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5092592593,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AZELASTINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7165354331,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AZELASTINE HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5087719298,NA,NA,NA,0.1356932153,NA,NA,NA,NA,NA,0.5309734513,NA,0.4057971014,NA,"AZITHROMYCIN",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3137254902,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AZITHROMYCIN","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1753246753,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AZITHROMYCIN","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7032258065,NA,NA,NA,"AZITHROMYCIN","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.01058201058,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BACLOFEN",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3168316832,"BARIATRIC SURGERY STATUS (dxo:ICD9:V4586)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4495412844,"BARIATRIC SURGERY STATUS (dxo:ICD9:V4586)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4811320755,"BARIATRIC SURGERY STATUS (dxo:ICD9:V4586)","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4074074074,"BARIATRIC SURGERY STATUS (dxo:ICD9:V4586)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5135135135,"BARIATRIC SURGERY STATUS (dxo:ICD9:V4586)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4385964912,"BARIATRIC SURGERY STATUS (dxo:ICD9:V4586)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4510869565,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN HYPERTENSIVE HEART DISEASE WITHOUT HEART FAILURE (dxo:ICD9:40210)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5151515152,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN NEOPLASM OF COLON (dxo:ICD9:2113)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.731092437,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN NEOPLASM OF COLON (dxo:ICD9:2113)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.697167756,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN NEOPLASM OF COLON (dxo:ICD9:2113)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.450617284,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN NEOPLASM OF COLON (dxo:ICD9:2113)","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7604166667,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN NEOPLASM OF COLON (dxo:ICD9:2113)","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN NEOPLASM OF SKIN OF TRUNK, EXCEPT SCROTUM (dxo:ICD9:2165)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3603603604,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN NEOPLASM OF SKIN OF TRUNK, EXCEPT SCROTUM (dxo:ICD9:2165)","ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1152416357,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN NEOPLASM OF SKIN OF TRUNK, EXCEPT SCROTUM (dxo:ICD9:2165)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4244186047,NA,NA,NA,NA,NA,"BENZONATATE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6492537313,NA,NA,NA,NA,NA,"BENZONATATE","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.393442623,NA,NA,NA,NA,0.3766233766,NA,NA,NA,NA,0.4338235294,NA,NA,0.2748091603,"BIPOLAR DISORDER, UNSPECIFIED (dxo:ICD9:29680)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6336633663,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BIPOLAR DISORDER, UNSPECIFIED (dxo:ICD9:29680)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6519607843,NA,NA,NA,NA,NA,NA,NA,NA,"BIPOLAR DISORDER, UNSPECIFIED (dxo:ICD9:29680)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6171428571,NA,NA,NA,"BIPOLAR DISORDER, UNSPECIFIED (dxo:ICD9:29680)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.3882352941,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BLEPHARITIS, UNSPECIFIED (dxo:ICD9:37300)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.3943217666,NA,NA,0.226519337,0.08181818182,NA,NA,NA,NA,NA,NA,0,NA,NA,"BODY MASS INDEX BETWEEN 19-24, ADULT (dxo:ICD9:V851)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6807228916,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BODY MASS INDEX BETWEEN 19-24, ADULT (dxo:ICD9:V851)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09352517986,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BODY MASS INDEX BETWEEN 19-24, ADULT (dxo:ICD9:V851)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",0.02188295165,0.05630760083,0.4398025524,0.6282151208,0.1183673469,0.371966991,0.1619741636,0.4020849681,0.1188118812,0.05505952381,0.3779214321,0.2148760331,0.4440898345,0.01890221738,0.4810254114,0.3690932728,"BUPROPION HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3274853801,"BUPROPION HCL","BUSPIRONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.04416961131,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.0198019802,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.007389162562,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"41-64","Female",NA,0.02325581395,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Female",0.03645833333,0.05872072702,0.535719514,NA,NA,0.4249649369,0.2233128834,0.4344023324,0.06666666667,NA,0.3674121406,NA,0.4553072626,0.02272727273,0.6094890511,0.4419911682,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6086956522,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","CLONAZEPAM",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5925925926,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","CLONAZEPAM","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,0.05392156863,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6176470588,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5755395683,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,0.05426356589,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,0.01986754967,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4827586207,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,0.03278688525,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7475728155,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3302752294,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3644067797,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","DOXEPIN HCL",NA,NA,NA,NA
"41-64","Female",NA,0.04444444444,0.5364963504,NA,NA,0.4690265487,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3465346535,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","DULOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.04285714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4038461538,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.552,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3052208835,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2727272727,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.04642166344,0.6172106825,NA,NA,NA,0.3080684597,NA,NA,NA,NA,NA,NA,NA,NA,0.3568376068,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Female",NA,0.05301204819,NA,NA,NA,NA,0.2947368421,NA,NA,NA,NA,NA,NA,NA,NA,0.48,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,0.08661417323,NA,NA,NA,NA,0.3384615385,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,NA,0.6470588235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA
"41-64","Female",NA,NA,0.6666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4577114428,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,0.08870967742,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4637223975,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4810126582,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5904761905,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2218309859,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,0.6713286713,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1608040201,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2382978723,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.05660377358,0.436997319,NA,NA,NA,NA,0.424437299,NA,NA,NA,NA,NA,NA,NA,0.3088023088,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.04864864865,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.416,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4306569343,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2896174863,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1584158416,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.255033557,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.0625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,0.7032258065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4918032787,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.2664233577,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1761252446,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA
"41-64","Female",NA,0.05072463768,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2178217822,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Diff & No Remiss",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1984732824,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2086330935,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","TRAZODONE HCL",NA
"41-64","Female",NA,NA,0.2156862745,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1555555556,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.119266055,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1842105263,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,0.3812785388,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.328358209,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3101265823,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2482758621,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Female",NA,NA,0.1642857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.162601626,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1238095238,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Female",NA,NA,0.4529147982,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2556053812,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,0.2259887006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.125,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1357142857,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,0.1592039801,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09746588694,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07570977918,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.05408805031,0.7025641026,NA,NA,0.49,0.2011019284,NA,NA,NA,NA,NA,0.6,0.01485148515,0.6045751634,0.5736478711,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.03524229075,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"41-64","Female",NA,0.05013428827,0.7247007617,NA,NA,NA,0.2275862069,0.495412844,NA,NA,NA,NA,0.5443037975,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,0.04042553191,0.5758969641,NA,NA,NA,0.2203389831,NA,NA,NA,NA,NA,0.5255474453,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,0.55,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,0.07,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"41-64","Female",NA,0.04379562044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008928571429,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,0.5751978892,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6103896104,0.5379853686,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6343283582,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SIMVASTATIN",NA,NA
"41-64","Female",NA,NA,0.5197368421,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3181818182,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4752475248,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,0.07301587302,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2631578947,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3176470588,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"41-64","Female",NA,0.03351955307,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4827586207,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,0.04291845494,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006849315068,NA,0.3227383863,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.06470588235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4797297297,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.06836327345,0.6622902991,NA,NA,0.5818181818,0.375,NA,NA,NA,NA,NA,NA,NA,NA,0.5856966708,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.6143497758,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8235294118,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Female",NA,0.05714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"41-64","Female",NA,0.06933333333,0.6829896907,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,0.05579399142,0.6052631579,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,0.6266094421,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA
"41-64","Female",NA,0.06930693069,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Remissions: 2+",NA,NA
"41-64","Female",NA,NA,0.6120689655,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5201342282,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,0.6102941176,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5773195876,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA,NA
"41-64","Female",NA,0.08762886598,0.6111111111,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5589519651,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Remissions: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06481481481,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.02016129032,0.4488054608,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3928067701,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.01860465116,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,0.02424242424,0.5213270142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,0.5365853659,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4633699634,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4568690096,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1572052402,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1948881789,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2321428571,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.248,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1967213115,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4390243902,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4442649435,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.525,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.6709265176,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6535326087,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.75,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7511737089,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,0.6343283582,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,0.6303030303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6511627907,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7577639752,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.547008547,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4782608696,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7121212121,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Remissions: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5730994152,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6715328467,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5267175573,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5276872964,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7923076923,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA
"41-64","Female",NA,0.4615384615,0.7342342342,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6708333333,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"41-64","Female",NA,0.472392638,0.6854460094,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6503144654,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6727272727,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Remissions: 2+",NA,NA,NA
"41-64","Female",NA,NA,0.7289719626,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6981132075,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5113636364,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2974504249,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2578125,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.08759124088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3664122137,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5045045045,NA,NA,NA,NA,0.5337423313,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Antidep: 2,3",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2673267327,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Antidep: 4+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.219123506,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2155172414,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.214953271,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Antidep: 4+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.5869565217,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,0.527173913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.6005586592,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5967741935,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Remissions: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7391304348,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.619047619,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","OMEPRAZOLE",NA,NA,NA,NA
"41-64","Female",NA,0.06289308176,0.4773869347,NA,NA,NA,NA,NA,NA,NA,0.44,NA,NA,NA,NA,0.3309352518,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.1016042781,0.2755775578,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1918443003,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1516853933,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,0.24,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1616871705,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4494382022,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2626865672,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.2352941176,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.209375,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1307189542,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.3443983402,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2772277228,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2045454545,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08152173913,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","RISPERIDONE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1117647059,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.5047619048,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4208037825,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.04076086957,0.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5117647059,NA,NA,0.3577512777,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2457627119,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7358490566,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,0.07151664612,0.4122211445,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01286764706,NA,0.3135864593,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2527472527,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.06031746032,0.5170068027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7185185185,0.3358681876,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.07465277778,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3107890499,"BUPROPION HCL","CLONAZEPAM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4424242424,"BUPROPION HCL","CLONAZEPAM","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3962264151,"BUPROPION HCL","CLONAZEPAM","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3286713287,"BUPROPION HCL","CLONAZEPAM","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5738636364,"BUPROPION HCL","CLONAZEPAM","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5042016807,"BUPROPION HCL","CLONAZEPAM","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2823834197,"BUPROPION HCL","CLONAZEPAM","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5135135135,"BUPROPION HCL","CLONAZEPAM","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1470588235,"BUPROPION HCL","CLONAZEPAM","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.02247191011,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CLONAZEPAM","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6455696203,"BUPROPION HCL","CLONAZEPAM","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2403846154,"BUPROPION HCL","CLONAZEPAM","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2756410256,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Female",0.009900990099,0.06518561824,NA,0.6460674157,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02272727273,0.6254180602,0.3070088845,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.0701754386,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",NA,NA,NA,NA
"41-64","Female",NA,0.04316546763,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,0.08510638298,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4747081712,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3439153439,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,0.03314917127,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,0.04306220096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3628691983,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.29,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,0.05357142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUCONAZOLE",NA,NA,NA,NA
"41-64","Female",NA,0.06278026906,NA,NA,NA,NA,NA,0.6036866359,NA,NA,NA,NA,NA,NA,NA,0.6595744681,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5612903226,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,0.06086956522,NA,NA,NA,NA,NA,0.7006802721,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,0.04294478528,NA,NA,NA,NA,NA,0.6755319149,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.552238806,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7248322148,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,0.05607476636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA
"41-64","Female",NA,0.05882352941,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA
"41-64","Female",NA,0.04929577465,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA
"41-64","Female",NA,0.01,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,0.09322033898,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02941176471,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL"
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01630434783,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA
"41-64","Female",0.006622516556,NA,NA,NA,NA,NA,NA,0.4910179641,NA,NA,NA,NA,NA,0.006060606061,0.5386996904,0.3205804749,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.05347593583,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01142857143,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5986842105,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA
"41-64","Female",NA,0.0511627907,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009404388715,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.820754717,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5071090047,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1677018634,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6084656085,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2972972973,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6124031008,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.775862069,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.03738317757,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7299270073,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7210526316,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.02127659574,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.02028985507,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"41-64","Female",NA,0.02591792657,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,0.01960784314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA
"41-64","Female",NA,0.02637362637,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA
"41-64","Female",NA,0.04575163399,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA
"41-64","Female",NA,0.02158273381,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,0.02857142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","VALACYCLOVIR HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6850393701,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2752808989,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","LEVOTHYROXINE SODIUM",NA,NA,NA,NA
"41-64","Female",NA,0.08661417323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA
"41-64","Female",NA,0.04296875,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Female",NA,0.05685618729,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA
"41-64","Female",NA,0.06003752345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"41-64","Female",NA,0.08,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA
"41-64","Female",NA,0.06172839506,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,0.06466512702,NA,0.7058823529,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3300492611,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.05434782609,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6690140845,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.1503759398,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03684210526,NA,0.2,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.07567567568,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","VALACYCLOVIR HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6293706294,0.5538461538,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.06704980843,NA,0.6879535559,NA,NA,0.1851851852,NA,NA,NA,NA,NA,NA,NA,NA,0.3494377343,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.314159292,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","DULOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.32,NA,NA,NA,NA,NA,NA,NA,NA,0.2465116279,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3121387283,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07718120805,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Female",NA,0.06430868167,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5476190476,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5267175573,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,0.1132075472,NA,0.6524822695,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5288461538,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4347826087,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5890410959,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5072463768,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5771428571,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2253521127,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2124183007,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1666666667,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1965811966,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.7123287671,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3178807947,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2621231979,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3846153846,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2920353982,"BUPROPION HCL","DEXLANSOPRAZOLE",NA,NA,NA,NA,NA
"41-64","Female",NA,0.06924643585,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02424242424,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.06488549618,NA,NA,0.3790322581,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3387096774,"BUPROPION HCL","DOXEPIN HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3348017621,"BUPROPION HCL","DOXEPIN HCL","DULOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.213592233,"BUPROPION HCL","DOXEPIN HCL","DULOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2923728814,"BUPROPION HCL","DOXEPIN HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3796610169,"BUPROPION HCL","DOXEPIN HCL","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09090909091,"BUPROPION HCL","DOXEPIN HCL","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Female",NA,0.06352941176,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3263888889,"BUPROPION HCL","DOXEPIN HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.04458598726,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DOXEPIN HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5088235294,"BUPROPION HCL","DOXEPIN HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3846153846,"BUPROPION HCL","DOXEPIN HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3021276596,"BUPROPION HCL","DOXEPIN HCL","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2167042889,"BUPROPION HCL","DOXEPIN HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1775700935,"BUPROPION HCL","DOXEPIN HCL","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3619047619,"BUPROPION HCL","DOXEPIN HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2407862408,"BUPROPION HCL","DOXEPIN HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3220338983,"BUPROPION HCL","DOXEPIN HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.02307692308,0.05631958088,0.4310344828,NA,NA,0.469762419,0.196969697,0.4456140351,NA,NA,0.3113207547,NA,0.4464831804,NA,0.5582822086,0.3617730705,"BUPROPION HCL","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.04049844237,NA,NA,NA,NA,0.3569230769,NA,NA,NA,NA,NA,NA,NA,NA,0.2880490296,"BUPROPION HCL","DULOXETINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Female",NA,0.04924242424,NA,NA,NA,NA,0.4274193548,NA,NA,NA,NA,NA,NA,NA,NA,0.4037267081,"BUPROPION HCL","DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3490566038,"BUPROPION HCL","DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3842105263,"BUPROPION HCL","DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4907407407,"BUPROPION HCL","DULOXETINE HCL","ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2396694215,"BUPROPION HCL","DULOXETINE HCL","ESCITALOPRAM OXALATE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1320754717,"BUPROPION HCL","DULOXETINE HCL","ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2740384615,"BUPROPION HCL","DULOXETINE HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.04219409283,NA,NA,NA,0.4261168385,NA,0.5288461538,NA,NA,NA,NA,NA,NA,NA,0.3289328933,"BUPROPION HCL","DULOXETINE HCL","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09803921569,"BUPROPION HCL","DULOXETINE HCL","FLUOXETINE HCL","LAMOTRIGINE",NA,NA,NA
"41-64","Female",NA,0.04494382022,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4736842105,"BUPROPION HCL","DULOXETINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6310679612,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5090909091,"BUPROPION HCL","DULOXETINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4804469274,"BUPROPION HCL","DULOXETINE HCL","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6379310345,"BUPROPION HCL","DULOXETINE HCL","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.625,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2926829268,"BUPROPION HCL","DULOXETINE HCL","FLUOXETINE HCL","Num Previous Antidep: 4+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.303030303,"BUPROPION HCL","DULOXETINE HCL","FLUOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3026315789,"BUPROPION HCL","DULOXETINE HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.536,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","GABAPENTIN","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2415730337,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1666666667,"BUPROPION HCL","DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07438016529,"BUPROPION HCL","DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.100591716,"BUPROPION HCL","DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3686635945,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2037037037,"BUPROPION HCL","DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2881355932,"BUPROPION HCL","DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1492537313,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1050228311,"BUPROPION HCL","DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09243697479,"BUPROPION HCL","DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1317991632,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07918552036,"BUPROPION HCL","DULOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.452991453,"BUPROPION HCL","DULOXETINE HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06701030928,"BUPROPION HCL","DULOXETINE HCL","LAMOTRIGINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1463414634,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06616257089,"BUPROPION HCL","DULOXETINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.04523424879,NA,NA,NA,0.5535987749,0.2,NA,NA,NA,NA,NA,NA,0,0.5572519084,0.4844444444,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.04310344828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"41-64","Female",NA,0.04573804574,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,0.04827586207,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009345794393,NA,NA,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4695340502,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4474034621,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.354368932,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.04,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3069306931,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2374100719,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"41-64","Female",NA,0.05325443787,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5909090909,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,0.05278592375,NA,NA,NA,0.4894736842,NA,NA,NA,NA,NA,NA,NA,0.03055555556,NA,0.3702422145,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6031746032,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,0.05294117647,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4406779661,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.1069444444,NA,NA,NA,0.6709677419,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5578703704,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.5755395683,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Female",NA,0.05741626794,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5447154472,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.671641791,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & Remiss","Num Previous Remissions: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6623376623,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,0.03147699758,NA,NA,NA,0.3022774327,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3918699187,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4141414141,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4396984925,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.115942029,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1747572816,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2164179104,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4233128834,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4331428571,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.48,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.686746988,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6008298755,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.743772242,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7475728155,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7528957529,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4840425532,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & Remiss","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6377952756,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4462809917,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.520661157,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & Remiss","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5247524752,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5149253731,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5789473684,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5006858711,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7049180328,"BUPROPION HCL","DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.7079207921,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6612244898,"BUPROPION HCL","DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.48,"BUPROPION HCL","DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.3064516129,NA,NA,NA,0.5881294964,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5682352941,"BUPROPION HCL","DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.537037037,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4344023324,"BUPROPION HCL","DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3417721519,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2789317507,"BUPROPION HCL","DULOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2206896552,"BUPROPION HCL","DULOXETINE HCL","MIRTAZAPINE","Num Previous Antidep: 4+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2513368984,"BUPROPION HCL","DULOXETINE HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3142857143,"BUPROPION HCL","DULOXETINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3039215686,"BUPROPION HCL","DULOXETINE HCL","NORTRIPTYLINE HCL","Num Previous Antidep: 4+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2595155709,"BUPROPION HCL","DULOXETINE HCL","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3394495413,"BUPROPION HCL","DULOXETINE HCL","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3311688312,"BUPROPION HCL","DULOXETINE HCL","Num Previous Antidep: 4+","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2463054187,"BUPROPION HCL","DULOXETINE HCL","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2824074074,"BUPROPION HCL","DULOXETINE HCL","Num Previous Antidep: 4+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2785774767,"BUPROPION HCL","DULOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2361111111,"BUPROPION HCL","DULOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3027027027,"BUPROPION HCL","DULOXETINE HCL","Num Previous Antidep: 4+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6513157895,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5462184874,"BUPROPION HCL","DULOXETINE HCL","Num Previous Remissions: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5,NA,NA,NA,NA,0.53,NA,NA,NA,NA,0.3791469194,"BUPROPION HCL","DULOXETINE HCL","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2486910995,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1695804196,"BUPROPION HCL","DULOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.16,"BUPROPION HCL","DULOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1647398844,"BUPROPION HCL","DULOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.37,"BUPROPION HCL","DULOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2978723404,"BUPROPION HCL","DULOXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1802816901,"BUPROPION HCL","DULOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1235521236,"BUPROPION HCL","DULOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.30651341,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2572815534,"BUPROPION HCL","DULOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2157676349,"BUPROPION HCL","DULOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5363636364,"BUPROPION HCL","DULOXETINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1079545455,"BUPROPION HCL","DULOXETINE HCL","RISPERIDONE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4083333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.374789916,"BUPROPION HCL","DULOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.04347826087,NA,NA,NA,0.480620155,NA,NA,NA,NA,NA,NA,0.562962963,NA,NA,0.3264746228,"BUPROPION HCL","DULOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2795031056,"BUPROPION HCL","DULOXETINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.04888888889,NA,NA,NA,0.3367252544,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2965383684,"BUPROPION HCL","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2587719298,"BUPROPION HCL","DULOXETINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5634517766,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,0.06018518519,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7169811321,0.3391812865,"BUPROPION HCL","DULOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.07428571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DYSMETABOLIC SYNDROME X (dxo:ICD9:2777)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02040816327,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DYSMETABOLIC SYNDROME X (dxo:ICD9:2777)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3064516129,"BUPROPION HCL","DYSTHYMIC DISORDER (dxo:ICD9:3004)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.1150442478,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869)",NA,NA,NA,NA,NA
"41-64","Female",0.0380952381,0.03826975817,0.5615763547,NA,NA,0.4535637149,0.3004898917,0.4243243243,0.1466666667,NA,0.3544973545,NA,0.4155578301,0.02247191011,0.6125186289,0.3033296744,"BUPROPION HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03970223325,NA,NA,NA,NA,0.2637362637,0.4322033898,NA,NA,NA,NA,0.42,NA,NA,0.3214285714,"BUPROPION HCL","ESCITALOPRAM OXALATE","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.02250803859,NA,NA,NA,NA,0.347107438,NA,NA,NA,NA,NA,NA,NA,NA,0.4491017964,"BUPROPION HCL","ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.640776699,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4609375,"BUPROPION HCL","ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4734042553,"BUPROPION HCL","ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5545454545,"BUPROPION HCL","ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.640776699,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1818181818,"BUPROPION HCL","ESCITALOPRAM OXALATE","FLUOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1439393939,"BUPROPION HCL","ESCITALOPRAM OXALATE","FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2130177515,"BUPROPION HCL","ESCITALOPRAM OXALATE","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.0703125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA
"41-64","Female",NA,0.02651515152,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,0.01657458564,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2661870504,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2735042735,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1251908397,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09734513274,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA
"41-64","Female",NA,0.03070175439,NA,NA,NA,NA,0.1549295775,NA,NA,NA,NA,NA,NA,NA,NA,0.1615384615,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Diff & No Remiss",NA,NA
"41-64","Female",NA,0.05217391304,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1123595506,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.118556701,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1165919283,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1203703704,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0985915493,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1277372263,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1944809461,NA,NA,NA,NA,NA,NA,NA,NA,0.2205882353,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1798941799,NA,NA,NA,NA,NA,NA,NA,NA,0.2019230769,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.18125,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2019704433,NA,NA,NA,NA,NA,NA,NA,NA,0.1675675676,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1203703704,NA,NA,NA,NA,NA,NA,NA,NA,0.2012987013,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1739130435,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1299435028,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08843537415,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2290909091,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1333333333,NA,NA,NA,NA,NA,NA,NA,NA,0.08673469388,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1428571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Diff & No Remiss",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07086614173,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06878306878,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1189710611,NA,NA,NA,NA,NA,NA,NA,NA,0.06614785992,"BUPROPION HCL","ESCITALOPRAM OXALATE","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.024,"BUPROPION HCL","ESCITALOPRAM OXALATE","LAMOTRIGINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05596107056,"BUPROPION HCL","ESCITALOPRAM OXALATE","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.03052382828,0.5925925926,NA,NA,0.4329268293,0.318608784,NA,NA,NA,NA,NA,0.5811965812,0.0153256705,0.6117318436,0.341813602,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3385826772,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA
"41-64","Female",NA,0.1746031746,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Female",NA,0.006872852234,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,0.03665521191,NA,NA,NA,NA,0.341222183,0.53125,NA,NA,NA,NA,0.5027624309,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,0.03212290503,0.6074074074,NA,NA,NA,0.3019578313,0.5073529412,NA,NA,NA,NA,0.5,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2731707317,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5825242718,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3045977011,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4026845638,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA
"41-64","Female",NA,0.04469273743,NA,NA,NA,NA,0.1904761905,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2191011236,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3581395349,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6062992126,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA
"41-64","Female",NA,0.05555555556,NA,NA,NA,NA,0.2825112108,NA,NA,NA,NA,NA,NA,0.01204819277,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3606557377,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,0.5973154362,NA,NA,0.3873873874,NA,NA,NA,NA,NA,NA,NA,NA,0.5751295337,0.3212713936,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3555555556,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2777777778,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4423076923,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,0.008,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,0.03730017762,NA,NA,NA,NA,0.1764705882,NA,NA,NA,NA,NA,NA,NA,NA,0.1929133858,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2314814815,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2211981567,NA,NA,NA,NA,NA,NA,NA,NA,0.1868131868,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"41-64","Female",NA,0.03344481605,NA,NA,NA,NA,0.325,NA,NA,NA,NA,NA,NA,NA,NA,0.3757225434,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,0.05354058722,NA,NA,NA,NA,0.2610062893,NA,NA,NA,NA,NA,NA,0.01785714286,NA,0.2827586207,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.03278688525,NA,NA,NA,NA,0.3251533742,NA,NA,NA,NA,NA,NA,NA,NA,0.4825174825,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.1023215821,NA,NA,NA,NA,0.6112054329,NA,NA,NA,NA,NA,NA,NA,NA,0.5328185328,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.5787234043,NA,NA,NA,NA,0.6811594203,NA,NA,NA,NA,NA,NA,NA,NA,0.7826086957,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Female",NA,0.08076009501,NA,NA,NA,NA,0.6403940887,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,0.02158273381,NA,NA,NA,NA,0.6082474227,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.6307692308,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.6137931034,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Remissions: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6764705882,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA,NA
"41-64","Female",NA,0.125,NA,NA,NA,NA,0.6219512195,NA,NA,NA,NA,NA,NA,NA,NA,0.6586826347,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Remissions: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.03235294118,NA,NA,NA,NA,0.1711956522,NA,NA,NA,NA,NA,NA,NA,NA,0.2645190563,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.02822580645,NA,NA,NA,NA,0.1906005222,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,0.02590673575,NA,NA,NA,NA,0.1810344828,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2748387097,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.380952381,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2952755906,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1312849162,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09917355372,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1034482759,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1333333333,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1730769231,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2058823529,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1666666667,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1802325581,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.462962963,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3891891892,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2985685072,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4258064516,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.5842293907,NA,NA,NA,NA,NA,NA,NA,NA,0.6367989056,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7788461538,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7525773196,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8849557522,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Remissions: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7932489451,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.6380952381,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.63,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6404958678,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7391304348,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4812030075,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7121212121,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Remissions: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.610619469,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5467625899,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6635514019,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6315789474,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.01886792453,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","LORAZEPAM","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6818181818,"BUPROPION HCL","ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.641025641,NA,NA,NA,NA,NA,NA,NA,NA,0.6524590164,"BUPROPION HCL","ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4814814815,"BUPROPION HCL","ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.512195122,"BUPROPION HCL","ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA
"41-64","Female",NA,0.3219814241,NA,NA,NA,NA,0.506263048,NA,NA,NA,NA,NA,NA,NA,NA,0.563772776,"BUPROPION HCL","ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.625,"BUPROPION HCL","ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4769230769,NA,NA,NA,NA,NA,NA,NA,NA,0.4367088608,"BUPROPION HCL","ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2476190476,NA,NA,NA,NA,NA,NA,NA,NA,0.1926345609,"BUPROPION HCL","ESCITALOPRAM OXALATE","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1794871795,"BUPROPION HCL","ESCITALOPRAM OXALATE","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.05172413793,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.222614841,"BUPROPION HCL","ESCITALOPRAM OXALATE","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.53125,NA,NA,NA,NA,0.5,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Num Previous Antidep: 2,3",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5971223022,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2538461538,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2290502793,"BUPROPION HCL","ESCITALOPRAM OXALATE","Num Previous Antidep: 4+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2849462366,NA,NA,NA,NA,NA,NA,NA,NA,0.2058823529,"BUPROPION HCL","ESCITALOPRAM OXALATE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.21484375,"BUPROPION HCL","ESCITALOPRAM OXALATE","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,0.5722543353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6484018265,"BUPROPION HCL","ESCITALOPRAM OXALATE","Num Previous Remissions: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,"BUPROPION HCL","ESCITALOPRAM OXALATE","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5118110236,"BUPROPION HCL","ESCITALOPRAM OXALATE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Female",NA,0.01960784314,NA,NA,NA,NA,0.3081395349,NA,NA,NA,0.5148514851,NA,NA,NA,NA,0.2623906706,"BUPROPION HCL","ESCITALOPRAM OXALATE","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.0572519084,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1558265583,"BUPROPION HCL","ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.114893617,"BUPROPION HCL","ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.125,"BUPROPION HCL","ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1430842607,"BUPROPION HCL","ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1153846154,"BUPROPION HCL","ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4236311239,"BUPROPION HCL","ESCITALOPRAM OXALATE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2338308458,"BUPROPION HCL","ESCITALOPRAM OXALATE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1214285714,NA,NA,NA,NA,NA,NA,NA,NA,0.1550925926,"BUPROPION HCL","ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07619047619,"BUPROPION HCL","ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1377952756,"BUPROPION HCL","ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2208955224,NA,NA,NA,NA,NA,NA,NA,NA,0.2051983584,"BUPROPION HCL","ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.197080292,"BUPROPION HCL","ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1120689655,"BUPROPION HCL","ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3363636364,"BUPROPION HCL","ESCITALOPRAM OXALATE","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4247787611,"BUPROPION HCL","ESCITALOPRAM OXALATE","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1317365269,"BUPROPION HCL","ESCITALOPRAM OXALATE","RISPERIDONE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04511278195,"BUPROPION HCL","ESCITALOPRAM OXALATE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2954545455,NA,NA,NA,NA,NA,NA,NA,NA,0.375,"BUPROPION HCL","ESCITALOPRAM OXALATE","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3681318681,NA,NA,NA,NA,NA,NA,NA,NA,0.51,"BUPROPION HCL","ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.03421052632,NA,NA,NA,NA,0.2179226069,NA,NA,NA,NA,NA,0.4825327511,NA,NA,0.2914147521,"BUPROPION HCL","ESCITALOPRAM OXALATE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2061068702,"BUPROPION HCL","ESCITALOPRAM OXALATE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5945945946,"BUPROPION HCL","ESCITALOPRAM OXALATE","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,0.05764411028,NA,NA,NA,NA,0.2674418605,NA,NA,NA,NA,NA,NA,0.01878612717,NA,0.2372347132,"BUPROPION HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1216931217,"BUPROPION HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.03395061728,NA,NA,NA,NA,0.2587209302,NA,NA,NA,NA,NA,NA,NA,0.6923076923,0.2929782082,"BUPROPION HCL","ESCITALOPRAM OXALATE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.07802547771,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESTROGEN,ESTER/ME-TESTOSTERONE",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01268498943,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESTROGEN,ESTER/ME-TESTOSTERONE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.07506702413,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUCONAZOLE",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01736111111,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUCONAZOLE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.06956521739,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUCONAZOLE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",0.01578947368,0.05372475264,0.4350132626,0.6170212766,NA,0.3795966785,0.1823076923,0.4856840434,0.08490566038,NA,0.3624454148,NA,0.4225092251,0.03246753247,0.5451174289,0.4084442927,"BUPROPION HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5904761905,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","GABAPENTIN",NA,NA,NA,NA
"41-64","Female",NA,0.05147058824,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5182926829,"BUPROPION HCL","FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4824561404,"BUPROPION HCL","FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4482758621,"BUPROPION HCL","FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2328358209,NA,NA,NA,NA,NA,NA,NA,0.1812596006,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA
"41-64","Female",NA,0.08474576271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2435897436,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Diff & No Remiss",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1666666667,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.141025641,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3185840708,NA,NA,NA,NA,NA,NA,NA,0.1581196581,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1388888889,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1150442478,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1444759207,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3885017422,NA,NA,NA,NA,NA,NA,NA,0.2819672131,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2752808989,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2695652174,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3706293706,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)"
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2555555556,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2672413793,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Num Previous Antidep: 2,3",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3680555556,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Num Previous Antidep: 2,3","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2246696035,NA,NA,NA,NA,NA,NA,NA,0.1798561151,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2307692308,NA,NA,NA,NA,NA,NA,NA,0.09090909091,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3869731801,NA,NA,NA,NA,NA,NA,NA,0.2679245283,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2075471698,NA,NA,NA,NA,NA,NA,NA,0.1413721414,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1238095238,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6226415094,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6115702479,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.1564039409,NA,NA,NA,NA,NA,NA,NA,0.07299270073,"BUPROPION HCL","FLUOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02912621359,"BUPROPION HCL","FLUOXETINE HCL","LAMOTRIGINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.1818181818,NA,NA,NA,NA,NA,NA,NA,0.06787330317,"BUPROPION HCL","FLUOXETINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.04939367051,NA,NA,NA,0.4893617021,0.2150837989,0.6333333333,NA,NA,NA,NA,NA,0.02403846154,0.5854545455,0.5412453433,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4962406015,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA
"41-64","Female",NA,0.04278074866,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"41-64","Female",NA,0.04173486088,NA,NA,NA,NA,0.2191780822,0.6222768798,NA,NA,NA,NA,0.4736842105,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,0.04054054054,NA,NA,NA,NA,0.2068965517,0.58203125,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4511627907,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6636363636,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA
"41-64","Female",NA,0.04794520548,NA,NA,NA,NA,NA,0.3262032086,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5673076923,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA
"41-64","Female",NA,0.02941176471,NA,NA,NA,NA,NA,0.4631578947,NA,NA,NA,NA,NA,0,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6518518519,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4814814815,0.5299417064,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.377245509,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3796296296,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,0.04028436019,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2619926199,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,0.05940594059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2393617021,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"41-64","Female",NA,0.02688172043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,0.0418760469,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01750972763,NA,0.3561643836,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.04390243902,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.44,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.07955182073,NA,NA,NA,0.5495495495,0.2782608696,0.660944206,NA,NA,NA,NA,NA,NA,NA,0.5227765727,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.5298804781,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7445255474,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Female",NA,0.06276747504,NA,NA,NA,NA,NA,0.6664482307,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,0.0487804878,NA,NA,NA,NA,NA,0.6243781095,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.670411985,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Remissions: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4542682927,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6875,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA,NA
"41-64","Female",NA,0.1299435028,NA,NA,NA,NA,NA,0.647260274,NA,NA,NA,NA,NA,NA,NA,0.6746987952,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Remissions: 2+",NA,NA,NA
"41-64","Female",NA,0.1181818182,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06569343066,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.02502502503,NA,NA,NA,NA,NA,0.3518312986,NA,NA,NA,NA,NA,NA,NA,0.3695652174,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.02941176471,NA,NA,NA,NA,NA,0.3948220065,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,0.01612903226,NA,NA,NA,NA,NA,0.3979591837,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4227642276,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4767616192,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.175,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1652173913,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1496062992,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1752021563,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2300884956,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2127659574,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1941176471,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4655172414,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4557721139,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5057471264,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6504065041,NA,NA,NA,NA,NA,NA,NA,0.6332029552,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8016528926,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7962962963,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7469879518,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8041958042,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Remissions: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8139534884,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6634615385,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.67,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6416666667,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7444444444,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5971223022,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5152838428,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7013574661,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Remissions: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.552238806,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5933333333,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.549950544,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5523809524,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6776315789,"BUPROPION HCL","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA
"41-64","Female",NA,0.4827586207,NA,NA,NA,NA,NA,0.6744186047,NA,NA,NA,NA,NA,NA,NA,0.6825396825,"BUPROPION HCL","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6610169492,"BUPROPION HCL","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6048387097,"BUPROPION HCL","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA
"41-64","Female",NA,0.4201388889,NA,NA,NA,NA,0.4869565217,0.6413662239,NA,NA,NA,NA,NA,NA,NA,0.5638489209,"BUPROPION HCL","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6991150442,"BUPROPION HCL","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Remissions: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7558139535,NA,NA,NA,NA,NA,NA,NA,0.6233766234,"BUPROPION HCL","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,0.3650793651,NA,NA,NA,NA,NA,0.5087719298,NA,NA,NA,NA,NA,NA,NA,0.4852216749,"BUPROPION HCL","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4528301887,NA,NA,NA,NA,NA,NA,NA,0.3062827225,"BUPROPION HCL","FLUOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1920529801,"BUPROPION HCL","FLUOXETINE HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.06722689076,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3372093023,"BUPROPION HCL","FLUOXETINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6214511041,NA,NA,NA,NA,0.4827586207,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3210526316,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5673076923,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4620689655,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6518518519,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3917050691,NA,NA,NA,NA,0.3302752294,NA,NA,0.2335025381,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2937062937,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3255813953,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 4+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2695035461,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 4+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3020408163,NA,NA,NA,NA,NA,NA,NA,0.2449922958,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2319277108,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1849710983,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 4+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.47,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6657608696,NA,NA,NA,NA,NA,NA,NA,0.6885245902,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Remissions: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2556053812,"BUPROPION HCL","FLUOXETINE HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1698113208,"BUPROPION HCL","FLUOXETINE HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,"BUPROPION HCL","FLUOXETINE HCL","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6759259259,"BUPROPION HCL","FLUOXETINE HCL","OMEPRAZOLE",NA,NA,NA,NA
"41-64","Female",NA,0.06374501992,NA,NA,NA,NA,NA,0.4577114428,NA,NA,0.472972973,NA,NA,NA,NA,0.3439716312,"BUPROPION HCL","FLUOXETINE HCL","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.06593406593,NA,NA,NA,NA,NA,0.3054587689,NA,NA,NA,NA,NA,NA,NA,0.2053571429,"BUPROPION HCL","FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1222707424,"BUPROPION HCL","FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.1824817518,NA,NA,NA,NA,NA,NA,NA,0.1692708333,"BUPROPION HCL","FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.128,"BUPROPION HCL","FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3942307692,NA,NA,NA,NA,NA,NA,NA,0.4142857143,"BUPROPION HCL","FLUOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5451263538,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3157894737,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5229357798,NA,NA,NA,NA,NA,NA,NA,0.2710997442,"BUPROPION HCL","FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.19375,NA,NA,NA,NA,NA,NA,NA,0.1932059448,"BUPROPION HCL","FLUOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2230215827,"BUPROPION HCL","FLUOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3019480519,NA,NA,NA,NA,NA,NA,NA,0.2715447154,"BUPROPION HCL","FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1707317073,"BUPROPION HCL","FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1666666667,"BUPROPION HCL","FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5289256198,"BUPROPION HCL","FLUOXETINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.1495327103,NA,NA,NA,NA,NA,NA,NA,0.1284722222,"BUPROPION HCL","FLUOXETINE HCL","RISPERIDONE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09420289855,"BUPROPION HCL","FLUOXETINE HCL","RISPERIDONE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.03636363636,NA,NA,NA,NA,NA,0.4512195122,NA,NA,NA,NA,NA,NA,NA,0.3876404494,"BUPROPION HCL","FLUOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6585365854,"BUPROPION HCL","FLUOXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.05066079295,NA,NA,NA,NA,0.2,0.4170940171,NA,NA,NA,NA,0.403960396,NA,NA,0.298136646,"BUPROPION HCL","FLUOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.188976378,"BUPROPION HCL","FLUOXETINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5714285714,NA,NA,NA,NA,NA,NA,NA,0.64,"BUPROPION HCL","FLUOXETINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,0.04938271605,NA,NA,NA,NA,NA,0.3549019608,NA,NA,NA,NA,NA,0.01990811639,NA,0.3045438154,"BUPROPION HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2746781116,"BUPROPION HCL","FLUOXETINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.05759162304,NA,NA,NA,NA,NA,0.4796954315,NA,NA,NA,NA,NA,NA,0.5803921569,0.3116634799,"BUPROPION HCL","FLUOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.0852173913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2833333333,"BUPROPION HCL","GABAPENTIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2374429224,"BUPROPION HCL","GABAPENTIN","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.04201680672,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GABAPENTIN","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.03308823529,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GABAPENTIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.06797116375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.314516129,"BUPROPION HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03773584906,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.02614379085,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,0.03433476395,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.0231277533,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.01769911504,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"41-64","Female",NA,0.046875,0.5755395683,NA,NA,0.336492891,0.1111111111,NA,NA,NA,0.5283018868,NA,NA,NA,0.6,0.2700892857,"BUPROPION HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1202185792,NA,NA,NA,NA,NA,NA,NA,0.5460992908,0.2351274788,"BUPROPION HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6380952381,NA,NA,NA,NA,NA,"BUPROPION HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4705882353,"BUPROPION HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08108108108,"BUPROPION HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.01834862385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5593220339,NA,NA,NA,NA,NA,"BUPROPION HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6280991736,NA,NA,NA,NA,NA,"BUPROPION HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5593220339,NA,NA,NA,NA,NA,"BUPROPION HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6041131105,NA,NA,NA,NA,NA,"BUPROPION HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.576,"BUPROPION HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",0.008645533141,0.06094808126,NA,NA,NA,NA,NA,NA,NA,0.04651162791,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.02112676056,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.01941747573,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA
"41-64","Female",NA,0.05405405405,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","HEADACHE (dxo:ICD9:7840)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"41-64","Female",NA,0.0972972973,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,"BUPROPION HCL","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02912621359,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","HYDROCODONE/ACETAMINOPHEN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1592356688,"BUPROPION HCL","IMIPRAMINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.06283662478,NA,NA,NA,0.1886792453,NA,NA,NA,NA,NA,NA,NA,NA,0.1674208145,0.1187270502,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1138211382,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08917197452,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1714285714,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1088435374,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1623931624,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,0.009615384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA
"41-64","Female",NA,0.05555555556,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2222222222,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA
"41-64","Female",NA,0.03381642512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05357142857,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.03856041131,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,0.08737864078,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1503267974,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1700680272,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1066666667,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1341463415,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09848484848,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2651515152,NA,NA,NA,NA,0.1483253589,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1034482759,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PAROXETINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.04964539007,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09225092251,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.22,NA,NA,0.1358695652,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1376146789,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07333333333,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08035714286,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2049689441,0.1226993865,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08633093525,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.185840708,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2634730539,NA,NA,0.1971326165,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.171314741,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.078125,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1367521368,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2377850163,0.154822335,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.2490974729,NA,NA,0.2604501608,0.07865168539,0.2337164751,NA,NA,0.2253521127,NA,0.2591093117,NA,0.3039723661,0.1321909425,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.07692307692,NA,NA,NA,NA,NA,NA,NA,NA,0.1297935103,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3884297521,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06756756757,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.05660377358,NA,NA,NA,NA,NA,NA,NA,NA,0.100456621,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.253164557,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1818181818,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2545454545,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08870967742,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2596153846,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3986928105,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Num Previous Antidep: 2,3","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.375,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.390070922,NA,NA,NA,NA,0.2222222222,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4071428571,NA,NA,NA,NA,0.185840708,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1446540881,0.08095238095,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06319702602,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.173553719,NA,NA,0.1463414634,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1727272727,0.1636363636,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.192139738,NA,NA,0.1259259259,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06481481481,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1694214876,0.125,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,0.231884058,NA,NA,0.231292517,0.05128205128,0.2089552239,NA,NA,NA,NA,0.2450331126,NA,0.2368421053,0.1340909091,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4126394052,NA,NA,0.2761506276,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05442176871,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.380952381,0.1829268293,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4007352941,NA,NA,0.2985074627,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1212121212,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4271356784,0.2025316456,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.06569343066,NA,NA,NA,0.1333333333,NA,NA,NA,NA,NA,NA,NA,NA,0.15625,0.09265175719,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"41-64","Female",NA,0.04761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1397058824,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06060606061,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1690821256,NA,NA,0.1335149864,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1183431953,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05761316872,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07382550336,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.224852071,0.1493055556,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.07407407407,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03174603175,NA,NA,"BUPROPION HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4380952381,0.01694915254,NA,NA,"BUPROPION HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"BUPROPION HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01395348837,NA,NA,"BUPROPION HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01296596434,NA,NA,"BUPROPION HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.01595744681,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02139037433,NA,NA,"BUPROPION HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.04166666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.1939163498,NA,NA,0.1040609137,0.1007194245,0.1395348837,NA,NA,NA,NA,0.1145833333,NA,0.1254901961,0.092547616,"BUPROPION HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1238938053,"BUPROPION HCL","LAMOTRIGINE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01904761905,"BUPROPION HCL","LAMOTRIGINE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.465648855,"BUPROPION HCL","LAMOTRIGINE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6290322581,"BUPROPION HCL","LAMOTRIGINE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6853932584,"BUPROPION HCL","LAMOTRIGINE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5142857143,"BUPROPION HCL","LAMOTRIGINE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"BUPROPION HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5196078431,"BUPROPION HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5874439462,"BUPROPION HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4460887949,"BUPROPION HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3738738739,"BUPROPION HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3947990544,"BUPROPION HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1113801453,"BUPROPION HCL","LAMOTRIGINE","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.128440367,"BUPROPION HCL","LAMOTRIGINE","MIRTAZAPINE","Num Previous Antidep: 4+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08212560386,"BUPROPION HCL","LAMOTRIGINE","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0625,"BUPROPION HCL","LAMOTRIGINE","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0972972973,"BUPROPION HCL","LAMOTRIGINE","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1096605744,"BUPROPION HCL","LAMOTRIGINE","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.125984252,"BUPROPION HCL","LAMOTRIGINE","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08193484699,"BUPROPION HCL","LAMOTRIGINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05084745763,"BUPROPION HCL","LAMOTRIGINE","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07258064516,"BUPROPION HCL","LAMOTRIGINE","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05208333333,"BUPROPION HCL","LAMOTRIGINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02702702703,"BUPROPION HCL","LAMOTRIGINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1320132013,"BUPROPION HCL","LAMOTRIGINE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.125,"BUPROPION HCL","LAMOTRIGINE","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05405405405,"BUPROPION HCL","LAMOTRIGINE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07339449541,"BUPROPION HCL","LAMOTRIGINE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08771929825,"BUPROPION HCL","LAMOTRIGINE","RISPERIDONE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09734513274,"BUPROPION HCL","LAMOTRIGINE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1216216216,"BUPROPION HCL","LAMOTRIGINE","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1072961373,"BUPROPION HCL","LAMOTRIGINE","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1361161525,NA,NA,0.09864603482,"BUPROPION HCL","LAMOTRIGINE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07067137809,"BUPROPION HCL","LAMOTRIGINE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07853810264,"BUPROPION HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07076350093,"BUPROPION HCL","LAMOTRIGINE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1150895141,0.1065217391,"BUPROPION HCL","LAMOTRIGINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.06299212598,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","LANSOPRAZOLE",NA,NA,NA,NA,NA
"41-64","Female",0.01129943503,0.06688417618,0.4756995582,NA,NA,0.3767482517,0.1460580913,0.4783765802,0.112244898,0.03053435115,0.4140625,NA,0.535359116,0.01037344398,0.5227781927,0.2786249677,"BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3220338983,"BUPROPION HCL","Last AD: Diff & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5526315789,"BUPROPION HCL","Last AD: Diff & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3564356436,"BUPROPION HCL","Last AD: Diff & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,0.2155688623,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7053571429,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.0531496063,NA,NA,NA,NA,NA,NA,0.2168674699,NA,NA,NA,NA,NA,NA,0.2953367876,"BUPROPION HCL","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,0.06015037594,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2254901961,"BUPROPION HCL","Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,0.032,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2342342342,"BUPROPION HCL","Last AD: Diff & No Remiss","MONTELUKAST SODIUM",NA,NA,NA,NA
"41-64","Female",NA,0.09708737864,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","MYOPIA (dxo:ICD9:3671)","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.08527131783,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","MYOPIA (dxo:ICD9:3671)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1572327044,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Female",NA,0.0490797546,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.01886792453,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,0.03325415677,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.04697986577,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.06148867314,NA,NA,NA,NA,NA,NA,NA,0.1494252874,NA,NA,NA,NA,NA,0.1736334405,"BUPROPION HCL","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.05283018868,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1413612565,"BUPROPION HCL","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,0.07692307692,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA,NA
"41-64","Female",NA,0.03496503497,NA,NA,NA,NA,NA,NA,NA,NA,0.563071298,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4796747967,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA
"41-64","Female",NA,0.03421052632,NA,NA,NA,NA,0.1914893617,NA,NA,NA,NA,NA,0.6350032531,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5660377358,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA
"41-64","Female",NA,0.04031209363,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.004357298475,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.03619909502,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.588,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,0.03883495146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.0234375,NA,NA,NA,NA,NA,NA,NA,NA,0.7042459736,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA
"41-64","Female",NA,0.05172413793,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2923976608,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA
"41-64","Female",NA,0.05988023952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.03816793893,NA,NA,NA,NA,0.2032967033,0.5169491525,NA,NA,NA,NA,0.6969899666,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,0.04166666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5691699605,0.007633587786,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6607142857,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,0.04730679157,NA,NA,NA,NA,0.1851851852,NA,NA,NA,NA,NA,NA,0.009708737864,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.05,NA,NA,NA,NA,0.2407407407,NA,NA,NA,NA,NA,0.5544554455,NA,0.7653061224,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.4379084967,NA,NA,NA,0.1895424837,0.5294117647,NA,NA,NA,NA,0.4407894737,NA,0.5813953488,0.2386495925,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.438247012,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2619047619,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5448275862,0.5522740697,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4090909091,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.58,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1200923788,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5487804878,0.4069264069,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5842696629,0.4425087108,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3135135135,"BUPROPION HCL","Last AD: Diff & No Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.28125,"BUPROPION HCL","Last AD: Diff & No Remiss","OMEPRAZOLE",NA,NA,NA,NA
"41-64","Female",NA,0.02985074627,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2685714286,"BUPROPION HCL","Last AD: Diff & No Remiss","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA
"41-64","Female",NA,0.04511278195,NA,NA,NA,NA,0.175,NA,NA,NA,0.6443298969,NA,NA,0.01639344262,0.6529411765,0.4741557547,"BUPROPION HCL","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.05839416058,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2181818182,"BUPROPION HCL","Last AD: Diff & No Remiss","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,0.05607476636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02173913043,NA,0.2692307692,"BUPROPION HCL","Last AD: Diff & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1461187215,"BUPROPION HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1449275362,"BUPROPION HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,0.05352112676,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2657004831,"BUPROPION HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,0.06126482213,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03345724907,NA,0.09677419355,"BUPROPION HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.0460251046,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2805755396,0.2195121951,"BUPROPION HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.04761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05714285714,"BUPROPION HCL","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1642512077,"BUPROPION HCL","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.075,NA,NA,NA,NA,NA,NA,NA,NA,0.09685230024,"BUPROPION HCL","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2164948454,"BUPROPION HCL","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06756756757,"BUPROPION HCL","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.04416403785,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.446969697,"BUPROPION HCL","Last AD: Diff & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1856060606,NA,NA,NA,0.3647798742,NA,NA,NA,NA,0.2903225806,"BUPROPION HCL","Last AD: Diff & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.04468718967,NA,NA,NA,0.4291666667,0.1911764706,NA,NA,NA,NA,NA,0.6722408027,0.03349282297,0.5650684932,0.5882181394,"BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.05240174672,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02257336343,NA,0.3880266075,"BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.07731958763,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4318181818,"BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3258928571,"BUPROPION HCL","Last AD: Diff & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2524752475,"BUPROPION HCL","Last AD: Diff & No Remiss","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5317919075,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.70625,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3178807947,"BUPROPION HCL","Last AD: Diff & No Remiss","TOPIRAMATE",NA,NA,NA,NA
"41-64","Female",NA,0.05068790731,NA,NA,NA,0.42,0.1477272727,NA,NA,NA,NA,NA,NA,0.01630595909,NA,0.1217687075,"BUPROPION HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.06382978723,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01546391753,0.5477386935,0.3962848297,"BUPROPION HCL","Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3281853282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,0.04677754678,NA,NA,NA,0.4659685864,0.2188679245,NA,NA,NA,NA,NA,NA,0.01734104046,0.6817204301,0.4727171492,"BUPROPION HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.1140766251,NA,NA,NA,0.5751295337,NA,NA,NA,NA,NA,NA,NA,0.1451612903,0.675862069,0.5729613734,"BUPROPION HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,0.6666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"41-64","Female",NA,0.5950920245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6543624161,"BUPROPION HCL","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7407407407,"BUPROPION HCL","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,0.6116071429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8285714286,"BUPROPION HCL","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,0.6655172414,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5620437956,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.6101694915,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.04761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6388888889,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","Num Previous Remissions: 2+","PAROXETINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6624605678,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","Num Previous Remissions: 2+","SERTRALINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6230769231,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA
"41-64","Female",NA,0.0643776824,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6579572447,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,0.07920792079,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6554878049,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,0.07453416149,NA,NA,NA,NA,NA,NA,NA,NA,0.6868932039,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,0.05706874189,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7067624177,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7314814815,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","SIMVASTATIN",NA,NA
"41-64","Female",NA,0.07117437722,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7699530516,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6388888889,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","PAROXETINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6791666667,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6754385965,0.5588235294,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6240601504,NA,NA,NA,NA,0.4024390244,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4765100671,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6436170213,0.43,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6470588235,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Remissions: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,0.0931372549,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6586826347,NA,NA,0.6853146853,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6985294118,0.5462184874,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Remissions: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.07307692308,NA,NA,NA,NA,NA,NA,NA,NA,0.6756756757,NA,NA,NA,NA,0.4560570071,"BUPROPION HCL","Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.05785123967,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,0.07626262626,NA,NA,NA,0.5740740741,0.2769230769,NA,NA,NA,NA,NA,0.7059848925,NA,0.679245283,0.5750551876,"BUPROPION HCL","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.1523809524,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0826446281,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.4285714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1146496815,NA,0.4761904762,"BUPROPION HCL","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.1034090909,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7283105023,0.5008605852,"BUPROPION HCL","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.02534191472,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2088091354,"BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,0.1722689076,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,0.01530612245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",NA,NA,NA,NA
"41-64","Female",NA,0.0261627907,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",NA,NA,NA,NA
"41-64","Female",NA,0.04934210526,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA
"41-64","Female",NA,0.0462962963,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","METHYLPHENIDATE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.03,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2782608696,"BUPROPION HCL","Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.24,"BUPROPION HCL","Last AD: Same & No Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.02362204724,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","MORBID OBESITY (dxo:ICD9:27801)",NA,NA,NA,NA
"41-64","Female",NA,0.02647975078,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA
"41-64","Female",NA,0.01485148515,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382)",NA,NA,NA,NA
"41-64","Female",NA,0.01397515528,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Female",NA,0.01276595745,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA
"41-64","Female",NA,0.01398601399,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA
"41-64","Female",NA,0.01117318436,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA
"41-64","Female",NA,0.009523809524,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1772151899,"BUPROPION HCL","Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2924528302,"BUPROPION HCL","Last AD: Same & No Remiss","NORTRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4094488189,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA
"41-64","Female",NA,0.0253164557,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4713375796,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,0.05109489051,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.02926829268,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.473354232,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,0.04945054945,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.016,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.03636363636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.03268514688,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2083333333,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,0.02542372881,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA
"41-64","Female",NA,0.03555555556,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4198473282,NA,NA,NA,NA,0.3872180451,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4527027027,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.02727272727,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA
"41-64","Female",NA,0.01652892562,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5376569038,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.490832158,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1759149941,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4622641509,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,0.05940594059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","VALACYCLOVIR HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4696969697,0.4484126984,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.02281879195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA
"41-64","Female",NA,0.0480349345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689)",NA,NA,NA,NA
"41-64","Female",NA,0.01746031746,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"41-64","Female",NA,0.01886792453,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,0.01477832512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA
"41-64","Female",NA,0.02255639098,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA
"41-64","Female",NA,0.03579418345,NA,NA,NA,NA,NA,NA,NA,NA,0.3715170279,NA,NA,NA,NA,0.380952381,"BUPROPION HCL","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1558441558,"BUPROPION HCL","Last AD: Same & No Remiss","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1917808219,"BUPROPION HCL","Last AD: Same & No Remiss","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4232715008,"BUPROPION HCL","Last AD: Same & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.04404873477,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1147540984,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1132075472,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1043478261,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1714285714,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL","VENLAFAXINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1688741722,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1440217391,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08510638298,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1494565217,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1219512195,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4970414201,"BUPROPION HCL","Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,0.03211009174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","PREGABALIN",NA,NA,NA,NA
"41-64","Female",NA,0.0101010101,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"41-64","Female",NA,0.03693931398,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2477876106,"BUPROPION HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1583333333,"BUPROPION HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1925465839,"BUPROPION HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2734375,"BUPROPION HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05,"BUPROPION HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1908396947,"BUPROPION HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,0.02546296296,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA
"41-64","Female",NA,0.008875739645,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,0.02145214521,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.02363823227,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4013986014,NA,NA,0.4320241692,"BUPROPION HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4841498559,"BUPROPION HCL","Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4236111111,"BUPROPION HCL","Last AD: Same & No Remiss","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.0223880597,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","TERBINAFINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.04743083004,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008080808081,NA,0.1765530126,"BUPROPION HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4725274725,"BUPROPION HCL","Last AD: Same & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.03550295858,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","UNSPECIFIED ENDOCRINE DISORDER (dxo:ICD9:2599)",NA,NA,NA,NA
"41-64","Female",NA,0.01709401709,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","UNSPECIFIED EPISODIC MOOD DISORDER (dxo:ICD9:29690)",NA,NA,NA,NA
"41-64","Female",NA,0.04081632653,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,0.0350877193,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA
"41-64","Female",NA,0.02388535032,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","VALACYCLOVIR HCL",NA,NA,NA,NA
"41-64","Female",NA,0.03626943005,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3608695652,0.3601108033,"BUPROPION HCL","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.5570328901,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6342415616,"BUPROPION HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8083067093,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7986111111,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8214285714,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7871621622,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.5555555556,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7930535456,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7768595041,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8705035971,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7669902913,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7780821918,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7671232877,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7727272727,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.4939341421,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.754601227,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7831325301,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7692307692,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8090909091,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7618025751,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7647058824,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8073394495,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Remissions: 2+","SERTRALINE HCL","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7459016393,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Remissions: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6923076923,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PRAMIPEXOLE DI-HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7851239669,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7456140351,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7658536585,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7708547889,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7379518072,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7806788512,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5847457627,"BUPROPION HCL","Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5234899329,"BUPROPION HCL","Last AD: Same & Remiss","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5583333333,"BUPROPION HCL","Last AD: Same & Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6703296703,NA,NA,NA,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6702508961,NA,NA,NA,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5352941176,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5419354839,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4651162791,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Antidep: 4+","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5185185185,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4910096819,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4798206278,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7771428571,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5918367347,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","SERTRALINE HCL","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6138613861,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6198347107,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6628895184,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.52734375,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4672131148,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6901408451,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.752293578,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5803108808,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Remissions: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.593495935,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Remissions: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6226415094,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Remissions: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6845637584,NA,NA,NA,NA,0.631496063,"BUPROPION HCL","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5282392027,"BUPROPION HCL","Last AD: Same & Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5801056338,"BUPROPION HCL","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5771812081,"BUPROPION HCL","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5454545455,"BUPROPION HCL","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5993520518,"BUPROPION HCL","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6101694915,"BUPROPION HCL","Last AD: Same & Remiss","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.568627451,"BUPROPION HCL","Last AD: Same & Remiss","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7126436782,NA,NA,0.6776119403,"BUPROPION HCL","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5253699789,"BUPROPION HCL","Last AD: Same & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.637254902,"BUPROPION HCL","Last AD: Same & Remiss","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5249827705,"BUPROPION HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5143979058,"BUPROPION HCL","Last AD: Same & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6744186047,0.6217990808,"BUPROPION HCL","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2582781457,"BUPROPION HCL","LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2771428571,"BUPROPION HCL","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3295454545,"BUPROPION HCL","LEVOTHYROXINE SODIUM","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08947368421,"BUPROPION HCL","LITHIUM CARBONATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2038834951,NA,"BUPROPION HCL","LITHIUM CARBONATE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.07412587413,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","LORAZEPAM",NA,NA,NA,NA,NA
"41-64","Female",NA,0.04580152672,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","LORAZEPAM","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.02130898021,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","LORAZEPAM","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.0974025974,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03875968992,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","LOSS OF WEIGHT (dxo:ICD9:78321)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,0.5288985823,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6990595611,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.687804878,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7793880837,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7316384181,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7102272727,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7083333333,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7342657343,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.5593220339,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6613545817,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6617647059,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.5165929204,NA,NA,NA,0.6779661017,0.6025641026,0.6666666667,NA,NA,NA,NA,0.6576576577,NA,NA,0.6759348035,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.5593220339,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6801705757,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6690647482,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6428571429,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5555555556,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6685552408,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6231884058,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.612565445,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5555555556,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.5112359551,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6950146628,NA,NA,0.7423076923,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5603448276,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.4930555556,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6427068724,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.54,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7784090909,0.6886446886,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3501945525,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1454545455,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2232142857,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,0.4097462514,0.6776859504,NA,NA,0.6167664671,0.4748784441,0.567251462,NA,NA,NA,NA,0.5877192982,NA,0.6033755274,0.5900007598,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5434380776,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4210526316,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","Num Previous Antidep: 4+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5151515152,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5572139303,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6007194245,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5204918033,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5443786982,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5297101449,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3216374269,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6814814815,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,0.4176245211,NA,NA,NA,NA,NA,NA,NA,NA,0.6188925081,NA,NA,NA,NA,0.66359447,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5643564356,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.5671641791,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6551724138,0.660944206,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7426470588,NA,NA,0.6507936508,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7643979058,0.6666666667,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5233160622,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.461928934,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2972972973,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4893617021,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","RISPERIDONE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5700757576,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5227272727,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.425795053,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6864564007,NA,NA,0.6291989664,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4898648649,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.4251805986,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2631578947,NA,0.5484657851,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6180555556,0.4541062802,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.4423592493,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6963087248,0.5745697897,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.07731958763,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.08114558473,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05602240896,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5409356725,NA,"BUPROPION HCL","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6151419558,NA,"BUPROPION HCL","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.1195652174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","METHYLPHENIDATE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01886792453,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05758426966,NA,NA,NA,0.2177419355,NA,NA,0.2046263345,NA,NA,NA,NA,NA,NA,0.2909903552,"BUPROPION HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2243667069,"BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2426470588,"BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2309250506,"BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1676136364,"BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1834862385,"BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3385826772,"BUPROPION HCL","MIRTAZAPINE","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1020408163,"BUPROPION HCL","MIRTAZAPINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07086614173,"BUPROPION HCL","MIRTAZAPINE","RISPERIDONE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.26,"BUPROPION HCL","MIRTAZAPINE","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4732142857,NA,NA,0.2848837209,"BUPROPION HCL","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.03921568627,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2056074766,"BUPROPION HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1677018634,"BUPROPION HCL","MIRTAZAPINE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2714285714,"BUPROPION HCL","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.1203007519,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","MODAFINIL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2816901408,"BUPROPION HCL","MONTELUKAST SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,0.07878787879,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","MORBID OBESITY (dxo:ICD9:27801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2635658915,"BUPROPION HCL","MULTIPLE SCLEROSIS (dxo:ICD9:340)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.07520564042,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05309734513,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.06474820144,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.04136163982,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.06306306306,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"41-64","Female",NA,0.03448275862,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA
"41-64","Female",NA,0.04511278195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.06666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.06592039801,NA,NA,NA,NA,NA,NA,NA,0.1772151899,NA,NA,NA,NA,NA,0.3058093995,"BUPROPION HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2631578947,"BUPROPION HCL","NORTRIPTYLINE HCL","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2628676471,"BUPROPION HCL","NORTRIPTYLINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1818181818,"BUPROPION HCL","NORTRIPTYLINE HCL","Num Previous Antidep: 4+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3515625,"BUPROPION HCL","NORTRIPTYLINE HCL","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3254901961,"BUPROPION HCL","NORTRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2274590164,"BUPROPION HCL","NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3436293436,"BUPROPION HCL","NORTRIPTYLINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5600649351,NA,NA,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6967320261,NA,NA,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3021978022,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5169491525,NA,NA,NA,NA,0.6943020802,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5610687023,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5631067961,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3189189189,NA,0.289017341,NA,NA,0.2546959567,"BUPROPION HCL","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3966005666,NA,NA,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 4+","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3538704581,"BUPROPION HCL","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4188679245,"BUPROPION HCL","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1964285714,"BUPROPION HCL","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3355176933,"BUPROPION HCL","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2962962963,"BUPROPION HCL","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09523809524,"BUPROPION HCL","Num Previous Antidep: 4+","RISPERIDONE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3358116481,"BUPROPION HCL","Num Previous Antidep: 4+","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3180076628,"BUPROPION HCL","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3023255814,"BUPROPION HCL","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3129770992,"BUPROPION HCL","Num Previous Antidep: 4+","ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3644859813,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 4+","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1923076923,"BUPROPION HCL","Num Previous Antidep: 4+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2311827957,"BUPROPION HCL","Num Previous Antidep: 4+","SERTRALINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3831775701,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 4+","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2553584627,"BUPROPION HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2176258993,"BUPROPION HCL","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2225475842,"BUPROPION HCL","Num Previous Antidep: 4+","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.4411764706,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Num Previous Episodes: 2+",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5564387917,NA,NA,NA,NA,NA,"BUPROPION HCL","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6543209877,NA,NA,NA,NA,0.525,"BUPROPION HCL","Num Previous Remissions: 2+","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6713947991,NA,NA,0.6739130435,"BUPROPION HCL","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7032967033,0.5390070922,"BUPROPION HCL","Num Previous Remissions: 2+","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.06896551724,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2106299213,"BUPROPION HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2909090909,"BUPROPION HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1884057971,"BUPROPION HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3382789318,"BUPROPION HCL","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7272727273,"BUPROPION HCL","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3402061856,"BUPROPION HCL","OMEPRAZOLE",NA,NA,NA,NA,NA
"41-64","Female",NA,0.06451612903,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05217391304,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4160583942,"BUPROPION HCL","OTHER ANXIETY STATES (dxo:ICD9:30009)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.07407407407,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OTHER CONVULSIONS (dxo:ICD9:78039)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3609022556,"BUPROPION HCL","OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.0724160632,NA,NA,NA,0.4956521739,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.06637168142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.04098360656,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3149606299,"BUPROPION HCL","OXYBUTYNIN CHLORIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2701421801,"BUPROPION HCL","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.08536585366,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA,NA
"41-64","Female",0.0325203252,0.04870199528,0.4664879357,NA,NA,0.4435695538,0.1722846442,0.3916913947,NA,NA,0.5175036056,NA,0.4986737401,0.01829268293,0.6309012876,0.3929968701,"BUPROPION HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05504587156,NA,NA,NA,NA,NA,NA,NA,NA,0.291005291,NA,NA,NA,NA,0.1652892562,"BUPROPION HCL","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1186440678,"BUPROPION HCL","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1509433962,"BUPROPION HCL","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2234636872,"BUPROPION HCL","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3693693694,NA,NA,NA,NA,0.2366412214,"BUPROPION HCL","PAROXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3988095238,"BUPROPION HCL","PAROXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5454545455,NA,NA,NA,NA,NA,"BUPROPION HCL","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.03846153846,NA,NA,NA,NA,NA,NA,NA,NA,0.4946808511,NA,0.4588235294,NA,NA,0.3433962264,"BUPROPION HCL","PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.07300884956,NA,NA,NA,NA,NA,NA,NA,NA,0.4003590664,NA,NA,0.03813559322,NA,0.3046783626,"BUPROPION HCL","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.02816901408,NA,NA,NA,NA,NA,NA,NA,NA,0.4864864865,NA,NA,NA,NA,0.2986577181,"BUPROPION HCL","PAROXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.0848733744,0.164893617,NA,NA,0.1681957187,NA,0.1641791045,NA,NA,NA,NA,0.2374100719,NA,0.2051671733,0.1181102362,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09145129225,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1747572816,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07857142857,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1443850267,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.09045226131,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2757697456,NA,NA,0.1964430073,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2892561983,NA,NA,0.1432835821,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1166666667,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.11875,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1465517241,0.08548931384,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1769911504,0.1627565982,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.05479452055,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.258097166,0.1630769231,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.0452920143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4341609051,"BUPROPION HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5446808511,"BUPROPION HCL","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4672897196,"BUPROPION HCL","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4202453988,"BUPROPION HCL","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2275132275,"BUPROPION HCL","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4404432133,"BUPROPION HCL","PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.329175705,"BUPROPION HCL","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.380794702,"BUPROPION HCL","PRAMIPEXOLE DI-HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.08943089431,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","PREGABALIN",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03910614525,NA,NA,NA,NA,NA,0.303030303,NA,NA,NA,NA,NA,NA,NA,0.2325581395,"BUPROPION HCL","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3701298701,"BUPROPION HCL","PROPOXYPHENE NAP/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1634615385,"BUPROPION HCL","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,0.05714285714,NA,0.2761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3039215686,0.1436090226,"BUPROPION HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5611510791,NA,NA,0.3076923077,"BUPROPION HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08733624454,"BUPROPION HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2204081633,"BUPROPION HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1336206897,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1063829787,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03883495146,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1693989071,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.153526971,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.102739726,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1684782609,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1908713693,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1914893617,0.085,0.2268907563,NA,NA,NA,NA,0.2230769231,NA,0.1993006993,0.1333333333,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2865497076,NA,NA,0.236453202,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2638297872,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07954545455,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2056074766,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.325732899,0.2147435897,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08854166667,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05825242718,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3248945148,"BUPROPION HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.465648855,NA,NA,NA,0.4145299145,"BUPROPION HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.488,"BUPROPION HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1077147016,"BUPROPION HCL","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1550387597,NA,NA,0.1169590643,"BUPROPION HCL","RISPERIDONE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09734513274,"BUPROPION HCL","RISPERIDONE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0786163522,"BUPROPION HCL","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1237623762,"BUPROPION HCL","RISPERIDONE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2236024845,0.1219512195,"BUPROPION HCL","RISPERIDONE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.05447154472,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4488636364,NA,NA,NA,0.406295272,"BUPROPION HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4473684211,"BUPROPION HCL","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.05504587156,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3239875389,"BUPROPION HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3897849462,"BUPROPION HCL","ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3333333333,"BUPROPION HCL","ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,0.08542713568,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05957446809,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.05850746269,NA,0.6513157895,NA,0.5294117647,0.1714285714,NA,NA,NA,0.3846153846,NA,NA,NA,NA,0.287037037,"BUPROPION HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7345132743,"BUPROPION HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.07,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA
"41-64","Female",NA,0.007751937984,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","VALACYCLOVIR HCL",NA,NA,NA,NA
"41-64","Female",0.01538461538,0.05178319565,0.4284009547,0.6541353383,NA,0.3840490798,0.1643835616,0.3959341723,0.1267605634,NA,0.4089834515,NA,0.535193032,0.02950819672,0.5767511177,0.4666617386,"BUPROPION HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6740740741,NA,NA,0.6942675159,"BUPROPION HCL","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,0.06435137896,NA,NA,NA,NA,0.1101694915,NA,NA,NA,NA,NA,0.4203323558,0.02260869565,NA,0.3374858437,"BUPROPION HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2485549133,"BUPROPION HCL","SERTRALINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.07076923077,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5119305857,NA,0.5789473684,0.3015214385,"BUPROPION HCL","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.109375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5961538462,NA,NA,0.3719912473,"BUPROPION HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2905027933,"BUPROPION HCL","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.614973262,NA,"BUPROPION HCL","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.08108108108,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","TERBINAFINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2711864407,"BUPROPION HCL","TOPIRAMATE",NA,NA,NA,NA,NA
"41-64","Female",0.04861111111,0.06799623116,0.3219373219,NA,NA,0.2774018945,0.1511254019,0.2641129032,NA,NA,0.3088235294,NA,0.3758865248,0.01856556576,0.2899159664,0.2907771193,"BUPROPION HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.073089701,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01945525292,0.3682460515,0.281504065,"BUPROPION HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3302752294,"BUPROPION HCL","TRAZODONE HCL","VILAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.07468879668,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","UNSPECIFIED ENDOCRINE DISORDER (dxo:ICD9:2599)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.06034482759,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","UNSPECIFIED EPISODIC MOOD DISORDER (dxo:ICD9:29690)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.07913669065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.06034482759,NA,NA,NA,0.4712643678,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.06329113924,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.06948640483,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","VALACYCLOVIR HCL",NA,NA,NA,NA,NA
"41-64","Female",0.006024096386,0.06323083586,0.4468085106,NA,NA,0.4848484848,0.2016806723,0.4572072072,0.1338582677,NA,0.3989071038,NA,0.4485294118,0.02092050209,0.5452847806,0.3482211613,"BUPROPION HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05825242718,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","VERAPAMIL HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5844594595,"BUPROPION HCL","VILAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4926108374,NA,NA,NA,0.1623376623,NA,NA,NA,NA,NA,0.571875,NA,NA,0.2892156863,"BUSPIRONE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6809815951,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4640522876,"BUSPIRONE HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4811594203,NA,NA,NA,NA,NA,NA,NA,NA,0.3783783784,"BUSPIRONE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUSPIRONE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4335664336,"BUSPIRONE HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3465346535,"BUSPIRONE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7297297297,NA,NA,0.4413793103,"BUSPIRONE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4375,"BUSPIRONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4272727273,NA,NA,NA,NA,NA,NA,NA,NA,"CANDIDIASIS OF VULVA AND VAGINA (dxo:ICD9:1121)",NA,NA,NA,NA,NA,NA
"41-64","Female",0.01157024793,NA,NA,NA,NA,NA,0.1647058824,NA,NA,NA,NA,NA,0.5527950311,0.02090592334,NA,NA,"CARISOPRODOL",NA,NA,NA,NA,NA,NA
"41-64","Female",0.005464480874,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CARISOPRODOL","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"41-64","Female",0.02830188679,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CARISOPRODOL","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CARISOPRODOL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1142857143,NA,NA,NA,0.3557692308,NA,NA,NA,NA,NA,"CEFDINIR",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5065104167,NA,NA,NA,NA,0.5183946488,NA,NA,NA,NA,0.5742574257,NA,NA,NA,"CELECOXIB",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7092198582,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CELECOXIB","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5151515152,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CELECOXIB","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7252747253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CELECOXIB","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6851851852,NA,NA,NA,NA,NA,NA,NA,NA,"CELECOXIB","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7211538462,NA,NA,NA,NA,NA,NA,NA,NA,"CELECOXIB","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.49,NA,0.02857142857,NA,NA,NA,NA,NA,NA,"CERVICALGIA (dxo:ICD9:7231)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5370152761,NA,0.1342281879,0.4455445545,0.120665742,NA,NA,NA,NA,NA,0.6260869565,NA,0.4790419162,NA,"CETIRIZINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6913793103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CETIRIZINE HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7042253521,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CETIRIZINE HCL","CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.429245283,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CETIRIZINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6893617021,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CETIRIZINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6742857143,NA,NA,NA,0.2732919255,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CETIRIZINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09708737864,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CETIRIZINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5179487179,NA,NA,NA,0.05454545455,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CETIRIZINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1116071429,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CETIRIZINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6605504587,NA,"CETIRIZINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4710743802,NA,0.4542372881,NA,"CHEST PAIN, OTHER (dxo:ICD9:78659)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5194174757,NA,NA,NA,"CHEST PAIN, OTHER (dxo:ICD9:78659)","CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4714285714,NA,NA,NA,0.1356932153,0.5389048991,NA,NA,0.358974359,NA,0.5317220544,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1242236025,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3426573427,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1962616822,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6338028169,NA,NA,NA,NA,NA,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4484848485,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7255813953,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5462184874,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1442307692,NA,NA,NA,NA,NA,0.5058823529,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1236263736,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6977329975,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02521008403,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.03571428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01846965699,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01652892562,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA
"41-64","Female",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4466292135,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5348837209,NA,NA,NA,"CHRONIC FATIGUE SYNDROME (dxo:ICD9:78071)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6474358974,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC FATIGUE SYNDROME (dxo:ICD9:78071)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01709401709,0.4449541284,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC PAIN SYNDROME (dxo:ICD9:3384)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7235772358,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC PAIN SYNDROME (dxo:ICD9:3384)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",0.01992846193,0.03480656066,0.5718607714,0.6374045802,0.1544117647,0.4318466028,0.2534385839,0.4737238651,0.1280653951,0.05646173149,0.4199576869,0.1762917933,0.4815481548,0.01774123756,0.6062413951,0.3363855943,"CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6531531532,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3996865204,"CITALOPRAM HYDROBROMIDE","CLONAZEPAM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3546511628,"CITALOPRAM HYDROBROMIDE","CLONAZEPAM","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4521276596,"CITALOPRAM HYDROBROMIDE","CLONAZEPAM","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5025641026,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","CLONAZEPAM","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6261682243,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","CLONAZEPAM","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6041666667,"CITALOPRAM HYDROBROMIDE","CLONAZEPAM","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6344086022,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","CODEINE PHOSPHATE/GUAIFENESIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7261146497,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4222222222,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4121621622,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7142857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",0,0.03179190751,0.681780709,0.5736434109,NA,NA,0.2695652174,0.6046511628,NA,NA,NA,NA,NA,0.02395209581,0.6498194946,0.3771186441,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6449704142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009345794393,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA
"41-64","Female",0,0.01913875598,NA,NA,NA,NA,NA,0.5267857143,NA,NA,NA,NA,NA,0,0.4428571429,0.2965517241,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.004329004329,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4496124031,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.04895104895,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6497695853,0.3888888889,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006944444444,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,0.4082474227,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.2727272727,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,0.6994727592,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7011494253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","LEVOTHYROXINE SODIUM",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.362962963,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7295081967,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.00495049505,NA,0.5395683453,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7020648968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.3507462687,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7297297297,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5964912281,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2996108949,"CITALOPRAM HYDROBROMIDE","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3023255814,"CITALOPRAM HYDROBROMIDE","DESVENLAFAXINE SUCCINATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3861386139,"CITALOPRAM HYDROBROMIDE","DEXLANSOPRAZOLE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6824324324,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEXTROAMPHETAMINE/AMPHETAMINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6862745098,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DIAPHRAGMATIC HERNIA WITHOUT MENTION OF OBSTRUCTION OR GANGRENE (dxo:ICD9:5533)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6313432836,NA,0.3543307087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3773584906,"CITALOPRAM HYDROBROMIDE","DOXEPIN HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.8510638298,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DOXEPIN HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.858490566,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DOXEPIN HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,0.6725663717,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DOXEPIN HCL","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3238636364,"CITALOPRAM HYDROBROMIDE","DOXEPIN HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.03703703704,0.6073871409,NA,NA,0.5273522976,0.3376623377,0.4578313253,NA,NA,NA,NA,0.4975845411,NA,0.5486725664,0.3411829135,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.246835443,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09565217391,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Female",NA,0.03759398496,0.7877237852,NA,NA,0.6034912718,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3938679245,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.8009049774,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,0.7572815534,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,0.7590909091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3828828829,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5428571429,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01639344262,NA,0.4896551724,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5984251969,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Diff & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,NA,0.6513761468,NA,NA,0.611814346,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4429065744,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.4183673469,NA,NA,0.2585551331,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3760683761,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5315315315,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4978354978,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.6203703704,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4812030075,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6019900498,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5886075949,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3168316832,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3243243243,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3518518519,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.7594936709,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.384,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4819277108,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.4366197183,NA,NA,0.3788395904,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3606729758,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3706293706,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7692307692,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ELETRIPTAN HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7387755102,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ENCOUNTER FOR OTHER SPECIFIED AFTERCARE (dxo:ICD9:V5889)",NA,NA,NA,NA,NA
"41-64","Female",0.01652892562,0.02672605791,0.6863792446,NA,NA,0.4658385093,0.368861024,0.4210526316,NA,NA,0.4244604317,NA,0.5388513514,0.03289473684,0.6191950464,0.2685934489,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5643564356,NA,NA,NA,NA,NA,NA,NA,0.2307692308,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.3806451613,NA,NA,NA,0.1866028708,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1797752809,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA
"41-64","Female",NA,0.02259887006,0.7298969072,NA,NA,0.4566929134,0.3893016345,NA,NA,NA,NA,NA,NA,0.04098360656,0.5977653631,0.3190839695,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7574626866,NA,NA,NA,0.4105263158,NA,NA,NA,NA,NA,0.5909090909,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,0.6450704225,NA,NA,NA,0.3468950749,NA,NA,NA,NA,NA,0.572815534,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2592592593,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,0.65625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2809364548,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4256756757,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3073170732,NA,NA,NA,NA,NA,NA,0.01503759398,NA,0.4759615385,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.03571428571,0.7941176471,NA,NA,NA,0.4860883797,NA,NA,NA,NA,NA,NA,NA,NA,0.3456561922,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4810606061,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3611111111,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3378378378,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,0.4855072464,NA,NA,NA,0.2036553525,NA,NA,NA,NA,NA,NA,NA,NA,0.3005780347,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2024793388,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,0.4927536232,NA,NA,NA,0.2096069869,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,0.5109034268,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4520547945,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4139072848,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.7432188065,NA,NA,NA,0.6313559322,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6325301205,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,0.6515151515,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5925925926,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA,NA,0.5227272727,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2796610169,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3653846154,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5909090909,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Num Previous Antidep: 2,3",NA,NA,NA,NA
"41-64","Female",NA,NA,0.649321267,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.3082706767,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07407407407,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1307692308,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5431034483,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4427480916,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5441176471,NA,NA,0.2101449275,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5962962963,NA,NA,NA,0.3096330275,NA,NA,NA,NA,NA,NA,0.01290322581,NA,0.3339070568,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3551401869,NA,NA,NA,NA,NA,NA,NA,NA,0.2727272727,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESOMEPRAZOLE MAGNESIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.456928839,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESOMEPRAZOLE MAGNESIUM","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7588235294,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESOMEPRAZOLE MAGNESIUM","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6895705521,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4074074074,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7135802469,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.85,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","Last AD: Same & Remiss","SIMVASTATIN",NA,NA,NA
"41-64","Female",NA,NA,0.6237623762,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","LISINOPRIL/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7772511848,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7469879518,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESTROGEN,CON/M-PROGEST ACET",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7337662338,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESTROGEN,CON/M-PROGEST ACET","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.4215686275,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESTROGEN,CON/M-PROGEST ACET","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7614678899,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESTROGEN,CON/M-PROGEST ACET","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.775862069,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESTROGENS, CONJUGATED",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6728110599,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESZOPICLONE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7881355932,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESZOPICLONE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.688172043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","EXAMINATION OF EYES AND VISION (dxo:ICD9:V720)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7175572519,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","EZETIMIBE/SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7522123894,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","EZETIMIBE/SIMVASTATIN","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6960784314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","FENOFIBRATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7232142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","FEXOFENADINE/PSEUDOEPHEDRINE",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05630630631,0.5391891892,NA,NA,0.3470319635,0.2522796353,0.5540393013,NA,NA,0.3725490196,NA,0.442455243,NA,0.5953488372,0.2715803453,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03738317757,0.75,NA,NA,NA,0.2926829268,NA,NA,NA,NA,NA,NA,NA,NA,0.3170731707,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7076923077,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,0.6363636364,NA,NA,NA,NA,0.6807228916,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,0.6357142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2977099237,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03149606299,NA,NA,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.71875,NA,NA,NA,NA,0.7142857143,NA,NA,NA,NA,NA,NA,NA,0.3712121212,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.3755274262,NA,NA,NA,NA,0.3846153846,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3963963964,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5074626866,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.7401574803,NA,NA,NA,NA,0.6746031746,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6237623762,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.731092437,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7085889571,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6211180124,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.141509434,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.4642857143,NA,NA,NA,NA,0.5094339623,NA,NA,NA,NA,NA,NA,NA,0.2410714286,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.4006622517,NA,NA,NA,NA,0.4014336918,NA,NA,NA,NA,NA,0.03311258278,NA,0.3333333333,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.4358974359,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1728395062,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6893203883,NA,NA,0.476635514,0.3714285714,NA,NA,NA,NA,NA,NA,NA,NA,0.448441247,"CITALOPRAM HYDROBROMIDE","GABAPENTIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4563106796,"CITALOPRAM HYDROBROMIDE","GABAPENTIN","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4598540146,"CITALOPRAM HYDROBROMIDE","GABAPENTIN","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.4324324324,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GABAPENTIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7177419355,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GABAPENTIN","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7168141593,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GABAPENTIN","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5588235294,"CITALOPRAM HYDROBROMIDE","GABAPENTIN","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7236842105,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GEMFIBROZIL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.0380952381,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3137254902,"CITALOPRAM HYDROBROMIDE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02586206897,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.674796748,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GUAIFENESIN/P-EPHED HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6655844156,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GUAIFENESIN/PHENYLEPHRINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6952975048,NA,NA,NA,0.2454873646,NA,NA,NA,0.4708737864,NA,NA,NA,0.734082397,0.3620071685,"CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4285714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1315789474,NA,NA,NA,NA,NA,NA,NA,NA,0.381294964,"CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1879194631,NA,NA,NA,NA,NA,NA,NA,NA,0.2901554404,"CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.4307359307,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.43125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,0.6552845528,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","LORATADINE",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6513761468,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6206896552,"CITALOPRAM HYDROBROMIDE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",0.01457725948,NA,NA,NA,NA,NA,NA,NA,NA,0.06467661692,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"41-64","Female",0.0119047619,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1640625,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","HEADACHE (dxo:ICD9:7840)","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6802721088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","HEMATURIA (dxo:ICD9:5997)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.504950495,"CITALOPRAM HYDROBROMIDE","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7238493724,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","HYDROCODONE/HOMATROPINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","HYDROCODONE/HOMATROPINE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6788990826,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","HYDROCODONE/HOMATROPINE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","HYDROXYCHLOROQUINE SULFATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7210884354,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","IBUPROFEN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.47,"CITALOPRAM HYDROBROMIDE","IMIPRAMINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.3477537438,NA,NA,NA,0.1962616822,NA,NA,NA,NA,NA,NA,NA,NA,0.1152941176,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.2314049587,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA
"41-64","Female",NA,NA,0.2149253731,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,0.1061946903,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"41-64","Female",NA,NA,0.7128712871,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Female",NA,NA,0.2429378531,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07602339181,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,0.2547169811,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1172413793,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07432432432,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,0.2660944206,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1353846154,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.4202101051,NA,NA,0.25,0.1195335277,0.2372881356,NA,NA,0.2838709677,NA,0.2736842105,NA,0.4015151515,0.1857410882,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09027777778,NA,NA,NA,NA,NA,NA,NA,NA,0.1518324607,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09032258065,NA,NA,NA,NA,NA,NA,NA,0.2403846154,0.1174496644,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA
"41-64","Female",NA,NA,0.3012820513,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,0.1899441341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"41-64","Female",NA,NA,0.3025641026,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,0.5733333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & Remiss",NA,NA,NA
"41-64","Female",NA,NA,0.3982300885,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,0.2044728435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1102362205,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,0.2137931034,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1176470588,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,0.2023121387,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,0.4197080292,NA,NA,0.1774193548,0.1315789474,0.2196969697,NA,NA,NA,NA,0.2260869565,NA,0.2619047619,0.1603174603,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,0.3612334802,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.243902439,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,0.3348314607,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3333333333,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.2442159383,NA,NA,NA,0.09558823529,NA,NA,NA,NA,NA,NA,NA,NA,0.1254237288,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.1793721973,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,0.2265625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1555555556,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.68288854,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02843601896,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3739837398,0.009389671362,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6120689655,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,0.6363636364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02032520325,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01785714286,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01169590643,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009132420091,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.4218181818,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01724137931,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.6757679181,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01694915254,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6923076923,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","IRREGULAR MENSTRUAL CYCLE (dxo:ICD9:6264)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6900584795,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LABORATORY EXAMINATION (dxo:ICD9:V726)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.77,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LABORATORY EXAMINATION, UNSPECIFIED (dxo:ICD9:V7260)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.1492103076,NA,NA,0.1583333333,0.1127819549,0.1052631579,NA,NA,NA,NA,0.2125984252,NA,NA,0.08920863309,"CITALOPRAM HYDROBROMIDE","LAMOTRIGINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.06984126984,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LAMOTRIGINE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.1293103448,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07692307692,"CITALOPRAM HYDROBROMIDE","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",0.006880733945,0.01764199656,NA,NA,NA,0.373540856,0.1839407745,0.4386363636,0.1237623762,0.02419354839,0.3446475196,NA,0.4276184123,0.008885298869,0.4781783681,0.3151738997,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.2162162162,NA,NA,NA,NA,NA,NA,0.5681818182,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,0.01327433628,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7300613497,NA,NA,NA,NA,NA,NA,0.1333333333,NA,NA,NA,NA,NA,0.4965517241,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7264957265,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,0.5859872611,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.464516129,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,0.6315789474,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7158469945,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,0.5568281938,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01556420233,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,0.6648351648,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,0.775,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7320441989,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.6364665912,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007518796992,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.768907563,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2773722628,NA,NA,NA,NA,NA,0.464,NA,0.5172413793,0.2619047619,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4952380952,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.6242038217,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2953020134,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.5527847049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5003548616,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.6614583333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6553672316,0.4739336493,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.008620689655,0.7570093458,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2625698324,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.02459016393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1308411215,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02212389381,NA,0.2586206897,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1619047619,NA,NA,NA,NA,NA,NA,NA,NA,0.1560283688,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.179245283,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2264150943,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6376811594,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5953757225,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1656804734,NA,NA,NA,0.314516129,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.01746724891,0.7529411765,NA,NA,NA,0.1770833333,NA,NA,NA,NA,NA,NA,0,0.4637681159,0.3054755043,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005813953488,NA,0.4836065574,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4051724138,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4086956522,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA
"41-64","Female",NA,0.02164502165,0.627017842,NA,NA,NA,0.2068965517,NA,NA,NA,NA,NA,NA,0.01484230056,NA,0.5460683082,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01162790698,NA,0.5,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3824884793,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,0.01860465116,0.7507507508,NA,NA,NA,0.2121212121,NA,NA,NA,NA,NA,NA,NA,0.6870897155,0.4515418502,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.04,0.06397058824,NA,0.6554054054,NA,0.5110837438,0.3235059761,0.6408934708,0.2421875,NA,0.5532646048,NA,0.6279411765,0.03956043956,0.6414201183,0.412591051,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,0.5047619048,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7072072072,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,0.06060606061,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7070063694,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6019417476,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6129032258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","Num Previous Remissions: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,0.5571428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006622516556,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,0.6589285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01268498943,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3732394366,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,0.625498008,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4806629834,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,0.5446428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3591331269,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.6278195489,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04273504274,NA,0.5047619048,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5073529412,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4701986755,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","OMEPRAZOLE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3295454545,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5887850467,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2875816993,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6506024096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5217391304,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3302752294,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.07,0.75,NA,NA,NA,0.3235294118,NA,NA,NA,NA,NA,0.7770700637,NA,NA,0.4459930314,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4277777778,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6165137615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02827521206,NA,0.4913580247,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4897959184,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7111111111,NA,NA,NA,0.3421052632,NA,NA,NA,NA,NA,NA,NA,0.7442922374,0.417989418,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.3926009815,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4196078431,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.3921568627,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5095057034,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3035714286,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,0.4095238095,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","MONTELUKAST SODIUM",NA,NA,NA,NA
"41-64","Female",NA,NA,0.3902439024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3931034483,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5042735043,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,0.449704142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4957983193,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.3929320156,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,0.462962963,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.4107142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SIMVASTATIN",NA,NA,NA
"41-64","Female",NA,NA,0.4328358209,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4383561644,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5140186916,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,0.4411764706,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA
"41-64","Female",NA,NA,0.4748358862,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.4355828221,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.3865979381,NA,NA,NA,NA,NA,NA,NA,0.3290322581,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4122807018,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.2343541944,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2217391304,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5388127854,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6725663717,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA
"41-64","Female",NA,NA,0.4322033898,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PRAVASTATIN SODIUM",NA,NA,NA,NA
"41-64","Female",NA,NA,0.3068181818,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.4579439252,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PROGESTERONE, MICRONIZED",NA,NA,NA,NA
"41-64","Female",NA,NA,0.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"41-64","Female",NA,NA,0.3540669856,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2426470588,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.2252747253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.2540983607,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.1147540984,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","RISPERIDONE",NA,NA,NA,NA
"41-64","Female",NA,NA,0.4234234234,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.376146789,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.3987341772,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4203821656,NA,NA,0.237704918,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4873417722,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.4486607143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,0.512605042,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","TOPIRAMATE",NA,NA,NA,NA
"41-64","Female",NA,NA,0.3858921162,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0119047619,NA,0.4044233807,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5085470085,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.3968253968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.3630363036,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.3300970874,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","VALACYCLOVIR HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.3955555556,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4615384615,0.3015873016,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7175115507,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4946996466,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7142857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7047244094,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7281553398,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.6730769231,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","METAXALONE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5777777778,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7731092437,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","MONTELUKAST SODIUM",NA,NA,NA,NA
"41-64","Female",NA,NA,0.8097560976,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6046511628,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7196261682,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,0.5907111756,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,0.8656716418,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5877862595,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,0.7131782946,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6338983051,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.8652094718,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Remissions: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5878787879,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.8067978533,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7874015748,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6538461538,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6050955414,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6641791045,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA
"41-64","Female",NA,NA,0.7310344828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","PRAVASTATIN SODIUM",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7254901961,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","PREGABALIN",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6173913043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6909090909,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","PROGESTERONE, MICRONIZED",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5531914894,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5483870968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6509433962,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6327160494,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5503875969,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.7394957983,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","ROSUVASTATIN CALCIUM",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7281553398,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7804878049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6896551724,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7886524823,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6643356643,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","TOPIRAMATE",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7122641509,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6170960187,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5268817204,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.7393617021,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6898954704,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.735042735,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","VALACYCLOVIR HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5961538462,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6694214876,0.6100628931,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,"CITALOPRAM HYDROBROMIDE","LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6830601093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LEVONORGESTREL-ETHIN ESTRADIOL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7045075125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3992248062,"CITALOPRAM HYDROBROMIDE","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4210526316,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LEVOTHYROXINE SODIUM","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.8125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LEVOTHYROXINE SODIUM","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7462686567,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LISINOPRIL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7052868391,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LISINOPRIL/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4297082228,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LISINOPRIL/HYDROCHLOROTHIAZIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6734693878,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LISINOPRIL/HYDROCHLOROTHIAZIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7540983607,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LISINOPRIL/HYDROCHLOROTHIAZIDE","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7547770701,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LORATADINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6373626374,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LORAZEPAM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4426229508,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LORAZEPAM","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6494252874,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7185354691,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LOVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4214285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LOVASTATIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7934782609,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LOVASTATIN","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7024793388,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7290909091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6652719665,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6923076923,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.688,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7252747253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4578947368,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.4273858921,0.7063074901,NA,NA,0.5543478261,0.5846774194,0.7267759563,NA,NA,0.6568627451,NA,0.6756756757,NA,NA,0.5815412186,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7229437229,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6116504854,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6425233645,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2461538462,NA,0.5981595092,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5657894737,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5762711864,NA,"CITALOPRAM HYDROBROMIDE","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6616541353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","METAXALONE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.641025641,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","MIGRAINE WITHOUT AURA, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34610)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4932502596,NA,NA,NA,NA,NA,0.2112676056,NA,NA,NA,NA,NA,NA,0.3136942675,"CITALOPRAM HYDROBROMIDE","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1176470588,"CITALOPRAM HYDROBROMIDE","MIRTAZAPINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.456043956,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3215962441,"CITALOPRAM HYDROBROMIDE","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2695035461,"CITALOPRAM HYDROBROMIDE","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.73,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3885714286,"CITALOPRAM HYDROBROMIDE","MONTELUKAST SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4311926606,"CITALOPRAM HYDROBROMIDE","MULTIPLE SCLEROSIS (dxo:ICD9:340)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7115384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05014749263,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5821205821,NA,NA,NA,NA,NA,NA,0.1511627907,NA,NA,NA,NA,NA,0.4539419087,"CITALOPRAM HYDROBROMIDE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6022099448,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","NORTRIPTYLINE HCL","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.34375,"CITALOPRAM HYDROBROMIDE","NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3465346535,"CITALOPRAM HYDROBROMIDE","NORTRIPTYLINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.700913242,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2336448598,"CITALOPRAM HYDROBROMIDE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3046357616,"CITALOPRAM HYDROBROMIDE","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.6846846847,NA,NA,NA,NA,NA,NA,NA,0.6435643564,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6228571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5605947955,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6529680365,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.852173913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Remissions: 2+",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6094182825,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5128205128,"CITALOPRAM HYDROBROMIDE","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1674418605,"CITALOPRAM HYDROBROMIDE","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2695652174,"CITALOPRAM HYDROBROMIDE","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7567024129,NA,NA,NA,0.4347826087,NA,NA,NA,NA,NA,NA,NA,NA,0.5106382979,"CITALOPRAM HYDROBROMIDE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7952755906,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2897196262,NA,NA,NA,NA,NA,NA,NA,NA,0.4365853659,"CITALOPRAM HYDROBROMIDE","OMEPRAZOLE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.465648855,"CITALOPRAM HYDROBROMIDE","OTHER ANXIETY STATES (dxo:ICD9:30009)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4620689655,"CITALOPRAM HYDROBROMIDE","OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02777777778,NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6293706294,NA,NA,NA,0.2269503546,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6511627907,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","OTHER NONSPECIFIC ABNORMAL FINDING OF LUNG FIELD (dxo:ICD9:79319)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7605042017,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6568627451,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.736196319,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","OTHER SPECIFIED PRE-OPERATIVE EXAMINATION (dxo:ICD9:V7283)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3986928105,"CITALOPRAM HYDROBROMIDE","OXYBUTYNIN CHLORIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6631205674,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3825136612,"CITALOPRAM HYDROBROMIDE","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02536231884,0.5616547335,NA,NA,0.3913043478,0.2222222222,0.4356435644,NA,NA,0.5405017921,NA,0.5055350554,NA,0.6206896552,0.2659430122,"CITALOPRAM HYDROBROMIDE","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.494047619,NA,NA,NA,NA,NA,NA,NA,0.4964539007,NA,NA,NA,NA,0.3239875389,"CITALOPRAM HYDROBROMIDE","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.722513089,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PEN NEEDLE, DIABETIC",NA,NA,NA,NA,NA
"41-64","Female",NA,0.06796116505,0.3249490143,NA,NA,0.2054054054,NA,0.1729323308,NA,NA,NA,NA,0.2294117647,NA,NA,0.1205400193,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.3333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1404682274,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1866666667,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.2679640719,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0625,NA,0.1980413493,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1267605634,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.2727272727,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.13,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5501813785,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5240770465,"CITALOPRAM HYDROBROMIDE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6166666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5858585859,"CITALOPRAM HYDROBROMIDE","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.520661157,"CITALOPRAM HYDROBROMIDE","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4279835391,"CITALOPRAM HYDROBROMIDE","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7643312102,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PRAVASTATIN SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7012448133,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PREGABALIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6366666667,NA,NA,NA,NA,0.4122807018,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6784565916,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PROGESTERONE, MICRONIZED",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3826086957,"CITALOPRAM HYDROBROMIDE","PROPOXYPHENE NAP/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6117647059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.3695652174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.52734375,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.272,NA,NA,0.178,"CITALOPRAM HYDROBROMIDE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4957983193,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2804428044,"CITALOPRAM HYDROBROMIDE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.3104693141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.153256705,"CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.2666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1884816754,"CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.3642039542,NA,NA,0.1395348837,0.1526315789,0.1764705882,NA,NA,NA,NA,0.1882352941,NA,NA,0.216066482,"CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.3047619048,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.2161290323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2245430809,"CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7121212121,NA,NA,NA,NA,NA,NA,NA,NA,0.1881188119,NA,NA,NA,0.5,"CITALOPRAM HYDROBROMIDE","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.649122807,NA,NA,NA,NA,NA,NA,NA,NA,0.3884297521,NA,NA,NA,0.600536193,"CITALOPRAM HYDROBROMIDE","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5142857143,"CITALOPRAM HYDROBROMIDE","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.1660447761,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1111111111,"CITALOPRAM HYDROBROMIDE","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.2471910112,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09538461538,"CITALOPRAM HYDROBROMIDE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7419354839,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ROFECOXIB",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5717455621,NA,NA,NA,NA,NA,NA,NA,NA,0.4039735099,NA,NA,NA,0.531372549,"CITALOPRAM HYDROBROMIDE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4160583942,"CITALOPRAM HYDROBROMIDE","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4672897196,"CITALOPRAM HYDROBROMIDE","ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7122302158,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.6634615385,NA,0.5483870968,0.3273273273,NA,NA,NA,0.5214723926,NA,NA,NA,NA,0.3571428571,"CITALOPRAM HYDROBROMIDE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7131147541,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6445182724,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6929824561,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","SCREENING FOR UNSPECIFIED CONDITION (dxo:ICD9:V829)",NA,NA,NA,NA,NA
"41-64","Female",0.01904761905,0.02845528455,0.53125,NA,NA,0.3438914027,0.2168674699,0.4153846154,NA,NA,0.4200743494,NA,0.5427852349,0,0.5267175573,0.2799442897,"CITALOPRAM HYDROBROMIDE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4314285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4550408719,0.01442307692,NA,0.350148368,"CITALOPRAM HYDROBROMIDE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.48,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5503875969,NA,NA,0.2127659574,"CITALOPRAM HYDROBROMIDE","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7529274005,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6934306569,NA,NA,0.4469565217,"CITALOPRAM HYDROBROMIDE","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6870229008,"CITALOPRAM HYDROBROMIDE","SIMVASTATIN","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6886792453,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","SODIUM, POTASSIUM,MAG SULFATES",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6532258065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4496644295,"CITALOPRAM HYDROBROMIDE","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.688034188,NA,"CITALOPRAM HYDROBROMIDE","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7043010753,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","TIZANIDINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7028571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4732142857,"CITALOPRAM HYDROBROMIDE","TOPIRAMATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6827956989,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","TRAMADOL HCL/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Female",0.02645502646,0.03731343284,0.5034866189,NA,NA,0.2865853659,0.2240184758,0.3612716763,NA,NA,0.3410404624,NA,0.3285302594,0.02131336406,0.4120603015,0.4186464201,"CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4328358209,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01401869159,0.6038961039,0.3601108033,"CITALOPRAM HYDROBROMIDE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6825396825,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","UNSPECIFIED CONSTIPATION (dxo:ICD9:56400)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7027027027,NA,NA,0.5560640732,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6336633663,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6689655172,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","UNSPECIFIED TEAR FILM INSUFFICIENCY (dxo:ICD9:37515)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6464968153,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6972789116,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","VALACYCLOVIR HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","VARENICLINE TARTRATE",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02877697842,0.5597964377,NA,NA,0.4957264957,0.2707774799,0.4703703704,NA,NA,0.4429530201,NA,0.4143518519,NA,0.6845513414,0.3214876033,"CITALOPRAM HYDROBROMIDE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.01168224299,0.03337612323,0.4487021014,NA,NA,NA,0.1868556701,0.4077253219,0.1546391753,NA,NA,NA,0.5427901524,0.006720430108,0.4545454545,0.2639175258,"CLONAZEPAM",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.015625,0.5242718447,NA,"CLONAZEPAM","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.375,"CLONAZEPAM","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3947368421,"CLONAZEPAM","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3272727273,"CLONAZEPAM","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4098360656,"CLONAZEPAM","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.299270073,"CLONAZEPAM","DULOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5609756098,"CLONAZEPAM","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.375,NA,NA,NA,NA,NA,NA,NA,NA,0.34767642,"CLONAZEPAM","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2116788321,"CLONAZEPAM","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3642857143,"CLONAZEPAM","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1589958159,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CLONAZEPAM","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.6785714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CLONAZEPAM","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3774834437,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CLONAZEPAM","ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4761904762,"CLONAZEPAM","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6567164179,NA,NA,NA,NA,NA,NA,NA,0.4267310789,"CLONAZEPAM","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3257575758,"CLONAZEPAM","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3523809524,"CLONAZEPAM","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5032679739,"CLONAZEPAM","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",0.008474576271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CLONAZEPAM","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4466019417,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5405405405,0.007067137809,NA,NA,"CLONAZEPAM","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5153846154,"CLONAZEPAM","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5196078431,"CLONAZEPAM","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3,"CLONAZEPAM","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.308988764,"CLONAZEPAM","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2931034483,"CLONAZEPAM","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4090909091,"CLONAZEPAM","Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4429824561,"CLONAZEPAM","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3949044586,"CLONAZEPAM","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4794520548,NA,NA,NA,"CLONAZEPAM","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.004524886878,NA,NA,"CLONAZEPAM","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6943521595,NA,NA,NA,"CLONAZEPAM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.02884615385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CLONAZEPAM","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3925233645,"CLONAZEPAM","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.01459854015,NA,NA,NA,NA,NA,0.1927710843,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CLONAZEPAM","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6746794872,NA,NA,0.4363885089,"CLONAZEPAM","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5815217391,"CLONAZEPAM","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02118644068,NA,0.3254593176,"CLONAZEPAM","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5310734463,"CLONAZEPAM","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6859504132,0.4150141643,"CLONAZEPAM","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01666666667,NA,NA,"CLONAZEPAM","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01379310345,NA,NA,"CLONIDINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.3867403315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CLOTRIMAZOLE/BETAMETHASONE DIP",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4714912281,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006423982869,0.3452380952,NA,"CODEINE PHOSPHATE/GUAIFENESIN",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007874015748,NA,NA,"CODEINE PHOSPHATE/GUAIFENESIN","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01,NA,NA,"CODEINE PHOSPHATE/GUAIFENESIN","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01754385965,NA,NA,NA,NA,NA,0.5592105263,NA,NA,NA,NA,NA,NA,NA,NA,"CONGESTIVE HEART FAILURE, UNSPECIFIED (dxo:ICD9:4280)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6796116505,NA,NA,NA,NA,NA,NA,NA,NA,"CONGESTIVE HEART FAILURE, UNSPECIFIED (dxo:ICD9:4280)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.07439824945,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CONTACT DERMATITIS AND OTHER ECZEMA, DUE TO UNSPECIFIED CAUSE (dxo:ICD9:6929)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.1153846154,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CONTACT DERMATITIS AND OTHER ECZEMA, DUE TO UNSPECIFIED CAUSE (dxo:ICD9:6929)","HYDROXYZINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.3984063745,NA,NA,NA,NA,0.4278074866,NA,NA,NA,NA,0.425257732,NA,NA,NA,"CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7260273973,NA,NA,NA,"CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1844660194,0.4774193548,NA,NA,NA,0.2433862434,NA,0.005958291956,NA,NA,"CYCLOBENZAPRINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"CYCLOBENZAPRINE HCL","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007692307692,NA,NA,"CYCLOBENZAPRINE HCL","IBUPROFEN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"CYCLOBENZAPRINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.003802281369,NA,NA,"CYCLOBENZAPRINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"CYCLOBENZAPRINE HCL","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01442307692,NA,NA,"CYCLOBENZAPRINE HCL","TRAMADOL HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01234567901,NA,NA,"CYCLOBENZAPRINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005,NA,NA,"CYCLOBENZAPRINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"CYCLOBENZAPRINE HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4875207987,NA,NA,NA,0.1683168317,0.5551330798,NA,NA,0.4868804665,NA,0.5351351351,NA,NA,0.3263598326,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3706896552,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3435582822,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7282913165,NA,NA,NA,NA,NA,NA,NA,0.4386792453,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.768,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4677419355,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4785714286,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7402597403,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7302904564,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7081545064,NA,NA,NA,NA,0.3560606061,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7140115163,NA,NA,0.4484304933,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4558823529,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.01685891748,0.02424612877,0.5359028511,0.6473526474,0.1840659341,0.4495515695,0.1572383073,0.5676406926,NA,0.0625,0.482,0.3187250996,0.6114285714,0.01431670282,0.5755208333,0.3155949741,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.7455752212,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7986111111,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.4504504505,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DESVENLAFAXINE SUCCINATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.7667731629,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DESVENLAFAXINE SUCCINATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.02643171806,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.5652173913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DOXEPIN HCL",NA,NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,0.6110019646,NA,NA,NA,NA,NA,NA,NA,0.009009009009,0.721822542,0.389261745,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6129032258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DULOXETINE HCL","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA
"41-64","Female",0.01739130435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0.5265957447,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01587301587,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7435897436,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DULOXETINE HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6746031746,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DULOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01941747573,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DULOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3018018018,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2321428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DULOXETINE HCL","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.7150537634,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6645962733,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DULOXETINE HCL","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5550660793,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DULOXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01775147929,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5480769231,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DYSTHYMIC DISORDER (dxo:ICD9:3004)",NA,NA,NA,NA,NA
"41-64","Female",0.008403361345,0.06271777003,0.8285714286,NA,NA,NA,0.3480769231,0.6624203822,NA,NA,NA,NA,NA,0.03448275862,0.6747252747,0.3217115689,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3238095238,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02564102564,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA
"41-64","Female",0.02197802198,0.01898734177,0.5974842767,NA,NA,NA,NA,0.509202454,NA,NA,NA,NA,NA,0.01910828025,0.5572139303,0.1891252955,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01265822785,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2745098039,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6633663366,0.5,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1214574899,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2097902098,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.147826087,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09221311475,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.7658730159,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.7412935323,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3194444444,NA,NA,NA,NA,NA,NA,NA,NA,0.4076923077,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01369863014,NA,0.5042016807,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5305466238,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6317626527,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7207792208,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7530562347,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5863874346,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESTRADIOL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7491408935,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESTRADIOL","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7641509434,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESTRADIOL","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.75,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESTROGEN,CON/M-PROGEST ACET","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.496350365,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESTROGENS, CONJUGATED",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7126436782,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESTROGENS, CONJUGATED","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUCONAZOLE",NA,NA,NA,NA,NA
"41-64","Female",0.03759398496,0.02313624679,NA,0.649122807,NA,NA,NA,0.6977016886,NA,NA,NA,NA,NA,0.01234567901,0.7008130081,0.419001218,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6902654867,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","GABAPENTIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7067307692,NA,NA,NA,NA,NA,NA,0.7394957983,0.4038461538,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.656779661,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6168224299,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & Remiss",NA,NA,NA
"41-64","Female",0.009009009009,0.02173913043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0.4894736842,0.3357933579,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02255639098,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6909090909,NA,NA,NA,NA,NA,0.01421800948,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4100719424,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,0.07079646018,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6927710843,0.4139344262,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0253164557,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4107526882,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.421875,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6660305344,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7272727273,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & Remiss","SIMVASTATIN",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7058823529,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.707641196,NA,NA,NA,NA,NA,NA,NA,0.4537815126,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","LEVOTHYROXINE SODIUM",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7535211268,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6972477064,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6222222222,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6826923077,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6807511737,NA,NA,NA,NA,NA,NA,NA,0.4285714286,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.774691358,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5405405405,NA,NA,NA,NA,NA,0.02392344498,NA,0.6107784431,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6816326531,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7115384615,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6194690265,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6463414634,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA
"41-64","Female",0.02631578947,0.03164556962,NA,NA,NA,NA,0.1705426357,0.5625,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03501945525,0.7054263566,NA,NA,NA,0.1160714286,0.5183823529,NA,NA,0.4959349593,NA,0.6761133603,NA,0.6701986755,0.2470588235,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6415929204,NA,NA,NA,0.7669902913,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7450980392,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7228915663,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.747311828,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.01616628176,0.01639344262,NA,NA,NA,NA,NA,NA,NA,0.04897959184,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"41-64","Female",0.02030456853,NA,NA,NA,NA,NA,NA,NA,NA,0.04347826087,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HEADACHE (dxo:ICD9:7840)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA
"41-64","Female",0.008,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HEADACHE (dxo:ICD9:7840)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4467005076,0.1907216495,NA,NA,NA,NA,NA,0.625,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HYDROCODONE/ACETAMINOPHEN","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.75,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HYDROCODONE/ACETAMINOPHEN","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02380952381,0.288372093,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2857142857,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3565217391,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.401459854,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.01058201058,0.4714285714,NA,NA,NA,NA,0.5226480836,NA,NA,NA,NA,NA,0.006976744186,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.004444444444,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.009174311927,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02661596958,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005494505495,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","ZOLPIDEM TARTRATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.6371681416,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5825688073,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01395348837,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02564102564,0.7387387387,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5424836601,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6043165468,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5104895105,0.2446043165,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",0.006802721088,0.02083333333,NA,NA,NA,NA,NA,0.4473684211,NA,NA,NA,NA,NA,0.01351351351,0.4779411765,0.375,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3914893617,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7086092715,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.0347826087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0127388535,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03846153846,0.64,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6435643564,0.3833333333,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.01898734177,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6898148148,0.4064516129,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.671875,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3936170213,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1027027027,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3564356436,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3952095808,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.392,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4716981132,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4075342466,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4655532359,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3855421687,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005340453939,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4205518554,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7445255474,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6897810219,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7258064516,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7584541063,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7329105004,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1782178218,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","LEVOFLOXACIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6306818182,NA,NA,NA,NA,0.5755813953,NA,NA,NA,NA,0.6447368421,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7833333333,NA,NA,0.3071428571,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","LEVOTHYROXINE SODIUM","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.452173913,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","LEVOTHYROXINE SODIUM","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.01515151515,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","LORAZEPAM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4618644068,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7260273973,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.03105590062,NA,NA,NA,NA,NA,NA,0.5363636364,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.008130081301,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","MORBID OBESITY (dxo:ICD9:27801)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01935483871,NA,NA,NA,NA,NA,0.568,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01536312849,NA,NA,NA,NA,0.2279411765,0.4859813084,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2378854626,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.0297029703,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03773584906,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OBESITY, UNSPECIFIED (dxo:ICD9:27800)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"41-64","Female",NA,0.02782608696,NA,0.6503496503,NA,0.4428571429,0.1417910448,0.5030674847,NA,NA,NA,NA,NA,NA,0.6382978723,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.0275862069,NA,0.6692913386,NA,0.4652406417,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",0.009836065574,NA,0.5190839695,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6168831169,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",0.01052631579,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7712418301,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",0.04098360656,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OXYCODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.462585034,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"41-64","Female",0.02727272727,0.03370786517,NA,NA,NA,NA,NA,NA,NA,NA,0.6649899396,NA,NA,0.02,0.6965174129,0.3325791855,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6192468619,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009090909091,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",0.01754385965,0.01857585139,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2803030303,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006849315068,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.04693140794,NA,NA,NA,NA,0.1666666667,NA,NA,NA,NA,NA,NA,0,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01169590643,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",0.005797101449,0.01503759398,NA,0.7069892473,NA,0.4750499002,0.1471282455,0.5853658537,NA,NA,0.4531835206,NA,NA,NA,NA,0.316017316,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.464516129,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2426470588,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5808823529,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6916666667,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)",NA,NA,NA,NA,NA
"41-64","Female",0.005882352941,0.01671309192,NA,0.6216216216,NA,0.5871559633,0.2277227723,0.6086956522,NA,NA,NA,NA,0.7476432197,0.005988023952,0.6814580032,0.4161979753,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4230769231,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03083700441,NA,0.6769230769,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6116504854,NA,NA,NA,NA,0.6359223301,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5673076923,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7125,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005494505495,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","TRAMADOL HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02479338843,NA,0.3821138211,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03896103896,0.582781457,0.6,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4579439252,0.1650485437,0.5024154589,NA,NA,NA,NA,NA,0.03703703704,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4341085271,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.497005988,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7336244541,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.0206185567,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","VALACYCLOVIR HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03422053232,NA,0.7603305785,NA,0.6095238095,NA,0.6165413534,NA,NA,NA,NA,NA,0.01492537313,0.7125965251,0.3451327434,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5289256198,NA,NA,NA,NA,NA,0.00956937799,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4378378378,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF FOOT (dxo:ICD9:1104)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6638655462,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF FOOT (dxo:ICD9:1104)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4839108911,NA,NA,NA,0.1334816463,0.4763458401,NA,NA,0.40562249,NA,NA,NA,NA,0.2126436782,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.335483871,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09223300971,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2627118644,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6806930693,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3655172414,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6714285714,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1274509804,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6845637584,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1464285714,NA,NA,NA,0.3333333333,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09965635739,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESLORATADINE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2079207921,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESLORATADINE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1139896373,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESLORATADINE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6170212766,NA,NA,NA,"DESOGESTREL-ETHINYL ESTRADIOL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7593984962,NA,NA,NA,"DESOGESTREL-ETHINYL ESTRADIOL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.02614379085,0.04310344828,0.5134020619,0.5272464814,NA,0.5782493369,0.2075718016,0.472972973,NA,NA,0.39375,NA,0.5592105263,0.04716981132,0.717368962,0.3152997187,"DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3602484472,"DESVENLAFAXINE SUCCINATE","DOXEPIN HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6473988439,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2670565302,"DESVENLAFAXINE SUCCINATE","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6885245902,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2899159664,"DESVENLAFAXINE SUCCINATE","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3567010309,NA,NA,NA,NA,NA,NA,NA,NA,0.305764411,"DESVENLAFAXINE SUCCINATE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4695652174,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2450331126,"DESVENLAFAXINE SUCCINATE","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.6976744186,NA,NA,NA,0.5806451613,NA,NA,NA,NA,NA,NA,NA,0.3173076923,"DESVENLAFAXINE SUCCINATE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3502824859,"DESVENLAFAXINE SUCCINATE","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.2805755396,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.1888888889,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.1291793313,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08838383838,"DESVENLAFAXINE SUCCINATE","LAMOTRIGINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.04587155963,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","LAMOTRIGINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07331378299,"DESVENLAFAXINE SUCCINATE","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.02010050251,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02702702703,0.568,0.3278688525,"DESVENLAFAXINE SUCCINATE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02966101695,NA,0.6264367816,"DESVENLAFAXINE SUCCINATE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7608695652,NA,"DESVENLAFAXINE SUCCINATE","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.04545454545,NA,0.8106060606,NA,0.6017699115,NA,NA,NA,NA,NA,NA,NA,NA,0.7272727273,0.3742690058,"DESVENLAFAXINE SUCCINATE","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.6637931034,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06666666667,NA,NA,"DESVENLAFAXINE SUCCINATE","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.4600840336,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.1538461538,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.5205479452,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5327868852,"DESVENLAFAXINE SUCCINATE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5779467681,"DESVENLAFAXINE SUCCINATE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.7086614173,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.6014084507,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5482954545,"DESVENLAFAXINE SUCCINATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.7156862745,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4482758621,"DESVENLAFAXINE SUCCINATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2575107296,"DESVENLAFAXINE SUCCINATE","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4117647059,"DESVENLAFAXINE SUCCINATE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2167832168,"DESVENLAFAXINE SUCCINATE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.8362068966,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","Num Previous Remissions: 2+",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5333333333,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.2067736185,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1709401709,"DESVENLAFAXINE SUCCINATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.185840708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.5092592593,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4600938967,"DESVENLAFAXINE SUCCINATE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.4860335196,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.2465753425,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1337209302,"DESVENLAFAXINE SUCCINATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.1596638655,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1282051282,"DESVENLAFAXINE SUCCINATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.3099630996,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1891891892,"DESVENLAFAXINE SUCCINATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.2685185185,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.515625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5034482759,"DESVENLAFAXINE SUCCINATE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.7464788732,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.745472837,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.6956521739,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.7345132743,NA,NA,NA,NA,NA,NA,NA,NA,0.6053412463,NA,NA,0.3688212928,"DESVENLAFAXINE SUCCINATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2822580645,"DESVENLAFAXINE SUCCINATE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.5731132075,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05882352941,NA,0.34137577,"DESVENLAFAXINE SUCCINATE","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3553113553,"DESVENLAFAXINE SUCCINATE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.751572327,0.275,"DESVENLAFAXINE SUCCINATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3714285714,NA,"DEXAMETHASONE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3879310345,NA,"DEXAMETHASONE","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2670454545,"DEXLANSOPRAZOLE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4746835443,"DEXLANSOPRAZOLE","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3539823009,"DEXLANSOPRAZOLE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4173913043,"DEXLANSOPRAZOLE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4923076923,NA,NA,NA,0.1907894737,0.4464285714,NA,NA,NA,NA,0.487804878,0,0.4841269841,NA,"DEXTROAMPHETAMINE/AMPHETAMINE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.641025641,NA,NA,NA,NA,NA,NA,NA,NA,"DEXTROAMPHETAMINE/AMPHETAMINE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7194244604,NA,NA,NA,"DEXTROAMPHETAMINE/AMPHETAMINE","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6881028939,NA,NA,NA,"DEXTROAMPHETAMINE/AMPHETAMINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7364341085,NA,"DEXTROAMPHETAMINE/AMPHETAMINE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.02243589744,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED (dxo:ICD9:25001)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.02770330652,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2698412698,NA,NA,NA,NA,"DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.01360544218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03424657534,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03174603175,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02721088435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5584415584,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DIAPHRAGMATIC HERNIA WITHOUT MENTION OF OBSTRUCTION OR GANGRENE (dxo:ICD9:5533)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5081967213,NA,NA,NA,NA,0.4447439353,NA,NA,NA,NA,0.5255474453,0.01030927835,0.4235294118,NA,"DIAZEPAM",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6587677725,NA,NA,NA,NA,NA,NA,NA,NA,"DIAZEPAM","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.640625,NA,NA,NA,"DIAZEPAM","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7156862745,NA,"DIAZEPAM","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4696969697,NA,NA,NA,NA,0.4211956522,NA,NA,NA,NA,NA,NA,NA,NA,"DIFFUSE CYSTIC MASTOPATHY (dxo:ICD9:6101)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6842105263,NA,NA,NA,NA,NA,NA,NA,NA,"DIFFUSE CYSTIC MASTOPATHY (dxo:ICD9:6101)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,0.02027027027,NA,NA,NA,NA,NA,NA,"DISTURBANCE OF SKIN SENSATION (dxo:ICD9:7820)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06611570248,NA,NA,NA,NA,NA,NA,"DISTURBANCE OF SKIN SENSATION (dxo:ICD9:7820)","GABAPENTIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01764705882,NA,NA,NA,NA,NA,NA,"DISTURBANCE OF SKIN SENSATION (dxo:ICD9:7820)","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5234899329,NA,NA,NA,0.1075268817,0.4195519348,NA,0.0376344086,NA,NA,0.5159817352,NA,0.4342105263,0.216374269,"DIZZINESS AND GIDDINESS (dxo:ICD9:7804)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6387434555,NA,NA,NA,NA,NA,NA,NA,NA,"DIZZINESS AND GIDDINESS (dxo:ICD9:7804)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03246753247,NA,NA,NA,NA,NA,NA,"DIZZINESS AND GIDDINESS (dxo:ICD9:7804)","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"41-64","Female",0.01826484018,0.02525252525,0.4327272727,NA,0.3381649731,0.3229571984,0.1393939394,0.306122449,NA,NA,0.3597122302,NA,0.3919753086,NA,0.447257384,0.3692285632,"DOXEPIN HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.3788546256,0.570977918,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3762376238,"DOXEPIN HCL","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6614785992,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4930555556,"DOXEPIN HCL","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.66,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","DULOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5797101449,"DOXEPIN HCL","DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3519163763,"DOXEPIN HCL","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.3700787402,NA,0.3514285714,NA,NA,NA,NA,NA,NA,NA,NA,0.3328,"DOXEPIN HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3833333333,NA,NA,NA,NA,NA,NA,NA,NA,0.3354037267,"DOXEPIN HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3931034483,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3262411348,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3,"DOXEPIN HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3010752688,"DOXEPIN HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.2733485194,NA,NA,0.5748218527,NA,NA,NA,NA,NA,NA,NA,0.4190821256,"DOXEPIN HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5367231638,"DOXEPIN HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.67752443,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5405405405,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5614035088,"DOXEPIN HCL","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.67752443,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4297520661,NA,NA,NA,NA,NA,NA,NA,0.2962962963,"DOXEPIN HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.3771929825,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","HYDROXYZINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.2051282051,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","HYDROXYZINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1037974684,"DOXEPIN HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06043956044,"DOXEPIN HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.01449275362,NA,NA,NA,NA,0.1436781609,NA,NA,NA,NA,NA,0.4315068493,0.005747126437,NA,0.2943037975,"DOXEPIN HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6220930233,NA,NA,NA,"DOXEPIN HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7375328084,NA,NA,NA,"DOXEPIN HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.431372549,"DOXEPIN HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7227722772,NA,"DOXEPIN HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4406779661,"DOXEPIN HCL","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.525,"DOXEPIN HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01438848921,NA,NA,"DOXEPIN HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7374100719,0.4958677686,"DOXEPIN HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4666666667,"DOXEPIN HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7090909091,NA,NA,NA,"DOXEPIN HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6956521739,NA,NA,0.4907407407,"DOXEPIN HCL","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.1482611348,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.1891891892,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4444444444,"DOXEPIN HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.1557377049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","Last AD: Same & No Remiss","UNSPECIFIED URTICARIA (dxo:ICD9:7089)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.6109422492,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5596072931,"DOXEPIN HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.580952381,"DOXEPIN HCL","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5683453237,"DOXEPIN HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5203252033,"DOXEPIN HCL","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.5031847134,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4626865672,"DOXEPIN HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3888888889,"DOXEPIN HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2704402516,"DOXEPIN HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2340425532,"DOXEPIN HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3259259259,"DOXEPIN HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3372093023,"DOXEPIN HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7367149758,NA,NA,NA,"DOXEPIN HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2444444444,"DOXEPIN HCL","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2026315789,"DOXEPIN HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1897810219,"DOXEPIN HCL","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.3191489362,NA,NA,NA,NA,NA,0.6157024793,NA,NA,NA,NA,0.3944954128,"DOXEPIN HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4392523364,"DOXEPIN HCL","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4436090226,"DOXEPIN HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1550387597,"DOXEPIN HCL","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4088785047,"DOXEPIN HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.358490566,NA,NA,NA,NA,NA,NA,NA,0.6437941473,NA,NA,0.4222503161,"DOXEPIN HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3387096774,"DOXEPIN HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3139303483,"DOXEPIN HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.364548495,"DOXEPIN HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.3392857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","UNSPECIFIED URTICARIA (dxo:ICD9:7089)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.2974683544,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6980519481,0.3729308666,"DOXEPIN HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5390070922,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXYCYCLINE MONOHYDRATE",NA,NA,NA,NA,NA,NA
"41-64","Female",0.01965923984,0.03352559481,0.5088776157,NA,0.08333333333,0.4681513947,0.2244467861,0.5056938001,0.123100304,0.05974842767,0.406185567,0.2130434783,0.5034709536,0.02073170732,0.6371115174,0.3330772652,"DULOXETINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",0.009803921569,0.02536231884,0.644549763,NA,NA,0.584496124,0.3785259327,0.4031007752,NA,NA,0.4057971014,NA,0.4350649351,NA,0.598540146,0.3048729696,"DULOXETINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2529411765,"DULOXETINE HCL","ESCITALOPRAM OXALATE","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.224137931,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.24,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06832298137,"DULOXETINE HCL","ESCITALOPRAM OXALATE","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09259259259,"DULOXETINE HCL","ESCITALOPRAM OXALATE","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.01754385965,NA,NA,NA,0.5758835759,0.4367245658,NA,NA,NA,NA,NA,NA,0.009090909091,0.5740740741,0.3492063492,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4517374517,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3632286996,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5882352941,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3319327731,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3714285714,NA,NA,NA,NA,NA,NA,0.009433962264,NA,0.4140625,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5479452055,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6203208556,0.5331010453,NA,NA,NA,NA,NA,NA,NA,NA,0.4336283186,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4761904762,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3631284916,0.1967741935,NA,NA,NA,NA,NA,NA,NA,NA,0.2772277228,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.219047619,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3768115942,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3617021277,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6568627451,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5461538462,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.472392638,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.546875,NA,NA,NA,NA,NA,NA,NA,NA,0.4972375691,"DULOXETINE HCL","ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2809917355,"DULOXETINE HCL","ESCITALOPRAM OXALATE","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.32,"DULOXETINE HCL","ESCITALOPRAM OXALATE","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09638554217,"DULOXETINE HCL","ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1538461538,"DULOXETINE HCL","ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3983050847,"DULOXETINE HCL","ESCITALOPRAM OXALATE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.28,"DULOXETINE HCL","ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3915343915,"DULOXETINE HCL","ESCITALOPRAM OXALATE","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2580645161,"DULOXETINE HCL","ESCITALOPRAM OXALATE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4727272727,0.2886597938,NA,NA,NA,NA,NA,NA,NA,NA,0.2925890279,"DULOXETINE HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.21875,"DULOXETINE HCL","ESCITALOPRAM OXALATE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6515151515,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","ESZOPICLONE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6296296296,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","EZETIMIBE/SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02380952381,0.4198113208,NA,NA,0.499377335,0.25,0.6036757776,NA,NA,NA,NA,0.4608294931,NA,0.5779816514,0.3174120712,"DULOXETINE HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.41,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1,"DULOXETINE HCL","FLUOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1031746032,"DULOXETINE HCL","FLUOXETINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.01666666667,NA,NA,NA,0.587962963,NA,0.7009803922,NA,NA,NA,NA,NA,NA,NA,0.4015151515,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7429078014,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6779661017,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3595505618,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01604278075,NA,0.5496688742,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.598540146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6392694064,NA,0.7238095238,NA,NA,NA,NA,NA,NA,NA,0.4481012658,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6954022989,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.375,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3616071429,NA,0.3776824034,NA,NA,NA,NA,NA,NA,NA,0.3677419355,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5338983051,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5054151625,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7045454545,NA,NA,NA,NA,NA,NA,NA,0.5928571429,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5550847458,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6237623762,NA,0.756302521,NA,NA,NA,NA,NA,NA,NA,0.5291262136,"DULOXETINE HCL","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3925233645,"DULOXETINE HCL","FLUOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3173076923,"DULOXETINE HCL","FLUOXETINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7429577465,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.237804878,"DULOXETINE HCL","FLUOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2547169811,NA,0.2710280374,NA,NA,NA,NA,NA,NA,NA,0.09027777778,"DULOXETINE HCL","FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1904761905,"DULOXETINE HCL","FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.368852459,"DULOXETINE HCL","FLUOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"DULOXETINE HCL","FLUOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2264150943,"DULOXETINE HCL","FLUOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3571428571,NA,0.454248366,NA,NA,NA,NA,NA,NA,NA,0.3617193836,"DULOXETINE HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2780487805,"DULOXETINE HCL","FLUOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.609141791,0.2403846154,NA,NA,NA,NA,NA,NA,NA,NA,0.4677419355,"DULOXETINE HCL","GABAPENTIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2857142857,"DULOXETINE HCL","GABAPENTIN","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4455445545,"DULOXETINE HCL","GABAPENTIN","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5023255814,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5925925926,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","Last AD: Diff & No Remiss","TRAZODONE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4488188976,"DULOXETINE HCL","GABAPENTIN","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3436960276,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3173333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","Last AD: Same & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6506666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6625514403,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","Last AD: Same & Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.641509434,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","PREGABALIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5170068027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","TRAMADOL HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5158730159,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6605633803,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4237288136,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",0.01515151515,NA,NA,NA,NA,NA,NA,NA,NA,0.05217391304,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"41-64","Female",0.02272727273,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1475409836,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","HEADACHE (dxo:ICD9:7840)","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5948553055,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3490566038,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","HYDROCODONE/ACETAMINOPHEN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5727272727,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","HYDROCODONE/ACETAMINOPHEN","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2853185596,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1089385475,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1228070175,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1568627451,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2211538462,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.104,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0775862069,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2511210762,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1604477612,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.3113207547,NA,NA,0.3568345324,0.1161616162,0.362962963,NA,NA,NA,NA,0.3172413793,NA,NA,0.1632653061,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1826923077,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2323651452,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1503759398,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2512077295,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4854368932,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1862745098,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1132075472,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1756756757,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3417721519,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2170818505,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3406113537,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2902097902,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1137931034,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1843971631,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1617647059,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1149425287,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02614379085,NA,NA,"DULOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"DULOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009756097561,NA,NA,"DULOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005714285714,NA,NA,"DULOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009009009009,NA,NA,"DULOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006993006993,NA,NA,"DULOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02162162162,NA,NA,"DULOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.1834862385,NA,NA,0.1275757576,0.09708737864,0.1428571429,NA,NA,NA,NA,0.188034188,NA,NA,0.08361204013,"DULOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1132404181,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","LAMOTRIGINE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4450127877,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4355828221,"DULOXETINE HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4132231405,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2833333333,"DULOXETINE HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1015625,"DULOXETINE HCL","LAMOTRIGINE","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1176470588,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07920792079,"DULOXETINE HCL","LAMOTRIGINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04385964912,"DULOXETINE HCL","LAMOTRIGINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04464285714,"DULOXETINE HCL","LAMOTRIGINE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07272727273,"DULOXETINE HCL","LAMOTRIGINE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09803921569,"DULOXETINE HCL","LAMOTRIGINE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1441441441,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09375,"DULOXETINE HCL","LAMOTRIGINE","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0495049505,"DULOXETINE HCL","LAMOTRIGINE","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1634615385,NA,NA,0.1228070175,"DULOXETINE HCL","LAMOTRIGINE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09397024276,"DULOXETINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09615384615,"DULOXETINE HCL","LAMOTRIGINE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07926829268,"DULOXETINE HCL","LAMOTRIGINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.007575757576,0.02211981567,0.4568138196,NA,NA,0.6044776119,0.189987163,0.5206286837,NA,0.05479452055,0.3522727273,NA,0.4798711755,0.009592326139,0.5076708508,0.2970195272,"DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5212121212,NA,NA,0.203539823,NA,NA,NA,NA,NA,NA,0.4538461538,"DULOXETINE HCL","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,0.02752293578,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5910652921,NA,NA,NA,0.1261261261,NA,NA,NA,NA,NA,0.5179282869,"DULOXETINE HCL","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4897959184,"DULOXETINE HCL","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6056338028,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5377358491,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7322175732,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03913043478,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7426470588,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7699115044,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02931034483,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3486590038,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5247524752,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4166666667,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5047619048,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4569045412,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5189873418,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6733668342,0.3604060914,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4158415842,"DULOXETINE HCL","Last AD: Diff & No Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.567251462,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4221105528,"DULOXETINE HCL","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05084745763,NA,0.2363636364,"DULOXETINE HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5364583333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1575342466,"DULOXETINE HCL","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2958579882,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2164179104,"DULOXETINE HCL","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5555555556,"DULOXETINE HCL","Last AD: Diff & No Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5844155844,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.550802139,"DULOXETINE HCL","Last AD: Diff & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5491803279,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","ROPINIROLE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,0.01704545455,NA,NA,NA,0.5744680851,0.2432432432,NA,NA,NA,NA,NA,0.7605633803,NA,NA,0.4553571429,"DULOXETINE HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01515151515,NA,0.5182481752,"DULOXETINE HCL","Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6136363636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,0.02040816327,NA,NA,NA,0.5338097856,NA,NA,NA,NA,NA,NA,NA,0.02223371251,NA,0.5066144047,"DULOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5579470199,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5871559633,NA,NA,NA,NA,NA,NA,NA,0.02285714286,NA,0.4379562044,"DULOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5882352941,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.01169590643,NA,NA,NA,0.6512915129,NA,NA,NA,NA,NA,NA,NA,NA,0.7236614853,0.3734015345,"DULOXETINE HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.02727272727,0.06798245614,0.5858208955,NA,NA,0.6718213058,0.2838196286,0.6156351792,NA,NA,0.5192307692,NA,0.6594982079,0.04198473282,0.6581986143,0.4246169056,"DULOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6944444444,"DULOXETINE HCL","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.609375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02,NA,NA,"DULOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7245508982,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01719197708,NA,NA,"DULOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6573426573,"DULOXETINE HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4306930693,"DULOXETINE HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6037735849,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6374269006,"DULOXETINE HCL","Last AD: Diff & Remiss","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6923076923,NA,NA,NA,NA,0.4428571429,"DULOXETINE HCL","Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5891472868,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5754189944,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5660377358,"DULOXETINE HCL","Last AD: Diff & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5924528302,NA,NA,NA,NA,NA,NA,0.7661538462,NA,NA,0.4712328767,"DULOXETINE HCL","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5840286055,NA,NA,NA,NA,NA,NA,NA,0.0350877193,NA,0.5195530726,"DULOXETINE HCL","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5871886121,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & Remiss","TRAZODONE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.7087378641,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.7054545455,NA,NA,NA,NA,NA,NA,NA,NA,0.7816593886,0.3636363636,"DULOXETINE HCL","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2952019757,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3559322034,"DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4153846154,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4642857143,"DULOXETINE HCL","Last AD: Same & No Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.375,"DULOXETINE HCL","Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3773265651,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4871794872,"DULOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4590643275,"DULOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4098360656,"DULOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3136094675,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2783171521,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2695652174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2158273381,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2937062937,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3208955224,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.58,"DULOXETINE HCL","Last AD: Same & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1834319527,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1857142857,"DULOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5828877005,"DULOXETINE HCL","Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,"DULOXETINE HCL","Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3875968992,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","PREGABALIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4639175258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","PREGABALIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.178313253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2314814815,"DULOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1339285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","RISPERIDONE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4090909091,"DULOXETINE HCL","Last AD: Same & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5241935484,"DULOXETINE HCL","Last AD: Same & No Remiss","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2567567568,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3470790378,NA,NA,NA,NA,NA,NA,0.4195121951,NA,NA,0.328358209,"DULOXETINE HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4879725086,"DULOXETINE HCL","Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.335078534,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","TRAMADOL HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3272727273,NA,NA,NA,NA,NA,NA,NA,0.0135501355,NA,0.3899082569,"DULOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4372623574,"DULOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3392122281,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3726708075,NA,NA,NA,NA,NA,NA,NA,NA,0.5214285714,0.4,"DULOXETINE HCL","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6657645467,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5803698435,"DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8376068376,"DULOXETINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6594594595,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7469879518,"DULOXETINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7777777778,"DULOXETINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5608108108,"DULOXETINE HCL","Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5542857143,"DULOXETINE HCL","Last AD: Same & Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6230769231,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7009345794,"DULOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6564102564,"DULOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.7786259542,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & Remiss","Num Previous Remissions: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6511627907,"DULOXETINE HCL","Last AD: Same & Remiss","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6966292135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.7333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5866935484,"DULOXETINE HCL","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6610169492,"DULOXETINE HCL","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6227272727,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & Remiss","PREGABALIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6700507614,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & Remiss","PREGABALIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5639534884,"DULOXETINE HCL","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5735294118,"DULOXETINE HCL","Last AD: Same & Remiss","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6789667897,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5775862069,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7131782946,"DULOXETINE HCL","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5309278351,"DULOXETINE HCL","Last AD: Same & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.7011494253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & Remiss","TRAMADOL HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.7191780822,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.575328084,"DULOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5561497326,"DULOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6497220016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.64,NA,NA,NA,NA,NA,NA,NA,NA,0.6862745098,0.615942029,"DULOXETINE HCL","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3113207547,"DULOXETINE HCL","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7162162162,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6923076923,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6914979757,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.660326087,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.762962963,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6498054475,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4663461538,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.4038461538,NA,NA,NA,0.5785732419,0.4545454545,NA,NA,NA,NA,NA,NA,NA,NA,0.529739777,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.626984127,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4366197183,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.734375,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7431192661,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4752475248,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4356435644,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6916666667,NA,NA,0.512195122,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5552941176,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5259095921,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.427184466,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5573770492,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6085106383,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","MELOXICAM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4443319838,NA,NA,0.2041237113,NA,NA,NA,NA,NA,NA,0.3205882353,"DULOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2543859649,"DULOXETINE HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09900990099,"DULOXETINE HCL","MIRTAZAPINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3173076923,"DULOXETINE HCL","MIRTAZAPINE","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3059701493,"DULOXETINE HCL","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3629893238,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2751798561,"DULOXETINE HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2746478873,"DULOXETINE HCL","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.43,"DULOXETINE HCL","MONTELUKAST SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6916666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4468085106,"DULOXETINE HCL","MULTIPLE SCLEROSIS (dxo:ICD9:340)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03086419753,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5933908046,NA,NA,NA,0.1683168317,NA,NA,NA,NA,NA,0.3880484115,"DULOXETINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3554216867,"DULOXETINE HCL","NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.390625,"DULOXETINE HCL","NORTRIPTYLINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5299145299,NA,NA,NA,NA,NA,"DULOXETINE HCL","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7466666667,NA,NA,NA,NA,NA,"DULOXETINE HCL","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7642405063,NA,NA,NA,"DULOXETINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3070175439,"DULOXETINE HCL","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2522123894,"DULOXETINE HCL","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2678132678,"DULOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2847457627,"DULOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5403225806,NA,NA,NA,NA,NA,"DULOXETINE HCL","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5863453815,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6301369863,"DULOXETINE HCL","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2215909091,"DULOXETINE HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4566326531,"DULOXETINE HCL","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4337899543,"DULOXETINE HCL","OMEPRAZOLE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4259259259,"DULOXETINE HCL","OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5944055944,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5494505495,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6073619632,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4628099174,"DULOXETINE HCL","OXYBUTYNIN CHLORIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.645320197,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5727272727,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5818181818,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","PAIN IN JOINT, SITE UNSPECIFIED (dxo:ICD9:71940)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6341463415,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3448275862,"DULOXETINE HCL","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4485981308,NA,NA,0.5028328612,0.2727272727,NA,NA,NA,0.5621621622,NA,0.4774774775,NA,NA,0.3773049645,"DULOXETINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4375,NA,NA,NA,NA,0.3829787234,NA,NA,NA,NA,0.4534534535,"DULOXETINE HCL","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.2264150943,NA,NA,0.2712456345,NA,0.2136752137,NA,NA,NA,NA,NA,NA,NA,0.1325966851,"DULOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1322751323,"DULOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1459854015,"DULOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2231237323,NA,NA,NA,NA,NA,NA,NA,0.03571428571,NA,0.1807228916,"DULOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1869158879,"DULOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1428571429,"DULOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4427412083,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4716763006,"DULOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5944272446,"DULOXETINE HCL","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4224137931,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4797687861,"DULOXETINE HCL","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3622047244,"DULOXETINE HCL","PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4041994751,"DULOXETINE HCL","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4821428571,"DULOXETINE HCL","PRAMIPEXOLE DI-HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6516853933,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","PREGABALIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6861063465,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","PREGABALIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5172413793,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2283464567,"DULOXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2944444444,"DULOXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3125,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1404958678,"DULOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08,"DULOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2857142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1596638655,"DULOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3148148148,0.1404958678,NA,NA,NA,NA,NA,NA,NA,NA,0.1659693166,"DULOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1666666667,"DULOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2917705736,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2079646018,"DULOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.35,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1587301587,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4262295082,"DULOXETINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4364261168,NA,NA,NA,0.5629820051,"DULOXETINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5963855422,"DULOXETINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4615384615,"DULOXETINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5754716981,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","RHEUMATOID ARTHRITIS (dxo:ICD9:7140)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1444043321,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1181318681,"DULOXETINE HCL","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1962025316,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1448467967,"DULOXETINE HCL","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4538461538,NA,NA,NA,NA,NA,0.4200542005,NA,NA,NA,0.473993668,"DULOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4534161491,"DULOXETINE HCL","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3405405405,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4042553191,"DULOXETINE HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4884792627,"DULOXETINE HCL","ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6507936508,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5774193548,0.3106796117,NA,NA,NA,NA,NA,NA,NA,NA,0.3652173913,"DULOXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6220472441,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,0.02252252252,0.3805309735,NA,NA,0.509054326,0.2044728435,0.4126984127,NA,NA,NA,NA,0.6330690827,NA,0.5833333333,0.3598389532,"DULOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4113475177,NA,NA,NA,NA,NA,NA,0.4651162791,NA,NA,0.3494208494,"DULOXETINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5238095238,NA,NA,0.3267973856,"DULOXETINE HCL","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4309210526,"DULOXETINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4427860697,"DULOXETINE HCL","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7261904762,NA,"DULOXETINE HCL","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4245283019,"DULOXETINE HCL","TIZANIDINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4808362369,"DULOXETINE HCL","TOPIRAMATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6336996337,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","TRAMADOL HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.7136363636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","TRAMADOL HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",0.03260869565,0.030651341,0.3191489362,NA,NA,0.4222861842,0.1711409396,0.2974683544,NA,NA,NA,NA,0.2794117647,0.03246753247,0.419047619,0.3789358544,"DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5749235474,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","TRAZODONE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5661764706,NA,NA,NA,NA,NA,NA,NA,NA,0.6603773585,0.3207843137,"DULOXETINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5779816514,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6386806597,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5972222222,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.728,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","VALSARTAN/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,0.0269058296,0.5034965035,NA,NA,0.635538262,0.2337662338,0.4766839378,NA,NA,NA,NA,0.5076923077,NA,0.7216374269,0.3080704629,"DULOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.05940594059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DYSFUNCTION OF EUSTACHIAN TUBE (dxo:ICD9:38181)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.04021447721,NA,NA,NA,0.4653465347,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DYSMETABOLIC SYNDROME X (dxo:ICD9:2777)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5235602094,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DYSPHAGIA (dxo:ICD9:7872)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4235294118,NA,"DYSPHAGIA, UNSPECIFIED (dxo:ICD9:78720)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7339449541,NA,"DYSPHAGIA, UNSPECIFIED (dxo:ICD9:78720)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.0113960114,NA,NA,NA,NA,NA,NA,0.5591397849,NA,NA,NA,NA,0.5777777778,0.01006711409,0.5782918149,0.3445945946,"DYSTHYMIC DISORDER (dxo:ICD9:3004)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6132075472,NA,"DYSTHYMIC DISORDER (dxo:ICD9:3004)","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7108433735,NA,NA,NA,NA,NA,NA,NA,NA,"DYSTHYMIC DISORDER (dxo:ICD9:3004)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.64,NA,"DYSTHYMIC DISORDER (dxo:ICD9:3004)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",0.01869158879,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DYSTHYMIC DISORDER (dxo:ICD9:3004)","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6440677966,NA,"DYSTHYMIC DISORDER (dxo:ICD9:3004)","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.01960784314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DYSTHYMIC DISORDER (dxo:ICD9:3004)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6864608076,NA,"DYSTHYMIC DISORDER (dxo:ICD9:3004)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5238095238,NA,NA,NA,"ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963)","PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4920634921,NA,NA,NA,"ELDERLY MULTIGRAVIDA, WITH ANTEPARTUM CONDITION OR COMPLICATION (dxo:ICD9:65963)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.446969697,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ELETRIPTAN HYDROBROMIDE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.02702702703,0.5570776256,NA,NA,NA,0.1775956284,0.5533596838,NA,NA,NA,NA,NA,NA,NA,0.4390243902,"ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4117647059,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7272727273,NA,NA,NA,NA,NA,NA,NA,NA,"ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02678571429,NA,NA,NA,NA,0.2274509804,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4913793103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ENCOUNTER FOR OTHER SPECIFIED AFTERCARE (dxo:ICD9:V5889)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3109243697,NA,NA,NA,NA,NA,"ERGOCALCIFEROL (VITAMIN D2)",NA,NA,NA,NA,NA,NA
"41-64","Female",0.02189781022,0.02566086396,0.653901919,NA,0.1182608696,0.495026178,0.3111506004,0.4584597876,0.1309620049,0.06176783813,0.4116962467,0.1865889213,0.4768811206,0.02155172414,0.582324198,0.252783664,"ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7137681159,NA,NA,NA,0.3134715026,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ESOMEPRAZOLE MAGNESIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6857142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ESOMEPRAZOLE MAGNESIUM","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1161971831,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ESOMEPRAZOLE MAGNESIUM","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3391304348,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ESOMEPRAZOLE MAGNESIUM","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.7549019608,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6549295775,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3911671924,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ESTROGEN,CON/M-PROGEST ACET",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1571428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ESTROGEN,CON/M-PROGEST ACET","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.38,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ESTROGEN,CON/M-PROGEST ACET","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3461538462,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","EZETIMIBE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.8064516129,NA,NA,NA,0.4083044983,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","EZETIMIBE/SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.08053691275,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","EZETIMIBE/SIMVASTATIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4651162791,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FENOFIBRATE NANOCRYSTALLIZED",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.188976378,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FENOFIBRATE NANOCRYSTALLIZED","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",0.02752293578,0.02475247525,0.6395348837,NA,NA,0.488372093,0.2799704906,0.5759377859,NA,NA,0.352173913,NA,0.4503042596,0.006666666667,0.5904059041,0.2501368363,"ESCITALOPRAM OXALATE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2075471698,0.3703703704,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,0.02931596091,NA,NA,NA,0.4485981308,0.375,0.6666666667,NA,NA,NA,NA,NA,NA,0.5144927536,0.3010989011,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3958333333,0.6686159844,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3424657534,0.6263736264,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3235294118,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01639344262,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4406779661,0.7612903226,NA,NA,NA,NA,NA,NA,NA,0.4097222222,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.166023166,0.3546910755,NA,NA,NA,NA,NA,NA,NA,0.218487395,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1450381679,0.4265734266,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1382113821,0.4130434783,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3850574713,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.5123966942,0.6467065868,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4678362573,0.6568627451,NA,NA,NA,NA,NA,NA,NA,0.4769230769,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6692607004,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3245614035,NA,NA,NA,NA,NA,NA,NA,0.06569343066,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.253164557,0.4545454545,NA,NA,NA,NA,0.5137614679,NA,NA,0.223880597,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2895522388,0.440397351,NA,NA,NA,NA,NA,0.02430555556,NA,0.2796005706,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3457943925,0.552,NA,NA,NA,NA,NA,NA,NA,0.2739726027,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5459770115,0.4203581527,NA,NA,NA,NA,NA,NA,NA,NA,0.3405017921,"ESCITALOPRAM OXALATE","GABAPENTIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4424778761,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1851851852,"ESCITALOPRAM OXALATE","GABAPENTIN","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.37,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GABAPENTIN","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1607142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GABAPENTIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2246376812,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GABAPENTIN","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.7165991903,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GABAPENTIN","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4454545455,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GABAPENTIN","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4117647059,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GABAPENTIN","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.02083333333,NA,NA,NA,NA,0.3395522388,NA,NA,NA,NA,NA,NA,NA,NA,0.3089430894,"ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01485148515,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1634241245,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.07643312102,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3456221198,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2682926829,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GUAIFENESIN/P-EPHED HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1121076233,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GUAIFENESIN/P-EPHED HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2957746479,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GUAIFENESIN/PHENYLEPHRINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1232227488,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GUAIFENESIN/PHENYLEPHRINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6507936508,NA,NA,NA,0.225974026,NA,NA,NA,0.4489795918,NA,NA,NA,NA,0.2275862069,"ESCITALOPRAM OXALATE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5644171779,0.1692307692,"ESCITALOPRAM OXALATE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2352941176,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1075514874,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.5284552846,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",0.02261306533,NA,NA,NA,NA,NA,NA,NA,NA,0.06018518519,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"41-64","Female",0.0202020202,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.162601626,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","HEADACHE (dxo:ICD9:7840)","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.286908078,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1557788945,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","HYDROCODONE/ACETAMINOPHEN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.135483871,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","HYDROCODONE/ACETAMINOPHEN","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3531746032,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","HYDROCODONE/ACETAMINOPHEN","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3965517241,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","HYDROCODONE/HOMATROPINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3592814371,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","HYDROXYCHLOROQUINE SULFATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.2884615385,NA,NA,NA,0.2145669291,NA,NA,NA,NA,NA,NA,NA,NA,0.1073943662,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09954751131,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.08267716535,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09160305344,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)"
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02290076336,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1361702128,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09392265193,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05882352941,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1395348837,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1287128713,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.3748584371,NA,NA,0.1901840491,0.1832091016,0.247706422,NA,NA,0.248447205,NA,0.2866972477,NA,0.3056133056,0.1314475874,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.106557377,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.08474576271,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1071428571,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2052980132,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL"
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1913043478,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0593220339,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Female",NA,NA,0.3684210526,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.252173913,0.08847184987,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1832061069,NA,NA,NA,NA,NA,NA,NA,NA,0.1538461538,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1589648799,NA,NA,NA,NA,NA,NA,0.009708737864,NA,0.1965811966,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.117147708,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1315789474,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.08965517241,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.07926829268,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1235294118,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1047619048,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.504950495,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.55,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Female",NA,NA,0.1293103448,NA,NA,NA,0.1036585366,NA,NA,NA,NA,NA,NA,NA,0.1531531532,0.09523809524,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06730769231,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,0.3703703704,NA,NA,0.2376237624,0.1890660592,0.2386363636,NA,NA,0.2277227723,NA,0.304029304,NA,0.2960288809,0.1004497751,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1987951807,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1586206897,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1743119266,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1619496855,NA,NA,NA,NA,NA,NA,NA,NA,0.2096774194,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1774193548,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1461377871,NA,NA,NA,NA,NA,NA,NA,NA,0.06516853933,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09150326797,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0487804878,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1278195489,NA,NA,NA,NA,NA,NA,NA,NA,0.07906976744,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.7614678899,NA,NA,NA,NA,0.6120689655,NA,NA,NA,NA,0.5486725664,0.0351758794,NA,NA,"ESCITALOPRAM OXALATE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5982142857,NA,NA,NA,NA,0.4890510949,NA,NA,NA,NA,0.4770114943,0.01379310345,NA,NA,"ESCITALOPRAM OXALATE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"ESCITALOPRAM OXALATE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009933774834,NA,NA,"ESCITALOPRAM OXALATE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01271186441,NA,NA,"ESCITALOPRAM OXALATE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01923076923,NA,NA,"ESCITALOPRAM OXALATE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009615384615,NA,NA,"ESCITALOPRAM OXALATE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01081081081,NA,NA,"ESCITALOPRAM OXALATE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.08153846154,0.1073825503,NA,NA,NA,NA,0.1464646465,NA,NA,0.06807511737,"ESCITALOPRAM OXALATE","LAMOTRIGINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.06367924528,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LAMOTRIGINE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09657320872,NA,NA,NA,NA,NA,NA,NA,NA,0.08099173554,"ESCITALOPRAM OXALATE","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07857142857,"ESCITALOPRAM OXALATE","LAMOTRIGINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.01230228471,0.01903520209,0.6050993181,NA,NA,0.4101587302,0.359832636,0.4873026767,0.09523809524,0.05844155844,0.4352941176,NA,0.5040723982,0.01451187335,0.5177570093,0.1903335331,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1544117647,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3380782918,NA,0.2296296296,NA,NA,NA,NA,NA,NA,0.343373494,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3945945946,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,0.01337792642,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3544973545,NA,NA,0.08910891089,NA,NA,NA,NA,NA,0.3553719008,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3609271523,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2847682119,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.362962963,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3536585366,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3009708738,NA,NA,NA,0.5476190476,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1928571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3179487179,NA,NA,NA,NA,NA,0.6367041199,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2990492653,NA,NA,NA,NA,NA,NA,0.0101010101,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3434343434,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3721973094,NA,NA,NA,0.7416666667,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.185483871,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3951612903,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2945736434,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3759791123,NA,NA,NA,NA,NA,0.7064777328,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3280254777,NA,NA,NA,NA,NA,NA,0.01297016861,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3642384106,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.008403361345,0.5989304813,NA,NA,0.42,NA,0.3798449612,NA,NA,NA,NA,0.4936708861,NA,0.5811965812,0.2132796781,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2702702703,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4411764706,0.2561983471,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2669616519,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5473684211,0.3333333333,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1810344828,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2321428571,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","OMEPRAZOLE",NA,NA,NA,NA
"41-64","Female",NA,0.04195804196,NA,NA,NA,0.4071428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1357142857,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA
"41-64","Female",NA,0.01282051282,NA,NA,NA,NA,0.3170731707,NA,NA,NA,0.6916666667,NA,NA,NA,0.5819672131,0.2395437262,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.0218579235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06194690265,NA,0.1428571429,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1860465116,NA,NA,NA,NA,NA,NA,0.03738317757,NA,0.1353383459,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4273504274,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1666666667,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0790960452,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2258064516,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.121761658,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1960784314,NA,NA,NA,NA,NA,NA,NA,NA,0.1538461538,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3039215686,NA,NA,NA,NA,NA,NA,NA,NA,0.5172413793,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3974358974,NA,NA,NA,NA,NA,NA,NA,NA,0.6023391813,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3611111111,NA,NA,NA,NA,0.4074074074,NA,NA,NA,NA,0.1581920904,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.02325581395,0.6635514019,NA,NA,0.4262295082,0.3731617647,NA,NA,NA,NA,NA,0.7794117647,0.01709401709,0.5138121547,0.2842741935,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2162162162,NA,NA,NA,NA,NA,NA,0.01117318436,NA,0.3162393162,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.7328244275,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1596638655,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2352941176,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4663461538,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2761904762,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","TOPIRAMATE",NA,NA,NA,NA
"41-64","Female",NA,0.01119402985,NA,NA,NA,0.3879310345,0.3134747349,NA,NA,NA,NA,NA,NA,0.01406752412,NA,0.3229166667,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2719298246,NA,NA,NA,NA,NA,NA,0.0218579235,NA,0.3828125,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4080996885,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,0.0365448505,NA,NA,NA,0.4925373134,0.3517915309,NA,NA,NA,NA,NA,NA,NA,0.6477495108,0.3474576271,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.025,0.09379310345,0.7332535885,NA,NA,0.5440528634,NA,0.5563380282,0.296,NA,0.5487804878,NA,0.6666666667,0.07763975155,0.6405228758,0.4157245632,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,0.5238095238,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6714285714,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.7333333333,NA,NA,NA,NA,NA,NA,0.54,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.6055045872,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.6274509804,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","Num Previous Remissions: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.5704697987,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.6101694915,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.380952381,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.6504854369,NA,NA,NA,NA,NA,NA,0.02380952381,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3398058252,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.467032967,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.6081081081,NA,NA,NA,NA,NA,NA,NA,NA,0.5350877193,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4678899083,NA,NA,NA,NA,NA,NA,NA,NA,0.4533333333,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3986928105,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4134078212,NA,NA,NA,NA,NA,NA,NA,NA,0.5566037736,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3720930233,NA,NA,NA,NA,NA,0.7898550725,NA,NA,0.4186851211,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.6175,NA,NA,NA,NA,NA,NA,0.05061559508,NA,0.5162037037,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5098039216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,0.1261261261,NA,NA,NA,NA,0.4351464435,NA,NA,NA,NA,NA,NA,NA,0.7443181818,0.4032786885,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1399505766,NA,NA,NA,NA,NA,NA,NA,NA,0.3378378378,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.291954023,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2568807339,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1492537313,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","MORBID OBESITY (dxo:ICD9:27801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1661016949,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1641791045,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1239669421,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.288590604,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.11,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1684782609,NA,NA,NA,NA,NA,0.3841059603,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1754385965,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1984126984,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1100917431,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1732673267,NA,NA,NA,NA,NA,0.3949044586,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1814671815,NA,NA,NA,NA,NA,NA,0.008196721311,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1870503597,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1843600818,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1458333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1833333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","OMEPRAZOLE",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1662024141,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1315789474,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SIMVASTATIN",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2818671454,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1467181467,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1557788945,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","OLMESARTAN MEDOXOMIL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1544117647,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","OMEPRAZOLE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1449275362,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","OMEPRAZOLE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1125827815,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1178861789,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09868421053,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PALPITATIONS (dxo:ICD9:7851)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1062355658,NA,NA,NA,0.3138297872,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4019607843,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.147826087,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1531531532,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.13,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5694444444,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2019230769,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PREGABALIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.08196721311,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1092436975,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.145631068,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1336032389,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1641791045,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1102362205,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1035137702,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09523809524,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1470588235,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1034482759,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1551724138,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","RAMIPRIL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2086956522,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1074380165,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","RISEDRONATE SODIUM",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.06802721088,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","RISPERIDONE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.33,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1160714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1103896104,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1458333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SIMVASTATIN",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1255411255,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1242236025,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1553090333,NA,NA,NA,NA,NA,0.3472584856,NA,NA,0.262295082,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4124293785,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1391076115,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TOPIRAMATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1531531532,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TRAMADOL HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1673699015,NA,NA,NA,NA,NA,NA,0.01178781925,NA,0.2851323829,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3957446809,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1402714932,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1436464088,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","VALSARTAN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.144,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","VALSARTAN/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1724941725,NA,NA,NA,NA,NA,NA,NA,0.4452054795,0.2795031056,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.6841704074,NA,NA,NA,NA,NA,NA,NA,NA,0.5268292683,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.5810055866,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.6300984529,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7329545455,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.7416666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","MORBID OBESITY (dxo:ICD9:27801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.7479338843,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5631067961,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.541025641,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.866,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.9047619048,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6569767442,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.8554006969,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Remissions: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.7432024169,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.7514124294,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","OMEPRAZOLE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.7482993197,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5853018373,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6019417476,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.5315315315,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6259541985,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.755240027,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.5904761905,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.7568807339,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.5794871795,NA,NA,NA,NA,NA,NA,NA,NA,0.593814433,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7256637168,0.5693430657,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.308411215,"ESCITALOPRAM OXALATE","LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2914285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LEVOFLOXACIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1759259259,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LEVOFLOXACIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1262135922,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LEVOFLOXACIN","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3308823529,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LEVOFLOXACIN","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3857142857,NA,NA,NA,NA,NA,NA,NA,NA,0.3346456693,"ESCITALOPRAM OXALATE","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1150442478,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LEVOTHYROXINE SODIUM","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3006993007,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LEVOTHYROXINE SODIUM","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6713286713,NA,NA,NA,0.3661971831,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LISINOPRIL/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1176470588,"ESCITALOPRAM OXALATE","LITHIUM CARBONATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3835616438,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LOVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1690140845,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LOVASTATIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5625,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.628332064,NA,NA,NA,NA,NA,NA,NA,NA,0.6413043478,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.6991150442,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,NA,NA,NA,NA,NA,0.6231884058,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3925233645,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MILD (dxo:ICD9:29631)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.30472103,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.3064516129,0.69375,NA,NA,NA,0.4957542458,0.6602564103,0.4818181818,NA,0.6607142857,NA,0.6274509804,0.1932773109,NA,0.5323159785,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6153846154,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4256756757,NA,NA,NA,NA,NA,NA,NA,NA,0.4554455446,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4833597464,NA,NA,NA,NA,NA,NA,0.2091503268,NA,0.5107142857,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5745856354,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5413533835,NA,"ESCITALOPRAM OXALATE","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4237288136,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.347826087,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.290201005,NA,0.2228915663,NA,NA,NA,NA,NA,NA,0.2435185185,"ESCITALOPRAM OXALATE","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1090909091,"ESCITALOPRAM OXALATE","MIRTAZAPINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1578947368,"ESCITALOPRAM OXALATE","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2628205128,NA,NA,NA,NA,NA,NA,NA,NA,0.2395833333,"ESCITALOPRAM OXALATE","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2727272727,"ESCITALOPRAM OXALATE","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3348837209,"ESCITALOPRAM OXALATE","MONTELUKAST SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4446902655,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","MORBID OBESITY (dxo:ICD9:27801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4462809917,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","MORBID OBESITY (dxo:ICD9:27801)","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2857142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","MOXIFLOXACIN HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2991452991,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","MOXIFLOXACIN HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4223300971,NA,NA,NA,NA,NA,NA,NA,NA,0.4173913043,"ESCITALOPRAM OXALATE","MULTIPLE SCLEROSIS (dxo:ICD9:340)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01712328767,NA,NA,NA,NA,0.3975084938,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3620689655,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3739445115,NA,NA,0.147107438,NA,NA,NA,NA,NA,0.3360995851,"ESCITALOPRAM OXALATE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3301886792,"ESCITALOPRAM OXALATE","NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5704697987,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7286821705,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7064676617,NA,NA,NA,"ESCITALOPRAM OXALATE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5865384615,NA,NA,NA,"ESCITALOPRAM OXALATE","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.419047619,NA,NA,NA,"ESCITALOPRAM OXALATE","Num Previous Antidep: 4+","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2638888889,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5954773869,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Num Previous Episodes: 2+",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5555555556,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5882352941,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.4601769912,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5333333333,"ESCITALOPRAM OXALATE","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1407407407,"ESCITALOPRAM OXALATE","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.7538461538,NA,NA,NA,0.4274691358,NA,NA,NA,NA,NA,NA,NA,NA,0.3882352941,"ESCITALOPRAM OXALATE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3907284768,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.359375,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","OLMESARTAN MEDOXOMIL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4215304799,NA,NA,NA,NA,NA,NA,NA,NA,0.3503401361,"ESCITALOPRAM OXALATE","OMEPRAZOLE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3901345291,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","OMEPRAZOLE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3138686131,"ESCITALOPRAM OXALATE","OTHER ANXIETY STATES (dxo:ICD9:30009)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4572864322,"ESCITALOPRAM OXALATE","OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4087591241,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.01481481481,NA,NA,NA,0.5520833333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4214285714,NA,NA,NA,NA,NA,NA,NA,NA,0.3853211009,"ESCITALOPRAM OXALATE","OXYBUTYNIN CHLORIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4205128205,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","OXYCODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3317230274,NA,NA,NA,NA,NA,NA,NA,NA,0.2735849057,"ESCITALOPRAM OXALATE","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3076923077,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","PALPITATIONS (dxo:ICD9:7851)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.0297029703,0.6188118812,NA,NA,NA,0.3059701493,0.5111111111,NA,NA,0.5296610169,NA,0.4709141274,NA,0.5637583893,0.2627824019,"ESCITALOPRAM OXALATE","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2229299363,NA,NA,NA,0.4173913043,NA,NA,0.01910828025,NA,0.3130699088,"ESCITALOPRAM OXALATE","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.04081632653,0.2486910995,NA,NA,0.2718446602,0.284965035,0.2259887006,NA,NA,NA,NA,0.1519607843,NA,0.314516129,0.1070826307,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07427055703,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1408450704,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08888888889,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1447902571,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1954022989,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0987654321,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3639947438,NA,NA,NA,NA,NA,NA,NA,NA,0.5093632959,"ESCITALOPRAM OXALATE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4396551724,NA,NA,NA,NA,NA,NA,NA,NA,0.5637065637,"ESCITALOPRAM OXALATE","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4910714286,"ESCITALOPRAM OXALATE","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4183673469,"ESCITALOPRAM OXALATE","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4036697248,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","PRAVASTATIN SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4263959391,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","PREGABALIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2724358974,0.3785714286,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.213592233,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.253968254,"ESCITALOPRAM OXALATE","PROPOXYPHENE NAP/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3203883495,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2091836735,NA,NA,NA,NA,NA,0.2115384615,NA,NA,0.1982758621,"ESCITALOPRAM OXALATE","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.4851485149,NA,NA,0.2672413793,0.2776470588,NA,NA,NA,NA,NA,0.3082706767,NA,0.2832369942,0.108365019,"ESCITALOPRAM OXALATE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2170212766,"ESCITALOPRAM OXALATE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2405498282,NA,NA,NA,NA,NA,NA,NA,NA,0.1327967807,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1333333333,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1971830986,NA,NA,NA,NA,NA,NA,NA,NA,0.1346704871,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2071428571,0.2135135135,0.2266666667,NA,NA,NA,NA,0.18359375,NA,0.2298850575,0.1672760512,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1523809524,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1948424069,NA,NA,NA,NA,NA,NA,NA,NA,0.1731207289,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1503267974,NA,NA,NA,NA,NA,NA,NA,NA,0.07746478873,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3174603175,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.391959799,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","RAMIPRIL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.25,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","RANITIDINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4402985075,NA,NA,NA,NA,NA,NA,NA,NA,0.4428571429,"ESCITALOPRAM OXALATE","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3270440252,NA,NA,NA,NA,0.4131147541,NA,NA,NA,0.5147928994,"ESCITALOPRAM OXALATE","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2961783439,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","RISEDRONATE SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09271523179,NA,NA,NA,NA,NA,NA,NA,NA,0.1333333333,"ESCITALOPRAM OXALATE","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1030927835,"ESCITALOPRAM OXALATE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3070539419,NA,NA,NA,NA,0.3535791757,NA,NA,NA,0.4850115296,"ESCITALOPRAM OXALATE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3950276243,"ESCITALOPRAM OXALATE","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4017857143,"ESCITALOPRAM OXALATE","ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3493975904,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3910614525,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.03816793893,NA,NA,NA,0.5728643216,0.3385771718,NA,NA,NA,0.5405405405,NA,NA,NA,NA,0.2431077694,"ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4136690647,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.4504504505,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","TRAMADOL HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3365384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3503401361,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2287234043,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"41-64","Female",0.01298701299,0.02494331066,0.619047619,NA,NA,0.4437086093,0.2520325203,0.3987473904,0.1307692308,NA,0.3480825959,NA,0.560461285,0.01621621622,0.5637393768,0.246685879,"ESCITALOPRAM OXALATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2089552239,NA,NA,NA,NA,NA,0.4727272727,0.01893939394,NA,0.2859116022,"ESCITALOPRAM OXALATE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5384615385,NA,NA,0.2944162437,"ESCITALOPRAM OXALATE","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.787755102,NA,NA,NA,0.4031209363,NA,NA,NA,NA,NA,0.7339449541,NA,NA,0.2950819672,"ESCITALOPRAM OXALATE","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3676975945,"ESCITALOPRAM OXALATE","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6363636364,NA,"ESCITALOPRAM OXALATE","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3744075829,NA,NA,NA,NA,NA,NA,NA,NA,0.4188679245,"ESCITALOPRAM OXALATE","TOPIRAMATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3511904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","TRAMADOL HCL",NA,NA,NA,NA,NA
"41-64","Female",0.03726708075,0.02094240838,0.4554140127,NA,NA,0.3716216216,0.2980172852,0.3633333333,NA,NA,0.2810810811,NA,0.3575418994,0.01643348879,0.4656862745,0.298186167,"ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2622377622,NA,NA,NA,NA,NA,NA,0.02105263158,0.5949367089,0.2884071631,"ESCITALOPRAM OXALATE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5658153242,0.3712737127,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6638655462,NA,NA,NA,0.3454545455,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3601398601,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","VALSARTAN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.3279569892,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","VALSARTAN/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA
"41-64","Female",0.04225352113,0.03667481663,0.6170212766,NA,NA,0.4905660377,0.3189407024,0.4333333333,NA,NA,0.4489795918,NA,0.4380610413,0.02068965517,0.6721170396,0.2817311694,"ESCITALOPRAM OXALATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.487862177,NA,NA,NA,0.1185929648,0.4761904762,NA,NA,NA,NA,NA,NA,NA,NA,"ESOMEPRAZOLE MAGNESIUM",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6795977011,NA,NA,NA,NA,NA,NA,NA,NA,"ESOMEPRAZOLE MAGNESIUM","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.376984127,NA,NA,NA,NA,NA,NA,NA,NA,"ESOMEPRAZOLE MAGNESIUM","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.39,NA,NA,NA,NA,NA,NA,NA,NA,"ESOMEPRAZOLE MAGNESIUM","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6728624535,NA,NA,NA,NA,NA,NA,NA,NA,"ESOMEPRAZOLE MAGNESIUM","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.552,NA,NA,NA,0.1363636364,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESOMEPRAZOLE MAGNESIUM","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09722222222,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESOMEPRAZOLE MAGNESIUM","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02739726027,0.4892703863,NA,NA,0.4174757282,NA,0.5871559633,NA,NA,0.4801762115,NA,0.6048387097,NA,0.5374479889,0.311627907,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6241610738,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4769230769,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4666666667,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7811447811,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5163398693,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5202312139,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","LISINOPRIL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5437788018,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","LISINOPRIL/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.731884058,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4649681529,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5546875,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","PRAVASTATIN SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5135135135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3423423423,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7920792079,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5573333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5488958991,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.702970297,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.4745762712,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4358974359,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7361111111,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.568,NA,NA,NA,NA,0.5157480315,NA,NA,NA,NA,0.5917431193,NA,NA,NA,"ESTRADIOL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6878936319,NA,NA,NA,NA,NA,NA,NA,NA,"ESTRADIOL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7346938776,NA,NA,NA,NA,NA,NA,NA,NA,"ESTRADIOL","FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3922077922,NA,NA,NA,NA,NA,NA,NA,NA,"ESTRADIOL","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2992125984,NA,NA,NA,NA,NA,NA,NA,NA,"ESTRADIOL","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7386609071,NA,NA,NA,NA,NA,NA,NA,NA,"ESTRADIOL","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7744360902,NA,NA,NA,NA,NA,NA,NA,NA,"ESTRADIOL","FLUOXETINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6287878788,NA,NA,NA,NA,NA,NA,NA,NA,"ESTRADIOL","FLUOXETINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4711538462,NA,NA,NA,NA,0.7391304348,NA,NA,NA,"ESTRADIOL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7678571429,NA,NA,NA,"ESTRADIOL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5085714286,NA,NA,NA,"ESTRADIOL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7958477509,NA,NA,NA,"ESTRADIOL","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5855263158,NA,NA,NA,"ESTRADIOL","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8260869565,NA,NA,NA,"ESTRADIOL","LEVOTHYROXINE SODIUM","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6725663717,NA,NA,NA,"ESTRADIOL","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7548076923,NA,NA,NA,"ESTRADIOL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA,NA,"ESTRADIOL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4380952381,NA,NA,NA,NA,NA,NA,NA,NA,"ESTRADIOL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5803571429,NA,NA,NA,0.1421383648,0.539184953,NA,NA,0.463022508,NA,0.6320206585,NA,NA,NA,"ESTROGEN,CON/M-PROGEST ACET",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7477160928,NA,NA,NA,NA,NA,NA,NA,NA,"ESTROGEN,CON/M-PROGEST ACET","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7748344371,NA,NA,NA,NA,NA,NA,NA,NA,"ESTROGEN,CON/M-PROGEST ACET","FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4939759036,NA,NA,NA,NA,NA,NA,NA,NA,"ESTROGEN,CON/M-PROGEST ACET","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6916996047,NA,NA,NA,NA,NA,NA,NA,NA,"ESTROGEN,CON/M-PROGEST ACET","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6688963211,NA,NA,NA,0.0931372549,NA,NA,NA,0.425,NA,0.6869300912,NA,NA,NA,"ESTROGEN,CON/M-PROGEST ACET","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7295597484,NA,NA,NA,NA,NA,"ESTROGEN,CON/M-PROGEST ACET","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7768924303,NA,NA,NA,"ESTROGEN,CON/M-PROGEST ACET","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5081300813,NA,NA,NA,"ESTROGEN,CON/M-PROGEST ACET","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7801608579,NA,NA,NA,"ESTROGEN,CON/M-PROGEST ACET","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6703703704,NA,NA,NA,NA,NA,"ESTROGEN,CON/M-PROGEST ACET","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.152284264,NA,NA,NA,0.3805970149,NA,NA,NA,NA,NA,"ESTROGEN,CON/M-PROGEST ACET","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7735849057,NA,NA,NA,"ESTROGEN,CON/M-PROGEST ACET","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01317523057,NA,NA,NA,NA,NA,0.536407767,NA,NA,NA,NA,0.5742725881,NA,NA,NA,"ESTROGEN,ESTER/ME-TESTOSTERONE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7044025157,NA,NA,NA,NA,NA,NA,NA,NA,"ESTROGEN,ESTER/ME-TESTOSTERONE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4390243902,NA,NA,NA,NA,NA,NA,NA,NA,"ESTROGEN,ESTER/ME-TESTOSTERONE","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6948051948,NA,NA,NA,NA,NA,NA,NA,NA,"ESTROGEN,ESTER/ME-TESTOSTERONE","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5583333333,NA,NA,NA,"ESTROGEN,ESTER/ME-TESTOSTERONE","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4786324786,NA,NA,NA,"ESTROGEN,ESTER/ME-TESTOSTERONE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7627118644,NA,NA,NA,"ESTROGEN,ESTER/ME-TESTOSTERONE","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7256637168,NA,NA,NA,"ESTROGEN,ESTER/ME-TESTOSTERONE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5144694534,NA,NA,NA,NA,0.5298507463,NA,NA,NA,NA,0.5802752294,NA,NA,NA,"ESTROGENS, CONJUGATED",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7199017199,NA,NA,NA,NA,NA,NA,NA,NA,"ESTROGENS, CONJUGATED","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.75,NA,NA,NA,NA,NA,NA,NA,NA,"ESTROGENS, CONJUGATED","FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4090909091,NA,NA,NA,NA,NA,NA,NA,NA,"ESTROGENS, CONJUGATED","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7175572519,NA,NA,NA,NA,NA,NA,NA,NA,"ESTROGENS, CONJUGATED","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5153846154,NA,NA,NA,NA,0.6175438596,NA,NA,NA,"ESTROGENS, CONJUGATED","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7727272727,NA,NA,NA,"ESTROGENS, CONJUGATED","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4142011834,NA,NA,NA,"ESTROGENS, CONJUGATED","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7391304348,NA,NA,NA,"ESTROGENS, CONJUGATED","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5637583893,NA,NA,NA,"ESTROGENS, CONJUGATED","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7109375,NA,NA,NA,"ESTROGENS, CONJUGATED","LEVOTHYROXINE SODIUM","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7639097744,NA,NA,NA,"ESTROGENS, CONJUGATED","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4885057471,NA,NA,0.3943089431,NA,0.476,NA,NA,NA,NA,0.4813278008,0,NA,NA,"ESZOPICLONE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6755319149,NA,NA,NA,NA,NA,NA,NA,NA,"ESZOPICLONE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4715447154,NA,NA,NA,NA,0.5287356322,0.008333333333,NA,NA,"ESZOPICLONE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8088235294,NA,NA,NA,"ESZOPICLONE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5454545455,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5764705882,NA,NA,NA,"ETHINYL ESTRADIOL/DROSPIRENONE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1461988304,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ETHINYL ESTRADIOL/DROSPIRENONE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05035971223,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ETONOGESTREL/ETHINYL ESTRADIOL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5302713987,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"EXAMINATION OF EYES AND VISION (dxo:ICD9:V720)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1851851852,NA,NA,NA,NA,NA,NA,NA,NA,NA,"EZETIMIBE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5271966527,NA,NA,0.4953703704,0.1633986928,0.5562700965,NA,NA,0.4576271186,NA,0.606557377,0.02816901408,0.6462882096,NA,"EZETIMIBE/SIMVASTATIN",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7444168734,NA,NA,NA,NA,NA,NA,NA,NA,"EZETIMIBE/SIMVASTATIN","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7894736842,NA,NA,NA,NA,NA,NA,NA,NA,"EZETIMIBE/SIMVASTATIN","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8171428571,NA,NA,NA,"EZETIMIBE/SIMVASTATIN","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7459016393,NA,NA,NA,NA,NA,"EZETIMIBE/SIMVASTATIN","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1739130435,NA,NA,NA,NA,NA,NA,NA,NA,NA,"EZETIMIBE/SIMVASTATIN","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7576601671,NA,NA,NA,"EZETIMIBE/SIMVASTATIN","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7653429603,NA,"EZETIMIBE/SIMVASTATIN","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.1619047619,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2293577982,NA,NA,NA,"FAMILY PSYCHOTHERAPY (CONJOINT PSYCHOTHERAPY) (WITH PATIENT PRESENT), 50 MINUTES (px:CPT4:90847)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1240875912,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FAMOTIDINE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6141732283,NA,NA,NA,NA,0.576,NA,NA,NA,NA,0.5528169014,NA,NA,NA,"FENOFIBRATE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7938931298,NA,NA,NA,NA,NA,NA,NA,NA,"FENOFIBRATE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.814516129,NA,NA,NA,"FENOFIBRATE","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.77734375,NA,NA,NA,"FENOFIBRATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1722972973,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FENOFIBRATE NANOCRYSTALLIZED",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6460176991,NA,NA,NA,"FENOFIBRATE,MICRONIZED",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1748251748,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FENTANYL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5384615385,NA,NA,NA,NA,NA,NA,NA,0.4545454545,NA,NA,NA,NA,NA,"FEVER AND OTHER PHYSIOLOGIC DISTURBANCES OF TEMPERATURE REGULATION (dxo:ICD9:7806)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4345794393,NA,"FEVER, UNSPECIFIED (dxo:ICD9:78060)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6896551724,NA,"FEVER, UNSPECIFIED (dxo:ICD9:78060)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005509641873,0.4682539683,NA,"FEXOFENADINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"FEXOFENADINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"FEXOFENADINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.552238806,NA,NA,NA,NA,NA,NA,NA,0.4132231405,NA,NA,NA,NA,NA,"FEXOFENADINE/PSEUDOEPHEDRINE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7211538462,NA,NA,NA,NA,NA,"FEXOFENADINE/PSEUDOEPHEDRINE","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05128205128,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FITTING AND ADJUSTMENT OF VASCULAR CATHETER (dxi:ICD9:V5881)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5142180095,NA,NA,NA,"FITTING AND ADJUSTMENT OF VASCULAR CATHETER (dxo:ICD9:V5881)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7943925234,NA,NA,NA,"FITTING AND ADJUSTMENT OF VASCULAR CATHETER (dxo:ICD9:V5881)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7603686636,NA,NA,NA,"FITTING AND ADJUSTMENT OF VASCULAR CATHETER (dxo:ICD9:V5881)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1374045802,NA,NA,NA,0.3378378378,NA,0.4224422442,NA,NA,NA,"FLATULENCE, ERUCTATION, AND GAS PAIN (dxo:ICD9:7873)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1451612903,NA,NA,NA,0.2389380531,NA,NA,NA,NA,NA,"FLATULENCE, ERUCTATION, AND GAS PAIN (dxo:ICD9:7873)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7571428571,NA,NA,NA,"FLATULENCE, ERUCTATION, AND GAS PAIN (dxo:ICD9:7873)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02127659574,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FLUCONAZOLE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.0207253886,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FLUCONAZOLE","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01403508772,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FLUCONAZOLE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",0.02012148823,0.03353019623,0.5178008822,0.6648501362,0.09752066116,0.4347391565,0.1979624665,0.5421570955,0.1291118421,0.0547309833,0.4268229167,0.1452513966,0.4729652817,0.02001356852,0.582229018,0.3207589144,"FLUOXETINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5263157895,NA,0.6989730424,NA,NA,NA,NA,NA,NA,NA,0.4138817481,"FLUOXETINE HCL","GABAPENTIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6910569106,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GABAPENTIN","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.425,"FLUOXETINE HCL","GABAPENTIN","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4074889868,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GABAPENTIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4042553191,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GABAPENTIN","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7074468085,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GABAPENTIN","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7142857143,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GABAPENTIN","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5648148148,"FLUOXETINE HCL","GABAPENTIN","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.738317757,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GABAPENTIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6341463415,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.375,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6782608696,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6448979592,NA,NA,NA,0.2125748503,0.6473302571,NA,NA,0.507082153,NA,0.6814814815,NA,0.7122302158,0.3498419389,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1510791367,NA,NA,NA,NA,NA,NA,NA,0.5396825397,0.3020408163,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.375,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6287878788,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6639344262,0.3874172185,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3004115226,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3081081081,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2214765101,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5884146341,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","LEVOTHYROXINE SODIUM",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5739130435,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5281385281,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5789473684,"FLUOXETINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",0.006269592476,NA,NA,NA,NA,NA,NA,0.6628571429,NA,0.03181818182,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"41-64","Female",0.006993006993,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3076923077,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1484375,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","HEADACHE (dxo:ICD9:7840)","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6766467066,NA,NA,NA,NA,NA,NA,NA,0.3008849558,"FLUOXETINE HCL","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3790322581,"FLUOXETINE HCL","IMIPRAMINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1092436975,NA,0.3379310345,NA,NA,NA,NA,NA,NA,0.1833333333,0.142599278,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2081218274,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.1119402985,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2118644068,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2327586207,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2692307692,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.1551724138,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.1507936508,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1481481481,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.762295082,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2603305785,NA,NA,NA,NA,NA,NA,NA,0.08717948718,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2745098039,NA,NA,NA,NA,NA,NA,NA,0.09523809524,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1212121212,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2660550459,NA,NA,NA,NA,NA,NA,NA,0.2051282051,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.2798742138,NA,NA,0.2655737705,0.09183673469,0.4073932927,NA,NA,0.253164557,NA,0.2946428571,NA,0.2966101695,0.2182163188,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.07258064516,NA,NA,NA,NA,NA,NA,NA,NA,0.2346368715,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.357615894,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL"
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2710280374,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04424778761,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.07462686567,NA,NA,NA,NA,NA,NA,NA,NA,0.09960159363,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2660550459,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2931034483,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2667501565,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2327586207,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.1732851986,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2347826087,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.1578947368,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2975830816,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4782608696,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.375,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3539823009,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.72,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.357615894,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Num Previous Antidep: 2,3","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2710280374,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2126789366,NA,NA,NA,NA,NA,NA,0.1869918699,0.1283783784,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2268518519,NA,NA,NA,NA,NA,NA,NA,0.08032128514,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.1186440678,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.186770428,NA,NA,NA,NA,NA,NA,NA,0.1481481481,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2815533981,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA
"41-64","Female",NA,NA,0.247311828,NA,NA,0.2551724138,0.09944751381,0.4045936396,NA,NA,NA,NA,0.2647058824,NA,0.2627118644,0.1445966514,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3362831858,NA,NA,NA,NA,NA,NA,NA,0.2637362637,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3444444444,NA,NA,NA,NA,NA,NA,NA,0.3224043716,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3650793651,NA,NA,NA,NA,NA,NA,0.3896103896,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.259391771,NA,NA,NA,NA,NA,NA,NA,0.1167048055,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.1721311475,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2090163934,NA,NA,NA,NA,NA,NA,NA,0.1217105263,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6889487871,NA,NA,NA,NA,NA,0.02285714286,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5960451977,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6607669617,NA,NA,NA,NA,NA,0.005154639175,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01212121212,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6689655172,NA,NA,NA,NA,NA,0.006622516556,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01595744681,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3812233286,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4039408867,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6728476821,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5193133047,NA,NA,NA,NA,NA,0.01687763713,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6363636364,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","ZOLPIDEM TARTRATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3805970149,"FLUOXETINE HCL","LABORATORY EXAMINATION (dxo:ICD9:V726)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.1973684211,NA,NA,0.1283783784,0.088,0.1474714519,NA,NA,NA,NA,0.1794871795,NA,NA,0.09519038076,"FLUOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.100308642,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LAMOTRIGINE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4193548387,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09677419355,"FLUOXETINE HCL","LAMOTRIGINE","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.1071428571,NA,NA,NA,NA,NA,NA,NA,0.05940594059,"FLUOXETINE HCL","LAMOTRIGINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03773584906,"FLUOXETINE HCL","LAMOTRIGINE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2142857143,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LAMOTRIGINE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.102484472,NA,NA,NA,NA,NA,NA,NA,0.08872901679,"FLUOXETINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07079646018,"FLUOXETINE HCL","LAMOTRIGINE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09459459459,"FLUOXETINE HCL","LAMOTRIGINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.008130081301,0.01614310646,0.4663923182,NA,NA,0.4089347079,0.1466666667,NA,0.09923664122,0.03846153846,0.367816092,NA,0.4743049705,0.01145038168,0.4822771214,0.2980656506,"FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4413407821,"FLUOXETINE HCL","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6274509804,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,0.009389671362,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"FLUOXETINE HCL","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6658097686,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.632183908,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4064516129,"FLUOXETINE HCL","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5970873786,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5333333333,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6533333333,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5909090909,NA,NA,NA,NA,0.5748502994,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5585885486,NA,NA,NA,NA,NA,0.03115264798,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6422764228,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7107142857,NA,NA,0.7898550725,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2901234568,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6405228758,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6676557864,NA,NA,NA,NA,0.696485623,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5991486343,NA,NA,NA,NA,NA,0.02037845706,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6833046472,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.02631578947,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4931506849,NA,0.4405594406,0.2692307692,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3144654088,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4653465347,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SIMVASTATIN","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4829443447,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5309734513,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,0.354368932,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.0198019802,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.285046729,"FLUOXETINE HCL","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1474358974,"FLUOXETINE HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03418803419,NA,0.2376237624,"FLUOXETINE HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1941747573,"FLUOXETINE HCL","Last AD: Diff & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1451612903,"FLUOXETINE HCL","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1810344828,"FLUOXETINE HCL","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.272,"FLUOXETINE HCL","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6026490066,"FLUOXETINE HCL","Last AD: Diff & No Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5689655172,"FLUOXETINE HCL","Last AD: Diff & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2137931034,NA,NA,NA,NA,NA,NA,NA,NA,0.2820512821,"FLUOXETINE HCL","Last AD: Diff & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.02127659574,NA,NA,NA,NA,0.1705426357,0.6601941748,NA,NA,NA,NA,NA,NA,0.5964912281,0.325648415,"FLUOXETINE HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006097560976,NA,0.4666666667,"FLUOXETINE HCL","Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4553571429,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA
"41-64","Female",NA,0.01809954751,NA,NA,NA,NA,0.1869918699,0.5770609319,NA,NA,NA,NA,NA,0.0236001851,NA,0.5357142857,"FLUOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0.5454545455,"FLUOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4513888889,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,0.004566210046,NA,NA,NA,NA,0.1748251748,0.6845637584,NA,NA,NA,NA,NA,0.02,0.7253668763,0.4189814815,"FLUOXETINE HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.03272727273,0.05397301349,0.6666666667,0.6319444444,NA,0.4834532374,0.2387732749,NA,0.2209302326,NA,0.58125,NA,0.6078431373,0.06896551724,0.655396619,0.4132588265,"FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,0.6138613861,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6481481481,"FLUOXETINE HCL","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5278969957,NA,NA,"FLUOXETINE HCL","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.03,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6604938272,NA,NA,NA,NA,NA,NA,NA,0.4740740741,"FLUOXETINE HCL","Last AD: Diff & Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6845637584,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & Remiss","NORTRIPTYLINE HCL","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.533557047,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","Num Previous Remissions: 2+","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5053763441,NA,NA,NA,NA,NA,0.03246753247,NA,NA,"FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5414012739,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6100993377,NA,NA,NA,NA,NA,0.0303030303,NA,NA,"FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6754966887,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3157894737,"FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.56,"FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3615384615,"FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2909090909,"FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.556547619,NA,NA,NA,NA,NA,0.03968253968,NA,0.5397350993,"FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5546218487,"FLUOXETINE HCL","Last AD: Diff & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7807017544,NA,NA,NA,NA,NA,NA,NA,0.3471502591,"FLUOXETINE HCL","Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5964912281,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2472527473,"FLUOXETINE HCL","Last AD: Diff & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5524861878,NA,NA,NA,NA,NA,NA,NA,0.5568181818,"FLUOXETINE HCL","Last AD: Diff & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7483870968,NA,NA,NA,NA,0.7214285714,NA,NA,0.3925925926,"FLUOXETINE HCL","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4675324675,"FLUOXETINE HCL","Last AD: Diff & Remiss","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3883495146,"FLUOXETINE HCL","Last AD: Diff & Remiss","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6084615385,NA,NA,NA,NA,NA,0.04581673307,NA,0.4623541888,"FLUOXETINE HCL","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4071428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,0.07079646018,NA,NA,NA,NA,NA,0.7087378641,NA,NA,NA,NA,NA,NA,0.6896551724,0.3995098039,"FLUOXETINE HCL","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.344167054,NA,NA,NA,NA,NA,NA,NA,0.3251533742,"FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3985507246,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5042492918,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4847161572,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3963414634,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","MASTODYNIA (dxo:ICD9:61171)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.362745098,"FLUOXETINE HCL","Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3577981651,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","MONTELUKAST SODIUM",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5205479452,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","MULTIPLE SCLEROSIS (dxo:ICD9:340)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3544303797,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4444444444,"FLUOXETINE HCL","Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3431372549,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4207920792,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3461538462,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4225352113,NA,NA,NA,NA,NA,0.008547008547,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3751280475,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2051282051,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2279069767,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3231939163,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4358974359,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SIMVASTATIN",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4686468647,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4910714286,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3291139241,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.368852459,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2891566265,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3710691824,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3888888889,NA,NA,0.3542857143,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2174320525,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2252252252,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.162055336,"FLUOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5691489362,"FLUOXETINE HCL","Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5789473684,"FLUOXETINE HCL","Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4545454545,"FLUOXETINE HCL","Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4352941176,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PREGABALIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2185658153,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.1611111111,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3818181818,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2369477912,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2789855072,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2123893805,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2392344498,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.224011713,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.1627906977,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.09219858156,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","RISPERIDONE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5392156863,"FLUOXETINE HCL","Last AD: Same & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2985074627,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3873626374,NA,NA,NA,NA,0.3470031546,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4297520661,"FLUOXETINE HCL","Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.466179159,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4470588235,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","TOPIRAMATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3541033435,NA,NA,NA,NA,NA,0.01838235294,NA,0.4202090592,"FLUOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4796747967,"FLUOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3681818182,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4630541872,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2732919255,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3245614035,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4111842105,NA,NA,NA,NA,NA,NA,0.4166666667,0.3406593407,"FLUOXETINE HCL","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4109589041,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","ZOLPIDEM TARTRATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7022352941,NA,NA,NA,NA,NA,NA,NA,0.4662576687,"FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.8047337278,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7263157895,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7745454545,"FLUOXETINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6745098039,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5873015873,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","MASTODYNIA (dxo:ICD9:61171)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5752212389,"FLUOXETINE HCL","Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7745098039,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","MONTELUKAST SODIUM",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7828947368,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","MULTIPLE SCLEROSIS (dxo:ICD9:340)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7222222222,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6335403727,"FLUOXETINE HCL","Last AD: Same & Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6549295775,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.526429342,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.8374291115,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7486631016,"FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6175637394,"FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.8369175627,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Remissions: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7708333333,"FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7142857143,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6808510638,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7228464419,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4863013699,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6015625,"FLUOXETINE HCL","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7167630058,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","PREGABALIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5422535211,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5524861878,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5945945946,"FLUOXETINE HCL","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6229508197,"FLUOXETINE HCL","Last AD: Same & Remiss","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.8214285714,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","ROSUVASTATIN CALCIUM",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7450110865,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.65,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7760479042,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7457627119,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","TIZANIDINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7023809524,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","TOPIRAMATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6543778802,NA,NA,NA,NA,NA,NA,NA,0.6383507203,"FLUOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5820895522,"FLUOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.684596577,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7276785714,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6594202899,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6218487395,NA,NA,NA,NA,NA,NA,0.6261682243,0.5611111111,"FLUOXETINE HCL","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6791666667,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","ZOLPIDEM TARTRATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6621803499,NA,NA,NA,NA,NA,NA,NA,0.3410852713,"FLUOXETINE HCL","LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2861736334,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4017857143,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6533864542,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6924708378,NA,NA,NA,NA,NA,NA,NA,0.4481481481,"FLUOXETINE HCL","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3848580442,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LEVOTHYROXINE SODIUM","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7359050445,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LEVOTHYROXINE SODIUM","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6956521739,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LEVOTHYROXINE SODIUM","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.1531531532,NA,NA,NA,NA,NA,NA,NA,0.1041666667,"FLUOXETINE HCL","LITHIUM CARBONATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.09271523179,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LITHIUM CARBONATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.09016393443,NA,NA,NA,NA,NA,NA,NA,0.07936507937,"FLUOXETINE HCL","LITHIUM CARBONATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LORAZEPAM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3414634146,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LORAZEPAM","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7207207207,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LORAZEPAM","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7237569061,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7412587413,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LOVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6909090909,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7142857143,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7012195122,NA,NA,NA,NA,NA,NA,NA,0.6151515152,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7096774194,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6951219512,NA,NA,NA,NA,NA,NA,NA,0.6652173913,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6984615385,NA,NA,NA,NA,NA,NA,NA,0.4556962025,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3413173653,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.625,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3333333333,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,0.4658227848,0.7054263566,NA,NA,0.6408163265,0.532967033,0.6576620825,0.4347826087,NA,NA,NA,0.7391304348,0.2362204724,0.7202797203,0.5659745479,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.520661157,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7595907928,NA,NA,NA,NA,NA,NA,NA,0.6455696203,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6312056738,NA,NA,NA,NA,NA,NA,NA,0.5849056604,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5762711864,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6039488966,NA,NA,NA,NA,NA,0.2044609665,NA,0.5195402299,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4672897196,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.602739726,NA,NA,NA,NA,NA,NA,NA,0.5423728814,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7130434783,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7279596977,NA,NA,NA,NA,NA,NA,0.5353159851,NA,"FLUOXETINE HCL","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5940594059,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6181818182,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MASTODYNIA (dxo:ICD9:61171)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6598639456,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","METOPROLOL SUCCINATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.68,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","METRONIDAZOLE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4938132733,0.2002617801,NA,NA,NA,NA,NA,NA,0.3123486683,"FLUOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6292682927,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MIRTAZAPINE","Num Previous Antidep: 2,3",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1962616822,"FLUOXETINE HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4795321637,NA,NA,NA,NA,NA,NA,NA,0.3116591928,"FLUOXETINE HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2317880795,"FLUOXETINE HCL","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6691729323,NA,NA,NA,NA,NA,NA,NA,0.4161849711,"FLUOXETINE HCL","MONTELUKAST SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7418699187,NA,NA,NA,NA,NA,NA,NA,0.4266666667,"FLUOXETINE HCL","MULTIPLE SCLEROSIS (dxo:ICD9:340)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.677734375,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6380952381,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","NONDEPENDENT ALCOHOL ABUSE, UNSPECIFIED DRUNKENNESS (dxo:ICD9:30500)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02371541502,NA,NA,NA,NA,NA,0.6961325967,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6075949367,NA,0.1541916168,NA,NA,NA,NA,NA,0.4455370651,"FLUOXETINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6641221374,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","NORTRIPTYLINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4915254237,NA,NA,NA,NA,NA,NA,NA,0.3492647059,"FLUOXETINE HCL","NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3366336634,"FLUOXETINE HCL","NORTRIPTYLINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5990338164,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.55,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7117437722,NA,NA,0.7935483871,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.28,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6405228758,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6656804734,NA,NA,NA,NA,0.6580976864,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5981638418,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6843910806,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.406504065,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4035087719,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 4+","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4175257732,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 4+","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3805668016,NA,NA,NA,NA,NA,NA,NA,0.225433526,"FLUOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2488038278,"FLUOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.5142857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Episodes: 2+",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5700934579,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.8310580205,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Remissions: 2+",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5727699531,NA,NA,NA,NA,NA,NA,NA,0.556122449,"FLUOXETINE HCL","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1740139211,"FLUOXETINE HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2242990654,"FLUOXETINE HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7461928934,NA,NA,NA,NA,NA,NA,NA,0.4518716578,"FLUOXETINE HCL","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6548672566,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","OLANZAPINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6927083333,NA,NA,NA,NA,NA,NA,NA,0.4397905759,"FLUOXETINE HCL","OMEPRAZOLE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5833333333,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","OTHER DYSCHROMIA (dxo:ICD9:70909)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.649122807,NA,NA,NA,NA,NA,NA,NA,0.4491525424,"FLUOXETINE HCL","OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4237288136,NA,NA,NA,NA,"FLUOXETINE HCL","OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.03846153846,NA,NA,NA,0.5864197531,NA,0.6747311828,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6929133858,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6540880503,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","OTHER SPECIFIED DISEASE OF SEBACEOUS GLANDS (dxo:ICD9:7068)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7381818182,NA,NA,NA,NA,NA,NA,NA,0.5111111111,"FLUOXETINE HCL","OXYBUTYNIN CHLORIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6827195467,NA,NA,NA,NA,NA,NA,NA,0.3560209424,"FLUOXETINE HCL","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6803278689,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PANTOPRAZOLE SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,0.04733727811,0.5421052632,NA,NA,0.2741935484,0.2212765957,0.5754231052,NA,NA,0.5164066703,NA,0.4580152672,0.009433962264,NA,0.280952381,"FLUOXETINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4696969697,NA,NA,0.426035503,NA,NA,0.02525252525,NA,0.3495702006,"FLUOXETINE HCL","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.05369127517,0.2462311558,NA,NA,0.1811320755,NA,0.3291079812,NA,NA,0.1981981982,NA,0.251497006,NA,0.2145214521,0.1329437546,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3294797688,NA,NA,NA,NA,NA,NA,NA,0.09478672986,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2807017544,NA,NA,NA,NA,NA,NA,NA,0.1602209945,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2707581227,NA,NA,NA,NA,NA,0.01324503311,NA,0.1862003781,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1550802139,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2042253521,NA,NA,NA,NA,NA,NA,0.297752809,0.1008064516,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6536312849,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","POLYETHYLENE GLYCOL 3350",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5359828142,NA,NA,NA,NA,NA,NA,NA,0.5110384301,"FLUOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6126126126,NA,NA,NA,NA,NA,NA,NA,0.5753424658,"FLUOXETINE HCL","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4770114943,"FLUOXETINE HCL","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3873626374,"FLUOXETINE HCL","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7323600973,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PREGABALIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5416666667,NA,NA,NA,NA,0.4988929889,NA,NA,NA,NA,NA,NA,NA,0.335078534,"FLUOXETINE HCL","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4552238806,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4081632653,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4010989011,"FLUOXETINE HCL","PROPOXYPHENE NAP/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.546031746,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4360313316,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3178294574,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1403508772,0.5170603675,NA,NA,NA,NA,0.2752293578,NA,0.3237410072,0.1599264706,"FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4416666667,NA,NA,NA,NA,NA,NA,NA,0.2684563758,"FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3661971831,NA,NA,NA,NA,NA,NA,NA,0.1290322581,"FLUOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04958677686,"FLUOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2474747475,NA,NA,NA,NA,NA,NA,NA,0.1804878049,"FLUOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.223880597,0.1292134831,0.3896103896,NA,NA,NA,NA,0.2094594595,NA,0.2802547771,0.2005012531,"FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3403614458,NA,NA,NA,NA,NA,NA,NA,0.2620689655,"FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2897727273,NA,NA,NA,NA,NA,NA,NA,0.1118421053,"FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7481481481,NA,NA,NA,NA,NA,NA,NA,0.4753521127,"FLUOXETINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6042780749,NA,NA,NA,0.3958868895,NA,NA,NA,0.5983606557,"FLUOXETINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4903846154,"FLUOXETINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2218181818,NA,NA,NA,NA,NA,NA,NA,0.1304347826,"FLUOXETINE HCL","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2097902098,NA,NA,NA,NA,NA,NA,NA,0.1487603306,"FLUOXETINE HCL","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6425339367,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","RIZATRIPTAN BENZOATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5073170732,NA,NA,NA,0.3741794311,NA,NA,NA,0.5295214419,"FLUOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4145658263,"FLUOXETINE HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7829457364,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.6926605505,NA,0.5320512821,0.2598425197,0.6522108844,NA,NA,0.5681818182,NA,NA,NA,NA,0.3908045977,"FLUOXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",0.02836879433,0.029143898,0.4,NA,NA,0.3125,0.168784029,0.5114379085,0.1176470588,NA,0.3843537415,NA,0.4874213836,0.02173913043,0.5964912281,0.2721936904,"FLUOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3333333333,NA,NA,NA,NA,0.4430379747,0.0223880597,NA,0.3407155026,"FLUOXETINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.62,NA,NA,NA,NA,0.504,NA,NA,0.3197278912,"FLUOXETINE HCL","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7575480329,NA,NA,NA,NA,0.7222222222,NA,NA,0.4084507042,"FLUOXETINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7047619048,"FLUOXETINE HCL","SIMVASTATIN","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7021276596,NA,NA,NA,NA,NA,NA,NA,0.416909621,"FLUOXETINE HCL","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6513409962,NA,"FLUOXETINE HCL","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.7010676157,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","TIZANIDINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6494252874,NA,NA,NA,NA,NA,NA,NA,0.469924812,"FLUOXETINE HCL","TOPIRAMATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6725663717,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","TRAMADOL HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6902654867,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","TRAMADOL HCL/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Female",0.02127659574,0.03664122137,0.3636363636,NA,NA,0.2910662824,0.1956947162,0.4679009558,NA,NA,0.3109756098,NA,0.3488372093,0.02303976217,0.4451410658,0.404714725,"FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4,NA,NA,NA,NA,NA,0.0216802168,0.5036764706,0.3476531424,"FLUOXETINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.661971831,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","UNSPECIFIED ALOPECIA (dxo:ICD9:70400)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5961945032,NA,0.6449511401,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6731707317,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6602870813,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","UNSPECIFIED TEAR FILM INSUFFICIENCY (dxo:ICD9:37515)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6855345912,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","UNSPECIFIED TRANSIENT CEREBRAL ISCHEMIA (dxo:ICD9:4359)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6584093872,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA
"41-64","Female",0.02727272727,0.03023758099,0.4568965517,NA,NA,0.4910714286,0.1641468683,0.5615167406,NA,NA,0.4413407821,NA,0.4470046083,0.01630434783,0.6394517282,0.303030303,"FLUOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.702970297,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","VERAPAMIL HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.6624113475,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"41-64","Female",0.006622516556,0.03356367226,0.5130597015,NA,NA,0.3487621098,0.180078125,0.5255952381,NA,0.05169628433,0.3981900452,NA,0.4943011398,NA,NA,0.2761087268,"GABAPENTIN",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07582938389,NA,NA,NA,NA,NA,NA,"GABAPENTIN","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3731343284,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5185185185,NA,NA,NA,NA,0.4569536424,NA,NA,NA,"GABAPENTIN","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3333333333,"GABAPENTIN","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4351145038,"GABAPENTIN","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0826446281,NA,NA,NA,NA,NA,NA,"GABAPENTIN","Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3770491803,NA,NA,NA,"GABAPENTIN","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.426035503,NA,NA,NA,"GABAPENTIN","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7570093458,NA,NA,NA,NA,NA,"GABAPENTIN","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7461706783,NA,NA,NA,"GABAPENTIN","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.02127659574,NA,NA,NA,NA,0.2175925926,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1703703704,NA,NA,NA,NA,NA,NA,"GABAPENTIN","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1843575419,NA,NA,NA,NA,NA,0.6285714286,NA,NA,NA,"GABAPENTIN","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1886792453,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","OMEPRAZOLE",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01851851852,NA,NA,NA,0.3652694611,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3786982249,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3651452282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6990595611,NA,NA,NA,NA,0.393129771,"GABAPENTIN","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4255952381,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","PREGABALIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3842592593,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","PREGABALIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3404255319,0.1375,NA,NA,NA,0.3728813559,NA,NA,NA,NA,NA,"GABAPENTIN","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5670103093,0.3203883495,NA,NA,NA,NA,NA,0.7137511693,NA,NA,0.4462809917,"GABAPENTIN","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7413793103,NA,NA,NA,"GABAPENTIN","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6116504854,NA,NA,NA,NA,NA,NA,0.7076923077,NA,NA,NA,"GABAPENTIN","SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5479452055,NA,NA,NA,NA,0.6140350877,NA,NA,NA,NA,0.5675675676,NA,NA,NA,"GABAPENTIN","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.328358209,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","TRAMADOL HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3826530612,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","TRAMADOL HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3866666667,"GABAPENTIN","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3831417625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3142857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3679565513,NA,0.5234899329,NA,NA,NA,NA,0.4528301887,NA,NA,NA,"GABAPENTIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5872093023,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4633507853,"GABAPENTIN","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5229357798,NA,NA,NA,NA,NA,NA,NA,0.3818181818,NA,0.6014492754,NA,NA,NA,"GEMFIBROZIL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7089552239,NA,NA,NA,NA,NA,"GEMFIBROZIL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7410714286,NA,NA,NA,"GEMFIBROZIL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.03048780488,0.02815315315,NA,NA,NA,NA,0.1430842607,0.4985994398,NA,NA,NA,NA,0.5628571429,NA,NA,0.2633928571,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA,NA
"41-64","Female",0.01104972376,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4864864865,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6642335766,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.04,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","LORAZEPAM",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02380952381,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.008928571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.04761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",0.04424778761,NA,NA,NA,NA,NA,0.1305418719,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.04166666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6769230769,NA,NA,0.4214285714,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4158415842,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4364261168,NA,NA,0.4130434783,0.1234735414,NA,NA,NA,NA,NA,NA,NA,0.4701986755,NA,"GUAIFENESIN/P-EPHED HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09826589595,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GUAIFENESIN/P-EPHED HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5250737463,NA,NA,NA,0.1529411765,NA,NA,NA,NA,NA,NA,NA,0.5263157895,NA,"GUAIFENESIN/PHENYLEPHRINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.106918239,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GUAIFENESIN/PHENYLEPHRINE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1517857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GUAIFENESIN/PHENYLEPHRINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4485294118,NA,NA,NA,NA,0.4571428571,NA,NA,NA,0.5901639344,NA,"GUAIFENESIN/PSEUDOEPHEDRNE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4084880637,NA,NA,NA,NA,NA,"GUAIFENESIN/PSEUDOEPHEDRNE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6971153846,NA,NA,NA,NA,NA,"GUAIFENESIN/PSEUDOEPHEDRNE HCL","GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6643835616,NA,NA,NA,NA,NA,"GUAIFENESIN/PSEUDOEPHEDRNE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0,0.02239641657,0.5998851894,NA,NA,0.3958051421,0.1148864592,0.5072212594,NA,NA,0.4201376313,NA,0.6056930693,NA,0.6015392254,0.2180094787,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2025862069,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","IMIPRAMINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.2561983471,NA,NA,NA,0.07672634271,NA,NA,NA,0.2207792208,NA,NA,NA,0.2876712329,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.374301676,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3802816901,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,0.2138728324,NA,NA,NA,0.05601317957,NA,NA,NA,0.1954314721,NA,NA,NA,0.2565055762,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2718446602,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5810810811,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5821917808,NA,NA,NA,NA,NA,NA,NA,0.4509803922,NA,NA,NA,NA,0.2101449275,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","LABORATORY EXAMINATION (dxo:ICD9:V726)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6639344262,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","LABORATORY EXAMINATION (dxo:ICD9:V726)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1133333333,NA,NA,NA,NA,NA,NA,NA,0.5043478261,0.2,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1317829457,NA,NA,NA,NA,NA,NA,NA,0.5373134328,0.3209876543,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3784860558,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3495934959,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7009345794,0.2995780591,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2115384615,NA,NA,NA,NA,NA,NA,NA,0.652892562,0.3852140078,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3855421687,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09139784946,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2768595041,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3350253807,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3153564899,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4378109453,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4158730159,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6733067729,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6918604651,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6759776536,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5673076923,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6203703704,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","LEVONORGESTREL-ETHIN ESTRADIOL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.53,NA,NA,NA,NA,0.6066481994,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7875457875,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","LEVOTHYROXINE SODIUM","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.631372549,NA,NA,NA,0.1009174312,NA,NA,NA,0.459807074,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","LORATADINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6923076923,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","LORATADINE","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4748201439,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4952380952,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","MASTODYNIA (dxo:ICD9:61171)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6206896552,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01769911504,NA,NA,NA,NA,0.1367521368,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02051282051,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09893048128,NA,NA,NA,NA,NA,NA,NA,0.555,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999)",NA,NA,NA,NA,NA
"41-64","Female",0.005714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6961325967,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.07407407407,NA,NA,NA,0.4090909091,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5089820359,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6296296296,NA,NA,NA,0.2110817942,NA,NA,NA,0.6491136601,NA,NA,NA,0.7133956386,0.2962962963,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3620689655,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6393442623,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL","ROFECOXIB",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6435643564,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6271186441,NA,NA,NA,NA,0.5950413223,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5825242718,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3162393162,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6721311475,NA,NA,NA,0.08866995074,0.3882352941,NA,NA,0.3028169014,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.2391304348,NA,NA,NA,0.07142857143,NA,NA,NA,0.2259887006,NA,NA,NA,0.2314814815,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6312056738,NA,NA,NA,0.101754386,NA,NA,NA,0.4802631579,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","ROFECOXIB",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01785714286,NA,NA,NA,NA,NA,NA,NA,NA,0.4901960784,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5338345865,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6650717703,NA,NA,NA,0.1868852459,NA,NA,NA,0.491638796,NA,0.7096279248,NA,0.7183908046,0.3702239789,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6341463415,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7333333333,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6018518519,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SERTRALINE HCL","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6369426752,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SERTRALINE HCL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.524822695,NA,NA,NA,0.5976900866,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6705202312,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3490566038,NA,NA,NA,NA,0.3911764706,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5178571429,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09677419355,NA,NA,NA,NA,NA,0.6,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.585106383,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4444444444,NA,NA,NA,0.1206896552,NA,NA,NA,NA,NA,0.5608695652,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2272727273,NA,NA,NA,0.5301204819,NA,NA,NA,0.703163017,0.3477321814,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.009523809524,0.02896995708,0.5140186916,NA,NA,NA,NA,0.4583333333,NA,0.0512755102,NA,NA,0.52734375,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Female",0.009615384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","HYOSCYAMINE SULFATE",NA,NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01923076923,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641)",NA,NA,NA,NA,NA
"41-64","Female",0.007575757576,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",0.01376146789,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",0.01709401709,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05855855856,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","NORTRIPTYLINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0457433291,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04069767442,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","MIGRAINE WITHOUT AURA, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34610)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05691056911,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","MIGRAINE WITHOUT AURA, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34610)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA
"41-64","Female",0.006451612903,NA,NA,NA,NA,NA,NA,NA,NA,0.06488549618,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1804878049,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA
"41-64","Female",0.005405405405,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",0.005934718101,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0347826087,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA
"41-64","Female",0.016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","MORPHINE SULFATE",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02702702703,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",0.005025125628,NA,NA,NA,NA,NA,NA,NA,NA,0.1642651297,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1232876712,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","NORTRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.03064066852,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",0.01094890511,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",0.005319148936,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",0.01716738197,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","OXYCODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.01020408163,NA,NA,NA,NA,NA,NA,NA,NA,0.08196721311,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.02727272727,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03603603604,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Female",0.004811547715,0.03378378378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",0.01639344262,NA,NA,NA,NA,NA,NA,NA,NA,0.05426356589,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.00296735905,NA,NA,NA,NA,NA,NA,NA,NA,0.07878787879,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.008403361345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",0.015625,NA,NA,NA,NA,NA,NA,NA,NA,0.06474820144,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5216400911,NA,NA,NA,NA,NA,NA,NA,0.4305555556,NA,NA,NA,NA,NA,"HEMATURIA (dxo:ICD9:5997)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.603960396,NA,NA,NA,NA,NA,"HEMATURIA (dxo:ICD9:5997)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4504504505,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEMATURIA, UNSPECIFIED (dxo:ICD9:59970)",NA,NA,NA,NA,NA,NA
"41-64","Female",0.006172839506,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HERPES ZOSTER WITHOUT MENTION OF COMPLICATION (dxo:ICD9:0539)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01265822785,NA,NA,"HIP JOINT REPLACEMENT BY OTHER MEANS (dxo:ICD9:V4364)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3942857143,NA,NA,NA,"HYDRALAZINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",0.02123893805,0.03144654088,NA,NA,NA,0.3284883721,0.1474103586,0.5105263158,NA,0.07142857143,0.4460784314,0.2397476341,0.5266940452,0.01037613489,NA,0.2854122622,"HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5037037037,0.01709401709,NA,NA,"HYDROCODONE/ACETAMINOPHEN","IBUPROFEN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4592592593,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"HYDROCODONE/ACETAMINOPHEN","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7530120482,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2810457516,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","LUMBAGO (dxo:ICD9:7242)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3785310734,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3018867925,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5701754386,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",0.0119760479,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7821782178,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01818181818,NA,NA,"HYDROCODONE/ACETAMINOPHEN","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Female",0,0.02739726027,NA,NA,NA,0.3563636364,0.1573033708,0.3867924528,NA,NA,NA,NA,NA,NA,NA,0.2231404959,"HYDROCODONE/ACETAMINOPHEN","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7251184834,NA,NA,0.3777777778,"HYDROCODONE/ACETAMINOPHEN","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3709677419,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","TRAMADOL HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006097560976,NA,NA,"HYDROCODONE/ACETAMINOPHEN","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3689320388,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4721780604,NA,NA,NA,0.144486692,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROCODONE/HOMATROPINE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4117647059,NA,NA,NA,NA,NA,NA,NA,NA,0.5135135135,NA,"HYDROCORTISONE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5075757576,NA,NA,NA,0.1428571429,NA,NA,NA,NA,NA,0.5590062112,NA,NA,NA,"HYDROXYCHLOROQUINE SULFATE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8034682081,NA,NA,NA,"HYDROXYCHLOROQUINE SULFATE","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7609756098,NA,NA,NA,"HYDROXYCHLOROQUINE SULFATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02803738318,NA,NA,0.1620029455,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROXYZINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.1643835616,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROXYZINE HCL","UNSPECIFIED PRURITIC DISORDER (dxo:ICD9:6989)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.1912350598,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROXYZINE HCL","UNSPECIFIED URTICARIA (dxo:ICD9:7089)",NA,NA,NA,NA,NA
"41-64","Female",0.006072874494,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1909090909,"HYOSCYAMINE SULFATE",NA,NA,NA,NA,NA,NA
"41-64","Female",0.009090909091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYOSCYAMINE SULFATE","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYOSCYAMINE SULFATE","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",0.005882352941,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYOSCYAMINE SULFATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2781954887,NA,NA,NA,NA,"HYPERSOMNIA WITH SLEEP APNEA, UNSPECIFIED (dxo:ICD9:78053)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4227642276,NA,"HYPERTROPHY OF NASAL TURBINATES (dxo:ICD9:4780)",NA,NA,NA,NA,NA,NA
"41-64","Female",0.02608695652,NA,0.4500846024,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4744588745,0.009049773756,NA,NA,"IBUPROFEN",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.385,NA,NA,NA,"IBUPROFEN","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01639344262,NA,NA,"IBUPROFEN","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7170542636,NA,NA,NA,"IBUPROFEN","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4876033058,NA,NA,NA,"IBUPROFEN","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5283018868,NA,NA,NA,"IBUPROFEN","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007352941176,NA,NA,"IBUPROFEN","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.699410609,NA,NA,NA,"IBUPROFEN","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007518796992,NA,NA,"IBUPROFEN","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2245762712,"IMIPRAMINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1176470588,"IMIPRAMINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1205673759,"IMIPRAMINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4642857143,"IMIPRAMINE HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.43,"IMIPRAMINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.01764705882,0.03237410072,0.2182361734,0.2045454545,NA,0.1622073579,0.08061749571,0.1920529801,NA,NA,0.15625,NA,0.1447876448,0.03255813953,0.1823085221,0.1301703163,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.1111111111,NA,NA,0.08854166667,0.07210031348,0.1140350877,NA,NA,NA,NA,0.08152173913,NA,0.1125827815,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1677852349,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","SERTRALINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.119266055,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.08372093023,NA,NA,NA,NA,NA,0.06617647059,NA,0.09322033898,0.09708737864,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07438016529,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05357142857,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.236453202,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL","VENLAFAXINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1525423729,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.126984127,NA,NA,NA,NA,NA,NA,NA,NA,0.1510791367,0.05263157895,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2153846154,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.33,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09580838323,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2277227723,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.188976378,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.200811359,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1363636364,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02631578947,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1825396825,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1706349206,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7391304348,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.701754386,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.693877551,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1226415094,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3613861386,NA,NA,NA,NA,0.1314984709,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.32,NA,NA,NA,NA,0.048,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.132231405,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2034883721,NA,NA,NA,NA,0.1317073171,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.02985074627,0.1727748691,0.131147541,NA,0.1893491124,NA,0.1150442478,NA,NA,NA,NA,0.1428571429,0.01298701299,0.1433691756,0.112033195,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3052631579,NA,NA,0.1322751323,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2403846154,NA,NA,0.1875,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0390625,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.164021164,0.1395348837,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2209944751,0.09952606635,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.02272727273,0.09259259259,0.1384615385,NA,0.1111111111,0.07171314741,NA,NA,NA,NA,NA,0.1127819549,NA,0.1764705882,0.08064516129,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08823529412,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05882352941,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1015228426,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1612903226,NA,NA,NA,NA,NA,NA,0.3570581257,NA,NA,0.1142857143,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2958199357,NA,NA,0.1984536082,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04430379747,0.1351351351,0.100795756,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2394014963,0.1756440281,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2652123995,0.1077441077,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.03448275862,0.2262479871,0.3095890411,0.02517985612,0.222752931,0.07160282996,0.2217664753,NA,NA,0.1879762913,NA,0.2340820807,0.01548205489,0.2799210872,0.1555555556,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.05627705628,NA,NA,NA,NA,NA,0.04504504505,NA,0.06862745098,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.02830188679,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01907356948,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006711409396,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3709677419,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL"
"41-64","Female",NA,NA,NA,NA,NA,NA,0.05164319249,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.0671641791,NA,NA,NA,NA,NA,NA,NA,NA,0.1007194245,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05970149254,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.05349794239,NA,NA,NA,NA,NA,NA,NA,NA,0.1389728097,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2413793103,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.05405405405,NA,NA,NA,NA,NA,NA,NA,NA,0.1559633028,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.141025641,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.05679012346,NA,NA,NA,NA,NA,NA,NA,NA,0.1446808511,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2721088435,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.04444444444,NA,NA,NA,NA,NA,NA,NA,NA,0.1791044776,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.325,0.25,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.0890052356,NA,NA,NA,NA,NA,NA,NA,NA,0.1605839416,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05714285714,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2444444444,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2379032258,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1487603306,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2233009709,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2156862745,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1578947368,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1754385965,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1741573034,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3093858633,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3050314465,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2932369644,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.004716981132,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2972258917,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5853658537,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4484536082,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5317460317,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.198019802,NA,NA,NA,NA,0.2672413793,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.1741935484,NA,NA,NA,NA,0.1666666667,NA,NA,NA,NA,0.2318181818,NA,NA,0.144,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3603603604,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1923076923,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,0.6822429907,NA,NA,NA,0.6262626263,0.7565217391,NA,NA,NA,NA,0.75,NA,0.6453488372,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6336633663,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7285714286,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.6345177665,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6356589147,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6764705882,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1147540984,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2624584718,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.28125,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3645833333,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Num Previous Antidep: 2,3","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3191489362,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.04379562044,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.2943548387,NA,NA,0.2571428571,0.07912087912,0.2258064516,NA,NA,0.3860977288,NA,0.2910958904,NA,0.3739837398,0.1501501502,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2364341085,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2764227642,NA,NA,NA,NA,0.08333333333,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2384615385,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,0.2797202797,NA,NA,NA,0.1101694915,NA,NA,NA,0.3682373473,NA,0.2916666667,NA,0.25,0.1310679612,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4233576642,NA,NA,NA,NA,0.2561983471,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3178294574,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3626373626,NA,NA,NA,NA,0.243697479,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.143812709,NA,NA,0.1148459384,0.1060606061,0.1516393443,NA,NA,0.1071428571,NA,0.1033519553,0.0396039604,0.1344165436,0.09405940594,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.1675675676,0.1092436975,NA,0.1011904762,0.0547112462,0.1449275362,NA,NA,0.06481481481,NA,0.09543568465,NA,0.1491525424,0.06481481481,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2204301075,NA,NA,0.09318996416,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2272727273,NA,NA,0.1166666667,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04201680672,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2,0.08411214953,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL","VENLAFAXINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.222826087,0.0622406639,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2250580046,NA,0.0701754386,0.08823529412,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2016460905,NA,NA,0.16,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1890243902,0.1052631579,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1981818182,0.07881773399,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.1538461538,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2127659574,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","POSTTRAUMATIC STRESS DISORDER (dxo:ICD9:30981)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.1836734694,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.1826923077,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Female",NA,NA,0.1982578397,0.2853932584,NA,0.20657277,0.06689759688,0.2010282776,NA,NA,0.1809045226,NA,0.2150724638,0.01401869159,0.2474720596,0.1274298056,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.2907801418,NA,NA,0.06389776358,NA,NA,NA,0.1412639405,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,0.2336065574,NA,NA,0.2091503268,0.1111111111,0.2325581395,NA,NA,0.2260869565,NA,0.4108469539,NA,0.2739273927,0.1725601132,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3722627737,NA,NA,0.2808988764,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2119565217,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1525,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4074074074,0.3284671533,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2283105023,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,NA,0.3739837398,NA,NA,0.2413793103,0.1461538462,NA,NA,NA,NA,NA,0.2264150943,NA,0.3694721826,0.2115732369,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.1310344828,NA,NA,NA,0.04225352113,0.1559633028,NA,NA,NA,NA,0.1571428571,NA,0.14,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.298245614,NA,NA,0.07307692308,NA,NA,NA,0.1450777202,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.2455696203,NA,NA,0.2294117647,0.07361111111,0.24,NA,NA,0.2270531401,NA,0.4136092819,NA,0.315696649,0.1739130435,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3575525813,NA,NA,0.2938596491,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4471544715,NA,0.46,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2771084337,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.2285714286,NA,NA,0.1714285714,0.05668016194,NA,NA,NA,NA,NA,0.253968254,0.02536231884,0.2908163265,0.1810584958,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3814655172,0.2620320856,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1947368421,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.3253588517,NA,NA,0.2689393939,0.1206896552,0.2288557214,NA,NA,NA,NA,0.269035533,NA,0.4,0.2574850299,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.1639676113,0.1062271062,NA,0.1403846154,0.06633906634,0.1401869159,NA,NA,0.1090047393,NA,0.1350364964,0.005649717514,0.1694915254,0.07471264368,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1935483871,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1798941799,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02803738318,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1790123457,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2181069959,NA,NA,NA,NA,0.08095238095,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1067961165,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.05982905983,NA,NA,NA,NA,NA,0.1196581197,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.08333333333,NA,NA,NA,NA,NA,0.2533589251,NA,NA,0.07804878049,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1853658537,NA,NA,0.1063829787,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1861702128,0.1513944223,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2279909707,0.09736842105,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.008174386921,0.02524271845,0.4557575758,NA,0.1181102362,NA,0.1732283465,0.4744551626,0.1361867704,NA,0.425,NA,0.496196319,0.00850701829,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008064516129,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6344827586,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009174311927,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7394366197,0.004201680672,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009708737864,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005813953488,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008771929825,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01485148515,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.3925233645,NA,NA,NA,NA,0.390625,NA,NA,NA,NA,0.4163265306,0.01869158879,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.004329004329,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.016,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6642857143,0.02525252525,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02100840336,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01492537313,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4299065421,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0025,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.016,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4077791719,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008547008547,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","TRAMADOL HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006435366536,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006079027356,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","TRAZODONE HCL","ZOLPIDEM TARTRATE",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6896551724,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.461038961,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4921875,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01935483871,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",0.005649717514,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009803921569,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008333333333,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02419354839,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3278688525,NA,NA,NA,NA,NA,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.015625,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006269592476,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009345794393,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007299270073,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","ZOLPIDEM TARTRATE",NA,NA,NA,NA
"41-64","Female",0.008695652174,NA,NA,NA,NA,NA,NA,NA,0.1037735849,NA,NA,NA,NA,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7052054795,0.01339285714,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7065868263,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6348314607,0.03097345133,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6446280992,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7192982456,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SERTRALINE HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA
"41-64","Female",NA,NA,0.4059405941,NA,NA,NA,NA,0.5048543689,NA,NA,NA,NA,0.5720720721,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01445086705,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TEMAZEPAM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TEMAZEPAM","ZOLPIDEM TARTRATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAMADOL HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02469135802,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAMADOL HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01216931217,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02298850575,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAZODONE HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.54,NA,NA,NA,NA,0.4761904762,0,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005714285714,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4526315789,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03496503497,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4935483871,NA,NA,NA,NA,0.5340314136,0.009679821296,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4206349206,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"IRREGULAR MENSTRUAL CYCLE (dxo:ICD9:6264)",NA,NA,NA,NA,NA,NA
"41-64","Female",0.004672897196,0.02074688797,NA,NA,NA,NA,NA,NA,NA,0.05882352941,NA,NA,NA,NA,NA,NA,"IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04761904762,NA,NA,NA,NA,NA,NA,"IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641)","Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",0.006172839506,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",0.01398601399,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5463414634,NA,NA,NA,"ISOMETHEPT/DICHLPHN/ACETAMINOP",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6956521739,NA,NA,NA,"ISOMETHEPT/DICHLPHN/ACETAMINOP","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5384615385,NA,NA,NA,"KETOCONAZOLE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5036319613,NA,NA,NA,NA,NA,NA,NA,0.4692307692,NA,NA,NA,NA,0.1912751678,"LABORATORY EXAMINATION (dxo:ICD9:V726)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5882352941,NA,NA,NA,NA,0.2641509434,"LABORATORY EXAMINATION (dxo:ICD9:V726)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3963963964,NA,NA,NA,NA,NA,"LABORATORY EXAMINATION (dxo:ICD9:V726)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3937007874,"LABORATORY EXAMINATION (dxo:ICD9:V726)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3859649123,"LABORATORY EXAMINATION (dxo:ICD9:V726)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4155844156,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4588235294,NA,0.4099099099,NA,"LABORATORY EXAMINATION, UNSPECIFIED (dxo:ICD9:V7260)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7156862745,NA,"LABORATORY EXAMINATION, UNSPECIFIED (dxo:ICD9:V7260)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.3842105263,NA,NA,NA,0.1228070175,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LACTULOSE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.1538461538,0.1256476684,0.03738317757,0.1082496726,0.06787878788,0.1415192508,0.03910614525,NA,0.07582938389,0.1184210526,0.1607611549,0.02739726027,0.1541313559,0.08713074271,"LAMOTRIGINE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1603053435,NA,NA,NA,NA,NA,"LAMOTRIGINE","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1221532091,NA,NA,NA,"LAMOTRIGINE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07582938389,NA,"LAMOTRIGINE","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7268041237,"LAMOTRIGINE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5245901639,"LAMOTRIGINE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5587188612,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5947136564,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6017699115,NA,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5042016807,NA,0.4765100671,NA,NA,NA,NA,NA,NA,0.4184782609,0.4094754653,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4064516129,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4604316547,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2636363636,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4185441941,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3629032258,0.3636363636,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4657534247,0.4312796209,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09698078683,"LAMOTRIGINE","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1314553991,"LAMOTRIGINE","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08145580589,"LAMOTRIGINE","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09743589744,"LAMOTRIGINE","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08131868132,"LAMOTRIGINE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1094527363,"LAMOTRIGINE","NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1307189542,"LAMOTRIGINE","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1568627451,"LAMOTRIGINE","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1219081272,"LAMOTRIGINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1186440678,"LAMOTRIGINE","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1354166667,NA,NA,NA,NA,0.05909090909,"LAMOTRIGINE","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09448818898,NA,NA,NA,NA,0.1,"LAMOTRIGINE","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.07476635514,0.07317073171,NA,0.05696202532,NA,NA,NA,NA,NA,NA,NA,NA,0.1210526316,NA,"LAMOTRIGINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1188118812,NA,NA,NA,"LAMOTRIGINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05072463768,0.05,"LAMOTRIGINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09543568465,0.04402515723,"LAMOTRIGINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08625730994,"LAMOTRIGINE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09855072464,"LAMOTRIGINE","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07692307692,"LAMOTRIGINE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04838709677,"LAMOTRIGINE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07476635514,"LAMOTRIGINE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07,NA,"LAMOTRIGINE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2012195122,NA,NA,NA,NA,"LAMOTRIGINE","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06930693069,0.06775700935,"LAMOTRIGINE","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05251641138,"LAMOTRIGINE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1124260355,0.08088235294,"LAMOTRIGINE","RISPERIDONE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1896955504,NA,NA,NA,0.1070395371,"LAMOTRIGINE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.122324159,"LAMOTRIGINE","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1118421053,"LAMOTRIGINE","ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.1612903226,NA,NA,0.09900990099,0.06349206349,0.1534883721,NA,NA,NA,NA,0.1387656313,NA,NA,0.08183079057,"LAMOTRIGINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.122605364,NA,NA,0.08143939394,"LAMOTRIGINE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1504424779,NA,NA,NA,"LAMOTRIGINE","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.1588785047,NA,NA,0.08480565371,NA,0.1222222222,NA,NA,NA,NA,NA,NA,0.08755760369,0.09446511104,"LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1180904523,0.0866851595,"LAMOTRIGINE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.104,NA,NA,NA,NA,0.2676056338,NA,0.1559063998,0.08238636364,"LAMOTRIGINE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01923076923,0.4552845528,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LANSOPRAZOLE",NA,NA,NA,NA,NA,NA
"41-64","Female",0,0.02006688963,NA,0.5949367089,NA,0.2843137255,0.1764705882,0.5048543689,NA,NA,NA,NA,0.5112359551,0.01004536617,0.5102040816,NA,"Last AD: Diff & No Remiss",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1095890411,NA,NA,"Last AD: Diff & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.625,NA,"Last AD: Diff & No Remiss","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.02369668246,NA,NA,NA,NA,0.1276595745,NA,NA,NA,NA,NA,0.4117647059,0.003731343284,NA,0.26875,"Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5811965812,NA,NA,NA,"Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6651982379,NA,NA,NA,"Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.2033898305,NA,NA,NA,NA,NA,NA,0.4043715847,"Last AD: Diff & No Remiss","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.251497006,NA,NA,NA,NA,0.02054794521,NA,0.2637362637,"Last AD: Diff & No Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.22,NA,NA,NA,NA,NA,0.6844444444,0.5625,"Last AD: Diff & No Remiss","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.02325581395,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.01724137931,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.01136363636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.02097902098,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.00518134715,0.0281124498,0.3272727273,NA,NA,0.3101265823,0.1262798635,0.3970588235,NA,NA,NA,NA,0.4358974359,0.01851851852,0.2951807229,0.2904458599,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6415929204,NA,NA,NA,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7019230769,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7166666667,NA,NA,NA,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009433962264,NA,NA,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4761904762,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2125984252,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5583333333,0.3267326733,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4971751412,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1439393939,NA,NA,NA,NA,NA,0.5248618785,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.213740458,NA,NA,NA,0.006097560976,NA,0.2526315789,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3095238095,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6631944444,0.4514563107,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5211267606,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.664516129,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5531197302,NA,NA,0.007575757576,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2792792793,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7008547009,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","SIMVASTATIN","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6213282248,0.01438848921,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6605839416,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01,0.5698005698,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6141732283,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7038327526,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6559714795,NA,NA,0.009404388715,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.75,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.303030303,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7326732673,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6592592593,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","SERTRALINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6744186047,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.737704918,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6698049765,0.01697530864,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7113043478,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01826484018,0.7108433735,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2272727273,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4309623431,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5666666667,0.2992125984,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2522522523,NA,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5775862069,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5573770492,NA,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,0.5471698113,NA,NA,NA,0.1476510067,NA,NA,NA,NA,NA,NA,NA,0.5275590551,0.3271375465,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5399879735,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5652173913,0.3743842365,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5555555556,NA,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2745098039,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5895895896,0.5178571429,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2930232558,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4230769231,"Last AD: Diff & No Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.30625,"Last AD: Diff & No Remiss","OMEPRAZOLE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.35,"Last AD: Diff & No Remiss","PALPITATIONS (dxo:ICD9:7851)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",0.003610108303,0.02110817942,0.4455252918,NA,NA,0.353125,0.135734072,0.4501779359,0.1366906475,NA,NA,NA,0.4854368932,0.01282051282,0.4592696629,0.253298153,"Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05263157895,NA,0.1826923077,"Last AD: Diff & No Remiss","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.03816793893,NA,NA,NA,NA,0.1545454545,NA,NA,NA,NA,NA,NA,NA,0.64,0.3744075829,"Last AD: Diff & No Remiss","PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009900990099,NA,NA,"Last AD: Diff & No Remiss","PAROXETINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0.5688073394,NA,NA,0.01898734177,NA,0.5149963424,"Last AD: Diff & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.05,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.654676259,0.3321799308,"Last AD: Diff & No Remiss","PAROXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01709401709,NA,NA,"Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.0275862069,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.102739726,"Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02713178295,NA,0.238317757,"Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03816793893,NA,0.1798561151,"Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03488372093,0.2731707317,0.2167487685,"Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,0.05,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.147826087,"Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02362204724,NA,NA,"Last AD: Diff & No Remiss","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7368421053,NA,"Last AD: Diff & No Remiss","PRAMIPEXOLE DI-HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.05555555556,NA,NA,NA,NA,NA,NA,NA,NA,0.1411042945,"Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1256544503,"Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1,NA,NA,NA,NA,NA,NA,NA,NA,0.164874552,"Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3216783217,"Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1531531532,"Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2620689655,"Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.144,"Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4592274678,"Last AD: Diff & No Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6447368421,"Last AD: Diff & No Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.024,NA,0.4533762058,"Last AD: Diff & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6313131313,"Last AD: Diff & No Remiss","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01435406699,NA,NA,"Last AD: Diff & No Remiss","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6767676768,0.624,"Last AD: Diff & No Remiss","ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.6959459459,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1144278607,NA,NA,NA,0.3032258065,NA,NA,NA,NA,0.3333333333,"Last AD: Diff & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.08571428571,NA,NA,NA,NA,NA,NA,NA,NA,0.3766233766,"Last AD: Diff & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1946902655,NA,NA,NA,0.3465346535,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.00422832981,0.02127659574,0.4118705036,NA,NA,0.3569682152,0.123025371,0.4189602446,0.05581395349,0.01526717557,0.3399209486,NA,NA,0.01444043321,0.4656820156,0.3337837838,"Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2820512821,"Last AD: Diff & No Remiss","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3697478992,NA,"Last AD: Diff & No Remiss","SERTRALINE HCL","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA
"41-64","Female",NA,0.02489626556,NA,NA,NA,NA,0.1488095238,NA,NA,NA,NA,NA,0.6031746032,0.01710171017,NA,0.5722465477,"Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02,NA,0.4561403509,"Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3513513514,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,0.02202643172,NA,NA,NA,NA,0.23125,NA,NA,NA,NA,NA,0.7323943662,0.009259259259,0.6864197531,0.4105960265,"Last AD: Diff & No Remiss","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3915662651,"Last AD: Diff & No Remiss","SIMVASTATIN","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3538461538,"Last AD: Diff & No Remiss","SUMATRIPTAN SUCCINATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6571428571,NA,"Last AD: Diff & No Remiss","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,"Last AD: Diff & No Remiss","TOPIRAMATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",0.001615508885,0.02278942571,0.4048843188,NA,NA,0.2745098039,0.1237541528,0.4050235479,0.09937888199,0.03448275862,0.2871972318,NA,0.4196787149,0.01968205905,0.399185336,0.3355365474,"Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3034188034,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","TRAZODONE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,0.01829268293,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02076970067,0.6378504673,0.5534441805,"Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3509933775,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.007633587786,0.02658788774,0.4515539305,NA,NA,0.3597359736,0.1566380134,0.4256880734,0.1015625,0.05357142857,0.3506944444,NA,0.5006587615,0.009685230024,0.7142857143,0.3099652375,"Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.08102345416,NA,0.6742301459,NA,0.5545746388,NA,NA,0.306,NA,NA,NA,NA,0.06785589367,0.6511134677,NA,"Last AD: Diff & Remiss",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.609375,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5690607735,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.5333333333,NA,NA,NA,NA,NA,NA,0.6455696203,NA,NA,NA,NA,0.4921348315,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.6708074534,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.592920354,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.6146788991,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6204379562,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4545454545,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5181058496,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5855263158,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6881188119,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.438247012,NA,NA,NA,NA,NA,NA,0.4709677419,"Last AD: Diff & Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.3103448276,NA,NA,NA,NA,NA,NA,0.5148514851,"Last AD: Diff & Remiss","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6176470588,NA,"Last AD: Diff & Remiss","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.04444444444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5396825397,"Last AD: Diff & Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7254098361,NA,NA,NA,"Last AD: Diff & Remiss","NORTRIPTYLINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7215686275,NA,NA,0.4632352941,"Last AD: Diff & Remiss","NORTRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7565217391,NA,"Last AD: Diff & Remiss","NORTRIPTYLINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6952380952,NA,NA,NA,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","Num Previous Remissions: 2+","PAROXETINE HCL","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6167247387,NA,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","Num Previous Remissions: 2+","SERTRALINE HCL","TRAZODONE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5871559633,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","Num Previous Remissions: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6184210526,NA,NA,NA,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6414141414,0.0101010101,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6233766234,0.04273504274,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Remissions: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6366197183,NA,NA,0.005154639175,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6353297953,0.01739130435,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7253521127,NA,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02229299363,0.6823529412,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6952380952,NA,NA,NA,NA,NA,"Last AD: Diff & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6304347826,"Last AD: Diff & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5855513308,0.5688888889,"Last AD: Diff & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.614379085,NA,NA,NA,NA,0.4166666667,"Last AD: Diff & Remiss","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3701298701,"Last AD: Diff & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3753026634,"Last AD: Diff & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.615942029,0.397993311,"Last AD: Diff & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6842105263,NA,NA,NA,NA,0.5483870968,"Last AD: Diff & Remiss","Num Previous Remissions: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4655172414,"Last AD: Diff & Remiss","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6222910217,0.05325443787,NA,0.624535316,"Last AD: Diff & Remiss","Num Previous Remissions: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08653846154,0.5785714286,0.5534351145,"Last AD: Diff & Remiss","Num Previous Remissions: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5172413793,"Last AD: Diff & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.427184466,"Last AD: Diff & Remiss","OMEPRAZOLE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",0.02352941176,0.04885993485,0.6666666667,NA,NA,0.536977492,0.2539964476,0.6203966006,NA,NA,NA,NA,0.6684350133,0.09121621622,0.6486486486,0.3563278008,"Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6759259259,NA,NA,NA,NA,0.4009661836,"Last AD: Diff & Remiss","PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6326889279,NA,NA,0.0501618123,NA,0.4788418708,"Last AD: Diff & Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6783216783,NA,NA,NA,0.7522123894,0.3714285714,"Last AD: Diff & Remiss","PAROXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6850393701,NA,NA,NA,"Last AD: Diff & Remiss","PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03921568627,NA,NA,"Last AD: Diff & Remiss","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3048128342,"Last AD: Diff & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1857142857,"Last AD: Diff & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5069767442,"Last AD: Diff & Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5200892857,"Last AD: Diff & Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6412556054,NA,NA,0.5492227979,"Last AD: Diff & Remiss","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07438016529,NA,NA,"Last AD: Diff & Remiss","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6516129032,0.5593220339,"Last AD: Diff & Remiss","ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.6646706587,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.401459854,"Last AD: Diff & Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",0.03333333333,0.04081632653,0.5813953488,0.75625,NA,0.5163934426,0.23117338,0.6269592476,0.2513089005,NA,0.4796747967,NA,NA,0.06293706294,0.6441207076,0.418784029,"Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4833333333,"Last AD: Diff & Remiss","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4339622642,"Last AD: Diff & Remiss","SERTRALINE HCL","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6336489439,0.04619388419,NA,0.4944275583,"Last AD: Diff & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4870466321,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & Remiss","SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,0.0593220339,NA,NA,NA,NA,0.3103448276,NA,NA,NA,NA,NA,0.7734375,NA,0.7393162393,0.4498777506,"Last AD: Diff & Remiss","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3564356436,"Last AD: Diff & Remiss","SIMVASTATIN","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04888402027,NA,0.7075471698,"Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0522875817,0.6634050881,0.4969474969,"Last AD: Diff & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5511811024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",0.04571428571,0.06559139785,0.6304909561,NA,NA,0.5668276973,0.2517482517,0.6353887399,NA,NA,0.6212121212,NA,0.6744186047,0.06578947368,0.7684729064,0.4000751315,"Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.1111111111,NA,NA,NA,NA,NA,NA,NA,0.1264667536,"Last AD: Same & No Remiss",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.424,NA,NA,NA,"Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4501424501,NA,NA,NA,"Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1278538813,NA,NA,"Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4558139535,NA,"Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5074626866,NA,NA,NA,"Last AD: Same & No Remiss","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3439065109,NA,"Last AD: Same & No Remiss","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4185022026,NA,NA,NA,"Last AD: Same & No Remiss","MASTODYNIA (dxo:ICD9:61171)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05555555556,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1322241681,NA,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1150895141,NA,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","MIRTAZAPINE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,"Last AD: Same & No Remiss","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.223880597,"Last AD: Same & No Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3653846154,"Last AD: Same & No Remiss","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.368,NA,NA,NA,"Last AD: Same & No Remiss","MYOPIA (dxo:ICD9:3671)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4449760766,NA,NA,NA,"Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06011960969,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4146341463,"Last AD: Same & No Remiss","NORTRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2,"Last AD: Same & No Remiss","NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4598214286,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4807692308,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4618644068,0,NA,NA,"Last AD: Same & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4814814815,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1215277778,"Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.407960199,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3231818182,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2829268293,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3706896552,NA,NA,NA,NA,0.4063492063,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2621359223,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.407651715,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4380165289,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5121495327,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4554455446,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4578947368,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.375,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4105960265,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAMADOL HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007674597084,NA,0.1560693642,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3739130435,0.5046728972,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3948317308,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4675324675,NA,NA,NA,"Last AD: Same & No Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4296875,"Last AD: Same & No Remiss","OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2598870056,NA,NA,NA,NA,"Last AD: Same & No Remiss","OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Same & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3976190476,NA,NA,NA,"Last AD: Same & No Remiss","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2991452991,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PALPITATIONS (dxo:ICD9:7851)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3209876543,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.396039604,NA,NA,NA,"Last AD: Same & No Remiss","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3250114521,NA,NA,NA,NA,0.2803738318,"Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.199592668,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1294964029,"Last AD: Same & No Remiss","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5943396226,"Last AD: Same & No Remiss","PAROXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3687943262,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1842105263,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3185840708,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3383545771,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3502824859,NA,0.3755656109,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4482758621,"Last AD: Same & No Remiss","PAROXETINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3398058252,NA,NA,0.01038062284,NA,0.3646563815,"Last AD: Same & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4125,"Last AD: Same & No Remiss","PAROXETINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3779527559,NA,NA,NA,0.4622641509,NA,"Last AD: Same & No Remiss","PAROXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Same & No Remiss","PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07216494845,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2962962963,NA,NA,NA,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.162601626,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2420948617,NA,NA,NA,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1520912548,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02946593002,NA,NA,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1545064378,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2083936324,NA,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3805147059,"Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4060150376,"Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5172413793,"Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5653846154,"Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5449101796,"Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4545454545,NA,NA,NA,"Last AD: Same & No Remiss","PRAVASTATIN SODIUM","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4607329843,NA,NA,NA,"Last AD: Same & No Remiss","PREGABALIN","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4028776978,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3565891473,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1203703704,"Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3394833948,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2162162162,"Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3697478992,NA,"Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2671232877,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03333333333,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2578125,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.296875,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2392638037,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01030927835,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2782608696,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.225464191,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1221374046,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2316513761,NA,NA,NA,NA,"Last AD: Same & No Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08127208481,NA,NA,NA,"Last AD: Same & No Remiss","RISPERIDONE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1342281879,NA,"Last AD: Same & No Remiss","RISPERIDONE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2225705329,NA,NA,NA,NA,"Last AD: Same & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5593220339,"Last AD: Same & No Remiss","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5070422535,NA,NA,NA,"Last AD: Same & No Remiss","ROSUVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Same & No Remiss","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3973766225,NA,NA,0.3785714286,"Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4690663667,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.497005988,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4652173913,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","TOPIRAMATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3848920863,0.006980802792,NA,0.435413643,"Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.48,"Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4173387097,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3730569948,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3714285714,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3119266055,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4444444444,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4696356275,NA,0.4395604396,0.3965517241,"Last AD: Same & No Remiss","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4528301887,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Same & No Remiss","SPECIAL SCREENING FOR MALIGNANT NEOPLASMS, COLON (dxo:ICD9:V7651)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3657817109,NA,"Last AD: Same & No Remiss","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007042253521,NA,NA,"Last AD: Same & No Remiss","TRAMADOL HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008881803689,NA,0.2301740812,"Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008955223881,NA,NA,"Last AD: Same & No Remiss","TRAZODONE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Same & No Remiss","TRAZODONE HCL","UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01975308642,0.3152941176,0.4215909091,"Last AD: Same & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005602240896,NA,NA,"Last AD: Same & No Remiss","TRAZODONE HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3255813953,NA,"Last AD: Same & No Remiss","UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3618623482,0.367965368,"Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5525062372,"Last AD: Same & Remiss",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8063241107,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7943548387,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8064516129,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7900552486,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7715736041,NA,NA,NA,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7157652474,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7514619883,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.712,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6929824561,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7611940299,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7402597403,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6571428571,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7006802721,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7222222222,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7672413793,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6968838527,NA,NA,NA,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7882352941,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4396551724,NA,0.7531461762,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7323943662,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7739130435,0.7073170732,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.75,NA,NA,NA,"Last AD: Same & Remiss","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7302052786,NA,"Last AD: Same & Remiss","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7411764706,NA,NA,NA,"Last AD: Same & Remiss","MASTODYNIA (dxo:ICD9:61171)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.73,NA,NA,NA,"Last AD: Same & Remiss","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.5426695842,NA,NA,NA,NA,NA,NA,0.5632850242,"Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4776119403,"Last AD: Same & Remiss","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4910714286,"Last AD: Same & Remiss","MIRTAZAPINE","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5677966102,"Last AD: Same & Remiss","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5822306238,"Last AD: Same & Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5893719807,"Last AD: Same & Remiss","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7757009346,NA,NA,NA,"Last AD: Same & Remiss","MULTIPLE SCLEROSIS (dxo:ICD9:340)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8058252427,NA,NA,NA,"Last AD: Same & Remiss","MYOPIA (dxo:ICD9:3671)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7247706422,NA,NA,NA,"Last AD: Same & Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5649717514,NA,NA,NA,NA,NA,0.6016042781,"Last AD: Same & Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4516129032,"Last AD: Same & Remiss","NORTRIPTYLINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5984848485,"Last AD: Same & Remiss","NORTRIPTYLINE HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6413043478,"Last AD: Same & Remiss","NORTRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5386819484,"Last AD: Same & Remiss","NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6358695652,"Last AD: Same & Remiss","NORTRIPTYLINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6682926829,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6523809524,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5742574257,"Last AD: Same & Remiss","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4275362319,"Last AD: Same & Remiss","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5294117647,"Last AD: Same & Remiss","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5172413793,"Last AD: Same & Remiss","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8519855596,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8930434783,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7451923077,"Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8125,"Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8423236515,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5265822785,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5652173913,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6717557252,"Last AD: Same & Remiss","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5778688525,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6480446927,"Last AD: Same & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6349809886,"Last AD: Same & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.560371517,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8419354839,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Remissions: 2+","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8907996561,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.719844358,"Last AD: Same & Remiss","Num Previous Remissions: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7696969697,"Last AD: Same & Remiss","Num Previous Remissions: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8448979592,NA,"Last AD: Same & Remiss","Num Previous Remissions: 2+","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8130841121,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7749419954,NA,NA,NA,"Last AD: Same & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7705977383,NA,NA,NA,"Last AD: Same & Remiss","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6428571429,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7047619048,NA,NA,NA,"Last AD: Same & Remiss","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7021391094,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.614213198,"Last AD: Same & Remiss","PAROXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6818181818,"Last AD: Same & Remiss","PAROXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7524691358,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6126126126,NA,NA,NA,NA,0.6028257457,"Last AD: Same & Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5324675325,NA,NA,NA,"Last AD: Same & Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5980861244,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5888501742,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5813953488,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5353535354,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6073752711,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.623853211,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5558510638,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6155844156,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.81640625,NA,NA,NA,"Last AD: Same & Remiss","PRAVASTATIN SODIUM","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7404255319,NA,NA,NA,"Last AD: Same & Remiss","PREGABALIN","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6378600823,NA,NA,NA,"Last AD: Same & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.86,NA,NA,NA,"Last AD: Same & Remiss","RAMIPRIL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6595744681,NA,NA,NA,NA,"Last AD: Same & Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7699115044,NA,NA,NA,"Last AD: Same & Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7909090909,NA,NA,NA,"Last AD: Same & Remiss","RIZATRIPTAN BENZOATE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6082949309,NA,NA,NA,0.6090008258,"Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6820987654,"Last AD: Same & Remiss","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5833333333,"Last AD: Same & Remiss","ROPINIROLE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.572640509,"Last AD: Same & Remiss","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6129032258,"Last AD: Same & Remiss","ROPINIROLE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6118598383,"Last AD: Same & Remiss","ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8232445521,NA,NA,NA,"Last AD: Same & Remiss","ROSUVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7438822751,NA,NA,0.5025125628,"Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8156073002,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7735849057,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7441077441,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","TOPIRAMATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6449567723,"Last AD: Same & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5852272727,"Last AD: Same & Remiss","SERTRALINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.730474732,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7055214724,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8117647059,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7378640777,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6923076923,0.5851851852,"Last AD: Same & Remiss","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7450980392,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7407407407,NA,"Last AD: Same & Remiss","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.605558744,"Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6956521739,0.5889649273,"Last AD: Same & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7371134021,NA,"Last AD: Same & Remiss","UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7294045048,0.5643153527,"Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6203703704,"Last AD: Same & Remiss","VILAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4329268293,NA,NA,0.3497536946,NA,0.4833659491,NA,0.4036885246,0.2016348774,"LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7368421053,NA,NA,NA,"LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.2891566265,NA,NA,NA,NA,NA,NA,NA,NA,"LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3212435233,NA,NA,NA,NA,NA,"LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.686746988,NA,NA,0.3409090909,"LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4012738854,NA,"LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.446969697,NA,NA,NA,"LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6428571429,NA,"LEIOMYOMA OF UTERUS, UNSPECIFIED (dxo:ICD9:2189)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.7450980392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LEVOCETIRIZINE DIHYDROCHLORIDE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4666666667,NA,NA,NA,0.1496881497,0.5197368421,NA,NA,NA,NA,NA,NA,NA,NA,"LEVOFLOXACIN",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1282798834,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LEVOFLOXACIN","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5515320334,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5756578947,NA,NA,NA,"LEVONORGESTREL-ETHIN ESTRADIOL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6956521739,NA,NA,NA,"LEVONORGESTREL-ETHIN ESTRADIOL","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7455012853,NA,NA,NA,"LEVONORGESTREL-ETHIN ESTRADIOL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5062656642,NA,NA,NA,0.1526418787,0.5249196141,NA,NA,0.4022988506,NA,0.5513072814,NA,0.4563106796,0.2430213465,"LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4933774834,NA,NA,NA,"LEVOTHYROXINE SODIUM","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4700973574,NA,NA,NA,"LEVOTHYROXINE SODIUM","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7948717949,NA,NA,NA,"LEVOTHYROXINE SODIUM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8387096774,NA,NA,NA,"LEVOTHYROXINE SODIUM","Last AD: Same & Remiss","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4913793103,NA,NA,NA,"LEVOTHYROXINE SODIUM","LORAZEPAM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6116504854,NA,NA,NA,"LEVOTHYROXINE SODIUM","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5044247788,NA,NA,NA,"LEVOTHYROXINE SODIUM","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5392156863,NA,NA,NA,"LEVOTHYROXINE SODIUM","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.519379845,NA,NA,NA,NA,NA,NA,NA,NA,"LEVOTHYROXINE SODIUM","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6283185841,NA,NA,NA,"LEVOTHYROXINE SODIUM","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8195876289,NA,NA,NA,"LEVOTHYROXINE SODIUM","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6617647059,NA,NA,NA,NA,0.3293413174,"LEVOTHYROXINE SODIUM","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5607476636,NA,NA,NA,"LEVOTHYROXINE SODIUM","PRAVASTATIN SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8387096774,NA,NA,NA,"LEVOTHYROXINE SODIUM","PRAVASTATIN SODIUM","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.59375,NA,NA,NA,"LEVOTHYROXINE SODIUM","ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8231707317,NA,NA,NA,"LEVOTHYROXINE SODIUM","ROSUVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1184210526,0.4807692308,NA,NA,NA,NA,NA,NA,NA,0.2340425532,"LEVOTHYROXINE SODIUM","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7731269785,NA,NA,0.4916943522,"LEVOTHYROXINE SODIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7865168539,NA,NA,NA,"LEVOTHYROXINE SODIUM","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7613636364,NA,NA,NA,"LEVOTHYROXINE SODIUM","SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.736,NA,NA,NA,"LEVOTHYROXINE SODIUM","SERTRALINE HCL","UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5722891566,NA,NA,NA,"LEVOTHYROXINE SODIUM","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3798449612,"LEVOTHYROXINE SODIUM","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5258215962,NA,NA,NA,"LEVOTHYROXINE SODIUM","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5041322314,NA,NA,NA,"LEVOTHYROXINE SODIUM","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5945945946,NA,NA,NA,"LEVOTHYROXINE SODIUM","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4709677419,NA,NA,NA,"LEVOTHYROXINE SODIUM","UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7532467532,0.4458333333,"LEVOTHYROXINE SODIUM","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LIDOCAINE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5164473684,NA,NA,NA,0.1267605634,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LISINOPRIL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4980214811,NA,NA,NA,0.1403508772,0.4776119403,NA,NA,NA,NA,0.5789473684,NA,NA,NA,"LISINOPRIL/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5089285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LISINOPRIL/HYDROCHLOROTHIAZIDE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1280788177,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LISINOPRIL/HYDROCHLOROTHIAZIDE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4618834081,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LISINOPRIL/HYDROCHLOROTHIAZIDE","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09150326797,0.1270718232,NA,NA,NA,NA,NA,0.03067484663,0.1583710407,0.07894736842,"LITHIUM CARBONATE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2330097087,NA,NA,NA,NA,NA,"LITHIUM CARBONATE","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1584158416,NA,"LITHIUM CARBONATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.125,"LITHIUM CARBONATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09352517986,"LITHIUM CARBONATE","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1395348837,NA,"LITHIUM CARBONATE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1605351171,0.1342281879,"LITHIUM CARBONATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6275862069,NA,NA,NA,0.1045751634,NA,NA,NA,0.4697217676,NA,NA,NA,NA,NA,"LORATADINE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4227642276,NA,NA,NA,NA,NA,"LORATADINE","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7131782946,NA,NA,NA,NA,NA,"LORATADINE","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7,NA,NA,NA,"LORATADINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.006825938567,0.03433835846,0.4529505582,NA,NA,NA,NA,0.4459459459,NA,NA,NA,NA,0.4790011351,NA,NA,NA,"LORAZEPAM",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3575418994,NA,NA,NA,"LORAZEPAM","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.703125,NA,NA,NA,"LORAZEPAM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.02027027027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LORAZEPAM","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LORAZEPAM","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",0.005714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LORAZEPAM","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LORAZEPAM","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7407407407,NA,NA,NA,"LORAZEPAM","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02285714286,0.4251592357,NA,NA,NA,NA,0.4680851064,0.1165803109,NA,0.3732057416,NA,0.4835443038,NA,0.5031055901,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1277777778,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.255952381,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1379310345,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.632,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.008583690987,NA,0.5218978102,NA,NA,NA,0.1472727273,0.4782608696,NA,NA,NA,NA,NA,NA,NA,NA,"LOVASTATIN",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3681818182,NA,0.45,NA,NA,NA,NA,NA,0.004291845494,NA,NA,"LUMBAGO (dxo:ICD9:7242)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3652173913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LUMBAGO (dxo:ICD9:7242)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4351464435,NA,"LUMP OR MASS IN BREAST (dxo:ICD9:61172)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6638655462,NA,"LUMP OR MASS IN BREAST (dxo:ICD9:61172)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.524137931,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6795513112,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.6754098361,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.763592233,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7619647355,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.61,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7068965517,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7022900763,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7016129032,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7677165354,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6538461538,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7087378641,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.65,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7716535433,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6802443992,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6764705882,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6200873362,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.5340755735,0.6765799257,0.7058823529,NA,0.6662404092,0.6429447853,0.6731707317,0.5596330275,0.4859813084,NA,NA,0.662992126,0.4723435226,0.6821480406,0.6733997468,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.5523012552,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.50625,NA,0.6779359431,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4821428571,NA,0.6888454012,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6802721088,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.5914893617,NA,NA,NA,NA,NA,NA,0.7055555556,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6257309942,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6339869281,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6489361702,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6814814815,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7297297297,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.734375,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6265432099,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5680473373,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6268456376,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6271777003,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7171651495,NA,NA,0.7159090909,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7423580786,NA,NA,0.6648044693,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4643274854,NA,0.6619128817,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6976744186,0.6656346749,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7134948097,0.6421232877,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2265625,NA,NA,NA,NA,NA,NA,0.02941176471,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MILD (dxo:ICD9:29631)",NA,NA,NA,NA,NA,NA
"41-64","Female",0.01923076923,NA,0.5,NA,NA,0.375,NA,0.5304878049,NA,NA,NA,NA,0.5169491525,0.03968253968,0.5197368421,0.3655913978,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1909090909,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3855421687,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.145631068,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.1900826446,NA,NA,NA,NA,0.2063492063,NA,NA,NA,NA,0.1885714286,NA,NA,0.1328125,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2089552239,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7613636364,NA,NA,0.4404761905,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7537313433,0.4444444444,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4126984127,NA,NA,0.3015075377,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1379310345,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.640776699,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.2948113208,0.4145352765,0.6567544605,0.6499429875,0.3346303502,0.5719221106,0.5060782241,0.6286516854,0.4626006904,0.423255814,0.5938511327,NA,0.638996139,0.3295523597,0.6212389381,0.5567137413,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.4616402116,NA,NA,NA,NA,NA,NA,0.57001321,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4828660436,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4836601307,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3706896552,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5315315315,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4376811594,NA,NA,NA,NA,NA,0.6180451128,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5862068966,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4232804233,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4957264957,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4702842377,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.34,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6761904762,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Remissions: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,0.4833333333,NA,NA,NA,0.6213592233,0.5347222222,NA,NA,NA,0.6183844011,NA,NA,NA,NA,0.5968468468,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6879432624,NA,NA,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5896656535,NA,NA,0.3081081081,NA,0.5633187773,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.6462585034,0.7622377622,0.75,NA,0.672985782,NA,0.6442307692,NA,NA,NA,NA,0.6605504587,NA,0.7082294264,0.6898148148,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7390029326,NA,NA,0.6713286713,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7692307692,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7379032258,0.7155963303,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7118320611,0.6467391304,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5482014388,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5426829268,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.6524822695,NA,NA,NA,NA,NA,NA,NA,NA,0.5940594059,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4645669291,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5153846154,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4980544747,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4222222222,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5839416058,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","RISPERIDONE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.533,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5365448505,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.4164222874,0.6478873239,NA,NA,0.5433789954,0.5404699739,0.5592105263,NA,NA,NA,NA,0.7007077856,NA,NA,0.5605504587,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6817288802,0.1957446809,NA,0.576433121,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.552,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.3481781377,NA,NA,NA,0.505952381,0.506097561,0.5227272727,NA,NA,NA,NA,NA,0.3284132841,0.52,0.5454919381,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2,0.6464968153,0.5339185954,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.4248927039,NA,NA,NA,NA,0.5153061224,0.5826086957,NA,NA,NA,NA,NA,NA,0.6615884116,0.5746753247,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02586206897,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MILD (dxo:ICD9:29621)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.04821802935,NA,NA,NA,NA,NA,0.4957983193,NA,NA,NA,NA,0.5057471264,NA,NA,0.45,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.02040816327,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6971428571,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05066666667,NA,NA,NA,0.4518518519,NA,NA,NA,NA,NA,NA,0.4945652174,0.01694915254,0.6153846154,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7433628319,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7481481481,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03741496599,NA,NA,NA,NA,NA,0.5135453475,NA,NA,NA,NA,0.5092693566,NA,0.4431125131,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.01818181818,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5259259259,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1644736842,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.752851711,NA,0.5710227273,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3947368421,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4380952381,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)","TAMOXIFEN CITRATE",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.641025641,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3694915254,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","TAMOXIFEN CITRATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6511627907,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","TAMOXIFEN CITRATE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3469387755,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5516224189,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6721915285,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1111111111,0.4303030303,NA,NA,NA,NA,0.4586148649,NA,0.3537604457,0.2247191011,"MASTODYNIA (dxo:ICD9:61171)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09803921569,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MASTODYNIA (dxo:ICD9:61171)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6841155235,NA,NA,NA,"MASTODYNIA (dxo:ICD9:61171)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.380952381,NA,"MASTODYNIA (dxo:ICD9:61171)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6637168142,NA,"MASTODYNIA (dxo:ICD9:61171)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4596774194,NA,NA,NA,"MECLIZINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1366459627,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MEDROXYPROGESTERONE ACETATE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1734693878,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MEDROXYPROGESTERONE ACETATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3210116732,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MELOXICAM",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2641509434,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MELOXICAM","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.312,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MELOXICAM","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3392857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MELOXICAM","TRAMADOL HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3907284768,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MELOXICAM","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4756944444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"METAXALONE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4337899543,NA,0.568914956,NA,NA,0.287037037,"METFORMIN HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7216981132,NA,NA,NA,NA,NA,"METFORMIN HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7307692308,NA,NA,NA,"METFORMIN HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5639097744,NA,NA,NA,"METHOTREXATE SODIUM",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.02857142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"METHYLPHENIDATE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4388489209,NA,NA,NA,NA,NA,NA,NA,NA,"METOCLOPRAMIDE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5258964143,NA,NA,NA,NA,NA,NA,NA,NA,"METOPROLOL SUCCINATE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4591194969,NA,NA,NA,NA,0.4270833333,NA,NA,NA,NA,0.5126582278,NA,0.4307692308,NA,"METRONIDAZOLE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7672955975,NA,NA,NA,"METRONIDAZOLE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4676258993,NA,NA,NA,"MIGRAINE WITHOUT AURA, WITH INTRACTABLE MIGRAINE, SO STATED, WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34611)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4638157895,NA,NA,NA,NA,NA,NA,0.04,NA,NA,0.5365853659,NA,NA,NA,"MIGRAINE WITHOUT AURA, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34610)",NA,NA,NA,NA,NA,NA
"41-64","Female",0.009071877181,0.03765690377,0.3909090909,NA,0.13,NA,0.1384615385,0.4450549451,NA,0.05375,NA,NA,0.5294117647,NA,NA,NA,"MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2329317269,NA,NA,NA,NA,NA,NA,"MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.01209677419,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",0.002457002457,NA,NA,NA,NA,NA,0.1726618705,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7004830918,NA,NA,NA,"MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.008695652174,NA,NA,NA,NA,NA,NA,NA,NA,0.04761904762,NA,NA,0.4965034965,NA,NA,NA,"MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA
"41-64","Female",0.02592592593,0.02102102102,0.3489361702,NA,NA,0.3049853372,0.1493848858,0.3311897106,0.2618302174,NA,0.3755274262,NA,0.367965368,0.006896551724,0.4005167959,0.3093457265,"MIRTAZAPINE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3105882353,"MIRTAZAPINE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2252252252,"MIRTAZAPINE","NORTRIPTYLINE HCL","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2442748092,"MIRTAZAPINE","NORTRIPTYLINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2761904762,"MIRTAZAPINE","NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,"MIRTAZAPINE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2246376812,"MIRTAZAPINE","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.39,"MIRTAZAPINE","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3391304348,"MIRTAZAPINE","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2960526316,"MIRTAZAPINE","Num Previous Antidep: 4+","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3,"MIRTAZAPINE","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2376650452,"MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1961852861,"MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2098765432,"MIRTAZAPINE","Num Previous Antidep: 4+","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.2075471698,NA,0.5166340509,NA,NA,NA,NA,0.3024118738,"MIRTAZAPINE","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3258426966,"MIRTAZAPINE","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1094339623,"MIRTAZAPINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1214285714,"MIRTAZAPINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1221374046,"MIRTAZAPINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1962616822,"MIRTAZAPINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2894736842,0.1413043478,"MIRTAZAPINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4082969432,"MIRTAZAPINE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.287037037,"MIRTAZAPINE","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1343283582,"MIRTAZAPINE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1428571429,"MIRTAZAPINE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1550387597,"MIRTAZAPINE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1237864078,"MIRTAZAPINE","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1259259259,"MIRTAZAPINE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.171641791,"MIRTAZAPINE","RISPERIDONE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.2369942197,NA,NA,NA,NA,NA,NA,0.3721264368,"MIRTAZAPINE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3248407643,"MIRTAZAPINE","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.3134796238,NA,NA,NA,NA,NA,NA,NA,"MIRTAZAPINE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.2095730918,NA,NA,NA,0.5334538879,NA,NA,0.3234265734,"MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3797468354,NA,NA,0.2863436123,"MIRTAZAPINE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2452830189,"MIRTAZAPINE","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.1742424242,NA,NA,0.2576530612,NA,NA,NA,NA,NA,NA,0.2933558559,"MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.564516129,0.251497006,"MIRTAZAPINE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1782945736,NA,NA,NA,NA,NA,0.6161764706,0.2963855422,"MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MITRAL VALVE DISORDERS (dxo:ICD9:4240)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.08270676692,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MITRAL VALVE DISORDERS (dxo:ICD9:4240)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",0.01408450704,NA,NA,NA,NA,NA,NA,0.5181818182,NA,NA,NA,NA,NA,NA,NA,NA,"MIXED HYPERLIPIDEMIA (dxo:ICD9:2722)",NA,NA,NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MIXED HYPERLIPIDEMIA (dxo:ICD9:2722)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02197802198,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6030534351,NA,NA,NA,"MODAFINIL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7289156627,NA,NA,NA,"MODAFINIL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.02479338843,NA,NA,NA,NA,0.3684210526,NA,NA,NA,NA,NA,NA,0.5943396226,NA,NA,NA,"MONONEURITIS OF UNSPECIFIED SITE (dxo:ICD9:3559)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4939759036,NA,NA,NA,NA,0.5054644809,NA,NA,NA,NA,NA,NA,NA,0.2660550459,"MONTELUKAST SODIUM",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3461538462,"MONTELUKAST SODIUM","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4805825243,"MONTELUKAST SODIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4409937888,"MONTELUKAST SODIUM","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5763888889,NA,NA,NA,"MORBID OBESITY (dxi:ICD9:27801)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.0329218107,NA,NA,NA,NA,0.1736363636,NA,0.056,NA,NA,NA,NA,NA,NA,NA,"MORBID OBESITY (dxo:ICD9:27801)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.02717391304,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MORBID OBESITY (dxo:ICD9:27801)","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2133891213,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MORBID OBESITY (dxo:ICD9:27801)","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1336898396,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MORBID OBESITY (dxo:ICD9:27801)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",0.01366120219,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MORPHINE SULFATE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1059190031,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MOXIFLOXACIN HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1083333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MOXIFLOXACIN HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3904761905,0.1494252874,0.5521628499,NA,NA,NA,NA,0.5487804878,NA,NA,0.3033707865,"MULTIPLE SCLEROSIS (dxo:ICD9:340)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7794871795,NA,NA,0.4391891892,"MULTIPLE SCLEROSIS (dxo:ICD9:340)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4179104478,"MULTIPLE SCLEROSIS (dxo:ICD9:340)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4444444444,NA,"MUSCLE WEAKNESS (GENERALIZED) (dxo:ICD9:72887)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.04048843188,0.5304621849,NA,NA,NA,0.152866242,0.5321336761,NA,NA,0.4649122807,NA,0.5476477684,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.01421800948,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.06206896552,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5840707965,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1620111732,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7699316629,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.005681818182,NA,NA,NA,NA,NA,0.1351351351,NA,NA,NA,NA,NA,0.5297157623,NA,NA,NA,"NAPROXEN",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7557603687,NA,NA,NA,"NAPROXEN","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04672897196,NA,NA,NA,NA,NA,NA,"NECK SPRAIN AND STRAIN (dxo:ICD9:8470)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.03951890034,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.008474576271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02777777778,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.664,NA,NA,NA,"NONALLOPATHIC LESION OF CERVICAL REGION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:7391)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.37109375,NA,NA,NA,NA,NA,"NONALLOPATHIC LESION OF THORACIC REGION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:7392)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.690647482,NA,NA,NA,NA,NA,"NONALLOPATHIC LESION OF THORACIC REGION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:7392)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.32,NA,NA,NA,NA,NA,"NONALLOPATHIC LESION OF THORACIC REGION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:7392)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3850931677,NA,NA,NA,NA,NA,0.01652892562,NA,NA,"NONDEPENDENT ALCOHOL ABUSE, UNSPECIFIED DRUNKENNESS (dxo:ICD9:30500)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01851851852,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxi:ICD9:3051)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.0197,NA,NA,NA,NA,0.1647746818,0.4899193548,0.1516587678,NA,NA,NA,0.4942704354,0.009596928983,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.0347826087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1342281879,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OMEPRAZOLE",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01782178218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01265822785,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1352941176,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05263157895,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01075268817,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.06481481481,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.0198019802,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.04032258065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.02279202279,NA,NA,NA,NA,0.1619585687,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03426791277,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6981132075,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02684563758,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","VALACYCLOVIR HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01568627451,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","VARENICLINE TARTRATE",NA,NA,NA,NA,NA
"41-64","Female",NA,0.04329004329,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5458167331,NA,NA,NA,"NORETHINDRONE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.75,NA,NA,NA,"NORETHINDRONE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1302083333,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NORETHINDRONE-E.ESTRADIOL-IRON","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5882352941,NA,NA,NA,"NORETHINDRONE-ETHIN. ESTRADIOL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5114155251,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NORGESTIMATE-ETHINYL ESTRADIOL",NA,NA,NA,NA,NA,NA
"41-64","Female",0.01315789474,0.03125,0.3874755382,NA,NA,0.3617021277,0.1229508197,0.3978494624,NA,0.1639983058,0.311827957,NA,0.396460177,0.015625,0.3957528958,0.4024458477,"NORTRIPTYLINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7192982456,NA,NA,NA,NA,NA,"NORTRIPTYLINE HCL","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7074235808,NA,NA,NA,"NORTRIPTYLINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.270531401,"NORTRIPTYLINE HCL","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2975206612,"NORTRIPTYLINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2080536913,"NORTRIPTYLINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1300309598,0.5446293495,NA,NA,NA,NA,0.4484451718,"NORTRIPTYLINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.380952381,"NORTRIPTYLINE HCL","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08108108108,"NORTRIPTYLINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4816955684,"NORTRIPTYLINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1403508772,"NORTRIPTYLINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.157480315,"NORTRIPTYLINE HCL","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1363636364,NA,NA,NA,NA,NA,0.4416403785,"NORTRIPTYLINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1557591623,NA,NA,0.6260043828,NA,NA,0.4512860483,"NORTRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3962264151,"NORTRIPTYLINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2064896755,NA,NA,NA,NA,NA,0.3510145959,"NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3469387755,"NORTRIPTYLINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.18,NA,NA,NA,NA,NA,NA,"NORTRIPTYLINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1552631579,NA,NA,NA,NA,0.6679245283,0.3724088635,"NORTRIPTYLINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5045045045,NA,NA,NA,NA,NA,"Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5499231951,NA,NA,NA,NA,NA,"Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,NA,NA,"Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7788461538,NA,0.6957831325,NA,NA,NA,"Num Previous Antidep: 2,3","PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.658456486,NA,NA,NA,NA,NA,"Num Previous Antidep: 2,3","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7259259259,NA,NA,NA,NA,NA,"Num Previous Antidep: 2,3","PAROXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3,NA,NA,NA,"Num Previous Antidep: 2,3","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7314814815,NA,NA,NA,"Num Previous Antidep: 2,3","PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6571428571,NA,NA,NA,"Num Previous Antidep: 2,3","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6649484536,NA,NA,NA,"Num Previous Antidep: 2,3","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7384615385,NA,NA,NA,"Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6670765447,NA,NA,NA,"Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7175925926,NA,NA,NA,"Num Previous Antidep: 2,3","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2970588235,NA,0.2419354839,NA,NA,0.2326103216,"Num Previous Antidep: 4+",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.378238342,NA,NA,NA,NA,NA,"Num Previous Antidep: 4+","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3305084746,NA,NA,NA,NA,NA,"Num Previous Antidep: 4+","PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3780487805,"Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.456,"Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4214285714,"Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3472222222,"Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2644628099,"Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.339658444,"Num Previous Antidep: 4+","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3240816327,"Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3611111111,"Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4206896552,NA,NA,NA,"Num Previous Antidep: 4+","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.46,NA,NA,NA,"Num Previous Antidep: 4+","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2621535666,"Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2598870056,"Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1512195122,"Num Previous Antidep: 4+","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,NA,NA,NA,NA,NA,"Num Previous Episodes: 2+","PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5505279035,NA,NA,NA,NA,NA,"Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6583333333,NA,NA,NA,NA,NA,"Num Previous Episodes: 2+","PAROXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5327868852,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8312883436,NA,NA,NA,NA,NA,"Num Previous Remissions: 2+","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6589595376,NA,NA,NA,NA,0.5541401274,"Num Previous Remissions: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8834710744,NA,NA,0.4761904762,"Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6226851852,NA,NA,0.6321525886,"Num Previous Remissions: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5858310627,0.5568181818,"Num Previous Remissions: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.784,NA,"Num Previous Remissions: 2+","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03460207612,NA,NA,NA,NA,NA,0.6018518519,0.0946969697,NA,NA,NA,NA,NA,NA,NA,"OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.0379403794,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OBESITY, UNSPECIFIED (dxo:ICD9:27800)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03680981595,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OBESITY, UNSPECIFIED (dxo:ICD9:27800)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.04268292683,NA,NA,NA,NA,0.21,NA,NA,NA,NA,NA,NA,NA,NA,0.178802589,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1768292683,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1438848921,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1782729805,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2344827586,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2317880795,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1900826446,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.004184100418,NA,0.5223413762,NA,NA,NA,0.1874371859,0.5679758308,NA,NA,0.4402730375,0.2544378698,0.5528804815,0,0.5465838509,0.3580246914,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7782258065,NA,NA,NA,NA,0.4223300971,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7,NA,NA,NA,NA,NA,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4466019417,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,0.1790393013,NA,NA,NA,0.3698630137,NA,NA,NA,NA,NA,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7790224033,NA,NA,0.5348837209,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8636363636,NA,NA,NA,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Female",NA,NA,0.6089385475,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6780821918,NA,NA,NA,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3228346457,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8064516129,0.4578005115,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1364421416,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OLMESARTAN MEDOXOMIL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4367088608,NA,NA,NA,NA,NA,NA,NA,NA,0.5387931034,NA,"OLMESARTAN/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7764705882,NA,"OLMESARTAN/HYDROCHLOROTHIAZIDE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05172413793,0.4504504505,NA,NA,NA,0.1507788162,0.5326797386,NA,NA,NA,NA,NA,NA,0.4714285714,0.2246696035,"OMEPRAZOLE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1472868217,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OMEPRAZOLE","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3897435897,"OMEPRAZOLE","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1370967742,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OMEPRAZOLE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4447174447,"OMEPRAZOLE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1147540984,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OMEPRAZOLE","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.316091954,"OMEPRAZOLE","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3906705539,"OMEPRAZOLE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008064516129,NA,NA,"OPIOID TYPE DEPENDENCE, UNSPECIFIED (dxo:ICD9:30400)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.421875,NA,NA,NA,0.125,NA,NA,NA,0.4074074074,NA,NA,NA,NA,NA,"OSELTAMIVIR PHOSPHATE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2772277228,NA,NA,NA,NA,NA,"OSELTAMIVIR PHOSPHATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01360544218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OSTEOARTHROSIS, UNSPECIFIED WHETHER GENERALIZED OR LOCALIZED, UNSPECIFIED SITE (dxo:ICD9:71590)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4437869822,NA,"OTHER (ABNORMAL) FINDINGS ON RADIOLOGICAL EXAMINATION OF BREAST (dxo:ICD9:79389)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7467532468,NA,"OTHER (ABNORMAL) FINDINGS ON RADIOLOGICAL EXAMINATION OF BREAST (dxo:ICD9:79389)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4915254237,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER ACNE (dxo:ICD9:7061)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3555555556,NA,NA,NA,"OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE, UNSPECIFIED DRUNKENNESS (dxo:ICD9:30390)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.037470726,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.01538461538,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.5487804878,NA,NA,NA,NA,0.5772357724,NA,NA,NA,"OTHER AND UNSPECIFIED HYPERLIPIDEMIA (dxo:ICD9:2724)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5673076923,NA,NA,NA,"OTHER AND UNSPECIFIED HYPERLIPIDEMIA (dxo:ICD9:2724)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3202614379,"OTHER ANXIETY STATES (dxo:ICD9:30009)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4744525547,"OTHER ANXIETY STATES (dxo:ICD9:30009)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4260869565,"OTHER ANXIETY STATES (dxo:ICD9:30009)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.09467455621,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER ATOPIC DERMATITIS AND RELATED CONDITIONS (dxo:ICD9:6918)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4638554217,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4292035398,NA,"OTHER CHRONIC PAIN (dxo:ICD9:33829)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.427184466,NA,"OTHER CHRONIC SINUSITIS (dxo:ICD9:4738)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.04705882353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER CONVULSIONS (dxo:ICD9:78039)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4489795918,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER DISORDERS OF BONE AND CARTILAGE (dxo:ICD9:73399)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4626865672,NA,NA,NA,NA,0.395256917,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER DYSCHROMIA (dxo:ICD9:70909)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.04310344828,0.5120481928,NA,NA,NA,0.1578947368,0.4351851852,NA,NA,NA,0.3263239875,0.5722891566,NA,NA,0.4035532995,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4809160305,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5680473373,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3875968992,NA,NA,NA,NA,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5303643725,NA,NA,NA,NA,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4341238472,NA,NA,NA,0.5145228216,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.475,NA,NA,NA,NA,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4233576642,NA,NA,NA,NA,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)","ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7264150943,NA,NA,0.5275590551,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4746543779,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER GENERAL SYMPTOMS (dxo:ICD9:78099)",NA,NA,NA,NA,NA,NA
"41-64","Female",0.02,0.02392460126,NA,0.5807560137,NA,0.3960554371,0.1490514905,0.5055900621,NA,NA,0.4378109453,NA,0.5766666667,0.003442340792,0.5250737463,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5846153846,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3571428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5339805825,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3851351351,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6115702479,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.06060606061,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.0223880597,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009756097561,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02304147465,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,0.02222222222,NA,0.660944206,NA,0.3873626374,0.1343283582,0.4939271255,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4514285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,0.05696202532,NA,NA,NA,0.6420454545,NA,NA,NA,NA,NA,NA,0.7425742574,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4700854701,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3152173913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","TRAMADOL HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.006666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","UNSPECIFIED ENDOCRINE DISORDER (dxo:ICD9:2599)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02873563218,NA,NA,NA,0.3953488372,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03043478261,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","VALACYCLOVIR HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02727272727,NA,NA,NA,0.6195652174,NA,NA,NA,NA,NA,NA,NA,NA,0.6690140845,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4801980198,NA,NA,NA,0.09500489716,NA,NA,NA,NA,NA,NA,NA,0.6048780488,NA,"OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1176470588,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1681415929,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4722222222,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER NONSPECIFIC ABNORMAL FINDING OF LUNG FIELD (dxo:ICD9:79319)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.02127659574,0.4884910486,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA,NA,NA
"41-64","Female",0.005356639414,NA,0.5036194416,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5652985075,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA,NA
"41-64","Female",0.007042253521,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","PROPOXYPHENE NAP/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5112359551,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Female",0.007291286912,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",0.009090909091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA
"41-64","Female",0.004237288136,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",0.02068965517,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA
"41-64","Female",NA,NA,0.5672727273,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5375,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7379310345,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7347893916,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5454545455,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA
"41-64","Female",0.002949852507,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",0.005952380952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5727272727,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5824175824,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4696969697,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER SEBORRHEIC KERATOSIS (dxo:ICD9:70219)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4147727273,NA,"OTHER SPECIFIED CARDIAC DYSRHYTHMIAS (dxo:ICD9:42789)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3278688525,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER SPECIFIED COUNSELING (dxo:ICD9:V6549)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4166666667,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER SPECIFIED DISEASE OF SEBACEOUS GLANDS (dxo:ICD9:7068)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.45,NA,NA,0.2283464567,NA,NA,NA,NA,NA,NA,NA,NA,0.3101265823,NA,"OTHER SPECIFIED NONINFLAMMATORY DISORDER OF VAGINA (dxo:ICD9:6238)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5109170306,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER SPECIFIED PRE-OPERATIVE EXAMINATION (dxo:ICD9:V7283)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.04680851064,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4136125654,NA,NA,NA,"OVERWEIGHT (dxo:ICD9:27802)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.696,NA,NA,NA,"OVERWEIGHT (dxo:ICD9:27802)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1634980989,0.5810810811,NA,NA,NA,NA,0.6044776119,NA,NA,0.2961373391,"OXYBUTYNIN CHLORIDE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.78,NA,NA,0.5753424658,"OXYBUTYNIN CHLORIDE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4736842105,"OXYBUTYNIN CHLORIDE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.01710526316,NA,NA,NA,NA,NA,0.1648106904,NA,NA,NA,0.391025641,NA,NA,0.0119047619,NA,NA,"OXYCODONE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.02325581395,NA,NA,NA,NA,0.152173913,NA,NA,NA,NA,NA,NA,0.003623188406,NA,NA,"OXYCODONE HCL/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3655006031,NA,NA,NA,NA,NA,NA,0.5,NA,NA,NA,"PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4920634921,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)","PREGABALIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3611111111,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)","TRAMADOL HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3495145631,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)","TRAMADOL HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.387755102,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0223880597,NA,NA,"PAIN IN JOINT, SHOULDER REGION (dxo:ICD9:71941)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3908629442,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PAIN IN JOINT, SITE UNSPECIFIED (dxo:ICD9:71940)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4178082192,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PAIN IN JOINT, SITE UNSPECIFIED (dxo:ICD9:71940)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4954954955,NA,NA,NA,0.1545454545,0.536,NA,0.05357142857,0.5,NA,NA,NA,0.4412955466,NA,"PAIN IN SOFT TISSUES OF LIMB (dxo:ICD9:7295)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7047619048,NA,"PAIN IN SOFT TISSUES OF LIMB (dxo:ICD9:7295)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4491887276,NA,NA,0.3393213573,0.1282161235,0.4383763838,NA,NA,0.3779904306,NA,0.5108153078,NA,NA,0.1824104235,"PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5916955017,NA,NA,NA,NA,0.4015748031,"PALPITATIONS (dxo:ICD9:7851)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6698113208,NA,NA,NA,NA,NA,"PALPITATIONS (dxo:ICD9:7851)","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3043478261,0.1265306122,NA,NA,NA,0.338028169,NA,NA,NA,NA,NA,"PALPITATIONS (dxo:ICD9:7851)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7546296296,NA,NA,0.3621399177,"PALPITATIONS (dxo:ICD9:7851)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.373015873,"PALPITATIONS (dxo:ICD9:7851)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3090909091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PALPITATIONS (dxo:ICD9:7851)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3025641026,"PALPITATIONS (dxo:ICD9:7851)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.04488330341,0.4146341463,NA,NA,NA,NA,0.5048543689,NA,NA,0.399339934,NA,0.5093167702,NA,NA,NA,"PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6774193548,NA,NA,NA,NA,NA,"PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3703703704,NA,NA,NA,NA,NA,"PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6978723404,NA,NA,NA,"PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5217391304,NA,NA,NA,NA,0.5477386935,NA,NA,NA,NA,NA,NA,NA,0.1779661017,"PANTOPRAZOLE SODIUM",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4210526316,NA,NA,NA,0.480620155,"PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5643564356,"PARALYSIS AGITANS (dxo:ICD9:3320)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.514084507,"PARALYSIS AGITANS (dxo:ICD9:3320)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.01709943002,0.0321903429,0.5309597523,0.6272040302,0.1206225681,0.4292168675,0.1902205177,0.4875981162,0.1519274376,0.05133470226,0.5336564419,0.1516393443,0.5120879121,0.02734012975,0.6102731349,0.2976068875,"PAROXETINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.2470588235,NA,NA,0.2016806723,NA,0.2523364486,NA,NA,0.328081557,NA,0.1984732824,NA,NA,0.0895140665,"PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2796610169,NA,NA,NA,NA,0.07346938776,"PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.145631068,"PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2929061785,NA,NA,NA,NA,0.1614583333,"PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1102362205,"PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1343283582,"PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5096525097,NA,NA,NA,NA,0.525,"PAROXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5734265734,"PAROXETINE HCL","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6875,NA,NA,NA,NA,NA,"PAROXETINE HCL","PRAVASTATIN SODIUM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6140350877,NA,NA,NA,NA,NA,"PAROXETINE HCL","PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.347826087,"PAROXETINE HCL","PROPOXYPHENE NAP/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1923076923,NA,NA,NA,0.5226586103,NA,NA,NA,NA,0.1530612245,"PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3121693122,"PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3097345133,NA,NA,NA,NA,0.1201413428,"PAROXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2941176471,NA,NA,NA,NA,0.25625,"PAROXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4594594595,"PAROXETINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3933333333,NA,NA,NA,0.5517241379,"PAROXETINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.158974359,NA,NA,NA,NA,0.1304347826,"PAROXETINE HCL","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1553398058,NA,NA,NA,NA,0.1367521368,"PAROXETINE HCL","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6723163842,NA,NA,NA,NA,NA,"PAROXETINE HCL","ROFECOXIB",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.529318542,0.3853904282,NA,NA,NA,0.5275974026,"PAROXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4480519481,"PAROXETINE HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.625,NA,NA,NA,NA,NA,"PAROXETINE HCL","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6466666667,NA,NA,NA,NA,NA,"PAROXETINE HCL","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.2298136646,NA,NA,NA,0.6251129178,NA,NA,NA,NA,0.3435582822,"PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5857142857,NA,NA,NA,NA,NA,"PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SPECIAL SCREENING EXAMINATION, HUMAN PAPILLOMAVIRUS [HPV] (dxo:ICD9:V7381)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7033898305,NA,NA,NA,NA,NA,"PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5410958904,NA,NA,NA,NA,NA,"PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6525423729,NA,NA,NA,NA,NA,"PAROXETINE HCL","SCREENING MAMMOGRAM FOR HIGH-RISK PATIENT (dxo:ICD9:V7611)",NA,NA,NA,NA,NA
"41-64","Female",0.008403361345,0.03353658537,0.487804878,NA,NA,0.3577235772,0.1921824104,0.4166666667,NA,NA,0.4958133971,NA,0.539346247,0.01851851852,0.6141732283,0.3207317073,"PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4171428571,NA,0.375,0.01714285714,NA,0.323782235,"PAROXETINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6954022989,NA,NA,NA,NA,0.4236111111,"PAROXETINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6140350877,NA,NA,NA,NA,0.4360465116,"PAROXETINE HCL","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6198830409,NA,NA,NA,0.6340206186,NA,"PAROXETINE HCL","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7175572519,NA,NA,NA,NA,0.2777777778,"PAROXETINE HCL","TOPIRAMATE",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03550295858,0.3743589744,NA,NA,0.2984293194,0.1729957806,0.3225806452,NA,NA,0.4769515478,NA,0.3613861386,0.02382954864,0.419047619,0.4250559284,"PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3888888889,NA,NA,0.01960784314,NA,0.3496503497,"PAROXETINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.592920354,NA,NA,NA,NA,0.6025104603,NA,NA,NA,NA,NA,"PAROXETINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6158940397,NA,NA,NA,NA,NA,"PAROXETINE HCL","VALACYCLOVIR HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05109489051,0.4921465969,NA,NA,NA,0.2012987013,0.4642857143,NA,NA,0.5525902669,NA,0.4776119403,0.01785714286,0.6754098361,0.3180300501,"PAROXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4601226994,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PEN NEEDLE, DIABETIC",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4024390244,NA,0.1081081081,NA,NA,NA,NA,NA,NA,NA,0.487012987,0.01489361702,NA,NA,"PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7124183007,NA,NA,NA,"PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02013422819,NA,NA,"PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.04675324675,0.04542372881,0.2025658339,0.1659751037,NA,0.1797124601,0.1392694064,0.2037617555,0.1727272727,NA,0.1971608833,NA,0.2015050167,0.03590192644,0.2006021829,0.1273148148,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.04294478528,0.1124260355,0.1246290801,NA,0.1390728477,0.08108108108,0.1812080537,NA,NA,0.12,NA,0.1673306773,NA,0.140625,0.08947368421,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2990196078,NA,NA,0.09409190372,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.304,NA,NA,0.1421568627,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06637168142,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1941747573,0.1292134831,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3037974684,0.07425742574,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08,NA,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1119402985,NA,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","RISPERIDONE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.07142857143,0.2342857143,NA,NA,0.1846153846,NA,0.134502924,NA,NA,0.1452991453,NA,0.3645937813,NA,0.3101265823,0.1296296296,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2684085511,0.04511278195,NA,0.1920152091,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1474358974,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.265625,NA,NA,0.1363636364,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,0.2307692308,NA,NA,0.1363636364,NA,NA,NA,NA,NA,NA,NA,0.0636550308,0.1839762611,0.1055155875,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.025,0.23878327,0.1736745887,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,0.04929577465,0.2482758621,NA,NA,0.2093023256,NA,0.1304347826,NA,NA,NA,NA,0.2357142857,NA,0.2867005814,0.1165600569,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03012048193,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"POLYCYSTIC OVARIES (dxo:ICD9:2564)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4526748971,NA,NA,NA,NA,NA,NA,NA,NA,"POLYETHYLENE GLYCOL 3350",NA,NA,NA,NA,NA,NA
"41-64","Female",0.007434944238,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"POLYNEUROPATHY IN DIABETES (dxo:ICD9:3572)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4366197183,NA,NA,NA,"POSTTRAUMATIC STRESS DISORDER (dxo:ICD9:30981)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.700729927,NA,NA,NA,"POSTTRAUMATIC STRESS DISORDER (dxo:ICD9:30981)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",0.0197044335,0.04273504274,0.4208633094,NA,NA,0.3044496487,0.1211072664,0.3436293436,NA,NA,0.3594771242,NA,0.4115523466,0.0368852459,0.3689320388,0.4617700493,"PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5302267003,"PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.55,"PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7094594595,NA,NA,0.5656934307,"PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5833333333,"PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6136363636,"PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4384735202,"PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4709302326,"PRAMIPEXOLE DI-HCL","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3661800487,"PRAMIPEXOLE DI-HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5072463768,"PRAMIPEXOLE DI-HCL","ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5714285714,NA,NA,0.518734388,"PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4263565891,"PRAMIPEXOLE DI-HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02904564315,NA,0.3826709732,"PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3784530387,"PRAMIPEXOLE DI-HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5388026608,0.4592696629,"PRAMIPEXOLE DI-HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5433526012,NA,NA,NA,0.152173913,NA,NA,NA,0.4658634538,NA,0.5683563748,NA,NA,0.2714285714,"PRAVASTATIN SODIUM",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1229508197,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PRAVASTATIN SODIUM","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8058608059,NA,NA,0.3818181818,"PRAVASTATIN SODIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PREDNISONE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.04502369668,0.4949494949,NA,NA,0.4269662921,0.1754385965,0.4459459459,NA,NA,0.4503816794,NA,0.5214285714,0.02205882353,0.5066666667,NA,"PREGABALIN",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7473309609,NA,NA,NA,"PREGABALIN","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4150943396,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PREGABALIN","TRAMADOL HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4401709402,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PREGABALIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7302631579,NA,"PREGABALIN","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4776119403,NA,NA,NA,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5209302326,NA,NA,NA,"PREGNANT STATE, INCIDENTAL (dxo:ICD9:V222)","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"41-64","Female",0.005376344086,0.02272727273,0.4768786127,NA,NA,NA,0.1019011407,0.3332421341,NA,NA,0.2976190476,NA,NA,0.01339285714,NA,0.1627906977,"PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09706546275,0.3069620253,NA,NA,0.1962616822,NA,NA,NA,NA,NA,"PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.395480226,NA,NA,NA,NA,NA,NA,NA,0.4159292035,"PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.3070866142,NA,NA,NA,NA,NA,NA,NA,NA,"PREMENSTRUAL TENSION SYNDROMES (dxo:ICD9:6254)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1743119266,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PRESBYOPIA (dxo:ICD9:3674)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5038167939,NA,NA,NA,"PRIMARY OPEN-ANGLE GLAUCOMA (dxo:ICD9:36511)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1088435374,NA,NA,NA,NA,NA,NA,NA,"PROCHLORPERAZINE MALEATE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4677419355,NA,NA,NA,NA,NA,NA,NA,0.4074074074,NA,NA,NA,NA,NA,"PROGESTERONE, MICRONIZED",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2483660131,NA,NA,NA,NA,NA,"PROGESTERONE, MICRONIZED","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",0.01169590643,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PROMETHAZINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",0.003164556962,NA,NA,NA,NA,NA,0.1181102362,NA,NA,NA,0.4285714286,NA,NA,NA,NA,0.2409972299,"PROPOXYPHENE NAP/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.324742268,"PROPOXYPHENE NAP/ACETAMINOPHEN","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3356164384,"PROPOXYPHENE NAP/ACETAMINOPHEN","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01904761905,0.5136986301,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PROPRANOLOL HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.2655502392,NA,NA,0.1730769231,0.1037037037,0.2483069977,NA,NA,0.2229299363,NA,0.2684458399,NA,0.2657004831,0.1741573034,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.2121710526,NA,NA,0.1573033708,0.08168028005,0.2330097087,NA,NA,0.1346153846,NA,0.2127045236,NA,0.171875,0.1153846154,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.1944444444,NA,NA,NA,0.04237288136,0.203539823,NA,NA,NA,NA,0.1616161616,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.04385964912,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4220779221,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2916666667,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4476744186,0.2211538462,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1908396947,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5372670807,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6062992126,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.3018867925,NA,NA,NA,0.1367521368,0.2292993631,NA,NA,NA,NA,0.3154761905,NA,NA,0.2147651007,"PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792)",NA,NA,NA,NA,NA,NA
"41-64","Female",0.009111617312,0.0339869281,0.244057971,0.3016574586,NA,0.2332878581,0.0841263799,0.2433361995,0.1516587678,0.0756302521,0.2033293698,NA,0.2542635659,0.01736111111,0.2811016144,0.1419354839,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,0.08762886598,NA,NA,NA,0.1901408451,NA,NA,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.2362204724,NA,NA,0.2596153846,NA,NA,NA,NA,NA,NA,0.56272838,NA,0.3470588235,0.1816623822,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4685314685,NA,NA,0.3236245955,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1464088398,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5137614679,0.3625498008,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2444444444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5795454545,0.213963964,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.1895734597,0.1530054645,NA,0.1859296482,0.1119133574,0.2276422764,NA,NA,NA,NA,0.1787709497,0.03235294118,0.231316726,0.1424332344,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.1151079137,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1304347826,0.08620689655,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06730769231,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3365695793,NA,NA,0.1177884615,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4057971014,NA,NA,0.2032085561,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02142857143,NA,0.1666666667,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3093922652,0.2179836512,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3223684211,0.1435523114,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.1996424315,0.2400589102,0.05809128631,0.1560178306,0.07129572226,0.2156983931,0.07352941176,0.04347826087,0.1292517007,NA,0.2016260163,0.01413427562,0.2013786312,0.1523588554,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.1706161137,NA,NA,NA,0.05867346939,0.25,NA,NA,NA,NA,0.1875,NA,0.1811023622,0.1688311688,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3096446701,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.04424778761,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.1909090909,NA,NA,0.1720430108,0.111969112,0.1338582677,NA,NA,NA,NA,0.3622895623,NA,0.2327044025,0.1952232606,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.327510917,NA,NA,0.2671755725,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02409638554,0.2564102564,0.1883116883,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3168654174,0.268442623,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.162601626,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3669064748,0.1944055944,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2700729927,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","VILAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.07647058824,0.05988023952,0.1151079137,NA,NA,NA,NA,0.1044776119,NA,NA,0.07407407407,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2487309645,NA,NA,0.1282051282,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.2169312169,NA,NA,NA,0.0824742268,0.2574257426,NA,NA,NA,NA,0.2369477912,NA,0.2627737226,0.2123287671,"PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5031446541,NA,NA,NA,"PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1534653465,NA,NA,NA,NA,NA,0.5419847328,NA,NA,NA,"RABEPRAZOLE SODIUM",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1073825503,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RABEPRAZOLE SODIUM","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8018018018,NA,NA,NA,"RABEPRAZOLE SODIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1631016043,NA,NA,NA,NA,NA,0.5850746269,NA,0.5,NA,"RAMIPRIL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7469879518,NA,NA,NA,"RAMIPRIL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7719298246,NA,"RAMIPRIL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.09915014164,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RANITIDINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.1009174312,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RASH AND OTHER NONSPECIFIC SKIN ERUPTION (dxo:ICD9:7821)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.03349282297,0.5205882353,NA,NA,0.4085365854,0.1972789116,0.4885844749,NA,NA,NA,0.2368804665,0.5121107266,NA,0.4551724138,0.4116930572,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4427826087,NA,NA,NA,0.4781553398,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3888888889,0.6666666667,NA,NA,0.5980861244,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5392156863,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4966887417,NA,NA,NA,0.4121212121,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4862385321,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3872180451,NA,NA,NA,0.5689655172,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2018348624,0.7639344262,NA,NA,0.4681440443,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3134328358,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7058823529,0.4795539033,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01639344262,NA,NA,NA,0.3460076046,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RHEUMATOID ARTHRITIS (dxo:ICD9:7140)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3581081081,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RHEUMATOID ARTHRITIS (dxo:ICD9:7140)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1367013373,NA,NA,NA,0.4471544715,NA,NA,NA,NA,NA,"RISEDRONATE SODIUM",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1428571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RISEDRONATE SODIUM","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.1586206897,NA,NA,0.1570680628,0.06726457399,0.1428571429,NA,NA,0.1596638655,NA,0.1538461538,NA,0.163410302,0.1169794849,"RISPERIDONE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1644736842,"RISPERIDONE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1333333333,"RISPERIDONE","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1675126904,NA,NA,0.09705882353,"RISPERIDONE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2074688797,NA,NA,0.1158940397,"RISPERIDONE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1199611462,"RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.193220339,0.1240601504,"RISPERIDONE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1946446962,0.1313269494,"RISPERIDONE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.487704918,NA,NA,NA,NA,0.515,NA,NA,0.2288135593,"RIZATRIPTAN BENZOATE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7561837456,NA,NA,NA,"RIZATRIPTAN BENZOATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.6064516129,NA,NA,0.3548387097,0.1038647343,NA,NA,NA,0.3969849246,NA,NA,NA,NA,NA,"ROFECOXIB",NA,NA,NA,NA,NA,NA
"41-64","Female",0.03115264798,0.03968253968,0.4166666667,NA,NA,0.3064903846,0.1577726218,0.3316195373,0.1214285714,0.08064516129,0.2933333333,0.3946988821,0.3909574468,0.02386117137,0.3608247423,0.4353624688,"ROPINIROLE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3888888889,0.5507692308,NA,NA,0.5364154528,"ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4417989418,"ROPINIROLE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4020618557,NA,0.03229813665,NA,0.3716893343,"ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3813559322,0.3764478764,"ROPINIROLE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3904761905,NA,NA,0.525887574,0.4745581146,"ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5586034913,0.685483871,NA,0.4485981308,NA,0.5658362989,NA,NA,NA,NA,0.5599489796,0.008510638298,0.547008547,0.35,"ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7968217934,NA,NA,NA,"ROSUVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8468468468,0.4423076923,"ROSUVASTATIN CALCIUM","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03312191684,NA,NA,0.1292517007,NA,0.1511627907,NA,NA,NA,0.4094202899,NA,0.4772727273,0.008103727715,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.036598493,NA,NA,0.1363636364,NA,0.1033755274,NA,NA,NA,0.3573883162,NA,NA,NA,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01413427562,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","SPECIAL SCREENING FOR MALIGNANT NEOPLASMS, COLON (dxo:ICD9:V7651)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","TRAMADOL HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.002577319588,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02290076336,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005025125628,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02293577982,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"41-64","Female",0.006635273973,0.03220290681,NA,0.6735520454,0.1271820449,0.3878015476,0.1339946805,0.4680056049,0.1316225166,NA,0.3573577502,NA,NA,NA,NA,0.2532517215,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.16,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SCAR CONDITION AND FIBROSIS OF SKIN (dxo:ICD9:7092)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4485981308,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SCREENING FOR LIPOID DISORDERS (dxo:ICD9:V7791)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4615384615,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4333333333,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SCREENING MAMMOGRAM FOR HIGH-RISK PATIENT (dxo:ICD9:V7611)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.04464285714,NA,0.6974789916,NA,0.5652173913,0.2311827957,NA,NA,NA,0.5105263158,NA,NA,NA,NA,0.4126213592,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1299559471,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.320754717,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SPECIAL SCREENING EXAMINATION, HUMAN PAPILLOMAVIRUS [HPV] (dxo:ICD9:V7381)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1481481481,NA,NA,NA,0.3063063063,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA
"41-64","Female",NA,0.03433476395,NA,NA,NA,NA,NA,NA,NA,NA,0.3705357143,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1550802139,NA,NA,NA,0.4033613445,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","TOPIRAMATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3369565217,0.1333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","TRAMADOL HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.347826087,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1386138614,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED ACUTE REACTION TO STRESS (dxo:ICD9:3089)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1212121212,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED CONSTIPATION (dxo:ICD9:56400)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.05072463768,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",NA,NA,NA,NA,NA
"41-64","Female",0,0.02898550725,NA,NA,NA,0.3483870968,0.1251758087,NA,NA,NA,0.3050847458,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.2878787879,0.1300160514,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1278538813,0.45,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA
"41-64","Female",NA,0.02702702703,NA,NA,NA,NA,NA,NA,NA,NA,0.3046875,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","VALACYCLOVIR HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1682242991,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","VALSARTAN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.072,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","VALSARTAN/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,0.8226950355,NA,0.6606060606,0.1917808219,NA,NA,NA,0.4962406015,NA,NA,NA,NA,0.3461538462,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1136363636,NA,NA,NA,NA,NA,NA,NA,NA,NA,"SCAR CONDITION AND FIBROSIS OF SKIN (dxo:ICD9:7092)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4030683403,NA,NA,0.275862069,NA,NA,NA,NA,NA,NA,0.4441747573,NA,0.4041450777,NA,"SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7209302326,NA,NA,NA,"SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.3481012658,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.390625,NA,NA,NA,"SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.375,NA,NA,NA,NA,NA,"SCREENING FOR LIPOID DISORDERS (dxo:ICD9:V7791)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5502336449,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5109170306,NA,0.5748502994,NA,"SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7565217391,NA,NA,NA,"SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5032679739,NA,"SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7034220532,NA,"SCREENING FOR MALIGNANT NEOPLASM OF THE CERVIX (dxo:ICD9:V762)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4423791822,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"SCREENING FOR UNSPECIFIED CONDITION (dxo:ICD9:V829)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4761904762,NA,NA,NA,NA,NA,"SCREENING MAMMOGRAM FOR HIGH-RISK PATIENT (dxo:ICD9:V7611)",NA,NA,NA,NA,NA,NA
"41-64","Female",0.0178335535,0.02965841685,0.4708831469,0.6662420382,0.1314363144,0.4368700751,0.1785175406,0.4420437956,0.130952381,0.05098389982,0.3984655958,0.1627358491,0.5959650419,0.01895734597,0.5973443697,0.3541067546,"SERTRALINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5940594059,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7812941509,NA,NA,0.4473282443,"SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6307692308,NA,NA,0.7014925373,"SERTRALINE HCL","SIMVASTATIN","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8444444444,NA,NA,NA,"SERTRALINE HCL","SIMVASTATIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7375231054,NA,NA,0.4380165289,"SERTRALINE HCL","SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6265060241,NA,NA,NA,"SERTRALINE HCL","SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6369863014,NA,"SERTRALINE HCL","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7251908397,NA,NA,NA,"SERTRALINE HCL","TEMAZEPAM",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7453051643,NA,NA,0.4229390681,"SERTRALINE HCL","TOPIRAMATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5188679245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"SERTRALINE HCL","TRAMADOL HCL",NA,NA,NA,NA,NA
"41-64","Female",0.03783783784,0.039408867,0.3410138249,NA,NA,0.3064935065,0.1510067114,0.318627451,0.1061946903,NA,0.3127962085,NA,0.5246707917,0.02128556375,0.4430894309,0.4531453716,"SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4249201278,0.025,0.5208333333,0.3365079365,"SERTRALINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6927374302,NA,NA,NA,"SERTRALINE HCL","UNSPECIFIED CONSTIPATION (dxo:ICD9:56400)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.5667938931,NA,NA,NA,NA,NA,NA,0.7278911565,NA,NA,NA,"SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7237113402,NA,NA,NA,"SERTRALINE HCL","UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6726039016,NA,NA,NA,"SERTRALINE HCL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6754385965,NA,NA,NA,"SERTRALINE HCL","UNSPECIFIED VIRAL INFECTION, IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE (dxo:ICD9:07999)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7363896848,NA,NA,NA,"SERTRALINE HCL","UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7130977131,NA,NA,NA,"SERTRALINE HCL","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA
"41-64","Female",0.0078125,0.02669404517,0.4812834225,NA,NA,0.4210526316,0.1975560081,0.4166666667,NA,NA,0.3591160221,NA,0.5699177438,0.005847953216,0.6792763158,0.346826127,"SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7142857143,NA,NA,NA,"SERTRALINE HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4637681159,NA,NA,NA,NA,NA,NA,NA,NA,"SILVER SULFADIAZINE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.05365853659,0.5355093257,NA,NA,NA,0.147735709,0.5626794258,NA,NA,0.3917525773,NA,0.5760869565,NA,0.5483870968,0.2692307692,"SIMVASTATIN",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4392523364,"SIMVASTATIN","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.537037037,NA,NA,NA,NA,0.5590062112,NA,NA,NA,"SIMVASTATIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6991150442,0.4423076923,"SIMVASTATIN","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5343915344,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"SODIUM, POTASSIUM,MAG SULFATES",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.39375,NA,"SPECIAL SCREENING EXAMINATION, HUMAN PAPILLOMAVIRUS [HPV] (dxo:ICD9:V7381)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3267326733,NA,"SPECIAL SCREENING EXAMINATION, HUMAN PAPILLOMAVIRUS [HPV] (dxo:ICD9:V7381)","SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7365269461,NA,"SPECIAL SCREENING EXAMINATION, HUMAN PAPILLOMAVIRUS [HPV] (dxo:ICD9:V7381)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009646302251,NA,NA,"SPECIAL SCREENING FOR MALIGNANT NEOPLASMS, COLON (dxo:ICD9:V7651)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008,NA,NA,"SPECIAL SCREENING FOR MALIGNANT NEOPLASMS, COLON (dxo:ICD9:V7651)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5206185567,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"SPECIAL SCREENING FOR OTHER SPECIFIED CONDITIONS (dxo:ICD9:V8289)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4350649351,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"SULFAMETHOXAZOLE/TRIMETHOPRIM",NA,NA,NA,NA,NA,NA
"41-64","Female",0,NA,0.5303643725,NA,NA,NA,0.1538461538,0.5021276596,NA,0.04580152672,0.4366812227,NA,0.5577172503,NA,NA,0.2196531792,"SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2926829268,"SUMATRIPTAN SUCCINATE","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3760932945,"SUMATRIPTAN SUCCINATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.009433962264,NA,NA,NA,NA,NA,0.49375,NA,NA,NA,NA,0.4293552812,NA,NA,NA,"SUPERVISION OF OTHER NORMAL PREGNANCY (dxo:ICD9:V221)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.006097560976,0.5375722543,NA,NA,NA,NA,NA,NA,NA,0.3724832215,NA,0.5384615385,NA,0.4719438878,NA,"SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6355932203,NA,"SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4727272727,NA,"SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3333333333,NA,"SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)","UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6887280248,NA,"SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3823529412,NA,"TAMOXIFEN CITRATE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5845410628,0.004264392324,NA,NA,"TEMAZEPAM",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.03663003663,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TERBINAFINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4014084507,NA,NA,NA,NA,NA,NA,0.3358208955,NA,"TERCONAZOLE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5492227979,NA,NA,NA,NA,NA,NA,0.03398058252,NA,NA,NA,NA,NA,NA,"THORACIC OR LUMBOSACRAL NEURITIS OR RADICULITIS, UNSPECIFIED (dxo:ICD9:7244)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2447552448,NA,NA,NA,NA,NA,"TIETZE'S DISEASE (dxo:ICD9:7336)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4879518072,NA,NA,NA,NA,0.4914772727,NA,NA,NA,NA,0.5793650794,NA,NA,0.2359550562,"TIZANIDINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2090909091,"TOLTERODINE TARTRATE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5088028169,NA,NA,NA,0.1834451902,0.4951644101,NA,NA,0.3789173789,NA,0.5763358779,NA,NA,0.2409972299,"TOPIRAMATE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3586206897,"TOPIRAMATE","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.411971831,"TOPIRAMATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01470588235,NA,NA,NA,0.3589364845,0.1648148148,0.4636363636,NA,NA,0.3383838384,0.2398373984,0.5152838428,0.007952286282,0.4569892473,NA,"TRAMADOL HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02189781022,NA,NA,"TRAMADOL HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3861607143,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"TRAMADOL HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7358490566,NA,"TRAMADOL HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01298701299,NA,NA,"TRAMADOL HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.474537037,NA,NA,0.3795918367,NA,0.4574132492,NA,NA,NA,NA,NA,NA,NA,NA,"TRAMADOL HCL/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"41-64","Female",0.014015844,0.03208937485,0.3631086746,0.4373927959,0.1952054795,0.2779489437,0.1420311714,0.343083276,0.1122019635,0.0623853211,0.2787427626,0.1547619048,0.3684210526,0.02175573049,0.3409627183,0.3482900548,"TRAZODONE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3513513514,NA,NA,NA,NA,NA,NA,NA,0.02554744526,NA,NA,"TRAZODONE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006097560976,NA,NA,"TRAZODONE HCL","UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050)",NA,NA,NA,NA,NA
"41-64","Female",0.05,0.03768844221,0.3492647059,NA,NA,0.387755102,0.1518624642,0.3096446701,NA,NA,0.40625,NA,0.3705357143,0.02417144281,0.4748268289,0.3753478184,"TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4802259887,"TRAZODONE HCL","VILAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01365187713,NA,NA,"TRAZODONE HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4913043478,NA,"UNSPECIFIED ABNORMAL MAMMOGRAM (dxo:ICD9:79380)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1538461538,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED ACUTE REACTION TO STRESS (dxo:ICD9:3089)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4058823529,NA,NA,NA,"UNSPECIFIED ADJUSTMENT REACTION (dxo:ICD9:3099)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.03414634146,NA,NA,NA,NA,NA,0.447761194,NA,NA,NA,NA,NA,NA,0.4461538462,NA,"UNSPECIFIED ALOPECIA (dxo:ICD9:70400)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.05309734513,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED ANEMIA (dxi:ICD9:2859)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1732851986,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED CEREBRAL ARTERY OCCLUSION WITH CEREBRAL INFARCTION (dxi:ICD9:43491)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.3728813559,NA,NA,NA,0.2117647059,0.3944954128,NA,NA,0.3653846154,NA,0.4422222222,NA,NA,NA,"UNSPECIFIED CONSTIPATION (dxo:ICD9:56400)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.02385321101,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED ENDOCRINE DISORDER (dxo:ICD9:2599)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.01739130435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED EPILEPSY WITHOUT MENTION OF INTRACTABLE EPILEPSY (dxo:ICD9:34590)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.02816901408,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED EPISODIC MOOD DISORDER (dxo:ICD9:29690)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.04255319149,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5267857143,NA,"UNSPECIFIED ESSENTIAL HYPERTENSION (dxi:ICD9:4019)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.04060913706,NA,NA,NA,NA,NA,0.591160221,0.1369047619,NA,NA,NA,NA,0.004618937644,0.5308641975,NA,"UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4565217391,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED HEARING LOSS (dxo:ICD9:3899)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6371681416,NA,NA,NA,"UNSPECIFIED HEMORRHOIDS WITHOUT MENTION OF COMPLICATION (dxo:ICD9:4556)",NA,NA,NA,NA,NA,NA
"41-64","Female",0.007518796992,0.01369863014,NA,NA,NA,0.4198473282,NA,NA,NA,0.08695652174,NA,NA,0.4928571429,NA,NA,NA,"UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.4466019417,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4380165289,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED INFLAMMATORY AND TOXIC NEUROPATHY (dxo:ICD9:3579)",NA,NA,NA,NA,NA,NA
"41-64","Female",0.01486988848,0.02447552448,0.4485106383,NA,NA,0.3859697387,0.1638190955,0.4735547355,NA,0.05243445693,0.4,NA,0.5096963044,0.005070993915,0.5121212121,NA,"UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4217687075,NA,NA,NA,"UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.6150870406,NA,NA,NA,NA,NA,NA,NA,NA,0.6505376344,NA,"UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"41-64","Female",NA,0.01851851852,NA,NA,NA,NA,NA,0.4933333333,0.1451612903,NA,NA,NA,NA,NA,0.525974026,NA,"UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.0988372093,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED PERIPHERAL VASCULAR DISEASE (dxo:ICD9:4439)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.1062992126,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED PRURITIC DISORDER (dxo:ICD9:6989)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4892086331,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED SEBORRHEIC DERMATITIS (dxo:ICD9:69010)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008888888889,NA,NA,"UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050)",NA,NA,NA,NA,NA,NA
"41-64","Female",0.004672897196,NA,0.427244582,NA,NA,NA,NA,0.3854748603,NA,NA,NA,NA,0.4654545455,NA,NA,NA,"UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3930635838,NA,NA,NA,"UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4890282132,NA,NA,NA,NA,0.4816753927,NA,NA,NA,NA,0.5294117647,NA,NA,NA,"UNSPECIFIED TEAR FILM INSUFFICIENCY (dxo:ICD9:37515)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,0.4914529915,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED TRANSIENT CEREBRAL ISCHEMIA (dxo:ICD9:4359)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.1552795031,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED URTICARIA (dxo:ICD9:7089)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.431510876,NA,NA,0.3272311213,0.1336302895,0.4114114114,NA,NA,0.3540372671,NA,0.4611754612,NA,0.4059701493,NA,"UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6016260163,NA,"UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4591194969,NA,NA,NA,"UNSPECIFIED VENOUS (PERIPHERAL) INSUFFICIENCY (dxo:ICD9:45981)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5720720721,NA,NA,NA,"UNSPECIFIED VIRAL INFECTION, IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE (dxo:ICD9:07999)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,0.1367521368,NA,NA,NA,NA,NA,NA,0.1683168317,0.5216606498,NA,0.4285714286,NA,"UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7258979206,NA,"UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.5174825175,NA,NA,NA,0.1802721088,0.481300813,NA,NA,NA,NA,0.5392822502,NA,NA,NA,"URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.0308310992,0.4588441331,NA,NA,NA,NA,NA,NA,NA,0.3586956522,NA,NA,NA,NA,NA,"VALACYCLOVIR HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,0.1385642738,NA,NA,NA,NA,NA,NA,NA,NA,NA,"VALSARTAN",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,0.3662790698,0.09510869565,NA,NA,NA,NA,NA,NA,NA,NA,NA,"VALSARTAN/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.02723735409,0.4668508287,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"VARENICLINE TARTRATE",NA,NA,NA,NA,NA,NA
"41-64","Female",0.02309058615,0.04022288003,0.508611049,0.7891156463,0.118852459,0.5509596294,0.2040594418,0.485705865,0.1254355401,0.0652173913,0.4315569488,0.1605839416,0.5036292574,0.02303754266,0.5472819401,0.3186061328,"VENLAFAXINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.01369863014,NA,NA,NA,NA,0.175,0.5472972973,NA,NA,NA,NA,NA,NA,NA,NA,"VERAPAMIL HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7032679739,"VILAZODONE HCL",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,NA,0.4744525547,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ZALEPLON",NA,NA,NA,NA,NA,NA
"41-64","Female",NA,0.05172413793,0.4437086093,NA,0.1338028169,NA,0.1162790698,0.4703296703,NA,NA,NA,NA,0.5746691871,0.01185395922,NA,NA,"ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA,NA
"41-64","Male",0.039746963,0.06972467502,0.5077703027,0.4686668032,0.2190795781,0.3937961393,0.228310086,0.4966058475,0.2219643597,0.1173213359,0.4660223411,0.3503593145,0.5226897749,0.03034837107,0.4989358092,0.3458687023,NA,NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04237288136,NA,NA,0.492,NA,0.5333333333,NA,"ABDOMINAL PAIN, UNSPECIFIED SITE (dxo:ICD9:78900)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.04356435644,NA,NA,NA,NA,NA,NA,NA,NA,0.4161849711,NA,0.5416666667,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.06145251397,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","BUPROPION HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.02985074627,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6953125,NA,NA,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5048543689,NA,NA,NA,"ACETAMINOPHEN WITH CODEINE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5422885572,NA,NA,NA,"ACTINIC KERATOSIS (dxo:ICD9:7020)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4701754386,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.525974026,NA,NA,NA,"ACUTE SINUSITIS, UNSPECIFIED (dxo:ICD9:4619)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.4338235294,NA,NA,NA,NA,NA,NA,NA,NA,"ACUTE UPPER RESPIRATORY INFECTIONS OF UNSPECIFIED SITE (dxo:ICD9:4659)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.009090909091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ACUTE, BUT ILL-DEFINED, CEREBROVASCULAR DISEASE (dxo:ICD9:436)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.0243902439,0.4765625,NA,NA,NA,0.1131221719,NA,NA,NA,NA,NA,0.5733333333,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.04861111111,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Male",NA,0.03140096618,0.4666666667,NA,NA,NA,0.1046153846,NA,0.1197183099,NA,NA,NA,0.4768518519,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.07936507937,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Male",NA,0.05982905983,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","BUPROPION HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.0237388724,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1346153846,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1074380165,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Male",NA,NA,0.2556053812,NA,NA,NA,0.07692307692,0.1836734694,NA,NA,NA,NA,0.2142857143,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"41-64","Male",NA,NA,0.1716738197,NA,NA,NA,0.05968169761,0.1943319838,NA,NA,0.1629213483,NA,0.1832191781,NA,0.1481481481,0.1134751773,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5188679245,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4424778761,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.1743119266,NA,NA,NA,0.07857142857,NA,NA,NA,NA,NA,0.2052631579,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Male",NA,0.03409090909,0.2234042553,NA,NA,NA,0.06818181818,NA,NA,NA,NA,NA,0.2365591398,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.07159353349,NA,NA,NA,NA,NA,0.2314814815,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01652892562,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)","SILDENAFIL CITRATE",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01449275362,0.5064102564,NA,NA,NA,NA,NA,NA,NA,0.4117647059,NA,NA,NA,NA,NA,"ALBUTEROL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.6454545455,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALBUTEROL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.625,NA,NA,NA,NA,NA,"ALBUTEROL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1741293532,NA,NA,NA,0.4184397163,NA,NA,NA,0.4241245136,NA,"ALBUTEROL SULFATE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7364864865,NA,"ALBUTEROL SULFATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.5337423313,NA,NA,NA,NA,0.5422077922,NA,NA,NA,"ALLOPURINOL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.7904761905,NA,NA,NA,NA,NA,NA,NA,NA,"ALLOPURINOL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7533333333,NA,NA,NA,"ALLOPURINOL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.05217391304,0.4625322997,NA,NA,NA,0.1710963455,0.4814814815,NA,NA,0.4857142857,NA,0.5077910174,0.009803921569,0.4549763033,NA,"ALPRAZOLAM",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.12,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5125,NA,NA,NA,"ALPRAZOLAM","ATORVASTATIN CALCIUM",NA,NA,NA,NA,NA
"41-64","Male",NA,0.02608695652,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","BUPROPION HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.6595744681,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3661202186,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.65,NA,NA,NA,NA,NA,NA,NA,NA,"ALPRAZOLAM","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4504504505,NA,NA,NA,"ALPRAZOLAM","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3854166667,NA,NA,NA,"ALPRAZOLAM","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7109004739,NA,NA,NA,"ALPRAZOLAM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.662055336,NA,NA,NA,"ALPRAZOLAM","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",0.06466657385,0.03667136812,0.3820395738,NA,NA,0.3137860082,0.1618421053,0.3995157385,0.141509434,0.1287553648,0.3045685279,NA,0.3734939759,0.0110701107,0.4006968641,0.3782641823,"AMITRIPTYLINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",0.06896551724,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","AMLODIPINE BESYLATE",NA,NA,NA,NA,NA
"41-64","Male",0.07737226277,0.06255835668,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2681139756,"AMITRIPTYLINE HCL","BUPROPION HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3293650794,"AMITRIPTYLINE HCL","BUPROPION HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2962962963,"AMITRIPTYLINE HCL","BUPROPION HCL","DULOXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2543103448,"AMITRIPTYLINE HCL","BUPROPION HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3070175439,"AMITRIPTYLINE HCL","BUPROPION HCL","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08484848485,"AMITRIPTYLINE HCL","BUPROPION HCL","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Male",0.05809128631,0.05805243446,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1477987421,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.08670520231,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1263736264,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",NA,0.01886792453,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1909090909,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.524137931,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5591054313,"AMITRIPTYLINE HCL","BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2697368421,"AMITRIPTYLINE HCL","BUPROPION HCL","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2777777778,"AMITRIPTYLINE HCL","BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2605932203,"AMITRIPTYLINE HCL","BUPROPION HCL","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2529880478,"AMITRIPTYLINE HCL","BUPROPION HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3227848101,"AMITRIPTYLINE HCL","BUPROPION HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3393501805,"AMITRIPTYLINE HCL","BUPROPION HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.04511278195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2083739046,"AMITRIPTYLINE HCL","BUPROPION HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2608695652,"AMITRIPTYLINE HCL","BUPROPION HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",0.08480565371,NA,0.6009009009,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4466608846,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Male",0.1023622047,NA,0.7215189873,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4965753425,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.7213114754,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Male",NA,NA,0.60625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Male",NA,NA,0.6107784431,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4727272727,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",0.0625,NA,0.7088607595,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5625,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3969465649,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6173469388,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.6022099448,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Male",NA,NA,0.4594594595,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3409961686,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",0.05295950156,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Male",0.01892744479,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.338028169,"AMITRIPTYLINE HCL","DOXEPIN HCL",NA,NA,NA,NA,NA
"41-64","Male",0.1067761807,NA,NA,NA,NA,0.4794520548,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3987291501,"AMITRIPTYLINE HCL","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2905982906,"AMITRIPTYLINE HCL","DULOXETINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Male",0.08510638298,NA,NA,NA,NA,0.4942965779,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4409448819,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4366197183,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.5794392523,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3454545455,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5949367089,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4230769231,"AMITRIPTYLINE HCL","DULOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.4465408805,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3003194888,"AMITRIPTYLINE HCL","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4326923077,"AMITRIPTYLINE HCL","DULOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",0.06605222734,NA,NA,NA,NA,NA,0.3566878981,NA,NA,NA,NA,NA,NA,NA,NA,0.3010146561,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Male",0.03645833333,NA,NA,NA,NA,NA,0.3033707865,NA,NA,NA,NA,NA,NA,NA,NA,0.26171875,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3186440678,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2692307692,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2565789474,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2790697674,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2916666667,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",0.05319148936,NA,NA,NA,NA,NA,NA,0.5584291188,NA,NA,NA,NA,NA,NA,NA,0.4500860585,"AMITRIPTYLINE HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",0.06557377049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5775577558,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.642599278,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.5882352941,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5125,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",0.0396039604,NA,NA,NA,NA,NA,NA,0.6909090909,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.6883116883,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4202898551,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6623376623,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.6357142857,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.419047619,NA,NA,NA,NA,NA,NA,NA,0.3588516746,"AMITRIPTYLINE HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3286713287,"AMITRIPTYLINE HCL","GABAPENTIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1981981982,"AMITRIPTYLINE HCL","GABAPENTIN","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",0.07623318386,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"41-64","Male",0.0102739726,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",0.0703125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Male",0.0347826087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HYDROCODONE/ACETAMINOPHEN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",0.04273504274,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007352941176,NA,NA,"AMITRIPTYLINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1304347826,"AMITRIPTYLINE HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1458333333,"AMITRIPTYLINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.04901960784,0.3739130435,NA,NA,0.2997118156,0.171875,0.4657534247,NA,0.05673758865,0.3404255319,NA,0.4557823129,0.00824742268,0.4413793103,0.294214876,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5267175573,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7096774194,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6729411765,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2868852459,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4380165289,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4771573604,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1818181818,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",0.09,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4916666667,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",0.05357142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5145888594,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",0.06470588235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006666666667,NA,0.186440678,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7217391304,0.4882352941,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7087912088,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6699029126,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",0.078125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7135416667,NA,NA,0.5196850394,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",0.01985878199,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"41-64","Male",0.056,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","MORPHINE SULFATE",NA,NA,NA,NA
"41-64","Male",0.0243902439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Male",0.02173913043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","OXYCODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4262295082,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3564356436,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0.1333333333,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6001881468,"AMITRIPTYLINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5454545455,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5833333333,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.622754491,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5576923077,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5632911392,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",0.3194888179,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5260115607,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4862385321,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5045045045,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2986842105,"AMITRIPTYLINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2919254658,"AMITRIPTYLINE HCL","MIRTAZAPINE","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2711864407,"AMITRIPTYLINE HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2649006623,"AMITRIPTYLINE HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2242990654,"AMITRIPTYLINE HCL","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",0.1965811966,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","MORPHINE SULFATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3463687151,"AMITRIPTYLINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5281690141,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7045454545,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6631130064,NA,NA,NA,"AMITRIPTYLINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2994505495,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2706896552,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5281690141,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.42,"AMITRIPTYLINE HCL","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Male",0.1073825503,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","OXYCODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",0.07058823529,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5618811881,NA,NA,NA,NA,0.4249649369,"AMITRIPTYLINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4227642276,"AMITRIPTYLINE HCL","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",0.06930693069,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1028037383,"AMITRIPTYLINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Male",0.08,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5190562613,"AMITRIPTYLINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4238410596,"AMITRIPTYLINE HCL","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1122994652,"AMITRIPTYLINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1012658228,"AMITRIPTYLINE HCL","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Male",0.07142857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4532577904,"AMITRIPTYLINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3658536585,"AMITRIPTYLINE HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",0.06623931624,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6150656531,NA,NA,0.4840466926,"AMITRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4788732394,NA,NA,0.3079584775,"AMITRIPTYLINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4554455446,"AMITRIPTYLINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",0.09734513274,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01834862385,NA,0.288851821,"AMITRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2912621359,"AMITRIPTYLINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",0.1076923077,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6478873239,0.3851784081,"AMITRIPTYLINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",0,NA,NA,NA,NA,NA,0.1666666667,NA,NA,NA,NA,NA,NA,0.005586592179,NA,NA,"AMLODIPINE BESYLATE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1415525114,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMLODIPINE BESYLATE/BENAZEPRIL",NA,NA,NA,NA,NA,NA
"41-64","Male",0.01785714286,0.0265129683,0.5534591195,NA,NA,NA,0.1649144506,0.5196850394,NA,NA,0.4116322702,NA,0.6914893617,0.01793721973,0.6322580645,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.07843137255,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.04635761589,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA
"41-64","Male",NA,0.06086956522,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Male",NA,0.06015037594,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Male",NA,0.06504065041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1742424242,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.05517241379,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Male",NA,0.0522875817,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,0.02931596091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.007575757576,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1007194245,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUSPIRONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.131147541,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.35625,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01834862385,NA,NA,NA,NA,0.2072072072,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.02459016393,NA,NA,NA,NA,0.1796116505,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CLONAZEPAM",NA,NA,NA,NA,NA
"41-64","Male",NA,0.0178041543,NA,NA,NA,NA,0.1902268761,0.4566929134,NA,NA,0.46105919,NA,0.62,NA,0.6635514019,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3819095477,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.119047619,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6651162791,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3932659933,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01829268293,NA,NA,NA,NA,NA,NA,NA,NA,0.4454545455,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3050847458,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1464019851,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1904761905,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1608040201,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.7024793388,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.4960629921,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.4268292683,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1472868217,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESOMEPRAZOLE MAGNESIUM",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.7212121212,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1845238095,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","GABAPENTIN",NA,NA,NA,NA,NA
"41-64","Male",NA,0.0325203252,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.179245283,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.0875,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.08813559322,NA,NA,NA,0.1941176471,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.126984127,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.024,NA,NA,NA,NA,0.1241830065,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4262295082,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3920863309,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6986027944,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.04375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","LORAZEPAM",NA,NA,NA,NA,NA
"41-64","Male",NA,0.0225,NA,NA,NA,NA,0.1739130435,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1869158879,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.101910828,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","OMEPRAZOLE",NA,NA,NA,NA,NA
"41-64","Male",NA,0.02631578947,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.176,NA,NA,NA,0.4018691589,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1873015873,NA,NA,NA,0.4179104478,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3076923077,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3211678832,NA,NA,NA,0.6637816245,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.04032258065,NA,NA,NA,NA,0.09210526316,NA,NA,NA,0.1652173913,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3823529412,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.05660377358,NA,NA,NA,NA,0.2222222222,NA,NA,NA,NA,NA,0.7013888889,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.05109489051,NA,NA,NA,NA,NA,NA,NA,NA,0.3565891473,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","SILDENAFIL CITRATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1793478261,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.17,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.2089552239,0.1534090909,NA,0.1649122807,0.1353383459,NA,NA,NA,NA,NA,0.1565217391,NA,0.1841004184,0.1215277778,"ARIPIPRAZOLE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1588235294,"ARIPIPRAZOLE","BUPROPION HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1883116883,"ARIPIPRAZOLE","BUPROPION HCL","DULOXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1437125749,"ARIPIPRAZOLE","BUPROPION HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1583333333,"ARIPIPRAZOLE","BUPROPION HCL","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1230769231,"ARIPIPRAZOLE","BUPROPION HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1125,"ARIPIPRAZOLE","BUPROPION HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.16,"ARIPIPRAZOLE","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.078125,"ARIPIPRAZOLE","CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,0.1879194631,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ARIPIPRAZOLE","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.2412698413,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1614349776,"ARIPIPRAZOLE","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.1666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ARIPIPRAZOLE","DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.2013888889,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1166666667,"ARIPIPRAZOLE","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1904761905,NA,NA,NA,NA,NA,NA,NA,NA,0.1481481481,"ARIPIPRAZOLE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.0593220339,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ARIPIPRAZOLE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1730769231,"ARIPIPRAZOLE","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.2519685039,NA,NA,NA,NA,NA,NA,NA,0.1357142857,"ARIPIPRAZOLE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1619047619,NA,NA,NA,"ARIPIPRAZOLE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.234939759,NA,NA,0.1405405405,"ARIPIPRAZOLE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1885245902,NA,NA,0.1875,"ARIPIPRAZOLE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1166666667,"ARIPIPRAZOLE","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1900826446,NA,"ARIPIPRAZOLE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1628959276,0.1770833333,"ARIPIPRAZOLE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.04827586207,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATENOLOL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01923076923,NA,NA,"ATHEROSCLEROSIS OF AORTA (dxo:ICD9:4400)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.540625,NA,NA,NA,0.1384408602,0.5620814013,NA,NA,0.4581151832,NA,0.584073107,NA,0.536,0.2785046729,"ATORVASTATIN CALCIUM",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2765957447,"ATORVASTATIN CALCIUM","BUPROPION HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2727272727,"ATORVASTATIN CALCIUM","BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6346153846,NA,NA,NA,"ATORVASTATIN CALCIUM","BUPROPION HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6197183099,NA,NA,NA,"ATORVASTATIN CALCIUM","CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.7255813953,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4756097561,"ATORVASTATIN CALCIUM","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.68,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","CITALOPRAM HYDROBROMIDE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA
"41-64","Male",NA,NA,0.4641509434,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.8211382114,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.8235294118,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","CITALOPRAM HYDROBROMIDE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1829268293,0.6166666667,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.7777777778,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.78,NA,NA,NA,"ATORVASTATIN CALCIUM","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.75,NA,NA,NA,0.3694267516,NA,NA,NA,NA,NA,NA,NA,NA,0.3455497382,"ATORVASTATIN CALCIUM","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1552795031,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.5222222222,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5145631068,NA,"ATORVASTATIN CALCIUM","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.752303523,NA,NA,NA,NA,NA,NA,NA,0.4203821656,"ATORVASTATIN CALCIUM","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.6814159292,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL","GABAPENTIN",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.4689265537,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.4803149606,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.7908256881,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.6902654867,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL","SILDENAFIL CITRATE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.5785123967,NA,NA,NA,NA,0.5302013423,NA,NA,NA,"ATORVASTATIN CALCIUM","GABAPENTIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5825242718,NA,NA,NA,"ATORVASTATIN CALCIUM","IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5894736842,NA,NA,NA,"ATORVASTATIN CALCIUM","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4263157895,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4660194175,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4756493506,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8121387283,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5531914894,NA,NA,NA,"ATORVASTATIN CALCIUM","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.6428571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5917602996,NA,NA,NA,"ATORVASTATIN CALCIUM","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7927927928,NA,NA,NA,"ATORVASTATIN CALCIUM","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5568181818,NA,NA,NA,"ATORVASTATIN CALCIUM","OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7730496454,NA,NA,NA,"ATORVASTATIN CALCIUM","OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6368876081,NA,NA,NA,NA,0.2944444444,"ATORVASTATIN CALCIUM","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6125,NA,NA,NA,"ATORVASTATIN CALCIUM","RAMIPRIL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8155339806,NA,NA,NA,"ATORVASTATIN CALCIUM","RAMIPRIL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7895981087,NA,NA,0.4644351464,"ATORVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7610062893,NA,NA,NA,"ATORVASTATIN CALCIUM","SERTRALINE HCL","SILDENAFIL CITRATE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.820754717,NA,NA,NA,"ATORVASTATIN CALCIUM","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.9130434783,NA,NA,NA,"ATORVASTATIN CALCIUM","SERTRALINE HCL","SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644)",NA,NA,NA,NA
"41-64","Male",NA,NA,0.4414414414,NA,NA,NA,NA,0.592920354,NA,NA,NA,NA,0.5363984674,NA,NA,NA,"ATORVASTATIN CALCIUM","SILDENAFIL CITRATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.515625,NA,NA,NA,"ATORVASTATIN CALCIUM","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6375,NA,NA,NA,"ATORVASTATIN CALCIUM","SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.431372549,"ATORVASTATIN CALCIUM","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5259259259,NA,NA,NA,"ATORVASTATIN CALCIUM","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6948356808,0.4217687075,"ATORVASTATIN CALCIUM","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.03736654804,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.02424242424,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.119047619,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","BUPROPION HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.02173913043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.02884615385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITH HYPERACTIVITY (dxo:ICD9:31401)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.0521609538,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.1005586592,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","BUPROPION HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.04918032787,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.07547169811,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","METHYLPHENIDATE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01886792453,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATTENTION DEFICIT DISORDER OF CHILDHOOD WITHOUT MENTION OF HYPERACTIVITY (dxo:ICD9:31400)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5242718447,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AZELASTINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4829931973,NA,NA,NA,0.134529148,NA,NA,NA,NA,NA,0.5576923077,NA,NA,NA,"AZITHROMYCIN",NA,NA,NA,NA,NA,NA
"41-64","Male",0.03149606299,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BACLOFEN",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4580152672,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN HYPERTENSIVE HEART DISEASE WITHOUT HEART FAILURE (dxo:ICD9:40210)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.5027322404,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN NEOPLASM OF COLON (dxo:ICD9:2113)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.7566137566,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN NEOPLASM OF COLON (dxo:ICD9:2113)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1454545455,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN NEOPLASM OF SKIN OF TRUNK, EXCEPT SCROTUM (dxo:ICD9:2165)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4436090226,NA,NA,NA,NA,NA,"BENZONATATE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.48,NA,NA,NA,"BIPOLAR DISORDER, UNSPECIFIED (dxo:ICD9:29680)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.2450980392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BODY MASS INDEX BETWEEN 19-24, ADULT (dxo:ICD9:V851)",NA,NA,NA,NA,NA,NA
"41-64","Male",0.01624815362,0.06336014893,0.4204252577,0.6034482759,0.1347150259,0.3386648122,0.1627553238,0.3706451613,0.111409396,0.1004016064,0.3542600897,0.2203389831,0.4147937411,0.01376811594,0.4456152277,0.3466855072,"BUPROPION HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.04692082111,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01550387597,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.02424242424,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"41-64","Male",NA,0.04608294931,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Male",NA,0.05874454515,0.5109784694,NA,NA,0.3558558559,0.1877256318,0.3591836735,NA,NA,0.3138686131,NA,0.447761194,0.008333333333,0.5474860335,0.4129135114,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.33,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","DULOXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.04651162791,0.6086956522,NA,NA,NA,0.2705882353,NA,NA,NA,NA,NA,NA,NA,NA,0.3296703297,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Male",NA,0.03703703704,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2385321101,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Male",NA,0.06338028169,0.3529411765,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3301886792,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.29,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1893203883,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA
"41-64","Male",NA,NA,0.3790322581,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1214285714,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA
"41-64","Male",NA,NA,0.1875,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05202312139,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Male",NA,0.0459670425,0.7067209776,NA,NA,NA,0.140625,NA,NA,NA,NA,NA,NA,NA,0.5135135135,0.5515653775,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.06406685237,0.7382352941,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Male",NA,0.08450704225,0.5923076923,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Male",NA,NA,0.588377724,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5247349823,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2295081967,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Male",NA,0.03012048193,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Male",NA,0.07246376812,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01176470588,NA,0.2976190476,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,0.07993966817,0.657635468,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5546218487,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.06829268293,0.6484018265,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Male",NA,NA,0.6764705882,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Male",NA,NA,0.65,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",NA,0.04021447721,0.3194444444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4202247191,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.44,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4504132231,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4477272727,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6617210682,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7549019608,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5294117647,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,0.4030612245,0.6744186047,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5481727575,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2748815166,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2166666667,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,0.5847826087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2574257426,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.3392070485,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1850899743,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1393034826,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4545454545,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2522522523,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2214285714,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2415730337,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08411214953,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","RISPERIDONE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3956834532,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.06428571429,0.4322580645,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4076923077,NA,NA,0.3288888889,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.08554572271,0.375328084,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009803921569,NA,0.3140442133,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.4426229508,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3043478261,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.103960396,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3003952569,"BUPROPION HCL","CLONAZEPAM",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.226993865,"BUPROPION HCL","CLONAZEPAM","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.04964539007,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CLONAZEPAM","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.06494587843,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5744680851,0.3505154639,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5481481481,0.2653061224,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01438848921,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.747826087,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,0.02279792746,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.01724137931,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"41-64","Male",NA,0.03783783784,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",NA,0.03144654088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA
"41-64","Male",NA,0.024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA
"41-64","Male",NA,0.07692307692,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Male",NA,0.05263157895,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"41-64","Male",NA,0.06470588235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA
"41-64","Male",NA,0.1333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SILDENAFIL CITRATE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7115384615,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.06701030928,NA,0.6606060606,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3538230885,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA
"41-64","Male",NA,0.04273504274,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2608695652,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.08450704225,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.02450980392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.06172839506,NA,NA,0.3526011561,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3011889036,"BUPROPION HCL","DOXEPIN HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2924528302,"BUPROPION HCL","DOXEPIN HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Male",NA,0.07027027027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DOXEPIN HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1555555556,"BUPROPION HCL","DOXEPIN HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1973684211,"BUPROPION HCL","DOXEPIN HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.07971656333,0.4230769231,NA,NA,0.4449130206,0.1736526946,NA,NA,NA,NA,NA,NA,NA,NA,0.3295530354,"BUPROPION HCL","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.05263157895,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2423312883,"BUPROPION HCL","DULOXETINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3360655738,"BUPROPION HCL","DULOXETINE HCL","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.125,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08494208494,"BUPROPION HCL","DULOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06542056075,"BUPROPION HCL","DULOXETINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,0.06857142857,NA,NA,NA,0.56167979,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4787735849,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.06666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3744075829,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",NA,0.08653846154,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Male",NA,0.0625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02803738318,NA,NA,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,0.1743589744,NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5769230769,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.05594405594,NA,NA,NA,0.2670807453,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2748538012,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3482142857,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3744075829,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6625,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.5361445783,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5034246575,"BUPROPION HCL","DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3195020747,"BUPROPION HCL","DULOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2600619195,"BUPROPION HCL","DULOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.2167832168,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1435897436,"BUPROPION HCL","DULOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1188118812,"BUPROPION HCL","DULOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3076923077,"BUPROPION HCL","DULOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2110091743,"BUPROPION HCL","DULOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3225806452,"BUPROPION HCL","DULOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3009259259,"BUPROPION HCL","DULOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.05732484076,NA,NA,NA,0.2717770035,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2595628415,"BUPROPION HCL","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2838983051,"BUPROPION HCL","DULOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.05617597293,0.55,NA,NA,0.4822695035,0.2797955831,0.3090909091,0.1261261261,NA,0.3591160221,NA,0.3994252874,0.01724137931,0.587628866,0.2986183074,"BUPROPION HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01754385965,NA,NA,NA,NA,0.2320441989,NA,NA,NA,NA,NA,NA,NA,NA,0.2809917355,"BUPROPION HCL","ESCITALOPRAM OXALATE","FLUOXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.02777777778,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1346153846,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA
"41-64","Male",NA,0.07476635514,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Diff & No Remiss",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1441441441,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1451104101,NA,NA,NA,NA,NA,NA,NA,NA,0.3,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1434262948,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1711711712,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.07633587786,NA,NA,NA,NA,NA,NA,NA,NA,0.0830449827,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05660377358,"BUPROPION HCL","ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.09219858156,NA,NA,NA,NA,NA,NA,NA,NA,0.08208955224,"BUPROPION HCL","ESCITALOPRAM OXALATE","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Male",NA,0.05110274341,NA,NA,NA,0.5294117647,0.3265454545,NA,NA,NA,NA,NA,NA,0,0.6306306306,0.3654320988,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.0303030303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"41-64","Male",NA,0.04901960784,NA,NA,NA,NA,0.3458128079,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Male",NA,0.04522613065,NA,NA,NA,NA,0.2963752665,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3805309735,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3296178344,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2083333333,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Male",NA,0.05309734513,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Male",NA,0.05825242718,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,0.04363636364,NA,NA,NA,NA,0.2535211268,NA,NA,NA,NA,NA,NA,0.03947368421,NA,0.186746988,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,0.1138014528,NA,NA,NA,NA,0.5835294118,NA,NA,NA,NA,NA,NA,NA,NA,0.5767195767,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.6422018349,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Male",NA,0.09677419355,NA,NA,NA,NA,0.59375,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Male",NA,0.01846965699,NA,NA,NA,NA,0.1258907363,NA,NA,NA,NA,NA,NA,NA,NA,0.2673130194,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1503759398,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1559633028,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2798507463,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2522522523,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1338028169,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1057692308,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2815315315,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6384615385,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.75,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5585106383,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.5603448276,NA,NA,NA,NA,NA,NA,NA,NA,0.68,"BUPROPION HCL","ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"41-64","Male",NA,0.3021582734,NA,NA,NA,NA,0.5056818182,NA,NA,NA,NA,NA,NA,NA,NA,0.5164556962,"BUPROPION HCL","ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4112903226,"BUPROPION HCL","ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.231092437,"BUPROPION HCL","ESCITALOPRAM OXALATE","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1971830986,"BUPROPION HCL","ESCITALOPRAM OXALATE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3184713376,"BUPROPION HCL","ESCITALOPRAM OXALATE","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.0756302521,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1433891993,"BUPROPION HCL","ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1485148515,"BUPROPION HCL","ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1024390244,"BUPROPION HCL","ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4298245614,"BUPROPION HCL","ESCITALOPRAM OXALATE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1729323308,"BUPROPION HCL","ESCITALOPRAM OXALATE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1666666667,"BUPROPION HCL","ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2672413793,NA,NA,NA,NA,NA,NA,NA,NA,0.1976744186,"BUPROPION HCL","ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1363636364,"BUPROPION HCL","ESCITALOPRAM OXALATE","RISPERIDONE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.385620915,"BUPROPION HCL","ESCITALOPRAM OXALATE","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.04195804196,NA,NA,NA,NA,0.2476190476,NA,NA,NA,NA,NA,0.472972973,NA,NA,0.3184931507,"BUPROPION HCL","ESCITALOPRAM OXALATE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.05637982196,NA,NA,NA,NA,0.245243129,NA,NA,NA,NA,NA,NA,0.04609929078,NA,0.2052696078,"BUPROPION HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.07874015748,NA,NA,NA,NA,0.2796610169,NA,NA,NA,NA,NA,NA,NA,NA,0.2668810289,"BUPROPION HCL","ESCITALOPRAM OXALATE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.06375545852,0.3619047619,NA,NA,0.3636363636,0.1746835443,0.4655751469,NA,NA,0.4117647059,NA,0.3708791209,NA,0.527638191,0.3942452222,"BUPROPION HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.2916666667,NA,NA,NA,NA,NA,NA,NA,0.2574850299,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.4054054054,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1724137931,"BUPROPION HCL","FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.1467889908,NA,NA,NA,NA,NA,NA,NA,0.0790513834,"BUPROPION HCL","FLUOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA
"41-64","Male",NA,0.04847207587,NA,NA,NA,NA,NA,0.6012658228,NA,NA,NA,NA,NA,NA,NA,0.5535499398,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.04743083004,NA,NA,NA,NA,NA,0.6606260297,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.6053412463,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5316455696,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",NA,0.07142857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Male",NA,0.0625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02873563218,NA,0.3467741935,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,0.1018957346,NA,NA,NA,NA,NA,0.6233421751,NA,NA,NA,NA,NA,NA,NA,0.4931506849,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.08074534161,NA,NA,NA,NA,NA,0.6342857143,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Male",NA,0.03597122302,NA,NA,NA,NA,NA,0.339055794,NA,NA,NA,NA,NA,NA,NA,0.3929539295,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4093959732,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4709677419,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2695652174,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1287128713,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4508474576,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6330935252,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5163934426,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.6434108527,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"41-64","Male",NA,0.4295302013,NA,NA,NA,NA,NA,0.6064981949,NA,NA,NA,NA,NA,NA,NA,0.618556701,"BUPROPION HCL","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4887218045,"BUPROPION HCL","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2376237624,"BUPROPION HCL","FLUOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.6606260297,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2033195021,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2452830189,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2,"BUPROPION HCL","FLUOXETINE HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA
"41-64","Male",NA,0.07843137255,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3416666667,"BUPROPION HCL","FLUOXETINE HCL","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.3187919463,NA,NA,NA,NA,NA,NA,NA,0.2065217391,"BUPROPION HCL","FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1621621622,"BUPROPION HCL","FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4016393443,"BUPROPION HCL","FLUOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1845238095,"BUPROPION HCL","FLUOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2391304348,"BUPROPION HCL","FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.141509434,"BUPROPION HCL","FLUOXETINE HCL","RISPERIDONE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4609929078,"BUPROPION HCL","FLUOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.06944444444,NA,NA,NA,NA,NA,0.4720496894,NA,NA,NA,NA,0.4310344828,NA,NA,0.3073170732,"BUPROPION HCL","FLUOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.07352941176,NA,NA,NA,NA,NA,0.3565891473,NA,NA,NA,NA,NA,0.02293577982,NA,0.2887624467,"BUPROPION HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.1282051282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3252595156,"BUPROPION HCL","FLUOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.09565217391,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2894736842,"BUPROPION HCL","GABAPENTIN",NA,NA,NA,NA,NA
"41-64","Male",NA,0.05357142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GABAPENTIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.05099150142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.02250803859,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.07339449541,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Male",NA,0.09537572254,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.0221402214,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.0390625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784)","SILDENAFIL CITRATE",NA,NA,NA,NA
"41-64","Male",NA,0.07647058824,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09016393443,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"41-64","Male",NA,0.03968253968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA
"41-64","Male",NA,0.04119850187,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1391304348,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PAROXETINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02027027027,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09836065574,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3358778626,NA,NA,0.2610294118,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06787330317,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2554744526,0.1870503597,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.2454545455,0.07692307692,NA,NA,NA,NA,NA,0.2348484848,NA,0.3125,0.1498371336,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.05185185185,NA,NA,NA,NA,NA,NA,NA,NA,0.1544117647,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06626506024,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3823529412,NA,NA,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1171171171,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07006369427,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2735849057,0.1163522013,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3673469388,NA,NA,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4580152672,NA,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08695652174,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.18,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PAROXETINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,NA,NA,0.1611111111,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05882352941,"BUPROPION HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008474576271,NA,NA,"BUPROPION HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02747252747,NA,NA,"BUPROPION HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02573529412,NA,NA,"BUPROPION HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,0.1698113208,NA,NA,0.127388535,NA,0.186440678,NA,NA,NA,NA,0.2293577982,NA,0.1775700935,0.0910635406,"BUPROPION HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5213675214,"BUPROPION HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4193548387,"BUPROPION HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3930348259,"BUPROPION HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1135531136,"BUPROPION HCL","LAMOTRIGINE","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09523809524,"BUPROPION HCL","LAMOTRIGINE","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1217948718,"BUPROPION HCL","LAMOTRIGINE","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08641975309,"BUPROPION HCL","LAMOTRIGINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07462686567,"BUPROPION HCL","LAMOTRIGINE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04166666667,"BUPROPION HCL","LAMOTRIGINE","RISPERIDONE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1041666667,"BUPROPION HCL","LAMOTRIGINE","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1038251366,NA,NA,0.1030927835,"BUPROPION HCL","LAMOTRIGINE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07485226527,"BUPROPION HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04545454545,"BUPROPION HCL","LAMOTRIGINE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1834862385,0.1282051282,"BUPROPION HCL","LAMOTRIGINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",0.01796407186,0.0696969697,0.4584070796,NA,NA,0.3418604651,0.1752475248,0.4869215292,0.1398963731,NA,0.4022988506,NA,0.5124835742,0.01415701416,0.5222222222,0.2804689911,"BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.358974359,"BUPROPION HCL","Last AD: Diff & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA
"41-64","Male",NA,0.06763285024,NA,NA,NA,NA,NA,NA,0.2323232323,NA,NA,NA,NA,NA,NA,0.2976190476,"BUPROPION HCL","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Male",NA,0.05504587156,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","MIRTAZAPINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Male",NA,0.02803738318,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,0.04150943396,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,0.05263157895,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5056603774,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA
"41-64","Male",NA,0.04615384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6498993964,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Male",NA,0.0594795539,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02325581395,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Male",NA,0.02083333333,NA,NA,NA,NA,NA,NA,NA,NA,0.7201492537,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"41-64","Male",NA,0.04166666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7060773481,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,0.06258503401,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02152641879,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,0.06024096386,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7317073171,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.251552795,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4060402685,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5108877722,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1043219076,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6571428571,0.5778688525,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3153153153,"BUPROPION HCL","Last AD: Diff & No Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2788461538,"BUPROPION HCL","Last AD: Diff & No Remiss","OMEPRAZOLE",NA,NA,NA,NA
"41-64","Male",NA,0.03292894281,NA,NA,NA,NA,0.2242990654,NA,NA,NA,0.7075471698,NA,NA,NA,NA,0.4806070826,"BUPROPION HCL","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1241830065,"BUPROPION HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1009174312,"BUPROPION HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Male",NA,0.06976744186,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,0.06168831169,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02013422819,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,0.05982905983,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1059602649,"BUPROPION HCL","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1386138614,"BUPROPION HCL","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Male",NA,0.09448818898,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.03909643788,NA,NA,NA,NA,0.1985294118,NA,NA,NA,NA,NA,0.7016574586,NA,NA,0.5488013699,"BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.02840909091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005263157895,NA,0.4084507042,"BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2516129032,"BUPROPION HCL","Last AD: Diff & No Remiss","SILDENAFIL CITRATE",NA,NA,NA,NA
"41-64","Male",NA,0.07042253521,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","SILDENAFIL CITRATE","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3591549296,"BUPROPION HCL","Last AD: Diff & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"41-64","Male",NA,0.05308352849,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.021667761,NA,0.1261410788,"BUPROPION HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.02857142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02380952381,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,0.05473372781,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6974169742,0.5287356322,"BUPROPION HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.1403286979,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5534883721,"BUPROPION HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,0.6559633028,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7816901408,"BUPROPION HCL","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Male",NA,0.6610169492,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6043165468,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7055837563,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"41-64","Male",NA,0.07042253521,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.66796875,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,0.1035856574,NA,NA,NA,NA,NA,NA,NA,NA,0.6727272727,NA,NA,NA,NA,0.5,"BUPROPION HCL","Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.09287925697,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6704545455,NA,NA,0.5496688742,"BUPROPION HCL","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.4418604651,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1448275862,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.1176470588,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6555555556,0.5544041451,"BUPROPION HCL","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.0295626523,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1901140684,"BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,0.1826484018,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Male",NA,0.04968944099,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2295081967,"BUPROPION HCL","Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Male",NA,0.03603603604,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA
"41-64","Male",NA,0.01582417582,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Male",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",NA,0.008333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA
"41-64","Male",NA,0.01935483871,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SILDENAFIL CITRATE",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4095238095,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4074074074,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,0.04156171285,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.46,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4945054945,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4920634921,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1661016949,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,0.05405405405,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA
"41-64","Male",NA,0.02325581395,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689)",NA,NA,NA,NA
"41-64","Male",NA,0.03322259136,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"41-64","Male",NA,0.009009009009,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA
"41-64","Male",NA,0.07843137255,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA
"41-64","Male",NA,0.02463054187,NA,NA,NA,NA,NA,NA,NA,NA,0.2721893491,NA,NA,NA,NA,0.3906810036,"BUPROPION HCL","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4587628866,"BUPROPION HCL","Last AD: Same & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,0.05803571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2053571429,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1014492754,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1166666667,"BUPROPION HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Male",NA,0.02793296089,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Male",NA,0.02647058824,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA
"41-64","Male",NA,0.03867403315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3561151079,NA,NA,0.4138655462,"BUPROPION HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4743589744,"BUPROPION HCL","Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,0.02319587629,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","SILDENAFIL CITRATE",NA,NA,NA,NA
"41-64","Male",NA,0.04672897196,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"41-64","Male",NA,0.02431610942,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","TADALAFIL",NA,NA,NA,NA
"41-64","Male",NA,0.04501607717,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007380073801,NA,0.1691542289,"BUPROPION HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4896907216,"BUPROPION HCL","Last AD: Same & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,0.04761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","VALACYCLOVIR HCL",NA,NA,NA,NA
"41-64","Male",NA,0.03240740741,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.355704698,0.3857142857,"BUPROPION HCL","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.5195195195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6457318636,"BUPROPION HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.72,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7904761905,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,0.5017667845,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7402777778,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7462686567,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.796875,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7839285714,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.811023622,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5841924399,"BUPROPION HCL","Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5462962963,"BUPROPION HCL","Last AD: Same & Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6060606061,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6643356643,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6487603306,"BUPROPION HCL","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"BUPROPION HCL","Last AD: Same & Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6114649682,"BUPROPION HCL","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5095057034,"BUPROPION HCL","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6728571429,"BUPROPION HCL","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5801526718,"BUPROPION HCL","Last AD: Same & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5392702536,"BUPROPION HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5467980296,"BUPROPION HCL","Last AD: Same & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6247191011,"BUPROPION HCL","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03787878788,"BUPROPION HCL","LITHIUM CARBONATE",NA,NA,NA,NA,NA
"41-64","Male",NA,0.06542056075,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","LORAZEPAM",NA,NA,NA,NA,NA
"41-64","Male",NA,0.05294117647,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","LORAZEPAM","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.5346062053,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6929955291,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.6634615385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7512437811,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7674418605,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6943521595,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.5282258065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6588693957,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6885245902,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6818181818,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5849056604,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6198347107,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7096774194,NA,NA,NA,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.5625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6582857143,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6260162602,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3418803419,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.4066889632,NA,NA,NA,0.5879120879,0.5222672065,0.5,NA,NA,NA,NA,NA,NA,0.6028037383,0.5638597905,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.564231738,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4219653179,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.48,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5238095238,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4703389831,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,0.3897058824,NA,NA,NA,NA,NA,NA,NA,NA,0.6241610738,NA,NA,NA,NA,0.6315789474,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.6090909091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6308724832,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5404040404,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6823529412,NA,NA,0.6111111111,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5096153846,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,0.4074941452,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5276098347,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4285714286,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,0.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,0.5070422535,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.06962025316,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.126984127,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","METHYLPHENIDATE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.07903225806,NA,NA,NA,0.2,NA,NA,0.2168674699,NA,NA,NA,NA,NA,NA,0.2730189285,"BUPROPION HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2108843537,"BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2092696629,"BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1712328767,"BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1370967742,"BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3423423423,"BUPROPION HCL","MIRTAZAPINE","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1123595506,"BUPROPION HCL","MIRTAZAPINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1016949153,"BUPROPION HCL","MIRTAZAPINE","RISPERIDONE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2772277228,"BUPROPION HCL","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.02702702703,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2096069869,"BUPROPION HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2385964912,"BUPROPION HCL","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.0871559633,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.06930693069,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.0486066105,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.05263157895,NA,NA,NA,NA,NA,NA,NA,0.1550802139,NA,NA,NA,NA,NA,0.3402298851,"BUPROPION HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2868852459,"BUPROPION HCL","NORTRIPTYLINE HCL","Num Previous Antidep: 4+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1712328767,"BUPROPION HCL","NORTRIPTYLINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2307692308,"BUPROPION HCL","NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.519434629,NA,NA,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7331081081,NA,NA,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.706,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2336530078,"BUPROPION HCL","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3687943262,NA,NA,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 4+","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3694581281,"BUPROPION HCL","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3155555556,"BUPROPION HCL","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3106382979,"BUPROPION HCL","Num Previous Antidep: 4+","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2321981424,"BUPROPION HCL","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3766816143,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 4+","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2355802641,"BUPROPION HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.19348659,"BUPROPION HCL","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1980676329,"BUPROPION HCL","Num Previous Antidep: 4+","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5192982456,NA,NA,NA,NA,NA,"BUPROPION HCL","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6754385965,NA,NA,NA,"BUPROPION HCL","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.08805031447,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1615598886,"BUPROPION HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.145631068,"BUPROPION HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3429487179,"BUPROPION HCL","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3046875,"BUPROPION HCL","OMEPRAZOLE",NA,NA,NA,NA,NA
"41-64","Male",NA,0.06918238994,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.0495049505,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.04939422181,0.4603174603,NA,NA,0.3870967742,0.1946902655,0.3684210526,NA,NA,0.4914826498,NA,0.4060606061,NA,0.61,0.3930348259,"BUPROPION HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2623762376,NA,NA,NA,NA,0.1376811594,"BUPROPION HCL","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1592920354,"BUPROPION HCL","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,0.07936507937,NA,NA,NA,NA,NA,NA,NA,NA,0.324742268,NA,NA,0.02586206897,NA,0.3196721311,"BUPROPION HCL","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.234375,"BUPROPION HCL","PAROXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.08463035019,NA,NA,NA,0.1141304348,NA,NA,NA,NA,NA,NA,0.1666666667,NA,0.1651090343,0.1003976143,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07301587302,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2564102564,NA,NA,0.1975308642,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1865284974,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09037328094,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1401869159,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2590673575,0.173126615,"BUPROPION HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.08139534884,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.425070688,"BUPROPION HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4205607477,"BUPROPION HCL","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.406504065,"BUPROPION HCL","PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3434535104,"BUPROPION HCL","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.07407407407,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","PREGABALIN",NA,NA,NA,NA,NA
"41-64","Male",NA,0.07189542484,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1224489796,"BUPROPION HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2522522523,"BUPROPION HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09433962264,"BUPROPION HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1230769231,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1822660099,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1592920354,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07981220657,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2285714286,0.1609403255,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3529411765,NA,NA,0.2731481481,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.132231405,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09756097561,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08411214953,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1166666667,"BUPROPION HCL","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09633027523,"BUPROPION HCL","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1052631579,"BUPROPION HCL","RISPERIDONE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.06640625,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4380165289,NA,NA,NA,0.3936842105,"BUPROPION HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4305555556,"BUPROPION HCL","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2701949861,"BUPROPION HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3931623932,"BUPROPION HCL","ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.0514541387,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.05824972129,0.4123376623,NA,NA,0.3467741935,0.1678004535,0.3657142857,0.1153846154,NA,0.3195876289,NA,0.5063721325,0.03787878788,0.5821596244,0.4324491055,"BUPROPION HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.05053191489,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4168797954,0.008547008547,NA,0.3237311385,"BUPROPION HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.04761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5379746835,NA,NA,0.2874493927,"BUPROPION HCL","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.07142857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.268722467,"BUPROPION HCL","SILDENAFIL CITRATE",NA,NA,NA,NA,NA
"41-64","Male",NA,0.04666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3927125506,"BUPROPION HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",NA,0.1008403361,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","TADALAFIL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.09523809524,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","TESTOSTERONE",NA,NA,NA,NA,NA
"41-64","Male",NA,0.0720086627,0.2820512821,NA,NA,0.2830188679,0.1687242798,0.2426035503,NA,NA,NA,NA,0.2934131737,0.02235861464,0.2625,0.268930665,"BUPROPION HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.06382978723,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03773584906,0.3988095238,0.2719568567,"BUPROPION HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.09401709402,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.09248554913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","VALACYCLOVIR HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.06886045094,0.42,NA,NA,NA,0.2027027027,0.3728813559,NA,NA,NA,NA,0.4601769912,NA,0.5207303157,0.3473833767,"BUPROPION HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6283185841,"BUPROPION HCL","VILAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.138028169,NA,NA,NA,NA,NA,0.572327044,NA,NA,0.2644628099,"BUSPIRONE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.4710743802,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUSPIRONE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6171428571,"CARBIDOPA/LEVODOPA","PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,"CARBIDOPA/LEVODOPA","PARALYSIS AGITANS (dxo:ICD9:3320)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Male",0.009554140127,NA,NA,NA,NA,NA,0.2272727273,NA,NA,NA,NA,NA,0.5283018868,0.005952380952,NA,NA,"CARISOPRODOL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5258358663,NA,NA,NA,NA,0.5315315315,NA,NA,NA,NA,NA,NA,NA,NA,"CELECOXIB",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.7251908397,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CELECOXIB","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5422885572,NA,NA,NA,0.1236749117,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CETIRIZINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.7416666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CETIRIZINE HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4251968504,NA,"CHEST PAIN, OTHER (dxo:ICD9:78659)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6293706294,NA,NA,NA,"CHEST PAIN, OTHER (dxo:ICD9:78659)","CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4308943089,NA,NA,NA,0.1485451761,0.490990991,NA,NA,0.4095940959,NA,0.5064766839,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1266666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3035714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1320754717,NA,NA,NA,NA,NA,0.4569536424,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6735751295,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.02327935223,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.02148227712,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.02,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA
"41-64","Male",NA,NA,0.5317460317,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC FATIGUE SYNDROME (dxo:ICD9:78071)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4619883041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC PAIN SYNDROME (dxo:ICD9:3384)",NA,NA,NA,NA,NA,NA
"41-64","Male",0.02613240418,0.04141018467,0.568129192,0.6204819277,0.1368421053,0.4064885496,0.2727272727,0.4599109131,0.1245421245,0.08778625954,0.4269662921,0.196969697,0.470217239,0.01824817518,0.6038406828,0.3260909424,"CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.6783625731,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4427860697,"CITALOPRAM HYDROBROMIDE","CLONAZEPAM",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.713592233,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.03389830508,0.6875,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6559633028,0.4265402844,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.008695652174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5172413793,0.3237410072,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.4017857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.6816143498,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.7313432836,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.54,NA,0.3773584906,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4154411765,"CITALOPRAM HYDROBROMIDE","DOXEPIN HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.6165884194,NA,NA,0.4836601307,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3680672269,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.5725806452,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.464,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3205574913,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.02285714286,0.6867346939,NA,NA,NA,0.3776908023,0.4897959184,NA,NA,0.5042735043,NA,0.5156950673,NA,0.6237623762,0.2417910448,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Male",NA,0.007518796992,0.7346938776,NA,NA,NA,0.4107883817,NA,NA,NA,NA,NA,NA,NA,NA,0.243697479,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.768,NA,NA,NA,0.436416185,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Male",NA,NA,0.6928104575,NA,NA,NA,0.3899371069,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Male",NA,NA,0.6927710843,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2162162162,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.00826446281,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.4545454545,NA,NA,NA,NA,NA,NA,NA,NA,0.37,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.4618181818,NA,NA,NA,0.1960784314,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.419047619,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"41-64","Male",NA,NA,0.4330708661,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",NA,NA,0.7512195122,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.68,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.276119403,NA,NA,NA,NA,NA,NA,0.01481481481,NA,0.2727272727,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.7160883281,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESOMEPRAZOLE MAGNESIUM",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.7899159664,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESOMEPRAZOLE MAGNESIUM","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.6875,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.3533333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.608974359,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.7902097902,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","SIMVASTATIN",NA,NA,NA,NA
"41-64","Male",NA,NA,0.7175141243,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","EZETIMIBE/SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.8015267176,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","FENOFIBRATE",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01550387597,0.504950495,NA,NA,NA,NA,0.5360169492,NA,NA,NA,NA,0.3829787234,NA,NA,0.2589641434,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.3303571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.285,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.7227272727,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4171779141,"CITALOPRAM HYDROBROMIDE","GABAPENTIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.7432432432,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GEMFIBROZIL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.3083832335,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1287128713,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"41-64","Male",NA,NA,0.293814433,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Male",NA,NA,0.1779661017,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1913580247,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,0.4269503546,NA,NA,NA,0.1182432432,NA,NA,NA,NA,NA,0.2546583851,NA,NA,0.2297297297,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.07643312102,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1132075472,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Male",NA,NA,0.2984749455,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Male",NA,NA,0.3247863248,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Male",NA,NA,0.2228915663,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Male",NA,NA,0.4097222222,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2342342342,NA,0.2547169811,0.1535580524,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Male",NA,NA,0.2782608696,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,0.2873563218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,0.2259615385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08805031447,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"41-64","Male",NA,NA,0.1333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Male",NA,NA,0.6755319149,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009009009009,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01063829787,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,0.3801652893,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.1587802313,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09265175719,"CITALOPRAM HYDROBROMIDE","LAMOTRIGINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.1126760563,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LAMOTRIGINE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.1402439024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07482993197,"CITALOPRAM HYDROBROMIDE","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",0.007407407407,0.02491961415,NA,NA,NA,0.3712121212,0.2233766234,0.4557640751,0.09615384615,NA,0.399122807,NA,0.4534711965,0.01768488746,0.5073891626,0.3242271747,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1844660194,NA,NA,NA,NA,NA,NA,0.5221238938,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Male",NA,0.01481481481,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Male",NA,NA,0.551980198,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7071428571,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,0.6515151515,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3857142857,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Male",NA,NA,0.5510688836,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4784313725,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1666666667,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Male",NA,0.02,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2727272727,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.02631578947,0.6297169811,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01077586207,NA,0.5183946488,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.686440678,0.3619047619,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.08318264014,NA,NA,NA,0.4353448276,0.3406374502,0.5966850829,NA,NA,0.6641791045,NA,0.6793103448,0.05529953917,0.6506024096,0.419556172,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7476635514,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Male",NA,NA,0.5905511811,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,0.65625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01470588235,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,0.5808823529,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5185185185,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5196078431,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3846153846,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.6448598131,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03225806452,NA,0.5196850394,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.3979381443,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3495145631,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4528301887,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Male",NA,NA,0.4053826745,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4264705882,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,0.4502923977,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Male",NA,NA,0.2655502392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Male",NA,NA,0.3565217391,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Male",NA,NA,0.2296296296,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"41-64","Male",NA,NA,0.2807017544,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Male",NA,NA,0.4403669725,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4285714286,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.3526570048,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","SILDENAFIL CITRATE",NA,NA,NA,NA
"41-64","Male",NA,NA,0.4719101124,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"41-64","Male",NA,NA,0.3715846995,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.004237288136,NA,0.3519855596,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.7287576021,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5913043478,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.68,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Male",NA,NA,0.54,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Male",NA,NA,0.880733945,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6153846154,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,0.8766519824,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Remissions: 2+",NA,NA,NA,NA
"41-64","Male",NA,NA,0.76,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5517241379,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6930693069,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.72,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","SILDENAFIL CITRATE",NA,NA,NA,NA
"41-64","Male",NA,NA,0.786407767,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","SIMVASTATIN",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6161290323,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.6902654867,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LISINOPRIL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.7215496368,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LISINOPRIL/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4705882353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LISINOPRIL/HYDROCHLOROTHIAZIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.7771428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LISINOPRIL/HYDROCHLOROTHIAZIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.7625570776,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LOVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.7088036117,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.671641791,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.4318181818,0.7082706767,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5887096774,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.762295082,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Male",NA,NA,0.725,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5362903226,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.4836363636,NA,NA,NA,NA,NA,0.228125,NA,NA,NA,NA,NA,NA,0.318128655,"CITALOPRAM HYDROBROMIDE","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1188118812,"CITALOPRAM HYDROBROMIDE","MIRTAZAPINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2947019868,"CITALOPRAM HYDROBROMIDE","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.02285714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.625,NA,NA,NA,NA,NA,NA,0.1807228916,NA,NA,NA,NA,NA,0.4491803279,"CITALOPRAM HYDROBROMIDE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6785714286,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.5476190476,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.8734177215,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Remissions: 2+",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6893203883,"CITALOPRAM HYDROBROMIDE","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2014925373,"CITALOPRAM HYDROBROMIDE","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.7785336357,NA,NA,NA,0.4296875,NA,NA,NA,NA,NA,NA,NA,NA,0.4954682779,"CITALOPRAM HYDROBROMIDE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.7987012987,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SIMVASTATIN",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4014084507,"CITALOPRAM HYDROBROMIDE","OMEPRAZOLE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.723880597,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.7469879518,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.02608695652,0.5601577909,NA,NA,NA,NA,NA,NA,NA,0.5114235501,NA,0.3983739837,NA,NA,0.2607526882,"CITALOPRAM HYDROBROMIDE","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3412698413,"CITALOPRAM HYDROBROMIDE","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.3171745152,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1419491525,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09142857143,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Male",NA,NA,0.2802547771,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2144638404,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.5482866044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5435606061,"CITALOPRAM HYDROBROMIDE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6260869565,"CITALOPRAM HYDROBROMIDE","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"CITALOPRAM HYDROBROMIDE","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.7743902439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PRAVASTATIN SODIUM",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.53125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1747368421,"CITALOPRAM HYDROBROMIDE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2711864407,"CITALOPRAM HYDROBROMIDE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.3197674419,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1404958678,"CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2426470588,"CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.3408577878,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1777777778,"CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.303030303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2142857143,"CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4626865672,NA,NA,NA,0.5785714286,"CITALOPRAM HYDROBROMIDE","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.1993464052,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1212121212,"CITALOPRAM HYDROBROMIDE","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.2288135593,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1307189542,"CITALOPRAM HYDROBROMIDE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.5589353612,NA,NA,NA,NA,NA,NA,NA,NA,0.4743589744,NA,NA,NA,0.5357142857,"CITALOPRAM HYDROBROMIDE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.376146789,"CITALOPRAM HYDROBROMIDE","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.7083333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA
"41-64","Male",NA,0.06153846154,0.539184953,NA,NA,NA,0.2089552239,0.4031007752,NA,NA,0.4159292035,NA,0.5215562566,NA,0.6074766355,0.2455858748,"CITALOPRAM HYDROBROMIDE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.3623188406,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3708609272,NA,NA,0.3024193548,"CITALOPRAM HYDROBROMIDE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.6477987421,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.407079646,"CITALOPRAM HYDROBROMIDE","SILDENAFIL CITRATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.7640562249,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4676806084,"CITALOPRAM HYDROBROMIDE","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.0347826087,0.4838076546,NA,NA,0.368852459,0.2015503876,0.3035714286,NA,NA,NA,NA,0.2840236686,0.0100536193,NA,0.3876850461,"CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2941176471,"CITALOPRAM HYDROBROMIDE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.6695652174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.06626506024,0.5028328612,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3649635036,NA,0.6707692308,0.2990264256,"CITALOPRAM HYDROBROMIDE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",0.03846153846,0.05813953488,0.4598930481,NA,NA,NA,0.1658163265,0.4504504505,0.1703296703,NA,NA,NA,0.4567901235,0.01257861635,0.4195402299,0.2551440329,"CLONAZEPAM",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.404109589,"CLONAZEPAM","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3948717949,NA,NA,NA,NA,NA,NA,NA,NA,0.3539823009,"CLONAZEPAM","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1843971631,"CLONAZEPAM","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CLONAZEPAM","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3475935829,"CLONAZEPAM","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03816793893,NA,NA,"CLONAZEPAM","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3464052288,"CLONAZEPAM","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4380952381,"CLONAZEPAM","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007575757576,NA,NA,"CLONAZEPAM","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7345132743,NA,NA,NA,"CLONAZEPAM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.277027027,NA,NA,NA,NA,NA,NA,NA,"CLONAZEPAM","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.375,"CLONAZEPAM","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.685106383,NA,NA,0.4098360656,"CLONAZEPAM","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03448275862,NA,0.3311258278,"CLONAZEPAM","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6771653543,0.3837209302,"CLONAZEPAM","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4528301887,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CLOTRIMAZOLE/BETAMETHASONE DIP",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4609375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009900990099,NA,NA,"CODEINE PHOSPHATE/GUAIFENESIN",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.07633587786,NA,NA,NA,NA,NA,0.5357142857,NA,NA,NA,NA,NA,NA,NA,NA,"CONGESTIVE HEART FAILURE, UNSPECIFIED (dxo:ICD9:4280)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,0.09239130435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CONTACT DERMATITIS AND OTHER ECZEMA, DUE TO UNSPECIFIED CAUSE (dxo:ICD9:6929)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.3904761905,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3649635036,NA,NA,NA,"CONTACT WITH OR EXPOSURE TO VENEREAL DISEASES (dxo:ICD9:V016)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.004073319756,NA,NA,"CYCLOBENZAPRINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"CYCLOBENZAPRINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.4802259887,NA,NA,NA,0.1470588235,0.5596330275,NA,NA,0.4146341463,NA,0.4669421488,NA,NA,0.3043478261,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7215189873,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6972972973,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",0.0247311828,0.03778337531,0.5537017727,0.6263345196,0.1065088757,0.4429223744,0.164594729,0.524738676,NA,0.1039755352,0.4586288416,0.2820512821,0.6111675127,0.02187286398,0.5935809592,0.2893982808,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,0.6978723404,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA
"41-64","Male",NA,0.02469135802,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.5644599303,NA,NA,NA,NA,NA,NA,NA,NA,0.6901408451,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.33,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.02912621359,NA,NA,NA,NA,0.3371757925,NA,NA,NA,NA,NA,NA,NA,0.6769230769,0.3209302326,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Male",NA,0.006993006993,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5682819383,0.198019802,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.130859375,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.6862745098,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.5685279188,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6246786632,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6926070039,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.6845983788,NA,NA,NA,NA,NA,NA,0.7315789474,0.4851485149,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3302752294,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.4898989899,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.3518518519,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.6832669323,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.7692307692,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.145631068,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"41-64","Male",0.01992031873,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.4379084967,0.1764705882,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Male",NA,0.05487804878,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05072463768,0.2456140351,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.220657277,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.5575221239,NA,NA,NA,NA,NA,0.008528784648,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.004366812227,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04511278195,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.009009009009,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4964539007,0.3172413793,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.375,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7227722772,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7155963303,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3759398496,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3720930233,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01035196687,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.495,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.719047619,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7254901961,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7289377289,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0297029703,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","NONDEPENDENT ALCOHOL ABUSE, UNSPECIFIED DRUNKENNESS (dxo:ICD9:30500)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.03676470588,NA,NA,NA,NA,0.1578947368,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.05263157895,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.02826086957,NA,NA,NA,0.4635193133,0.1544715447,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6743554953,NA,NA,NA,0.7028571429,0.3515151515,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.03414634146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.288,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01858736059,NA,NA,NA,NA,0.1282051282,NA,NA,NA,0.4867256637,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.05042016807,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7405159332,NA,0.662601626,0.4061433447,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.0245398773,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SILDENAFIL CITRATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2265625,0.5118110236,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.593220339,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.623853211,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01449275362,NA,0.41,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5514018692,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.04,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6938416422,0.4341463415,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04132231405,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.4158415842,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF FOOT (dxo:ICD9:1104)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5217391304,NA,NA,NA,0.1858190709,0.5813953488,0.1203703704,NA,0.4526315789,NA,NA,NA,NA,0.2429906542,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.368852459,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6435643564,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1124260355,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESLORATADINE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.04395604396,0.4797297297,0.487928465,NA,NA,0.2434782609,0.3269230769,NA,NA,NA,NA,0.4444444444,NA,0.6911764706,0.297532656,"DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2937062937,"DESVENLAFAXINE SUCCINATE","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2983870968,NA,NA,NA,NA,NA,NA,NA,NA,0.25,"DESVENLAFAXINE SUCCINATE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,0.1310043668,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08333333333,"DESVENLAFAXINE SUCCINATE","LAMOTRIGINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,0.4714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,0.5659574468,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5076923077,"DESVENLAFAXINE SUCCINATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.224137931,"DESVENLAFAXINE SUCCINATE","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,0.228,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,0.1543209877,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,0.2675159236,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,0.5930232558,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.36,"DESVENLAFAXINE SUCCINATE","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2941176471,"DESVENLAFAXINE SUCCINATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5462962963,NA,NA,NA,0.1583333333,NA,NA,NA,NA,NA,0.5405405405,NA,NA,NA,"DEXTROAMPHETAMINE/AMPHETAMINE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6315789474,NA,NA,NA,"DEXTROAMPHETAMINE/AMPHETAMINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",0.01310043668,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED (dxo:ICD9:25001)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.02845528455,NA,NA,NA,NA,NA,NA,NA,NA,0.5047619048,NA,NA,NA,NA,NA,"DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.03100775194,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.02142857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.02941176471,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5084745763,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DIAPHRAGMATIC HERNIA WITHOUT MENTION OF OBSTRUCTION OR GANGRENE (dxo:ICD9:5533)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.4881889764,NA,NA,NA,NA,0.4901960784,0.01242236025,0.5392156863,NA,"DIAZEPAM",NA,NA,NA,NA,NA,NA
"41-64","Male",0.01463414634,NA,NA,NA,NA,NA,NA,NA,NA,0.09016393443,NA,NA,NA,NA,NA,NA,"DISTURBANCE OF SKIN SENSATION (dxo:ICD9:7820)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.5582822086,NA,NA,NA,NA,0.5514018692,NA,NA,NA,"DIZZINESS AND GIDDINESS (dxo:ICD9:7804)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.02654867257,NA,NA,0.3391699092,0.3069306931,0.1504424779,NA,NA,NA,NA,NA,0.3846153846,NA,NA,0.3481298808,"DOXEPIN HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.5310344828,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3805309735,"DOXEPIN HCL","DULOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,0.2377622378,NA,0.3258928571,NA,NA,NA,NA,NA,NA,NA,NA,0.2751091703,"DOXEPIN HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.375,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3942307692,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,0.3237410072,NA,NA,0.5131578947,NA,NA,NA,NA,NA,NA,NA,0.4166666667,"DOXEPIN HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3,"DOXEPIN HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1111111111,"DOXEPIN HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3767123288,"DOXEPIN HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7739130435,NA,NA,NA,"DOXEPIN HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,0.1658767773,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,0.5824175824,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5812807882,"DOXEPIN HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5865384615,"DOXEPIN HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.51,"DOXEPIN HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2925925926,"DOXEPIN HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.756097561,NA,NA,NA,"DOXEPIN HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1681415929,"DOXEPIN HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6744186047,NA,NA,NA,NA,0.3722627737,"DOXEPIN HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3720930233,"DOXEPIN HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,0.356097561,NA,NA,NA,NA,NA,NA,NA,0.6169590643,NA,NA,0.367816092,"DOXEPIN HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.265141319,"DOXEPIN HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,0.37,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7043478261,0.326007326,"DOXEPIN HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",0.02401372213,0.03796296296,0.5005025126,NA,0.1409395973,0.4462746107,0.2021521906,0.4235294118,0.1578947368,0.1,0.4334203655,0.1634615385,0.4907677357,0.02473498233,0.6467236467,0.3238291833,"DULOXETINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.02777777778,NA,NA,NA,0.5048076923,0.3906020558,NA,NA,NA,NA,NA,0.4571428571,NA,NA,0.2921052632,"DULOXETINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.4827586207,0.4765625,NA,NA,NA,NA,NA,NA,NA,NA,0.303030303,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.5112359551,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3076923077,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3209876543,"DULOXETINE HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.4441340782,NA,0.575,NA,NA,NA,NA,NA,NA,NA,0.3013937282,"DULOXETINE HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4455445545,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.7087378641,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.6822429907,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3043478261,"DULOXETINE HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.6159844055,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4480519481,"DULOXETINE HCL","GABAPENTIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3240740741,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.675,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.6166666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.7073170732,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.275862069,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09933774834,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.2085889571,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.1751824818,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02884615385,NA,NA,"DULOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.1268292683,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08436213992,"DULOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.08196721311,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","LAMOTRIGINE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.4036697248,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.1363636364,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09818181818,"DULOXETINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",0.02702702703,0.03137254902,0.5195530726,NA,NA,NA,0.1619937695,0.5,NA,NA,NA,NA,0.5041322314,0,0.5577689243,0.3228021978,"DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7213114754,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01895734597,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.4907407407,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4552529183,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5147058824,"DULOXETINE HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.5054466231,NA,NA,NA,NA,NA,NA,NA,0.01809954751,NA,0.4886363636,"DULOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.6746031746,NA,NA,NA,NA,NA,NA,NA,NA,0.7213114754,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.06779661017,NA,NA,NA,0.693877551,0.3014705882,NA,NA,NA,NA,NA,NA,NA,0.6976744186,0.4309210526,"DULOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01904761905,NA,NA,"DULOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7071428571,NA,NA,0.4818181818,"DULOXETINE HCL","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.6008583691,NA,NA,NA,NA,NA,NA,NA,0.04016064257,NA,0.536,"DULOXETINE HCL","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.292834891,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3285714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5044247788,"DULOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3786407767,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.1133603239,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.4015748031,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","PREGABALIN",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.24,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.298136646,NA,NA,NA,NA,NA,NA,NA,0.01398601399,NA,0.4006968641,"DULOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3859649123,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.6733897202,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5701754386,"DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5714285714,"DULOXETINE HCL","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6638655462,"DULOXETINE HCL","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5631691649,"DULOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.6481481481,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.6738609113,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6637931034,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.5736040609,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5343035343,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.6036866359,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4347826087,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3673469388,NA,NA,0.2514124294,NA,NA,NA,NA,NA,NA,0.3354271357,"DULOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1666666667,"DULOXETINE HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3656716418,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2604166667,"DULOXETINE HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.5656565657,NA,NA,NA,0.1603053435,NA,NA,NA,NA,NA,0.4382352941,"DULOXETINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7170731707,NA,NA,NA,"DULOXETINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2475247525,"DULOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4304932735,"DULOXETINE HCL","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.5756302521,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.4679245283,NA,NA,NA,NA,0.5726495726,NA,NA,NA,NA,0.3970037453,"DULOXETINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.2727272727,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09489051095,"DULOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.2574850299,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1403508772,"DULOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3967213115,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4464692483,"DULOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3097345133,"DULOXETINE HCL","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.5884773663,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","PREGABALIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1597938144,"DULOXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1582278481,"DULOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3217665615,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.194092827,"DULOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3109243697,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2700729927,"DULOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,"DULOXETINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.2682926829,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1310344828,"DULOXETINE HCL","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07518796992,"DULOXETINE HCL","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.426597582,NA,NA,NA,NA,NA,0.3679245283,NA,NA,NA,0.4751655629,"DULOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4206349206,"DULOXETINE HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.6884057971,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.487804878,0.1694915254,NA,NA,NA,NA,NA,0.5984427141,NA,NA,0.3769968051,"DULOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3540145985,"DULOXETINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","TRAMADOL HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3973294839,0.12,NA,NA,NA,NA,NA,NA,0.04362416107,NA,0.358739255,"DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3,"DULOXETINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.5995423341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.6519337017,NA,NA,NA,NA,NA,NA,NA,NA,0.7234042553,0.331838565,"DULOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.0223880597,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DYSMETABOLIC SYNDROME X (dxo:ICD9:2777)",NA,NA,NA,NA,NA,NA
"41-64","Male",0.01550387597,NA,NA,NA,NA,NA,NA,0.5794392523,NA,NA,NA,NA,NA,0.01886792453,0.5717884131,0.3867924528,"DYSTHYMIC DISORDER (dxo:ICD9:3004)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7258064516,NA,"DYSTHYMIC DISORDER (dxo:ICD9:3004)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.03626943005,0.5555555556,NA,NA,NA,0.1798107256,0.5885714286,NA,NA,NA,NA,NA,NA,NA,0.2586206897,"ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3644859813,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4514285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ENCOUNTER FOR OTHER SPECIFIED AFTERCARE (dxo:ICD9:V5889)",NA,NA,NA,NA,NA,NA
"41-64","Male",0.02002670227,0.0267910897,0.6785789808,NA,0.1565217391,0.4931921331,0.3142857143,0.4530005311,0.1391304348,0.07142857143,0.4245283019,0.2727272727,0.4743202417,0.01795977011,0.5701275046,0.2454952895,"ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3535353535,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ESOMEPRAZOLE MAGNESIUM",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1557377049,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ESOMEPRAZOLE MAGNESIUM","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3017241379,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","EZETIMIBE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3448275862,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","EZETIMIBE/SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1470588235,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","EZETIMIBE/SIMVASTATIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.4106280193,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FENOFIBRATE NANOCRYSTALLIZED",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1640625,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FENOFIBRATE NANOCRYSTALLIZED","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,0.04310344828,NA,NA,NA,NA,0.2793367347,0.5699152542,NA,NA,NA,NA,0.43125,NA,NA,0.2183486239,"ESCITALOPRAM OXALATE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3827160494,NA,NA,NA,NA,NA,NA,NA,NA,0.2464788732,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3983739837,0.7477477477,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1782945736,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.75,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2231404959,NA,NA,NA,NA,NA,NA,NA,NA,0.2886597938,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3957219251,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GABAPENTIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1756756757,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GABAPENTIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3381642512,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1944444444,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2987012987,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1643835616,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","HYDROCODONE/ACETAMINOPHEN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,0.2313432836,NA,NA,NA,0.2206405694,NA,NA,NA,NA,NA,NA,NA,NA,0.08303249097,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1130434783,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.07462686567,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1254752852,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05555555556,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1055900621,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,0.3401759531,NA,NA,NA,0.1774193548,0.2621359223,NA,NA,NA,NA,0.320754717,NA,0.3314606742,0.2075471698,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1551724138,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1032608696,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1260504202,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.134529148,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1136974038,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1181818182,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1247484909,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07299270073,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Male",NA,NA,0.3065326633,NA,NA,NA,0.1725067385,NA,NA,NA,NA,NA,0.2941176471,NA,0.308411215,0.1241610738,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1494252874,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1952191235,NA,NA,NA,NA,NA,NA,NA,NA,0.06563706564,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1157894737,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05882352941,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"ESCITALOPRAM OXALATE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"ESCITALOPRAM OXALATE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008230452675,NA,NA,"ESCITALOPRAM OXALATE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.09219858156,NA,NA,NA,NA,NA,NA,NA,NA,0.05675675676,"ESCITALOPRAM OXALATE","LAMOTRIGINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.05381165919,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LAMOTRIGINE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.08571428571,NA,NA,NA,NA,NA,NA,NA,NA,0.0632183908,"ESCITALOPRAM OXALATE","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",0,0.02179836512,0.6650141643,NA,NA,0.4113712375,NA,0.5,0.1019417476,NA,0.4519774011,NA,0.4994350282,0.01538461538,0.5392320534,0.1924798568,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3684210526,NA,0.2352941176,NA,NA,NA,NA,NA,NA,0.3539823009,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.4363636364,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3",NA,NA,NA
"41-64","Male",NA,0.01398601399,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.4117647059,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5925925926,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3195876289,NA,NA,NA,NA,NA,NA,0.008333333333,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3883495146,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2556390977,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2976190476,NA,NA,NA,NA,NA,0.6685714286,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3155339806,NA,NA,NA,NA,NA,NA,0.009345794393,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.347107438,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,0.6341463415,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.24375,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2211538462,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.280876494,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2276422764,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3724137931,NA,NA,NA,NA,NA,NA,NA,NA,0.28125,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.006896551724,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01923076923,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09322033898,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1223628692,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2464788732,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,0.04,NA,NA,NA,NA,0.3236714976,NA,NA,NA,NA,NA,NA,NA,NA,0.2475728155,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.015625,NA,NA,NA,NA,0.2969837587,NA,NA,NA,NA,NA,NA,0.01112140871,NA,0.3230593607,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.02542372881,NA,NA,NA,NA,0.3414634146,NA,NA,NA,NA,NA,NA,NA,0.7027027027,0.4076923077,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.1144781145,0.7762430939,NA,NA,0.5637583893,NA,0.6612903226,NA,NA,NA,NA,0.6643356643,0.1304347826,0.6855345912,0.4244604317,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6785714286,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.6418604651,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3983739837,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.6222910217,NA,NA,NA,NA,NA,NA,0.04501607717,NA,0.4733333333,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1461328615,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2769230769,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1216216216,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.170846395,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2293577982,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3175965665,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1767371601,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1729323308,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","OLMESARTAN MEDOXOMIL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1408450704,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","OMEPRAZOLE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1516853933,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1504424779,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1224489796,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1573033708,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.09345794393,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1272084806,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1038961039,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1326259947,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1619047619,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","RAMIPRIL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1358024691,NA,NA,NA,NA,NA,0.3529411765,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1360294118,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2218309859,NA,NA,NA,NA,NA,NA,0.004149377593,NA,0.26875,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1681415929,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.6856886093,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.6329113924,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.5625,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.8859060403,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.876344086,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Remissions: 2+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.7485207101,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6078431373,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.6788321168,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","SIMVASTATIN",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6056338028,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2660550459,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LEVOFLOXACIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.4672897196,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LISINOPRIL/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3211678832,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LOVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.22,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LOVASTATIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.6558935361,NA,NA,NA,NA,NA,NA,NA,NA,0.6791044776,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.465085639,NA,NA,NA,NA,NA,NA,NA,NA,0.5078431373,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.4034334764,NA,NA,NA,NA,NA,NA,0.1696428571,NA,0.4774774775,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3091247672,NA,0.2361809045,NA,NA,NA,NA,NA,NA,0.2905660377,"ESCITALOPRAM OXALATE","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2324723247,"ESCITALOPRAM OXALATE","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.44,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","MORBID OBESITY (dxo:ICD9:27801)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.03937007874,NA,NA,NA,NA,0.3736842105,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3901345291,NA,NA,0.2372881356,NA,NA,NA,NA,NA,0.3261648746,"ESCITALOPRAM OXALATE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6575342466,NA,NA,NA,"ESCITALOPRAM OXALATE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.6363636364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Num Previous Episodes: 2+",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1179487179,"ESCITALOPRAM OXALATE","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.7700534759,NA,NA,NA,0.4577075099,NA,NA,NA,NA,NA,NA,NA,NA,0.4047619048,"ESCITALOPRAM OXALATE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.36,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","OLMESARTAN MEDOXOMIL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3754152824,NA,NA,NA,NA,NA,NA,NA,NA,0.3425925926,"ESCITALOPRAM OXALATE","OMEPRAZOLE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3464566929,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.47,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","OXYCODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3223684211,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3184210526,NA,NA,NA,0.5488826816,NA,0.408,NA,NA,0.2211055276,"ESCITALOPRAM OXALATE","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2416666667,"ESCITALOPRAM OXALATE","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.3021276596,NA,NA,NA,0.3179190751,NA,NA,NA,NA,NA,0.2090909091,NA,NA,0.09302325581,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05928853755,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1147540984,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.28,NA,NA,NA,NA,NA,NA,NA,NA,0.5020325203,"ESCITALOPRAM OXALATE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3018867925,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Male",NA,NA,0.4807692308,NA,NA,NA,0.2465116279,NA,NA,NA,NA,NA,NA,NA,NA,0.1324110672,"ESCITALOPRAM OXALATE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2,NA,NA,NA,NA,NA,NA,NA,NA,0.08712121212,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1081081081,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2346491228,NA,NA,NA,NA,NA,0.1655172414,NA,NA,0.1804222649,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2320441989,NA,NA,NA,NA,NA,NA,NA,NA,0.1730769231,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3205128205,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","RAMIPRIL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4029850746,"ESCITALOPRAM OXALATE","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5544554455,"ESCITALOPRAM OXALATE","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1018518519,NA,NA,NA,NA,NA,NA,NA,NA,0.13,"ESCITALOPRAM OXALATE","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08450704225,"ESCITALOPRAM OXALATE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3578336557,NA,NA,NA,NA,0.3831168831,NA,NA,NA,0.4726477024,"ESCITALOPRAM OXALATE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3798882682,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.04395604396,0.6306306306,NA,NA,NA,0.2544434051,0.3734939759,NA,NA,0.3612903226,NA,0.5248667851,NA,0.5333333333,0.2412342216,"ESCITALOPRAM OXALATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2547770701,NA,NA,NA,NA,NA,0.4297520661,0.01754385965,NA,0.2765957447,"ESCITALOPRAM OXALATE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.7397260274,NA,NA,NA,0.4071729958,NA,NA,NA,NA,NA,NA,NA,NA,0.3040935673,"ESCITALOPRAM OXALATE","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01675977654,0.4586466165,NA,NA,NA,0.2968790302,0.2718446602,NA,NA,NA,NA,0.3404255319,0.01856763926,NA,0.272889115,"ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2924528302,"ESCITALOPRAM OXALATE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.3169014085,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2866242038,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","VALSARTAN",NA,NA,NA,NA,NA
"41-64","Male",NA,0.03012048193,NA,NA,NA,NA,0.3068893528,NA,NA,NA,NA,NA,0.380952381,NA,0.6930379747,0.2759084791,"ESCITALOPRAM OXALATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5,NA,NA,NA,0.1652754591,0.4730769231,NA,NA,NA,NA,NA,NA,NA,NA,"ESOMEPRAZOLE MAGNESIUM",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.693877551,NA,NA,NA,NA,NA,NA,NA,NA,"ESOMEPRAZOLE MAGNESIUM","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.05434782609,0.4922839506,NA,NA,0.3666666667,NA,0.5879396985,NA,NA,0.4331983806,NA,0.5769230769,NA,0.5730769231,0.3215686275,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3398058252,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4797297297,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7469135802,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.5170068027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","LISINOPRIL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5857142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","LISINOPRIL/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.6019417476,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6944444444,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5310344828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5075757576,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.741697417,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.492,NA,NA,0.3356643357,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"ESZOPICLONE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4267515924,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"EXAMINATION OF EYES AND VISION (dxo:ICD9:V720)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1902439024,NA,NA,NA,NA,NA,NA,NA,NA,NA,"EZETIMIBE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5367483296,NA,NA,0.5,0.1559405941,0.5263157895,NA,NA,0.4485294118,NA,0.548,0.02919708029,0.5268817204,NA,"EZETIMIBE/SIMVASTATIN",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.7676767677,NA,NA,NA,NA,NA,NA,NA,NA,"EZETIMIBE/SIMVASTATIN","FLUOXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7154471545,NA,NA,NA,NA,NA,"EZETIMIBE/SIMVASTATIN","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8217821782,NA,NA,NA,"EZETIMIBE/SIMVASTATIN","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8089171975,NA,"EZETIMIBE/SIMVASTATIN","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5536723164,NA,NA,NA,NA,0.6390977444,NA,NA,NA,NA,0.5582010582,NA,NA,0.336,"FENOFIBRATE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8348623853,NA,NA,NA,"FENOFIBRATE","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8333333333,NA,NA,NA,"FENOFIBRATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.20657277,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FENOFIBRATE NANOCRYSTALLIZED",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6610169492,NA,NA,NA,"FENOFIBRATE,MICRONIZED",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2358490566,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FENTANYL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5102040816,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FEVER AND OTHER PHYSIOLOGIC DISTURBANCES OF TEMPERATURE REGULATION (dxo:ICD9:7806)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01265822785,NA,NA,"FEXOFENADINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4215686275,NA,NA,NA,NA,NA,"FEXOFENADINE/PSEUDOEPHEDRINE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.02521008403,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FITTING AND ADJUSTMENT OF VASCULAR CATHETER (dxi:ICD9:V5881)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5596330275,NA,NA,NA,"FITTING AND ADJUSTMENT OF VASCULAR CATHETER (dxo:ICD9:V5881)",NA,NA,NA,NA,NA,NA
"41-64","Male",0.03448275862,0.0426988266,0.4695906433,0.6666666667,0.1242937853,0.4165366615,0.2112794613,0.5508177304,0.1485013624,0.08474576271,0.4321966693,NA,0.4382275629,0.02151639344,0.5639742673,0.3162230672,"FLUOXETINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.706,NA,NA,NA,NA,NA,NA,NA,0.4958677686,"FLUOXETINE HCL","GABAPENTIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.4680851064,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GABAPENTIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.7298850575,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GABAPENTIN","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.3323782235,NA,NA,NA,NA,NA,NA,NA,0.088,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.2080924855,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.3278688525,NA,NA,NA,NA,NA,NA,NA,0.213836478,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1492537313,0.3986013986,NA,NA,NA,NA,NA,NA,0.3114754098,0.2642857143,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09433962264,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.3076923077,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.3469387755,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.2189349112,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.3879003559,NA,NA,NA,NA,NA,NA,NA,0.1212121212,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.3305084746,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.2690763052,NA,NA,NA,NA,NA,NA,NA,0.0987654321,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.2085889571,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1386138614,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.6326086957,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.6078431373,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01550387597,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.4390243902,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.6298342541,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.1353658537,NA,NA,NA,NA,NA,NA,NA,0.08098591549,"FLUOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.09933774834,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LAMOTRIGINE","Last AD: Same & No Remiss",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.08379888268,NA,NA,NA,NA,NA,NA,NA,0.07843137255,"FLUOXETINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.03416557162,0.4309623431,NA,NA,0.4708994709,0.177184466,NA,0.1047619048,NA,0.4480519481,NA,0.4986666667,0.0206185567,0.4464285714,0.3228271251,"FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.5259067358,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6929824561,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.5903954802,NA,NA,NA,NA,NA,0.01530612245,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.6699029126,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3760683761,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5695067265,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02005730659,NA,0.580493537,"FLUOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7033898305,0.4150943396,"FLUOXETINE HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.06352941176,0.698630137,NA,NA,0.4784946237,0.3037974684,NA,NA,NA,NA,NA,0.5947712418,0.06857142857,0.6402116402,0.4522522523,"FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.5166666667,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.587628866,NA,NA,NA,NA,NA,0.02298850575,NA,NA,"FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5048543689,"FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.5894988067,NA,NA,NA,NA,NA,0.03695652174,NA,0.5866666667,"FLUOXETINE HCL","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.3858024691,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.4275132275,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.54375,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.2113821138,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.3006134969,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.4375,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.4285714286,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","SILDENAFIL CITRATE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.4632034632,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.3373493976,NA,NA,NA,NA,NA,0.01030927835,NA,0.4353233831,"FLUOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.7210710128,NA,NA,NA,NA,NA,NA,NA,0.5299145299,"FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.5825688073,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.8333333333,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.8391608392,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Remissions: 2+",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6517857143,"FLUOXETINE HCL","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.7264150943,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","SILDENAFIL CITRATE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.8060606061,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","SIMVASTATIN",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6206225681,"FLUOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.1715976331,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LITHIUM CARBONATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.7001897533,NA,NA,NA,NA,NA,NA,NA,0.7037037037,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.7913669065,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.4615384615,NA,NA,NA,NA,0.536,0.6721883173,NA,NA,NA,NA,NA,NA,NA,0.5987525988,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.7777777778,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.6153846154,NA,NA,NA,NA,NA,0.19,NA,0.5071428571,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.4926004228,0.2090909091,NA,NA,NA,NA,NA,NA,0.3355978261,"FLUOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.310483871,"FLUOXETINE HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.7037037037,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.6008230453,NA,0.1459459459,NA,NA,NA,NA,NA,0.4679487179,"FLUOXETINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6923076923,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.5907172996,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.6699029126,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.8113207547,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Remissions: 2+",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.5677966102,NA,NA,NA,NA,NA,NA,NA,0.5135135135,"FLUOXETINE HCL","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1740740741,"FLUOXETINE HCL","OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.8139534884,NA,NA,NA,NA,NA,NA,NA,0.4954954955,"FLUOXETINE HCL","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4537037037,"FLUOXETINE HCL","OMEPRAZOLE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.6616541353,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.03149606299,NA,NA,NA,NA,NA,0.5361305361,NA,NA,0.5418994413,NA,NA,NA,NA,0.2668810289,"FLUOXETINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2900763359,"FLUOXETINE HCL","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.3408833522,NA,NA,NA,NA,NA,NA,0.2047244094,0.1214574899,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1038961039,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.2581967213,NA,NA,NA,NA,NA,NA,NA,0.1904761905,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.5581395349,NA,NA,NA,NA,NA,NA,NA,0.4628099174,"FLUOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.5544554455,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.5371900826,NA,NA,NA,NA,NA,NA,NA,0.1440443213,"FLUOXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.2978723404,NA,NA,NA,NA,NA,NA,NA,0.1183431953,"FLUOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2016129032,"FLUOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.3779527559,NA,NA,NA,NA,NA,NA,NA,0.1794871795,"FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.3359375,NA,NA,NA,NA,NA,NA,NA,0.3153846154,"FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.09448818898,NA,NA,NA,NA,NA,NA,NA,0.09502262443,"FLUOXETINE HCL","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1437125749,"FLUOXETINE HCL","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.5327510917,NA,NA,NA,0.4097222222,NA,NA,NA,0.4806378132,"FLUOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3277310924,"FLUOXETINE HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.7142857143,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA
"41-64","Male",NA,0.0641025641,0.3582089552,NA,NA,NA,0.2080536913,0.4815229563,NA,NA,NA,NA,0.5077910174,NA,NA,0.2721238938,"FLUOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.4191176471,NA,NA,NA,NA,NA,NA,NA,0.3701657459,"FLUOXETINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.6639344262,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","SILDENAFIL CITRATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.7730923695,NA,NA,NA,NA,NA,NA,NA,0.4564102564,"FLUOXETINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",NA,0.03225806452,NA,NA,NA,0.2788461538,0.152173913,0.4449528937,NA,NA,NA,NA,0.3039215686,0.02378190255,NA,0.4170021312,"FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01960784314,NA,0.3461538462,"FLUOXETINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.7011494253,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01680672269,NA,NA,NA,NA,NA,0.537037037,NA,NA,NA,NA,0.4035087719,NA,0.6538461538,0.3143669986,"FLUOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.6704545455,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"41-64","Male",0.01015228426,0.01851851852,0.4531835206,NA,NA,0.3453422542,0.1583476764,0.4940397351,NA,0.05735660848,0.398089172,NA,0.4927344782,NA,NA,0.2463054187,"GABAPENTIN",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3758865248,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2764227642,"GABAPENTIN","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4953271028,NA,NA,NA,"GABAPENTIN","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6896551724,NA,NA,NA,"GABAPENTIN","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.03333333333,NA,NA,NA,NA,0.1846153846,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1883116883,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3465346535,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7247191011,NA,NA,NA,NA,0.362745098,"GABAPENTIN","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3816254417,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","PREGABALIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6971428571,NA,NA,0.4805194805,"GABAPENTIN","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6428571429,NA,NA,NA,"GABAPENTIN","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3359683794,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","TRAMADOL HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3407407407,"GABAPENTIN","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3531914894,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3461538462,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4188034188,"GABAPENTIN","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5729537367,NA,NA,NA,NA,NA,NA,NA,0.4937759336,NA,0.5853658537,NA,NA,NA,"GEMFIBROZIL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7333333333,NA,NA,NA,NA,NA,"GEMFIBROZIL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7739130435,NA,NA,NA,"GEMFIBROZIL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",0.009803921569,0.0455075846,NA,NA,NA,NA,0.1618625277,0.4186046512,NA,NA,NA,NA,0.6060606061,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.03787878788,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01785714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.731092437,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4018691589,NA,NA,NA,0.1877394636,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GUAIFENESIN/P-EPHED HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1554878049,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GUAIFENESIN/PHENYLEPHRINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4071428571,NA,NA,NA,NA,NA,"GUAIFENESIN/PSEUDOEPHEDRNE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5968992248,NA,NA,NA,NA,NA,"GUAIFENESIN/PSEUDOEPHEDRNE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",0.01683501684,0.04214559387,NA,NA,NA,NA,NA,0.5461538462,NA,0.06240126382,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04166666667,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"41-64","Male",0.02325581395,NA,NA,NA,NA,NA,NA,NA,NA,0.07619047619,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1712707182,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.009523809524,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Male",0.03100775194,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","OXYCODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",0.01754385965,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4278074866,NA,NA,NA,NA,NA,NA,NA,0.4,NA,NA,NA,NA,NA,"HEMATURIA (dxo:ICD9:5997)",NA,NA,NA,NA,NA,NA
"41-64","Male",0.006289308176,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HERPES ZOSTER WITHOUT MENTION OF COMPLICATION (dxo:ICD9:0539)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005882352941,NA,NA,"HIP JOINT REPLACEMENT BY OTHER MEANS (dxo:ICD9:V4364)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4855769231,NA,NA,NA,"HYDRALAZINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",0.01477104874,0.04567307692,NA,NA,NA,0.3460365854,0.1689373297,0.4900990099,NA,0.0990990991,0.4162895928,0.2802197802,0.5275482094,0.01590457256,NA,0.2526539278,"HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.2994011976,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","LUMBAGO (dxo:ICD9:7242)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3703703704,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02027027027,NA,NA,"HYDROCODONE/ACETAMINOPHEN","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7154811715,NA,NA,NA,"HYDROCODONE/ACETAMINOPHEN","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4747474747,NA,NA,NA,0.1588785047,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROCODONE/HOMATROPINE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,0.1648351648,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROXYZINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",0.01960784314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYOSCYAMINE SULFATE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2987804878,0.6349206349,NA,NA,NA,"HYPERSOMNIA WITH SLEEP APNEA, UNSPECIFIED (dxo:ICD9:78053)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4151785714,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4775280899,0.009900990099,NA,NA,"IBUPROFEN",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6847826087,NA,NA,NA,"IBUPROFEN","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2410501193,"IMIPRAMINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.096,"IMIPRAMINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"41-64","Male",NA,0.03711790393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4847094801,NA,NA,NA,"IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8071428571,NA,NA,NA,"IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.01492537313,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.02542372881,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4552238806,NA,NA,NA,"IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784)","OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.708994709,NA,NA,NA,"IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.03448275862,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4088888889,NA,NA,NA,"IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784)","SILDENAFIL CITRATE",NA,NA,NA,NA,NA
"41-64","Male",NA,0.02339181287,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784)","TADALAFIL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.0372960373,0.2197802198,0.1778846154,NA,0.1285714286,0.1015625,0.1605504587,NA,NA,0.1420765027,NA,0.1671087533,0.04377104377,0.2093023256,0.1662971175,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.09259259259,0.07106598985,NA,NA,NA,NA,NA,0.1018518519,NA,0.1353383459,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.07432432432,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2301587302,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2354948805,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01388888889,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2463768116,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1157024793,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3666666667,NA,NA,NA,NA,0.1593406593,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.05714285714,0.1603773585,NA,NA,0.145631068,NA,NA,NA,NA,NA,NA,NA,0.02307692308,0.103030303,0.09243697479,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3305785124,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2091503268,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,0.141509434,NA,NA,0.06770833333,NA,NA,NA,NA,NA,0.1467889908,NA,NA,0.1386138614,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1496062992,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3844621514,NA,NA,0.141025641,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2467532468,NA,NA,0.1747572816,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1151832461,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3136094675,0.1857142857,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3048245614,0.1462450593,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.2066772655,0.3603603604,0.1086956522,0.2180451128,0.07598212185,0.2166910688,NA,NA,0.1928571429,NA,0.2138945927,0.02065613609,0.2564102564,0.1401425178,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.06578947368,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009523809524,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.09523809524,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1377245509,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1118012422,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1176470588,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2390670554,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2654320988,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1692307692,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2809667674,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2950075643,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009523809524,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3092783505,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1428571429,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.6136363636,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"41-64","Male",NA,NA,0.2781954887,NA,NA,NA,0.08823529412,NA,NA,NA,0.411420205,NA,0.2429906542,NA,NA,0.132231405,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2056737589,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4296875,NA,NA,NA,NA,0.1005586592,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2549019608,NA,NA,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,0.1333333333,NA,NA,0.1015228426,NA,0.1333333333,NA,NA,0.1119402985,NA,0.1293532338,NA,0.1476923077,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Male",NA,NA,0.06666666667,NA,NA,0.08490566038,0.05371900826,NA,NA,NA,NA,NA,0.1088435374,NA,0.1258278146,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2110091743,NA,NA,0.09649122807,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1909090909,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1826923077,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1968911917,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,0.1849529781,0.2806122449,NA,0.2040816327,0.06754148977,0.1890547264,NA,NA,0.1607981221,NA,0.1908690869,0.0119047619,0.220705347,0.1147260274,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4429530201,NA,NA,0.1506849315,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3852459016,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.12,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4454976303,0.1730769231,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,0.2335766423,NA,NA,0.2285714286,0.14,NA,NA,NA,NA,NA,0.4424357755,NA,0.3045977011,0.1791907514,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3883495146,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0.1489361702,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3571428571,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.08441558442,NA,NA,NA,NA,NA,NA,NA,0.4339622642,0.2323943662,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,0.1471389646,0.1533333333,NA,0.1386138614,0.06782608696,0.1264822134,NA,NA,0.1569767442,NA,0.1657142857,0.02127659574,0.1964285714,0.1183800623,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.174863388,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.28125,NA,NA,NA,NA,0.09322033898,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.08152173913,NA,NA,NA,NA,NA,0.12,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.261589404,NA,NA,0.0725388601,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2019230769,NA,NA,0.1272727273,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1287878788,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2159090909,0.1276595745,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90807)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",0.02222222222,0.02521008403,0.4350828729,NA,0.1707317073,NA,0.1494252874,0.4920792079,0.2317380353,NA,0.4484304933,NA,0.5025510204,0.01136644428,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01869158879,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01785714286,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.004291845494,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4043715847,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006641366224,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","TRAZODONE HCL","ZOLPIDEM TARTRATE",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6889952153,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4901960784,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01886792453,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007751937984,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006097560976,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6876267748,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009259259259,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5460526316,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009708737864,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TEMAZEPAM",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02592592593,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009900990099,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAZODONE HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01960784314,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.5403225806,NA,NA,NA,NA,0.5362318841,0.009696969697,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"41-64","Male",0.01612903226,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4697986577,NA,NA,NA,NA,NA,NA,NA,0.4454976303,NA,NA,NA,NA,0.2118644068,"LABORATORY EXAMINATION (dxo:ICD9:V726)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5882352941,NA,NA,NA,NA,NA,"LABORATORY EXAMINATION (dxo:ICD9:V726)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.373015873,NA,NA,NA,0.1466666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LACTULOSE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.1376262626,0.1125,NA,0.1248618785,0.07142857143,0.1343283582,0.04929577465,NA,0.12,0.06542056075,0.1410437236,0.01769911504,0.1582633053,0.08824940048,"LAMOTRIGINE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1161616162,NA,NA,NA,"LAMOTRIGINE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1158536585,NA,"LAMOTRIGINE","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5779816514,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3973799127,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3342939481,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4660194175,NA,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09844559585,"LAMOTRIGINE","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1164658635,"LAMOTRIGINE","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04761904762,"LAMOTRIGINE","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06349206349,"LAMOTRIGINE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07954545455,"LAMOTRIGINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2222222222,NA,NA,NA,NA,0.04672897196,"LAMOTRIGINE","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.132231405,"LAMOTRIGINE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.125,"LAMOTRIGINE","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.095,"LAMOTRIGINE","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04242424242,"LAMOTRIGINE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1883116883,NA,NA,NA,0.1136363636,"LAMOTRIGINE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09090909091,"LAMOTRIGINE","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.158008658,NA,NA,0.08243727599,"LAMOTRIGINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1455696203,NA,NA,0.09433962264,"LAMOTRIGINE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.08910891089,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09000793021,"LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1198156682,0.07647058824,"LAMOTRIGINE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1683937824,0.1051724138,"LAMOTRIGINE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.04166666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LANSOPRAZOLE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.03846153846,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.004804392588,NA,NA,"Last AD: Diff & No Remiss",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.004807692308,NA,NA,NA,NA,0.16,NA,NA,NA,NA,NA,0.42,0,NA,0.2756097561,"Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.69,NA,NA,NA,"Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.252173913,NA,NA,NA,NA,NA,NA,0.5267175573,"Last AD: Diff & No Remiss","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.2658227848,NA,NA,NA,NA,0.008771929825,NA,0.296969697,"Last AD: Diff & No Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.31,NA,NA,NA,NA,NA,NA,0.4608695652,"Last AD: Diff & No Remiss","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.0303030303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.04347826087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.02830188679,NA,NA,NA,0.347107438,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2751677852,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4946619217,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6162790698,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5461538462,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7570093458,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6772908367,NA,NA,0.007633587786,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6434343434,0.01255230126,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7852348993,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7603305785,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4676923077,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3190184049,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5591397849,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2883895131,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5261044177,0.5057471264,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3006993007,"Last AD: Diff & No Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",0,0.01437699681,0.4779874214,NA,NA,0.35,0.1578947368,0.4534412955,0.1007751938,NA,NA,NA,0.4966139955,0.01714285714,0.5543859649,0.2907239819,"Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01149425287,NA,0.5201342282,"Last AD: Diff & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04587155963,NA,NA,"Last AD: Diff & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1226415094,"Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.168,"Last AD: Diff & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1445783133,"Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1171875,"Last AD: Diff & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4705882353,"Last AD: Diff & No Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4055944056,"Last AD: Diff & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",0.0119047619,0.02455871067,0.4007858546,NA,NA,0.3801916933,0.1573770492,0.4689119171,0.1135135135,NA,0.3461538462,NA,NA,0.01499250375,0.4808988764,0.3254658385,"Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01694915254,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01923076923,NA,0.5578231293,"Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6228070175,0.4135338346,"Last AD: Diff & No Remiss","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2910447761,"Last AD: Diff & No Remiss","SIMVASTATIN","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",0.01941747573,0.02985074627,0.4081081081,NA,NA,0.2217898833,0.118902439,0.3622641509,0.1153846154,NA,0.3222748815,NA,0.4365591398,0.01642335766,0.3819444444,0.3052754073,"Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01479915433,0.6379928315,0.5637065637,"Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.02572898799,0.4743589744,NA,NA,0.3888888889,0.2026143791,0.4179104478,NA,NA,NA,NA,0.5454545455,0.02205882353,NA,0.3187919463,"Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.1031468531,NA,0.75,NA,0.5486725664,NA,NA,0.3897280967,NA,NA,NA,NA,0.08385370205,0.6838709677,NA,"Last AD: Diff & Remiss",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.544,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.48,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.7037037037,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6422764228,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4577114428,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.4570815451,NA,NA,NA,NA,NA,NA,0.5113636364,"Last AD: Diff & Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6054421769,NA,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7142857143,NA,NA,NA,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6554455446,0.02127659574,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01785714286,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3816793893,"Last AD: Diff & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5392156863,"Last AD: Diff & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.05821917808,0.641025641,NA,NA,0.487394958,0.2441860465,0.5606060606,NA,NA,NA,NA,0.66,0.1408450704,0.6725146199,0.3601953602,"Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6756756757,NA,NA,0.04705882353,NA,0.4610778443,"Last AD: Diff & Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5477707006,"Last AD: Diff & Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",0.03738317757,0.07066052227,0.5854700855,NA,NA,0.5158730159,0.2588726514,0.579787234,0.3111111111,NA,0.5064935065,NA,NA,0.05952380952,0.7166123779,0.4277456647,"Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.65917603,0.04975922953,NA,0.5,"Last AD: Diff & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4036697248,"Last AD: Diff & Remiss","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05309734513,NA,NA,"Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07278481013,0.6507936508,0.4615384615,"Last AD: Diff & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.07284768212,0.6261682243,NA,NA,0.5167785235,0.2352941176,0.5826771654,NA,NA,NA,NA,0.637037037,0.1171171171,0.7142857143,0.4231292517,"Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.0564516129,NA,NA,NA,NA,NA,NA,NA,0.1398026316,"Last AD: Same & No Remiss",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4421768707,NA,NA,NA,"Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1009174312,NA,NA,"Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1608430394,NA,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4455445545,NA,NA,NA,"Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06190885641,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1473214286,"Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3496932515,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.408,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4016351559,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2897196262,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","SILDENAFIL CITRATE",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4285714286,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4734299517,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.002735978112,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4244897959,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5099009901,NA,NA,NA,"Last AD: Same & No Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.427184466,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4977973568,NA,NA,NA,"Last AD: Same & No Remiss","OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5714285714,"Last AD: Same & No Remiss","PARALYSIS AGITANS (dxo:ICD9:3320)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3365352208,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2138554217,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3177570093,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2325581395,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3039215686,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2900763359,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL","SILDENAFIL CITRATE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3362831858,NA,NA,0,NA,0.3518518519,"Last AD: Same & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Same & No Remiss","PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09923664122,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2452471483,NA,NA,NA,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1559633028,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01647058824,NA,NA,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1780487805,NA,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4221453287,"Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4347826087,"Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3916083916,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3432835821,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2767857143,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3206650831,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2283464567,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2394957983,NA,NA,NA,NA,"Last AD: Same & No Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1083333333,NA,NA,NA,"Last AD: Same & No Remiss","RISPERIDONE","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2382397572,NA,NA,NA,NA,"Last AD: Same & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3846153846,NA,NA,NA,"Last AD: Same & No Remiss","ROSUVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Same & No Remiss","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3991931701,NA,NA,0.3944954128,"Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3853211009,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","SILDENAFIL CITRATE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4928909953,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4818181818,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3823529412,0.01045296167,NA,0.4052173913,"Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4166666667,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005376344086,NA,NA,"Last AD: Same & No Remiss","TRAMADOL HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007847996696,NA,0.2706422018,"Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005882352941,NA,NA,"Last AD: Same & No Remiss","TRAZODONE HCL","UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0275862069,0.3355704698,0.3855421687,"Last AD: Same & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.003759398496,NA,NA,"Last AD: Same & No Remiss","TRAZODONE HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3730543506,NA,"Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5820805773,"Last AD: Same & Remiss",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7783783784,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7441860465,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6826347305,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7441860465,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6929133858,NA,NA,NA,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6961077844,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7372262774,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.5801687764,NA,NA,NA,NA,NA,NA,0.5608974359,"Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5369318182,"Last AD: Same & Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5641025641,NA,NA,NA,NA,NA,0.61003861,"Last AD: Same & Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5294117647,"Last AD: Same & Remiss","NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8817204301,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","PAROXETINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8783783784,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.9074074074,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6204819277,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5695876289,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5727272727,"Last AD: Same & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.593220339,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8769230769,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Remissions: 2+","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8806366048,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.9082568807,NA,"Last AD: Same & Remiss","Num Previous Remissions: 2+","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.786163522,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7714285714,NA,NA,NA,"Last AD: Same & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8205128205,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)","PAROXETINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7630922693,NA,NA,NA,"Last AD: Same & Remiss","OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6222222222,"Last AD: Same & Remiss","PARALYSIS AGITANS (dxo:ICD9:3320)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7194910353,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7264150943,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","PAROXETINE HCL","SILDENAFIL CITRATE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6575342466,"Last AD: Same & Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6168831169,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6595744681,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6341463415,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6428571429,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.595505618,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6293706294,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8725490196,NA,NA,NA,"Last AD: Same & Remiss","PRAVASTATIN SODIUM","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.45,NA,NA,NA,"Last AD: Same & Remiss","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5983606557,NA,NA,NA,0.6584022039,"Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7358490566,"Last AD: Same & Remiss","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5560538117,"Last AD: Same & Remiss","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6363636364,"Last AD: Same & Remiss","ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8101265823,NA,NA,NA,"Last AD: Same & Remiss","ROSUVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7447085255,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7174515235,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","SILDENAFIL CITRATE",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7806191117,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7397260274,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6429699842,"Last AD: Same & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7105263158,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.614976102,"Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6296296296,"Last AD: Same & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7188073394,0.5875486381,"Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1592039801,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LEVOFLOXACIN",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5629139073,NA,NA,NA,0.1909090909,0.6273291925,NA,NA,NA,NA,0.5427251732,NA,NA,0.2962962963,"LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8041237113,NA,NA,NA,"LEVOTHYROXINE SODIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4915966387,NA,NA,NA,0.1887755102,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LISINOPRIL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5486381323,NA,NA,NA,0.1436619718,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LISINOPRIL/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.47,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LISINOPRIL/HYDROCHLOROTHIAZIDE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5547445255,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LISINOPRIL/HYDROCHLOROTHIAZIDE","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.1739130435,NA,NA,NA,NA,NA,0.0390625,0.1532846715,0.09558823529,"LITHIUM CARBONATE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1409395973,NA,"LITHIUM CARBONATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5847953216,NA,NA,NA,0.1349206349,NA,NA,NA,0.4410480349,NA,NA,NA,NA,NA,"LORATADINE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6836734694,NA,NA,NA,NA,NA,"LORATADINE","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",0.004566210046,0.0527638191,0.4208144796,NA,NA,NA,NA,0.4899328859,NA,NA,NA,NA,0.5011820331,NA,NA,NA,"LORAZEPAM",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7191780822,NA,NA,NA,"LORAZEPAM","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.04390243902,0.4199475066,NA,NA,NA,NA,0.4777777778,0.1708967851,NA,0.3333333333,NA,0.4208333333,NA,0.5412844037,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.248,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Male",0.008196721311,NA,0.562642369,NA,NA,NA,0.1798941799,0.4907407407,NA,NA,NA,NA,NA,NA,NA,NA,"LOVASTATIN",NA,NA,NA,NA,NA,NA
"41-64","Male",0.007407407407,NA,NA,NA,NA,0.320855615,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"LUMBAGO (dxo:ICD9:7242)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.5191986644,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6878283713,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.6962025316,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7569832402,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7509025271,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6261682243,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.672823219,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.557844691,0.663507109,NA,NA,0.6418918919,0.587020649,0.6470588235,0.5517241379,NA,NA,NA,0.692,0.472168906,0.6516853933,0.6649484536,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.6779661017,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7056074766,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6106870229,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.5955555556,NA,NA,NA,NA,NA,NA,0.6391304348,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5904761905,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.648,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6733668342,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7232289951,NA,NA,0.7154471545,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4375,NA,0.6381987578,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7361376673,0.6573033708,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5390070922,NA,NA,NA,NA,0.6071428571,NA,NA,NA,NA,0.522875817,NA,NA,0.3010204082,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1570247934,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7549019608,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3148148148,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, SEVERE, WITHOUT MENTION OF PSYCHOTIC BEHAVIOR (dxo:ICD9:29633)",NA,NA,NA,NA,NA,NA
"41-64","Male",0.2803738318,0.4313684211,0.634551495,0.6177370031,0.3739130435,0.5735042735,0.5061804697,0.6264367816,0.4616724739,0.4225352113,0.5897435897,NA,0.6010544815,0.2869995502,0.6354895105,0.5480225989,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.5145797599,NA,NA,NA,NA,NA,NA,0.528379773,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3885714286,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5184381779,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.462962963,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.503875969,NA,NA,NA,NA,NA,0.5983263598,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4090909091,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.4915254237,NA,NA,NA,NA,NA,NA,NA,NA,0.6257961783,NA,NA,NA,NA,0.5445026178,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6893939394,NA,NA,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.6095238095,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6726190476,0.6055045872,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7785714286,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7606382979,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5502008032,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3909090909,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.480620155,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4756554307,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5031446541,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.4638554217,NA,NA,NA,NA,0.4296296296,0.5666666667,NA,NA,NA,NA,0.6981865285,NA,NA,0.5913242009,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.587628866,NA,NA,0.5463917526,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.4251968504,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2807525326,0.5607476636,0.5114305916,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5836065574,0.5709876543,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,0.5714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6544776119,0.6073781291,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.04861111111,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5892857143,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.07920792079,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE (dxo:ICD9:29622)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.0625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6377952756,NA,"MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED (dxo:ICD9:29620)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3067729084,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MELOXICAM",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.485106383,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"METAXALONE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4907407407,NA,0.5870646766,NA,NA,NA,"METFORMIN HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7441860465,NA,NA,NA,NA,NA,"METFORMIN HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7087378641,NA,NA,NA,"METFORMIN HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.0612244898,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"METHYLPHENIDATE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1538461538,0.5797101449,NA,NA,NA,NA,NA,NA,NA,NA,"METOPROLOL SUCCINATE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.04310344828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"METOPROLOL TARTRATE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5037037037,NA,NA,NA,"METRONIDAZOLE",NA,NA,NA,NA,NA,NA
"41-64","Male",0.01025641026,NA,NA,NA,NA,NA,0.2450980392,NA,NA,0.06802721088,NA,NA,NA,NA,NA,NA,"MIGRAINE, UNSPECIFIED WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS (dxo:ICD9:34690)",NA,NA,NA,NA,NA,NA
"41-64","Male",0.02083333333,0.01230769231,0.2884615385,NA,NA,0.2888888889,0.1628440367,0.2727272727,0.2916188289,NA,0.253968254,NA,0.3434650456,0.01379310345,0.3444976077,0.3079200592,"MIRTAZAPINE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2408163265,"MIRTAZAPINE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6724137931,NA,NA,NA,"MIRTAZAPINE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1836065574,"MIRTAZAPINE","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2206060606,"MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1581196581,"MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.2752808989,NA,0.46105919,NA,NA,NA,NA,0.3156498674,"MIRTAZAPINE","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3205128205,"MIRTAZAPINE","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1721311475,NA,NA,NA,NA,NA,NA,0.096,"MIRTAZAPINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09090909091,"MIRTAZAPINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2427184466,0.1374045802,"MIRTAZAPINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4078014184,"MIRTAZAPINE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.185840708,"MIRTAZAPINE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1538461538,"MIRTAZAPINE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07975460123,"MIRTAZAPINE","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1176470588,"MIRTAZAPINE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.2627118644,NA,NA,NA,NA,NA,NA,0.3464788732,"MIRTAZAPINE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.2207792208,NA,NA,NA,0.4976958525,NA,NA,0.336461126,"MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4903846154,NA,NA,0.3646209386,"MIRTAZAPINE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.2647058824,NA,NA,NA,NA,NA,NA,0.2902578797,"MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2488479263,"MIRTAZAPINE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.2530487805,NA,NA,NA,NA,NA,0.5545722714,0.2885572139,"MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1343283582,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MITRAL VALVE DISORDERS (dxo:ICD9:4240)",NA,NA,NA,NA,NA,NA
"41-64","Male",0.0350877193,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MIXED HYPERLIPIDEMIA (dxo:ICD9:2722)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.05384615385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MODAFINIL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4968553459,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2061068702,"MONTELUKAST SODIUM",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.05161290323,NA,NA,NA,NA,0.1505102041,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MORBID OBESITY (dxo:ICD9:27801)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2159090909,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MORBID OBESITY (dxo:ICD9:27801)","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Male",0.01814058957,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MORPHINE SULFATE",NA,NA,NA,NA,NA,NA
"41-64","Male",0.01418439716,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MORPHINE SULFATE","OXYCODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.131147541,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MOXIFLOXACIN HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.2083333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MULTIPLE SCLEROSIS (dxo:ICD9:340)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.05140186916,0.5536912752,NA,NA,NA,0.1703296703,0.5971563981,NA,NA,NA,NA,0.509375,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7315436242,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",0.005291005291,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5752212389,NA,NA,NA,"NAPROXEN",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7297297297,NA,NA,NA,"NAPROXEN","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.04391891892,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN (dxo:ICD9:2382)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4666666667,NA,NA,NA,NA,NA,"NONALLOPATHIC LESION OF THORACIC REGION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:7392)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4375,NA,NA,NA,NA,0.4430379747,NA,NA,NA,NA,NA,0.01226993865,NA,NA,"NONDEPENDENT ALCOHOL ABUSE, UNSPECIFIED DRUNKENNESS (dxo:ICD9:30500)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01030927835,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxi:ICD9:3051)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.02290851095,NA,NA,NA,NA,0.1607335491,0.5158730159,0.1788617886,NA,NA,NA,0.4947589099,0.01398601399,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.045,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1928571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.007843137255,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01608579088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01709401709,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01498127341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.03472222222,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7192982456,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01875,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","SILDENAFIL CITRATE",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01515151515,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","TADALAFIL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01886792453,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.02040816327,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","VARENICLINE TARTRATE",NA,NA,NA,NA,NA
"41-64","Male",0.005524861878,0.02395209581,0.3981042654,NA,NA,0.3818897638,0.1398963731,0.3504273504,NA,0.1743304699,0.3644859813,NA,0.397260274,NA,0.352,0.3864848844,"NORTRIPTYLINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.308411215,"NORTRIPTYLINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4844720497,NA,NA,NA,NA,0.4775280899,"NORTRIPTYLINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.448,"NORTRIPTYLINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4230769231,"NORTRIPTYLINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1753554502,NA,NA,0.6115942029,NA,NA,0.4495114007,"NORTRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2196969697,NA,NA,NA,NA,NA,0.3094660194,"NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6802721088,0.3682310469,"NORTRIPTYLINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4983606557,NA,NA,NA,NA,NA,"Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.744,NA,NA,NA,"Num Previous Antidep: 2,3","PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,NA,NA,"Num Previous Antidep: 2,3","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6373626374,NA,NA,NA,"Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7743902439,NA,NA,NA,"Num Previous Antidep: 2,3","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3133333333,NA,NA,NA,NA,0.1963302752,"Num Previous Antidep: 4+",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3709677419,NA,NA,NA,NA,NA,"Num Previous Antidep: 4+","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.31,"Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.37,"Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3551912568,"Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3918918919,"Num Previous Antidep: 4+","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3225806452,"Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3515981735,NA,NA,NA,"Num Previous Antidep: 4+","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2149817296,"Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1576763485,"Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4936305732,NA,NA,NA,NA,NA,"Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8640776699,NA,NA,NA,NA,NA,"Num Previous Remissions: 2+","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8756345178,NA,NA,NA,"Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7297297297,NA,NA,0.5533980583,"Num Previous Remissions: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5454545455,NA,"Num Previous Remissions: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8851351351,NA,"Num Previous Remissions: 2+","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.04859335038,NA,NA,NA,NA,NA,NA,0.2248803828,NA,NA,NA,NA,NA,NA,NA,"OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.05511811024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1701492537,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2142857143,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1111111111,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1955555556,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1709401709,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",0.008620689655,NA,0.5497728211,NA,NA,NA,0.1866458415,0.5628571429,0.1879194631,NA,0.5058139535,0.2994923858,0.5715408805,0.006153846154,0.5680473373,0.3442622951,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1724137931,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","OMEPRAZOLE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1962616822,NA,NA,NA,NA,NA,0.5960264901,NA,NA,NA,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7452574526,NA,NA,NA,NA,0.4631578947,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7566063978,NA,NA,0.5221518987,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8323353293,NA,NA,NA,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Male",NA,NA,0.5555555556,NA,NA,NA,0.2314814815,NA,NA,NA,NA,NA,0.6507177033,NA,NA,NA,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.323943662,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.796875,0.5088495575,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1513859275,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OLMESARTAN MEDOXOMIL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.04861111111,NA,NA,NA,NA,0.1240951396,0.5433526012,NA,NA,NA,NA,NA,NA,NA,0.2546419098,"OMEPRAZOLE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.465648855,"OMEPRAZOLE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01764705882,NA,NA,"OPIOID TYPE DEPENDENCE, UNSPECIFIED (dxo:ICD9:30400)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1165048544,NA,NA,NA,0.3947368421,NA,NA,NA,NA,NA,"OSELTAMIVIR PHOSPHATE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1871657754,"OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE, UNSPECIFIED DRUNKENNESS (dxi:ICD9:30390)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.04132231405,0.3450292398,NA,NA,NA,0.1574074074,NA,NA,NA,NA,NA,0.389261745,0.02941176471,NA,0.2719298246,"OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE, UNSPECIFIED DRUNKENNESS (dxo:ICD9:30390)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.03571428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER AND UNSPECIFIED BIPOLAR DISORDERS (dxo:ICD9:29689)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5298507463,NA,NA,NA,NA,0.5257142857,NA,NA,NA,NA,0.5269461078,NA,NA,NA,"OTHER AND UNSPECIFIED HYPERLIPIDEMIA (dxo:ICD9:2724)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3884297521,NA,"OTHER CHRONIC PAIN (dxo:ICD9:33829)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.0375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER CONVULSIONS (dxo:ICD9:78039)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3796610169,NA,NA,NA,0.4419642857,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5017857143,NA,NA,NA,NA,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.03109452736,NA,0.6326530612,NA,0.4076576577,0.1412742382,0.4968152866,NA,NA,0.472826087,NA,0.5657894737,0.01041666667,0.6315789474,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.02912621359,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.02173913043,NA,NA,NA,NA,0.125984252,NA,NA,NA,NA,NA,NA,0.01,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3523809524,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.137254902,NA,NA,NA,NA,NA,NA,NA,0.5503875969,NA,"OTHER MISCELLANEOUS PROCEDURES (px:ICD9:9999)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4958677686,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER NONSPECIFIC ABNORMAL FINDING OF LUNG FIELD (dxo:ICD9:79319)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.02865329513,0.4237288136,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5701754386,NA,"OTHER SPECIFIED CARDIAC DYSRHYTHMIAS (dxo:ICD9:42789)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4659685864,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER SPECIFIED PRE-OPERATIVE EXAMINATION (dxo:ICD9:V7283)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.05263157895,0.4863013699,NA,NA,NA,0.1806930693,NA,NA,NA,0.3719165085,NA,0.5364010989,NA,NA,NA,"OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6890459364,NA,NA,NA,NA,NA,"OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7631887456,NA,NA,NA,"OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8269230769,NA,NA,NA,"OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4406779661,NA,NA,NA,"OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)","SILDENAFIL CITRATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6025641026,NA,NA,NA,"OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",0.02108433735,NA,NA,NA,NA,NA,0.1534653465,NA,NA,NA,0.4010152284,NA,NA,0.01769911504,NA,NA,"OXYCODONE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0,NA,NA,NA,NA,0.1985294118,NA,NA,NA,NA,NA,NA,0.009756097561,NA,NA,"OXYCODONE HCL/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3730769231,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.424,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.380952381,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PAIN IN JOINT, SITE UNSPECIFIED (dxo:ICD9:71940)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4393939394,NA,NA,0.3567567568,0.1453104359,0.487804878,NA,NA,0.3810810811,NA,0.5115384615,NA,NA,0.2079207921,"PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6612903226,NA,NA,NA,NA,NA,"PALPITATIONS (dxo:ICD9:7851)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.04850746269,NA,NA,NA,NA,NA,NA,NA,NA,0.3976470588,NA,0.5981308411,NA,NA,NA,"PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.711790393,NA,NA,NA,NA,NA,"PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)","PAROXETINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5129310345,NA,NA,NA,0.5589430894,"PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5322580645,"PARALYSIS AGITANS (dxo:ICD9:3320)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6478873239,NA,NA,NA,0.5497835498,"PARALYSIS AGITANS (dxo:ICD9:3320)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4841269841,"PARALYSIS AGITANS (dxo:ICD9:3320)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",0.01715265866,0.03462709285,0.5030599755,0.6774193548,0.1467889908,0.4247871334,0.2,0.4636290967,0.1335149864,0.05952380952,0.5405924921,0.2222222222,0.484398977,0.03745318352,0.6600698487,0.3025477707,"PAROXETINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3410958904,NA,NA,NA,NA,0.1187904968,"PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1090909091,"PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2577777778,NA,NA,NA,NA,0.2007168459,"PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5378486056,NA,NA,NA,NA,0.5193133047,"PAROXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6965811966,NA,NA,NA,NA,NA,"PAROXETINE HCL","PRAVASTATIN SODIUM",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5174418605,NA,NA,NA,NA,0.1253731343,"PAROXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3943661972,NA,NA,NA,NA,0.2285714286,"PAROXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1176470588,NA,NA,NA,NA,NA,"PAROXETINE HCL","RISPERIDONE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6214689266,0.4583333333,NA,NA,NA,0.5171102662,"PAROXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6568627451,NA,NA,NA,NA,NA,"PAROXETINE HCL","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.04255319149,0.4326923077,NA,NA,NA,0.2403100775,NA,NA,NA,0.4769230769,NA,0.5110192837,NA,NA,0.2772020725,"PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3861386139,NA,NA,0.3488372093,"PAROXETINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5971014493,NA,NA,NA,NA,0.3762376238,"PAROXETINE HCL","SILDENAFIL CITRATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7467248908,NA,NA,NA,NA,0.3894736842,"PAROXETINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5968586387,NA,NA,NA,NA,NA,"PAROXETINE HCL","TADALAFIL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.03550295858,NA,NA,NA,NA,0.1067961165,NA,NA,NA,0.4646988432,NA,NA,0.02138690862,NA,0.4131205674,"PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2941176471,"PAROXETINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6796116505,NA,NA,NA,NA,NA,"PAROXETINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5564304462,NA,NA,NA,0.6984924623,0.2567901235,"PAROXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4594594595,0.006896551724,NA,NA,"PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01869158879,NA,NA,"PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",0.03167420814,0.04636920385,0.236673774,0.160944206,NA,0.1711840228,0.1419354839,0.2101010101,0.1164021164,NA,0.1897233202,NA,0.2053231939,0.02171290712,0.1981200289,0.1302998966,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.02857142857,0.1959459459,0.1059602649,NA,0.1666666667,0.109540636,NA,NA,NA,0.175,NA,0.1170212766,NA,0.2119565217,0.1228070175,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08333333333,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1360544218,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1058823529,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.1363636364,NA,NA,NA,NA,NA,NA,0.375711575,NA,NA,0.1294117647,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2915451895,NA,NA,0.19,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02573529412,0.1640625,0.1502242152,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2386363636,0.1531531532,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2833186231,0.1247672253,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",0.01321585903,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"POLYNEUROPATHY IN DIABETES (dxo:ICD9:3572)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3987730061,NA,NA,NA,"POSTTRAUMATIC STRESS DISORDER (dxo:ICD9:30981)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.641509434,NA,NA,NA,"POSTTRAUMATIC STRESS DISORDER (dxo:ICD9:30981)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.01459854015,0.4095238095,NA,NA,0.328358209,0.1165644172,NA,NA,NA,NA,NA,0.3695652174,0.006535947712,0.358490566,0.4770929818,"PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5754985755,"PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5727272727,"PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4782608696,"PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3566433566,"PRAMIPEXOLE DI-HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5643340858,NA,NA,0.53125,"PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02564102564,NA,0.3913234005,"PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5113268608,0.475,"PRAMIPEXOLE DI-HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.564738292,NA,NA,NA,0.1694214876,0.5514018692,NA,NA,0.4148148148,NA,0.5231481481,NA,NA,0.336,"PRAVASTATIN SODIUM",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7753164557,NA,NA,NA,"PRAVASTATIN SODIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.03255813953,0.4916666667,NA,NA,0.3978996499,0.1707317073,0.5063291139,NA,NA,NA,NA,0.5464480874,NA,0.4622641509,NA,"PREGABALIN",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.761627907,NA,NA,NA,"PREGABALIN","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3950617284,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PREGABALIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1133333333,NA,NA,NA,NA,NA,NA,NA,"PROCHLORPERAZINE MALEATE",NA,NA,NA,NA,NA,NA
"41-64","Male",0.0162601626,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PROMETHAZINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",0.02314814815,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4411764706,NA,NA,NA,NA,0.1869918699,"PROPOXYPHENE NAP/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.2910216718,NA,NA,NA,0.1084337349,0.3019480519,NA,NA,0.2321428571,NA,0.2782101167,NA,NA,0.2057142857,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.214673913,NA,NA,0.180952381,0.09285714286,0.2022160665,NA,NA,0.1086956522,NA,0.2254160363,NA,0.2027027027,0.1225806452,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2195121951,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4387755102,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5730994152,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.325203252,NA,NA,NA,0.08673469388,0.2991452991,NA,NA,NA,NA,0.3191489362,NA,NA,0.2727272727,"PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792)",NA,NA,NA,NA,NA,NA
"41-64","Male",0.02868852459,0.03744292237,0.2315541601,0.2530413625,NA,0.240234375,0.09100204499,0.2171945701,0.1387434555,NA,0.1835883171,NA,0.2348484848,0.04263565891,0.2466165414,0.1348314607,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5175202156,NA,NA,0.1747211896,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3492063492,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1481481481,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4842767296,0.1627118644,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.2183098592,0.1260504202,NA,0.08490566038,0.07843137255,0.1677419355,NA,NA,NA,NA,0.2361111111,0.01652892562,0.1544715447,0.1445783133,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4301075269,NA,NA,0.1410788382,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1935483871,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1708333333,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1339285714,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3015873016,0.1324503311,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.21069869,0.1826086957,0.02586206897,0.1928104575,0.08724461623,0.212962963,0.0641025641,NA,0.142394822,NA,0.212,0.01230228471,0.2222222222,0.1516393443,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.1826923077,NA,NA,NA,0.1018518519,NA,NA,NA,NA,NA,0.206185567,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.072,NA,NA,NA,NA,NA,0.3733333333,NA,NA,0.1725768322,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2798353909,NA,NA,0.2701421801,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01886792453,NA,0.1725239617,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3391812865,0.2211538462,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3526170799,0.1659388646,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.119047619,NA,NA,NA,NA,NA,0.1666666667,NA,NA,0.09821428571,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2636363636,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90836)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.2745098039,NA,NA,NA,0.09743589744,NA,NA,NA,NA,NA,0.2176470588,NA,NA,NA,"PSYCHOTHERAPY, 60 MINUTES WITH PATIENT (px:CPT4:90837)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1624365482,NA,NA,NA,NA,NA,0.5882352941,NA,NA,NA,"RABEPRAZOLE SODIUM",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1484375,NA,NA,NA,NA,NA,0.6124567474,NA,0.5972222222,NA,"RAMIPRIL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7388059701,NA,NA,NA,"RAMIPRIL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1347826087,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RANITIDINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5080645161,NA,NA,NA,0.1545454545,NA,NA,NA,NA,0.3033707865,0.4927536232,NA,NA,0.4375,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4899894626,NA,NA,NA,0.5359116022,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4672131148,NA,NA,NA,0.5847457627,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7480916031,NA,NA,0.3965517241,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.1407035176,NA,NA,0.1473684211,0.06622516556,0.1074380165,NA,NA,NA,NA,0.1950207469,NA,0.1820895522,0.1154138193,"RISPERIDONE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.162962963,NA,NA,0.1333333333,"RISPERIDONE","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2279411765,NA,NA,0.1418439716,"RISPERIDONE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1128871129,"RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1982758621,0.07692307692,"RISPERIDONE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1856148492,0.1076388889,"RISPERIDONE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.65,NA,NA,NA,0.1784511785,NA,NA,NA,0.4777777778,NA,NA,NA,NA,NA,"ROFECOXIB",NA,NA,NA,NA,NA,NA
"41-64","Male",0.01680672269,0.04219409283,0.3812154696,NA,NA,0.3162055336,0.1351351351,0.2972972973,NA,NA,NA,0.4263817928,0.404494382,0.01149425287,0.3333333333,0.433998762,"ROPINIROLE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4009009009,0.5606060606,NA,NA,0.5328467153,"ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4534161491,"ROPINIROLE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02285714286,NA,0.3514800953,"ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3358778626,"ROPINIROLE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4564102564,NA,NA,0.5208845209,0.5050505051,"ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4893617021,0.6695652174,NA,0.48,0.162962963,0.6099585062,NA,NA,NA,NA,0.5090361446,0,NA,0.2535211268,"ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7748344371,NA,NA,NA,"ROSUVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",0,0.03599712023,NA,NA,0.1233766234,NA,0.156641604,NA,NA,NA,0.4389489954,NA,0.5220883534,0.01011959522,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.73,NA,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","SERTRALINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","SPECIAL SCREENING FOR MALIGNANT NEOPLASMS, COLON (dxo:ICD9:V7651)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0198019802,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.02312138728,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01351351351,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4615384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"SCREENING EXAMINATION FOR VENEREAL DISEASE (dxo:ICD9:V745)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,NA,NA,NA,NA,NA,"SCREENING FOR LIPOID DISORDERS (dxo:ICD9:V7791)",NA,NA,NA,NA,NA,NA
"41-64","Male",0.02553626149,0.04325095057,0.4285213735,0.6328502415,0.1258064516,0.420678337,0.197466468,0.4254215305,0.1551561022,0.1015228426,0.391634981,0.2573099415,0.5852682739,0.01943699732,0.5964724746,0.3452186536,"SERTRALINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6926454446,NA,NA,0.3801652893,"SERTRALINE HCL","SILDENAFIL CITRATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7860752386,NA,NA,0.4872611465,"SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7758112094,NA,NA,NA,"SERTRALINE HCL","SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.731092437,NA,NA,NA,"SERTRALINE HCL","TOPIRAMATE",NA,NA,NA,NA,NA
"41-64","Male",NA,0.04980842912,0.2662721893,NA,NA,0.3805309735,0.1769911504,0.2763157895,NA,NA,NA,NA,0.5030953364,0.01954887218,NA,0.4204570185,"SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3925233645,0.02777777778,NA,0.2950310559,"SERTRALINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6555891239,NA,NA,NA,"SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Male",NA,0.05813953488,0.359223301,NA,NA,NA,0.2700729927,NA,NA,NA,NA,NA,0.5322580645,NA,0.6483516484,0.3323657475,"SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7777777778,NA,NA,NA,"SERTRALINE HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"41-64","Male",NA,0.03052631579,0.4637096774,NA,NA,NA,NA,0.4942528736,NA,NA,0.3636363636,NA,0.4881012658,NA,0.4780487805,0.2084063047,"SILDENAFIL CITRATE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.431372549,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5780346821,NA,NA,NA,"SILDENAFIL CITRATE","SIMVASTATIN",NA,NA,NA,NA,NA
"41-64","Male",NA,0.02097902098,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"SILDENAFIL CITRATE","TADALAFIL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3925233645,"SILDENAFIL CITRATE","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6991869919,NA,"SILDENAFIL CITRATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,0.05351170569,0.5337701613,NA,NA,NA,0.1824267782,0.5387509406,NA,NA,0.4581939799,NA,0.5850340136,NA,NA,0.3339552239,"SIMVASTATIN",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6071428571,NA,NA,NA,"SIMVASTATIN","SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2446043165,"SIMVASTATIN","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3353293413,"SIMVASTATIN","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.45625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"SODIUM, POTASSIUM,MAG SULFATES",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.489539749,NA,NA,NA,NA,NA,0.1489361702,NA,NA,NA,0.5460829493,NA,NA,NA,"SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01140684411,NA,NA,"SPECIAL SCREENING FOR MALIGNANT NEOPLASMS, COLON (dxo:ICD9:V7651)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2627118644,"SUMATRIPTAN SUCCINATE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.03256936068,NA,NA,NA,NA,NA,NA,NA,NA,0.3925729443,NA,NA,NA,NA,NA,"TADALAFIL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4956521739,NA,NA,NA,NA,NA,"TAMSULOSIN HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,0.005747126437,NA,NA,"TEMAZEPAM",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.02840909091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TERBINAFINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.01731601732,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TESTOSTERONE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5,NA,NA,NA,NA,NA,NA,0.05633802817,NA,NA,NA,NA,NA,NA,"THORACIC OR LUMBOSACRAL NEURITIS OR RADICULITIS, UNSPECIFIED (dxo:ICD9:7244)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.5034965035,NA,NA,NA,NA,0.5188679245,NA,NA,NA,NA,NA,NA,NA,NA,"TIZANIDINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4736842105,NA,NA,NA,"TOPIRAMATE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3461538462,0.171875,0.5041322314,NA,NA,0.4068965517,0.3606557377,0.4402985075,0.007072135785,NA,NA,"TRAMADOL HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005952380952,NA,NA,"TRAMADOL HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.3177570093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TRAMADOL HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"TRAMADOL HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4337349398,NA,NA,0.3925233645,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TRAMADOL HCL/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"41-64","Male",0.02219321149,0.04358237548,0.3474240423,0.4886363636,0.1845238095,0.2763395545,0.128190899,0.2921348315,0.1240544629,0.05531914894,0.2649434572,0.2352941176,0.3584752636,0.01988574958,0.3067700987,0.3261116894,"TRAZODONE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.08552631579,NA,NA,NA,NA,0.1788617886,NA,NA,NA,NA,NA,NA,0.02342487884,0.4505462061,0.3373599824,"TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01257861635,NA,NA,"TRAZODONE HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009523809524,NA,NA,"UNLISTED PSYCHIATRIC SERVICE OR PROCEDURE (px:CPT4:90899)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1692307692,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED ACUTE REACTION TO STRESS (dxo:ICD9:3089)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1468926554,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED CEREBRAL ARTERY OCCLUSION WITH CEREBRAL INFARCTION (dxi:ICD9:43491)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,0.4528301887,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4810126582,NA,NA,NA,"UNSPECIFIED CONSTIPATION (dxo:ICD9:56400)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.09615384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED EPISODIC MOOD DISORDER (dxo:ICD9:29690)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.02314814815,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED ESSENTIAL HYPERTENSION (dxi:ICD9:4019)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.02542372881,NA,NA,NA,NA,NA,0.6330935252,0.2247706422,NA,NA,NA,NA,0.009009009009,0.5158730159,NA,"UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",NA,NA,NA,NA,NA,NA
"41-64","Male",0.007142857143,NA,NA,NA,NA,0.4317180617,NA,NA,NA,0.07317073171,NA,NA,0.5480769231,NA,NA,NA,"UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569)",NA,NA,NA,NA,NA,NA
"41-64","Male",0.006451612903,0.02590673575,0.4590163934,NA,NA,0.3611751152,0.1455223881,0.4589235127,NA,NA,0.3971962617,NA,0.5137844612,0.008849557522,0.5619047619,NA,"UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1650485437,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED PERIPHERAL VASCULAR DISEASE (dxo:ICD9:4439)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0198019802,NA,NA,"UNSPECIFIED PSYCHOSIS (dxi:ICD9:2989)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01063829787,NA,NA,"UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,0.4919354839,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED TRANSIENT CEREBRAL ISCHEMIA (dxo:ICD9:4359)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,0.1592356688,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED URTICARIA (dxo:ICD9:7089)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5523809524,NA,NA,NA,"UNSPECIFIED VIRAL INFECTION, IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE (dxo:ICD9:07999)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4700854701,NA,0.4784946237,NA,"UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8086956522,NA,"UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4959349593,NA,NA,NA,"URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.0272479564,0.4671052632,NA,NA,NA,NA,NA,NA,NA,0.4388489209,NA,NA,NA,NA,NA,"VALACYCLOVIR HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,0.1674528302,NA,NA,NA,NA,NA,NA,NA,NA,NA,"VALSARTAN",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,0.4150943396,0.1649484536,NA,NA,NA,NA,NA,NA,NA,NA,NA,"VALSARTAN/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,0.02173913043,0.4673366834,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"VARENICLINE TARTRATE",NA,NA,NA,NA,NA,NA
"41-64","Male",0.03594080338,0.03836571998,0.4750593824,NA,0.1020408163,0.5427841635,0.2111913357,0.4243458476,0.187150838,0.1278195489,0.4238095238,0.2173913043,0.4755952381,0.02346805737,0.535256195,0.3033728861,"VENLAFAXINE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.704,"VILAZODONE HCL",NA,NA,NA,NA,NA,NA
"41-64","Male",NA,NA,NA,NA,0.2173913043,NA,0.1328671329,0.4401114206,0.157480315,NA,NA,NA,0.5239726027,0.007451564829,NA,NA,"ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA,NA
"65-79","Female",0.03368322669,0.0635703459,0.5510872926,0.5292199649,0.289806369,0.4235847625,0.2258417707,0.5860887097,0.1759479414,0.1050494534,0.5303445835,0.3512897137,0.5842777626,0.0268722467,0.5459596093,0.4486772677,NA,NA,NA,NA,NA,NA,NA
"65-79","Female",NA,0.04635761589,NA,NA,NA,NA,NA,NA,NA,NA,0.4311926606,NA,0.4941176471,NA,NA,NA,"ABNORMAL WEIGHT GAIN (dxo:ICD9:7831)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4603174603,NA,NA,NA,"ACTINIC KERATOSIS (dxo:ICD9:7020)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4054054054,NA,NA,NA,0.1,NA,NA,NA,NA,NA,0.3277310924,NA,NA,NA,"ADJUSTMENT DISORDER WITH DEPRESSED MOOD (dxo:ICD9:3090)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.05442176871,NA,NA,NA,NA,NA,0.4054054054,NA,NA,NA,"ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD (dxo:ICD9:30928)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4039735099,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ALBUTEROL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3888888889,NA,"ALBUTEROL SULFATE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7582417582,NA,"ALBUTEROL SULFATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.496124031,NA,NA,NA,NA,0.4863013699,NA,NA,NA,"ALLOPURINOL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.72,NA,NA,NA,NA,NA,NA,NA,NA,"ALLOPURINOL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4112903226,NA,NA,NA,0.04784688995,NA,NA,NA,NA,NA,0.4458333333,NA,NA,NA,"ALPRAZOLAM",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4765625,NA,NA,NA,"ALPRAZOLAM","ATORVASTATIN CALCIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8235294118,NA,NA,NA,"ALPRAZOLAM","ATORVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4566929134,NA,NA,NA,"ALPRAZOLAM","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7598039216,NA,NA,NA,"ALPRAZOLAM","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4864864865,NA,NA,NA,"ALPRAZOLAM","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.2313432836,NA,0.4517766497,NA,NA,0.3080808081,NA,NA,NA,NA,0.2142857143,"ALZHEIMER'S DISEASE (dxo:ICD9:3310)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4545454545,"ALZHEIMER'S DISEASE (dxo:ICD9:3310)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2671755725,"ALZHEIMER'S DISEASE (dxo:ICD9:3310)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.6949152542,NA,NA,NA,NA,NA,NA,NA,NA,"ALZHEIMER'S DISEASE (dxo:ICD9:3310)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5759493671,NA,NA,NA,NA,NA,"ALZHEIMER'S DISEASE (dxo:ICD9:3310)","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4679487179,"ALZHEIMER'S DISEASE (dxo:ICD9:3310)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",0.04459608492,0.05839416058,0.3397129187,NA,NA,0.3428571429,0.1107692308,0.3391812865,0.1328413284,0.1103202847,0.3076923077,NA,0.3869499241,0.01208459215,0.3774104683,0.4622382851,"AMITRIPTYLINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",0.05581395349,0.03636363636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3603254552,"AMITRIPTYLINE HCL","BUPROPION HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4517766497,"AMITRIPTYLINE HCL","BUPROPION HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4153846154,"AMITRIPTYLINE HCL","BUPROPION HCL","DULOXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3630136986,"AMITRIPTYLINE HCL","BUPROPION HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4092827004,"AMITRIPTYLINE HCL","BUPROPION HCL","FLUOXETINE HCL",NA,NA,NA,NA
"65-79","Female",0.01183431953,0.02232142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09452736318,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09649122807,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1517857143,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.600660066,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5181818182,"AMITRIPTYLINE HCL","BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3522012579,"AMITRIPTYLINE HCL","BUPROPION HCL","Num Previous Antidep: 4+",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3493150685,"AMITRIPTYLINE HCL","BUPROPION HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"AMITRIPTYLINE HCL","BUPROPION HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3811881188,"AMITRIPTYLINE HCL","BUPROPION HCL","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4806629834,"AMITRIPTYLINE HCL","BUPROPION HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.308411215,"AMITRIPTYLINE HCL","BUPROPION HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3731343284,"AMITRIPTYLINE HCL","BUPROPION HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",0.03720930233,NA,0.6288888889,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5606694561,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4489795918,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","DULOXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4765625,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"65-79","Female",0.02314814815,NA,0.6698113208,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5975855131,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7058823529,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,NA,0.5340909091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"65-79","Female",NA,NA,0.5368421053,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5590551181,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"65-79","Female",0.04060913706,NA,0.7457627119,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5535714286,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.803030303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4345238095,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6804511278,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.5330188679,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5317460317,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4574468085,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",0.07481296758,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"65-79","Female",0.01871657754,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4159663866,"AMITRIPTYLINE HCL","DOXEPIN HCL",NA,NA,NA,NA,NA
"65-79","Female",0.07262569832,NA,NA,NA,NA,0.5422535211,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4663178548,"AMITRIPTYLINE HCL","DULOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.45,"AMITRIPTYLINE HCL","DULOXETINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5660377358,"AMITRIPTYLINE HCL","DULOXETINE HCL","FLUOXETINE HCL",NA,NA,NA,NA
"65-79","Female",0.04864864865,NA,NA,NA,NA,0.5159235669,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4542682927,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4049079755,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.47,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"65-79","Female",0.08,NA,NA,NA,NA,0.6766917293,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3333333333,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3805309735,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5726872247,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4698795181,"AMITRIPTYLINE HCL","DULOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4903846154,"AMITRIPTYLINE HCL","DULOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.4660194175,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.382183908,"AMITRIPTYLINE HCL","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",0.03273809524,NA,NA,NA,NA,NA,0.338770389,NA,NA,NA,NA,NA,NA,NA,NA,0.3089005236,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"65-79","Female",0.02183406114,NA,NA,NA,NA,NA,0.2791878173,NA,NA,NA,NA,NA,NA,NA,NA,0.2830188679,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2769230769,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3076923077,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2450980392,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2173913043,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5849056604,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3212669683,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",0.0467404674,NA,NA,NA,NA,NA,NA,0.643728223,NA,NA,NA,NA,NA,NA,NA,0.5453885258,"AMITRIPTYLINE HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",0.0234375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6149870801,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7007042254,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.6319444444,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5939086294,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"65-79","Female",0.04054054054,NA,NA,NA,NA,NA,NA,0.7222222222,NA,NA,NA,NA,NA,NA,NA,0.5643564356,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7206703911,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3970588235,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6402116402,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.698245614,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5106382979,"AMITRIPTYLINE HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3472222222,"AMITRIPTYLINE HCL","GABAPENTIN",NA,NA,NA,NA,NA
"65-79","Female",0.0498687664,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"65-79","Female",0.02544529262,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1422018349,"AMITRIPTYLINE HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.3684210526,NA,NA,0.3039215686,0.07207207207,0.3211009174,0.1028037383,0.07272727273,NA,NA,0.4356060606,0.003412969283,NA,0.3004484305,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5045045045,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6178010471,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6617283951,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009090909091,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2169811321,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5066666667,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6054421769,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08387096774,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5486725664,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"65-79","Female",0.01960784314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5463576159,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",0.04522613065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.702970297,NA,NA,0.6518650089,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",0.04609929078,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0036900369,NA,0.1371841155,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6420454545,0.599078341,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7440944882,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7076923077,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",0.03603603604,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7490494297,NA,NA,0.5625,"AMITRIPTYLINE HCL","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",0.01565708419,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"65-79","Female",0.01340482574,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA
"65-79","Female",0.002178649237,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA
"65-79","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3119266055,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4819277108,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5428571429,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1538461538,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6505263158,"AMITRIPTYLINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6504854369,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6803278689,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5741626794,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5845588235,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7567567568,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5130890052,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6220930233,"AMITRIPTYLINE HCL","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",0.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","LOVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",0.02325581395,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","LOVASTATIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"65-79","Female",0.2332268371,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5543644717,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4697508897,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",0.03361344538,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3897058824,"AMITRIPTYLINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3774834437,"AMITRIPTYLINE HCL","MIRTAZAPINE","Num Previous Antidep: 4+",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3169398907,"AMITRIPTYLINE HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3333333333,"AMITRIPTYLINE HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",0.03636363636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.448441247,"AMITRIPTYLINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.68,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6704805492,NA,NA,NA,"AMITRIPTYLINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3913043478,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4158415842,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5054347826,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3769633508,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3716814159,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3333333333,"AMITRIPTYLINE HCL","OMEPRAZOLE",NA,NA,NA,NA,NA
"65-79","Female",0.02508960573,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"65-79","Female",0.02097902098,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"65-79","Female",0.03198294243,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6228070175,NA,NA,NA,NA,0.53125,"AMITRIPTYLINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5772357724,"AMITRIPTYLINE HCL","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",0.06,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","POLYNEUROPATHY IN DIABETES (dxo:ICD9:3572)",NA,NA,NA,NA,NA
"65-79","Female",0.03759398496,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5417956656,"AMITRIPTYLINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.53125,"AMITRIPTYLINE HCL","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4679802956,"AMITRIPTYLINE HCL","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5086206897,"AMITRIPTYLINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1266666667,"AMITRIPTYLINE HCL","RISPERIDONE",NA,NA,NA,NA,NA
"65-79","Female",0.04263565891,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4803921569,NA,NA,NA,0.5083591331,"AMITRIPTYLINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4135135135,"AMITRIPTYLINE HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",0.01960784314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"65-79","Female",0.0450928382,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6737726098,NA,NA,0.6123778502,"AMITRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5689655172,NA,NA,0.5053380783,"AMITRIPTYLINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3365853659,"AMITRIPTYLINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",0.04961832061,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3786381109,"AMITRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4528301887,"AMITRIPTYLINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",0.07219251337,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6544901065,0.5088702148,"AMITRIPTYLINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",0,NA,NA,NA,NA,NA,0.1139896373,NA,NA,NA,NA,NA,NA,0.005970149254,NA,NA,"AMLODIPINE BESYLATE",NA,NA,NA,NA,NA,NA
"65-79","Female",0.01973684211,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMLODIPINE BESYLATE","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01,NA,NA,"AMLODIPINE BESYLATE","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"AMLODIPINE BESYLATE","UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1274509804,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMLODIPINE BESYLATE/BENAZEPRIL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1090909091,NA,NA,NA,NA,NA,NA,NA,"ANOREXIA (dxo:ICD9:7830)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1180555556,NA,NA,NA,NA,NA,NA,NA,"ANOREXIA (dxo:ICD9:7830)","LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA
"65-79","Female",NA,0.04077253219,NA,NA,NA,NA,0.1052820697,NA,NA,0.05660377358,0.3571966843,0.2233009709,NA,0.01945525292,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,0.04960835509,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,0.009584664537,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1037735849,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUSPIRONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,0.01923076923,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.4472049689,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2232142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7288135593,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1621621622,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7619047619,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1232876712,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3641346907,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.5042735043,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","GABAPENTIN",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1007583965,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1504424779,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.7268907563,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.4621848739,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","OMEPRAZOLE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1098484848,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","GABAPENTIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1034482759,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3202416918,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7737068966,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.08370044053,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1310344828,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.08962264151,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","OMEPRAZOLE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1132075472,NA,NA,NA,0.3271028037,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6862745098,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6358024691,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.05357142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","RANITIDINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.07194244604,NA,NA,NA,0.4099378882,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1932773109,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1071428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.25,NA,NA,NA,NA,NA,NA,NA,NA,0.3302752294,0.1791044776,"ARIPIPRAZOLE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1651376147,"ARIPIPRAZOLE","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.1871921182,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.223880597,"ARIPIPRAZOLE","DULOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.197080292,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1830065359,"ARIPIPRAZOLE","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1746031746,"ARIPIPRAZOLE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3557692308,NA,NA,0.2307692308,"ARIPIPRAZOLE","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2,"ARIPIPRAZOLE","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2710843373,0.1727272727,"ARIPIPRAZOLE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01818181818,NA,NA,NA,0.03645833333,NA,NA,"ATHEROSCLEROSIS OF AORTA (dxo:ICD9:4400)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.3547297297,NA,NA,NA,NA,0.4407894737,NA,NA,NA,NA,0.423255814,NA,NA,0.2403846154,"ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES, UNSPECIFIED (dxo:ICD9:44020)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.6355140187,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES, UNSPECIFIED (dxo:ICD9:44020)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.3543307087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES, UNSPECIFIED (dxo:ICD9:44020)","DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7348484848,NA,NA,NA,NA,NA,NA,NA,NA,"ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES, UNSPECIFIED (dxo:ICD9:44020)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4669172932,NA,NA,NA,0.1194029851,0.5319320938,NA,NA,0.5114942529,NA,0.504391468,NA,NA,0.2479338843,"ATORVASTATIN CALCIUM",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.7739130435,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.675,NA,NA,0.4411764706,"ATORVASTATIN CALCIUM","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.7804878049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","CITALOPRAM HYDROBROMIDE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA
"65-79","Female",NA,NA,0.3552123552,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.8729016787,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7851851852,NA,NA,NA,"ATORVASTATIN CALCIUM","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7883597884,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.3425925926,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"ATORVASTATIN CALCIUM","DULOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.73,NA,NA,NA,0.3065326633,NA,NA,NA,NA,NA,0.623853211,NA,NA,0.3263888889,"ATORVASTATIN CALCIUM","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4749034749,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7962604771,NA,NA,NA,NA,NA,NA,NA,0.4966887417,"ATORVASTATIN CALCIUM","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.8019323671,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL","GABAPENTIN",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.4318181818,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.8413793103,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.6972477064,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL","UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.5213675214,NA,NA,NA,NA,0.4985337243,NA,NA,NA,"ATORVASTATIN CALCIUM","GABAPENTIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8848920863,NA,NA,NA,"ATORVASTATIN CALCIUM","GABAPENTIN","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8090614887,NA,NA,NA,"ATORVASTATIN CALCIUM","GABAPENTIN","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.416,NA,NA,NA,"ATORVASTATIN CALCIUM","HYDRALAZINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4644549763,NA,NA,NA,"ATORVASTATIN CALCIUM","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8214285714,NA,NA,NA,"ATORVASTATIN CALCIUM","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6422018349,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.435,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4262536873,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8623853211,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Same & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8669817691,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5400943396,NA,NA,NA,"ATORVASTATIN CALCIUM","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.9176470588,NA,NA,NA,"ATORVASTATIN CALCIUM","LEVOTHYROXINE SODIUM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8394793926,NA,NA,NA,"ATORVASTATIN CALCIUM","LEVOTHYROXINE SODIUM","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4692307692,NA,NA,NA,"ATORVASTATIN CALCIUM","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5145631068,NA,NA,NA,"ATORVASTATIN CALCIUM","METFORMIN HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.481865285,NA,NA,NA,"ATORVASTATIN CALCIUM","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.864628821,NA,NA,NA,"ATORVASTATIN CALCIUM","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7366071429,NA,NA,NA,NA,0.4230769231,"ATORVASTATIN CALCIUM","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8103599649,NA,NA,0.5679012346,"ATORVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7399103139,NA,NA,NA,"ATORVASTATIN CALCIUM","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5620437956,NA,NA,NA,"ATORVASTATIN CALCIUM","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4624505929,NA,NA,NA,"ATORVASTATIN CALCIUM","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4909090909,NA,NA,NA,"ATORVASTATIN CALCIUM","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.75,0.5078125,"ATORVASTATIN CALCIUM","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4142857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN HYPERTENSIVE HEART DISEASE WITHOUT HEART FAILURE (dxo:ICD9:40210)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.5886524823,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN NEOPLASM OF COLON (dxo:ICD9:2113)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.75,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN NEOPLASM OF COLON (dxo:ICD9:2113)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.3879310345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BLEPHARITIS, UNSPECIFIED (dxo:ICD9:37300)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4599156118,NA,NA,0.2101910828,NA,NA,NA,NA,NA,NA,NA,0.02054794521,NA,NA,"BODY MASS INDEX BETWEEN 19-24, ADULT (dxo:ICD9:V851)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.6666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BODY MASS INDEX BETWEEN 19-24, ADULT (dxo:ICD9:V851)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"65-79","Female",0.01639344262,0.05379231413,0.4134419552,0.6283185841,NA,0.3310961969,0.1797366915,0.4213528932,0.1353383459,0.05940594059,0.3762214984,NA,0.4248900063,0.02164502165,0.4504792332,0.4597620714,"BUPROPION HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,0.05521472393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",NA,NA,NA,NA,NA
"65-79","Female",NA,0.01670644391,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,0.004237288136,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"65-79","Female",NA,0.0414507772,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"65-79","Female",NA,0.05521885522,0.6078016329,NA,NA,0.3263888889,0.2585034014,0.3432835821,NA,NA,NA,NA,0.4325842697,NA,0.59,0.572039072,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4301075269,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","DULOXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.44,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4411764706,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.03189066059,0.7180094787,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6533907427,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,0.03378378378,0.7530864198,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,NA,0.6007067138,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"65-79","Female",NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6211031175,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"65-79","Female",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01904761905,NA,0.4213836478,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,0.06175771971,0.7191780822,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6302083333,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA
"65-79","Female",NA,0.05555555556,0.7326388889,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,0.02739726027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5034482759,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6037735849,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5369458128,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5442708333,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.728314239,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.786407767,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6204620462,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,0.675,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6195652174,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.431372549,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.312,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,0.5945945946,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5033112583,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.512605042,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4803149606,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7904761905,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,0.01694915254,0.5099601594,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03076923077,NA,0.4568661972,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4678899083,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2844036697,"BUPROPION HCL","CLONAZEPAM",NA,NA,NA,NA,NA
"65-79","Female",NA,0.062,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2941176471,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"65-79","Female",NA,0.0308988764,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4383116883,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA
"65-79","Female",NA,0.06748466258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",NA,NA,NA,NA,NA
"65-79","Female",NA,0.01492537313,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.416856492,"BUPROPION HCL","DOXEPIN HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,0.05227655987,NA,NA,NA,0.5085043988,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4577114428,"BUPROPION HCL","DULOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4285714286,"BUPROPION HCL","DULOXETINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4606741573,"BUPROPION HCL","DULOXETINE HCL","FLUOXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.126984127,"BUPROPION HCL","DULOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA
"65-79","Female",NA,0.04719764012,NA,NA,NA,0.582278481,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5279069767,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,0.04761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4462365591,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3474576271,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6203703704,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"65-79","Female",NA,0.05696202532,NA,NA,NA,0.7119341564,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6396396396,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3896103896,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3555555556,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3826714801,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6415584416,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6150442478,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5390625,"BUPROPION HCL","DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4311926606,"BUPROPION HCL","DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3614457831,"BUPROPION HCL","DULOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3516483516,"BUPROPION HCL","DULOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4260869565,"BUPROPION HCL","DULOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5327868852,"BUPROPION HCL","DULOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4382716049,"BUPROPION HCL","DULOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.4102564103,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3327171904,"BUPROPION HCL","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.464,"BUPROPION HCL","DULOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.05555555556,NA,NA,NA,NA,0.3708832335,NA,NA,NA,NA,NA,0.4102564103,NA,NA,0.3932038835,"BUPROPION HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3488372093,"BUPROPION HCL","ESCITALOPRAM OXALATE","FLUOXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.04697986577,NA,NA,NA,NA,0.4082446809,NA,NA,NA,NA,NA,NA,NA,NA,0.4464534075,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,0.05,NA,NA,NA,NA,0.3821989529,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3191489362,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4337016575,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04587155963,NA,0.3605442177,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,0.1030927835,NA,NA,NA,NA,0.6388888889,NA,NA,NA,NA,NA,NA,NA,NA,0.6448598131,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.6492890995,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,0,NA,NA,NA,NA,0.1900826446,NA,NA,NA,NA,NA,NA,NA,NA,0.2590361446,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2380952381,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3623853211,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3670886076,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6557863501,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5625,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.4854771784,NA,NA,NA,NA,NA,NA,NA,NA,0.4918918919,"BUPROPION HCL","ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4545454545,"BUPROPION HCL","ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3296089385,"BUPROPION HCL","ESCITALOPRAM OXALATE","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4210526316,"BUPROPION HCL","ESCITALOPRAM OXALATE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1851851852,"BUPROPION HCL","ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1937984496,"BUPROPION HCL","ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5095541401,"BUPROPION HCL","ESCITALOPRAM OXALATE","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3362831858,"BUPROPION HCL","ESCITALOPRAM OXALATE","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.009433962264,NA,NA,NA,NA,0.3066666667,NA,NA,NA,NA,NA,NA,0.03571428571,NA,0.3146387833,"BUPROPION HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.392,"BUPROPION HCL","ESCITALOPRAM OXALATE","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.05337620579,0.4201680672,NA,NA,0.3284671533,0.2236024845,0.5555555556,NA,NA,NA,NA,0.4251207729,NA,NA,0.5630885122,"BUPROPION HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.1981132075,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA
"65-79","Female",NA,0.04242424242,NA,NA,NA,NA,NA,0.7103448276,NA,NA,NA,NA,NA,NA,NA,0.6980854197,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,0.04347826087,NA,NA,NA,NA,NA,0.6700767263,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.627027027,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7041800643,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4671052632,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,0.07612456747,NA,NA,NA,NA,NA,0.6804733728,NA,NA,NA,NA,NA,NA,NA,0.6802721088,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"65-79","Female",NA,0.07619047619,NA,NA,NA,NA,NA,0.6741214058,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4946808511,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5798816568,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5658682635,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7343096234,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.566539924,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,0.3185840708,NA,NA,NA,NA,NA,0.6165803109,NA,NA,NA,NA,NA,NA,NA,0.5230769231,"BUPROPION HCL","FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3613445378,"BUPROPION HCL","FLUOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.6709183673,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3211009174,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5701754386,"BUPROPION HCL","FLUOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5838926174,"BUPROPION HCL","FLUOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.05140186916,NA,NA,NA,NA,NA,0.3861788618,NA,NA,NA,NA,NA,0.03731343284,NA,0.4357592093,"BUPROPION HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,"BUPROPION HCL","FLUOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.08018867925,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2815533981,"BUPROPION HCL","GABAPENTIN",NA,NA,NA,NA,NA
"65-79","Female",NA,0.05035971223,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GABAPENTIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,0.1267605634,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA
"65-79","Female",NA,0.01785714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03076923077,NA,NA,"BUPROPION HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1206896552,"BUPROPION HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2765957447,"BUPROPION HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.246031746,"BUPROPION HCL","LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1056338028,"BUPROPION HCL","LAMOTRIGINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1709401709,"BUPROPION HCL","LAMOTRIGINE","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1102831595,"BUPROPION HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.4148148148,NA,NA,0.297979798,0.1342857143,0.4397590361,NA,NA,NA,NA,0.4098360656,0.01445086705,0.3898305085,0.3103130755,"BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,0.04191616766,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3636363636,"BUPROPION HCL","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5562913907,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6373626374,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"65-79","Female",NA,0.02857142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.725,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"65-79","Female",NA,0.04918032787,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7182835821,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,0.0157480315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01824817518,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2462686567,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5935828877,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6187845304,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4132231405,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1066997519,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5546875,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA
"65-79","Female",NA,0.015625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6083550914,"BUPROPION HCL","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.03990024938,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6432748538,NA,NA,0.6933497537,"BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02586206897,NA,0.4293785311,"BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,0.03669724771,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02370990237,NA,0.1109530583,"BUPROPION HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.02985074627,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7,0.5185185185,"BUPROPION HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.1044083527,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6730769231,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7259259259,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA
"65-79","Female",NA,0.075,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7622739018,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,0.02013422819,NA,NA,NA,NA,NA,NA,NA,NA,0.722513089,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.06613756614,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7628361858,NA,NA,0.6737967914,"BUPROPION HCL","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1376146789,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.07096774194,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.700729927,NA,"BUPROPION HCL","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.0215372456,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,0.08,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"65-79","Female",NA,0.007530120482,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"65-79","Female",NA,0.02008032129,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5346534653,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5320197044,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1124260355,"BUPROPION HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,0.01869158879,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA
"65-79","Female",NA,0.0251572327,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3868613139,"BUPROPION HCL","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5821917808,"BUPROPION HCL","Last AD: Same & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,0.03100775194,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4454545455,NA,NA,0.5265306122,"BUPROPION HCL","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.513368984,"BUPROPION HCL","Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,0.02479338843,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008695652174,NA,0.1760722348,"BUPROPION HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5588235294,"BUPROPION HCL","Last AD: Same & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4368932039,"BUPROPION HCL","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.6267942584,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6929703653,"BUPROPION HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7483443709,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7751937984,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.754985755,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6984615385,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5924170616,"BUPROPION HCL","Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.57,"BUPROPION HCL","Last AD: Same & Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5148514851,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5517241379,"BUPROPION HCL","Last AD: Same & Remiss","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6711409396,"BUPROPION HCL","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6090225564,"BUPROPION HCL","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6399082569,"BUPROPION HCL","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7687366167,"BUPROPION HCL","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5481481481,"BUPROPION HCL","Last AD: Same & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5871559633,"BUPROPION HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5757575758,"BUPROPION HCL","Last AD: Same & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6764705882,"BUPROPION HCL","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.5119617225,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.747706422,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8303571429,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6821705426,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.49,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.66437684,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6343283582,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6260869565,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6444805195,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.2518277823,NA,NA,NA,0.43,0.3716814159,NA,NA,NA,NA,NA,NA,NA,NA,0.5381054131,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.528,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4807692308,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4571428571,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5066225166,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5652173913,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5803108808,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4140625,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,0.2871287129,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7131782946,NA,NA,0.6033519553,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.2608695652,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4717090069,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4245283019,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6396396396,0.5601851852,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.06306306306,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA,NA
"65-79","Female",NA,0.06302521008,NA,NA,NA,NA,NA,NA,0.2631578947,NA,NA,NA,NA,NA,NA,0.3741534989,"BUPROPION HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.303030303,"BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3133462282,"BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4135802469,"BUPROPION HCL","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2760736196,"BUPROPION HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3435582822,"BUPROPION HCL","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.03770197487,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"65-79","Female",NA,0,NA,NA,NA,NA,NA,NA,NA,0.1428571429,NA,NA,NA,NA,NA,0.3855606759,"BUPROPION HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.224137931,"BUPROPION HCL","NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.54375,NA,NA,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7352941176,NA,NA,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7188049209,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3179791976,"BUPROPION HCL","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.465,"BUPROPION HCL","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4558823529,"BUPROPION HCL","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4040114613,"BUPROPION HCL","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4461077844,"BUPROPION HCL","Num Previous Antidep: 4+","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3543788187,"BUPROPION HCL","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.435483871,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 4+","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3452991453,"BUPROPION HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3212851406,"BUPROPION HCL","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5465838509,NA,NA,NA,NA,NA,"BUPROPION HCL","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.08333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3482142857,"BUPROPION HCL","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2330827068,"BUPROPION HCL","OMEPRAZOLE",NA,NA,NA,NA,NA
"65-79","Female",NA,0.06167400881,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"65-79","Female",NA,0.03810775296,NA,NA,NA,NA,NA,NA,NA,NA,0.5965362412,NA,NA,NA,NA,0.5395555556,"BUPROPION HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5841584158,NA,NA,NA,NA,0.4944134078,"BUPROPION HCL","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.05726872247,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.497438286,"BUPROPION HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4803625378,"BUPROPION HCL","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.424,"BUPROPION HCL","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.46875,"BUPROPION HCL","PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3992146597,"BUPROPION HCL","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1437908497,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1129032258,"BUPROPION HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1403508772,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3153153153,"BUPROPION HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5205479452,NA,NA,NA,0.4690265487,"BUPROPION HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1058495822,"BUPROPION HCL","RISPERIDONE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08173076923,"BUPROPION HCL","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.05056179775,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3986013986,NA,NA,NA,0.4854304636,"BUPROPION HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5055555556,"BUPROPION HCL","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.376114082,"BUPROPION HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"BUPROPION HCL","ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.04835589942,0.4269005848,NA,NA,0.3521126761,0.2019704433,0.4634146341,NA,NA,NA,NA,0.6048141377,NA,NA,0.5943432778,"BUPROPION HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,0.04605263158,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4959016393,0.03496503497,NA,0.4519230769,"BUPROPION HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4711538462,"BUPROPION HCL","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2680412371,"BUPROPION HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,0.05139565795,NA,NA,NA,0.2540983607,0.06542056075,NA,NA,NA,NA,NA,NA,0.02242152466,NA,0.3625626121,"BUPROPION HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3764705882,0.3742757822,"BUPROPION HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.04651162791,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4180327869,NA,0.5761217949,0.4655462185,"BUPROPION HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.09765625,NA,NA,NA,NA,NA,0.3398058252,NA,NA,NA,"BUSPIRONE HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.4621212121,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUSPIRONE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4433497537,"CARBIDOPA/LEVODOPA","PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5744680851,"CARBIDOPA/LEVODOPA","PARALYSIS AGITANS (dxo:ICD9:3320)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5196078431,"CARBIDOPA/LEVODOPA","PARALYSIS AGITANS (dxo:ICD9:3320)","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.471291866,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CELECOXIB",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.8036363636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CELECOXIB","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.8217821782,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CELECOXIB","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.5048543689,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CETIRIZINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1530612245,NA,NA,NA,NA,NA,0.505952381,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7520661157,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,0.02398989899,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,0.02461538462,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"65-79","Female",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA
"65-79","Female",NA,NA,0.3454545455,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC FATIGUE SYNDROME (dxo:ICD9:78071)",NA,NA,NA,NA,NA,NA
"65-79","Female",0.02551020408,0.03791174643,0.6474247571,NA,0.1770334928,0.3940990516,0.2868916797,0.5072164948,0.1076779026,0.06666666667,0.3970432946,0.1660079051,0.5161498708,0.01032565528,0.537428023,0.4172581248,"CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.7777777778,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5023255814,"CITALOPRAM HYDROBROMIDE","CLONAZEPAM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.7430167598,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4620253165,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.3391304348,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.8394495413,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7050847458,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006896551724,0.6836734694,0.4204545455,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.025,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,0.3529411765,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.8439716312,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01459854015,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7093023256,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.2877697842,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.8223684211,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.6321428571,NA,0.4277108434,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5223367698,"CITALOPRAM HYDROBROMIDE","DOXEPIN HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.6498161765,NA,NA,0.5306122449,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4491017964,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.7464788732,NA,NA,0.5346534653,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5022026432,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7281553398,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,NA,0.6730769231,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"65-79","Female",NA,NA,0.6698113208,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4672897196,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"65-79","Female",NA,NA,0.7014925373,NA,NA,0.5898876404,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5526315789,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5165562914,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.63,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.6587301587,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.534351145,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.4854368932,NA,NA,0.4350649351,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.470212766,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7720930233,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ENCOUNTER FOR OTHER SPECIFIED AFTERCARE (dxo:ICD9:V5889)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.745272525,NA,NA,NA,0.3621621622,0.4563106796,NA,NA,NA,NA,0.4956896552,NA,NA,0.3368669022,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.7512437811,NA,NA,NA,0.356979405,NA,NA,NA,NA,NA,NA,NA,NA,0.3394833948,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.75,NA,NA,NA,0.3680781759,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,NA,0.6103896104,NA,NA,NA,0.3419354839,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"65-79","Female",NA,NA,0.6172839506,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3513513514,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"65-79","Female",NA,NA,0.86,NA,NA,NA,0.4653061224,NA,NA,NA,NA,NA,NA,NA,NA,0.4285714286,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.504,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,NA,0.5628415301,NA,NA,NA,0.141025641,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4054054054,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,0.8494623656,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3388429752,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,0.6285714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2100840336,NA,NA,NA,NA,NA,NA,NA,NA,0.4373259053,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7507739938,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESOMEPRAZOLE MAGNESIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.425,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESOMEPRAZOLE MAGNESIUM","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7644230769,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESOMEPRAZOLE MAGNESIUM","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7061728395,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.3913043478,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7527472527,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.6893203883,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","PRAVASTATIN SODIUM",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7926829268,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7835820896,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","EZETIMIBE/SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.6511299435,NA,NA,NA,NA,0.6590909091,NA,NA,NA,NA,0.5086206897,NA,NA,0.4105263158,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.465,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.8056265985,NA,NA,0.4052287582,0.3703703704,NA,NA,NA,NA,NA,NA,NA,NA,0.5069444444,"CITALOPRAM HYDROBROMIDE","GABAPENTIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4074074074,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GABAPENTIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.825,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GABAPENTIN","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7540983607,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GABAPENTIN","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,0.5877862595,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7630057803,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006289308176,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01941747573,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.024,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02631578947,NA,NA,"CITALOPRAM HYDROBROMIDE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.1529680365,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1694915254,"CITALOPRAM HYDROBROMIDE","LAMOTRIGINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1181818182,"CITALOPRAM HYDROBROMIDE","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",0.0078125,0.01866666667,NA,NA,NA,0.3180212014,0.1833333333,0.3486590038,0.1124031008,NA,0.3131868132,NA,0.4076433121,0.01129943503,0.3454545455,0.3380634391,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.6780821918,NA,NA,NA,NA,NA,0.213836478,NA,NA,NA,NA,NA,NA,0.5518394649,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,0.6764705882,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,NA,0.5950413223,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"65-79","Female",NA,NA,0.592,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5230769231,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Episodes: 2+",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6019417476,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"65-79","Female",NA,NA,0.5856873823,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6793478261,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,0.6666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3625,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Female",NA,NA,0.5869947276,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5669064748,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6916666667,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6805555556,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7615384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4522613065,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3564356436,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,0.6680911681,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0111662531,NA,0.6126914661,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.801980198,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7731092437,0.5281690141,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.07142857143,NA,NA,NA,0.4607508532,0.310880829,0.6411764706,0.246835443,NA,NA,NA,0.5823170732,0.03597122302,0.5555555556,0.4854045038,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.6625,NA,NA,NA,NA,NA,0.3050847458,NA,NA,NA,NA,NA,NA,0.5514018692,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,0.641221374,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","Num Previous Remissions: 2+","TRAZODONE HCL",NA
"65-79","Female",NA,NA,0.6394557823,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,0.7485380117,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01612903226,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,0.6319444444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7450980392,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,0.6647398844,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5424836601,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,0.6266666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7117117117,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,0.6347826087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.6038961039,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6525423729,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.6428571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7578125,NA,NA,0.5586206897,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4615384615,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,0.719047619,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02707275804,NA,0.5953757225,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7450980392,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.3724237099,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.33,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4095238095,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4822695035,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,0.3803748622,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Female",NA,NA,0.37,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","SIMVASTATIN",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4311111111,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,0.4019138756,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6818181818,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.34,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"65-79","Female",NA,NA,0.396039604,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4074074074,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.4015748031,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,0.3255813953,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01639344262,NA,0.408045977,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.822295475,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4864864865,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.850877193,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7283950617,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6034482759,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,0.6555555556,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Female",NA,NA,0.9109414758,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8318584071,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6932515337,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,0.9108910891,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Remissions: 2+",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8095238095,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,0.8697916667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6557377049,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.8015267176,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","PRAVASTATIN SODIUM",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6932270916,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5263157895,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,0.8507936508,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,0.8317757009,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7002096436,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7976190476,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.7701149425,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LISINOPRIL/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.350877193,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LISINOPRIL/HYDROCHLOROTHIAZIDE","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.861003861,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LISINOPRIL/HYDROCHLOROTHIAZIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.8013245033,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LISINOPRIL/HYDROCHLOROTHIAZIDE","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,0.6954314721,NA,NA,NA,NA,NA,0.08133971292,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.3596491228,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LOSS OF WEIGHT (dxo:ICD9:78321)","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7904290429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LOVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4058823529,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LOVASTATIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.8403361345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LOVASTATIN","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7723004695,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.7315789474,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4850746269,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.7394957983,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5197505198,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.6536312849,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6068965517,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.5628318584,NA,NA,NA,NA,NA,0.2185886403,NA,NA,NA,NA,NA,NA,0.4696174044,"CITALOPRAM HYDROBROMIDE","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.5714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","MIRTAZAPINE","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Female",NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3977777778,"CITALOPRAM HYDROBROMIDE","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7314814815,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","MONTELUKAST SODIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.6082725061,NA,NA,NA,NA,NA,NA,0.1215686275,NA,NA,NA,NA,NA,0.5398773006,"CITALOPRAM HYDROBROMIDE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4565217391,"CITALOPRAM HYDROBROMIDE","NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6801801802,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.5480769231,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.5825242718,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.9033816425,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Remissions: 2+",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.6170212766,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7320261438,"CITALOPRAM HYDROBROMIDE","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7906976744,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.533557047,"CITALOPRAM HYDROBROMIDE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.7967479675,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4485714286,"CITALOPRAM HYDROBROMIDE","OMEPRAZOLE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.519379845,"CITALOPRAM HYDROBROMIDE","OMEPRAZOLE","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7433628319,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","OTHER DISORDERS OF BONE AND CARTILAGE (dxo:ICD9:73399)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.7830687831,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","OTHER NONSPECIFIC ABNORMAL FINDING OF LUNG FIELD (dxo:ICD9:79319)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.7322404372,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5319148936,"CITALOPRAM HYDROBROMIDE","OXYBUTYNIN CHLORIDE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.7387387387,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.6359649123,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4268774704,"CITALOPRAM HYDROBROMIDE","PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5480769231,"CITALOPRAM HYDROBROMIDE","PARALYSIS AGITANS (dxo:ICD9:3320)","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.5922077922,NA,NA,NA,NA,NA,NA,NA,0.5627376426,NA,NA,NA,NA,0.3467741935,"CITALOPRAM HYDROBROMIDE","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3818181818,"CITALOPRAM HYDROBROMIDE","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7535545024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PEN NEEDLE, DIABETIC",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.3946188341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2025862069,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.2697368421,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2352941176,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.5859106529,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.611752361,"CITALOPRAM HYDROBROMIDE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6837944664,"CITALOPRAM HYDROBROMIDE","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5839416058,"CITALOPRAM HYDROBROMIDE","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5550239234,"CITALOPRAM HYDROBROMIDE","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7375690608,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4705882353,"CITALOPRAM HYDROBROMIDE","PRAVASTATIN SODIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.7046979866,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PREGABALIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.6272189349,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.6358024691,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3262032086,"CITALOPRAM HYDROBROMIDE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1551724138,"CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4963235294,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2275132275,"CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2561983471,"CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7891566265,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5162790698,"CITALOPRAM HYDROBROMIDE","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.6834532374,NA,NA,NA,NA,NA,NA,NA,NA,0.4548611111,NA,NA,NA,0.6686217009,"CITALOPRAM HYDROBROMIDE","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.610619469,"CITALOPRAM HYDROBROMIDE","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,0.2140350877,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1762452107,"CITALOPRAM HYDROBROMIDE","RISPERIDONE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1282051282,"CITALOPRAM HYDROBROMIDE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.5749506903,NA,NA,NA,NA,NA,NA,NA,NA,0.3914209115,NA,NA,NA,0.6114996115,"CITALOPRAM HYDROBROMIDE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5537634409,"CITALOPRAM HYDROBROMIDE","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.737704918,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.5778894472,NA,NA,0.3839285714,0.1801242236,0.3309352518,NA,NA,0.4,NA,0.6135721018,NA,NA,0.4318936877,"CITALOPRAM HYDROBROMIDE","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4180327869,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5611510791,NA,NA,0.4685534591,"CITALOPRAM HYDROBROMIDE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7844202899,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6736842105,NA,NA,0.4875886525,"CITALOPRAM HYDROBROMIDE","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.731092437,"CITALOPRAM HYDROBROMIDE","SIMVASTATIN","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7372262774,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","SODIUM, POTASSIUM,MAG SULFATES",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.6697247706,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","TRAMADOL HCL/ACETAMINOPHEN",NA,NA,NA,NA,NA
"65-79","Female",NA,0.03225806452,0.5733701423,NA,NA,0.2287581699,0.1586206897,0.3853211009,NA,NA,NA,NA,0.4010152284,0.01419446416,NA,0.532717475,"CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4422442244,"CITALOPRAM HYDROBROMIDE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.81,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","UNSPECIFIED INFLAMMATORY AND TOXIC NEUROPATHY (dxo:ICD9:3579)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.4602272727,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.7636363636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.6272965879,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5288461538,NA,0.7409638554,0.4371941272,"CITALOPRAM HYDROBROMIDE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4777070064,NA,NA,NA,0.1428571429,NA,0.1354166667,NA,NA,NA,0.4663212435,0.01351351351,NA,0.28125,"CLONAZEPAM",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4822335025,"CLONAZEPAM","DULOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3769633508,"CLONAZEPAM","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5394736842,"CLONAZEPAM","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3768115942,"CLONAZEPAM","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7642276423,NA,NA,0.496124031,"CLONAZEPAM","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3247863248,"CLONAZEPAM","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5670731707,"CLONAZEPAM","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02112676056,NA,NA,"CLONIDINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.4220779221,NA,NA,NA,NA,NA,NA,NA,NA,"CONGESTIVE HEART FAILURE, UNSPECIFIED (dxo:ICD9:4280)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7692307692,NA,NA,NA,NA,NA,NA,NA,NA,"CONGESTIVE HEART FAILURE, UNSPECIFIED (dxo:ICD9:4280)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,0.1470588235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CONTACT DERMATITIS AND OTHER ECZEMA, DUE TO UNSPECIFIED CAUSE (dxo:ICD9:6929)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"CYCLOBENZAPRINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.519630485,NA,NA,NA,NA,NA,NA,NA,0.4807692308,NA,0.5612648221,NA,NA,0.3169014085,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.816,NA,NA,NA,NA,NA,NA,NA,0.4958677686,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8258064516,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8461538462,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7395626243,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8082901554,NA,NA,0.5325443787,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8214285714,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",0.02595419847,0.03855421687,0.5685131195,0.632183908,0.1984732824,0.4181818182,0.1304347826,0.6283018868,NA,0.08928571429,0.4820846906,0.2340425532,0.5467836257,0.007867132867,0.5161290323,0.3744493392,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,0.7983193277,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.5658536585,NA,NA,NA,NA,NA,NA,NA,NA,0.625,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","DULOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2901234568,NA,NA,NA,NA,NA,NA,NA,0.5703125,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01666666667,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.103626943,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,0.5337837838,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6030534351,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7212121212,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7678321678,NA,NA,NA,NA,NA,NA,0.5980392157,0.4957264957,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.4408602151,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.8616352201,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.8152173913,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.03571428571,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",0.01333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005063291139,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02285714286,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007142857143,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","ZOLPIDEM TARTRATE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009523809524,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09090909091,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2903225806,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01686746988,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4644194757,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8797814208,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8859649123,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8136363636,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.756302521,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.756302521,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","MUSCLE WEAKNESS (GENERALIZED) (dxo:ICD9:72887)","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2083333333,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,0.04166666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"65-79","Female",0.04132231405,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7480620155,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8006872852,0.0245398773,0.6121212121,0.4605263158,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01612903226,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009174311927,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","TRAMADOL HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008310249307,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.690647482,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.703125,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.741580756,0.427184466,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009174311927,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4218316374,NA,NA,NA,0.1125592417,0.390438247,0.1109785203,NA,0.332361516,NA,NA,NA,NA,0.3571428571,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.321656051,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1336898396,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7454545455,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1355932203,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1014492754,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.2081632653,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.05940594059,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","OMEPRAZOLE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5836575875,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.06194690265,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4261363636,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1021505376,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,0.5681435782,NA,NA,0.1694915254,NA,NA,NA,NA,NA,NA,NA,0.7262569832,0.3723849372,"DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,0.4503816794,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,0.553030303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3474576271,"DESVENLAFAXINE SUCCINATE","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,0.6350364964,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4416666667,"DESVENLAFAXINE SUCCINATE","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",0.03246753247,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED (dxo:ICD9:25001)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,0.03971119134,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2391304348,NA,NA,NA,NA,"DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.5273972603,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DIAPHRAGMATIC HERNIA WITHOUT MENTION OF OBSTRUCTION OR GANGRENE (dxo:ICD9:5533)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.4736842105,NA,NA,NA,NA,NA,NA,NA,NA,"DONEPEZIL HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.6824324324,NA,NA,NA,NA,NA,NA,NA,NA,"DONEPEZIL HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.3821138211,NA,0.4350649351,NA,0.1327433628,NA,NA,NA,NA,NA,0.4180327869,NA,NA,0.4357306809,"DOXEPIN HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6244725738,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4444444444,"DOXEPIN HCL","DULOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6339285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,0.493902439,NA,0.284,NA,NA,NA,NA,NA,NA,NA,NA,0.3955223881,"DOXEPIN HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2592592593,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2660550459,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,0.3777777778,NA,NA,0.6865079365,NA,NA,NA,NA,NA,NA,NA,0.4666666667,"DOXEPIN HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3412698413,"DOXEPIN HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.780141844,NA,NA,NA,"DOXEPIN HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,0.1953642384,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,0.7264957265,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5960912052,"DOXEPIN HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6173913043,"DOXEPIN HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.626984127,"DOXEPIN HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3939393939,"DOXEPIN HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7712418301,NA,NA,NA,"DOXEPIN HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,0.4587155963,NA,NA,NA,NA,NA,0.6244343891,NA,NA,NA,NA,0.5581395349,"DOXEPIN HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4970760234,"DOXEPIN HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5322580645,"DOXEPIN HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,0.3537735849,NA,NA,NA,NA,NA,NA,NA,0.7048346056,NA,NA,0.5,"DOXEPIN HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4100486224,"DOXEPIN HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6906077348,0.3985239852,"DOXEPIN HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",0.009661835749,0.03557312253,0.5055865922,NA,0.1652173913,0.5074270557,0.1910377358,0.5410958904,0.122605364,0.05128205128,0.4130434783,0.1120689655,0.5375722543,0.0406504065,0.5637065637,0.4166300527,"DULOXETINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.5331325301,0.3550135501,NA,NA,NA,NA,NA,0.495049505,NA,NA,0.3655913978,"DULOXETINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.5462555066,0.3894389439,NA,NA,NA,NA,NA,NA,NA,NA,0.3744075829,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3268292683,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.4761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3984375,"DULOXETINE HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2803738318,"DULOXETINE HCL","ESCITALOPRAM OXALATE","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3816091954,"DULOXETINE HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.5620437956,NA,0.6977547496,NA,NA,NA,NA,NA,NA,NA,0.4123867069,"DULOXETINE HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.679389313,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4934210526,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7482517483,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6481481481,NA,0.8108108108,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5752212389,"DULOXETINE HCL","FLUOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7517241379,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5039164491,"DULOXETINE HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6491677337,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4644351464,"DULOXETINE HCL","GABAPENTIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.3018867925,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.3495934959,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","Last AD: Same & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.7639484979,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.7475728155,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","Last AD: Same & Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6460176991,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","TRAMADOL HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.4954954955,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6719242902,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006369426752,NA,NA,"DULOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.1499118166,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.130952381,"DULOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.1900826446,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1060606061,"DULOXETINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",0,0.01796407186,0.447761194,NA,NA,NA,0.1009463722,0.5070422535,NA,NA,NA,NA,0.4435797665,0.007518796992,0.4350649351,0.3257790368,"DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.4285714286,NA,NA,0.2583333333,NA,NA,NA,NA,NA,NA,0.4919786096,"DULOXETINE HCL","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.4803921569,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5625,"DULOXETINE HCL","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6475409836,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7777777778,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009302325581,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5043478261,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.4233576642,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5146067416,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4351851852,"DULOXETINE HCL","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6633663366,"DULOXETINE HCL","Last AD: Diff & No Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.4577464789,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.615942029,"DULOXETINE HCL","Last AD: Diff & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.5612244898,NA,NA,NA,NA,NA,NA,0.7459016393,NA,NA,0.5161290323,"DULOXETINE HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.5060240964,NA,NA,NA,NA,NA,NA,NA,0.01519756839,NA,0.5533049041,"DULOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.5236051502,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6516129032,NA,NA,NA,NA,NA,NA,NA,NA,0.7651006711,0.5161290323,"DULOXETINE HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.6285714286,NA,NA,0.6425120773,0.2524271845,NA,NA,NA,NA,NA,NA,NA,NA,0.5044378698,"DULOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.5961538462,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7966101695,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0234375,NA,NA,"DULOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.69,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & Remiss","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.4918032787,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6024096386,NA,NA,NA,NA,NA,NA,0.8,NA,NA,0.4258064516,"DULOXETINE HCL","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6690647482,NA,NA,NA,NA,NA,NA,NA,0.06188925081,NA,0.5634517766,"DULOXETINE HCL","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.7166666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Diff & Remiss","TRAZODONE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5631067961,"DULOXETINE HCL","Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.2916666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.2788461538,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.36,"DULOXETINE HCL","Last AD: Same & No Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.3121693122,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4137931034,"DULOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5193370166,"DULOXETINE HCL","Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.350877193,NA,NA,NA,NA,NA,NA,NA,0,NA,0.4,"DULOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.3319587629,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.7426160338,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,"DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6574074074,"DULOXETINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6178343949,"DULOXETINE HCL","Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.625,"DULOXETINE HCL","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.7307692308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & Remiss","PREGABALIN",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6253968254,"DULOXETINE HCL","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6086956522,"DULOXETINE HCL","Last AD: Same & Remiss","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6176470588,"DULOXETINE HCL","Last AD: Same & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6018518519,"DULOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.7725118483,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.7104722793,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7222222222,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4640522876,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.5334394904,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4876190476,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.4801444043,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4912718204,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.5950413223,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","MELOXICAM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.4165651644,NA,NA,0.2188841202,NA,NA,NA,NA,NA,NA,0.3846153846,"DULOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2679738562,"DULOXETINE HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3027522936,"DULOXETINE HCL","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.3353658537,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.374717833,"DULOXETINE HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.5352697095,NA,NA,NA,0.1222222222,NA,NA,NA,NA,NA,0.4689655172,"DULOXETINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3740458015,"DULOXETINE HCL","NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7818696884,NA,NA,NA,"DULOXETINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4553571429,"DULOXETINE HCL","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3028571429,"DULOXETINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6724137931,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4827586207,"DULOXETINE HCL","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4266666667,"DULOXETINE HCL","OMEPRAZOLE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.53,"DULOXETINE HCL","OXYBUTYNIN CHLORIDE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6138613861,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4125874126,"DULOXETINE HCL","PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.5504885993,NA,NA,NA,NA,0.6681318681,NA,NA,NA,NA,0.4127516779,"DULOXETINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5592105263,"DULOXETINE HCL","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.3388429752,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2075471698,"DULOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.436036036,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5866141732,"DULOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6586345382,"DULOXETINE HCL","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4962962963,"DULOXETINE HCL","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4913793103,"DULOXETINE HCL","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.7142857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","PREGABALIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6935483871,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","PREGABALIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3047619048,"DULOXETINE HCL","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1571428571,"DULOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2700729927,"DULOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.2987551867,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.261682243,"DULOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.3070866142,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.277027027,"DULOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4428571429,"DULOXETINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5170731707,NA,NA,NA,0.6013071895,"DULOXETINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5436241611,"DULOXETINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.2160493827,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1979695431,"DULOXETINE HCL","RISPERIDONE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1678321678,"DULOXETINE HCL","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.4275510204,NA,NA,NA,NA,NA,0.3788546256,NA,NA,NA,0.578683834,"DULOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.4196428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4517958412,"DULOXETINE HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6810344828,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.5466847091,0.21875,NA,NA,NA,NA,NA,0.6990131579,NA,NA,0.4604072398,"DULOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.4033613445,NA,NA,NA,NA,NA,NA,0.515625,NA,NA,0.4776422764,"DULOXETINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5288461538,"DULOXETINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6585365854,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","TRAMADOL HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.4666849465,0.125,NA,NA,NA,NA,NA,NA,0.03389830508,NA,0.4753432605,"DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.4897959184,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","TRAZODONE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4832402235,"DULOXETINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6462303231,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6180257511,NA,NA,NA,NA,NA,NA,NA,NA,0.7418032787,0.4237037037,"DULOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008064516129,NA,NA,"DYSTHYMIC DISORDER (dxo:ICD9:3004)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1438356164,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (dxo:ICD9:V5869)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4491525424,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ENCOUNTER FOR OTHER SPECIFIED AFTERCARE (dxo:ICD9:V5889)",NA,NA,NA,NA,NA,NA
"65-79","Female",0.02268431002,0.02099236641,0.6312464101,NA,0.09941520468,0.4117154812,0.3177217102,0.4689042448,0.1200941915,0.0487804878,0.3951612903,0.175257732,0.4708365311,0.01606086221,0.508650519,0.2945093605,"ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.6060606061,NA,NA,NA,0.3316582915,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ESOMEPRAZOLE MAGNESIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.15,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ESOMEPRAZOLE MAGNESIUM","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3045977011,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FAMOTIDINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1034482759,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FAMOTIDINE","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.4068965517,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FENOFIBRATE NANOCRYSTALLIZED",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2659732541,0.6402877698,NA,NA,NA,NA,0.4181818182,NA,NA,0.3083900227,"ESCITALOPRAM OXALATE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2932330827,NA,NA,NA,NA,NA,NA,NA,NA,0.28,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.27,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4193548387,"ESCITALOPRAM OXALATE","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.4411764706,0.3875,NA,NA,NA,NA,NA,NA,NA,NA,0.3095238095,"ESCITALOPRAM OXALATE","GABAPENTIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.158974359,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GABAPENTIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.7467532468,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GABAPENTIN","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.4661654135,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GABAPENTIN","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2462686567,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1428571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"ESCITALOPRAM OXALATE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01724137931,NA,NA,"ESCITALOPRAM OXALATE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01515151515,NA,NA,"ESCITALOPRAM OXALATE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01621621622,NA,NA,"ESCITALOPRAM OXALATE","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1308411215,NA,NA,NA,NA,NA,NA,NA,NA,0.06993006993,"ESCITALOPRAM OXALATE","LAMOTRIGINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07751937984,"ESCITALOPRAM OXALATE","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",0.01388888889,0.01301518438,0.5512820513,NA,NA,0.3310185185,NA,0.4340277778,0.09652509653,NA,0.3240223464,NA,0.41325811,0.008928571429,0.4170040486,0.1858349578,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2783505155,NA,0.246835443,NA,NA,NA,NA,NA,NA,0.336,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2911877395,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3333333333,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Episodes: 2+",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2966101695,NA,NA,NA,NA,NA,NA,NA,NA,0.396039604,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2047058824,NA,NA,NA,NA,NA,NA,0.008547008547,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3352601156,NA,NA,NA,NA,NA,0.6592178771,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2718446602,NA,NA,NA,NA,NA,NA,0.01123595506,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.4285714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","VENLAFAXINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.178807947,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2973421927,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2692307692,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.56,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.305785124,NA,NA,NA,NA,NA,NA,NA,NA,0.2681564246,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.572815534,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1333333333,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2768987342,NA,NA,NA,NA,NA,NA,0.0181200453,NA,0.3410507569,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.4201183432,NA,NA,NA,NA,NA,NA,NA,0.6422018349,0.3361344538,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.0873015873,0.681372549,NA,NA,0.4821428571,NA,NA,0.3106796117,NA,NA,NA,0.6057692308,0.06896551724,NA,0.4829659319,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.4112149533,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.6403508772,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3727272727,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3679245283,NA,NA,NA,NA,NA,NA,NA,NA,0.5438596491,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.6202531646,NA,NA,NA,NA,NA,NA,0.08695652174,NA,0.642384106,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1164383562,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2060606061,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3076923077,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2617449664,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1038961039,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1522678186,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3303167421,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1608040201,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1090909091,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","OLMESARTAN MEDOXOMIL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.06563706564,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","OMEPRAZOLE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.07006369427,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1183431953,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.07042253521,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","RANITIDINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.08620689655,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","RISEDRONATE SODIUM",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1018518519,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1232876712,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1136363636,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1360946746,NA,NA,NA,NA,NA,NA,0.02189781022,NA,0.289048474,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.0625,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","VALSARTAN",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.7463087248,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.6707317073,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.947761194,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.9391891892,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","Num Previous Remissions: 2+",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.7573529412,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.7884615385,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","OMEPRAZOLE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6973180077,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.8415841584,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.8487394958,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6536312849,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1161290323,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1367521368,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LOSS OF WEIGHT (dxo:ICD9:78321)","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3044982699,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LOVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.05940594059,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LOVASTATIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.626349892,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4198473282,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.4039133473,NA,NA,NA,NA,NA,NA,NA,NA,0.4413965087,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.4273127753,NA,NA,NA,NA,NA,NA,NA,NA,0.4421487603,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2745490982,NA,0.2206047032,NA,NA,NA,NA,NA,NA,0.3148301574,"ESCITALOPRAM OXALATE","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1274509804,"ESCITALOPRAM OXALATE","MIRTAZAPINE","RISPERIDONE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2937062937,NA,NA,NA,NA,NA,NA,NA,NA,0.2429906542,"ESCITALOPRAM OXALATE","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.4464285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","MORBID OBESITY (dxo:ICD9:27801)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3246753247,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3423076923,NA,NA,0.1674418605,NA,NA,NA,NA,NA,0.347826087,"ESCITALOPRAM OXALATE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6807511737,NA,NA,NA,"ESCITALOPRAM OXALATE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.5871559633,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Num Previous Episodes: 2+",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.4101910828,NA,NA,NA,NA,NA,NA,NA,NA,0.4207650273,"ESCITALOPRAM OXALATE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2857142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","OLMESARTAN MEDOXOMIL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3648915187,NA,NA,NA,NA,NA,NA,NA,NA,0.3825136612,"ESCITALOPRAM OXALATE","OMEPRAZOLE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.4102564103,NA,NA,NA,NA,NA,NA,NA,NA,0.3675213675,"ESCITALOPRAM OXALATE","OXYBUTYNIN CHLORIDE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.316017316,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.328125,NA,NA,NA,NA,NA,NA,NA,NA,0.356223176,"ESCITALOPRAM OXALATE","PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5625,"ESCITALOPRAM OXALATE","PARALYSIS AGITANS (dxo:ICD9:3320)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5490196078,"ESCITALOPRAM OXALATE","PARALYSIS AGITANS (dxo:ICD9:3320)","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2763636364,NA,NA,NA,0.5389105058,NA,NA,NA,NA,0.264,"ESCITALOPRAM OXALATE","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4380952381,"ESCITALOPRAM OXALATE","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1090047393,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2079207921,"ESCITALOPRAM OXALATE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2992327366,NA,NA,NA,NA,NA,NA,NA,NA,0.5271903323,"ESCITALOPRAM OXALATE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5359477124,"ESCITALOPRAM OXALATE","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.467032967,"ESCITALOPRAM OXALATE","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3783783784,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","PRAVASTATIN SODIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3173076923,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","PREGABALIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2928571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2631578947,NA,NA,NA,NA,NA,NA,NA,NA,0.2067039106,"ESCITALOPRAM OXALATE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1527777778,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.168,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1778846154,NA,NA,NA,NA,NA,NA,NA,NA,0.1674641148,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2923076923,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3076923077,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","RAMIPRIL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3451327434,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","RANITIDINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4335664336,"ESCITALOPRAM OXALATE","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4636363636,NA,NA,NA,0.5695652174,"ESCITALOPRAM OXALATE","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3303571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","RISEDRONATE SODIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.0873015873,NA,NA,NA,NA,NA,NA,NA,NA,0.09049773756,"ESCITALOPRAM OXALATE","RISPERIDONE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05298013245,"ESCITALOPRAM OXALATE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2893481717,NA,NA,NA,NA,0.4243421053,NA,NA,NA,0.52,"ESCITALOPRAM OXALATE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4744525547,"ESCITALOPRAM OXALATE","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2580645161,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4745762712,NA,NA,NA,0.2628458498,0.4761904762,0.1029411765,NA,0.396039604,NA,0.5945151812,NA,NA,0.328440367,"ESCITALOPRAM OXALATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1851851852,NA,NA,NA,NA,NA,0.5454545455,NA,NA,0.3859649123,"ESCITALOPRAM OXALATE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.7884615385,NA,NA,NA,0.3483146067,NA,NA,NA,NA,NA,0.5963302752,NA,NA,0.390070922,"ESCITALOPRAM OXALATE","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4434782609,NA,NA,NA,0.3114901257,NA,NA,NA,NA,NA,0.4031007752,0.02035456336,NA,0.362082777,"ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4615384615,"ESCITALOPRAM OXALATE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3076923077,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","UNSPECIFIED CEREBRAL ARTERY OCCLUSION WITH CEREBRAL INFARCTION (dxi:ICD9:43491)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.4817518248,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3216080402,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","VALSARTAN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3615221987,NA,NA,NA,NA,NA,0.4090909091,NA,0.6872852234,0.3670634921,"ESCITALOPRAM OXALATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4268060837,NA,NA,NA,0.1032608696,0.4792626728,NA,NA,NA,NA,NA,NA,NA,NA,"ESOMEPRAZOLE MAGNESIUM",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7549019608,NA,NA,NA,NA,NA,NA,NA,NA,"ESOMEPRAZOLE MAGNESIUM","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4595300261,NA,0.18,0.3175675676,NA,NA,NA,NA,0.4369747899,NA,0.5130434783,NA,0.4589041096,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8571428571,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.3644067797,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4583333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","LISINOPRIL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.5225225225,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","LOVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.297029703,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4171122995,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","PRAVASTATIN SODIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.5247524752,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4752252252,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7364864865,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.4480519481,NA,NA,NA,NA,0.4951456311,NA,NA,NA,"ESTRADIOL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7901234568,NA,NA,NA,NA,NA,NA,NA,NA,"ESTRADIOL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.5398230088,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5342465753,NA,NA,NA,"ESTROGEN,CON/M-PROGEST ACET",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.712,NA,NA,NA,"ESTROGEN,CON/M-PROGEST ACET","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.5259259259,NA,NA,NA,NA,0.5194174757,NA,NA,NA,"ESTROGENS, CONJUGATED",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7578125,NA,NA,NA,NA,NA,NA,NA,NA,"ESTROGENS, CONJUGATED","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7189542484,NA,NA,NA,"ESTROGENS, CONJUGATED","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.48125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESZOPICLONE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1515151515,NA,NA,NA,NA,NA,NA,NA,NA,NA,"EZETIMIBE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4897959184,NA,NA,NA,0.08585858586,0.5153846154,NA,NA,NA,NA,0.55,NA,NA,NA,"EZETIMIBE/SIMVASTATIN",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.8102189781,NA,NA,NA,NA,NA,NA,NA,NA,"EZETIMIBE/SIMVASTATIN","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7795275591,NA,NA,NA,"EZETIMIBE/SIMVASTATIN","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.2075471698,0.1017811705,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FAMOTIDINE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5303643725,NA,NA,NA,"FENOFIBRATE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8991596639,NA,NA,NA,"FENOFIBRATE","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8540772532,NA,NA,NA,"FENOFIBRATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1293103448,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FENOFIBRATE NANOCRYSTALLIZED",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5110294118,NA,NA,NA,"FITTING AND ADJUSTMENT OF VASCULAR CATHETER (dxo:ICD9:V5881)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7572254335,NA,NA,NA,"FITTING AND ADJUSTMENT OF VASCULAR CATHETER (dxo:ICD9:V5881)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3106796117,NA,NA,NA,NA,NA,"FLATULENCE, ERUCTATION, AND GAS PAIN (dxo:ICD9:7873)",NA,NA,NA,NA,NA,NA
"65-79","Female",0.0250965251,0.04709345107,0.5208860759,NA,0.1379310345,0.4293606946,0.2078328982,0.6596601809,0.1567164179,0.09236947791,0.4412903226,0.124260355,0.5079812207,0.009080590238,0.5457705678,0.4175777965,"FLUOXETINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.8040904198,NA,NA,NA,NA,NA,NA,NA,0.5107526882,"FLUOXETINE HCL","GABAPENTIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.4047619048,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GABAPENTIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.8313253012,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GABAPENTIN","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7916666667,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GABAPENTIN","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7613882863,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008771929825,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.3785714286,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7431693989,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.2114427861,NA,NA,NA,NA,NA,NA,NA,0.08280254777,"FLUOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1171875,"FLUOXETINE HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.01421800948,0.4517766497,NA,NA,0.3072289157,0.110701107,NA,NA,NA,NA,NA,0.5220883534,0,0.4285714286,0.3561847988,"FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5231788079,"FLUOXETINE HCL","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.6092896175,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6981132075,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.6489795918,NA,NA,NA,NA,NA,0.01886792453,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3663366337,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5902777778,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5327102804,"FLUOXETINE HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.6686746988,NA,NA,NA,NA,NA,0.01858108108,NA,0.6496539792,"FLUOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4955752212,"FLUOXETINE HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.08152173913,0.6025641026,NA,NA,0.4782608696,0.3085714286,NA,0.3142857143,NA,NA,NA,0.5823529412,0.04700854701,0.606557377,0.4794007491,"FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.6607142857,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.6849015317,NA,NA,NA,NA,NA,0.03097345133,NA,NA,"FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4778761062,"FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.6055045872,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.6795366795,NA,NA,NA,NA,NA,0.04376012966,NA,0.6103448276,"FLUOXETINE HCL","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.3937823834,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.4220183486,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.4023972603,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5761589404,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.2549019608,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.437037037,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.4695652174,NA,NA,NA,NA,NA,0.01503759398,NA,0.4945054945,"FLUOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.8235947567,NA,NA,NA,NA,NA,NA,NA,0.547008547,"FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.8415841584,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7902097902,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6476190476,"FLUOXETINE HCL","Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.5666666667,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.9033816425,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7535211268,"FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.9090909091,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Remissions: 2+",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.78,"FLUOXETINE HCL","Last AD: Same & Remiss","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7086956522,"FLUOXETINE HCL","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7,"FLUOXETINE HCL","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.8543307087,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7114178168,"FLUOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.8175675676,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7843137255,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.8712871287,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LOVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7893518519,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.813559322,NA,NA,NA,NA,NA,NA,NA,0.5,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.6726296959,NA,NA,NA,NA,NA,NA,NA,0.5154929577,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.5862068966,NA,NA,NA,NA,NA,NA,NA,0.5658914729,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7887931034,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.6304347826,0.2363315697,NA,NA,NA,NA,NA,NA,0.462745098,"FLUOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MIRTAZAPINE","Num Previous Antidep: 2,3",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3906810036,"FLUOXETINE HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.6825938567,NA,0.1322751323,NA,NA,NA,NA,NA,0.6089385475,"FLUOXETINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7142857143,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.6490514905,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.8968253968,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Remissions: 2+",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.609929078,NA,NA,NA,NA,NA,NA,NA,0.7380952381,"FLUOXETINE HCL","Num Previous Remissions: 2+","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5208333333,"FLUOXETINE HCL","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4266666667,"FLUOXETINE HCL","OMEPRAZOLE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.496,"FLUOXETINE HCL","OXYBUTYNIN CHLORIDE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.746031746,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4173228346,"FLUOXETINE HCL","PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.631147541,NA,NA,0.6039387309,NA,NA,NA,NA,0.3473053892,"FLUOXETINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.4402985075,NA,NA,NA,NA,NA,NA,NA,0.145631068,"FLUOXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.5025125628,NA,NA,NA,NA,NA,NA,NA,0.5740740741,"FLUOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7049180328,"FLUOXETINE HCL","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4793814433,"FLUOXETINE HCL","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.8475609756,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PREGABALIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2307692308,"FLUOXETINE HCL","PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.4956521739,NA,NA,NA,NA,NA,NA,NA,0.2235294118,"FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2824427481,"FLUOXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7577639752,NA,NA,NA,NA,NA,NA,NA,0.5294117647,"FLUOXETINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.384180791,NA,NA,NA,0.6735751295,"FLUOXETINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1388888889,"FLUOXETINE HCL","RISPERIDONE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.5594512195,NA,NA,NA,0.4529147982,NA,NA,NA,0.576184379,"FLUOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4590747331,"FLUOXETINE HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.8257575758,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4285714286,NA,NA,NA,0.2366412214,0.5981161695,NA,NA,NA,NA,0.5917431193,NA,NA,0.4451038576,"FLUOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4325842697,"FLUOXETINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7822706065,NA,NA,NA,NA,NA,NA,NA,0.5044247788,"FLUOXETINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7524752475,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","SIMVASTATIN","UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA
"65-79","Female",NA,0.06611570248,NA,NA,NA,NA,0.1515151515,0.5754608295,NA,NA,NA,NA,0.32,0.02998001332,NA,0.5564516129,"FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4566210046,"FLUOXETINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.5483870968,NA,0.8044692737,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7325842697,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.7168141593,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","UNSPECIFIED TRANSIENT CEREBRAL ISCHEMIA (dxo:ICD9:4359)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.6295399516,NA,NA,NA,NA,NA,NA,0.6586826347,0.4433399602,"FLUOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,0.01465201465,0.4574829932,NA,NA,0.2858701582,0.1015523933,0.4622395833,NA,0.03832752613,0.4517133956,NA,0.4735830932,NA,NA,0.2708333333,"GABAPENTIN",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.431372549,NA,NA,NA,"GABAPENTIN","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.376,"GABAPENTIN","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4522292994,NA,NA,NA,"GABAPENTIN","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8,NA,NA,NA,NA,NA,"GABAPENTIN","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8095238095,NA,NA,NA,"GABAPENTIN","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8173076923,NA,NA,NA,"GABAPENTIN","Last AD: Same & Remiss","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.2108433735,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.08035714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","OMEPRAZOLE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.3025210084,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7264957265,NA,NA,NA,NA,0.3933333333,"GABAPENTIN","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.3205741627,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","PREGABALIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.4496644295,NA,NA,NA,NA,NA,NA,0.8191933241,NA,NA,0.5438596491,"GABAPENTIN","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8181818182,NA,NA,NA,"GABAPENTIN","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,0.4827586207,NA,NA,NA,NA,0.4568965517,NA,NA,NA,NA,0.4572368421,NA,NA,NA,"GABAPENTIN","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.2873134328,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","TRAMADOL HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3575418994,"GABAPENTIN","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.323943662,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.2277227723,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","UNSPECIFIED INFLAMMATORY AND TOXIC NEUROPATHY (dxo:ICD9:3579)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.2987249545,NA,NA,NA,NA,NA,NA,0.4220183486,NA,NA,NA,"GABAPENTIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4094488189,"GABAPENTIN","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4921465969,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GEMFIBROZIL",NA,NA,NA,NA,NA,NA
"65-79","Female",0.02919708029,0.04278074866,NA,NA,NA,NA,0.156626506,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GENERALIZED ANXIETY DISORDER (dxo:ICD9:30002)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1271186441,NA,NA,NA,0.3692307692,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7289719626,NA,NA,NA,NA,NA,"GYNECOLOGICAL EXAMINATION (dxo:ICD9:V723)","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",0.01155115512,NA,NA,NA,NA,NA,NA,NA,NA,0.03276353276,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04242424242,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1647727273,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"65-79","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA
"65-79","Female",0.009615384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4426229508,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HEMATURIA (dxo:ICD9:5997)",NA,NA,NA,NA,NA,NA
"65-79","Female",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HERPES ZOSTER WITHOUT MENTION OF COMPLICATION (dxo:ICD9:0539)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.004651162791,NA,NA,"HIP JOINT REPLACEMENT BY OTHER MEANS (dxo:ICD9:V4364)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.371040724,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4190283401,NA,NA,NA,"HYDRALAZINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8039215686,NA,NA,NA,"HYDRALAZINE HCL","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7692307692,NA,NA,NA,"HYDRALAZINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4473684211,NA,NA,NA,"HYDRALAZINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",0.01724137931,NA,NA,NA,NA,0.3072916667,0.08,NA,NA,NA,NA,0.25,0.4893617021,0.01083032491,NA,NA,"HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5139664804,NA,NA,NA,"HYDROXYCHLOROQUINE SULFATE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7936507937,NA,NA,NA,"HYDROXYCHLOROQUINE SULFATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,0.1805555556,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROXYZINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4823529412,0.005988023952,NA,NA,"IBUPROFEN",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2199630314,"IMIPRAMINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07901907357,"IMIPRAMINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2192982456,0.1504424779,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4262295082,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 20 TO 30 MINUTES","(px:CPT4:90805)","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.2361111111,NA,NA,0.2598425197,0.07954545455,0.2941176471,NA,NA,0.2403846154,NA,0.201320132,NA,0.3146067416,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3423423423,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,0.2298136646,NA,NA,NA,0.1016949153,NA,NA,NA,NA,NA,0.224852071,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4807692308,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4601769912,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",0.009708737864,NA,0.3975609756,NA,0.2169811321,NA,NA,0.4524180967,0.09119496855,NA,NA,NA,0.4576271186,0.01125082727,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009009009009,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009950248756,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3669724771,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01639344262,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Diff & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1268656716,NA,NA,NA,NA,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3170731707,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005154639175,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008771929825,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","TRAZODONE HCL","ZOLPIDEM TARTRATE",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.830449827,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008620689655,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7677902622,0.03496503497,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8176470588,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01503759398,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,0.4952380952,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4512195122,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02040816327,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TEMAZEPAM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAMADOL HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009280742459,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008051529791,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02857142857,NA,NA,NA,NA,NA,NA,"IRRITABLE BOWEL SYNDROME (dxo:ICD9:5641)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.3471502591,NA,NA,NA,0.09392265193,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LACTULOSE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.1438596491,NA,NA,0.1317567568,0.07692307692,0.1845493562,NA,NA,NA,NA,0.1456953642,NA,0.2017167382,0.1111713666,"LAMOTRIGINE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3516949153,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3461538462,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1333333333,"LAMOTRIGINE","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07906976744,"LAMOTRIGINE","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1354166667,"LAMOTRIGINE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1357142857,"LAMOTRIGINE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1978021978,"LAMOTRIGINE","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2205882353,NA,NA,NA,"LAMOTRIGINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.118245391,"LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.08121827411,"LAMOTRIGINE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1571969697,0.1241134752,"LAMOTRIGINE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1517857143,NA,NA,NA,NA,NA,NA,NA,"LANSOPRAZOLE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.003571428571,NA,NA,"Last AD: Diff & No Remiss",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.3503184713,NA,NA,NA,0.1034482759,NA,NA,NA,NA,NA,0.3274336283,0.003424657534,NA,0.288326301,"Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5568862275,NA,NA,NA,"Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6635514019,NA,NA,NA,"Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5185185185,"Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2236024845,"Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.496350365,"Last AD: Diff & No Remiss","MIRTAZAPINE","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.2516556291,NA,NA,NA,NA,NA,NA,0.5723905724,"Last AD: Diff & No Remiss","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1924290221,NA,NA,NA,NA,0.006779661017,NA,0.2615384615,"Last AD: Diff & No Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5714285714,0.5806451613,"Last AD: Diff & No Remiss","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2746781116,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6923076923,NA,NA,NA,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.652173913,"Last AD: Diff & No Remiss","NORTRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5526315789,NA,NA,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6137724551,0,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6215277778,NA,NA,0.01342281879,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.652892562,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7904761905,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","SIMVASTATIN","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6726283048,0.005988023952,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7089552239,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01923076923,0.8347826087,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5316091954,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3668639053,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5786240786,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3115384615,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5517241379,0.6617210682,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"65-79","Female",NA,0.01986754967,0.2732240437,NA,NA,0.2920353982,0.1028938907,0.3565217391,NA,NA,NA,NA,0.4354243542,0.01333333333,NA,0.3011583012,"Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01550387597,NA,0.5904486252,"Last AD: Diff & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.38,"Last AD: Diff & No Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7463768116,"Last AD: Diff & No Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4134078212,"Last AD: Diff & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6910994764,"Last AD: Diff & No Remiss","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006849315068,NA,NA,"Last AD: Diff & No Remiss","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",0.02189781022,0.01891891892,0.4118942731,NA,NA,0.3153153153,0.100286533,0.3829787234,0.1145833333,NA,0.2990654206,NA,NA,0.008503401361,0.4036697248,0.3476151981,"Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6654275093,0.01199563795,NA,0.6245975531,"Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6538461538,0.4579439252,"Last AD: Diff & No Remiss","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3612903226,"Last AD: Diff & No Remiss","SIMVASTATIN","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",0.009852216749,0.02051282051,0.3406862745,NA,NA,0.2577319588,0.08477842004,0.3917050691,0.1144781145,NA,0.3141025641,NA,0.361003861,0.01243455497,NA,0.336940482,"Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02549575071,0.6452702703,0.6605374823,"Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.0234375,0.4453781513,NA,NA,0.3025210084,0.09580838323,NA,NA,NA,NA,NA,0.4397163121,0.01675977654,NA,0.3791208791,"Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,0.09090909091,NA,NA,NA,0.5591836735,NA,NA,0.2807881773,NA,NA,NA,NA,0.05440613027,0.6473988439,NA,"Last AD: Diff & Remiss",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4336283186,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.375,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.6115702479,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3465045593,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.3854351687,NA,NA,NA,NA,NA,NA,0.4924623116,"Last AD: Diff & Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.731884058,NA,NA,NA,"Last AD: Diff & Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.2946428571,NA,NA,NA,0.7044025157,NA,NA,NA,"Last AD: Diff & Remiss","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8252427184,NA,NA,NA,"Last AD: Diff & Remiss","NORTRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6428571429,NA,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","Num Previous Remissions: 2+","SERTRALINE HCL","TRAZODONE HCL",NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5879396985,NA,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.619047619,NA,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","Num Previous Remissions: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6842105263,NA,NA,0.009803921569,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6753246753,0.01369863014,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008196721311,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6923076923,"Last AD: Diff & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5405405405,"Last AD: Diff & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6092715232,NA,NA,0.6583333333,"Last AD: Diff & Remiss","Num Previous Remissions: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,0.5321100917,NA,NA,0.4112149533,0.2913385827,NA,NA,NA,NA,NA,0.6095890411,0.1007194245,NA,0.4585365854,"Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6730769231,NA,NA,0.0365448505,NA,0.5744680851,"Last AD: Diff & Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5867768595,NA,NA,NA,"Last AD: Diff & Remiss","PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6206896552,"Last AD: Diff & Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6305220884,"Last AD: Diff & Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5986842105,NA,NA,0.5873015873,"Last AD: Diff & Remiss","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01904761905,NA,NA,"Last AD: Diff & Remiss","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,0.04089219331,0.5106382979,NA,NA,0.4618055556,0.2118644068,0.5763888889,0.2188841202,NA,0.5,NA,NA,0.04788732394,0.7085714286,0.4915611814,"Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.544,"Last AD: Diff & Remiss","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6761133603,0.03170409511,NA,0.618556701,"Last AD: Diff & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04915953061,NA,NA,"Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05291005291,0.6827794562,0.6064257028,"Last AD: Diff & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6052631579,NA,NA,NA,NA,NA,NA,NA,0.08396946565,0.8103448276,0.4800796813,"Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09795321637,"Last AD: Same & No Remiss",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4672897196,NA,NA,NA,"Last AD: Same & No Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3741007194,NA,"Last AD: Same & No Remiss","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1156515035,NA,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.04545454545,NA,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","MIRTAZAPINE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1607142857,NA,NA,NA,NA,NA,NA,0.3870967742,"Last AD: Same & No Remiss","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5135135135,"Last AD: Same & No Remiss","MIRTAZAPINE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2606060606,"Last AD: Same & No Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.09090909091,NA,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","MIRTAZAPINE","UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0500481232,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3755656109,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3962264151,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4522613065,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4822335025,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4642857143,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.002309468822,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.45,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4245614035,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5046728972,"Last AD: Same & No Remiss","PARALYSIS AGITANS (dxo:ICD9:3320)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3259557344,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2924528302,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4401544402,"Last AD: Same & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02083333333,NA,NA,"Last AD: Same & No Remiss","PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2702702703,NA,NA,NA,"Last AD: Same & No Remiss","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4128787879,"Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5167785235,"Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6639344262,"Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4315068493,NA,NA,NA,"Last AD: Same & No Remiss","PRAVASTATIN SODIUM","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5294117647,NA,NA,NA,"Last AD: Same & No Remiss","PREGABALIN","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2893401015,NA,NA,NA,"Last AD: Same & No Remiss","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2346938776,NA,NA,NA,NA,"Last AD: Same & No Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2181588903,NA,NA,NA,NA,"Last AD: Same & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4403669725,NA,NA,NA,"Last AD: Same & No Remiss","ROSUVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Same & No Remiss","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4124748491,NA,NA,0.4174757282,"Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4380403458,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4255319149,0.005617977528,NA,0.428057554,"Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.00701754386,NA,NA,"Last AD: Same & No Remiss","TRAMADOL HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008172605427,NA,0.2027027027,"Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009803921569,NA,NA,"Last AD: Same & No Remiss","TRAZODONE HCL","UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4219409283,"Last AD: Same & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Same & No Remiss","TRAZODONE HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4048543689,NA,"Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5973348783,"Last AD: Same & Remiss",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7448979592,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8450704225,NA,NA,NA,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6683168317,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7303370787,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.664,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7155963303,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.807106599,NA,NA,NA,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.687037037,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7452830189,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7894736842,NA,NA,NA,"Last AD: Same & Remiss","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8129496403,NA,"Last AD: Same & Remiss","MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.6453488372,NA,NA,NA,NA,NA,NA,0.622833843,"Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5648148148,"Last AD: Same & Remiss","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.562962963,"Last AD: Same & Remiss","MIRTAZAPINE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6142857143,"Last AD: Same & Remiss","MIRTAZAPINE","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6948051948,"Last AD: Same & Remiss","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5733788396,"Last AD: Same & Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6606060606,"Last AD: Same & Remiss","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.744966443,NA,NA,NA,NA,NA,0.6600877193,"Last AD: Same & Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6305732484,"Last AD: Same & Remiss","NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5514018692,"Last AD: Same & Remiss","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6355140187,"Last AD: Same & Remiss","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.9084507042,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","PAROXETINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.9362416107,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.947826087,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","SERTRALINE HCL","SIMVASTATIN",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7570093458,"Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6160714286,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6534296029,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7705882353,"Last AD: Same & Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.9084745763,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Remissions: 2+","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.9346405229,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7388059701,"Last AD: Same & Remiss","Num Previous Remissions: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8796296296,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8530612245,NA,NA,NA,"Last AD: Same & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5905511811,"Last AD: Same & Remiss","PARALYSIS AGITANS (dxo:ICD9:3320)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8148667602,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6330935252,"Last AD: Same & Remiss","PAROXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8440366972,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","PAROXETINE HCL","PRAVASTATIN SODIUM",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.821875,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7098445596,"Last AD: Same & Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6592734226,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7127071823,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5769230769,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6426735219,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5595238095,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6797752809,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8804347826,NA,NA,NA,"Last AD: Same & Remiss","PRAVASTATIN SODIUM","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8372093023,NA,NA,NA,"Last AD: Same & Remiss","PREGABALIN","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7155172414,NA,NA,NA,NA,"Last AD: Same & Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7013888889,NA,NA,NA,0.6718246293,"Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6851851852,"Last AD: Same & Remiss","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.536,"Last AD: Same & Remiss","ROPINIROLE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5734908136,"Last AD: Same & Remiss","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6534653465,"Last AD: Same & Remiss","ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8636363636,NA,NA,NA,"Last AD: Same & Remiss","ROSUVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8391304348,NA,NA,0.5140186916,"Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8567395907,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7532314924,"Last AD: Same & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8483146067,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6857638889,"Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7032810271,"Last AD: Same & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8181257707,0.64,"Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.07299270073,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LEVOFLOXACIN",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4533333333,NA,NA,NA,0.1,0.5238095238,NA,NA,NA,NA,0.4653893696,NA,NA,0.2443181818,"LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.372,NA,NA,NA,"LEVOTHYROXINE SODIUM","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.86,NA,NA,NA,"LEVOTHYROXINE SODIUM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8850574713,NA,NA,NA,"LEVOTHYROXINE SODIUM","Last AD: Same & Remiss","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4607329843,NA,NA,NA,"LEVOTHYROXINE SODIUM","PRAVASTATIN SODIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8660714286,NA,NA,NA,"LEVOTHYROXINE SODIUM","PRAVASTATIN SODIUM","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5606060606,NA,NA,NA,"LEVOTHYROXINE SODIUM","ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8181818182,NA,NA,NA,"LEVOTHYROXINE SODIUM","ROSUVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7963671128,NA,NA,NA,"LEVOTHYROXINE SODIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8564920273,NA,NA,NA,"LEVOTHYROXINE SODIUM","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,0.4414414414,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4774590164,NA,NA,NA,"LEVOTHYROXINE SODIUM","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4037267081,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LISINOPRIL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4351939451,NA,NA,NA,0.1073170732,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LISINOPRIL/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4524886878,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LISINOPRIL/HYDROCHLOROTHIAZIDE","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,0.05298013245,0.3771929825,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.423580786,NA,NA,NA,"LORAZEPAM",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7431192661,NA,NA,NA,"LORAZEPAM","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.3518248175,NA,NA,NA,NA,0.4318181818,0.1088769004,NA,0.3036437247,NA,0.4418604651,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1175115207,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.2173913043,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.186440678,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.2112676056,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6124031008,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1397379913,NA,NA,NA,0.6742424242,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1351351351,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1029411765,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA,NA
"65-79","Female",0.01694915254,NA,0.4275132275,NA,NA,NA,0.1160572337,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LOVASTATIN",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,0.4951140065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6866197183,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8263598326,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8114285714,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6766917293,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7024793388,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.715,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6860730594,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,0.496194825,0.6629213483,NA,NA,0.6705426357,0.5598455598,0.6774193548,0.5251798561,NA,NA,NA,0.652360515,0.4060606061,0.6987179487,0.6807994023,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6431924883,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6235294118,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.5306122449,NA,NA,NA,NA,NA,NA,0.662835249,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6608695652,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7138643068,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6759493671,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6294117647,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8164983165,NA,NA,0.6666666667,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3979238754,NA,0.6614785992,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7614678899,0.6824324324,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.5555555556,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4569892473,NA,NA,0.2916666667,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7908496732,NA,NA,0.5283018868,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4174757282,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",0.2196261682,0.2591380251,0.5529411765,0.5319148936,NA,0.4571428571,0.3525641026,0.5690866511,0.3328488372,0.3115942029,0.5079365079,NA,0.5849056604,0.1895093063,0.5328836425,0.5075757576,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.3771251932,NA,NA,NA,NA,NA,NA,0.536380597,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3818181818,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5769230769,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.462962963,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3333333333,NA,NA,NA,NA,NA,0.544600939,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.44,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6714513557,NA,NA,NA,NA,0.4819277108,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6545454545,NA,NA,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5875831486,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5183486239,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3185840708,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","RISPERIDONE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5606936416,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.493902439,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.3816793893,NA,0.3017241379,NA,NA,NA,0.7978142077,NA,NA,0.4760820046,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.619047619,NA,NA,0.5137254902,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1936056838,NA,0.518572825,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6237623762,0.5454545455,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6493987049,0.5278350515,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,0.01886792453,NA,NA,NA,NA,NA,0.502994012,NA,NA,NA,NA,0.4803418803,NA,0.4416749751,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8448844884,NA,NA,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5083333333,NA,NA,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6258992806,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7395411606,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4187192118,NA,NA,NA,"MASTODYNIA (dxo:ICD9:61171)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7722772277,NA,NA,NA,"MASTODYNIA (dxo:ICD9:61171)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4037267081,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3951367781,NA,NA,NA,"MECLIZINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7846153846,NA,NA,NA,"MECLIZINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.296460177,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MELOXICAM",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.452173913,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"METAXALONE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1111111111,NA,0.3515151515,NA,0.4586466165,NA,NA,NA,"METFORMIN HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7988505747,NA,NA,NA,NA,NA,"METFORMIN HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",0.01538461538,0.01875,0.3403908795,NA,NA,0.279491833,0.1379897785,0.2745098039,0.2473789516,NA,0.2698412698,NA,0.3559928444,0.015625,0.3623188406,0.39622488,"MIRTAZAPINE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4326241135,"MIRTAZAPINE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6637931034,NA,NA,NA,"MIRTAZAPINE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.309375,"MIRTAZAPINE","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.35,"MIRTAZAPINE","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.304,"MIRTAZAPINE","Num Previous Antidep: 4+","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3653846154,"MIRTAZAPINE","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3155216285,"MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2415730337,"MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3082706767,"MIRTAZAPINE","PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.2092050209,NA,0.5567928731,NA,NA,NA,NA,0.4426229508,"MIRTAZAPINE","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3522012579,"MIRTAZAPINE","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1339285714,"MIRTAZAPINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1404958678,"MIRTAZAPINE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5178571429,"MIRTAZAPINE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4954954955,"MIRTAZAPINE","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1968503937,"MIRTAZAPINE","PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1612318841,"MIRTAZAPINE","RISPERIDONE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1598746082,"MIRTAZAPINE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.2427184466,NA,NA,NA,NA,NA,NA,0.4401913876,"MIRTAZAPINE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4133333333,"MIRTAZAPINE","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.3490566038,NA,NA,NA,NA,NA,NA,NA,"MIRTAZAPINE","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.18,NA,0.2279693487,NA,NA,NA,0.6134316134,NA,NA,0.4723214286,"MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5555555556,NA,NA,0.4273504274,"MIRTAZAPINE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1906976744,NA,NA,NA,NA,0.032,NA,0.3485893417,"MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3412322275,"MIRTAZAPINE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.36,NA,NA,NA,NA,NA,NA,NA,"MIRTAZAPINE","UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.2662337662,NA,NA,NA,NA,NA,NA,NA,"MIRTAZAPINE","UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.2140077821,NA,NA,NA,NA,NA,0.6403940887,0.3977272727,"MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1436781609,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MITRAL VALVE DISORDERS (dxo:ICD9:4240)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4539007092,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MONTELUKAST SODIUM",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.126394052,NA,0.1503759398,NA,NA,NA,NA,NA,NA,NA,"MORBID OBESITY (dxo:ICD9:27801)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1240875912,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MOXIFLOXACIN HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.472,NA,"MUSCLE WEAKNESS (GENERALIZED) (dxo:ICD9:72887)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.752293578,NA,"MUSCLE WEAKNESS (GENERALIZED) (dxo:ICD9:72887)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,0.0737704918,0.3953488372,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5446428571,NA,NA,NA,"MYOPIA (dxo:ICD9:3671)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,0.02059357965,NA,NA,NA,NA,0.1044546851,NA,0.1157407407,NA,NA,NA,0.4219858156,0.005464480874,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,0.01092896175,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA,NA
"65-79","Female",0.01612903226,NA,0.3870967742,NA,NA,0.3115577889,0.1111111111,NA,0.11,0.1603568845,NA,NA,0.4421052632,NA,0.4,0.4799128751,"NORTRIPTYLINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7160493827,NA,NA,NA,"NORTRIPTYLINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3488372093,"NORTRIPTYLINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1304347826,0.7019607843,NA,NA,NA,NA,0.4889867841,"NORTRIPTYLINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5823754789,"NORTRIPTYLINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5596590909,"NORTRIPTYLINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1609195402,NA,NA,0.666,NA,NA,0.5965665236,"NORTRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1897810219,NA,NA,NA,NA,NA,0.4180569185,"NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1415929204,NA,NA,NA,NA,0.6720430108,0.5669781931,"NORTRIPTYLINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5498489426,NA,NA,NA,NA,NA,"Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6265822785,NA,NA,NA,NA,NA,"Num Previous Antidep: 2,3","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,"Num Previous Antidep: 2,3","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6719653179,NA,NA,NA,"Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.701986755,NA,NA,NA,"Num Previous Antidep: 2,3","SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2943469786,"Num Previous Antidep: 4+",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.41,NA,NA,NA,NA,NA,"Num Previous Antidep: 4+","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4074074074,"Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.495049505,"Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4593495935,"Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4070351759,"Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3512658228,"Num Previous Antidep: 4+","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.419804742,"Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4166666667,NA,NA,NA,"Num Previous Antidep: 4+","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3387779794,"Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2990654206,"Num Previous Antidep: 4+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5545722714,NA,NA,NA,NA,NA,"Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.9,NA,NA,NA,NA,NA,"Num Previous Remissions: 2+","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.9302694136,NA,NA,NA,"Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.625,NA,NA,0.7012195122,"Num Previous Remissions: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.547008547,NA,"Num Previous Remissions: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8662420382,NA,"Num Previous Remissions: 2+","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,0.03383458647,NA,NA,NA,NA,NA,NA,0.102189781,NA,NA,NA,NA,NA,NA,NA,"OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2592592593,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA,NA
"65-79","Female",0.01923076923,NA,0.5060240964,NA,NA,NA,0.1363220494,NA,0.09701492537,NA,0.4805825243,NA,0.530884808,0.01379310345,NA,0.376,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7740740741,NA,NA,NA,NA,0.4556962025,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8230769231,NA,NA,0.5192982456,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.85625,NA,NA,NA,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,0.5339805825,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.51875,NA,NA,NA,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3302752294,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5256410256,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.09785932722,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OLMESARTAN MEDOXOMIL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.09433962264,NA,NA,NA,NA,NA,NA,NA,NA,0.2782369146,"OMEPRAZOLE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3779069767,"OMEPRAZOLE","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4703947368,"OMEPRAZOLE","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4545454545,"OMEPRAZOLE","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.08878504673,NA,NA,NA,NA,NA,NA,NA,NA,0.380952381,"OMEPRAZOLE","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3435582822,"OMEPRAZOLE","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4912280702,"OMEPRAZOLE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4824561404,NA,NA,NA,NA,NA,0.1059602649,NA,NA,NA,NA,NA,NA,NA,"OTHER DISORDERS OF BONE AND CARTILAGE (dxo:ICD9:73399)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3175853018,NA,NA,NA,0.4166666667,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.608,NA,NA,NA,NA,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5183150183,NA,NA,NA,0.4351851852,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,0.02714932127,NA,NA,NA,0.3484486874,NA,NA,NA,NA,NA,NA,NA,0.01,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.3784860558,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER NONSPECIFIC ABNORMAL FINDING OF LUNG FIELD (dxo:ICD9:79319)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4293785311,NA,NA,NA,NA,NA,0.09248554913,NA,NA,NA,NA,NA,NA,NA,"OTHER PERSISTENT MENTAL DISORDERS DUE TO CONDITIONS CLASSIFIED ELSEWHERE (dxo:ICD9:2948)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,0.0162601626,0.3489583333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA,NA,NA
"65-79","Female",0.01296596434,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5255255255,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA,NA
"65-79","Female",0.006779661017,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7952755906,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.52,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER SPECIFIED PRE-OPERATIVE EXAMINATION (dxo:ICD9:V7283)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1318181818,NA,NA,NA,NA,NA,0.4807692308,NA,NA,0.2666666667,"OXYBUTYNIN CHLORIDE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4519230769,"OXYBUTYNIN CHLORIDE","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.530726257,"OXYBUTYNIN CHLORIDE","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3168316832,"OXYBUTYNIN CHLORIDE","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",0.005154639175,NA,NA,NA,NA,NA,0.1146496815,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OXYCODONE HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.36328125,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.3401360544,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PAIN IN JOINT, MULTIPLE SITES (dxo:ICD9:71949)","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.3366336634,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PAIN IN JOINT, SITE UNSPECIFIED (dxo:ICD9:71940)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.3633802817,NA,NA,0.3181818182,0.08023774146,0.469273743,NA,NA,0.3597122302,NA,0.3956043956,NA,NA,0.2316384181,"PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6926605505,NA,NA,NA,NA,NA,"PALPITATIONS (dxo:ICD9:7851)","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3454545455,NA,NA,NA,NA,NA,"PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6862745098,NA,NA,NA,NA,NA,"PANIC DISORDER WITHOUT AGORAPHOBIA (dxo:ICD9:30001)","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.3214285714,NA,NA,NA,0.09459459459,NA,NA,NA,NA,0.4542253521,0.4169278997,0.008333333333,NA,0.4457593688,"PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4888888889,"PARALYSIS AGITANS (dxo:ICD9:3320)","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5278450363,"PARALYSIS AGITANS (dxo:ICD9:3320)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5737704918,"PARALYSIS AGITANS (dxo:ICD9:3320)","PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5990990991,NA,NA,NA,0.5487804878,"PARALYSIS AGITANS (dxo:ICD9:3320)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6168224299,"PARALYSIS AGITANS (dxo:ICD9:3320)","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6816143498,NA,NA,0.5091575092,"PARALYSIS AGITANS (dxo:ICD9:3320)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5384615385,"PARALYSIS AGITANS (dxo:ICD9:3320)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",0.02801120448,0.04157549234,0.4899211218,NA,NA,0.4019715225,0.1740121581,0.4704,0.1456521739,0.03289473684,0.6228051392,0.1768292683,0.5104895105,0.02995391705,0.5186046512,0.3859191656,"PAROXETINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3851351351,NA,NA,NA,NA,NA,"PAROXETINE HCL","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5218658892,NA,NA,NA,NA,0.6029776675,"PAROXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6296296296,"PAROXETINE HCL","PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7605177994,NA,NA,NA,NA,NA,"PAROXETINE HCL","PRAVASTATIN SODIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.46,NA,NA,NA,NA,NA,"PAROXETINE HCL","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4403669725,"PAROXETINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4697986577,NA,NA,NA,0.5244755245,"PAROXETINE HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6279069767,NA,NA,NA,NA,NA,"PAROXETINE HCL","RISEDRONATE SODIUM",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.225,NA,NA,NA,NA,NA,"PAROXETINE HCL","RISPERIDONE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5948827292,0.4236311239,NA,NA,NA,0.6291913215,"PAROXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5592105263,"PAROXETINE HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7358490566,NA,NA,NA,NA,NA,"PAROXETINE HCL","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7055555556,NA,NA,NA,NA,NA,"PAROXETINE HCL","ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5798319328,NA,0.5647558386,NA,NA,0.3967611336,"PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.534351145,"PAROXETINE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7115384615,NA,NA,NA,NA,0.3769470405,"PAROXETINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5562390158,NA,NA,0.02190332326,NA,0.5394366197,"PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5391304348,"PAROXETINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6268656716,NA,NA,NA,0.5238095238,0.4110169492,"PAROXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.3966244726,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PEN NEEDLE, DIABETIC",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4765100671,0.01079136691,NA,NA,"PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.2630208333,NA,NA,0.1891891892,NA,NA,0.03896103896,NA,NA,NA,0.2602040816,0.02755905512,0.2183406114,0.183908046,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4773662551,NA,NA,0.1657754011,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3461538462,NA,NA,0.2195121951,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05882352941,NA,0.156462585,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2920353982,0.3119266055,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3388157895,0.2352941176,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",0.006493506494,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"POLYNEUROPATHY IN DIABETES (dxo:ICD9:3572)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,0.02631578947,0.3045977011,NA,NA,0.2094017094,0.1005586592,0.3916666667,0.1226415094,NA,NA,NA,0.3737864078,0.01142857143,0.3486238532,0.545154434,"PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5831775701,"PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5392156863,"PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6811023622,"PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.654676259,"PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6902654867,"PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5133574007,"PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6347826087,"PRAMIPEXOLE DI-HCL","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4326465927,"PRAMIPEXOLE DI-HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5850556439,NA,NA,0.6431767338,"PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5603864734,"PRAMIPEXOLE DI-HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.003389830508,NA,0.4799037304,"PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4918918919,"PRAMIPEXOLE DI-HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4606060606,0.5559322034,"PRAMIPEXOLE DI-HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4200426439,NA,NA,NA,0.08561643836,NA,NA,NA,0.38671875,NA,0.4553140097,NA,NA,0.2327586207,"PRAVASTATIN SODIUM",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8238434164,NA,NA,NA,"PRAVASTATIN SODIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4129554656,NA,NA,0.3640776699,0.1124260355,0.5433526012,NA,NA,NA,NA,0.4795321637,NA,NA,NA,"PREGABALIN",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7857142857,NA,NA,NA,"PREGABALIN","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.3411764706,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PREGABALIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.3891050584,NA,NA,NA,0.1065989848,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1194029851,NA,NA,NA,0.5283018868,NA,NA,NA,"PRIMARY OPEN-ANGLE GLAUCOMA (dxo:ICD9:36511)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7456140351,NA,NA,NA,"PRIMARY OPEN-ANGLE GLAUCOMA (dxo:ICD9:36511)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1224489796,NA,NA,NA,NA,NA,NA,NA,"PROCHLORPERAZINE MALEATE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.275862069,NA,NA,NA,0.08955223881,NA,NA,NA,NA,NA,0.4016620499,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.2232142857,NA,NA,NA,0.07947019868,NA,NA,NA,NA,NA,0.2628865979,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5454545455,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6887755102,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.2549019608,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4682539683,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.3039215686,NA,NA,0.2429378531,0.09796672828,0.3431372549,0.08532423208,NA,0.2279411765,NA,0.3608490566,NA,0.3787878788,0.2205882353,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6096256684,NA,NA,0.2795698925,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.168,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05660377358,NA,0.1920903955,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5384615385,NA,NA,0.2133333333,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.162962963,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.25,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3720930233,0.1376146789,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT WHEN PERFORMED WITH AN EVALUATION AND MANAGEMENT SERVICE (LIST SEPARATELY IN ADDITION TO THE CODE FOR PRIMARY P (px:CPT4:90833)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.2341137124,NA,NA,0.1728813559,0.07915057915,0.1978021978,NA,NA,NA,NA,0.2158590308,0.006097560976,0.2427184466,0.1751412429,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4955223881,NA,NA,0.2452830189,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3555555556,NA,NA,0.3271604938,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1871345029,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3305785124,0.3980582524,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4033898305,0.2307692308,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.09589041096,NA,NA,NA,NA,NA,0.4845814978,NA,NA,NA,"RAMIPRIL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8214285714,NA,NA,NA,"RAMIPRIL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.2072072072,0.08070866142,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RANITIDINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.427184466,NA,NA,NA,0.1388888889,NA,NA,NA,NA,0.2437238494,0.5252525253,NA,NA,0.4663212435,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5036166365,NA,NA,NA,0.517571885,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4641909814,0.7043010753,NA,NA,0.7166212534,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5460526316,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.502994012,NA,NA,NA,0.4143646409,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4285714286,NA,NA,NA,0.7048192771,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.756097561,NA,NA,0.5138888889,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4358974359,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.2357723577,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RHEUMATOID ARTHRITIS (dxo:ICD9:7140)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1088709677,NA,NA,NA,0.2866242038,NA,NA,NA,NA,NA,"RISEDRONATE SODIUM",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.1788856305,NA,NA,0.1695906433,0.07172995781,NA,0.08333333333,NA,NA,NA,0.1824324324,NA,0.2582417582,0.145272867,"RISPERIDONE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2105263158,"RISPERIDONE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1877934272,NA,NA,0.1561181435,"RISPERIDONE","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1988636364,NA,NA,0.1489361702,"RISPERIDONE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1324921136,"RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2038834951,0.1288343558,"RISPERIDONE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2184615385,0.1569506726,"RISPERIDONE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",0.03225806452,0.02197802198,0.3404255319,NA,NA,0.2278820375,0.127388535,0.3389830508,0.1237623762,NA,NA,0.4425207756,0.33,0.02469135802,0.3065693431,0.5154676843,"ROPINIROLE HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3875598086,0.590729783,NA,NA,0.647385103,"ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.496350365,"ROPINIROLE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5080213904,NA,0.009174311927,NA,0.4475661058,"ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.44140625,"ROPINIROLE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4060150376,NA,NA,0.5492662474,0.5621436716,"ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4752851711,NA,NA,0.3140495868,NA,0.5436893204,NA,NA,NA,NA,0.5081967213,0,NA,NA,"ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8333333333,NA,NA,NA,"ROSUVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,0.04464285714,NA,NA,NA,NA,NA,NA,NA,NA,0.3961038961,NA,NA,0.01126760563,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01503759398,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","SPECIAL SCREENING FOR MALIGNANT NEOPLASMS, COLON (dxo:ICD9:V7651)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01226993865,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01282051282,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",NA,NA,NA,NA,NA
"65-79","Female",0.01224489796,NA,NA,NA,NA,0.362962963,0.1244870041,NA,0.1037974684,NA,0.3901639344,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1034482759,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ROUTINE GYNECOLOGICAL EXAMINATION (dxo:ICD9:V7231)","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",0.02986857826,0.03256936068,0.4539059608,0.6086956522,0.156,0.3958333333,0.173346056,0.4501891551,0.1308627678,0.04815864023,0.3930921053,0.1753846154,0.6828550897,0.01551389787,0.5610200364,0.4420747489,"SERTRALINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8086096568,NA,NA,0.5045372051,"SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6017699115,NA,NA,0.7777777778,"SERTRALINE HCL","SIMVASTATIN","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8108108108,NA,NA,NA,"SERTRALINE HCL","SIMVASTATIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8322147651,NA,NA,NA,"SERTRALINE HCL","TOPIRAMATE",NA,NA,NA,NA,NA
"65-79","Female",NA,0.01724137931,0.4109589041,NA,NA,0.25,0.149122807,0.3577235772,NA,NA,NA,NA,0.5967329266,0.02083333333,NA,0.5674122717,"SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4868421053,"SERTRALINE HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.5172413793,NA,NA,NA,NA,NA,NA,0.7620320856,NA,NA,NA,"SERTRALINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7857142857,NA,NA,NA,"SERTRALINE HCL","UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.698630137,NA,NA,NA,"SERTRALINE HCL","UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7295081967,NA,NA,NA,"SERTRALINE HCL","URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6299112801,NA,0.6284916201,0.466819222,"SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4593120805,NA,NA,NA,0.099543379,0.536101083,NA,NA,0.3812154696,NA,0.4788235294,NA,NA,0.2945454545,"SIMVASTATIN",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3505976096,"SIMVASTATIN","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4365079365,NA,NA,NA,"SIMVASTATIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5067264574,"SIMVASTATIN","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.5393258427,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"SODIUM, POTASSIUM,MAG SULFATES",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01592356688,NA,NA,"SPECIAL SCREENING FOR MALIGNANT NEOPLASMS, COLON (dxo:ICD9:V7651)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4433962264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"SPECIAL SCREENING FOR OTHER SPECIFIED CONDITIONS (dxo:ICD9:V8289)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4362244898,NA,"SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6887417219,NA,"SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES (dxo:ICD9:6272)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007722007722,NA,NA,"TEMAZEPAM",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5602409639,NA,NA,NA,"TOPIRAMATE",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.2723279649,0.1308016878,NA,NA,NA,NA,0.2180094787,NA,0.01149425287,NA,NA,"TRAMADOL HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01773049645,NA,NA,"TRAMADOL HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.3333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TRAMADOL HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"TRAMADOL HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4139344262,NA,NA,0.3173076923,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TRAMADOL HCL/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"65-79","Female",0.02004454343,0.03821656051,0.3421633554,NA,NA,0.2418918919,0.1189979123,0.3574938575,0.1290849673,0.04326923077,0.3092269327,0.2,0.3579931973,0.02056743042,0.3293413174,0.4392921384,"TRAZODONE HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02786377709,0.5702097405,0.5074557316,"TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01834862385,NA,NA,"TRAZODONE HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1121076233,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED CEREBRAL ARTERY OCCLUSION WITH CEREBRAL INFARCTION (dxi:ICD9:43491)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4819277108,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4630541872,NA,NA,NA,"UNSPECIFIED CONSTIPATION (dxo:ICD9:56400)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.112033195,NA,NA,NA,NA,0.009345794393,NA,NA,"UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",NA,NA,NA,NA,NA,NA
"65-79","Female",0.01162790698,NA,NA,NA,NA,0.2834224599,NA,NA,NA,0.05882352941,NA,NA,0.4153846154,NA,NA,NA,"UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.4205607477,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED INFLAMMATORY AND TOXIC NEUROPATHY (dxo:ICD9:3579)",NA,NA,NA,NA,NA,NA
"65-79","Female",0.01680672269,NA,0.4153225806,NA,NA,0.3284169125,0.08849557522,0.5052631579,NA,NA,0.34,NA,0.4589285714,0,NA,NA,"UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,0.6571428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.4939271255,0.1182943604,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.09793814433,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED PERIPHERAL VASCULAR DISEASE (dxo:ICD9:4439)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,0.17,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED PRURITIC DISORDER (dxo:ICD9:6989)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"UNSPECIFIED PSYCHOSIS (dxi:ICD9:2989)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.00956937799,NA,NA,"UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.408,NA,NA,NA,"UNSPECIFIED SYMPTOM ASSOCIATED WITH FEMALE GENITAL ORGANS (dxo:ICD9:6259)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.3833333333,NA,NA,NA,NA,0.4117647059,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED TEAR FILM INSUFFICIENCY (dxo:ICD9:37515)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,0.4096385542,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED TRANSIENT CEREBRAL ISCHEMIA (dxo:ICD9:4359)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,0.2233009709,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED URTICARIA (dxo:ICD9:7089)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,0.3981191223,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4156378601,NA,NA,NA,"UNSPECIFIED VAGINITIS AND VULVOVAGINITIS (dxo:ICD9:61610)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.07246376812,NA,NA,0.2403846154,0.4928057554,NA,0.3582089552,NA,"UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.785467128,NA,"UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4520547945,NA,NA,NA,"URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.1004901961,NA,NA,NA,NA,NA,NA,NA,NA,NA,"VALSARTAN",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,0.05833333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,"VALSARTAN/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA,NA
"65-79","Female",0.03053435115,0.05378151261,0.5419103314,NA,0.1666666667,0.5022970904,0.2004357298,0.5262135922,0.1273712737,0.03669724771,0.4487951807,0.1419753086,0.5155737705,0.02044293015,0.6156418354,0.4128744423,"VENLAFAXINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.640625,"VILAZODONE HCL",NA,NA,NA,NA,NA,NA
"65-79","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4711538462,0.004287245445,NA,NA,"ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA,NA
"65-79","Male",0.03590551181,0.06713811769,0.5566496064,0.4973544974,0.2686890574,0.4034687109,0.2244993422,0.5729525608,0.1977289113,0.1089275688,0.5286304604,0.4045660567,0.5810285363,0.02631675943,0.5403739907,0.4354581713,NA,NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.5568862275,NA,NA,NA,NA,0.530726257,NA,NA,NA,"ALLOPURINOL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4516129032,NA,NA,NA,"ALPRAZOLAM",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.4677419355,NA,NA,0.3942307692,NA,NA,NA,NA,NA,"ALZHEIMER'S DISEASE (dxo:ICD9:3310)",NA,NA,NA,NA,NA,NA
"65-79","Male",0.05572682001,0,0.462962963,NA,NA,0.2985074627,0.1256038647,0.4711538462,NA,0.09649122807,NA,NA,0.4429824561,0.03225806452,NA,0.4517374517,"AMITRIPTYLINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Male",0.08609271523,0.04608294931,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3263433814,"AMITRIPTYLINE HCL","BUPROPION HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,0.02631578947,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4181818182,"AMITRIPTYLINE HCL","BUPROPION HCL","Num Previous Antidep: 4+",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2085561497,"AMITRIPTYLINE HCL","BUPROPION HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",0.07729468599,NA,0.5891238671,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.546875,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5964912281,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Male",0.06557377049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"65-79","Male",0.01,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Male",0.08196721311,NA,NA,NA,NA,0.5283687943,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4153846154,"AMITRIPTYLINE HCL","DULOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.4854368932,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Male",0.05673758865,NA,NA,NA,NA,NA,0.355450237,NA,NA,NA,NA,NA,NA,NA,NA,0.344,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"65-79","Male",0.04242424242,NA,NA,NA,NA,NA,NA,0.6452991453,NA,NA,NA,NA,NA,NA,NA,0.6049382716,"AMITRIPTYLINE HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","HEADACHE (dxo:ICD9:7840)","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.31,NA,NA,NA,NA,NA,NA,0.4803921569,0.007194244604,NA,0.3206896552,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6416666667,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6304347826,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02542372881,NA,NA,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",0.01909307876,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6704545455,"AMITRIPTYLINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6056338028,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3745173745,"AMITRIPTYLINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4150943396,"AMITRIPTYLINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.641221374,NA,NA,NA,"AMITRIPTYLINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3411764706,"AMITRIPTYLINE HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",0.06422018349,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6183574879,NA,NA,NA,NA,0.518134715,"AMITRIPTYLINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5458333333,"AMITRIPTYLINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5314861461,"AMITRIPTYLINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Male",0.01694915254,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6433566434,NA,NA,0.5196850394,"AMITRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",0.1118421053,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.335347432,"AMITRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6842105263,0.5318181818,"AMITRIPTYLINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",0.01041666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01081081081,NA,NA,"AMLODIPINE BESYLATE",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1217391304,NA,NA,NA,NA,NA,NA,NA,"ANOREXIA (dxo:ICD9:7830)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1428571429,NA,NA,NA,NA,NA,NA,NA,"ANOREXIA (dxo:ICD9:7830)","LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA
"65-79","Male",NA,0.02985074627,NA,NA,NA,NA,0.1469957082,NA,NA,NA,0.4064748201,NA,NA,0.01612903226,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,0.08527131783,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,0.05769230769,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.3127035831,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.1164658635,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2816901408,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8104575163,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6994219653,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02,NA,NA,"ATHEROSCLEROSIS OF AORTA (dxo:ICD9:4400)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.4652406417,NA,NA,NA,NA,0.4919354839,NA,NA,NA,NA,NA,NA,NA,NA,"ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES, UNSPECIFIED (dxo:ICD9:44020)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.4615384615,NA,NA,NA,0.1442307692,0.5573566085,NA,NA,0.4716981132,NA,0.5283806344,NA,NA,0.3154761905,"ATORVASTATIN CALCIUM",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.7982646421,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.86875,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,0.4444444444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.8047337278,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.4907407407,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.8530612245,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4888888889,NA,NA,NA,"ATORVASTATIN CALCIUM","GABAPENTIN",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8125,NA,NA,NA,"ATORVASTATIN CALCIUM","GABAPENTIN","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,NA,NA,NA,"ATORVASTATIN CALCIUM","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.473880597,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8498293515,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6157407407,NA,NA,NA,"ATORVASTATIN CALCIUM","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.843373494,NA,NA,NA,"ATORVASTATIN CALCIUM","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8298784846,NA,NA,NA,"ATORVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5070422535,NA,NA,NA,"ATORVASTATIN CALCIUM","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.6306306306,NA,NA,NA,NA,NA,NA,NA,NA,"BENIGN NEOPLASM OF COLON (dxo:ICD9:2113)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,0.06460344672,0.4315789474,NA,NA,0.3827655311,0.1609353508,0.4189473684,0.1598360656,NA,0.3807692308,NA,0.4376693767,0.02173913043,0.4346793349,0.4348799045,"BUPROPION HCL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,0.06228373702,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",NA,NA,NA,NA,NA
"65-79","Male",NA,0.01158301158,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Male",NA,0.01526717557,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA
"65-79","Male",NA,0.06201550388,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"65-79","Male",NA,0.04287901991,0.5735294118,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5518367347,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"65-79","Male",NA,0.02926829268,0.664516129,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.64,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,0.5428571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+",NA,NA
"65-79","Male",NA,NA,0.5315315315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6171428571,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"65-79","Male",NA,0.05612244898,0.7080291971,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4392523364,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7466063348,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,0.5128205128,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4152542373,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.07881773399,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA
"65-79","Male",NA,0.04054054054,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3619047619,"BUPROPION HCL","DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA
"65-79","Male",NA,0.1018518519,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3708609272,"BUPROPION HCL","DOXEPIN HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,0.05172413793,NA,NA,NA,0.5100671141,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4370946822,"BUPROPION HCL","DULOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,0.04615384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5460992908,"BUPROPION HCL","DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6363636364,"BUPROPION HCL","DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3419354839,"BUPROPION HCL","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.0406504065,NA,NA,NA,NA,0.3367243133,NA,NA,NA,NA,NA,NA,NA,NA,0.3766478343,"BUPROPION HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"65-79","Male",NA,0.03378378378,NA,NA,NA,NA,0.3555555556,NA,NA,NA,NA,NA,NA,NA,NA,0.4290322581,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Male",NA,0.0396039604,NA,NA,NA,NA,0.3571428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3959731544,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2450331126,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6320754717,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.284457478,"BUPROPION HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.08205128205,NA,NA,NA,NA,NA,0.5247058824,NA,NA,NA,NA,NA,NA,NA,0.5067264574,"BUPROPION HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,0.04511278195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6315789474,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.6611570248,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.625,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+",NA,NA,NA
"65-79","Male",NA,0.1467889908,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7080291971,"BUPROPION HCL","FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.6611570248,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","FLUOXETINE HCL","Num Previous Antidep: 2,3",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3905723906,"BUPROPION HCL","FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.1007194245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784)",NA,NA,NA,NA,NA
"65-79","Male",NA,0.0223880597,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784)","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1120448179,"BUPROPION HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1030927835,"BUPROPION HCL","LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,0.5284552846,NA,NA,NA,0.1144578313,NA,NA,NA,NA,NA,0.4423076923,0.006802721088,NA,0.2593250444,"BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,0.03007518797,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7407407407,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7487437186,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"65-79","Male",NA,0.03401360544,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02127659574,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6956521739,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1103448276,"BUPROPION HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,"BUPROPION HCL","Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.03888888889,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6890243902,"BUPROPION HCL","Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.03947368421,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02941176471,NA,0.1061093248,"BUPROPION HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6470588235,"BUPROPION HCL","Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.1184834123,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7401574803,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"65-79","Male",NA,0.02976190476,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7388059701,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.02925925926,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,0.01477832512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4324324324,"BUPROPION HCL","Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2075471698,"BUPROPION HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.6439393939,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6884576098,"BUPROPION HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.75,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7058823529,"BUPROPION HCL","Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6229508197,"BUPROPION HCL","Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6279069767,"BUPROPION HCL","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6075949367,"BUPROPION HCL","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.75,"BUPROPION HCL","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5825471698,"BUPROPION HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.504950495,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.75,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7463768116,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.4797687861,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6933962264,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6169154229,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.2517985612,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5307212823,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4511278195,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4645669291,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4676007005,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.03092783505,NA,NA,NA,NA,NA,NA,0.2629482072,NA,NA,NA,NA,NA,NA,0.3543078412,"BUPROPION HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2820512821,"BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.316017316,"BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2887323944,"BUPROPION HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.05487804878,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4210526316,"BUPROPION HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7579908676,NA,NA,NA,"BUPROPION HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3270676692,"BUPROPION HCL","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3039215686,"BUPROPION HCL","Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2745098039,"BUPROPION HCL","Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.297810219,"BUPROPION HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.06389776358,NA,NA,NA,NA,NA,NA,NA,NA,0.6117424242,NA,NA,NA,NA,0.564231738,"BUPROPION HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3481481481,"BUPROPION HCL","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.1111111111,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.484375,"BUPROPION HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4454545455,"BUPROPION HCL","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3432835821,"BUPROPION HCL","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1989247312,"BUPROPION HCL","RISPERIDONE",NA,NA,NA,NA,NA
"65-79","Male",NA,0.005617977528,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4686623012,"BUPROPION HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2968299712,"BUPROPION HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.0353460972,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5854456255,NA,NA,0.5905974535,"BUPROPION HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3908045977,"BUPROPION HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","SILDENAFIL CITRATE",NA,NA,NA,NA,NA
"65-79","Male",NA,0.07552870091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02716468591,NA,0.319213045,"BUPROPION HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3263598326,"BUPROPION HCL","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.09465020576,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5527522936,0.4812593703,"BUPROPION HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6822429907,"CARBIDOPA/LEVODOPA","Last AD: Same & Remiss","PARALYSIS AGITANS (dxo:ICD9:3320)","PRAMIPEXOLE DI-HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5740740741,NA,NA,NA,0.5346820809,"CARBIDOPA/LEVODOPA","PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6966292135,"CARBIDOPA/LEVODOPA","PARALYSIS AGITANS (dxo:ICD9:3320)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6695652174,"CARBIDOPA/LEVODOPA","PARALYSIS AGITANS (dxo:ICD9:3320)","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CELECOXIB",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.1384615385,NA,NA,NA,NA,NA,0.5730994152,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,0.02389078498,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,0.0201793722,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"65-79","Male",0.03664921466,0.03346203346,0.6540367076,NA,NA,0.4375,0.2850877193,0.5019455253,0.1177829099,NA,0.453038674,0.2566371681,0.5517826825,0.01901140684,0.5947242206,0.4416952474,"CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.8324324324,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.7170731707,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.6258992806,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4918032787,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,0.7557755776,NA,NA,NA,0.3650793651,NA,NA,NA,NA,NA,NA,NA,NA,0.3665594855,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.3706293706,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.4230769231,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3965517241,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,0.6815642458,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESOMEPRAZOLE MAGNESIUM",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.7413793103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.6960784314,NA,NA,NA,NA,0.6492537313,NA,NA,NA,NA,NA,NA,NA,0.4306569343,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.7338709677,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","GABAPENTIN",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.1658291457,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LAMOTRIGINE",NA,NA,NA,NA,NA
"65-79","Male",NA,0.01357466063,NA,NA,NA,0.396039604,0.2162162162,0.4351851852,0.1428571429,NA,NA,NA,0.4746543779,0.01639344262,0.45,0.3737373737,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5609756098,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Male",NA,NA,0.5112359551,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"65-79","Male",NA,NA,0.6267605634,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,0.5079365079,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.59566787,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,0.6428571429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005865102639,NA,0.643129771,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.0390625,NA,NA,NA,NA,0.2923076923,NA,NA,NA,NA,NA,0.690647482,NA,NA,0.519379845,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.7457627119,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,0.7137096774,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01746724891,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,0.4155783582,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.458781362,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Male",NA,NA,0.4083333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"65-79","Male",NA,NA,0.4492753623,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3899082569,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,0.8247595148,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.9109589041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+",NA,NA,NA
"65-79","Male",NA,NA,0.9121621622,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","Num Previous Remissions: 2+",NA,NA,NA,NA
"65-79","Male",NA,NA,0.8534201954,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6899224806,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6829268293,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,0.8452380952,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","SIMVASTATIN",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7207207207,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,0.7527472527,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LISINOPRIL/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.7080745342,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LOVASTATIN",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.7605633803,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.7447698745,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5928571429,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.5433789954,NA,NA,NA,NA,NA,0.2616033755,NA,NA,NA,NA,NA,NA,0.4632107023,"CITALOPRAM HYDROBROMIDE","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3679245283,"CITALOPRAM HYDROBROMIDE","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,0.6576576577,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.514084507,"CITALOPRAM HYDROBROMIDE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.5120772947,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,0.9072847682,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Remissions: 2+",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.8121387283,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5815217391,"CITALOPRAM HYDROBROMIDE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.6912751678,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4585152838,"CITALOPRAM HYDROBROMIDE","PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.5955882353,NA,NA,NA,NA,NA,NA,NA,0.546961326,NA,NA,NA,NA,0.3663366337,"CITALOPRAM HYDROBROMIDE","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.4247787611,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.5251141553,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5833333333,"CITALOPRAM HYDROBROMIDE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.8181818182,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PRAVASTATIN SODIUM",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.48,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4660194175,NA,NA,NA,0.6454545455,"CITALOPRAM HYDROBROMIDE","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,0.1866666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09448818898,"CITALOPRAM HYDROBROMIDE","RISPERIDONE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.6042780749,NA,NA,NA,NA,NA,NA,NA,NA,0.4827586207,NA,NA,NA,0.6265822785,"CITALOPRAM HYDROBROMIDE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4888888889,"CITALOPRAM HYDROBROMIDE","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,0.6457765668,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.63,NA,NA,0.4672489083,"CITALOPRAM HYDROBROMIDE","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4049586777,"CITALOPRAM HYDROBROMIDE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,0.8071895425,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5389221557,"CITALOPRAM HYDROBROMIDE","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.5528700906,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008591065292,NA,0.520287622,"CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.6266666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.753968254,0.3863636364,"CITALOPRAM HYDROBROMIDE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1548387097,NA,NA,NA,NA,0.01219512195,NA,0.4137931034,"CLONAZEPAM",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.4757281553,NA,NA,NA,NA,NA,NA,NA,NA,"CONGESTIVE HEART FAILURE, UNSPECIFIED (dxo:ICD9:4280)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.4961538462,NA,NA,NA,NA,NA,NA,NA,0.4952380952,NA,0.5274725275,NA,NA,0.2871287129,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7434210526,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7722772277,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",0.0293040293,0.04255319149,0.527027027,NA,NA,0.3630136986,0.181184669,0.5622119816,NA,NA,0.5,NA,0.6148148148,0.01497005988,0.4839319471,0.4257425743,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.3813559322,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.7463414634,NA,NA,NA,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02380952381,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01886792453,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009478672986,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5142857143,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8052631579,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7253521127,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7467811159,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.485042735,NA,NA,NA,0.1305263158,0.5092592593,0.1211538462,NA,0.4277108434,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.3402777778,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1261261261,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.2476190476,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7064220183,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,0.5123558484,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3456221198,"DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4285714286,"DESVENLAFAXINE SUCCINATE","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,0.008695652174,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3300970874,NA,NA,NA,NA,"DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED (dxo:ICD9:25000)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,0.4204435873,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.480964467,"DOXEPIN HCL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,0.2388663968,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.35,"DOXEPIN HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7102803738,NA,NA,0.5688073394,"DOXEPIN HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4429824561,"DOXEPIN HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",0.03448275862,0.05357142857,0.4746268657,NA,NA,0.491125016,0.2088772846,0.5542857143,0.1732673267,NA,NA,NA,0.5361111111,0.05084745763,0.5542168675,0.3995416348,"DULOXETINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.3953488372,NA,NA,NA,NA,NA,NA,NA,NA,0.3913043478,"DULOXETINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.41,"DULOXETINE HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.5299145299,NA,0.6714285714,NA,NA,NA,NA,NA,NA,NA,0.3988095238,"DULOXETINE HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.6237288136,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.2896551724,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.1442307692,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.1570247934,NA,NA,NA,NA,NA,0.4636363636,0,NA,0.3527131783,"DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4745762712,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.4647302905,NA,NA,NA,NA,NA,NA,NA,0.01224489796,NA,0.5269709544,"DULOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4846938776,"DULOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01652892562,NA,NA,"DULOXETINE HCL","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.2777307367,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3513513514,"DULOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.7504332756,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6842105263,"DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6431924883,"DULOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.6666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.5347593583,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.44375,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.4055944056,NA,NA,0.2393617021,NA,NA,NA,NA,NA,NA,0.4376470588,"DULOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3401360544,"DULOXETINE HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.421875,"DULOXETINE HCL","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6805555556,NA,NA,NA,NA,NA,"DULOXETINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.3714285714,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5153846154,"DULOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.637037037,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","PREGABALIN",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.4549019608,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5156695157,"DULOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.567839196,NA,NA,NA,NA,NA,NA,0.6834319527,NA,NA,0.4460966543,"DULOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.4606060606,NA,NA,NA,NA,NA,NA,NA,0.02919708029,NA,0.451183432,"DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.656,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3788819876,"DULOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.4112149533,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ENCOUNTER FOR OTHER SPECIFIED AFTERCARE (dxo:ICD9:V5889)",NA,NA,NA,NA,NA,NA
"65-79","Male",0.02,0.04255319149,0.6642494561,NA,NA,0.4807197943,0.320591161,0.5028089888,0.122244489,NA,0.4113924051,NA,0.5162882527,0.01670146138,0.5710723192,0.3094362745,"ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.3045685279,0.6315789474,NA,NA,NA,NA,NA,NA,NA,0.3274336283,"ESCITALOPRAM OXALATE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.3556701031,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GABAPENTIN",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.1743119266,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GABAPENTIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"65-79","Male",NA,0.02290076336,0.6170212766,NA,NA,0.339869281,NA,0.4356435644,0.1274509804,NA,NA,NA,0.4944649446,0.01276595745,0.5147058824,0.2363636364,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.2341772152,NA,NA,NA,NA,NA,NA,NA,NA,0.35,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.2173913043,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.2269503546,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.2550143266,NA,NA,NA,NA,NA,NA,0.03333333333,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2585365854,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.2543859649,NA,NA,NA,NA,NA,NA,0.01412429379,NA,0.2731958763,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4906542056,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.7058823529,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.1184417216,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.1630434783,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.1622807018,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.1016949153,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2554112554,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.7703703704,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.7894736842,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6857142857,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.6119402985,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.3798767967,NA,NA,NA,NA,NA,NA,NA,NA,0.3951612903,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.2829268293,NA,0.2459893048,NA,NA,NA,NA,NA,NA,0.3122743682,"ESCITALOPRAM OXALATE","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2752808989,"ESCITALOPRAM OXALATE","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.325203252,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.4149377593,NA,NA,NA,NA,NA,NA,NA,NA,0.380952381,"ESCITALOPRAM OXALATE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.4589041096,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","OMEPRAZOLE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.3365384615,NA,NA,NA,NA,NA,NA,NA,NA,0.3886010363,"ESCITALOPRAM OXALATE","PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5420560748,"ESCITALOPRAM OXALATE","PARALYSIS AGITANS (dxo:ICD9:3320)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5736842105,NA,NA,NA,NA,0.4117647059,"ESCITALOPRAM OXALATE","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.2941176471,NA,NA,NA,NA,NA,NA,NA,NA,0.596,"ESCITALOPRAM OXALATE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2212389381,"ESCITALOPRAM OXALATE","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.2328244275,NA,NA,NA,NA,0.4351145038,NA,NA,NA,0.5436893204,"ESCITALOPRAM OXALATE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.28125,NA,NA,NA,NA,NA,0.5864022663,NA,NA,0.3333333333,"ESCITALOPRAM OXALATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.3766816143,NA,NA,NA,NA,NA,NA,NA,NA,0.358490566,"ESCITALOPRAM OXALATE","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.2840283242,NA,NA,NA,NA,NA,NA,0.0136286201,NA,0.3069090909,"ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.3875968992,NA,NA,NA,NA,NA,NA,NA,0.7087378641,0.3389830508,"ESCITALOPRAM OXALATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.4364089776,NA,NA,NA,0.1360946746,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESOMEPRAZOLE MAGNESIUM",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.4978070175,NA,NA,0.3238095238,NA,NA,NA,NA,NA,NA,NA,NA,0.5,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.5661157025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7548076923,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.5760869565,NA,NA,NA,0.1111111111,NA,NA,NA,NA,NA,NA,NA,NA,NA,"EZETIMIBE/SIMVASTATIN",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.1095890411,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FAMOTIDINE",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5440414508,NA,NA,NA,"FENOFIBRATE",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8767123288,NA,NA,NA,"FENOFIBRATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.1632653061,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FENOFIBRATE NANOCRYSTALLIZED",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5201793722,NA,NA,NA,"FITTING AND ADJUSTMENT OF VASCULAR CATHETER (dxo:ICD9:V5881)",NA,NA,NA,NA,NA,NA
"65-79","Male",0.008474576271,0.02841918295,0.5256916996,NA,NA,0.3873873874,0.1939799331,0.6560312699,0.1504178273,NA,0.5059760956,NA,0.5265251989,0.0261627907,0.5283687943,0.4245014245,"FLUOXETINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.7509881423,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GABAPENTIN",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.786259542,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.1746031746,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","LAMOTRIGINE",NA,NA,NA,NA,NA
"65-79","Male",NA,0.02586206897,NA,NA,NA,NA,0.1142857143,NA,NA,NA,NA,NA,0.4504504505,0.02752293578,NA,0.3914590747,"FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.5229357798,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.6116071429,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6257668712,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0197044335,NA,0.6455331412,"FLUOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5350553506,"FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.6571428571,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.6623376623,NA,NA,NA,NA,NA,0.03333333333,NA,NA,"FLUOXETINE HCL","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.4243394716,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.4765100671,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.4666666667,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4247787611,"FLUOXETINE HCL","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.8409602401,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.9020618557,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss","SIMVASTATIN",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6872037915,"FLUOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.7476635514,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.6891025641,NA,NA,NA,NA,NA,NA,NA,0.5471698113,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.5945945946,0.2566037736,NA,NA,NA,NA,NA,NA,0.4813664596,"FLUOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.376146789,"FLUOXETINE HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.6150442478,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5238095238,"FLUOXETINE HCL","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6974789916,NA,NA,NA,NA,NA,"FLUOXETINE HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.6466165414,NA,NA,NA,NA,NA,NA,NA,0.5543478261,"FLUOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.577092511,NA,NA,NA,NA,NA,NA,NA,0.6666666667,"FLUOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.5846153846,NA,NA,NA,NA,0.6713286713,NA,NA,0.3888888889,"FLUOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.81724846,NA,NA,NA,NA,NA,NA,NA,0.5882352941,"FLUOXETINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.5409047161,NA,NA,NA,NA,NA,0.03921568627,NA,0.5363565285,"FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.6486486486,NA,NA,NA,NA,NA,NA,NA,0.4736842105,"FLUOXETINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,0.04195804196,0.4657534247,NA,NA,0.3047530289,0.1293375394,0.4948453608,NA,0.07926829268,0.3970588235,NA,0.4828431373,NA,NA,0.3,"GABAPENTIN",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.1391304348,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.417218543,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","PREGABALIN",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7663043478,NA,NA,NA,"GABAPENTIN","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4748201439,NA,NA,NA,"GABAPENTIN","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.2627737226,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","TRAMADOL HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.3430232558,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.2569444444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.5309734513,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GEMFIBROZIL",NA,NA,NA,NA,NA,NA
"65-79","Male",0.009756097561,NA,NA,NA,NA,NA,NA,NA,NA,0.02727272727,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"HIP JOINT REPLACEMENT BY OTHER MEANS (dxo:ICD9:V4364)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.4173913043,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4483775811,NA,NA,NA,"HYDRALAZINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.685483871,NA,NA,NA,"HYDRALAZINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",0.01526717557,NA,NA,NA,NA,0.3168316832,0.1451612903,NA,NA,NA,NA,0.3119266055,NA,0.005494505495,NA,NA,"HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,0.196969697,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HYDROXYZINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4111111111,NA,NA,NA,NA,NA,"HYPERTROPHY (BENIGN) OF PROSTATE WITH URINARY OBSTRUCTION AND OTHER LOWER URINARY TRACT SYMPTOMS [LUTS] (dxo:ICD9:60001)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1782178218,"IMIPRAMINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09045226131,"IMIPRAMINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"65-79","Male",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4924242424,NA,NA,NA,"IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7692307692,NA,NA,NA,"IMPOTENCE OF ORGANIC ORIGIN (dxo:ICD9:60784)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.253164557,NA,NA,NA,0.08139534884,NA,NA,NA,NA,NA,0.255952381,NA,NA,NA,"INDIVIDUAL PSYCHOTHERAPY, INSIGHT ORIENTED, BEHAVIOR MODIFYING AND/OR SUPPORTIVE, IN AN OFFICE OR OUTPATIENT FACILITY, APPROXIMATELY 45 TO 50 MINUTES","(px:CPT4:90806)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.5222929936,NA,NA,NA,NA,0.4929078014,0.1345454545,NA,NA,NA,0.4724770642,0.01380897583,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008871989861,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7535211268,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006993006993,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TEMAZEPAM",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02105263158,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01347708895,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.4205607477,NA,NA,NA,0.1395348837,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LACTULOSE",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.1888111888,NA,NA,0.1370967742,NA,NA,NA,NA,NA,NA,0.2027972028,NA,0.1386138614,0.1256476684,"LAMOTRIGINE",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3142857143,"LAMOTRIGINE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.174863388,"LAMOTRIGINE","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.145631068,"LAMOTRIGINE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1940298507,NA,NA,NA,"LAMOTRIGINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1457943925,"LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1534391534,NA,"LAMOTRIGINE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006611570248,NA,NA,"Last AD: Diff & No Remiss",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.09166666667,NA,NA,NA,NA,NA,0.381294964,0.01069518717,NA,0.2985781991,"Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,NA,NA,NA,"Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.568,"Last AD: Diff & No Remiss","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.25,NA,NA,NA,NA,0.01149425287,NA,0.2662337662,"Last AD: Diff & No Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5865384615,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6593137255,0.008547008547,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6396396396,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5656934307,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.75,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4054054054,NA,NA,0.3155555556,"Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0078125,NA,0.6480686695,"Last AD: Diff & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.02293577982,0.4494382022,NA,NA,0.325203252,0.1365313653,0.3706896552,0.1097560976,NA,NA,NA,NA,0.007220216606,0.3805309735,0.4079173838,"Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01,NA,0.6086956522,"Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3529411765,"Last AD: Diff & No Remiss","SIMVASTATIN","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.03539823009,0.3591160221,NA,NA,0.2824427481,0.09375,0.3431372549,0.1428571429,NA,NA,NA,0.4179104478,0.01428571429,NA,0.3131046614,"Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02307692308,0.6557377049,0.7089201878,"Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,"Last AD: Diff & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,0.1071428571,NA,NA,NA,NA,NA,NA,0.2437810945,NA,NA,NA,NA,0.0487804878,NA,NA,"Last AD: Diff & Remiss",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3009708738,NA,NA,"Last AD: Diff & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.5271565495,NA,NA,NA,NA,NA,NA,0.5897435897,"Last AD: Diff & Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.718061674,0.02912621359,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4583333333,"Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01769911504,NA,NA,"Last AD: Diff & Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,0.09090909091,NA,NA,NA,0.38,0.2700729927,NA,0.2830188679,NA,NA,NA,NA,0.03125,NA,0.5171790235,"Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.716,0.02536231884,NA,0.6173913043,"Last AD: Diff & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.04010695187,NA,NA,"Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07936507937,0.6448598131,NA,"Last AD: Diff & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5481927711,"Last AD: Diff & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1076115486,"Last AD: Same & No Remiss",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1483433735,NA,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.06994818653,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.375,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4958677686,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01423487544,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3653846154,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5169491525,"Last AD: Same & No Remiss","PARALYSIS AGITANS (dxo:ICD9:3320)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3529886914,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,"Last AD: Same & No Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.298245614,NA,NA,NA,NA,"Last AD: Same & No Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2567567568,NA,NA,NA,NA,"Last AD: Same & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01941747573,NA,NA,"Last AD: Same & No Remiss","ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4366914935,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4941176471,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4266666667,"Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01196381675,NA,NA,"Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Same & No Remiss","TRAZODONE HCL","ZOLPIDEM TARTRATE",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3979057592,NA,"Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6357615894,"Last AD: Same & Remiss",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7134502924,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.6632996633,NA,NA,NA,NA,NA,NA,0.6281755196,"Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5754385965,"Last AD: Same & Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6336633663,"Last AD: Same & Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.9417475728,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","PAROXETINE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.9393939394,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.9423076923,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Remissions: 2+","PAROXETINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.9396551724,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.9183673469,NA,NA,NA,"Last AD: Same & Remiss","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8306451613,NA,NA,NA,"Last AD: Same & Remiss","OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6228571429,"Last AD: Same & Remiss","PARALYSIS AGITANS (dxo:ICD9:3320)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8192968111,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6640625,"Last AD: Same & Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6897810219,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6147540984,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7393939394,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6683168317,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6393762183,"Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6262135922,"Last AD: Same & Remiss","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8320051004,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.85428051,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6947791165,"Last AD: Same & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6806181584,"Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6926829268,"Last AD: Same & Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8188854489,NA,"Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6071428571,NA,NA,NA,"LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8095238095,NA,NA,NA,"LEVOTHYROXINE SODIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.5073170732,NA,NA,NA,0.1442307692,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LISINOPRIL/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5196078431,NA,NA,NA,"LORAZEPAM",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.3988095238,NA,NA,NA,NA,NA,0.1393162393,NA,0.3095238095,NA,0.429245283,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1588785047,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.2580645161,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.5067024129,NA,NA,NA,0.1779141104,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LOVASTATIN",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,0.5555555556,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7046035806,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8181818182,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.722972973,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,0.5033557047,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4238095238,NA,0.6837560712,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.69,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6875,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7583333333,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.797979798,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3846153846,NA,0.6393442623,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7479674797,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.816,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE (dxo:ICD9:29632)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,0.2676886792,0.5925925926,NA,NA,0.4262820513,0.3483709273,0.5755813953,0.3192771084,NA,NA,NA,0.5362318841,0.2069857697,0.5466101695,0.510794897,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.3872053872,NA,NA,NA,NA,NA,NA,0.5324947589,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4736842105,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6993464052,NA,NA,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5966386555,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5343137255,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4311926606,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7632398754,NA,NA,0.5745856354,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2022727273,NA,0.5134719015,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6304347826,0.46,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.08771929825,NA,0.5405405405,NA,NA,NA,NA,NA,"METFORMIN HCL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.3869731801,NA,NA,0.3181818182,0.1096345515,0.4166666667,0.2910852077,NA,NA,NA,0.3601398601,0,0.4310344828,0.4004688063,"MIRTAZAPINE",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.325,"MIRTAZAPINE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5950413223,NA,NA,NA,"MIRTAZAPINE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3141993958,"MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4237288136,"MIRTAZAPINE","PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6242038217,NA,NA,NA,NA,0.4945054945,"MIRTAZAPINE","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5169230769,"MIRTAZAPINE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1302521008,"MIRTAZAPINE","RISPERIDONE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1161290323,"MIRTAZAPINE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.25,NA,NA,NA,NA,NA,NA,0.4819944598,"MIRTAZAPINE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.2276029056,NA,NA,NA,0.5592885375,NA,NA,0.4875,"MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3858267717,"MIRTAZAPINE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.282674772,NA,NA,NA,NA,NA,NA,0.3392612859,"MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.298013245,"MIRTAZAPINE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.268907563,NA,NA,NA,NA,NA,0.6231884058,0.375257732,"MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.1578947368,NA,NA,NA,NA,NA,NA,NA,NA,NA,"MORBID OBESITY (dxo:ICD9:27801)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,0.02118644068,NA,NA,NA,NA,0.1125827815,NA,0.1260504202,NA,NA,NA,0.4024390244,0.01025641026,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,0.01324503311,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"NONDEPENDENT TOBACCO USE DISORDER (dxo:ICD9:3051)","OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1645663454,NA,NA,NA,NA,NA,0.4328621908,"NORTRIPTYLINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6554621849,NA,NA,0.5643564356,"NORTRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3639344262,"NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5740740741,NA,NA,NA,NA,NA,"Num Previous Antidep: 2,3","Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6568848758,NA,NA,NA,"Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3333333333,"Num Previous Antidep: 4+",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4259259259,"Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3721973094,"Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3301158301,"Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5727272727,NA,NA,NA,NA,NA,"Num Previous Episodes: 2+","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.9345794393,NA,NA,NA,NA,NA,"Num Previous Remissions: 2+","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.9382716049,NA,NA,NA,"Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,0.009009009009,NA,NA,NA,NA,NA,NA,0.09677419355,NA,NA,NA,NA,NA,NA,NA,"OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2711864407,"OBSESSIVE-COMPULSIVE DISORDERS (dxo:ICD9:3003)",NA,NA,NA,NA,NA,NA
"65-79","Male",0,NA,0.5574092247,NA,NA,NA,0.1568627451,NA,0.2071005917,NA,0.4836956522,0.3278688525,0.5613682093,0.005235602094,NA,0.3944099379,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8055555556,NA,NA,NA,NA,NA,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8496240602,NA,NA,0.5485714286,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7966101695,NA,NA,NA,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"65-79","Male",NA,NA,0.4916666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6123595506,NA,NA,NA,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.1654135338,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OLMESARTAN MEDOXOMIL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.1255605381,NA,NA,NA,NA,NA,NA,NA,NA,0.2585034014,"OMEPRAZOLE",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3975903614,NA,NA,NA,NA,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4795081967,NA,NA,NA,NA,"OTHER EXTRAPYRAMIDAL DISEASE AND ABNORMAL MOVEMENT DISORDER (dxo:ICD9:33399)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,0.01777777778,NA,NA,NA,0.2686567164,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.3965517241,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER NONSPECIFIC ABNORMAL FINDING OF LUNG FIELD (dxo:ICD9:79319)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER PERSISTENT MENTAL DISORDERS DUE TO CONDITIONS CLASSIFIED ELSEWHERE (dxo:ICD9:2948)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.448,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER PROBLEMS RELATED TO LIFESTYLE (dxo:ICD9:V698)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.132231405,NA,NA,NA,0.4416666667,NA,0.5320512821,NA,NA,NA,"OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7722772277,NA,NA,NA,NA,NA,"OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8532818533,NA,NA,NA,"OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5660377358,NA,NA,NA,"OTHER TESTICULAR HYPOFUNCTION (dxo:ICD9:2572)","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Male",0.0157480315,NA,NA,NA,NA,NA,0.1532258065,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OXYCODONE HCL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.3831775701,NA,NA,NA,0.08898305085,NA,NA,NA,0.3534482759,NA,NA,NA,NA,NA,"PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.4253968254,NA,NA,NA,0.115727003,NA,NA,NA,0.4059405941,0.496350365,0.4702970297,0.0127388535,NA,0.5099150142,"PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4454545455,"PARALYSIS AGITANS (dxo:ICD9:3320)","PAROXETINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6004366812,"PARALYSIS AGITANS (dxo:ICD9:3320)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4820143885,"PARALYSIS AGITANS (dxo:ICD9:3320)","PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6474358974,NA,NA,NA,0.5528455285,"PARALYSIS AGITANS (dxo:ICD9:3320)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6090909091,"PARALYSIS AGITANS (dxo:ICD9:3320)","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7533039648,NA,NA,0.4810126582,"PARALYSIS AGITANS (dxo:ICD9:3320)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3693693694,"PARALYSIS AGITANS (dxo:ICD9:3320)","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",0.02777777778,0.04802259887,0.5117493473,NA,NA,0.4266666667,0.2286324786,0.4471544715,0.1295336788,NA,0.6305073791,NA,0.5010224949,0.03115264798,0.6078431373,0.4104432301,"PAROXETINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5426356589,NA,NA,NA,NA,0.5302013423,"PAROXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7361111111,NA,NA,NA,NA,NA,"PAROXETINE HCL","PRAVASTATIN SODIUM",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5492227979,0.4311926606,NA,NA,NA,0.5980392157,"PAROXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5355191257,NA,0.6153846154,NA,NA,NA,"PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.380952381,"PAROXETINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5726495726,NA,NA,0.016563147,NA,0.5584415584,"PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.4758064516,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PEN NEEDLE, DIABETIC",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.02189781022,NA,NA,"PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.2574257426,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2333333333,0.05844155844,0.2755905512,0.1344537815,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4188034188,NA,NA,NA,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4121621622,NA,"PHARMACOLOGIC MANAGEMENT, INCLUDING PRESCRIPTION, USE, AND REVIEW OF MEDICATION WITH NO MORE THAN MINIMAL MEDICAL PSYCHOTHERAPY (px:CPT4:90862)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",0.01801801802,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"POLYNEUROPATHY IN DIABETES (dxo:ICD9:3572)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.09900990099,NA,NA,NA,NA,NA,0.3534482759,NA,NA,0.5479980704,"PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6136363636,"PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.522875817,"PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4362745098,"PRAMIPEXOLE DI-HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6079027356,NA,NA,0.5643564356,"PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01379310345,NA,0.4661921708,"PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5555555556,0.5434782609,"PRAMIPEXOLE DI-HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.5428571429,NA,NA,NA,0.09701492537,NA,NA,NA,0.4318181818,NA,0.5153374233,NA,NA,NA,"PRAVASTATIN SODIUM",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8393782383,NA,NA,NA,"PRAVASTATIN SODIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.5538461538,NA,NA,0.382566586,NA,NA,NA,NA,NA,NA,0.5611814346,NA,NA,NA,"PREGABALIN",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8120300752,NA,NA,NA,"PREGABALIN","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.4029850746,NA,NA,NA,0.103626943,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1176470588,NA,NA,NA,0.4086956522,NA,NA,NA,"PRIMARY OPEN-ANGLE GLAUCOMA (dxo:ICD9:36511)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1171875,NA,NA,NA,NA,NA,NA,NA,"PROCHLORPERAZINE MALEATE",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.3203125,NA,NA,NA,0.08724832215,NA,NA,NA,NA,NA,0.3579766537,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2991452991,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.3759398496,NA,NA,0.2407407407,0.1049562682,NA,0.09493670886,NA,NA,NA,0.358662614,NA,NA,0.2435897436,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.288,NA,NA,0.1417910448,0.1068376068,NA,NA,NA,NA,NA,0.2450592885,0.008333333333,0.2093023256,0.21,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4722222222,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.35,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.1658291457,NA,NA,NA,NA,NA,0.5398230088,NA,NA,NA,"RAMIPRIL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.1374407583,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RANITIDINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2939632546,NA,NA,NA,0.5054347826,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5555555556,NA,NA,NA,0.5494071146,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5363636364,NA,NA,NA,0.6293103448,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,0.188172043,NA,NA,NA,0.06349206349,NA,0.125,NA,NA,NA,0.2137931034,NA,NA,0.1438016529,"RISPERIDONE",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2110091743,NA,NA,0.1810344828,"RISPERIDONE","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1818181818,"RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3114754098,NA,"RISPERIDONE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.389261745,NA,NA,0.28125,0.1076923077,NA,0.1775700935,NA,NA,0.4810372771,0.3724137931,0.01973684211,NA,0.5136605416,"ROPINIROLE HCL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4050632911,0.5668316832,NA,NA,0.6405529954,"ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5135135135,"ROPINIROLE HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008695652174,NA,0.4266600595,"ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4513274336,NA,NA,0.568627451,0.5875486381,"ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.525,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5459940653,0.01418439716,NA,NA,"ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8481675393,NA,NA,NA,"ROSUVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01670644391,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA,NA
"65-79","Male",0.01581027668,0.04495747266,0.4466950959,NA,0.1810344828,0.378559464,0.1901408451,0.455858748,0.148427673,0.07438016529,0.3798283262,0.2213114754,0.6786190411,0.01355421687,0.5271966527,0.4410828025,"SERTRALINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7756410256,NA,NA,NA,"SERTRALINE HCL","SILDENAFIL CITRATE",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7913961039,NA,NA,0.4673913043,"SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8712871287,NA,NA,NA,"SERTRALINE HCL","SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5889807163,0.01756440281,NA,0.5456120092,"SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6842105263,NA,0.6589147287,0.5354330709,"SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,0.04794520548,0.4619565217,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5171232877,NA,NA,NA,"SILDENAFIL CITRATE",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.5376088678,NA,NA,NA,0.1443123939,0.5525876461,NA,NA,0.4247787611,NA,0.533916849,NA,NA,0.3385093168,"SIMVASTATIN",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,NA,NA,NA,"SIMVASTATIN","SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644)",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4077669903,"SIMVASTATIN","TRAZODONE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,0.4925373134,NA,NA,NA,NA,NA,0.1739130435,NA,NA,NA,0.5362318841,NA,NA,NA,"SPECIAL SCREENING FOR MALIGNANT NEOPLASM OF PROSTATE (dxo:ICD9:V7644)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006578947368,NA,NA,"SPECIAL SCREENING FOR MALIGNANT NEOPLASMS, COLON (dxo:ICD9:V7651)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1538461538,NA,0.4154929577,NA,NA,NA,NA,NA,"TAMSULOSIN HCL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01069518717,NA,NA,"TEMAZEPAM",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.3558718861,NA,NA,NA,NA,NA,NA,NA,0.01079913607,NA,NA,"TRAMADOL HCL",NA,NA,NA,NA,NA,NA
"65-79","Male",0.01463414634,0.04347826087,0.3394160584,NA,NA,0.2661596958,0.1254071661,0.3096590909,0.1432160804,NA,0.2694300518,NA,0.3983870968,0.01932528113,0.3659305994,0.4104195063,"TRAZODONE HCL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0328358209,0.5306603774,0.4940334129,"TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.1483679525,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED CEREBRAL ARTERY OCCLUSION WITH CEREBRAL INFARCTION (dxi:ICD9:43491)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4368932039,NA,NA,NA,"UNSPECIFIED CONSTIPATION (dxo:ICD9:56400)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1532258065,NA,NA,NA,NA,0.01777777778,NA,NA,"UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",NA,NA,NA,NA,NA,NA
"65-79","Male",0,NA,NA,NA,NA,0.3805970149,NA,NA,NA,0.06796116505,NA,NA,0.4607843137,NA,NA,NA,"UNSPECIFIED HEREDITARY AND IDIOPATHIC PERIPHERAL NEUROPATHY (dxo:ICD9:3569)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,0.2822580645,NA,NA,NA,NA,NA,NA,0.4278606965,NA,NA,NA,"UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.1346153846,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED PERIPHERAL VASCULAR DISEASE (dxo:ICD9:4439)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0157480315,NA,NA,"UNSPECIFIED SLEEP DISTURBANCE (dxo:ICD9:78050)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,0.4666666667,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED TRANSIENT CEREBRAL ISCHEMIA (dxo:ICD9:4359)",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,0.1075268817,NA,NA,NA,NA,NA,NA,NA,NA,NA,"VALSARTAN",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,0.06274509804,0.516025641,NA,NA,0.4938271605,0.2239747634,0.5066666667,0.1575342466,NA,0.4509803922,NA,0.5259067358,0.03827751196,0.6102777778,0.4059240718,"VENLAFAXINE HCL",NA,NA,NA,NA,NA,NA
"65-79","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.004893964111,NA,NA,"ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA,NA
"80-89","Female",0.02184124002,0.06116584565,0.442839815,0.5467980296,0.2601067887,0.3267411866,0.1662853754,0.4891436129,0.130985622,0.06310679612,0.4753609901,0.3349325337,0.4902145792,0.01903935185,0.4857095655,0.4023461212,NA,NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2611464968,NA,NA,NA,"ALPRAZOLAM",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.2213740458,NA,0.3546099291,0.07236842105,NA,0.3613445378,NA,NA,NA,NA,NA,"ALZHEIMER'S DISEASE (dxo:ICD9:3310)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4252336449,"ALZHEIMER'S DISEASE (dxo:ICD9:3310)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.0775862069,NA,NA,NA,NA,NA,NA,NA,"ALZHEIMER'S DISEASE (dxo:ICD9:3310)","DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2953020134,"ALZHEIMER'S DISEASE (dxo:ICD9:3310)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,0.6044776119,NA,NA,NA,NA,NA,NA,NA,NA,"ALZHEIMER'S DISEASE (dxo:ICD9:3310)","FLUOXETINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.313559322,"ALZHEIMER'S DISEASE (dxo:ICD9:3310)","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.615942029,NA,NA,NA,NA,NA,"ALZHEIMER'S DISEASE (dxo:ICD9:3310)","PAROXETINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.461928934,"ALZHEIMER'S DISEASE (dxo:ICD9:3310)","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",0.03002610966,NA,0.2148760331,NA,NA,0.2598425197,0.1132075472,NA,NA,NA,NA,NA,0.3259668508,NA,NA,0.393675527,"AMITRIPTYLINE HCL",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3372781065,"AMITRIPTYLINE HCL","BUPROPION HCL",NA,NA,NA,NA,NA
"80-89","Female",0.05072463768,NA,0.5642023346,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5131086142,"AMITRIPTYLINE HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.5096153846,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4966442953,"AMITRIPTYLINE HCL","DULOXETINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.2535211268,NA,NA,NA,NA,NA,NA,NA,NA,0.243902439,"AMITRIPTYLINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2275449102,"AMITRIPTYLINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"80-89","Female",0.009118541033,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7333333333,"AMITRIPTYLINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4916666667,"AMITRIPTYLINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3854961832,"AMITRIPTYLINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6193548387,"AMITRIPTYLINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5024630542,"AMITRIPTYLINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"80-89","Female",0.03048780488,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6150793651,NA,NA,0.5622119816,"AMITRIPTYLINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",0.0625,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3376865672,"AMITRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008474576271,NA,NA,"AMLODIPINE BESYLATE",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.07294117647,NA,NA,NA,NA,NA,NA,NA,"ANOREXIA (dxo:ICD9:7830)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.05454545455,NA,NA,NA,NA,NA,NA,NA,"ANOREXIA (dxo:ICD9:7830)","DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1149825784,NA,NA,NA,NA,NA,NA,NA,"ANOREXIA (dxo:ICD9:7830)","LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.0687960688,NA,NA,NA,0.2242990654,NA,NA,0.006666666667,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.04132231405,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.3201438849,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.07423580786,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3137254902,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6548042705,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)","PAROXETINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01298701299,NA,NA,"ATHEROSCLEROSIS OF AORTA (dxo:ICD9:4400)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.265625,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3588516746,NA,NA,NA,"ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES, UNSPECIFIED (dxo:ICD9:44020)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.5517241379,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES, UNSPECIFIED (dxo:ICD9:44020)","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.2534246575,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES, UNSPECIFIED (dxo:ICD9:44020)","DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.3392857143,NA,NA,NA,NA,0.3593073593,NA,NA,NA,NA,0.3453536755,NA,NA,NA,"ATORVASTATIN CALCIUM",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.6775700935,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,0.6732026144,NA,NA,NA,NA,NA,NA,NA,NA,"ATORVASTATIN CALCIUM","FLUOXETINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4,NA,NA,NA,"ATORVASTATIN CALCIUM","GABAPENTIN",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3348214286,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8344594595,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2989130435,NA,NA,NA,"ATORVASTATIN CALCIUM","LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5982905983,NA,NA,NA,"ATORVASTATIN CALCIUM","LEVOTHYROXINE SODIUM","SERTRALINE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7044025157,NA,NA,NA,"ATORVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.2561983471,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BODY MASS INDEX BETWEEN 19-24, ADULT (dxo:ICD9:V851)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,0.04353448276,0.3507853403,NA,NA,0.2195121951,0.1352657005,0.3435114504,0.1119402985,NA,NA,NA,0.4600760456,NA,0.3619047619,0.4142055162,"BUPROPION HCL",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,0.03260869565,0.5544041451,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5142118863,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5980392157,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4230769231,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.4829545455,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4280155642,"BUPROPION HCL","DULOXETINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,0.008064516129,NA,NA,NA,NA,0.3449131514,NA,NA,NA,NA,NA,NA,NA,NA,0.3230337079,"BUPROPION HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.39,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2857142857,"BUPROPION HCL","ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,0.08396946565,NA,NA,NA,NA,NA,0.5196850394,NA,NA,NA,NA,NA,NA,NA,0.4972972973,"BUPROPION HCL","FLUOXETINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2619047619,"BUPROPION HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,0.009090909091,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,0.02935010482,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6480836237,"BUPROPION HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.496350365,"BUPROPION HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7033898305,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"80-89","Female",NA,0.1923076923,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4460784314,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3762376238,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.461928934,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,0.04464285714,NA,NA,NA,NA,NA,NA,0.2463768116,NA,NA,NA,NA,NA,NA,0.3795731707,"BUPROPION HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2867647059,"BUPROPION HCL","MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1853932584,"BUPROPION HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2796610169,"BUPROPION HCL","Num Previous Antidep: 4+",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3280632411,"BUPROPION HCL","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6276595745,NA,NA,NA,NA,0.5882352941,"BUPROPION HCL","PAROXETINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5504587156,"BUPROPION HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4595469256,"BUPROPION HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3953488372,"BUPROPION HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,0.02298850575,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5647058824,NA,NA,0.5592592593,"BUPROPION HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.431372549,"BUPROPION HCL","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,0.03875968992,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0.3224834237,"BUPROPION HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.664,0.4972972973,"BUPROPION HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3300970874,NA,NA,NA,"CHEST PAIN, UNSPECIFIED (dxo:ICD9:78650)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CHRONIC AIRWAY OBSTRUCTION, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:496)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,0.048,0.5560261554,NA,NA,0.3242009132,0.2334581773,0.3890784983,0.08962868118,NA,0.3772727273,NA,0.4606164384,0.01333333333,0.4242424242,0.3833287634,"CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.6748971193,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.5884476534,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.6034482759,NA,NA,0.4342857143,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.445,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5096153846,"CITALOPRAM HYDROBROMIDE","DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,0.6422764228,NA,NA,NA,0.2626262626,NA,NA,NA,NA,NA,NA,NA,NA,0.3675889328,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.2356687898,NA,NA,NA,NA,NA,NA,NA,NA,0.3225806452,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA
"80-89","Female",NA,NA,0.6985294118,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESOMEPRAZOLE MAGNESIUM",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.5039370079,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.1377245509,NA,0.09356725146,NA,NA,NA,0.3452380952,0.004672897196,NA,0.2871690428,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.4779411765,NA,NA,NA,NA,NA,0.1842105263,NA,NA,NA,NA,NA,NA,0.4269230769,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4672897196,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Episodes: 2+",NA,NA,NA
"80-89","Female",NA,NA,0.4790419162,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"80-89","Female",NA,NA,0.5165562914,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"80-89","Female",NA,NA,0.4833333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4782608696,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"80-89","Female",NA,NA,0.5095238095,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008438818565,NA,0.488372093,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.1862745098,NA,NA,NA,NA,NA,0.5428571429,NA,NA,0.4494047619,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.6803278689,NA,NA,NA,NA,NA,0.2926829268,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","MIRTAZAPINE",NA,NA,NA,NA
"80-89","Female",NA,NA,0.6683937824,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05147058824,NA,0.5952380952,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,0.2731760834,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2475247525,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4085365854,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA
"80-89","Female",NA,NA,0.3668122271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"80-89","Female",NA,NA,0.2857142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","SIMVASTATIN",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.358490566,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,0.8058823529,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5533980583,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA
"80-89","Female",NA,NA,0.8692810458,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","SIMVASTATIN",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6176470588,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,0.7037037037,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LISINOPRIL/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.6347826087,NA,NA,NA,NA,NA,0.1095890411,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1328125,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LOSS OF WEIGHT (dxo:ICD9:78321)","MIRTAZAPINE",NA,NA,NA,NA
"80-89","Female",NA,NA,0.704,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","LOVASTATIN",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.6333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.7276785714,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4754901961,"CITALOPRAM HYDROBROMIDE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.4934210526,NA,NA,NA,NA,NA,0.1517128874,NA,NA,NA,NA,NA,NA,0.4051383399,"CITALOPRAM HYDROBROMIDE","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.3557692308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3712121212,"CITALOPRAM HYDROBROMIDE","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5092592593,"CITALOPRAM HYDROBROMIDE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.4855769231,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,0.7517241379,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4339622642,"CITALOPRAM HYDROBROMIDE","OMEPRAZOLE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.6857142857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3805970149,"CITALOPRAM HYDROBROMIDE","PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6194690265,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","PAROXETINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.5384615385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6225680934,"CITALOPRAM HYDROBROMIDE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.5925925926,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4789473684,"CITALOPRAM HYDROBROMIDE","PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6339285714,"CITALOPRAM HYDROBROMIDE","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,0.2743362832,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1584699454,"CITALOPRAM HYDROBROMIDE","RISPERIDONE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1262135922,"CITALOPRAM HYDROBROMIDE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,0.5105633803,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.583106267,"CITALOPRAM HYDROBROMIDE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.5424657534,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6022988506,NA,NA,0.3726415094,"CITALOPRAM HYDROBROMIDE","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3796296296,"CITALOPRAM HYDROBROMIDE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,0.6771428571,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5147058824,"CITALOPRAM HYDROBROMIDE","SIMVASTATIN",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.4757630162,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009456264775,NA,0.4523663184,"CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.5869565217,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3787878788,"CITALOPRAM HYDROBROMIDE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1238938053,NA,NA,NA,NA,NA,NA,NA,"CLONAZEPAM",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.3607594937,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5044247788,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7808219178,NA,NA,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","PAROXETINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.744966443,NA,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxi:ICD9:311)","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",0,NA,NA,NA,NA,NA,0.05825242718,NA,NA,NA,NA,NA,NA,0.005424954792,0.3450292398,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01075268817,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01324503311,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6840148699,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.2974504249,NA,NA,NA,0.09548611111,0.3603603604,0.07778510218,NA,0.2372881356,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.2102564103,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1393939394,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","Last AD: Diff & No Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.07174887892,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.0762195122,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1658536585,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.2867647059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","SIMVASTATIN",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.06586826347,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.0820668693,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,0.6351351351,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DESVENLAFAXINE SUCCINATE",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,0.3636363636,NA,NA,NA,NA,NA,NA,NA,NA,"DONEPEZIL HCL",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,0.4228675136,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4632206759,"DOXEPIN HCL",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,0.09649122807,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DOXEPIN HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.362745098,"DOXEPIN HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.368852459,"DOXEPIN HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.4126984127,NA,NA,0.4399203764,0.1620689655,NA,0.07490636704,NA,NA,NA,0.4315068493,NA,NA,0.3795656466,"DULOXETINE HCL",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.2912087912,NA,NA,NA,NA,NA,NA,NA,NA,0.3276836158,"DULOXETINE HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.4901960784,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.1913043478,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","GABAPENTIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0.2612612613,"DULOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3545454545,"DULOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.3761904762,NA,NA,NA,NA,NA,NA,NA,0.007518796992,NA,0.4019607843,"DULOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4833333333,"DULOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.2032828283,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.2115384615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.755351682,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5804195804,"DULOXETINE HCL","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.6831683168,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.5014326648,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4444444444,"DULOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.364764268,NA,NA,0.1991150442,NA,NA,NA,NA,NA,NA,0.3817097416,"DULOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3449781659,"DULOXETINE HCL","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.72,NA,NA,NA,"DULOXETINE HCL","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5810055866,"DULOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.4235294118,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6409266409,"DULOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5428571429,"DULOXETINE HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.4742268041,NA,NA,NA,NA,NA,NA,0.6276923077,NA,NA,0.5024390244,"DULOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.4187935035,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.429760666,"DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.5912408759,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.3263888889,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ENCOUNTER FOR OTHER SPECIFIED AFTERCARE (dxo:ICD9:V5889)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,0.05555555556,0.5289256198,NA,NA,0.2943548387,0.2486320438,0.3978494624,0.09752925878,NA,0.324742268,NA,0.4012539185,0.01851851852,0.4464285714,0.2408579466,"ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.2406015038,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","FLUOXETINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.2991452991,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GABAPENTIN",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.1138211382,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","GABAPENTIN","Last AD: Same & No Remiss",NA,NA,NA,NA
"80-89","Female",NA,NA,0.4611872146,NA,NA,0.2547169811,NA,NA,0.1061452514,NA,NA,NA,0.3544776119,0.009049773756,NA,0.1517027864,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.148409894,NA,0.1363636364,NA,NA,NA,NA,NA,NA,0.2770562771,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.1313131313,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3",NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2772277228,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Episodes: 2+",NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.1485714286,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.1609498681,NA,NA,NA,NA,NA,NA,0.008771929825,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2056074766,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.1566731141,NA,NA,NA,NA,NA,NA,0.007272727273,NA,0.2135678392,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3714285714,"ESCITALOPRAM OXALATE","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.09389671362,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1953125,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.174863388,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.1352941176,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","Num Previous Episodes: 2+",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.04807692308,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2283105023,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.7315175097,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5871559633,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.05607476636,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1603773585,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","LOSS OF WEIGHT (dxo:ICD9:78321)","MIRTAZAPINE",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.64,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.2994454713,NA,NA,NA,NA,NA,NA,NA,NA,0.273255814,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.2175792507,NA,0.1710914454,NA,NA,NA,NA,NA,NA,0.2894736842,"ESCITALOPRAM OXALATE","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.1465517241,NA,NA,NA,NA,NA,NA,NA,NA,0.2303523035,"ESCITALOPRAM OXALATE","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.380952381,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.2818791946,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","OMEPRAZOLE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2941176471,"ESCITALOPRAM OXALATE","PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","PAROXETINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6571428571,"ESCITALOPRAM OXALATE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.3106382979,NA,NA,NA,NA,NA,NA,NA,NA,0.2168674699,"ESCITALOPRAM OXALATE","PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1543624161,"ESCITALOPRAM OXALATE","RISPERIDONE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1287128713,"ESCITALOPRAM OXALATE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.1987951807,NA,NA,NA,NA,NA,NA,NA,NA,0.5454545455,"ESCITALOPRAM OXALATE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.1566951567,NA,NA,NA,NA,NA,0.5176151762,NA,NA,0.2976744186,"ESCITALOPRAM OXALATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3921568627,"ESCITALOPRAM OXALATE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.1923076923,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","SIMVASTATIN",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.2031484258,NA,NA,NA,NA,NA,NA,0.01310043668,NA,0.2714636141,"ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3818181818,"ESCITALOPRAM OXALATE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.325,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESOMEPRAZOLE MAGNESIUM",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.3653136531,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.3185840708,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)","SIMVASTATIN",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.03076923077,NA,NA,NA,NA,NA,NA,NA,NA,NA,"FAMOTIDINE",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,0.03870967742,0.4,NA,NA,0.262195122,0.1411764706,0.6063504987,0.1095890411,NA,0.4196428571,NA,0.4380952381,0.02631578947,0.495412844,0.3876723439,"FLUOXETINE HCL",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,0.7272727273,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","GABAPENTIN",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2845528455,"FLUOXETINE HCL","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,0.5609756098,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5780346821,"FLUOXETINE HCL","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4690265487,"FLUOXETINE HCL","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,0.3517964072,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,0.831300813,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,0.6585365854,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,0.5525114155,0.2213114754,NA,NA,NA,NA,NA,NA,0.462006079,"FLUOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,0.564516129,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,"FLUOXETINE HCL","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6974789916,"FLUOXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,0.523364486,NA,NA,NA,NA,0.5329341317,NA,NA,NA,"FLUOXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,0.754601227,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,0.5810810811,NA,NA,NA,NA,NA,0.02604166667,NA,0.5233160622,"FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.3,NA,NA,0.1775862069,0.06603773585,0.3469387755,NA,NA,NA,NA,0.373549884,NA,NA,NA,"GABAPENTIN",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7174887892,NA,NA,NA,"GABAPENTIN","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4838709677,NA,NA,NA,"GABAPENTIN","SIMVASTATIN",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.1450381679,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GABAPENTIN","UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA
"80-89","Female",0.0125,NA,NA,NA,NA,NA,NA,NA,NA,0.02380952381,NA,NA,NA,NA,NA,NA,"HEADACHE (dxo:ICD9:7840)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006211180124,NA,NA,"HIP JOINT REPLACEMENT BY OTHER MEANS (dxo:ICD9:V4364)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.2761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3103448276,NA,NA,NA,"HYDRALAZINE HCL",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7008547009,NA,NA,NA,"HYDRALAZINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"HYDROCODONE/ACETAMINOPHEN",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1132075472,"IMIPRAMINE HCL",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1313559322,NA,NA,NA,0.3607954545,0.004811547715,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.005940594059,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7028985507,NA,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006622516556,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.00495049505,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.07239819005,"LAMOTRIGINE",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1428571429,"LAMOTRIGINE","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01041666667,NA,NA,"Last AD: Diff & No Remiss",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.2456140351,NA,NA,NA,0.04395604396,NA,NA,NA,NA,NA,0.3301886792,0.01276595745,NA,0.2250755287,"Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5488721805,NA,NA,NA,"Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5789473684,NA,NA,NA,"Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008403361345,NA,NA,"Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4504504505,"Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1386138614,"Last AD: Diff & No Remiss","MIRTAZAPINE","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1756756757,NA,NA,NA,NA,NA,NA,0.4961832061,"Last AD: Diff & No Remiss","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1517241379,NA,NA,NA,NA,0.007299270073,NA,0.1867007673,"Last AD: Diff & No Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.523364486,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5969827586,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5316455696,"Last AD: Diff & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2461538462,"Last AD: Diff & No Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4720496894,"Last AD: Diff & No Remiss","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,0.2804232804,NA,NA,NA,0.04982206406,NA,0.06167400881,NA,NA,NA,NA,0.004716981132,NA,0.3352826511,"Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01355932203,NA,0.5633187773,"Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,0.3,NA,NA,NA,0.04242424242,NA,0.06299212598,NA,NA,NA,0.3088235294,0.01153846154,NA,0.2281368821,"Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5725806452,0.5089285714,"Last AD: Diff & No Remiss","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1764705882,NA,NA,NA,NA,0.0406779661,NA,NA,"Last AD: Diff & Remiss",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.380952381,NA,NA,NA,NA,NA,NA,NA,"Last AD: Diff & Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6934306569,NA,NA,NA,"Last AD: Diff & Remiss","MIRTAZAPINE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.2075471698,NA,NA,NA,0.6993464052,NA,NA,NA,"Last AD: Diff & Remiss","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7644230769,NA,NA,NA,"Last AD: Diff & Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4392523364,"Last AD: Diff & Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.2095238095,NA,0.1886792453,NA,NA,NA,NA,0.03773584906,NA,0.5251798561,"Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7672413793,0.02604166667,NA,0.6176470588,"Last AD: Diff & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0447761194,NA,NA,"Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1287128713,"Last AD: Same & No Remiss",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.07883211679,NA,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2890625,"Last AD: Same & No Remiss","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4030612245,"Last AD: Same & No Remiss","MIRTAZAPINE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2075471698,"Last AD: Same & No Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.06993006993,NA,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","MIRTAZAPINE","UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01777777778,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4151785714,NA,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","SERTRALINE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Same & No Remiss","Num Previous Episodes: 2+","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2833607908,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1666666667,NA,NA,NA,NA,"Last AD: Same & No Remiss","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1848739496,NA,NA,NA,NA,"Last AD: Same & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3514957265,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3348623853,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4019607843,"Last AD: Same & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"Last AD: Same & No Remiss","TRAMADOL HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.006789524733,NA,NA,"Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3703703704,NA,"Last AD: Same & No Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5440613027,"Last AD: Same & Remiss",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6893203883,"Last AD: Same & Remiss","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.5610687023,NA,NA,NA,NA,NA,NA,0.6398390342,"Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6435643564,"Last AD: Same & Remiss","MIRTAZAPINE","ROPINIROLE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6984126984,"Last AD: Same & Remiss","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5576923077,"Last AD: Same & Remiss","MIRTAZAPINE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5472636816,"Last AD: Same & Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.935483871,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Episodes: 2+","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.936,NA,NA,NA,"Last AD: Same & Remiss","Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8452579035,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6577946768,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.525974026,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7129909366,"Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6348314607,"Last AD: Same & Remiss","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8216094541,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.873015873,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6344086022,"Last AD: Same & Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6324786325,"Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7966101695,NA,"Last AD: Same & Remiss","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3582966226,NA,NA,NA,"LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7052980132,NA,NA,NA,"LEVOTHYROXINE SODIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7317073171,NA,NA,NA,"LEVOTHYROXINE SODIUM","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4470046083,NA,NA,NA,"LEVOTHYROXINE SODIUM","SIMVASTATIN",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.32,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LISINOPRIL/HYDROCHLOROTHIAZIDE",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.2534246575,NA,NA,NA,NA,NA,0.07896160087,NA,NA,NA,0.3734439834,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.09545454545,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1642599278,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1151079137,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1479289941,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.0875,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.06779661017,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.02941176471,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.08333333333,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.3356164384,NA,NA,NA,0.07659574468,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LOVASTATIN",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6873508353,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6554621849,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3865546218,NA,0.6537313433,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.4409448819,NA,NA,NA,NA,NA,NA,0.6320754717,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7178217822,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6381578947,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,0.2107279693,0.4436090226,NA,NA,0.3455497382,0.2405405405,NA,0.2084168337,NA,NA,NA,0.4772727273,0.1232323232,0.5267857143,0.434864105,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.298791019,NA,NA,NA,NA,NA,NA,0.4416107383,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.3465346535,NA,NA,NA,NA,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.384083045,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5944444444,NA,NA,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","PAROXETINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5535714286,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7438271605,NA,NA,0.5,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4859813084,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1412639405,NA,0.450888681,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6147540984,0.4827586207,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3241758242,NA,0.3247863248,NA,"MALIGNANT NEOPLASM OF BREAST (FEMALE), UNSPECIFIED SITE (dxo:ICD9:1749)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2941176471,NA,NA,NA,"MECLIZINE HCL",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1057692308,NA,NA,NA,NA,NA,NA,NA,"METFORMIN HCL",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.2473404255,NA,NA,0.1653846154,0.08409090909,NA,0.1866873065,NA,NA,NA,0.337398374,0.005649717514,NA,0.3610426663,"MIRTAZAPINE",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.32,"MIRTAZAPINE","NORTRIPTYLINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5806451613,NA,NA,NA,"MIRTAZAPINE","Num Previous Antidep: 2,3","SERTRALINE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3288135593,"MIRTAZAPINE","Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2831858407,"MIRTAZAPINE","PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.2127659574,NA,0.5514403292,NA,NA,NA,NA,0.406779661,"MIRTAZAPINE","PAROXETINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5859872611,"MIRTAZAPINE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2796610169,"MIRTAZAPINE","PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.171641791,"MIRTAZAPINE","RISPERIDONE",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1215686275,"MIRTAZAPINE","RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.2049180328,NA,NA,NA,NA,NA,NA,0.5214953271,"MIRTAZAPINE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1683731513,NA,NA,NA,0.5741106719,NA,NA,0.4440677966,"MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5,NA,NA,0.4032258065,"MIRTAZAPINE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1561712846,NA,NA,NA,NA,0,NA,0.3259237875,"MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4124293785,"MIRTAZAPINE","TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.2038834951,NA,NA,NA,NA,NA,NA,NA,"MIRTAZAPINE","UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.2464788732,NA,NA,NA,NA,NA,NA,NA,"MIRTAZAPINE","UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1870503597,NA,NA,NA,NA,NA,0.5842105263,0.3959276018,"MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.09665427509,NA,NA,NA,NA,NA,0.364,"NORTRIPTYLINE HCL",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3374233129,"NORTRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5247524752,NA,NA,NA,NA,NA,"Num Previous Antidep: 2,3","PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5987903226,NA,NA,NA,"Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.35,"Num Previous Antidep: 4+",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4587155963,"Num Previous Antidep: 4+","PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4649681529,"Num Previous Antidep: 4+","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3253588517,"Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.9172932331,NA,NA,NA,"Num Previous Remissions: 2+","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1297709924,NA,NA,NA,NA,NA,NA,NA,"OBESITY, UNSPECIFIED (dxo:ICD9:27800)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.4071856287,NA,NA,NA,0.09090909091,NA,NA,NA,NA,NA,0.3095238095,NA,NA,NA,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.09482758621,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OLMESARTAN MEDOXOMIL",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.07988980716,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OMEPRAZOLE",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.07185628743,NA,NA,NA,NA,NA,NA,NA,"OTHER DISORDERS OF BONE AND CARTILAGE (dxo:ICD9:73399)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.1959459459,NA,NA,NA,NA,NA,NA,NA,0.006944444444,NA,NA,"OTHER MALAISE AND FATIGUE (dxo:ICD9:78079)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.347107438,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER NONSPECIFIC ABNORMAL FINDING OF LUNG FIELD (dxo:ICD9:79319)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.3925233645,NA,NA,NA,NA,NA,0.144,NA,NA,NA,NA,NA,NA,NA,"OTHER PERSISTENT MENTAL DISORDERS DUE TO CONDITIONS CLASSIFIED ELSEWHERE (dxo:ICD9:2948)",NA,NA,NA,NA,NA,NA
"80-89","Female",0.008333333333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OTHER SCREENING MAMMOGRAM (dxo:ICD9:V7612)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.09259259259,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OXYBUTYNIN CHLORIDE",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.03592814371,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PALPITATIONS (dxo:ICD9:7851)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.3493150685,NA,NA,NA,0.07462686567,NA,NA,NA,NA,NA,0.3948717949,NA,NA,0.4829931973,"PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5523809524,"PARALYSIS AGITANS (dxo:ICD9:3320)","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6944444444,NA,NA,0.4196428571,"PARALYSIS AGITANS (dxo:ICD9:3320)","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,0.01694915254,0.4135338346,NA,NA,0.347826087,0.159375,0.375,0.1244635193,NA,0.5948601663,NA,0.387283237,0.01401869159,NA,0.3666666667,"PAROXETINE HCL",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.701754386,"PAROXETINE HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5068493151,NA,0.5620437956,NA,NA,NA,"PAROXETINE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5265082267,NA,NA,0.02745098039,NA,0.4439655172,"PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009523809524,NA,NA,"PERSISTENT DISORDER OF INITIATING OR MAINTAINING SLEEP (dxo:ICD9:30742)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5786285961,"PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6355140187,"PRAMIPEXOLE DI-HCL","RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5607638889,"PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5939849624,"PRAMIPEXOLE DI-HCL","ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5705521472,NA,NA,0.5854700855,"PRAMIPEXOLE DI-HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5011185682,"PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.2542372881,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4253246753,NA,NA,NA,"PRAVASTATIN SODIUM",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.76,NA,NA,NA,"PRAVASTATIN SODIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.1923076923,NA,NA,NA,NA,NA,NA,0.3985507246,NA,NA,NA,"PREGABALIN",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.3011235955,NA,NA,NA,0.07724719101,NA,NA,NA,NA,NA,NA,NA,NA,0.216,"PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4675324675,"PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.04411764706,NA,NA,NA,0.3612903226,NA,NA,NA,"PRIMARY OPEN-ANGLE GLAUCOMA (dxo:ICD9:36511)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.1985294118,NA,NA,NA,0.08695652174,NA,NA,NA,NA,NA,0.3038869258,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2352941176,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6363636364,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.3157894737,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4114583333,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION WITH MEDICAL SERVICES (px:CPT4:90792)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.252688172,NA,NA,NA,0.07,NA,0.04,NA,NA,NA,0.3170731707,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC INTERVIEW EXAMINATION (px:CPT4:90801)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.03529411765,NA,NA,NA,NA,NA,NA,NA,"PSYCHOTHERAPY, 30 MINUTES WITH PATIENT (px:CPT4:90832)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.1268656716,NA,NA,NA,0.04568527919,NA,NA,NA,NA,NA,0.2356020942,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1818181818,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.0652173913,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RANITIDINE HCL",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2283464567,NA,NA,NA,NA,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5040871935,NA,NA,NA,0.4083969466,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3846153846,NA,NA,NA,0.6936936937,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,0.1630434783,NA,NA,NA,0.048,NA,0.01570680628,NA,NA,NA,0.2085561497,NA,NA,0.1559370529,"RISPERIDONE",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2066115702,NA,NA,0.1835443038,"RISPERIDONE","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2338709677,NA,NA,0.1176470588,"RISPERIDONE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1368015414,"RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.05769230769,NA,NA,0.4401664932,0.2475247525,NA,NA,0.5344628417,"ROPINIROLE HCL",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4375,0.5589353612,NA,NA,0.6398713826,"ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0.467791411,"ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.624,"ROPINIROLE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3440366972,NA,NA,NA,"ROSUVASTATIN CALCIUM",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7238095238,NA,NA,NA,"ROSUVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01136363636,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA,NA
"80-89","Female",0.0157480315,0.04761904762,0.3317013464,NA,NA,0.2826086957,0.1257253385,0.3551912568,0.1089108911,NA,0.3059210526,NA,0.6159116863,0.01140684411,0.3723849372,0.4251587542,"SERTRALINE HCL",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7331701346,NA,NA,0.4388489209,"SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5581395349,0.01621621622,NA,0.4965800274,"SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.632183908,NA,NA,NA,"SERTRALINE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.3264984227,NA,NA,NA,0.04501607717,0.4126213592,NA,NA,NA,NA,0.4269304403,NA,NA,0.2137931034,"SIMVASTATIN",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007874015748,NA,NA,"TEMAZEPAM",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.1725663717,NA,NA,NA,NA,NA,NA,NA,0.01836734694,NA,NA,"TRAMADOL HCL",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,0.04464285714,0.2928571429,NA,NA,0.2124183007,0.07600950119,0.2266666667,0.05335968379,NA,NA,NA,0.3031914894,0.01560486757,0.2553191489,0.3725424858,"TRAZODONE HCL",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05844155844,0.5373443983,0.4613050076,"TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.03980099502,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED CEREBRAL ARTERY OCCLUSION WITH CEREBRAL INFARCTION (dxi:ICD9:43491)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3759398496,NA,NA,NA,"UNSPECIFIED CONSTIPATION (dxo:ICD9:56400)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.08278867102,NA,NA,NA,NA,0,NA,NA,"UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.1111111111,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)","UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,0.1698564593,NA,NA,NA,NA,NA,NA,0.3435582822,NA,NA,NA,"UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.09752747253,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED OSTEOPOROSIS (dxo:ICD9:73300)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,0.07975460123,NA,NA,NA,0.40625,NA,NA,NA,"UNSPECIFIED VITAMIN D DEFICIENCY (dxo:ICD9:2689)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3043478261,NA,NA,NA,"URINARY TRACT INFECTION, SITE NOT SPECIFIED (dxo:ICD9:5990)",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,0.02941176471,NA,NA,NA,NA,NA,NA,NA,NA,NA,"VALSARTAN",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,0.3931034483,NA,NA,NA,0.1605839416,NA,0.072,NA,NA,NA,0.39453125,0.02702702703,0.5916292975,0.3955719557,"VENLAFAXINE HCL",NA,NA,NA,NA,NA,NA
"80-89","Female",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01090909091,NA,NA,"ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA,NA
"80-89","Male",0.02093397746,0.05571847507,0.465679677,0.5407407407,0.2550091075,0.3226809955,0.1726860992,0.4873153053,0.1524376021,0.07056798623,0.4661218931,0.3845060412,0.5145301781,0.01517389553,0.5233918129,0.4189134079,NA,NA,NA,NA,NA,NA,NA
"80-89","Male",0.03183520599,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4031007752,"AMITRIPTYLINE HCL",NA,NA,NA,NA,NA,NA
"80-89","Male",0.005882352941,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"AMITRIPTYLINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3308823529,"AMITRIPTYLINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"AMLODIPINE BESYLATE",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.100591716,NA,NA,NA,NA,NA,NA,NA,"ANOREXIA (dxo:ICD9:7830)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1140350877,NA,NA,NA,NA,NA,NA,NA,"ANOREXIA (dxo:ICD9:7830)","LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,0.0612244898,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ANXIETY STATE, UNSPECIFIED (dxo:ICD9:30000)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008620689655,NA,NA,"ATHEROSCLEROSIS OF AORTA (dxo:ICD9:4400)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,0.3274336283,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES, UNSPECIFIED (dxo:ICD9:44020)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,0.3434343434,NA,NA,NA,NA,0.4285714286,NA,NA,NA,NA,0.4441687345,NA,NA,NA,"ATORVASTATIN CALCIUM",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8173076923,NA,NA,NA,"ATORVASTATIN CALCIUM","Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7532894737,NA,NA,NA,"ATORVASTATIN CALCIUM","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,0.04,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4298245614,NA,NA,0.422832981,"BUPROPION HCL",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,0.5319148936,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5593220339,"BUPROPION HCL","CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,0.3196721311,NA,NA,NA,NA,NA,NA,NA,NA,0.3529411765,"BUPROPION HCL","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"80-89","Male",NA,0.04186046512,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"BUPROPION HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5357142857,"BUPROPION HCL","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3946188341,"BUPROPION HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5294117647,"BUPROPION HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.612244898,NA,NA,0.5555555556,"BUPROPION HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,0.04724409449,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3115577889,"BUPROPION HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,0.01801801802,0.581498829,NA,NA,0.3023255814,0.2113207547,0.496,0.09917355372,NA,NA,NA,0.5438596491,0.006211180124,NA,0.4176182708,"CITALOPRAM HYDROBROMIDE",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,0.2566371681,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3663366337,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4840764331,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.512,"CITALOPRAM HYDROBROMIDE","Last AD: Diff & Remiss",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,0.3054607509,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,0.8104166667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,0.5546558704,NA,NA,NA,NA,NA,0.1301369863,NA,NA,NA,NA,NA,NA,0.4514106583,"CITALOPRAM HYDROBROMIDE","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.35,"CITALOPRAM HYDROBROMIDE","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4513274336,"CITALOPRAM HYDROBROMIDE","PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5272727273,"CITALOPRAM HYDROBROMIDE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6460176991,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,0.6934306569,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CITALOPRAM HYDROBROMIDE","SIMVASTATIN",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,0.4915572233,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007299270073,NA,0.501953125,"CITALOPRAM HYDROBROMIDE","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.008163265306,NA,NA,"DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (dxo:ICD9:311)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,0.3824561404,NA,NA,NA,0.09157509158,NA,0.1055662188,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1180555556,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1818181818,NA,NA,NA,NA,NA,NA,NA,"DERMATOPHYTOSIS OF NAIL (dxo:ICD9:1101)","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,0.4173913043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3540372671,"DOXEPIN HCL",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,0.4397506925,NA,NA,NA,NA,NA,NA,0.4230769231,NA,NA,0.4413919414,"DULOXETINE HCL",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,0.2592592593,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DULOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,0.4761904762,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2698412698,"DULOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,0.4202898551,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3705357143,"DULOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,0.5473684211,NA,NA,NA,0.2695547533,NA,0.1450980392,NA,NA,NA,0.4892307692,0.01142857143,NA,0.2654867257,"ESCITALOPRAM OXALATE",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3898305085,NA,NA,0.1380952381,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,0.2028985507,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","TRAZODONE HCL",NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,0.2277777778,NA,NA,NA,NA,NA,NA,NA,NA,0.237704918,"ESCITALOPRAM OXALATE","Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,0.1060820368,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,0.6772486772,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,0.3313253012,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESCITALOPRAM OXALATE","MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,0.2554347826,NA,0.1931818182,NA,NA,NA,NA,NA,NA,0.3617021277,"ESCITALOPRAM OXALATE","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2,"ESCITALOPRAM OXALATE","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5350877193,NA,NA,NA,"ESCITALOPRAM OXALATE","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,0.2219626168,NA,NA,NA,NA,NA,NA,0.02666666667,NA,0.2702702703,"ESCITALOPRAM OXALATE","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,0.4019607843,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"ESSENTIAL HYPERTENSION, BENIGN (dxo:ICD9:4011)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,0.2,0.6093445814,0.0962962963,NA,NA,NA,0.4632768362,NA,NA,0.4125874126,"FLUOXETINE HCL",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,0.3640776699,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & No Remiss",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,0.8164556962,NA,NA,NA,NA,NA,NA,NA,NA,"FLUOXETINE HCL","Last AD: Same & Remiss",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5148514851,"FLUOXETINE HCL","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,0.5922330097,NA,NA,NA,NA,NA,NA,NA,0.5279187817,"FLUOXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,0.2039215686,0.1272727273,NA,NA,NA,NA,NA,0.4494382022,NA,NA,NA,"GABAPENTIN",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4471544715,NA,NA,NA,"HYDRALAZINE HCL",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1145038168,NA,NA,NA,0.3870967742,0.01453957997,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.007751937984,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"INSOMNIA, UNSPECIFIED (dxo:ICD9:78052)","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01104972376,NA,NA,"Last AD: Diff & No Remiss",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0.2431372549,"Last AD: Diff & No Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1454545455,NA,NA,NA,NA,NA,NA,0.2058823529,"Last AD: Diff & No Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5632911392,NA,NA,NA,"Last AD: Diff & No Remiss","Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009523809524,NA,0.2938596491,"Last AD: Diff & No Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.009009009009,NA,0.5722543353,"Last AD: Diff & No Remiss","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.04310344828,NA,NA,NA,NA,0.005882352941,NA,0.2493297587,"Last AD: Diff & No Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05882352941,NA,NA,"Last AD: Diff & Remiss",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5088757396,"Last AD: Diff & Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.05042016807,NA,NA,"Last AD: Diff & Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1033973412,NA,NA,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2696629213,NA,NA,NA,NA,NA,"Last AD: Same & No Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3235294118,NA,NA,NA,NA,"Last AD: Same & No Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.374260355,NA,NA,NA,"Last AD: Same & No Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.00920598389,NA,NA,"Last AD: Same & No Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.534351145,"Last AD: Same & Remiss",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.592,NA,NA,NA,NA,NA,NA,0.6442307692,"Last AD: Same & Remiss","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5537190083,"Last AD: Same & Remiss","MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8538011696,NA,NA,NA,NA,NA,"Last AD: Same & Remiss","PAROXETINE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7008196721,"Last AD: Same & Remiss","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5652173913,"Last AD: Same & Remiss","ROPINIROLE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8306332842,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8287671233,NA,NA,NA,"Last AD: Same & Remiss","SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6878612717,"Last AD: Same & Remiss","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3722627737,NA,NA,NA,"LEVOTHYROXINE SODIUM",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,0.3605442177,NA,NA,NA,NA,NA,0.1030150754,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.134751773,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","Last AD: Same & No Remiss","MIRTAZAPINE",NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.2325581395,NA,NA,NA,NA,NA,NA,NA,"LOSS OF WEIGHT (dxo:ICD9:78321)","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,0.4,NA,NA,NA,0.1100917431,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LOVASTATIN",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.671641791,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN FULL REMISSION (dxo:ICD9:29636)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6263345196,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, IN PARTIAL OR UNSPECIFIED REMISSION (dxo:ICD9:29635)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,0.2389380531,NA,NA,NA,NA,0.1901408451,NA,0.1937172775,NA,NA,NA,NA,0.07692307692,NA,0.4502446982,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.3554216867,NA,NA,NA,NA,NA,NA,0.4801980198,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","MIRTAZAPINE",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8118811881,NA,NA,NA,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4574132492,"MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, UNSPECIFIED (dxo:ICD9:29630)","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,0.3553719008,NA,NA,NA,0.1071428571,NA,0.2249745504,NA,NA,NA,0.3619047619,NA,NA,0.4036885246,"MIRTAZAPINE",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5603448276,"MIRTAZAPINE","PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4634146341,"MIRTAZAPINE","ROPINIROLE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.178030303,NA,NA,NA,0.6178861789,NA,NA,0.5063291139,"MIRTAZAPINE","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3664122137,"MIRTAZAPINE","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1739130435,NA,NA,NA,NA,NA,NA,0.321536906,"MIRTAZAPINE","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4833333333,"MIRTAZAPINE","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1187214612,NA,NA,NA,NA,NA,0.3333333333,"NORTRIPTYLINE HCL",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5568862275,NA,NA,NA,"Num Previous Antidep: 2,3","SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3818181818,"Num Previous Antidep: 4+","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,0.414507772,NA,NA,NA,0.06912442396,NA,NA,NA,NA,NA,0.503875969,NA,NA,NA,"OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) (dxo:ICD9:32723)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,0.1161290323,NA,NA,NA,NA,NA,NA,NA,NA,NA,"OMEPRAZOLE",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,0.3333333333,NA,NA,NA,0.07518796992,NA,NA,NA,NA,NA,0.4339622642,0,NA,0.4736842105,"PARALYSIS AGITANS (dxo:ICD9:3320)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.691588785,NA,NA,0.5344827586,"PARALYSIS AGITANS (dxo:ICD9:3320)","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6112637363,NA,0.4571428571,NA,NA,0.396039604,"PAROXETINE HCL",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6068965517,NA,NA,NA,NA,0.5319148936,"PAROXETINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6040723982,"PRAMIPEXOLE DI-HCL",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5628415301,"PRAMIPEXOLE DI-HCL","ROPINIROLE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5464788732,"PRAMIPEXOLE DI-HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4285714286,NA,NA,NA,"PRAVASTATIN SODIUM",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,0.3006134969,NA,NA,NA,0.1064516129,NA,NA,NA,NA,NA,NA,NA,NA,NA,"PRESENILE DEMENTIA, UNCOMPLICATED (dxo:ICD9:29010)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1111111111,NA,NA,NA,NA,NA,NA,NA,"PRIMARY OPEN-ANGLE GLAUCOMA (dxo:ICD9:36511)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3065693431,NA,NA,NA,"PSYCHIATRIC DIAGNOSTIC EVALUATION (px:CPT4:90791)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.23,NA,NA,NA,"PSYCHOTHERAPY, 45 MINUTES WITH PATIENT (px:CPT4:90834)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.2403846154,NA,NA,NA,NA,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5423728814,NA,NA,NA,NA,"RESTLESS LEGS SYNDROME [RLS] (dxo:ICD9:33394)","ROPINIROLE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1885245902,"RISPERIDONE",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.1299435028,"RISPERIDONE","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4912516824,NA,NA,NA,0.4938547486,"ROPINIROLE HCL",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.619047619,NA,NA,0.6446280992,"ROPINIROLE HCL","SERTRALINE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4038461538,"ROPINIROLE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.01162790698,NA,NA,"ROUTINE GENERAL MEDICAL EXAMINATION AT HEALTH CARE FACILITY (dxo:ICD9:V700)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,0.05084745763,0.4103585657,NA,NA,0.3865546218,0.1467576792,0.4551724138,0.09798994975,NA,0.3448275862,NA,0.6335877863,0.02057613169,NA,0.4313253012,"SERTRALINE HCL",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7785234899,NA,NA,NA,"SERTRALINE HCL","SIMVASTATIN",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5486725664,0.01,NA,0.5284872299,"SERTRALINE HCL","TRAZODONE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,0.4143646409,NA,NA,NA,0.1348314607,0.4416666667,NA,NA,NA,NA,0.4682814302,NA,NA,NA,"SIMVASTATIN",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1115384615,NA,NA,NA,NA,NA,NA,NA,"TAMSULOSIN HCL",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"TRAMADOL HCL",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,0.3216374269,NA,NA,NA,0.07975460123,NA,0.1198156682,NA,NA,NA,0.2923728814,0.0137342242,NA,0.3845238095,"TRAZODONE HCL",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.624,0.4293478261,"TRAZODONE HCL","VENLAFAXINE HCL",NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,0.06349206349,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED CEREBRAL ARTERY OCCLUSION WITH CEREBRAL INFARCTION (dxi:ICD9:43491)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,0.1638418079,NA,NA,NA,NA,0,NA,NA,"UNSPECIFIED ESSENTIAL HYPERTENSION (dxo:ICD9:4019)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,0.2352941176,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"UNSPECIFIED MYALGIA AND MYOSITIS (dxo:ICD9:7291)",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6362735382,0.4195979899,"VENLAFAXINE HCL",NA,NA,NA,NA,NA,NA
"80-89","Male",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,"ZOLPIDEM TARTRATE",NA,NA,NA,NA,NA,NA
